data_2a7y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2a7y _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.7 t60 . . . . . 0 CA--C 1.522 -0.12 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.0 161.94 13.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.074 0.464 . . . . 0.0 111.672 -173.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -148.41 147.36 29.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.335 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.452 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.7 p -86.47 142.01 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.957 0.408 . . . . 0.0 110.41 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.82 4.74 65.05 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -121.2 171.39 8.74 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.894 ' HB2' HG21 ' A' ' 59' ' ' VAL . 98.9 m-85 -109.81 146.35 35.17 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.398 0.618 . . . . 0.0 111.508 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.4 tt -99.14 140.11 33.78 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.828 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.555 HG22 ' CE1' ' A' ' 22' ' ' HIS . 55.6 t -130.81 151.54 36.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 O-C-N 124.839 1.337 . . . . 0.0 109.441 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.848 ' HB ' ' HB2' ' A' ' 21' ' ' GLN . 74.6 t . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.435 ' HB3' ' H ' ' A' ' 21' ' ' GLN . 16.3 m-20 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.426 0.155 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.848 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 14.0 mt-30 40.33 85.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.641 1.213 . . . . 0.0 112.347 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.712 ' CB ' ' HA ' ' A' ' 68' ' ' GLU . 7.2 m80 -118.49 146.58 44.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.249 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.522 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . . . -176.7 177.98 1.3 Allowed 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.103 0.877 . . . . 0.0 110.857 170.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.619 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 43.4 tt0 -98.58 127.47 44.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.273 0.558 . . . . 0.0 110.742 177.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' ' 9' ' ' LEU . 20.4 mt -88.48 103.04 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.177 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.664 HD13 ' HG3' ' A' ' 40' ' ' ARG . 0.2 OUTLIER -105.76 -19.78 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.249 178.022 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.833 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 68.8 mm-40 -134.08 111.0 10.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.764 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 30' ' ' SER . 38.6 t -98.89 116.16 41.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.922 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.49 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -88.83 32.3 0.81 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.008 0.433 . . . . 0.0 110.861 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.435 ' H ' HG12 ' A' ' 28' ' ' VAL . 34.2 t -148.94 149.21 30.82 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.52 -14.6 45.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.052 0.453 . . . . 0.0 110.219 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -130.53 -70.84 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.472 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.39 75.93 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.611 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 p -146.67 132.87 9.58 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -61.85 160.31 29.77 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.889 2.393 . . . . 0.0 112.098 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.52 179.26 22.23 Favored 'Cis proline' 0 N--CA 1.462 -0.34 0 C-N-CA 123.406 -1.498 . . . . 0.0 113.132 1.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -132.77 153.46 51.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.601 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.833 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 67.3 t -98.56 117.18 43.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 172.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.52 147.63 30.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.001 -164.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.773 ' HG2' ' HG3' ' A' ' 47' ' ' GLU . 98.7 mtt180 -115.4 131.88 56.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.633 176.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 13.8 m95 -85.38 101.3 12.47 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 168.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.703 ' HB2' ' HE1' ' A' ' 64' ' ' HIS . 12.7 mt -82.29 -55.55 4.45 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.432 0.634 . . . . 0.0 110.605 -173.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 65' ' ' ALA . 2.0 m -76.14 -5.7 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.581 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.679 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 45.9 m-80 -100.01 -64.22 1.06 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.756 173.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . 122.02 68.42 0.25 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.532 -0.842 . . . . 0.0 114.181 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.528 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 30.3 t60 -179.18 156.92 0.79 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.217 0.509 . . . . 0.0 110.819 172.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.773 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 25.4 mp0 -110.58 150.38 29.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 t -175.18 -179.95 1.43 Allowed 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.442 0.639 . . . . 0.0 111.806 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.4 m -119.98 124.06 45.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.177 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.6 m -127.32 160.46 36.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.329 0.585 . . . . 0.0 112.545 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -111.6 106.19 56.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.558 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.59 -178.6 3.49 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.7 2.267 . . . . 0.0 111.174 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.37 -155.17 9.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.843 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.3 t -70.95 157.11 38.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.649 0.261 . . . . 0.0 110.963 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 66.33 39.38 4.07 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.007 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -76.88 129.11 35.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.036 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 58' ' ' VAL . 11.2 t -126.38 163.82 27.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.555 -176.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.406 ' N ' HG11 ' A' ' 57' ' ' VAL . 53.9 t -115.27 119.62 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.526 0.203 . . . . 0.0 110.737 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.894 HG21 ' HB2' ' A' ' 8' ' ' TYR . 2.3 m -113.42 178.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.211 0.529 . . . . 0.0 111.94 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.6 p -119.31 -169.78 1.81 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.239 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -47.33 -49.6 23.81 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -171.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.24 -38.97 75.3 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 121.718 -0.614 . . . . 0.0 111.581 -172.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 2.8 mm-40 -67.7 -16.81 64.33 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.093 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.703 ' HE1' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -82.04 -41.96 19.93 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.722 -177.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.594 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -56.86 -73.77 0.06 Allowed 'General case' 0 C--O 1.243 0.74 0 CA-C-N 119.996 1.271 . . . . 0.0 111.639 -166.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 2.9 pt-20 -66.5 -49.67 65.81 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.547 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.545 ' HB1' ' O ' ' A' ' 63' ' ' GLU . . . -67.55 -31.6 71.81 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.955 -173.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.712 ' HA ' ' CB ' ' A' ' 22' ' ' HIS . 32.2 tt0 -76.09 -33.45 59.5 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 118.299 0.499 . . . . 0.0 110.626 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 99.6 mttt -54.1 -62.09 1.88 Allowed 'General case' 0 C--O 1.247 0.958 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.044 172.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -65.8 -45.19 83.34 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.739 0.78 . . . . 0.0 111.387 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.636 ' HB2' ' N ' ' A' ' 21' ' ' GLN . . . -78.75 -16.39 57.25 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.449 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . . . -77.46 -36.38 52.96 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.9 -29.31 66.95 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.022 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -74.66 -58.85 3.03 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.641 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.739 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -59.9 -64.83 0.81 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.838 0.855 . . . . 0.0 112.371 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.847 -171.06 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 . . . . . 0 CA--C 1.521 -0.172 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.29 140.14 39.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.769 0.795 . . . . 0.0 112.012 -165.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -139.06 140.82 38.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.708 -173.273 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.921 HG22 ' HA ' ' A' ' 26' ' ' ILE . 7.6 p -65.54 149.09 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 O-C-N 122.051 -0.406 . . . . 0.0 110.931 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.13 16.76 78.07 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-O 122.57 1.094 . . . . 0.0 110.449 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 1.4 t70 -139.09 144.12 38.6 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 112.572 -1.814 . . . . 0.0 107.678 -166.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 1.08 ' HB3' ' HE2' ' A' ' 22' ' ' HIS . 6.7 m-85 -135.79 142.46 44.9 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 -142.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.732 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 3.2 tt -136.53 139.94 42.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.132 0.968 . . . . 0.0 109.799 -153.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.718 ' N ' HD22 ' A' ' 9' ' ' LEU . 2.3 t -138.84 141.62 36.32 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 112.707 -2.042 . . . . 0.0 109.057 -165.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.485 ' H ' ' HB3' ' A' ' 21' ' ' GLN . 4.0 p . . . . . 0 C--N 1.315 -0.922 0 C-N-CA 117.645 -1.622 . . . . 0.0 109.389 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.912 ' HA ' ' HB3' ' A' ' 71' ' ' ALA . 11.3 m-20 . . . . . 0 C--O 1.223 -0.319 0 CA-C-O 120.981 0.419 . . . . 0.0 111.828 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.75 ' H ' ' HB3' ' A' ' 71' ' ' ALA . 51.3 tt0 149.61 128.16 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.292 1.437 . . . . 0.0 108.667 169.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 1.08 ' HE2' ' HB3' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -138.68 136.69 36.11 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 117.074 -1.85 . . . . 0.0 111.013 153.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HB3' HG12 ' A' ' 39' ' ' VAL . . . -142.08 144.06 33.38 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 111.29 -2.686 . . . . 0.0 109.38 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.854 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -134.99 138.61 44.16 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 124.698 2.19 . . . . 0.0 110.888 -177.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.565 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 19.9 mt -98.81 117.96 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 1 CA-C-N 108.363 -4.017 . . . . 0.0 111.203 -148.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.921 ' HA ' HG22 ' A' ' 5' ' ' VAL . 2.2 pp -114.56 -8.33 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 125.139 1.524 . . . . 0.0 110.166 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -138.8 132.22 30.27 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.433 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.9 t -138.06 101.33 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.535 -167.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -110.36 55.03 0.65 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.317 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -133.41 113.06 12.11 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.466 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.15 -42.4 17.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.343 0.592 . . . . 0.0 110.171 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -89.33 -7.78 54.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.056 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.81 18.15 60.33 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.355 -174.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 p -90.29 151.84 45.05 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 120.597 0.237 . . . . 0.0 111.173 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -63.48 164.8 19.51 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.851 2.367 . . . . 0.0 111.701 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.679 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.7 Cg_endo -79.5 -173.27 12.47 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.585 -1.423 . . . . 0.0 113.685 1.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -138.75 171.86 13.72 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.447 HG21 HG22 ' A' ' 49' ' ' THR . 83.9 t -137.7 116.21 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 CA-C-O 123.495 1.617 . . . . 0.0 107.257 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.635 HG12 ' HB3' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -139.25 177.78 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 CA-C-N 111.845 -2.434 . . . . 0.0 109.106 -151.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.856 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 15.6 mtm180 -138.32 145.61 41.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.602 ' CE3' ' HB3' ' A' ' 72' ' ' ALA . 11.4 m0 -101.37 84.78 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.717 HD12 ' HH ' ' A' ' 8' ' ' TYR . 3.4 mt -59.95 -68.04 0.33 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 112.483 -2.144 . . . . 0.0 112.772 -154.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.441 HG13 ' CE1' ' A' ' 64' ' ' HIS . 0.5 OUTLIER -60.14 -32.5 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.163 -176.268 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.408 ' ND2' ' HG2' ' A' ' 68' ' ' GLU . 39.9 m-80 -60.39 -64.08 1.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.113 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.13 51.19 0.27 Allowed Glycine 0 CA--C 1.523 0.546 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.512 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -139.18 170.95 15.02 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 117.53 0.665 . . . . 0.0 111.379 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.856 ' HG3' ' HD2' ' A' ' 40' ' ' ARG . 23.7 mp0 -138.26 106.98 5.9 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.9 t -139.74 -178.98 5.66 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -165.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.447 HG22 HG21 ' A' ' 38' ' ' VAL . 92.6 m -137.95 117.35 12.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.541 HG12 ' HZ2' ' A' ' 41' ' ' TRP . 15.3 m -138.84 177.87 4.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -161.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.679 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 5.2 m-85 -138.88 141.32 29.97 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.121 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.71 -48.42 0.11 Allowed 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.21 -63.77 0.27 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.846 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.485 ' HB2' HG23 ' A' ' 11' ' ' VAL . 27.4 m -79.3 -167.94 1.35 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.707 0.289 . . . . 0.0 111.417 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.87 -1.86 3.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.799 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 73.41 158.62 0.21 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.057 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 58' ' ' VAL . 17.2 t -138.9 163.39 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 175.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.443 ' H ' HG11 ' A' ' 57' ' ' VAL . 45.4 t -138.1 120.53 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.689 0.757 . . . . 0.0 109.294 -169.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.581 HG13 ' HG3' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -139.2 -179.91 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.311 -165.611 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 p -124.46 -163.43 1.16 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.145 -175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.11 -47.7 80.44 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -58.82 6.62 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.295 -0.878 . . . . 0.0 112.012 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.581 ' HG3' HG13 ' A' ' 59' ' ' VAL . 6.8 mm-40 -57.21 -25.27 58.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.962 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.771 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.26 -46.93 82.58 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.22 -178.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.93 -73.3 0.07 Allowed 'General case' 0 C--O 1.245 0.838 0 CA-C-O 121.97 0.89 . . . . 0.0 112.251 -165.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -55.86 29.22 Favored 'General case' 0 C--O 1.255 1.392 0 CA-C-N 114.076 -1.42 . . . . 0.0 112.141 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.632 ' O ' ' HB1' ' A' ' 71' ' ' ALA . . . -57.17 -41.98 80.26 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.464 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.771 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 4.1 tt0 -57.06 -52.18 66.3 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -56.95 -77.48 0.03 OUTLIER 'General case' 0 C--O 1.248 1.011 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.382 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -58.08 -68.32 0.26 Allowed 'General case' 0 C--O 1.255 1.394 0 CA-C-O 123.272 1.51 . . . . 0.0 112.377 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.912 ' HB3' ' HA ' ' A' ' 20' ' ' ASP . . . -57.46 -47.4 81.95 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.199 -1.818 . . . . 0.0 113.313 -173.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 68' ' ' GLU . . . -57.65 -36.89 72.46 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 119.483 1.038 . . . . 0.0 111.123 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.42 -39.31 72.85 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 119.471 -0.891 . . . . 0.0 109.113 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 71' ' ' ALA . 19.1 mtp180 -57.76 -56.91 15.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.408 167.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.487 ' HB1' ' CB ' ' A' ' 21' ' ' GLN . . . -41.98 -48.76 4.61 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.827 0.851 . . . . 0.0 112.603 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.543 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.982 -173.183 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.5 p80 . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.945 0.403 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.95 142.53 38.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.569 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 26.3 pttm -139.07 161.32 37.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.157 0.503 . . . . 0.0 111.054 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' A' ' 26' ' ' ILE . 2.9 p -73.03 151.7 7.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.718 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.45 17.4 62.34 Favored Glycine 0 CA--C 1.511 -0.193 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 1.2 m-20 -138.62 -179.09 5.61 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 113.627 -1.286 . . . . 0.0 107.658 -174.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.781 ' HB2' HG23 ' A' ' 59' ' ' VAL . 83.2 m-85 -137.28 168.6 19.3 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -170.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.9 tt -138.5 138.8 38.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.454 -168.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.846 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 12.4 t -138.81 169.09 18.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.485 ' N ' HG12 ' A' ' 10' ' ' VAL . 89.7 t . . . . . 0 C--N 1.316 -0.888 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 C--O 1.223 -0.294 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.949 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 56.2 mt-30 64.61 96.87 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.394 0 O-C-N 123.518 0.511 . . . . 0.0 110.395 -171.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.912 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.5 t-160 -138.99 121.71 16.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.53 0.681 . . . . 0.0 111.854 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -139.77 -178.33 5.37 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.749 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.733 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 15.0 tt0 -136.67 132.29 34.75 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.705 1.24 . . . . 0.0 109.679 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.571 HG22 HG22 ' A' ' 28' ' ' VAL . 59.8 mt -90.22 114.77 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 112.39 -2.186 . . . . 0.0 111.267 -167.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.706 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -106.79 -16.23 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.571 170.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.67 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 32.2 mt-10 -139.11 153.08 47.96 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.03 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.571 HG22 HG22 ' A' ' 25' ' ' ILE . 18.5 t -137.76 99.93 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -170.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -98.46 33.1 2.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -164.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 p -122.79 -90.86 0.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.702 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 176.0 -66.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.491 0.495 . . . . 0.0 109.919 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -92.75 -58.81 2.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.925 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.88 80.58 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.769 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.489 ' HB3' ' HD2' ' A' ' 35' ' ' PRO . 59.2 m -155.28 165.38 18.43 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 34' ' ' SER . 36.2 Cg_endo -66.85 155.7 69.46 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 121.937 1.758 . . . . 0.0 111.678 173.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.654 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 95.6 Cg_endo -87.91 -177.24 12.65 Favored 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.244 -1.565 . . . . 0.0 113.008 0.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -138.74 174.6 10.36 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.396 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 81.5 t -137.86 115.12 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.91 170.38 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.087 0 CA-C-N 112.556 -2.111 . . . . 0.0 109.091 -152.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 46' ' ' HIS . 25.9 ttm180 -138.73 132.03 30.12 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.669 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 9.8 m95 -78.47 83.76 4.66 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 169.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.641 HD23 ' HB3' ' A' ' 24' ' ' GLU . 5.7 mt -60.37 -66.2 0.56 Allowed 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 123.584 0.553 . . . . 0.0 111.261 -167.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.61 HG11 ' NE2' ' A' ' 64' ' ' HIS . 0.5 OUTLIER -60.19 -35.68 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.821 -176.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -60.4 -66.37 0.54 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.929 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 130.6 29.76 0.62 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.687 -0.768 . . . . 0.0 114.613 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.669 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 4.9 t-80 -139.29 168.85 18.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.386 1.093 . . . . 0.0 110.787 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.51 126.16 22.12 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.142 0.496 . . . . 0.0 110.05 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.506 HG23 ' CZ2' ' A' ' 41' ' ' TRP . 13.2 t -139.46 -178.97 5.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.107 0.956 . . . . 0.0 113.285 -162.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.508 ' HG1' HG23 ' A' ' 38' ' ' VAL . 87.3 m -137.93 115.52 11.29 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 m -138.77 175.77 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -161.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.654 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 26.6 m-85 -132.58 108.46 13.23 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.336 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.63 5.56 5.49 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.863 2.375 . . . . 0.0 112.564 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.62 -92.45 1.32 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.869 -177.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.2 t -170.19 178.26 3.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.7 t70 59.57 44.22 14.91 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.091 0.948 . . . . 0.0 109.716 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.9 128.19 35.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.964 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.2 m -105.11 143.3 16.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.647 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.74 118.2 46.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.052 0.453 . . . . 0.0 110.998 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.781 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -105.22 -179.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.735 -178.104 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.4 p -122.72 -164.52 1.2 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.87 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.58 -43.3 99.17 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -172.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -51.64 64.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.728 -0.607 . . . . 0.0 111.884 -174.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 32.0 mm-40 -62.91 -17.17 61.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.114 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.634 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -69.81 -34.22 73.41 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.454 -176.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.46 -76.43 0.06 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 122.109 0.956 . . . . 0.0 110.858 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.18 -55.8 22.08 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.214 -176.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 63' ' ' GLU . . . -64.91 -34.5 78.55 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.909 -173.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.912 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 32.9 tt0 -72.72 -34.56 67.18 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 119.554 -0.859 . . . . 0.0 110.717 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -52.93 -65.58 0.53 Allowed 'General case' 0 C--O 1.25 1.087 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.606 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.46 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 14.8 ptm180 -61.69 -47.77 83.82 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.943 0.878 . . . . 0.0 111.506 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.686 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -77.02 -17.14 59.02 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.2 -170.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.67 -41.02 55.07 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.317 172.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.59 -31.45 64.27 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.334 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 74' ' ' ARG . 2.4 mmt85 -80.33 -51.81 8.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.264 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.949 ' HB3' ' HA ' ' A' ' 21' ' ' GLN . . . -57.98 -65.97 0.55 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.161 0.505 . . . . 0.0 112.058 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.741 0 C-N-CA 119.872 -1.156 . . . . 0.0 111.94 -169.649 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 . . . . . 0 CA--C 1.518 -0.275 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.495 ' HA ' HG21 ' A' ' 58' ' ' VAL . . . -138.94 152.17 47.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.733 0.302 . . . . 0.0 111.478 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -139.1 172.78 12.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.221 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' A' ' 26' ' ' ILE . 4.1 p -93.08 144.89 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.401 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.27 17.38 59.09 Favored Glycine 0 CA--C 1.51 -0.257 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -138.74 -179.1 5.62 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.746 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 91.7 m-85 -137.11 172.75 12.53 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.093 -168.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.777 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 8.0 tt -138.56 142.78 39.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.844 -169.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.675 HG22 HG21 ' A' ' 59' ' ' VAL . 4.9 t -138.85 155.19 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 124.878 1.361 . . . . 0.0 109.356 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.668 HG21 ' H ' ' A' ' 53' ' ' GLY . 92.9 t . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.78 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 51.8 mt-30 53.48 90.6 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.165 0 O-C-N 124.159 0.912 . . . . 0.0 111.466 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.881 ' NE2' ' HA ' ' A' ' 64' ' ' HIS . 10.9 t60 -138.85 125.78 21.1 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 122.461 1.124 . . . . 0.0 113.227 -171.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.616 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.34 -178.56 5.43 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.701 -1.591 . . . . 0.0 109.017 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.746 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 14.4 tt0 -137.26 123.6 20.66 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.459 ' CG2' HG22 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -88.16 113.9 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.935 -168.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.747 ' HA ' HG21 ' A' ' 5' ' ' VAL . 1.3 pp -110.18 -7.75 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.951 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 1.117 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -138.91 127.74 23.54 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.459 HG22 ' CG2' ' A' ' 25' ' ' ILE . 32.3 t -138.28 110.98 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.6 -167.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.414 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 21.6 mmt85 -66.58 -46.0 77.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.072 0.463 . . . . 0.0 111.875 -173.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.0 m -154.34 144.41 21.92 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.494 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.49 0.37 29.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.555 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -71.29 -26.17 62.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.91 -10.75 29.64 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.399 173.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.4 m -69.11 130.54 91.22 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 117.542 0.671 . . . . 0.0 111.139 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -62.94 173.14 4.08 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.005 2.47 . . . . 0.0 111.451 174.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.596 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 95.0 Cg_endo -76.98 -170.75 9.01 Favored 'Cis proline' 0 CA--C 1.52 -0.218 0 C-N-CA 123.877 -1.301 . . . . 0.0 113.371 2.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -138.38 168.92 18.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.466 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 1.117 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 68.0 t -137.78 107.2 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.92 177.53 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 112.833 -1.985 . . . . 0.0 109.972 -151.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.705 ' HB2' HD21 ' A' ' 42' ' ' LEU . 86.1 mtm180 -138.74 133.8 32.68 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.498 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.616 ' CZ3' ' HB3' ' A' ' 23' ' ' ALA . 16.1 m95 -87.01 60.13 6.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 163.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.737 HD23 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -60.3 -52.66 64.32 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -158.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.524 HG21 ' OE2' ' A' ' 68' ' ' GLU . 0.5 OUTLIER -60.39 -33.76 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 118.555 0.616 . . . . 0.0 111.639 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -60.44 -42.94 97.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.384 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 130.68 6.6 3.66 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.549 -0.834 . . . . 0.0 114.58 172.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.474 ' ND1' ' H ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -138.92 176.55 8.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.798 1.299 . . . . 0.0 112.592 -176.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 1.9 mp0 -138.53 139.45 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.537 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.602 HG21 ' HE1' ' A' ' 41' ' ' TRP . 16.5 p -139.25 -179.37 5.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.691 0.758 . . . . 0.0 112.422 -169.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.442 HG23 HG23 ' A' ' 38' ' ' VAL . 31.6 m -138.33 107.96 6.23 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.1 m -138.9 179.94 2.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -157.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 14.1 m-85 -138.84 130.92 15.58 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 113.455 -1.702 . . . . 0.0 107.908 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.35 -170.77 0.8 Allowed 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.61 2.207 . . . . 0.0 112.882 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.668 ' H ' HG21 ' A' ' 11' ' ' VAL . . . -98.56 -132.48 7.64 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.855 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 11' ' ' VAL . 23.5 m -96.1 156.97 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 t70 70.88 -60.56 0.5 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.349 1.031 . . . . 0.0 110.122 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 51.95 132.14 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.937 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.88 HG21 ' H ' ' A' ' 58' ' ' VAL . 7.5 p -138.97 -179.79 2.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.017 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.88 ' H ' HG21 ' A' ' 57' ' ' VAL . 53.3 t -138.19 134.82 44.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.951 -172.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.675 HG21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.71 -179.84 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.968 -166.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.7 p -118.86 -164.33 1.03 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.135 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.04 -46.61 82.28 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -175.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -61.08 2.73 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 121.597 -0.689 . . . . 0.0 111.774 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.42 ' HG3' HG13 ' A' ' 59' ' ' VAL . 8.3 mm-40 -57.41 -24.87 58.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.937 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.881 ' HA ' ' NE2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.33 -45.17 84.56 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.126 -178.226 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.35 -73.21 0.09 Allowed 'General case' 0 C--O 1.254 1.326 0 CA-C-O 122.136 0.97 . . . . 0.0 112.587 -170.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.584 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -63.87 -42.9 97.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.76 -172.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.36 -27.81 67.43 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.778 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 3.2 tt0 -70.57 -31.03 67.9 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.677 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 50.4 mttp -56.03 -51.96 65.96 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.94 165.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 66' ' ' GLU . 2.3 mpt_? -56.93 -20.52 23.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.277 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.769 ' HB3' ' H ' ' A' ' 22' ' ' HIS . . . -75.99 -60.26 2.4 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.44 -22.03 64.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.046 0.451 . . . . 0.0 109.935 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.71 -73.43 0.26 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.281 169.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -82.56 -54.91 4.8 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -170.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.78 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -58.17 -60.49 3.67 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -172.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.712 0 C-N-CA 119.977 -1.106 . . . . 0.0 113.084 -171.82 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 24.0 t60 . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.807 0.337 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.29 119.41 38.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.837 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.609 ' HA ' HG21 ' A' ' 28' ' ' VAL . 14.5 tptm -126.35 164.62 20.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.863 0.363 . . . . 0.0 110.966 -175.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.897 HG21 ' HA ' ' A' ' 26' ' ' ILE . 3.0 p -66.27 150.03 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.319 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.11 1.71 48.32 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -143.06 175.92 9.49 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.881 ' HB2' HG21 ' A' ' 59' ' ' VAL . 93.5 m-85 -104.51 154.35 20.01 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.284 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.8 tt -98.96 132.2 44.46 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.395 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.59 HG23 ' HD1' ' A' ' 22' ' ' HIS . 10.5 t -137.79 143.65 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 124.951 1.407 . . . . 0.0 109.485 174.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 54' ' ' SER . 54.7 t . . . . . 0 C--O 1.245 0.844 0 CA-C-O 120.731 0.3 . . . . 0.0 111.561 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.457 ' OD2' ' HD3' ' A' ' 74' ' ' ARG . 18.7 t70 . . . . . 0 C--O 1.218 -0.6 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.711 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 7.0 mt-30 63.07 101.29 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.794 0.437 . . . . 0.0 110.352 -174.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.709 ' CE1' ' HA ' ' A' ' 64' ' ' HIS . 58.6 t60 -148.26 151.22 35.07 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -167.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -179.01 -179.82 0.61 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.944 1.298 . . . . 0.0 107.51 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.591 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 41.1 tt0 -98.34 129.91 45.01 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.064 -0.655 . . . . 0.0 112.106 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.475 ' CG1' ' HB2' ' A' ' 9' ' ' LEU . 53.0 mt -85.8 111.21 20.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.383 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.897 ' HA ' HG21 ' A' ' 5' ' ' VAL . 1.5 pp -120.44 -16.63 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.642 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.737 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 48.2 mt-10 -130.26 107.96 9.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.136 0.493 . . . . 0.0 110.718 175.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' A' ' 4' ' ' LYS . 58.6 t -98.74 114.25 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.477 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 29.0 mmt180 -95.5 38.78 1.14 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.244 0.545 . . . . 0.0 111.251 -176.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.8 m -151.37 150.3 30.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.761 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.77 69.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.438 . . . . 0.0 110.8 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -115.1 -65.5 1.18 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.752 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.46 104.12 0.17 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.592 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.8 t -154.28 145.68 16.62 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -67.26 155.07 72.13 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.44 2.094 . . . . 0.0 111.468 173.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.454 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 95.4 Cg_endo -87.89 178.87 19.07 Favored 'Cis proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.498 -1.459 . . . . 0.0 113.037 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -126.67 146.91 50.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.004 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.737 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 59.4 t -98.74 110.4 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.41 145.39 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.668 -159.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.704 ' HG2' ' HG3' ' A' ' 47' ' ' GLU . 73.4 mtp180 -106.36 129.42 54.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.493 0.664 . . . . 0.0 110.855 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.618 ' CE3' ' HB2' ' A' ' 72' ' ' ALA . 4.5 m0 -93.68 87.76 5.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.486 HD12 ' CD ' ' A' ' 24' ' ' GLU . 18.6 mt -70.05 -68.89 0.39 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.464 -162.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.526 HG22 ' OE2' ' A' ' 68' ' ' GLU . 4.2 m -74.96 -6.86 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.712 -173.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.06 -54.38 4.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.278 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.5 54.07 0.31 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.047 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -153.7 168.22 26.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.736 0.303 . . . . 0.0 111.131 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.704 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 32.7 tt0 -149.54 124.0 9.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 t -167.1 175.9 7.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.452 0.644 . . . . 0.0 112.029 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 m -101.5 110.25 22.21 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.292 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -106.88 149.77 10.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.39 0.614 . . . . 0.0 111.815 -171.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.454 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 81.9 m-85 -106.28 103.01 43.52 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.784 172.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.56 154.32 55.02 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.245 1.963 . . . . 0.0 110.861 175.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.84 -76.05 0.24 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.173 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.57 ' O ' HG12 ' A' ' 11' ' ' VAL . 28.4 t -169.68 162.63 9.83 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 55.51 60.28 3.43 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.285 0.564 . . . . 0.0 110.686 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.34 127.21 33.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.06 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.6 t -120.43 157.56 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.423 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -100.42 115.76 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.341 0.591 . . . . 0.0 111.94 -178.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.881 HG21 ' HB2' ' A' ' 8' ' ' TYR . 6.6 m -102.0 178.29 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.987 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 p -119.41 -165.1 1.11 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.807 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -50.1 -47.14 53.98 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.19 -38.1 78.46 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.49 -0.756 . . . . 0.0 112.248 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.668 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 30.5 mm-40 -74.97 -16.78 60.62 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.528 0.68 . . . . 0.0 109.352 176.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.709 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -71.84 -43.4 65.6 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.401 -177.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.04 -70.23 0.18 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-O 121.258 0.551 . . . . 0.0 112.362 -171.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -31.51 72.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.381 -173.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -80.97 -22.18 39.75 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.524 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.689 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 2.0 tt0 -73.81 -46.68 43.75 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.416 -0.913 . . . . 0.0 108.993 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -56.67 -71.46 0.09 Allowed 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.563 0.697 . . . . 0.0 110.285 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -66.35 -52.6 45.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.452 -171.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.676 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -82.07 -23.11 35.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.971 -167.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.618 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -76.41 -39.93 52.22 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.361 173.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.27 -29.32 67.49 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.518 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HD3' ' OD2' ' A' ' 20' ' ' ASP . 14.7 ttt180 -82.19 -40.66 21.41 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.726 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.711 ' HB3' ' HA ' ' A' ' 21' ' ' GLN . . . -54.07 -62.07 1.9 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.149 0.5 . . . . 0.0 110.774 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.643 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.368 -177.91 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 35.3 t-80 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.77 171.74 13.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.787 0.327 . . . . 0.0 111.373 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 8.3 ttpm? -139.03 151.97 47.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.803 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -82.96 139.33 17.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.17 26.71 27.73 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -168.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 14.5 m-20 -138.35 -178.92 5.5 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.665 ' CE2' ' HB2' ' A' ' 64' ' ' HIS . 88.9 m-85 -137.22 169.67 17.38 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -169.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' A' ' 52' ' ' PRO . 5.7 tt -138.66 145.36 40.34 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.205 -167.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 40.1 t -139.11 164.53 25.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.788 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.9 p . . . . . 0 C--N 1.318 -0.776 0 CA-C-O 120.877 0.37 . . . . 0.0 110.125 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 t70 . . . . . 0 C--O 1.226 -0.17 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.788 ' HB2' HG12 ' A' ' 11' ' ' VAL . 17.2 mt-30 53.73 104.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.466 0.706 . . . . 0.0 111.326 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.888 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 36.0 t-80 -138.7 123.78 19.04 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.199 0.523 . . . . 0.0 111.947 -171.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.725 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.45 -178.5 5.41 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.02 -176.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.652 ' HB3' HD21 ' A' ' 42' ' ' LEU . 3.3 tm-20 -137.4 122.78 19.48 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.274 1.035 . . . . 0.0 108.244 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.414 ' HA ' HG23 ' A' ' 39' ' ' VAL . 1.2 mt -87.05 105.03 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.158 -167.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.701 HD11 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -98.61 -13.37 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 124.091 0.869 . . . . 0.0 109.386 174.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.693 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.04 140.92 38.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.498 -0.774 . . . . 0.0 108.988 174.115 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.08 99.86 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -167.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -94.41 78.97 3.88 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.617 0.246 . . . . 0.0 110.787 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.511 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 23.4 p 172.23 -35.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.151 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 74.63 -16.44 0.55 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.761 0.824 . . . . 0.0 111.761 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.511 ' OD1' ' HB2' ' A' ' 30' ' ' SER . 4.2 p-10 -103.3 -37.91 7.46 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.71 8.31 3.52 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.441 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 48.9 m -76.19 143.99 74.34 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 122.633 -0.333 . . . . 0.0 110.369 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 17.9 Cg_exo -67.26 160.69 46.4 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.818 2.345 . . . . 0.0 111.938 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.58 ' HB3' ' HD1' ' A' ' 51' ' ' TYR . 90.0 Cg_endo -81.08 -171.28 9.43 Favored 'Cis proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.838 -1.317 . . . . 0.0 112.816 -1.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.52 175.91 9.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.532 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 98.1 t -137.89 112.75 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 25' ' ' ILE . 0.4 OUTLIER -138.95 169.44 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.761 -2.018 . . . . 0.0 109.339 -151.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 33.2 ttm180 -138.77 128.05 24.26 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.725 ' CZ3' ' HB1' ' A' ' 23' ' ' ALA . 5.7 m95 -80.07 86.03 5.58 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 170.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.652 HD21 ' HB3' ' A' ' 24' ' ' GLU . 7.1 mt -59.93 -67.17 0.41 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.606 -166.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.51 HG11 ' NE2' ' A' ' 64' ' ' HIS . 1.2 m -60.05 -34.24 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.496 -176.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.5 ' ND2' ' HB2' ' A' ' 72' ' ' ALA . 37.1 m-80 -60.45 -60.18 4.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.407 171.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.37 40.22 0.69 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.956 -0.565 . . . . 0.0 113.36 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.605 ' CB ' ' HD1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -139.11 160.89 38.72 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 117.25 0.525 . . . . 0.0 110.851 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -139.0 120.54 15.08 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.879 0.371 . . . . 0.0 110.446 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.578 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 8.8 t -139.29 -178.86 5.55 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.384 1.088 . . . . 0.0 113.807 -163.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.56 HG23 HG22 ' A' ' 38' ' ' VAL . 85.4 m -138.14 108.1 6.35 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.651 HG22 ' H ' ' A' ' 51' ' ' TYR . 4.6 p -138.9 176.31 6.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.046 -158.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.651 ' H ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -138.81 114.08 8.54 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.741 ' HB3' HD23 ' A' ' 9' ' ' LEU . 31.3 Cg_endo -64.01 -69.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.475 0.425 0 C-N-CA 123.13 2.553 . . . . 0.0 112.978 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.37 -164.67 37.38 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -91.2 20.78 4.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.125 0.488 . . . . 0.0 111.842 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -143.86 50.95 1.33 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.73 133.25 42.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.714 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.824 HG22 ' H ' ' A' ' 58' ' ' VAL . 5.3 p -138.96 -179.76 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.408 0.623 . . . . 0.0 109.882 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.824 ' H ' HG22 ' A' ' 57' ' ' VAL . 87.5 t -138.23 139.77 41.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.351 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.642 HG22 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.71 176.73 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 123.97 0.908 . . . . 0.0 110.82 -174.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 t -116.39 -169.18 1.57 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.23 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.03 -49.69 75.04 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.322 -175.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.51 -56.69 18.58 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.69 -0.631 . . . . 0.0 111.022 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -57.44 -26.26 60.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.47 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.759 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.3 -49.37 76.32 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 177.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . -56.98 -76.02 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.729 0.776 . . . . 0.0 111.883 -163.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -57.39 -59.13 5.61 Favored 'General case' 0 C--O 1.26 1.637 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.306 -178.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.599 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . . . -57.11 -37.18 71.58 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.944 -174.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.888 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 21.7 tt0 -71.68 -40.02 69.87 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.091 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 28.9 mtpp -52.61 -58.87 5.4 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.942 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.599 ' HE ' ' HA ' ' A' ' 67' ' ' ALA . 27.6 ptt180 -69.61 -53.16 20.12 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 122.137 0.97 . . . . 0.0 112.071 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.767 ' HB3' ' N ' ' A' ' 21' ' ' GLN . . . -70.43 -31.14 68.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.334 -170.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 22' ' ' HIS . . . -76.39 -34.56 58.86 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.187 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.15 54.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.576 0.548 . . . . 0.0 110.273 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -82.09 -47.82 12.12 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -46.36 -51.1 15.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.396 0.678 . . . . 0.0 112.714 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.424 ' HA3' ' CZ2' ' A' ' 41' ' ' TRP . . . . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.968 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 . . . . . 0 CA--C 1.522 -0.128 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.85 140.33 40.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.935 0.874 . . . . 0.0 111.057 -167.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 6.8 mmmm -138.96 141.08 38.43 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.44 -158.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.88 HG21 ' HA ' ' A' ' 26' ' ' ILE . 3.0 p -61.41 138.6 21.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 121.655 -0.653 . . . . 0.0 110.777 171.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.69 14.99 71.8 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 1.4 t70 -139.04 143.52 38.43 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.942 -1.629 . . . . 0.0 107.324 -167.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.768 ' HB2' HG22 ' A' ' 59' ' ' VAL 0.266 65.4 m-85 -134.37 141.9 47.02 Favored 'General case' 0 C--O 1.206 -1.227 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -142.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.809 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 4.6 tt -136.52 140.27 42.87 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.539 1.161 . . . . 0.0 110.401 -149.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.998 ' HB ' HG22 ' A' ' 57' ' ' VAL . 14.3 t -138.72 141.55 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 111.397 -2.638 . . . . 0.0 109.038 -153.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.32 -0.682 0 CA-C-O 122.257 1.027 . . . . 0.0 109.869 -173.201 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 21' ' ' GLN . 23.4 t70 . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 1.034 ' HG2' ' HB3' ' A' ' 74' ' ' ARG . 38.7 mt-30 64.87 105.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.353 0.408 . . . . 0.0 111.012 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.809 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 1.6 m170 -138.21 136.61 36.76 Favored 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 117.219 -1.792 . . . . 0.0 110.319 167.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.481 ' HB2' ' CG1' ' A' ' 39' ' ' VAL . . . -142.41 144.37 33.08 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 129.068 2.947 . . . . 0.0 107.055 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.739 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -134.56 139.85 45.69 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 122.269 2.304 . . . . 0.0 110.66 -166.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.729 HD12 HG23 ' A' ' 28' ' ' VAL . 5.4 pt -92.08 128.53 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 109.86 -3.336 . . . . 0.0 111.457 -159.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.88 ' HA ' HG21 ' A' ' 5' ' ' VAL . 1.8 pp -102.62 -6.29 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 112.022 -2.354 . . . . 0.0 108.981 169.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.631 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 33.3 mt-10 -139.02 139.69 37.9 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.901 172.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.729 HG23 HD12 ' A' ' 25' ' ' ILE . 8.5 t -138.28 139.81 41.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -175.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -125.8 25.31 6.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.388 0.613 . . . . 0.0 110.256 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 t -173.44 124.4 0.39 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.923 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.85 -16.45 41.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.323 0.582 . . . . 0.0 109.445 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.82 -46.0 55.41 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.291 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.29 40.12 0.49 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.651 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.4 m -117.58 151.53 48.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 122.197 0.199 . . . . 0.0 110.586 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.8 169.13 22.79 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.826 2.351 . . . . 0.0 112.334 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.58 179.9 29.5 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.603 -1.415 . . . . 0.0 112.63 0.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -138.71 142.07 38.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.723 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.849 HG21 HG22 ' A' ' 49' ' ' THR . 99.8 t -135.88 138.91 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 CA-C-O 125.147 2.403 . . . . 0.0 108.955 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 23' ' ' ALA . 47.2 t -139.7 142.17 33.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 108.558 -3.928 . . . . 0.0 112.533 -129.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.639 ' HG3' ' O ' ' A' ' 46' ' ' HIS . 51.7 ttp180 -137.19 139.5 41.13 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 166.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.516 ' HH2' ' HA3' ' A' ' 76' ' ' GLY . 10.1 m0 -99.38 70.2 1.71 Allowed 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.517 HD21 ' HE ' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -60.56 -41.34 94.39 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 113.357 -1.747 . . . . 0.0 113.15 -150.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.755 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -61.56 -41.48 90.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.075 174.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -61.48 -40.49 94.74 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.57 50.27 2.98 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.295 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.639 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 8.1 t-160 -139.3 159.32 42.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.593 0.696 . . . . 0.0 110.554 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.45 ' HG2' ' HD3' ' A' ' 40' ' ' ARG . 48.8 mt-10 -138.3 112.24 8.44 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.159 0.98 . . . . 0.0 110.46 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 t -139.68 -178.21 5.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.752 -1.567 . . . . 0.0 112.164 -165.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.849 HG22 HG21 ' A' ' 38' ' ' VAL . 94.6 m -137.65 122.19 18.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.454 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.752 HG12 ' H ' ' A' ' 51' ' ' TYR . 2.3 t -138.52 179.32 3.33 Favored 'Isoleucine or valine' 0 C--O 1.255 1.351 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.761 -164.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.752 ' H ' HG12 ' A' ' 50' ' ' VAL . 8.0 m-85 -138.78 114.69 8.67 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.203 176.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.634 ' HB3' HD21 ' A' ' 9' ' ' LEU . 27.6 Cg_exo -63.32 -66.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.312 2.674 . . . . 0.0 112.522 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.63 -136.18 8.71 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.734 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.7 p -101.27 162.19 13.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 58.9 45.76 14.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.913 0.863 . . . . 0.0 110.466 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.5 130.04 36.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.627 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.998 HG22 ' HB ' ' A' ' 10' ' ' VAL . 6.2 m -138.89 175.18 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.4 151.86 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -170.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 8' ' ' TYR . 3.0 m -138.87 178.78 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 C-N-CA 126.246 1.818 . . . . 0.0 109.69 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.1 p -117.69 -171.16 2.0 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.006 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.11 -47.77 80.28 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -174.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -54.26 48.87 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 121.67 -0.644 . . . . 0.0 111.166 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.442 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 21.1 mt-10 -57.12 -33.43 67.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.518 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.755 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.15 -37.97 72.83 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 114.563 -1.199 . . . . 0.0 114.107 -177.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.736 ' HA ' HG12 ' A' ' 43' ' ' VAL . . . -57.05 -76.29 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.053 0.93 . . . . 0.0 110.288 -171.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.44 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -57.37 -64.4 0.9 Allowed 'General case' 0 C--O 1.268 2.062 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.065 178.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 63' ' ' GLU . . . -56.88 -58.93 6.01 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.035 -175.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.696 ' HB3' ' O ' ' A' ' 64' ' ' HIS . 39.4 tt0 -57.41 -32.84 67.26 Favored 'General case' 0 C--O 1.204 -1.297 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.44 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -57.12 -71.33 0.1 Allowed 'General case' 0 C--O 1.261 1.676 0 CA-C-N 119.627 1.103 . . . . 0.0 110.808 174.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -53.82 53.83 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-O 123.262 1.506 . . . . 0.0 110.651 -175.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.778 ' O ' ' HA ' ' A' ' 21' ' ' GLN . . . -57.37 -39.39 75.93 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 112.999 -1.909 . . . . 0.0 112.923 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.464 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -57.1 -43.78 82.58 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 118.584 0.629 . . . . 0.0 109.891 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.49 -40.82 75.61 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 119.604 -0.839 . . . . 0.0 109.334 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 1.034 ' HB3' ' HG2' ' A' ' 21' ' ' GLN . 1.8 mpt_? -57.53 -57.93 10.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 172.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.593 ' HA ' HE21 ' A' ' 21' ' ' GLN . . . -47.09 -42.2 18.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.016 0.927 . . . . 0.0 113.065 -173.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.516 ' HA3' ' HH2' ' A' ' 41' ' ' TRP . . . . . . . . 0 C--N 1.323 -0.179 0 C-N-CA 118.661 -1.733 . . . . 0.0 113.35 -173.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.34 148.05 48.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.147 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.652 ' HA ' ' HE3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -130.92 169.58 15.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.843 0.354 . . . . 0.0 110.307 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.828 HG22 ' HA ' ' A' ' 26' ' ' ILE . 3.7 p -85.88 146.02 7.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.795 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.17 9.2 60.84 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -129.24 169.46 14.8 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.835 ' HB2' HG22 ' A' ' 59' ' ' VAL . 97.7 m-85 -105.95 150.77 25.37 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.317 0.579 . . . . 0.0 111.113 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.761 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 6.5 tt -98.75 146.22 26.13 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.468 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.763 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 47.8 t -127.65 144.74 36.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 O-C-N 125.295 1.622 . . . . 0.0 110.291 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.624 HG23 ' HB3' ' A' ' 52' ' ' PRO . 3.2 t . . . . . 0 C--O 1.236 0.368 0 O-C-N 123.588 0.555 . . . . 0.0 110.367 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 . . . . . 0 CA--C 1.519 -0.247 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.576 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 39.1 mt-30 52.61 87.86 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.622 0.576 . . . . 0.0 111.959 173.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.761 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 55.0 m170 -117.95 158.31 25.13 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -175.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.673 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . . . -169.92 179.17 3.71 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.41 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 34.4 tt0 -98.32 126.1 43.7 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.086 -175.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.453 ' CG2' HG23 ' A' ' 28' ' ' VAL . 7.7 mt -88.15 105.82 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.016 174.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.828 ' HA ' HG22 ' A' ' 5' ' ' VAL . 1.2 pp -109.39 -27.02 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.228 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 1.047 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 47.3 mt-10 -118.81 101.81 8.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.086 0.469 . . . . 0.0 110.034 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.453 HG23 ' CG2' ' A' ' 25' ' ' ILE . 28.5 t -98.97 104.07 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.1 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -90.02 35.48 0.85 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.374 0.607 . . . . 0.0 110.725 -174.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -156.54 141.52 17.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.589 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.18 92.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.008 0.432 . . . . 0.0 110.644 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.4 -78.25 0.43 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.948 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.44 108.5 0.21 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.191 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.8 p -156.12 137.52 9.55 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.41 153.5 53.64 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.76 2.307 . . . . 0.0 112.092 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 83.2 Cg_endo -83.36 167.64 62.76 Favored 'Cis proline' 0 N--CA 1.463 -0.293 0 C-N-CA 123.276 -1.552 . . . . 0.0 113.317 2.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -120.14 144.24 47.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.186 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 1.047 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 58.5 t -98.79 111.06 27.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.11 148.77 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.833 -164.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.827 ' HD2' ' HB3' ' A' ' 42' ' ' LEU . 31.2 ttm-85 -114.29 121.57 44.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.279 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.431 ' CE3' ' HB1' ' A' ' 23' ' ' ALA . 12.0 m95 -83.14 76.72 9.84 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 168.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.827 ' HB3' ' HD2' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -76.35 -34.03 58.96 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -166.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.531 HG22 ' OE2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -77.26 -9.31 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.924 179.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.19 -32.16 11.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.546 171.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.85 35.84 3.62 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.787 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -136.39 168.38 19.56 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 122.634 -0.333 . . . . 0.0 110.435 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -153.6 141.62 20.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 t -175.4 -179.96 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.691 0.758 . . . . 0.0 111.674 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.9 m -98.77 107.83 20.36 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.69 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.5 p -98.98 148.68 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.304 0.573 . . . . 0.0 111.196 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 24.2 m-85 -118.15 99.78 51.83 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.68 174.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HB3' HG23 ' A' ' 11' ' ' VAL . 3.3 Cg_exo -75.62 -46.15 0.22 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.721 2.28 . . . . 0.0 112.268 -175.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.3 -94.75 1.44 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.801 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.7 m -126.72 167.39 15.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.569 0.185 . . . . 0.0 111.137 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 67.25 22.14 9.74 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.933 0.771 . . . . 0.0 111.345 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.763 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -75.52 127.6 33.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.168 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.854 HG21 ' H ' ' A' ' 58' ' ' VAL . 7.4 p -147.27 -179.99 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.347 0.594 . . . . 0.0 110.346 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.854 ' H ' HG21 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -111.26 127.94 68.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.504 -175.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.835 HG22 ' HB2' ' A' ' 8' ' ' TYR . 1.4 m -119.57 179.24 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 123.285 0.634 . . . . 0.0 110.768 173.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 p -112.05 -171.79 1.92 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.55 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -49.14 -52.23 27.52 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -172.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.56 -40.94 84.92 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.308 -170.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -63.04 -24.93 68.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.411 0.624 . . . . 0.0 110.227 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.457 ' CE1' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -67.2 -49.37 64.87 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.687 -173.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.61 -67.66 0.23 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.828 0.823 . . . . 0.0 112.684 -164.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -52.48 64.21 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.349 -174.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.463 ' HB2' ' ND1' ' A' ' 22' ' ' HIS . . . -72.79 -16.69 61.62 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.673 ' OE1' ' HA ' ' A' ' 23' ' ' ALA . 29.9 tt0 -77.59 -40.68 41.36 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -55.56 -49.3 73.06 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.924 0.869 . . . . 0.0 109.105 170.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -68.33 -16.65 64.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.093 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -81.26 -41.19 22.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.648 0.261 . . . . 0.0 110.867 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.0 -27.29 68.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.25 -52.67 7.82 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.885 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -82.0 -65.61 0.99 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.51 73.91 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.041 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.973 -177.163 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 . . . . . 0 CA--C 1.521 -0.159 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.84 171.72 13.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.901 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 88.2 tttt -139.09 155.52 47.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.208 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.805 HG12 ' HA ' ' A' ' 26' ' ' ILE . 37.4 t -69.85 142.22 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.88 19.07 44.84 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -174.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 9.0 m-20 -138.7 -179.01 5.57 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 114.025 -1.087 . . . . 0.0 108.549 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.746 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 95.9 m-85 -137.17 165.13 26.82 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.971 -168.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.1 tt -138.63 138.73 38.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.662 -166.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.721 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 37.8 t -139.02 157.66 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.396 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.79 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.9 p . . . . . 0 C--N 1.323 -0.565 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.638 ' OD2' ' HD3' ' A' ' 74' ' ' ARG . 15.2 t70 . . . . . 0 C--O 1.222 -0.377 0 N-CA-C 111.249 0.092 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.79 ' HB2' HG12 ' A' ' 11' ' ' VAL . 78.8 mt-30 61.24 105.18 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.542 0.737 . . . . 0.0 111.707 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.949 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.7 t-160 -139.26 126.6 21.49 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 121.254 0.55 . . . . 0.0 111.599 -174.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.717 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.51 -178.65 5.49 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.402 1.081 . . . . 0.0 110.09 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.746 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 20.5 tt0 -136.95 122.51 19.67 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.287 1.042 . . . . 0.0 108.483 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.844 HG21 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -85.05 113.8 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.192 -174.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.805 ' HA ' HG12 ' A' ' 5' ' ' VAL . 1.5 pp -106.35 -3.51 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.237 172.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.834 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.0 124.46 19.35 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.284 172.032 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -138.19 99.67 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -105.49 -3.92 21.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.58 0.705 . . . . 0.0 109.97 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 6.9 m -65.0 -25.98 68.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.383 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 63.2 -82.17 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.791 0.682 . . . . 0.0 110.841 -176.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.75 -44.24 67.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.585 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 30' ' ' SER . . . 153.67 -164.25 31.1 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p 67.75 154.26 0.14 Allowed Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 124.476 1.111 . . . . 0.0 111.956 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.56 161.38 38.75 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.948 2.432 . . . . 0.0 112.533 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.646 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 89.4 Cg_endo -83.34 179.0 26.64 Favored 'Cis proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.071 -1.637 . . . . 0.0 113.376 0.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -138.76 173.52 11.49 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.834 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 97.4 t -137.77 115.58 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.844 HG23 HG21 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -138.84 171.16 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 CA-C-N 112.878 -1.965 . . . . 0.0 109.155 -152.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.404 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 31.6 ttt180 -138.66 123.75 19.07 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.732 ' HD1' ' HB2' ' A' ' 46' ' ' HIS . 25.6 m95 -78.99 84.42 5.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.681 HD23 ' HB3' ' A' ' 24' ' ' GLU . 6.9 mt -60.21 -68.6 0.28 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.346 0.593 . . . . 0.0 111.951 -166.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.68 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -60.25 -38.35 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.155 -174.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.495 ' ND2' ' HB1' ' A' ' 72' ' ' ALA . 44.3 m-80 -60.59 -50.86 71.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.298 171.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.98 48.94 0.86 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.506 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.732 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 46.9 m-70 -139.13 169.17 18.26 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.446 0.623 . . . . 0.0 111.283 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -138.88 119.14 13.62 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.519 HG22 ' CZ2' ' A' ' 41' ' ' TRP . 6.7 t -139.42 -179.36 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.315 1.055 . . . . 0.0 113.684 -165.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.437 HG21 HG23 ' A' ' 38' ' ' VAL . 57.8 m -138.55 112.67 8.59 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.092 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.445 HG12 ' HZ2' ' A' ' 41' ' ' TRP . 8.5 m -138.89 -179.8 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -163.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.646 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 50.1 m-85 -138.73 108.56 7.76 Favored Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.738 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HG3' HD12 ' A' ' 9' ' ' LEU . 72.6 Cg_endo -74.63 -169.2 0.58 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.089 2.526 . . . . 0.0 111.608 176.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.572 ' HA3' HG21 ' A' ' 11' ' ' VAL . . . -98.61 -166.2 30.78 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.546 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.8 m -97.07 21.58 9.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.34 0.59 . . . . 0.0 112.019 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -122.91 38.09 4.26 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.97 135.6 54.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.761 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.776 HG11 ' H ' ' A' ' 58' ' ' VAL . 2.9 t -138.71 179.93 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.776 ' H ' HG11 ' A' ' 57' ' ' VAL . 58.0 t -138.0 136.02 45.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.739 -174.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.636 HG22 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.75 177.33 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.752 -170.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.6 t -122.2 -164.02 1.13 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.799 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.25 94.2 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -42.68 72.64 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 121.858 -0.526 . . . . 0.0 110.98 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.563 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 9.4 mm-40 -62.14 -17.26 57.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.838 0.827 . . . . 0.0 109.446 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.68 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -81.73 -43.99 17.68 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.78 -172.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.77 -70.79 0.09 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.838 0.828 . . . . 0.0 111.627 -168.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -70.08 -55.04 10.49 Favored 'General case' 0 C--O 1.257 1.457 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.748 -175.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -59.55 -42.29 92.06 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.577 -175.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.949 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 36.0 tt0 -70.47 -35.78 73.5 Favored 'General case' 0 C--O 1.212 -0.921 0 C-N-CA 120.204 -0.599 . . . . 0.0 110.978 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 69' ' ' LYS . 11.1 tptm -51.87 -61.76 2.06 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.734 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -67.12 -52.77 37.63 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.235 1.017 . . . . 0.0 111.709 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.74 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -68.85 -30.7 69.28 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.248 -171.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.569 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . . . -69.74 -41.07 75.74 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.75 -35.42 56.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.825 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.638 ' HD3' ' OD2' ' A' ' 20' ' ' ASP . 49.6 ttt180 -81.79 -49.46 10.37 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.511 ' HA ' ' HG2' ' A' ' 21' ' ' GLN . . . -45.14 -50.23 11.39 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.63 0.772 . . . . 0.0 112.036 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.423 -178.039 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 p80 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.028 0.442 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.89 145.3 19.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.019 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -144.79 171.02 15.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.174 0.511 . . . . 0.0 111.561 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.961 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.3 p -72.63 147.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.197 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.31 -0.34 43.69 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -130.73 176.38 8.25 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.685 ' HB2' HG22 ' A' ' 59' ' ' VAL . 94.8 m-85 -115.59 151.54 34.75 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.116 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.3 tt -98.6 142.23 30.44 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.562 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 44.4 t -134.78 154.86 37.52 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.139 0 O-C-N 125.229 1.581 . . . . 0.0 109.848 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.747 HG21 ' HB3' ' A' ' 21' ' ' GLN . 29.5 m . . . . . 0 C--N 1.329 -0.322 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 168.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.7 t0 . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.747 ' HB3' HG21 ' A' ' 11' ' ' VAL . 0.6 OUTLIER 65.45 100.63 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 O-C-N 123.485 0.49 . . . . 0.0 110.175 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.725 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 3.8 m80 -129.79 146.64 51.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.167 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -160.8 176.38 11.54 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 172.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.609 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 43.9 tt0 -98.61 132.31 44.12 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.45 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.594 HG23 HG22 ' A' ' 28' ' ' VAL . 2.6 mt -97.43 109.69 23.85 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.96 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.961 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -109.03 -31.88 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.341 175.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.998 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 10.5 mm-40 -112.21 99.87 8.38 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.39 0.614 . . . . 0.0 109.427 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.646 HG12 ' H ' ' A' ' 30' ' ' SER . 15.7 t -106.86 144.72 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.017 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.3 mtp-105 -68.79 -35.98 77.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.361 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.646 ' H ' HG12 ' A' ' 28' ' ' VAL . 66.3 m 58.38 -159.75 0.27 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.856 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 65.39 -88.09 0.03 OUTLIER 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.829 0.452 . . . . 0.0 111.227 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -92.63 -27.47 17.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.733 0.301 . . . . 0.0 110.31 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.38 86.77 0.54 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.484 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.8 p -160.2 162.03 24.71 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.05 162.9 12.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.86 2.373 . . . . 0.0 112.126 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.21 151.64 96.87 Favored 'Cis proline' 0 C--N 1.343 0.262 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.747 2.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -111.46 139.9 46.5 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.998 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 57.8 t -98.35 99.92 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.62 142.02 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.212 -168.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -121.38 129.05 52.82 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.622 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.425 ' CZ3' ' HB1' ' A' ' 23' ' ' ALA . 12.8 m95 -81.05 100.39 8.97 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.605 HD11 ' CD ' ' A' ' 24' ' ' GLU . 13.2 mt -76.43 -56.78 4.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.249 0.547 . . . . 0.0 111.263 -172.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 65' ' ' ALA . 1.4 m -79.49 -7.89 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.245 -172.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -96.9 -47.98 5.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.791 170.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.49 70.81 0.82 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.746 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -174.11 148.62 1.36 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.843 0.354 . . . . 0.0 110.536 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.417 ' C ' ' HG1' ' A' ' 48' ' ' THR . 3.8 mp0 -99.04 143.87 28.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.824 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.417 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 24.9 m -154.6 167.16 31.06 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.818 0.342 . . . . 0.0 110.249 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.4 ' N ' HG23 ' A' ' 48' ' ' THR . 26.5 m -127.79 118.67 24.17 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.14 162.92 35.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.805 0.812 . . . . 0.0 113.054 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -120.8 99.86 46.85 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.229 171.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.691 ' HG3' HD12 ' A' ' 9' ' ' LEU . 43.3 Cg_endo -66.51 149.45 84.39 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.672 2.248 . . . . 0.0 112.248 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.24 68.08 3.59 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.054 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.0 m 69.21 168.19 0.29 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.112 0.565 . . . . 0.0 112.395 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.28 42.48 31.45 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.3 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -77.63 110.69 12.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.122 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.622 HG11 ' HB ' ' A' ' 10' ' ' VAL . 1.2 p -119.34 156.46 21.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.143 0.497 . . . . 0.0 110.84 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -102.21 107.08 20.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.467 -174.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.685 HG22 ' HB2' ' A' ' 8' ' ' TYR . 14.2 m -102.1 -179.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.589 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.2 t -96.71 -170.61 2.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.252 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.581 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . . . -63.38 -50.59 69.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.033 -172.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -71.8 -40.52 69.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.833 0.349 . . . . 0.0 111.689 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -55.78 -29.1 59.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.707 0.765 . . . . 0.0 109.698 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.721 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -82.22 -46.64 13.46 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -171.483 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' A' ' 43' ' ' VAL . . . -49.66 -60.15 3.14 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -159.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.74 -53.22 57.92 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 122.377 1.084 . . . . 0.0 110.33 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.93 -16.4 63.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.554 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 26.6 tt0 -70.77 -42.17 70.77 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 176.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -57.07 -47.15 81.69 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.639 0.733 . . . . 0.0 109.075 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -61.86 -24.05 66.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.647 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.67 ' HB1' ' H ' ' A' ' 22' ' ' HIS . . . -81.95 -48.86 10.95 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.445 -175.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.91 -23.39 65.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.61 -64.83 0.8 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.191 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -82.25 -60.12 2.32 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.589 ' HB3' ' CG ' ' A' ' 21' ' ' GLN . . . -52.51 -48.72 65.82 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.908 0.483 . . . . 0.0 112.033 -173.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.944 -175.456 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.984 0.421 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.53 150.68 40.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.6 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -137.02 146.76 45.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.951 0.405 . . . . 0.0 110.941 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.564 HG22 ' HA ' ' A' ' 26' ' ' ILE . 2.8 p -89.37 137.13 21.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.416 172.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.34 2.29 56.71 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.19 173.38 6.96 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.69 ' HE2' ' HB3' ' A' ' 42' ' ' LEU . 92.5 m-85 -110.96 161.13 16.16 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.382 -174.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.4 tt -106.92 137.38 45.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.247 -176.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.588 HG23 HG21 ' A' ' 59' ' ' VAL . 11.1 t -136.94 148.42 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.049 0.843 . . . . 0.0 108.89 172.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 21' ' ' GLN . 92.2 t . . . . . 0 C--N 1.321 -0.633 0 CA-C-O 121.138 0.494 . . . . 0.0 110.249 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 119.699 -0.191 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.687 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 78.8 mt-30 45.62 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.993 0.917 . . . . 0.0 112.374 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.712 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 59.8 t-80 -135.05 145.77 48.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -171.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.473 ' HB3' ' HZ3' ' A' ' 41' ' ' TRP . . . -169.81 179.81 3.54 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.808 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.664 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 38.4 tt0 -100.64 123.56 45.02 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.515 0.509 . . . . 0.0 110.469 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 9' ' ' LEU . 18.8 mt -91.85 106.1 17.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 120.7 0.286 . . . . 0.0 110.267 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.564 ' HA ' HG22 ' A' ' 5' ' ' VAL . 2.0 pp -114.93 -10.42 12.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.157 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.857 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 30.9 mt-10 -139.92 107.99 5.74 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.113 0.483 . . . . 0.0 110.839 173.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.65 126.85 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.298 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -74.4 -34.97 63.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.123 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.5 t -145.51 136.81 24.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.27 -18.41 65.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.917 0.389 . . . . 0.0 111.167 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -89.77 1.3 56.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.143 0.497 . . . . 0.0 110.021 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.03 99.47 0.52 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.714 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 53.8 m -139.89 121.22 9.56 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 2.9 Cg_exo -75.49 157.2 40.84 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.144 2.563 . . . . 0.0 111.763 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.45 ' HB3' ' CD1' ' A' ' 51' ' ' TYR . 79.8 Cg_endo -82.77 167.22 66.96 Favored 'Cis proline' 0 N--CA 1.462 -0.332 0 C-N-CA 123.111 -1.621 . . . . 0.0 112.889 -1.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -109.32 153.9 23.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.773 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.857 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 85.5 t -98.79 113.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.477 ' HB ' HG23 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -118.85 151.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.022 -166.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.516 ' HD2' ' OE1' ' A' ' 24' ' ' GLU . 37.7 ttm180 -116.81 137.18 52.39 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.065 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.473 ' HZ3' ' HB3' ' A' ' 23' ' ' ALA . 18.5 m95 -74.06 83.47 1.78 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 168.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.925 HD13 HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -22.52 -76.9 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.221 -1.808 . . . . 0.0 115.778 -170.252 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.925 HG23 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -95.34 0.33 10.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -168.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.408 ' N ' HD21 ' A' ' 44' ' ' ASN . 0.9 OUTLIER -88.91 -46.13 9.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.881 0.372 . . . . 0.0 110.074 173.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.77 73.26 1.06 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.38 -0.915 . . . . 0.0 113.564 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -170.29 137.63 1.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.95 142.45 46.77 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.758 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 t -157.51 176.49 12.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.167 -173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.4 m -105.3 108.81 20.52 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.749 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.477 HG23 ' HB ' ' A' ' 39' ' ' VAL . 35.1 m -106.49 152.18 8.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.356 0.598 . . . . 0.0 111.99 -174.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 36' ' ' PRO . 50.7 m-85 -116.19 99.8 52.97 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.181 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.97 168.31 12.24 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.803 2.335 . . . . 0.0 111.746 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 55' ' ' ASP . . . -66.26 162.8 43.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.015 175.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.3 m -76.47 29.0 0.12 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.008 0.433 . . . . 0.0 111.716 -177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 53' ' ' GLY . 9.6 t0 -144.3 55.65 1.29 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.787 0.803 . . . . 0.0 108.909 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.82 136.35 35.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.763 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.84 158.37 42.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 1.5 m -99.22 149.89 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.235 0.54 . . . . 0.0 112.319 -177.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -135.09 173.3 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.803 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.89 -168.15 1.61 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.053 -175.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.21 -42.57 81.59 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -71.19 -44.62 65.09 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.236 -0.915 . . . . 0.0 110.934 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.0 mm-40 -64.76 -16.42 62.96 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.986 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.641 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -69.73 -33.82 73.0 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.669 -174.49 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 64' ' ' HIS . . . -77.14 -73.77 0.28 Allowed 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.834 0.826 . . . . 0.0 112.8 -165.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.401 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -61.07 -39.66 90.72 Favored 'General case' 0 C--O 1.251 1.182 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.136 -175.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -69.48 -28.8 66.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.308 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.713 ' HB2' HD11 ' A' ' 42' ' ' LEU . 18.0 tt0 -57.37 -57.3 13.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 1.006 ' HE2' ' HA ' ' A' ' 69' ' ' LYS . 9.3 mmpt? -50.64 -64.85 0.68 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.656 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -66.15 -54.81 20.84 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.839 0.828 . . . . 0.0 111.625 -174.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.579 ' HB3' ' N ' ' A' ' 21' ' ' GLN . . . -77.02 -25.15 52.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.87 -167.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.82 -32.41 52.25 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.834 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.21 72.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.23 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -80.58 -44.03 19.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.254 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' A' ' 21' ' ' GLN . . . -54.65 -53.02 60.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.121 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.358 -177.852 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.437 ' O ' HG23 ' A' ' 58' ' ' VAL . 21.2 m80 . . . . . 0 CA--C 1.515 -0.366 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.76 166.64 23.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.029 0.442 . . . . 0.0 111.709 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -139.1 176.06 9.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.827 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.792 HG21 ' HA ' ' A' ' 26' ' ' ILE . 2.5 p -91.46 135.49 26.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.9 17.46 32.57 Favored Glycine 0 C--N 1.322 -0.201 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.36 -179.24 5.68 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.785 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 92.1 m-85 -137.03 169.54 17.6 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.595 -166.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 10' ' ' VAL . 6.1 tt -138.6 141.31 39.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.829 -164.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.811 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 37.2 t -138.75 151.98 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 124.889 1.368 . . . . 0.0 109.039 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.931 HG21 ' HB2' ' A' ' 54' ' ' SER . 0.5 OUTLIER . . . . . 0 C--N 1.31 -1.124 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.318 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.635 ' OD1' ' HD3' ' A' ' 74' ' ' ARG . 9.0 m-20 . . . . . 0 C--O 1.216 -0.678 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.882 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 6.2 tp-100 53.5 99.76 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.423 0 O-C-N 123.608 0.567 . . . . 0.0 110.533 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.921 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -138.69 103.04 4.74 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 121.451 -0.781 . . . . 0.0 110.376 -173.168 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.532 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.49 -178.77 5.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.207 -172.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.785 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 23.5 tt0 -137.07 127.77 27.07 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 122.473 1.13 . . . . 0.0 109.089 172.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.52 ' CG2' HG22 ' A' ' 28' ' ' VAL . 3.0 mt -87.46 111.48 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-N 112.518 -2.128 . . . . 0.0 110.084 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.792 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -106.13 -12.12 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 O-C-N 123.961 0.788 . . . . 0.0 109.401 172.239 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.578 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 33.0 mt-10 -138.98 139.58 37.96 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.933 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.52 HG22 ' CG2' ' A' ' 25' ' ' ILE . 23.2 t -137.89 102.65 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -163.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.41 35.83 0.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.27 -173.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.3 t -158.76 150.83 21.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.98 -14.5 29.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.401 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -118.54 -66.22 1.1 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.618 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 165.57 51.82 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.267 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 m -118.87 148.29 44.23 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.03 156.79 52.58 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.62 2.214 . . . . 0.0 111.925 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.583 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 75.1 Cg_endo -89.16 -172.43 6.82 Favored 'Cis proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.723 -1.365 . . . . 0.0 113.447 1.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.72 168.33 20.03 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.168 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 84.3 t -137.96 117.41 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.437 HG11 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.93 172.24 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 113.112 -1.858 . . . . 0.0 109.656 -154.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.841 ' HG2' HD23 ' A' ' 42' ' ' LEU . 11.6 ttt85 -138.71 134.48 33.62 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.598 ' CZ2' HG23 ' A' ' 48' ' ' THR . 9.9 m95 -78.68 89.32 4.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 168.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.841 HD23 ' HG2' ' A' ' 40' ' ' ARG . 8.3 mt -59.92 -72.66 0.1 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.328 0.585 . . . . 0.0 111.533 -168.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.617 HG12 ' NE2' ' A' ' 64' ' ' HIS . 2.4 m -60.08 -30.68 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.293 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.466 ' HB2' ' CB ' ' A' ' 41' ' ' TRP . 33.9 m-80 -60.68 -66.18 0.57 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.241 170.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.79 33.31 0.65 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.86 -0.686 . . . . 0.0 114.759 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.75 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 2.4 m170 -139.28 174.48 10.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.328 1.064 . . . . 0.0 112.164 175.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -138.49 127.7 24.28 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.598 HG23 ' CZ2' ' A' ' 41' ' ' TRP . 9.7 t -139.42 -179.23 5.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 122.065 0.936 . . . . 0.0 113.335 -168.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.533 HG21 HG23 ' A' ' 38' ' ' VAL . 63.4 m -138.46 110.67 7.36 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.87 -179.86 2.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -161.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.583 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 9.8 m-85 -138.71 121.93 10.95 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.264 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 24.6 Cg_exo -63.13 -53.45 1.53 Allowed 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 122.937 2.425 . . . . 0.0 112.653 -177.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.67 -46.82 1.11 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.204 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.931 ' HB2' HG21 ' A' ' 11' ' ' VAL . 26.4 m -91.66 -170.9 2.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.688 0.244 . . . . 0.0 111.33 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.61 -14.81 5.93 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.85 0.719 . . . . 0.0 110.525 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.4 ' HA ' HG23 ' A' ' 11' ' ' VAL . . . 71.44 130.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.985 172.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.547 HG21 ' HB ' ' A' ' 10' ' ' VAL . 29.0 m -135.41 169.84 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 122.046 -0.408 . . . . 0.0 110.969 176.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 2' ' ' HIS . 56.1 t -118.02 136.26 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -173.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.647 HG22 ' CB ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -123.86 174.74 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 123.111 0.565 . . . . 0.0 110.845 176.039 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -121.4 -164.97 1.18 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.503 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.15 91.17 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -171.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -81.82 -33.96 30.46 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.466 -0.771 . . . . 0.0 110.872 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 36.9 mt-10 -65.83 -16.52 63.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.919 0.866 . . . . 0.0 109.267 174.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.617 ' NE2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.37 -57.73 3.67 Favored 'General case' 0 C--O 1.198 -1.642 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.292 -176.028 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.84 -67.14 0.28 Allowed 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -160.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.26 -53.5 14.11 Favored 'General case' 0 C--O 1.259 1.593 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.132 -169.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.52 -17.69 63.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.271 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.921 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 10.9 tt0 -74.01 -44.73 53.47 Favored 'General case' 0 C--O 1.205 -1.272 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -50.14 -57.55 7.46 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.611 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.77 -60.56 2.96 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 121.838 0.828 . . . . 0.0 112.424 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.849 ' HB3' ' HB2' ' A' ' 22' ' ' HIS . . . -73.18 -16.64 61.42 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -169.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -79.93 -39.25 30.68 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 118.27 0.486 . . . . 0.0 109.948 174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.66 56.56 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.762 171.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.635 ' HD3' ' OD1' ' A' ' 20' ' ' ASP . 35.7 mtt180 -79.59 -42.93 23.91 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.65 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.882 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -46.05 -52.77 11.34 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.138 0.975 . . . . 0.0 112.228 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.523 0 C-N-CA 120.006 -1.092 . . . . 0.0 111.956 -176.723 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 68.9 m-70 . . . . . 0 C--O 1.23 0.068 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.96 154.76 17.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.534 0.207 . . . . 0.0 110.793 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -135.52 163.44 30.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 111.2 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.17 135.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.837 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.85 3.96 61.97 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.99 171.39 8.48 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.703 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 84.5 m-85 -106.25 148.58 27.79 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.321 0.581 . . . . 0.0 111.259 -175.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.4 tt -99.06 136.73 38.6 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.664 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 3.3 t -141.14 139.71 32.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 O-C-N 125.044 1.465 . . . . 0.0 109.895 174.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.0 t . . . . . 0 C--N 1.317 -0.819 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 170.892 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 t0 . . . . . 0 CA--C 1.534 0.351 0 CA-C-O 119.116 -0.468 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.694 ' N ' ' HB2' ' A' ' 71' ' ' ALA . 1.0 OUTLIER 43.23 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.807 0.843 . . . . 0.0 112.475 -177.38 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.933 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.7 t60 -134.49 137.96 44.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.565 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . . . -171.08 -179.86 2.85 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.488 173.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.703 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 38.4 tt0 -98.59 136.1 39.16 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.033 0.444 . . . . 0.0 110.341 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 9' ' ' LEU . 1.5 mt -97.17 107.18 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.697 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -107.33 -24.88 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.993 176.384 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 1.085 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 19.3 mm-40 -115.72 99.88 7.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.795 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.3 t -106.72 124.62 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.636 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -69.13 -37.81 78.52 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.5 p -146.07 144.65 30.16 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.95 74.1 0.88 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.078 0.466 . . . . 0.0 111.928 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 19.1 t70 -171.38 -57.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.092 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 146.39 89.99 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.949 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 p -132.02 97.05 18.91 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.857 0.361 . . . . 0.0 111.363 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.75 150.68 84.82 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.485 2.123 . . . . 0.0 111.213 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.406 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.3 Cg_endo -78.1 169.22 73.8 Favored 'Cis proline' 0 C--N 1.344 0.295 0 C-N-CA 123.346 -1.523 . . . . 0.0 112.826 0.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -113.58 155.47 25.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 1.085 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 66.4 t -98.76 102.07 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 172.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.408 HG21 ' HB2' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -106.14 158.01 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.077 -163.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.553 ' HB2' HD11 ' A' ' 26' ' ' ILE . 62.9 ttt180 -131.51 99.99 5.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.162 -169.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.736 ' HE1' HG21 ' A' ' 48' ' ' THR . 0.3 OUTLIER -81.75 71.66 8.78 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 174.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.526 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 3.0 pp -84.83 -23.7 28.96 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.86 -166.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.681 ' HB ' ' CE1' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -85.17 -6.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.968 0.889 . . . . 0.0 108.812 178.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.537 ' OD1' ' HA ' ' A' ' 69' ' ' LYS . 50.1 m-80 -99.84 -61.57 1.35 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.123 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.88 42.4 0.1 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.044 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -157.04 164.59 37.78 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.907 0.354 . . . . 0.0 110.927 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -149.44 133.56 17.24 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.736 HG21 ' HE1' ' A' ' 41' ' ' TRP . 12.0 t -167.49 177.8 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.541 0.686 . . . . 0.0 111.182 -176.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.4 m -98.88 123.04 42.88 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.533 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.84 155.85 41.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.216 0.531 . . . . 0.0 111.543 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 46.4 m-85 -107.24 99.94 30.23 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.04 174.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.446 ' HG3' HD12 ' A' ' 9' ' ' LEU . 43.6 Cg_endo -68.07 -30.48 31.92 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 122.68 2.253 . . . . 0.0 112.595 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.25 -128.8 9.02 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.9 m -124.59 164.31 20.09 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 59.71 53.77 4.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.466 0.65 . . . . 0.0 111.323 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.37 117.33 29.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.41 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.0 169.44 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.36 116.0 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.108 0.48 . . . . 0.0 111.106 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -109.22 178.3 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.302 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.7 p -126.96 -166.8 1.64 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.27 -176.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -51.6 -46.69 63.65 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.99 -50.78 67.17 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.481 -0.762 . . . . 0.0 111.441 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 25.2 mm-40 -63.57 -17.04 62.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.39 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.681 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -76.07 -32.68 59.4 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.462 -175.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.53 -77.22 0.06 Allowed 'General case' 0 C--O 1.25 1.114 0 CA-C-O 122.097 0.951 . . . . 0.0 111.609 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -47.58 80.09 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.741 -173.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 63' ' ' GLU . . . -66.63 -38.71 87.47 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.185 -177.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.933 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 41.2 tt0 -66.3 -39.95 89.69 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.479 -176.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.537 ' HA ' ' OD1' ' A' ' 44' ' ' ASN . 69.1 mttm -57.85 -63.3 1.29 Allowed 'General case' 0 C--O 1.25 1.096 0 C-N-CA 119.731 -0.787 . . . . 0.0 110.957 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -62.77 -43.14 99.58 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.425 0.631 . . . . 0.0 110.897 -174.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.694 ' HB2' ' N ' ' A' ' 21' ' ' GLN . . . -81.76 -16.79 49.93 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -171.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.71 -38.71 62.26 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 119.716 -0.794 . . . . 0.0 108.882 171.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.1 -38.69 80.15 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.06 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.15 -38.16 25.11 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.593 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -56.94 -53.79 53.97 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.946 0.403 . . . . 0.0 111.786 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.16 -178.381 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 . . . . . 0 CA--C 1.516 -0.337 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.89 149.84 45.29 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.56 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 52.1 tptt -139.06 148.51 43.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.469 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.723 HG21 ' HA ' ' A' ' 26' ' ' ILE . 5.2 p -80.13 146.23 7.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.5 38.81 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -172.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -138.56 -179.15 5.64 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.712 -1.244 . . . . 0.0 108.392 -176.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.636 ' CD2' HD22 ' A' ' 42' ' ' LEU . 87.9 m-85 -137.54 171.87 13.82 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.394 -172.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' ' 52' ' ' PRO . 9.2 tt -138.53 137.16 36.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.157 -169.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 93.3 t -139.22 161.29 28.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.992 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.9 HG23 ' HB2' ' A' ' 21' ' ' GLN . 26.7 m . . . . . 0 C--O 1.241 0.625 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.518 -0.276 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.935 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 2.2 mp0 57.73 97.64 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.385 0.428 . . . . 0.0 110.261 -170.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.692 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 82.8 t60 -138.75 127.31 23.23 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.832 0.825 . . . . 0.0 112.53 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.469 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -139.42 -178.7 5.5 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.308 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.602 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 28.6 tt0 -136.99 111.69 8.75 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.515 ' CG2' HG22 ' A' ' 28' ' ' VAL . 9.7 mt -81.14 103.06 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.402 -167.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.723 ' HA ' HG21 ' A' ' 5' ' ' VAL . 1.9 pp -107.88 -7.56 10.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.114 176.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.924 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 3.0 tp10 -139.21 136.2 34.76 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.382 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.515 HG22 ' CG2' ' A' ' 25' ' ' ILE . 46.8 t -137.99 99.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -168.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -105.26 84.03 2.05 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.6 m -151.61 109.64 3.71 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.605 -175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.81 -16.81 24.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.41 -45.28 9.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.528 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.88 40.11 3.41 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 -169.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.667 ' HB3' ' HD2' ' A' ' 35' ' ' PRO . 62.4 m -152.18 167.59 12.93 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.667 ' HD2' ' HB3' ' A' ' 34' ' ' SER . 12.5 Cg_endo -56.13 159.57 12.23 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.013 2.475 . . . . 0.0 112.68 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.546 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 84.3 Cg_endo -82.4 179.59 26.36 Favored 'Cis proline' 0 C--N 1.347 0.451 0 C-N-CA 123.153 -1.603 . . . . 0.0 113.263 1.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -138.76 174.86 10.08 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.924 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 84.2 t -137.6 122.32 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.64 176.19 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 CA-C-N 113.378 -1.737 . . . . 0.0 110.498 -149.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.602 ' HD3' ' OE2' ' A' ' 24' ' ' GLU . 35.6 ttt180 -138.54 124.04 19.53 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -174.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.443 ' HZ3' ' O ' ' A' ' 22' ' ' HIS . 8.9 m95 -65.16 102.98 0.7 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 166.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.636 HD22 ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -59.85 -89.58 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.902 -1.499 . . . . 0.0 113.845 -154.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.678 HG22 ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -60.41 -26.27 36.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -176.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -60.54 -57.2 13.74 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 172.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.33 51.41 0.72 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.64 -0.79 . . . . 0.0 114.152 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -139.21 170.37 16.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.062 0.431 . . . . 0.0 109.888 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 7.9 mp0 -138.21 134.73 34.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.515 0.674 . . . . 0.0 111.002 -175.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.485 ' CG2' HG11 ' A' ' 39' ' ' VAL . 10.0 t -139.36 -178.97 5.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.087 -172.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.476 HG21 HG22 ' A' ' 38' ' ' VAL . 44.7 m -138.21 113.71 9.6 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.87 -179.82 2.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-O 121.672 0.749 . . . . 0.0 112.954 -161.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 2.0 m-85 -138.86 116.7 9.01 Favored Pre-proline 0 N--CA 1.455 -0.223 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.674 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.702 ' HB3' HD23 ' A' ' 9' ' ' LEU . 28.5 Cg_endo -64.38 -65.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.474 0.353 0 C-N-CA 122.564 2.176 . . . . 0.0 113.55 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 138.05 -146.82 18.72 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.285 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.0 m -81.14 151.42 28.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 0.0 111.248 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 t70 48.74 64.81 1.55 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.813 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.882 ' HA ' HG13 ' A' ' 11' ' ' VAL . . . -79.46 133.61 36.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.817 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.681 HG11 ' H ' ' A' ' 58' ' ' VAL . 2.3 t -138.75 -179.83 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.681 ' H ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -138.18 152.37 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.983 -177.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.563 HG22 ' CB ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.77 179.75 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.018 -172.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.2 p -120.21 -165.44 1.19 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.302 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.451 ' O ' ' ND1' ' A' ' 64' ' ' HIS . . . -56.9 -48.2 78.76 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -59.96 4.34 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.102 -0.999 . . . . 0.0 111.827 -175.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -57.27 -21.27 33.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.021 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.615 ' HE2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.35 -44.12 84.07 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.263 -176.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.574 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . -57.62 -70.33 0.14 Allowed 'General case' 0 C--O 1.251 1.145 0 CA-C-O 122.337 1.065 . . . . 0.0 113.051 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -57.01 -55.01 40.23 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.553 -176.021 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.555 ' O ' ' HB1' ' A' ' 71' ' ' ALA . . . -57.41 -29.07 63.81 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.909 176.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.678 ' HG2' HG22 ' A' ' 43' ' ' VAL . 3.2 tp10 -56.87 -58.74 6.81 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.76 -72.63 0.08 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.825 -178.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.566 ' HG3' ' H ' ' A' ' 71' ' ' ALA . 31.9 ptt180 -57.46 -67.68 0.3 Allowed 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.743 0.783 . . . . 0.0 112.281 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.608 ' HB1' ' HB3' ' A' ' 22' ' ' HIS . . . -57.38 -47.79 80.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.074 -0.966 . . . . 0.0 113.584 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.38 -46.11 83.75 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.089 0.859 . . . . 0.0 111.177 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.97 -29.64 63.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.04 0.448 . . . . 0.0 111.322 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -81.59 -50.07 9.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.994 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.935 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -54.63 -66.53 0.39 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.661 0.784 . . . . 0.0 112.004 -176.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.634 0 C-N-CA 119.796 -1.193 . . . . 0.0 112.196 -172.452 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.5 m80 . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.564 0.221 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.06 120.18 14.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.729 ' HA ' HG21 ' A' ' 28' ' ' VAL . 98.6 mttt -138.88 176.31 8.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 112.144 -173.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.794 HG21 ' HA ' ' A' ' 26' ' ' ILE . 8.5 p -71.1 156.78 6.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.514 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.28 12.52 82.08 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.13 -178.79 5.5 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 113.754 -1.223 . . . . 0.0 107.836 -172.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.782 ' HB2' HG21 ' A' ' 59' ' ' VAL . 67.6 m-85 -137.39 174.03 11.04 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.535 -174.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.759 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 4.4 tt -138.14 153.11 49.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.23 -164.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 38.3 t -138.89 151.72 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 125.106 1.504 . . . . 0.0 109.614 -169.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.763 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.8 p . . . . . 0 C--N 1.322 -0.62 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.2 t0 . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 1.014 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 2.0 mp0 65.11 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.922 0.489 . . . . 0.0 110.94 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.759 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 1.2 m-70 -128.03 147.4 50.51 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 122.151 -0.343 . . . . 0.0 111.143 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.642 ' HA ' ' HE1' ' A' ' 64' ' ' HIS . . . -157.87 175.12 14.27 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.681 ' HA ' ' HD1' ' A' ' 8' ' ' TYR . 40.1 tt0 -98.63 130.85 45.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.769 0.795 . . . . 0.0 112.664 -172.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.631 HD13 ' HB2' ' A' ' 9' ' ' LEU . 49.4 mt -90.66 108.01 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.66 171.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.794 ' HA ' HG21 ' A' ' 5' ' ' VAL . 1.3 pp -108.01 -28.5 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.921 177.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.99 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 45.2 mt-10 -124.02 117.21 24.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.23 0.538 . . . . 0.0 110.123 175.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.729 HG21 ' HA ' ' A' ' 4' ' ' LYS . 79.5 t -98.87 116.18 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.854 -176.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 29' ' ' ARG . 14.8 mmm180 -88.18 -13.96 39.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.895 0.379 . . . . 0.0 111.342 -174.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 34' ' ' SER . 23.0 t -129.71 104.08 7.21 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.75 -35.13 55.75 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.738 0.649 . . . . 0.0 112.656 -174.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.45 -58.56 3.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 110.203 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.45 83.37 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.699 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 30' ' ' SER . 50.0 m -154.58 148.5 18.93 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 175.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 16.8 Cg_exo -68.36 160.3 49.65 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.768 2.312 . . . . 0.0 111.822 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -88.56 179.53 16.92 Favored 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.745 -1.356 . . . . 0.0 112.648 0.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -131.75 158.59 40.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.912 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.99 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 59.8 t -98.78 116.38 41.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.28 133.19 58.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.31 -162.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.527 ' HG2' HG12 ' A' ' 26' ' ' ILE . 6.5 ptp180 -112.0 142.84 43.92 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.533 176.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.586 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 23.6 m95 -90.56 111.02 22.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.45 HD22 ' HG3' ' A' ' 40' ' ' ARG . 7.2 mt -82.67 -58.44 2.9 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.198 0.523 . . . . 0.0 111.47 -169.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.936 HG22 ' HA ' ' A' ' 65' ' ' ALA . 1.3 m -80.58 -5.54 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.611 -170.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -100.04 -47.24 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.138 167.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.9 79.07 1.14 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.911 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.586 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -163.77 164.48 23.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.642 0.258 . . . . 0.0 110.911 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -134.79 121.01 20.09 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.0 p -143.09 -179.92 6.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.581 0.705 . . . . 0.0 111.861 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.2 m -123.75 110.09 14.5 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 168.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.13 139.16 25.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-O 121.526 0.679 . . . . 0.0 112.251 -166.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -105.5 99.61 21.98 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.884 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.449 ' HG3' HD12 ' A' ' 9' ' ' LEU . 90.9 Cg_endo -83.66 163.13 14.37 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.263 1.975 . . . . 0.0 111.63 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.61 171.42 53.99 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.684 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 17.2 m -61.26 145.91 49.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.505 0.193 . . . . 0.0 111.267 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 54' ' ' SER . 6.3 m-20 72.98 63.22 0.1 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.979 0.799 . . . . 0.0 110.643 -174.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -86.94 124.44 33.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.926 175.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' A' ' 10' ' ' VAL . 6.6 t -99.05 157.78 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -108.34 123.83 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.664 178.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.782 HG21 ' HB2' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -121.91 172.52 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-O 121.056 0.455 . . . . 0.0 111.278 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.604 ' CG2' ' H ' ' A' ' 61' ' ' ALA . 1.3 m -111.57 -173.92 2.35 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.604 ' H ' ' CG2' ' A' ' 60' ' ' THR . . . -52.51 -45.87 66.43 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -166.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.85 -61.0 2.44 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -58.28 -26.92 63.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.901 0.858 . . . . 0.0 109.699 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.642 ' HE1' ' HA ' ' A' ' 23' ' ' ALA . 47.4 t60 -64.1 -37.19 86.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.657 -1.156 . . . . 0.0 113.182 -175.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.936 ' HA ' HG22 ' A' ' 43' ' ' VAL . . . -64.09 -69.29 0.29 Allowed 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.726 0.774 . . . . 0.0 113.046 -169.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.47 -39.89 89.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.132 -175.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.13 -16.8 61.44 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.837 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 20.0 tt0 -72.56 -46.16 55.75 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.054 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -61.99 -40.39 95.45 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.653 176.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -64.41 -22.43 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.18 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 1.014 ' HA ' ' HG3' ' A' ' 21' ' ' GLN . . . -82.26 -42.92 18.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.718 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.46 -21.33 65.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.86 -64.3 0.99 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.584 172.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.516 ' HD2' ' OE1' ' A' ' 21' ' ' GLN . 62.8 mtt180 -81.84 -64.26 1.22 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -175.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.59 -52.68 62.44 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.953 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.223 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.973 -175.728 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.617 ' CD2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 m170 . . . . . 0 CA--C 1.519 -0.241 0 CA-C-O 120.941 0.4 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.16 124.07 43.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.556 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -125.01 158.26 34.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.672 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.834 HG21 ' HA ' ' A' ' 26' ' ' ILE . 4.3 p -75.39 144.62 11.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.296 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.36 11.99 74.07 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.607 ' OD2' ' HB ' ' A' ' 58' ' ' VAL . 6.5 t70 -132.73 149.29 52.3 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.559 ' CE2' ' HA ' ' A' ' 61' ' ' ALA . 95.3 m-85 -98.79 155.22 17.47 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.386 0.612 . . . . 0.0 111.314 -168.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.2 tt -98.69 136.27 38.99 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.918 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 1.1 p -132.69 167.54 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 170.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.583 HG13 ' H ' ' A' ' 21' ' ' GLN . 2.6 p . . . . . 0 C--N 1.318 -0.792 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.219 171.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 t70 . . . . . 0 CA--C 1.539 0.54 0 CA-C-O 119.478 -0.296 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.688 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 24.8 mt-30 -41.13 120.01 1.28 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.371 0.668 . . . . 0.0 112.581 -160.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.739 ' CD2' ' HA ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -128.35 144.34 51.12 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -165.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.492 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -179.17 -179.75 0.59 Allowed 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.279 0.987 . . . . 0.0 110.2 173.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 5.0 tp10 -98.28 128.73 44.86 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.581 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.491 ' CG2' HG23 ' A' ' 28' ' ' VAL . 14.0 mt -93.15 101.16 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.834 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -103.06 -23.33 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.297 178.183 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.802 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 38.7 mt-10 -129.59 103.35 6.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.017 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.491 HG23 ' CG2' ' A' ' 25' ' ' ILE . 46.3 t -98.98 110.66 26.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.146 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.87 -46.19 66.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.304 0.573 . . . . 0.0 110.052 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.3 m -125.29 112.73 16.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.907 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.28 66.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -173.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.617 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 18.0 t70 -78.16 -65.24 1.0 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.234 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 167.24 73.96 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.474 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.0 m -151.26 126.5 4.79 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.706 0.289 . . . . 0.0 110.242 177.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.59 166.87 20.59 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.191 2.594 . . . . 0.0 111.434 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.08 152.35 88.42 Favored 'Cis proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.783 -1.34 . . . . 0.0 112.974 3.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -106.17 137.84 43.39 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.802 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 61.0 t -98.64 107.53 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HB ' HG21 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -118.07 151.23 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.086 -165.587 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -126.74 128.21 46.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.377 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 11.4 m95 -76.03 106.59 7.71 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.89 -55.44 4.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.196 0.522 . . . . 0.0 110.517 -174.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -81.71 -4.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.719 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.579 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 39.4 m-80 -97.88 -71.52 0.68 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.232 165.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.71 73.85 0.14 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.349 -0.929 . . . . 0.0 114.569 171.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.94 169.0 1.61 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.242 0.521 . . . . 0.0 110.882 169.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -120.14 145.63 46.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.33 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.6 t -172.33 -179.86 2.38 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 121.668 0.747 . . . . 0.0 112.246 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.8 m -115.14 121.89 44.4 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.23 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.437 HG21 ' HB ' ' A' ' 39' ' ' VAL . 35.8 m -118.88 159.08 19.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 CA-C-O 121.571 0.7 . . . . 0.0 112.851 -170.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -125.07 99.9 33.9 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.892 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.653 ' HA ' ' NE2' ' A' ' 21' ' ' GLN . 73.3 Cg_endo -77.16 -24.48 9.5 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.358 2.039 . . . . 0.0 112.76 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.19 -163.59 15.83 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.935 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.1 p -86.09 166.14 16.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.464 0.132 . . . . 0.0 110.772 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 62.52 42.02 9.09 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.406 0.622 . . . . 0.0 110.689 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.25 135.04 33.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.67 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.491 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 10.4 t -124.09 158.73 30.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.607 ' HB ' ' OD2' ' A' ' 7' ' ' ASP . 1.6 m -102.87 125.3 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.139 0.495 . . . . 0.0 111.409 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.549 HG23 ' NE2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -118.77 175.24 3.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.252 -175.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -111.94 -168.85 1.37 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.025 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.559 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -60.56 -47.63 85.35 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -70.41 -36.76 74.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.834 0.35 . . . . 0.0 111.488 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.34 -16.28 62.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.585 0.707 . . . . 0.0 109.471 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.739 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 2.7 t-80 -82.89 -44.77 15.02 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.19 -68.68 0.23 Allowed 'General case' 0 C--O 1.247 0.973 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -164.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -60.81 -36.8 79.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.144 -175.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.46 -22.06 59.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.741 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.54 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 13.8 tt0 -79.67 -34.59 40.19 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.833 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -56.04 -65.44 0.6 Allowed 'General case' 0 C--O 1.244 0.807 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.412 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -59.63 -65.56 0.65 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.171 0.986 . . . . 0.0 111.824 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.22 -16.93 57.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.449 -165.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 68' ' ' GLU . . . -82.26 -35.37 28.17 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.811 173.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.62 -34.35 69.2 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.136 0.494 . . . . 0.0 110.154 171.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -81.81 -40.97 21.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.868 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.5 -57.52 12.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.13 0.572 . . . . 0.0 111.872 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.305 -176.636 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 47.3 t-80 . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.79 166.83 11.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.79 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.02 160.07 35.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.74 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' A' ' 26' ' ' ILE . 2.1 p -83.03 146.03 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.14 0.495 . . . . 0.0 111.398 -175.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.33 6.33 58.79 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.12 168.29 18.24 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.672 ' HB2' HG22 ' A' ' 59' ' ' VAL . 97.1 m-85 -103.14 157.38 17.04 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.448 0.642 . . . . 0.0 111.537 -171.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.68 ' HB2' HD12 ' A' ' 25' ' ' ILE . 9.4 tt -98.91 138.31 36.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.544 175.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 0.5 OUTLIER -136.94 164.89 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.459 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.888 ' HB ' ' HB3' ' A' ' 20' ' ' ASP . 69.8 t . . . . . 0 C--N 1.317 -0.832 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 171.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.888 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 3.2 t70 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.719 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 68.0 mt-30 -41.15 131.62 2.62 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.706 0.802 . . . . 0.0 112.235 -168.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.796 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 49.8 t-80 -145.68 142.48 29.05 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -165.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.502 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . . . -172.62 177.96 2.81 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.801 0.84 . . . . 0.0 109.858 173.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.685 ' HG3' HD11 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -98.6 126.6 44.24 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.6 0.238 . . . . 0.0 110.853 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.68 HD12 ' HB2' ' A' ' 9' ' ' LEU . 14.4 mt -94.95 106.5 18.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 -176.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.851 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -102.0 -27.7 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.727 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.962 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 69.1 mm-40 -119.64 101.68 8.09 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.118 0.485 . . . . 0.0 110.633 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -98.93 102.5 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.081 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -89.36 -1.37 58.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.489 0.661 . . . . 0.0 109.765 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.792 ' HB3' ' H ' ' A' ' 34' ' ' SER . 1.4 m -80.59 124.36 28.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.857 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.61 -41.32 98.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.299 0.571 . . . . 0.0 109.99 175.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 52.2 m-20 -114.66 -68.59 0.91 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.472 173.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.47 54.6 0.14 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.327 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.792 ' H ' ' HB3' ' A' ' 30' ' ' SER . 5.0 p -106.52 143.72 27.57 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 122.245 0.218 . . . . 0.0 111.165 -178.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.17 157.24 60.21 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.798 2.332 . . . . 0.0 111.611 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -87.46 174.34 29.17 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.45 -1.479 . . . . 0.0 112.937 -1.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -123.21 149.92 44.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.962 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 98.9 t -98.68 108.77 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 172.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.77 165.37 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.922 -162.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.549 ' HG3' HD22 ' A' ' 42' ' ' LEU . 9.9 ptp180 -142.36 133.07 25.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.958 0.408 . . . . 0.0 111.001 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -82.28 106.32 14.07 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.685 HD11 ' HG3' ' A' ' 24' ' ' GLU . 18.6 mt -77.51 -50.8 11.86 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.075 0.464 . . . . 0.0 110.977 -171.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.457 HG22 ' OE2' ' A' ' 68' ' ' GLU . 2.4 m -79.69 -6.02 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.167 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 41' ' ' TRP . 48.2 m-80 -100.03 -51.18 3.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.754 174.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.7 70.45 0.68 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.2 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.482 ' CB ' ' HD1' ' A' ' 41' ' ' TRP . 0.4 OUTLIER -174.49 161.39 3.31 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.802 0.441 . . . . 0.0 110.264 176.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.71 139.98 46.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 t -173.67 171.06 3.9 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.671 0.748 . . . . 0.0 112.359 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.7 m -98.87 111.39 23.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.943 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -107.92 156.75 8.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.502 0.667 . . . . 0.0 112.594 -169.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -120.14 104.69 43.32 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.032 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.426 ' HA ' ' OE1' ' A' ' 21' ' ' GLN . 72.1 Cg_endo -75.05 -5.22 16.5 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.829 2.353 . . . . 0.0 112.13 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.63 -78.76 1.96 Allowed Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.997 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.8 p -160.75 166.99 27.76 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.491 -0.189 . . . . 0.0 110.491 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 66.69 38.25 4.01 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.604 0.565 . . . . 0.0 111.9 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -77.63 132.4 38.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.155 0.503 . . . . 0.0 111.312 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.584 ' HB ' HG13 ' A' ' 10' ' ' VAL . 10.8 t -126.33 159.3 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.443 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.6 t -98.96 117.67 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.888 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -111.76 173.17 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.54 -178.34 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -122.67 -164.93 1.23 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.646 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -58.24 -44.95 88.53 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.35 -33.64 37.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.351 0.596 . . . . 0.0 110.96 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -63.4 -16.38 60.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.743 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.737 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.9 OUTLIER -81.8 -50.6 9.04 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -172.169 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.68 -70.5 0.1 Allowed 'General case' 0 C--O 1.247 0.964 0 CA-C-O 121.569 0.7 . . . . 0.0 112.613 -165.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.439 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -60.94 -49.4 77.59 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.376 -174.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.421 ' H ' ' CD ' ' A' ' 66' ' ' GLU . . . -64.88 -38.32 90.57 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.626 -175.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.796 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 25.5 tt0 -69.62 -41.6 75.45 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.057 -174.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -58.49 -57.49 12.73 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.674 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -63.62 -45.93 88.06 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.725 0.774 . . . . 0.0 111.157 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.719 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -81.45 -16.42 52.07 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.03 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.98 -39.72 61.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.35 -25.74 68.44 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.671 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -82.2 -56.54 3.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.972 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.6 -62.17 1.86 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.666 0.787 . . . . 0.0 112.413 -174.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.238 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.235 -174.418 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 70.7 t60 . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.2 152.4 19.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.74 0.305 . . . . 0.0 110.921 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.408 ' HD2' ' CG ' ' A' ' 7' ' ' ASP . 12.6 tmtt? -139.9 129.44 24.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.403 ' O ' ' HD3' ' A' ' 4' ' ' LYS . 7.4 p -80.24 141.2 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.024 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.04 6.86 71.14 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.408 ' CG ' ' HD2' ' A' ' 4' ' ' LYS . 1.1 m-20 -123.09 173.43 7.86 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.682 ' HB2' HG21 ' A' ' 59' ' ' VAL . 98.3 m-85 -107.92 152.9 23.81 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.37 0.605 . . . . 0.0 111.881 -173.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.79 HD12 ' HG3' ' A' ' 52' ' ' PRO . 6.8 tt -103.02 141.79 35.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.332 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 3.4 t -145.81 144.3 21.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 O-C-N 124.71 1.256 . . . . 0.0 109.707 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.1 m . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 121.194 0.521 . . . . 0.0 109.952 170.732 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.4 t0 . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 119.468 -0.301 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.609 ' N ' ' HB2' ' A' ' 71' ' ' ALA . 68.5 mt-30 38.19 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.767 1.227 . . . . 0.0 112.954 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.727 ' CE1' ' HA ' ' A' ' 64' ' ' HIS . 41.3 t-80 -133.37 139.9 47.06 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -169.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -168.02 -179.95 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.627 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.594 ' CD ' HD12 ' A' ' 42' ' ' LEU . 45.7 tt0 -98.58 129.57 45.12 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.036 0.446 . . . . 0.0 111.12 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.679 HD11 ' HB2' ' A' ' 9' ' ' LEU . 45.7 mt -92.01 105.54 16.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.765 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -102.47 -26.32 3.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.817 177.361 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 37.0 tt0 -129.69 119.83 24.16 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.405 0.621 . . . . 0.0 110.364 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.21 121.44 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.205 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -64.36 -33.58 76.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.98 0.419 . . . . 0.0 110.599 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.9 t -149.76 128.17 12.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.52 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.92 -23.06 67.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 0.0 111.006 -176.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.38 -17.63 64.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.411 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.38 5.49 39.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.336 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 6.6 m -67.54 122.53 83.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.572 0.225 . . . . 0.0 110.999 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 15.9 Cg_exo -68.65 165.52 29.14 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.412 2.741 . . . . 0.0 111.924 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 83.2 Cg_endo -80.56 -175.56 16.35 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.982 -1.258 . . . . 0.0 113.085 1.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -123.83 148.41 46.76 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 96.3 t -98.66 101.71 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 173.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.92 145.58 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.659 -163.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HG3' ' HG3' ' A' ' 47' ' ' GLU . 55.4 ttt180 -121.22 130.04 53.49 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.054 -176.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 13.0 m95 -79.79 96.24 6.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.594 HD12 ' CD ' ' A' ' 24' ' ' GLU . 20.1 mt -72.85 -61.28 1.87 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.352 0.596 . . . . 0.0 110.834 -173.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.463 HG22 ' OE2' ' A' ' 68' ' ' GLU . 2.0 m -73.93 -5.83 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.333 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 54.9 m-80 -98.61 -62.73 1.2 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.903 173.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.9 63.58 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.526 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -167.38 155.22 9.11 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.14 0.495 . . . . 0.0 111.794 173.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HG3' ' HG3' ' A' ' 40' ' ' ARG . 3.7 mp0 -111.77 141.91 44.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.094 175.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.451 HG21 HG21 ' A' ' 50' ' ' VAL . 8.8 t -165.89 179.84 5.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.583 0.706 . . . . 0.0 112.159 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 m -125.22 106.03 9.58 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.832 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.451 HG21 HG21 ' A' ' 48' ' ' THR . 70.3 t -109.42 147.43 13.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.32 0.581 . . . . 0.0 111.867 -169.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 62.2 m-85 -107.69 99.77 31.27 Favored Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.325 170.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.79 ' HG3' HD12 ' A' ' 9' ' ' LEU . 84.5 Cg_endo -82.12 -22.8 4.81 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.835 2.357 . . . . 0.0 111.805 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.49 -143.4 14.32 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 m -135.48 16.63 3.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.56 0.68 . . . . 0.0 110.687 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -106.49 16.46 24.62 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.124 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.51 114.68 3.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.986 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.801 HG23 ' H ' ' A' ' 58' ' ' VAL . 10.5 p -98.94 175.96 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.801 ' H ' HG23 ' A' ' 57' ' ' VAL . 46.5 t -119.36 125.1 74.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.291 -172.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.682 HG21 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -122.42 175.75 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.534 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -117.45 -167.12 1.27 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.525 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -59.66 -41.17 90.01 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -170.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.92 -46.25 62.8 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.893 -0.504 . . . . 0.0 111.462 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -62.35 -16.46 54.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.616 0.722 . . . . 0.0 109.947 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.727 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -73.47 -43.78 59.46 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.18 -176.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.58 -72.69 0.09 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.641 0.734 . . . . 0.0 112.295 -168.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.823 ' HA ' ' HE2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -61.84 -45.87 91.93 Favored 'General case' 0 C--O 1.253 1.254 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.42 -174.064 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.423 ' HA ' HH21 ' A' ' 70' ' ' ARG . . . -58.49 -46.22 87.11 Favored 'General case' 0 C--O 1.204 -1.311 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.245 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 15.4 tt0 -65.31 -39.68 92.79 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.906 -171.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.823 ' HE2' ' HA ' ' A' ' 66' ' ' GLU . 57.3 pttt -64.19 -56.61 13.53 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.883 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.423 HH21 ' HA ' ' A' ' 67' ' ' ALA . 59.9 mtm180 -60.91 -44.7 96.81 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.547 1.165 . . . . 0.0 110.752 -177.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.609 ' HB2' ' N ' ' A' ' 21' ' ' GLN . . . -80.47 -16.52 54.13 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.416 -172.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.2 -35.81 66.4 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.059 170.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -29.67 70.04 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.659 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 12.7 mmt180 -81.92 -58.13 3.11 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 21' ' ' GLN . . . -63.06 -63.48 1.19 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.025 0.53 . . . . 0.0 111.514 -174.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.603 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.206 -175.021 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 3.6 m-70 . . . . . 0 CA--C 1.516 -0.338 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.469 ' HB3' ' CD1' ' A' ' 25' ' ' ILE . . . -138.34 140.48 39.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 111.471 -163.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.836 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 28.8 mmtp -138.49 140.68 39.29 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.211 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 26' ' ' ILE . 24.7 t -70.23 136.36 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 O-C-N 122.211 -0.306 . . . . 0.0 111.23 176.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.98 17.41 51.5 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.836 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.6 m-20 -138.97 144.17 38.86 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.439 -1.881 . . . . 0.0 108.288 -166.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.823 ' CD1' ' HB2' ' A' ' 24' ' ' GLU . 74.6 m-85 -134.96 141.81 46.34 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -148.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.868 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 1.3 tt -136.71 139.56 42.02 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -152.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.664 HG22 ' CD2' ' A' ' 22' ' ' HIS . 3.9 t -139.14 140.58 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 O-C-N 126.683 2.489 . . . . 0.0 109.371 -167.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.912 HG22 ' HB2' ' A' ' 21' ' ' GLN . 14.6 m . . . . . 0 C--N 1.32 -0.705 0 CA-C-O 121.066 0.46 . . . . 0.0 110.604 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.681 ' OD1' ' HB3' ' A' ' 74' ' ' ARG . 2.1 t70 . . . . . 0 C--O 1.217 -0.622 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.912 ' HB2' HG22 ' A' ' 11' ' ' VAL . 75.3 mt-30 45.03 91.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.674 0.79 . . . . 0.0 111.413 -173.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.868 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.1 t-80 -138.85 116.24 11.21 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 121.255 0.55 . . . . 0.0 112.075 -168.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.559 ' HB1' ' NE1' ' A' ' 41' ' ' TRP . . . -139.65 -178.8 5.57 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.141 -1.391 . . . . 0.0 108.475 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.823 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 3.3 tm-20 -137.28 122.59 19.38 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.24 1.019 . . . . 0.0 110.312 -177.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.888 HG22 HG23 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -80.08 113.96 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 113.459 -1.701 . . . . 0.0 111.004 -174.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.725 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -98.86 -8.71 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.111 169.418 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.721 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -138.97 127.15 22.62 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.498 177.198 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.403 ' CG2' ' HB ' ' A' ' 25' ' ' ILE . 54.7 t -138.03 100.0 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.795 -169.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -103.81 20.35 18.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.163 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.528 ' HB3' ' H ' ' A' ' 34' ' ' SER . 3.6 m -108.88 111.08 22.6 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.434 177.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.06 93.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.31 0.576 . . . . 0.0 110.405 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 32.9 t70 -95.33 -56.83 2.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.007 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.1 70.37 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.422 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.528 ' H ' ' HB3' ' A' ' 30' ' ' SER . 20.0 t -150.25 142.6 15.79 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.32 151.56 9.5 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.467 2.778 . . . . 0.0 113.102 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.572 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.8 Cg_endo -85.51 -177.2 15.3 Favored 'Cis proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.108 -1.622 . . . . 0.0 113.664 3.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -138.78 173.36 11.65 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.157 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.721 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 72.4 t -137.78 114.47 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.453 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.888 HG23 HG22 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -138.75 165.3 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-N 111.965 -2.38 . . . . 0.0 107.664 -149.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.603 ' HB2' HD12 ' A' ' 26' ' ' ILE . 33.4 ttt180 -138.66 127.52 23.69 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.493 -172.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.608 ' CZ3' HG21 ' A' ' 48' ' ' THR . 3.4 m0 -86.99 83.79 7.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.532 HD13 ' CE1' ' A' ' 8' ' ' TYR . 8.0 mt -60.28 -64.22 1.03 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.986 -166.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.613 HG12 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -60.11 -33.07 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.216 -176.235 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 0.9 OUTLIER -60.53 -65.39 0.69 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.167 0.508 . . . . 0.0 110.792 168.505 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.33 39.11 0.6 Allowed Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.728 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -139.16 171.31 14.48 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 117.126 0.463 . . . . 0.0 110.457 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' HG3' ' HG3' ' A' ' 40' ' ' ARG . 1.7 mp0 -138.2 127.46 24.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.82 HG22 HG13 ' A' ' 39' ' ' VAL . 10.0 t -139.42 -179.64 6.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -164.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.6 m -138.48 120.55 15.62 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.593 HG23 ' H ' ' A' ' 51' ' ' TYR . 4.9 p -138.81 172.75 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.524 -160.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.593 ' H ' HG23 ' A' ' 50' ' ' VAL . 41.7 m-85 -138.57 100.03 8.44 Favored Pre-proline 0 N--CA 1.455 -0.22 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.281 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.08 163.56 16.46 Favored 'Trans proline' 0 N--CA 1.477 0.548 0 C-N-CA 123.423 2.749 . . . . 0.0 112.668 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.526 ' H ' HG23 ' A' ' 11' ' ' VAL . . . -86.4 -133.82 3.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.097 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.636 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 47.3 t -99.45 160.94 13.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 63.3 47.92 3.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.23 0.538 . . . . 0.0 110.243 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.752 ' HA ' HG12 ' A' ' 11' ' ' VAL . . . -72.89 130.53 40.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.65 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.78 179.97 2.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.04 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.32 136.81 44.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.823 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 11.9 m -138.54 175.38 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 C-N-CA 125.461 1.505 . . . . 0.0 109.262 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.521 ' H ' ' HG1' ' A' ' 60' ' ' THR . 0.4 OUTLIER -108.62 -165.48 1.03 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.4 -177.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -56.77 -47.55 79.87 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -175.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -59.04 5.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.708 0.766 . . . . 0.0 111.433 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 18.3 mt-10 -56.98 -27.97 61.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.397 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.652 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -57.36 -48.49 78.9 Favored 'General case' 0 C--O 1.198 -1.639 0 CA-C-N 114.254 -1.339 . . . . 0.0 114.207 177.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . -56.94 -72.34 0.08 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 119.201 0.91 . . . . 0.0 112.616 -162.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.21 -54.85 42.11 Favored 'General case' 0 C--O 1.281 2.722 0 CA-C-O 122.809 1.29 . . . . 0.0 112.61 -176.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.89 -50.89 71.14 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.883 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.765 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 24.3 tt0 -57.25 -31.13 65.24 Favored 'General case' 0 C--O 1.202 -1.426 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 96.1 mttt -57.08 -70.98 0.11 Allowed 'General case' 0 C--O 1.26 1.61 0 CA-C-O 121.8 0.81 . . . . 0.0 109.708 172.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -57.04 -53.22 60.57 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 123.179 1.466 . . . . 0.0 110.818 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.66 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . . . -57.18 -43.8 82.95 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.925 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.08 -37.33 71.73 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 118.487 0.585 . . . . 0.0 110.202 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.82 -64.12 0.98 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.489 174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.681 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 9.4 ttp180 -57.73 -46.49 84.37 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.748 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -55.14 -34.87 64.13 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.05 0.54 . . . . 0.0 111.852 -175.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.43 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.564 178.554 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.545 ' CE1' HG22 ' A' ' 58' ' ' VAL . 2.7 p-80 . . . . . 0 CA--C 1.516 -0.348 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.823 ' HB2' ' HA2' ' A' ' 33' ' ' GLY . . . -138.91 105.11 5.23 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.59 ' HA ' HG21 ' A' ' 28' ' ' VAL . 50.5 mttp -139.11 165.23 27.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.175 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.977 HG22 ' HA ' ' A' ' 26' ' ' ILE . 7.4 p -70.88 151.58 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.363 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.92 14.5 59.26 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 65.4 m-20 -138.65 -179.08 5.61 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.817 ' HB2' HG23 ' A' ' 59' ' ' VAL . 97.6 m-85 -137.45 173.21 11.91 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -174.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.802 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.8 tt -138.43 136.34 36.13 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.255 -166.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 59.9 t -139.03 143.52 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 125.917 2.011 . . . . 0.0 108.995 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 52' ' ' PRO . 70.6 t . . . . . 0 C--N 1.321 -0.638 0 CA-C-O 121.063 0.459 . . . . 0.0 110.757 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.601 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 32.3 m-20 . . . . . 0 C--O 1.22 -0.495 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.913 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 2.2 mp0 52.88 84.88 0.05 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.296 0.373 . . . . 0.0 110.973 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.802 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 6.7 t-80 -134.55 133.91 40.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.875 -174.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.451 ' N ' ' HD1' ' A' ' 22' ' ' HIS . . . -178.42 178.02 0.9 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.341 175.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.719 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 42.3 tt0 -98.45 131.38 44.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.457 0.646 . . . . 0.0 111.759 -174.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 26.7 mt -86.75 108.91 18.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.338 177.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.977 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -109.51 -28.02 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.517 176.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.853 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 14.7 mt-10 -120.25 111.98 18.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.59 HG21 ' HA ' ' A' ' 4' ' ' LYS . 47.2 t -98.81 115.36 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.09 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -64.62 -52.48 57.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.199 0.523 . . . . 0.0 110.193 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 43.4 m -117.55 110.42 17.92 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.362 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.426 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -63.63 -18.64 64.15 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.376 -170.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.16 -38.85 91.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.354 0.597 . . . . 0.0 110.107 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.823 ' HA2' ' HB2' ' A' ' 3' ' ' ALA . . . 129.08 53.42 0.11 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.533 -175.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 9.8 m -134.18 142.03 41.61 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.532 0.206 . . . . 0.0 110.658 -176.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.85 164.82 34.28 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.962 2.442 . . . . 0.0 111.898 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 73.1 Cg_endo -76.0 -179.59 27.56 Favored 'Cis proline' 0 C--N 1.347 0.463 0 C-N-CA 123.794 -1.336 . . . . 0.0 112.783 -0.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -131.04 142.72 50.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.216 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.853 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 58.3 t -98.62 103.4 14.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 170.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.09 138.85 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.81 -163.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.9 ' HG3' ' HB3' ' A' ' 47' ' ' GLU . 51.9 ttt180 -103.91 128.88 51.41 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.237 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.756 ' CE3' ' HB3' ' A' ' 72' ' ' ALA . 2.4 m0 -95.59 89.38 5.35 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.568 HD11 ' CD ' ' A' ' 24' ' ' GLU . 14.2 mt -70.48 -60.94 1.97 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.168 -165.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.545 HG12 ' CE1' ' A' ' 64' ' ' HIS . 3.1 m -77.76 -4.52 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.964 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.646 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 50.7 m-80 -93.84 -62.84 1.28 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.172 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.59 -80.09 0.1 Allowed Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.073 -1.06 . . . . 0.0 113.879 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.419 ' O ' ' HB2' ' A' ' 41' ' ' TRP . 20.7 m-70 -98.9 176.46 5.59 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.888 0.375 . . . . 0.0 111.903 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.9 ' HB3' ' HG3' ' A' ' 40' ' ' ARG . 13.7 pt-20 -120.03 152.06 38.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.387 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -167.06 178.35 5.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.526 0.679 . . . . 0.0 111.168 -176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.0 m -98.84 118.58 35.92 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.016 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.61 146.08 27.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 111.29 -172.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.535 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 75.8 m-85 -109.41 101.37 45.49 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.289 171.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HB2' HG23 ' A' ' 11' ' ' VAL . 72.2 Cg_endo -75.29 -10.87 20.92 Favored 'Trans proline' 0 N--CA 1.473 0.306 0 C-N-CA 122.962 2.441 . . . . 0.0 112.605 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.63 -102.52 2.88 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.677 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.9 m -153.31 171.11 19.08 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 62.2 41.06 11.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.309 0.576 . . . . 0.0 110.986 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.4 112.96 15.96 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.719 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.2 t -98.91 152.47 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.545 HG22 ' CE1' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -100.69 113.27 36.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.467 0.651 . . . . 0.0 111.867 -176.037 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.817 HG23 ' HB2' ' A' ' 8' ' ' TYR . 4.1 m -102.23 169.25 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.393 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.7 p -115.84 -163.73 0.91 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 -175.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -52.91 -46.89 68.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.23 -48.45 28.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.324 0.583 . . . . 0.0 110.866 -174.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 25.5 mt-10 -59.47 -16.6 25.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.038 176.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.724 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -75.9 -50.27 15.5 Favored 'General case' 0 C--O 1.205 -1.288 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.595 -177.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.36 -72.0 0.08 Allowed 'General case' 0 C--O 1.247 0.968 0 CA-C-O 121.779 0.799 . . . . 0.0 112.844 -163.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -66.16 -46.89 75.85 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.856 -172.304 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.42 -26.44 66.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.494 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.694 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 27.1 tt0 -73.62 -45.0 55.54 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.678 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 20.6 pttp -60.53 -47.86 84.33 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.438 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.491 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 10.9 ptp85 -68.06 -52.09 39.21 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.702 0.763 . . . . 0.0 111.669 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.601 ' HB2' ' HA ' ' A' ' 20' ' ' ASP . . . -77.98 -17.97 56.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.342 -169.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.756 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . . . -80.48 -37.18 32.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.389 173.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.02 -32.64 61.99 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.739 -0.384 . . . . 0.0 109.979 171.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -81.88 -37.19 27.26 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.684 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.913 ' HB3' ' HA ' ' A' ' 21' ' ' GLN . . . -59.52 -48.48 81.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.555 -172.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.912 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.365 -177.149 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.3 m170 . . . . . 0 CA--C 1.519 -0.244 0 CA-C-O 120.896 0.379 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.86 153.95 46.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.162 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.89 173.35 7.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.923 0.392 . . . . 0.0 110.496 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' A' ' 26' ' ' ILE . 1.7 p -73.76 136.47 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.933 175.271 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.99 8.33 60.47 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -175.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.443 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 68.4 m-20 -107.38 161.72 14.56 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.775 ' CD1' ' HA ' ' A' ' 61' ' ' ALA . 1.2 m-85 -103.52 146.79 28.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.413 0.625 . . . . 0.0 111.764 -176.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.578 HD23 ' HB3' ' A' ' 52' ' ' PRO . 9.8 tt -99.47 132.75 44.59 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.604 175.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.713 HG12 ' CE1' ' A' ' 22' ' ' HIS . 54.2 t -127.98 147.42 32.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 O-C-N 124.638 1.211 . . . . 0.0 109.29 174.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 52' ' ' PRO . 53.7 t . . . . . 0 C--N 1.318 -0.773 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 171.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 21' ' ' GLN . 5.8 t70 . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.749 ' N ' ' HB1' ' A' ' 71' ' ' ALA . 22.9 mt-30 58.83 94.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.206 0.602 . . . . 0.0 111.165 -177.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.713 ' CE1' HG12 ' A' ' 10' ' ' VAL . 3.4 m-70 -132.11 145.81 51.63 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.251 -0.281 . . . . 0.0 111.415 -173.498 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.649 ' HA ' ' HG3' ' A' ' 68' ' ' GLU . . . -179.04 176.09 0.92 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.568 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 41.4 tt0 -98.35 145.91 26.23 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.446 0.641 . . . . 0.0 111.201 -174.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.15 113.0 38.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.735 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -105.78 -15.5 8.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.894 0.378 . . . . 0.0 111.039 -178.622 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.949 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 37.7 mt-10 -132.15 103.59 6.34 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.658 0.742 . . . . 0.0 109.544 174.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.04 99.97 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.81 -176.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -104.56 53.57 0.73 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.603 0.716 . . . . 0.0 109.676 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.8 t -152.48 123.11 7.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.53 177.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.52 -26.27 20.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -89.88 -25.07 21.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.764 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.42 72.76 1.04 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.422 177.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 68.9 m -146.03 150.04 40.82 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.7 0.286 . . . . 0.0 110.886 178.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 19.5 Cg_exo -66.87 167.63 19.11 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.279 2.653 . . . . 0.0 112.062 177.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.99 154.66 94.11 Favored 'Cis proline' 0 C--N 1.345 0.366 0 C-N-CA 123.803 -1.332 . . . . 0.0 112.408 1.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -110.92 146.94 35.68 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.025 178.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.949 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 61.7 t -98.69 103.9 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 24' ' ' GLU . 53.2 t -116.19 121.51 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.013 -166.202 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.699 ' HB2' HD13 ' A' ' 26' ' ' ILE . 42.9 ttt180 -101.97 133.28 47.02 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.021 176.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.573 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 5.5 m0 -97.75 113.33 25.08 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.52 -49.69 17.94 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.884 0.373 . . . . 0.0 111.617 -167.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.728 ' HB ' ' HE2' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -93.96 -15.59 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.271 -176.356 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.573 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 33.0 m-80 -84.26 -36.23 22.82 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.875 175.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.01 34.73 9.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.654 177.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -123.59 166.81 14.83 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.522 -0.399 . . . . 0.0 110.438 179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -141.21 116.33 9.93 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 p -136.23 170.46 15.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.267 0.556 . . . . 0.0 112.254 -167.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.3 m -118.32 100.04 7.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 166.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.0 m -99.58 156.6 3.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-O 121.685 0.755 . . . . 0.0 112.776 -167.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -119.68 99.91 49.32 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.973 168.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.578 ' HB3' HD23 ' A' ' 9' ' ' LEU . 26.0 Cg_endo -63.7 -51.07 2.64 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.861 2.374 . . . . 0.0 112.868 -174.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.21 -117.02 1.55 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -175.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.3 m -129.64 154.13 47.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 62.65 58.05 1.69 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.931 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.66 119.44 26.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.205 0.526 . . . . 0.0 110.837 179.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 t -101.07 159.72 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.472 -178.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 4.1 p -121.14 118.77 57.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.358 0.599 . . . . 0.0 111.326 -178.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.589 HG22 ' CB ' ' A' ' 8' ' ' TYR . 2.4 m -116.64 -179.93 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 123.408 0.683 . . . . 0.0 111.411 -178.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -80.98 166.4 20.86 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.732 174.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.775 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . . . -68.86 -66.54 0.56 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.598 -169.58 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 p -80.73 -25.06 38.31 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -167.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -53.94 -58.94 5.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.612 0.72 . . . . 0.0 109.578 175.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.462 ' CE1' HG13 ' A' ' 59' ' ' VAL . 11.3 m-70 -82.44 -16.5 48.7 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.472 ' O ' HG21 ' A' ' 43' ' ' VAL . . . -45.39 -39.55 7.04 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -63.08 -44.39 95.88 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-O 123.564 1.65 . . . . 0.0 109.127 177.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.436 ' CB ' ' HD2' ' A' ' 22' ' ' HIS . . . -66.3 -16.59 64.16 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.418 173.246 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.651 ' HB2' ' HE2' ' A' ' 8' ' ' TYR . 10.3 tt0 -69.82 -40.09 76.12 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 171.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.728 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 66.7 mmtt -51.07 -61.65 2.1 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.123 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -62.26 1.89 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.744 1.259 . . . . 0.0 112.076 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.749 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -78.31 -16.96 57.21 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.197 -165.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.569 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -81.74 -34.54 30.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 118.645 0.657 . . . . 0.0 109.316 173.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.82 -36.14 64.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 170.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -74.7 -55.54 5.76 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.987 174.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -49.08 -56.94 7.53 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.743 0.817 . . . . 0.0 111.967 -176.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.499 ' HA3' ' HH2' ' A' ' 41' ' ' TRP . . . . . . . . 0 N--CA 1.444 -0.799 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.822 -176.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.901 0.381 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.86 140.81 38.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.338 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -139.12 164.24 30.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.959 0.409 . . . . 0.0 111.249 -177.37 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.798 HG22 ' HA ' ' A' ' 26' ' ' ILE . 4.0 p -65.15 145.43 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.939 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.06 17.28 41.08 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -174.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 7.6 m-20 -138.76 -179.06 5.6 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 113.902 -1.149 . . . . 0.0 108.415 -174.31 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.808 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 95.4 m-85 -137.02 164.93 27.2 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.314 -168.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 6.7 tt -138.63 142.2 39.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.769 -166.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.853 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 3.5 t -138.88 -179.99 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.276 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.755 ' H ' HG13 ' A' ' 10' ' ' VAL . 41.2 t . . . . . 0 C--N 1.312 -1.054 0 CA-C-O 121.648 0.737 . . . . 0.0 109.588 176.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 9.4 m-20 . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.853 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 4.7 mt-30 63.0 98.19 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.857 0.723 . . . . 0.0 110.197 -170.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.993 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 21.3 t-80 -139.05 121.43 16.04 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.354 0.597 . . . . 0.0 111.81 -175.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.77 -178.23 5.33 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 125.222 1.409 . . . . 0.0 110.239 -177.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.808 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 26.6 tt0 -136.75 123.58 21.28 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.478 1.133 . . . . 0.0 109.079 174.016 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.716 ' HB ' HG23 ' A' ' 28' ' ' VAL . 4.6 pt -82.69 115.42 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.96 -174.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.798 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -108.01 -8.41 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 113.808 -1.542 . . . . 0.0 108.477 170.435 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.596 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -138.9 122.22 17.09 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.447 175.437 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.716 HG23 ' HB ' ' A' ' 25' ' ' ILE . 20.8 t -138.49 119.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.877 -165.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 29' ' ' ARG . 5.0 mmp_? -68.87 -35.79 77.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -174.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.8 m -147.68 149.59 32.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.757 -176.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.45 -14.71 59.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.142 0.496 . . . . 0.0 110.694 -179.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.89 -72.75 0.37 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.256 0.55 . . . . 0.0 110.001 176.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.91 88.05 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.527 -177.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -143.47 125.1 8.33 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.36 161.0 38.37 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.729 2.286 . . . . 0.0 111.534 175.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.32 -175.07 15.75 Favored 'Cis proline' 0 C--N 1.342 0.234 0 C-N-CA 123.732 -1.362 . . . . 0.0 113.392 2.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -138.87 169.55 17.6 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.594 178.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 84.2 t -137.96 116.47 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.041 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.521 HG12 HG22 ' A' ' 48' ' ' THR . 0.4 OUTLIER -138.86 174.61 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 112.676 -2.056 . . . . 0.0 109.272 -152.558 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.836 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 62.9 mtt180 -138.67 133.56 32.51 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.725 ' HD1' ' HB2' ' A' ' 46' ' ' HIS . 16.1 m95 -79.53 84.6 5.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 166.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.586 HD12 ' CD ' ' A' ' 24' ' ' GLU . 6.5 mt -60.08 -64.21 1.03 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.2 0.524 . . . . 0.0 111.617 -167.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.713 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -60.03 -35.5 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.121 -176.623 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -60.53 -60.67 3.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.797 171.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.07 39.68 0.68 Allowed Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.113 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.725 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 37.5 m80 -139.16 167.11 22.79 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.119 0.459 . . . . 0.0 111.134 178.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.836 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 6.7 pt-20 -138.86 128.79 25.11 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.487 173.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.556 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 8.9 t -139.74 -179.26 5.82 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.758 -163.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.9 m -138.25 116.83 12.13 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.688 HG11 ' H ' ' A' ' 51' ' ' TYR . 1.6 t -138.69 175.95 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.193 0.521 . . . . 0.0 111.304 -162.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.688 ' H ' HG11 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -138.82 107.27 7.56 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.78 -178.758 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.71 141.33 90.33 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.736 2.291 . . . . 0.0 111.755 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.95 67.0 2.14 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.557 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t 67.22 173.12 0.26 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.944 0.438 . . . . 0.0 110.957 179.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 56.18 38.33 29.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.221 174.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.2 139.8 54.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.328 -176.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.861 HG23 ' H ' ' A' ' 58' ' ' VAL . 5.7 p -138.93 -179.7 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.832 177.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.861 ' H ' HG23 ' A' ' 57' ' ' VAL . 56.1 t -138.45 136.27 43.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.785 -171.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.728 HG22 ' HB2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -138.87 179.92 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 C-N-CA 123.355 0.662 . . . . 0.0 111.284 -174.17 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.9 p -120.55 -172.31 2.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.349 -176.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.02 -48.44 78.48 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -172.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -55.75 30.74 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.565 -0.71 . . . . 0.0 111.437 -178.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -56.98 -29.86 63.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.87 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.713 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.22 -45.32 83.96 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.286 -179.446 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.535 ' HA ' HG12 ' A' ' 43' ' ' VAL . . . -56.85 -73.4 0.06 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.912 0.863 . . . . 0.0 111.534 -167.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.44 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -57.08 -61.71 2.27 Favored 'General case' 0 C--O 1.268 2.059 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.671 -177.272 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.15 -50.21 73.54 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.462 -175.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.993 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 29.6 tt0 -57.14 -37.89 72.68 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 118.0 0.364 . . . . 0.0 111.575 -177.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -56.93 -68.12 0.25 Allowed 'General case' 0 C--O 1.253 1.24 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.572 176.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -57.28 -58.23 9.16 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 122.776 1.274 . . . . 0.0 111.675 -177.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.635 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -57.32 -25.23 59.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.321 -178.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.46 -40.95 73.4 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 118.894 0.77 . . . . 0.0 109.827 175.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.51 62.68 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.019 172.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.417 ' HG2' ' HB3' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -74.21 -57.16 4.13 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 176.263 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -51.12 -44.61 61.35 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.556 0.946 . . . . 0.0 113.556 -169.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.218 0 C-N-CA 119.8 -1.191 . . . . 0.0 112.651 -174.044 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 . . . . . 0 CA--C 1.517 -0.293 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.91 139.66 38.11 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.702 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 91.6 mttt -139.35 140.77 37.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.239 -173.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.804 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -71.29 139.63 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 169.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.55 13.82 66.93 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -172.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.702 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 1.8 m-20 -139.11 143.81 38.43 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.109 -2.045 . . . . 0.0 107.655 -167.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.813 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 33.2 m-85 -135.63 142.6 45.24 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -148.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.761 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 2.3 tt -136.69 140.2 42.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 119.334 0.97 . . . . 0.0 110.244 -156.473 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.614 HG22 ' HD1' ' A' ' 22' ' ' HIS . 42.3 t -138.87 140.75 38.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.211 -168.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.542 HG23 ' HA ' ' A' ' 56' ' ' ALA . 72.0 t . . . . . 0 C--N 1.32 -0.712 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -176.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t0 . . . . . 0 C--O 1.222 -0.354 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.709 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 51.8 mt-30 39.7 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.699 0.8 . . . . 0.0 112.817 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.761 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 54.7 t60 -138.57 138.98 38.46 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 122.634 1.207 . . . . 0.0 113.397 -176.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.588 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -140.43 -177.87 5.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 112.19 -2.277 . . . . 0.0 110.926 -174.011 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.813 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 10.7 tt0 -136.69 122.17 19.52 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 123.007 1.384 . . . . 0.0 108.046 166.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 66.0 mt -81.52 107.69 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 111.652 -2.522 . . . . 0.0 110.242 -170.028 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.804 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -102.38 -14.12 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.629 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 48.9 mm-40 -139.02 150.36 45.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.577 174.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.46 HG22 ' CG2' ' A' ' 25' ' ' ILE . 17.7 t -137.83 100.11 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -170.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -89.23 -29.08 19.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.663 -163.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.9 p -68.94 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.495 -176.378 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -176.95 -64.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.285 0.564 . . . . 0.0 109.954 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -151.05 88.13 1.44 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.905 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.64 172.84 44.11 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.218 -173.054 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m 69.36 156.76 0.15 Allowed Pre-proline 0 N--CA 1.467 0.419 0 CA-C-O 120.953 0.406 . . . . 0.0 111.529 178.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.402 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 8.8 Cg_exo -73.03 163.92 36.94 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.815 2.344 . . . . 0.0 112.331 178.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.543 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 18.9 Cg_endo -94.61 -178.01 7.35 Favored 'Cis proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.809 -1.329 . . . . 0.0 112.681 -1.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -138.83 174.27 10.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.059 177.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 89.6 t -138.03 114.54 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 174.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' A' ' 25' ' ' ILE . 0.4 OUTLIER -139.02 175.25 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.818 -153.658 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.775 ' HB2' HD22 ' A' ' 42' ' ' LEU . 84.7 mtt180 -138.51 134.96 34.6 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.74 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 12.2 m95 -80.1 81.02 6.44 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 166.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.775 HD22 ' HB2' ' A' ' 40' ' ' ARG . 3.7 mt -59.92 -67.8 0.35 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.515 0.509 . . . . 0.0 111.932 -162.573 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.54 HG21 ' OE2' ' A' ' 68' ' ' GLU . 0.9 OUTLIER -59.96 -31.19 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.974 -175.716 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.58 HD22 ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -60.59 -62.99 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.177 0.513 . . . . 0.0 110.591 169.637 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.05 43.16 0.34 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.811 -0.632 . . . . 0.0 113.576 177.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.74 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 44.6 t-80 -139.35 164.01 30.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 117.527 0.664 . . . . 0.0 111.069 178.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 42.0 tt0 -138.44 122.09 17.45 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.223 0.535 . . . . 0.0 110.023 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.47 HG23 ' CZ2' ' A' ' 41' ' ' TRP . 14.8 t -139.68 -179.0 5.67 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -165.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.8 m -138.15 110.55 7.45 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.73 -179.74 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -160.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.543 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 2.3 m-85 -138.78 125.64 12.95 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.048 -178.389 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.502 ' HB2' HG21 ' A' ' 11' ' ' VAL . 56.5 Cg_endo -74.37 -78.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.673 2.249 . . . . 0.0 113.234 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.41 -154.44 23.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.862 -178.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.7 m -87.62 159.1 18.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.569 0.184 . . . . 0.0 110.559 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 t70 65.91 39.85 4.4 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.94 0.876 . . . . 0.0 108.859 -174.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.542 ' HA ' HG23 ' A' ' 11' ' ' VAL . . . -79.9 137.74 36.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.126 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.723 HG11 ' H ' ' A' ' 58' ' ' VAL . 3.4 t -138.71 175.65 7.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -174.143 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.723 ' H ' HG11 ' A' ' 57' ' ' VAL . 58.9 t -138.34 138.33 43.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.613 0.72 . . . . 0.0 110.648 -175.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 3.1 m -138.62 179.99 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 C-N-CA 125.74 1.616 . . . . 0.0 110.023 -174.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.423 HG21 ' N ' ' A' ' 61' ' ' ALA . 5.9 t -121.85 -159.28 0.81 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.123 -174.572 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.423 ' N ' HG21 ' A' ' 60' ' ' THR . . . -56.99 -48.23 78.91 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.408 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.423 ' H ' HG21 ' A' ' 60' ' ' THR . 0.2 OUTLIER -57.35 -58.59 7.6 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 122.013 -0.429 . . . . 0.0 112.128 -179.697 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 29.5 mm-40 -57.15 -28.12 62.46 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.677 0.751 . . . . 0.0 110.307 -178.295 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.721 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.12 -42.52 81.04 Favored 'General case' 0 C--O 1.206 -1.233 0 CA-C-N 114.627 -1.17 . . . . 0.0 113.563 -176.707 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.2 -75.92 0.04 OUTLIER 'General case' 0 C--O 1.244 0.793 0 CA-C-O 122.331 1.062 . . . . 0.0 111.669 -170.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.576 ' HB2' ' NH1' ' A' ' 70' ' ' ARG . 1.2 pt-20 -57.24 -51.59 68.75 Favored 'General case' 0 C--O 1.265 1.915 0 CA-C-N 113.798 -1.547 . . . . 0.0 112.035 -177.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.11 -49.82 74.7 Favored 'General case' 0 C--O 1.2 -1.527 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.766 -178.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.721 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 4.4 tt0 -57.0 -35.73 69.57 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 118.019 0.372 . . . . 0.0 111.2 -176.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.58 ' HA ' HD22 ' A' ' 44' ' ' ASN . 93.6 mttt -57.13 -74.46 0.05 Allowed 'General case' 0 C--O 1.254 1.316 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.631 172.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.576 ' NH1' ' HB2' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -57.27 -60.87 2.98 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.908 1.337 . . . . 0.0 111.256 -173.978 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.541 ' HB3' ' N ' ' A' ' 21' ' ' GLN . . . -57.08 -51.15 70.43 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 112.928 -1.942 . . . . 0.0 113.869 -175.268 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 68' ' ' GLU . . . -57.31 -36.15 70.74 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 118.463 0.574 . . . . 0.0 111.081 -179.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.87 -48.76 77.4 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.835 174.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -57.57 -65.97 0.54 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 175.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.709 ' HB3' ' HA ' ' A' ' 21' ' ' GLN . . . -50.29 -37.11 34.63 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.99 0.916 . . . . 0.0 113.378 -166.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.21 0 C-N-CA 118.896 -1.621 . . . . 0.0 113.535 -172.405 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.343 0.592 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.83 166.36 10.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.286 -178.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -134.79 173.87 11.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.869 176.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.775 HG22 ' HA ' ' A' ' 26' ' ' ILE . 7.3 p -80.97 143.68 11.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.039 0.447 . . . . 0.0 110.642 177.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.5 8.97 67.36 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -177.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -108.06 174.43 5.88 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.713 ' CD1' ' HA ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER -104.57 138.13 41.37 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.267 0.556 . . . . 0.0 110.658 179.132 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.2 tt -99.02 136.84 38.42 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.852 179.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.738 HG22 ' CD2' ' A' ' 22' ' ' HIS . 55.4 t -133.16 160.38 42.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.801 174.29 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 44.6 t . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 118.052 0.387 . . . . 0.0 110.575 174.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 t70 . . . . . 0 C--O 1.224 -0.279 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.595 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.8 mp0 47.36 93.6 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.616 0.572 . . . . 0.0 112.208 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.856 ' HB2' ' HA ' ' A' ' 68' ' ' GLU . 20.8 m170 -125.49 141.52 52.0 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.894 -176.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.614 ' HA ' ' HG3' ' A' ' 68' ' ' GLU . . . -177.76 -179.85 0.83 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.833 0.708 . . . . 0.0 110.484 173.486 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.426 ' OE1' HD23 ' A' ' 42' ' ' LEU . 36.7 tt0 -98.77 131.61 44.77 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.287 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.504 ' HB ' HG22 ' A' ' 28' ' ' VAL . 3.8 pt -96.81 111.26 26.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.087 0.47 . . . . 0.0 110.839 178.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.775 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -104.2 -21.96 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.688 177.58 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 1.027 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 36.2 tt0 -123.45 99.96 6.58 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.403 0.62 . . . . 0.0 110.102 172.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.859 HG11 ' HE2' ' A' ' 37' ' ' TYR . 34.6 t -112.22 100.54 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.509 -178.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -95.14 11.83 30.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.135 0.493 . . . . 0.0 110.627 -176.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.1 t -136.62 126.03 25.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.601 -179.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.2 -20.74 25.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.586 -179.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.87 -29.0 22.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.288 179.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.581 ' HA2' ' OH ' ' A' ' 37' ' ' TYR . . . 104.4 73.19 0.91 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.764 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -142.98 128.24 10.04 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -177.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.728 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 21.3 Cg_endo -62.67 165.47 15.8 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.858 2.372 . . . . 0.0 112.231 177.223 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.19 156.61 83.19 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 124.011 -1.245 . . . . 0.0 113.248 3.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.859 ' HE2' HG11 ' A' ' 28' ' ' VAL . 34.3 m-85 -119.91 147.55 44.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.984 177.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 1.027 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 98.4 t -98.9 106.63 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -114.66 155.55 15.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.311 -163.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.709 ' HB2' HD13 ' A' ' 26' ' ' ILE . 23.9 ttt180 -128.86 115.76 18.38 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.048 -176.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.715 ' CB ' ' HB2' ' A' ' 44' ' ' ASN . 6.7 m95 -75.63 120.39 20.96 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.426 HD23 ' OE1' ' A' ' 24' ' ' GLU . 12.8 mt -88.42 -45.66 9.78 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.663 -176.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.647 HG21 ' O ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -90.75 -5.84 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.155 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.715 ' HB2' ' CB ' ' A' ' 41' ' ' TRP . 39.6 m-80 -96.06 -40.36 9.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 168.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.09 63.58 1.44 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.764 172.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.503 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 54.9 t60 -172.42 154.3 3.16 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.921 0.361 . . . . 0.0 110.42 176.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.602 ' HG2' ' HG3' ' A' ' 40' ' ' ARG . 38.6 mt-10 -113.33 145.91 40.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.104 178.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -172.11 176.83 3.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.47 0.652 . . . . 0.0 111.084 178.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.1 m -108.52 115.1 29.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.942 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.92 172.59 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.277 0.56 . . . . 0.0 111.68 -176.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -119.89 100.09 48.75 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.515 177.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.728 ' HD2' ' HB3' ' A' ' 35' ' ' PRO . 37.4 Cg_endo -66.08 -39.83 17.54 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.678 2.252 . . . . 0.0 112.486 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.94 -159.57 13.72 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.905 -178.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.519 ' O ' HG11 ' A' ' 11' ' ' VAL . 18.3 m -94.5 169.18 10.38 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.029 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 66.17 32.55 7.96 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.418 0.449 . . . . 0.0 110.765 178.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 11' ' ' VAL . . . -76.57 113.74 14.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.054 0.454 . . . . 0.0 111.008 -179.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.9 t -99.21 162.33 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.742 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.7 t -110.2 152.05 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.909 0.385 . . . . 0.0 111.235 -176.352 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.57 HG21 ' N ' ' A' ' 60' ' ' THR . 11.0 p -151.73 173.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.041 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.57 ' N ' HG21 ' A' ' 59' ' ' VAL . 47.8 p -90.2 169.39 11.18 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 175.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.713 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . . . -52.64 -64.55 0.78 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -172.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 p -75.18 -28.86 60.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -163.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -58.4 -62.6 1.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.103 0.478 . . . . 0.0 110.88 -176.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.498 ' HB2' HG12 ' A' ' 59' ' ' VAL . 3.2 m80 -81.95 -16.19 51.3 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.647 ' O ' HG21 ' A' ' 43' ' ' VAL . . . -43.36 -46.47 6.52 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -170.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -59.02 -48.69 80.69 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-O 123.37 1.557 . . . . 0.0 109.627 -179.167 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.65 -16.9 63.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.668 173.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.856 ' HA ' ' HB2' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -73.2 -40.88 64.39 Favored 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.679 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.552 ' HA ' ' ND2' ' A' ' 44' ' ' ASN . 46.4 tttp -53.62 -50.63 65.28 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -64.27 -66.12 0.59 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 122.129 0.966 . . . . 0.0 112.784 178.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.67 -16.9 62.84 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -169.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.648 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . . . -81.73 -33.78 30.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 173.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.75 -33.05 60.69 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.604 168.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 -76.74 -57.02 4.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.624 172.17 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -50.26 -51.52 44.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.846 0.859 . . . . 0.0 112.526 -176.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.201 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.959 -175.287 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.451 ' HB2' HG23 ' A' ' 58' ' ' VAL . . . -138.85 169.46 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.097 0.475 . . . . 0.0 112.062 -173.022 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 40.7 ttmt -139.3 166.13 25.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.412 -178.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 26' ' ' ILE . 6.1 p -71.53 142.65 15.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 173.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.1 16.18 45.31 Favored Glycine 0 N--CA 1.454 -0.147 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -173.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 64.7 m-20 -138.77 -178.88 5.51 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 113.971 -1.114 . . . . 0.0 108.205 -174.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.73 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 87.3 m-85 -136.83 170.13 16.6 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.932 -169.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.721 HD13 ' HG3' ' A' ' 52' ' ' PRO . 8.0 tt -138.75 144.94 39.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.61 -166.596 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.889 ' HB ' ' HB ' ' A' ' 57' ' ' VAL . 87.2 t -138.87 172.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.699 HG12 ' HB2' ' A' ' 54' ' ' SER . 13.5 t . . . . . 0 C--N 1.314 -0.948 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 119.32 -0.371 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.619 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 24.5 mt-30 43.72 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.767 0.827 . . . . 0.0 112.511 -173.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.975 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.3 t-160 -138.78 129.1 25.72 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.54 0.686 . . . . 0.0 111.424 -169.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.761 ' HB1' ' HZ3' ' A' ' 41' ' ' TRP . . . -139.59 -178.29 5.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.968 -176.462 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.73 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 24.2 tt0 -136.76 125.93 24.62 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.629 1.204 . . . . 0.0 109.264 173.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.593 HG21 HG23 ' A' ' 28' ' ' VAL . 4.3 mt -82.67 107.48 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 112.557 -2.11 . . . . 0.0 109.815 -170.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.902 HG12 ' HD3' ' A' ' 40' ' ' ARG . 1.8 pp -106.82 -12.68 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.274 175.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 1.08 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -138.88 136.61 35.71 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.614 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.593 HG23 HG21 ' A' ' 25' ' ' ILE . 11.2 t -138.36 107.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 -165.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.6 ' CZ ' ' HA ' ' A' ' 29' ' ' ARG . 2.7 mmp_? -71.26 -19.14 62.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.779 0.324 . . . . 0.0 111.756 -176.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 60.5 m -152.3 115.46 4.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.05 13.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.831 -174.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -93.5 -11.84 31.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.172 0.511 . . . . 0.0 110.279 176.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.18 71.37 0.99 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.171 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.458 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 17.0 m -136.47 125.86 15.72 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 15.8 Cg_exo -68.7 153.53 73.06 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.974 2.449 . . . . 0.0 112.145 178.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.553 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 6.2 Cg_exo -80.29 -169.81 8.05 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 124.129 -1.196 . . . . 0.0 113.086 2.344 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -138.42 172.8 12.35 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.994 178.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 1.08 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 48.5 t -137.84 116.8 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.077 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.91 176.57 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.964 -149.557 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 1.01 ' HG2' ' HG2' ' A' ' 47' ' ' GLU . 12.4 mtp180 -138.82 138.18 37.3 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.761 ' HZ3' ' HB1' ' A' ' 23' ' ' ALA . 11.8 m95 -86.27 82.5 7.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 168.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 24' ' ' GLU . 5.4 mt -59.89 -69.65 0.2 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.114 0.483 . . . . 0.0 111.985 -166.363 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -60.2 -34.09 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.089 -175.704 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 72' ' ' ALA . 42.6 m-80 -60.43 -45.68 92.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.287 172.543 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.7 39.75 1.99 Allowed Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.851 179.184 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.475 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 63.7 m80 -139.23 172.92 12.12 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.324 -0.515 . . . . 0.0 111.893 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 1.01 ' HG2' ' HG2' ' A' ' 40' ' ' ARG . 45.0 mt-10 -138.58 128.26 24.93 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.35 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.34 179.93 6.25 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.129 0.966 . . . . 0.0 113.599 -160.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 75.6 m -138.78 125.3 20.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 167.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.422 HG23 ' N ' ' A' ' 51' ' ' TYR . 8.0 p -138.87 165.21 24.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.415 -162.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.553 ' CD2' ' HB3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -138.72 99.86 8.35 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.254 178.187 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.721 ' HG3' HD13 ' A' ' 9' ' ' LEU . 55.3 Cg_endo -70.67 114.16 3.76 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.758 2.305 . . . . 0.0 111.632 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.08 81.98 1.14 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.419 178.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.699 ' HB2' HG12 ' A' ' 11' ' ' VAL . 43.7 t 177.79 -179.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.034 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -71.72 -15.08 62.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 80.92 162.07 0.16 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.564 172.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.889 ' HB ' ' HB ' ' A' ' 10' ' ' VAL . 21.6 t -138.95 170.16 16.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.094 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 38.5 t -138.47 128.02 32.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.94 176.77 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.853 -174.331 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 p -120.08 -166.68 1.33 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.345 -176.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.0 79.36 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.457 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.39 -55.86 29.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.396 0.544 . . . . 0.0 111.813 -175.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.433 ' HG3' HG12 ' A' ' 59' ' ' VAL . 1.6 mm-40 -56.81 -31.39 64.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.635 -176.392 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.694 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.38 -40.8 78.94 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.766 -176.467 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.707 ' HA ' HG12 ' A' ' 43' ' ' VAL . . . -57.53 -77.08 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.052 0.93 . . . . 0.0 111.294 -170.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -60.33 3.84 Favored 'General case' 0 C--O 1.267 1.998 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.173 -178.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -56.92 -56.44 21.64 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.853 -174.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.975 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 35.6 tt0 -57.27 -34.35 68.56 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -175.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 29.8 mtpp -57.1 -65.9 0.54 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.459 175.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -57.35 -53.79 54.13 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-O 123.544 1.64 . . . . 0.0 111.049 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.608 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -57.21 -45.47 83.78 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 112.627 -2.079 . . . . 0.0 113.105 -173.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.43 ' HB3' ' ND2' ' A' ' 44' ' ' ASN . . . -68.43 -33.31 73.99 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.806 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.87 -37.3 63.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 123.483 0.489 . . . . 0.0 110.22 174.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.8 mtp-105 -81.6 -47.0 13.6 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 173.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -48.25 -51.61 24.84 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.237 0.615 . . . . 0.0 111.633 -177.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.125 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.943 179.74 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -127.9 128.79 45.77 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.0 161.94 13.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.074 0.464 . . . . 0.0 111.672 -173.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -148.41 147.36 29.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.335 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.452 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.7 p -86.47 142.01 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.957 0.408 . . . . 0.0 110.41 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.82 4.74 65.05 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -121.2 171.39 8.74 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.894 ' HB2' HG21 ' A' ' 59' ' ' VAL . 98.9 m-85 -109.81 146.35 35.17 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.398 0.618 . . . . 0.0 111.508 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.4 tt -99.14 140.11 33.78 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.828 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.555 HG22 ' CE1' ' A' ' 22' ' ' HIS . 55.6 t -130.81 151.54 36.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 O-C-N 124.839 1.337 . . . . 0.0 109.441 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.855 HG12 ' HG3' ' A' ' 12' ' ' LYS . 74.6 t -134.23 151.32 32.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.855 ' HG3' HG12 ' A' ' 11' ' ' VAL . 8.9 mtpm? 78.53 138.38 0.07 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.599 0.714 . . . . 0.0 112.73 174.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.91 57.37 4.89 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 114.864 -1.062 . . . . 0.0 114.606 168.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.631 HG21 ' HB3' ' A' ' 55' ' ' ASP . 19.2 p -69.57 -17.22 63.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.498 0.649 . . . . 0.0 111.025 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -67.14 -15.07 63.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.112 0.482 . . . . 0.0 110.235 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.3 m 75.61 84.57 0.09 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.117 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.53 -60.13 0.15 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -123.41 105.89 10.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.141 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -103.11 112.99 26.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.025 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.527 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 16.3 m-20 -109.44 -166.06 1.07 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.231 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.848 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 14.0 mt-30 40.33 85.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.641 1.213 . . . . 0.0 112.347 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.712 ' CB ' ' HA ' ' A' ' 68' ' ' GLU . 7.2 m80 -118.49 146.58 44.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.249 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.522 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . . . -176.7 177.98 1.3 Allowed 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.103 0.877 . . . . 0.0 110.857 170.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.619 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 43.4 tt0 -98.58 127.47 44.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.273 0.558 . . . . 0.0 110.742 177.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' ' 9' ' ' LEU . 20.4 mt -88.48 103.04 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.177 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.664 HD13 ' HG3' ' A' ' 40' ' ' ARG . 0.2 OUTLIER -105.76 -19.78 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.249 178.022 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.833 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 68.8 mm-40 -134.08 111.0 10.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.764 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 30' ' ' SER . 38.6 t -98.89 116.16 41.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.922 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -88.83 32.3 0.81 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.008 0.433 . . . . 0.0 110.861 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.435 ' H ' HG12 ' A' ' 28' ' ' VAL . 34.2 t -148.94 149.21 30.82 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.52 -14.6 45.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.052 0.453 . . . . 0.0 110.219 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -130.53 -70.84 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.472 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.39 75.93 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.611 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 p -146.67 132.87 9.58 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -61.85 160.31 29.77 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.889 2.393 . . . . 0.0 112.098 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.52 179.26 22.23 Favored 'Cis proline' 0 N--CA 1.462 -0.34 0 C-N-CA 123.406 -1.498 . . . . 0.0 113.132 1.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -132.77 153.46 51.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.601 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.833 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 67.3 t -98.56 117.18 43.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 172.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.52 147.63 30.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.001 -164.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.773 ' HG2' ' HG3' ' A' ' 47' ' ' GLU . 98.7 mtt180 -115.4 131.88 56.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.633 176.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 13.8 m95 -85.38 101.3 12.47 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 168.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.703 ' HB2' ' HE1' ' A' ' 64' ' ' HIS . 12.7 mt -82.29 -55.55 4.45 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.432 0.634 . . . . 0.0 110.605 -173.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 65' ' ' ALA . 2.0 m -76.14 -5.7 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.581 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.679 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 45.9 m-80 -100.01 -64.22 1.06 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.756 173.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . 122.02 68.42 0.25 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.532 -0.842 . . . . 0.0 114.181 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.528 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 30.3 t60 -179.18 156.92 0.79 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.217 0.509 . . . . 0.0 110.819 172.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.773 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 25.4 mp0 -110.58 150.38 29.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 t -175.18 -179.95 1.43 Allowed 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.442 0.639 . . . . 0.0 111.806 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.4 m -119.98 124.06 45.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.177 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 80' ' ' THR . 29.6 m -127.32 160.46 36.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.329 0.585 . . . . 0.0 112.545 -172.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -111.6 106.19 56.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.558 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.59 -178.6 3.49 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.7 2.267 . . . . 0.0 111.174 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.37 -155.17 9.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.843 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.3 t -70.95 157.11 38.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.649 0.261 . . . . 0.0 110.963 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.631 ' HB3' HG21 ' A' ' 14' ' ' THR . 3.7 m-20 66.33 39.38 4.07 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.007 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -76.88 129.11 35.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.036 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 58' ' ' VAL . 11.2 t -126.38 163.82 27.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.555 -176.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.406 ' N ' HG11 ' A' ' 57' ' ' VAL . 53.9 t -115.27 119.62 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.526 0.203 . . . . 0.0 110.737 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.894 HG21 ' HB2' ' A' ' 8' ' ' TYR . 2.3 m -113.42 178.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.211 0.529 . . . . 0.0 111.94 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.6 p -119.31 -169.78 1.81 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.239 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -47.33 -49.6 23.81 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -171.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.24 -38.97 75.3 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 121.718 -0.614 . . . . 0.0 111.581 -172.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 2.8 mm-40 -67.7 -16.81 64.33 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.093 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.703 ' HE1' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -82.04 -41.96 19.93 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.722 -177.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.594 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -56.86 -73.77 0.06 Allowed 'General case' 0 C--O 1.243 0.74 0 CA-C-N 119.996 1.271 . . . . 0.0 111.639 -166.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 2.9 pt-20 -66.5 -49.67 65.81 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.547 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.545 ' HB1' ' O ' ' A' ' 63' ' ' GLU . . . -67.55 -31.6 71.81 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.955 -173.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.712 ' HA ' ' CB ' ' A' ' 22' ' ' HIS . 32.2 tt0 -76.09 -33.45 59.5 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 118.299 0.499 . . . . 0.0 110.626 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 99.6 mttt -54.1 -62.09 1.88 Allowed 'General case' 0 C--O 1.247 0.958 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.044 172.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -65.8 -45.19 83.34 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.739 0.78 . . . . 0.0 111.387 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.636 ' HB2' ' N ' ' A' ' 21' ' ' GLN . . . -78.75 -16.39 57.25 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.449 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . . . -77.46 -36.38 52.96 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.9 -29.31 66.95 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.022 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -74.66 -58.85 3.03 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.641 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.739 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -59.9 -64.83 0.81 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.838 0.855 . . . . 0.0 112.371 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.41 29.27 4.03 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.847 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.86 -24.28 30.95 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.08 -175.58 5.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.357 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 65.75 11.46 7.59 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.387 0.429 . . . . 0.0 111.877 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.427 HG23 HG13 ' A' ' 50' ' ' VAL . 24.5 p . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.902 -0.571 . . . . 0.0 110.071 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.784 ' HE2' ' HG ' ' A' ' 9' ' ' LEU . 23.8 ttt . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.955 0.407 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.502 ' N ' ' HG2' ' A' ' 1' ' ' MET . 11.5 m-70 -138.81 140.54 38.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.29 140.14 39.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.769 0.795 . . . . 0.0 112.012 -165.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -139.06 140.82 38.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.708 -173.273 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.921 HG22 ' HA ' ' A' ' 26' ' ' ILE . 7.6 p -65.54 149.09 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 O-C-N 122.051 -0.406 . . . . 0.0 110.931 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.13 16.76 78.07 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-O 122.57 1.094 . . . . 0.0 110.449 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 1.4 t70 -139.09 144.12 38.6 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 112.572 -1.814 . . . . 0.0 107.678 -166.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 1.08 ' HB3' ' HE2' ' A' ' 22' ' ' HIS . 6.7 m-85 -135.79 142.46 44.9 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 -142.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.784 ' HG ' ' HE2' ' A' ' 1' ' ' MET . 3.2 tt -136.53 139.94 42.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.132 0.968 . . . . 0.0 109.799 -153.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.718 ' N ' HD22 ' A' ' 9' ' ' LEU . 2.3 t -138.84 141.62 36.32 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 112.707 -2.042 . . . . 0.0 109.057 -165.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.485 ' H ' ' HB3' ' A' ' 21' ' ' GLN . 4.0 p -137.57 139.78 42.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 C-N-CA 117.645 -1.622 . . . . 0.0 109.389 174.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 12' ' ' LYS . 43.4 mtpt -97.27 115.54 27.82 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.045 -168.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.02 101.73 1.26 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 167.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -68.85 4.88 1.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.902 0.382 . . . . 0.0 111.541 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -61.66 2.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.224 0.535 . . . . 0.0 109.67 173.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.712 ' HB ' ' HG2' ' A' ' 18' ' ' ARG . 3.7 m -101.27 -2.15 31.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.199 177.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 69.27 25.39 5.64 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.529 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.712 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 4.2 ptm180 -104.07 178.63 4.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.189 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -99.62 115.34 29.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.31 0.576 . . . . 0.0 110.756 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.912 ' HA ' ' HB3' ' A' ' 71' ' ' ALA . 11.3 m-20 -122.31 93.82 4.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.828 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.75 ' H ' ' HB3' ' A' ' 71' ' ' ALA . 51.3 tt0 149.61 128.16 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.292 1.437 . . . . 0.0 108.667 169.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 1.08 ' HE2' ' HB3' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -138.68 136.69 36.11 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 117.074 -1.85 . . . . 0.0 111.013 153.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HB3' HG12 ' A' ' 39' ' ' VAL . . . -142.08 144.06 33.38 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 111.29 -2.686 . . . . 0.0 109.38 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.854 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -134.99 138.61 44.16 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 124.698 2.19 . . . . 0.0 110.888 -177.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.565 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 19.9 mt -98.81 117.96 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 1 CA-C-N 108.363 -4.017 . . . . 0.0 111.203 -148.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.921 ' HA ' HG22 ' A' ' 5' ' ' VAL . 2.2 pp -114.56 -8.33 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 125.139 1.524 . . . . 0.0 110.166 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -138.8 132.22 30.27 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.433 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.9 t -138.06 101.33 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.535 -167.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -110.36 55.03 0.65 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.317 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -133.41 113.06 12.11 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.466 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.15 -42.4 17.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.343 0.592 . . . . 0.0 110.171 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -89.33 -7.78 54.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.056 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 1' ' ' MET . . . 85.81 18.15 60.33 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.355 -174.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 p -90.29 151.84 45.05 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 120.597 0.237 . . . . 0.0 111.173 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -63.48 164.8 19.51 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.851 2.367 . . . . 0.0 111.701 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.679 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.7 Cg_endo -79.5 -173.27 12.47 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.585 -1.423 . . . . 0.0 113.685 1.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -138.75 171.86 13.72 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.447 HG21 HG22 ' A' ' 49' ' ' THR . 83.9 t -137.7 116.21 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 CA-C-O 123.495 1.617 . . . . 0.0 107.257 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.635 HG12 ' HB3' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -139.25 177.78 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 CA-C-N 111.845 -2.434 . . . . 0.0 109.106 -151.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.856 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 15.6 mtm180 -138.32 145.61 41.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.602 ' CE3' ' HB3' ' A' ' 72' ' ' ALA . 11.4 m0 -101.37 84.78 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.717 HD12 ' HH ' ' A' ' 8' ' ' TYR . 3.4 mt -59.95 -68.04 0.33 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 112.483 -2.144 . . . . 0.0 112.772 -154.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.441 HG13 ' CE1' ' A' ' 64' ' ' HIS . 0.5 OUTLIER -60.14 -32.5 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.163 -176.268 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.408 ' ND2' ' HG2' ' A' ' 68' ' ' GLU . 39.9 m-80 -60.39 -64.08 1.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.113 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.13 51.19 0.27 Allowed Glycine 0 CA--C 1.523 0.546 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.512 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -139.18 170.95 15.02 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 117.53 0.665 . . . . 0.0 111.379 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.856 ' HG3' ' HD2' ' A' ' 40' ' ' ARG . 23.7 mp0 -138.26 106.98 5.9 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.9 t -139.74 -178.98 5.66 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -165.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.447 HG22 HG21 ' A' ' 38' ' ' VAL . 92.6 m -137.95 117.35 12.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.541 HG12 ' HZ2' ' A' ' 41' ' ' TRP . 15.3 m -138.84 177.87 4.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -161.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.679 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 5.2 m-85 -138.88 141.32 29.97 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.121 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.71 -48.42 0.11 Allowed 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.21 -63.77 0.27 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.846 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.485 ' HB2' HG23 ' A' ' 11' ' ' VAL . 27.4 m -79.3 -167.94 1.35 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.707 0.289 . . . . 0.0 111.417 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.87 -1.86 3.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.799 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 73.41 158.62 0.21 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.057 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 58' ' ' VAL . 17.2 t -138.9 163.39 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 175.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.652 HG21 ' HE3' ' A' ' 1' ' ' MET . 45.4 t -138.1 120.53 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.689 0.757 . . . . 0.0 109.294 -169.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.581 HG13 ' HG3' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -139.2 -179.91 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.311 -165.611 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 p -124.46 -163.43 1.16 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.145 -175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.11 -47.7 80.44 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -58.82 6.62 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.295 -0.878 . . . . 0.0 112.012 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.581 ' HG3' HG13 ' A' ' 59' ' ' VAL . 6.8 mm-40 -57.21 -25.27 58.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.962 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.771 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.26 -46.93 82.58 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.22 -178.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.93 -73.3 0.07 Allowed 'General case' 0 C--O 1.245 0.838 0 CA-C-O 121.97 0.89 . . . . 0.0 112.251 -165.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -55.86 29.22 Favored 'General case' 0 C--O 1.255 1.392 0 CA-C-N 114.076 -1.42 . . . . 0.0 112.141 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.632 ' O ' ' HB1' ' A' ' 71' ' ' ALA . . . -57.17 -41.98 80.26 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.464 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.771 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 4.1 tt0 -57.06 -52.18 66.3 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -56.95 -77.48 0.03 OUTLIER 'General case' 0 C--O 1.248 1.011 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.382 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -58.08 -68.32 0.26 Allowed 'General case' 0 C--O 1.255 1.394 0 CA-C-O 123.272 1.51 . . . . 0.0 112.377 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.912 ' HB3' ' HA ' ' A' ' 20' ' ' ASP . . . -57.46 -47.4 81.95 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.199 -1.818 . . . . 0.0 113.313 -173.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 68' ' ' GLU . . . -57.65 -36.89 72.46 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 119.483 1.038 . . . . 0.0 111.123 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.42 -39.31 72.85 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 119.471 -0.891 . . . . 0.0 109.113 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 71' ' ' ALA . 19.1 mtp180 -57.76 -56.91 15.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.408 167.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.487 ' HB1' ' CB ' ' A' ' 21' ' ' GLN . . . -41.98 -48.76 4.61 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.827 0.851 . . . . 0.0 112.603 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.33 35.03 4.86 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.982 -173.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -66.46 -24.76 66.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.99 0.424 . . . . 0.0 110.617 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.23 14.96 17.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.616 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -125.1 98.88 5.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.018 0.437 . . . . 0.0 110.829 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.196 178.555 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' SD ' ' HA3' ' A' ' 33' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -138.92 122.67 17.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.945 0.403 . . . . 0.0 110.531 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.95 142.53 38.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.569 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 26.3 pttm -139.07 161.32 37.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.157 0.503 . . . . 0.0 111.054 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' A' ' 26' ' ' ILE . 2.9 p -73.03 151.7 7.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.718 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.45 17.4 62.34 Favored Glycine 0 CA--C 1.511 -0.193 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 1.2 m-20 -138.62 -179.09 5.61 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 113.627 -1.286 . . . . 0.0 107.658 -174.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.781 ' HB2' HG23 ' A' ' 59' ' ' VAL . 83.2 m-85 -137.28 168.6 19.3 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -170.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.9 tt -138.5 138.8 38.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.454 -168.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.846 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 12.4 t -138.81 169.09 18.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.485 ' N ' HG12 ' A' ' 10' ' ' VAL . 89.7 t -138.38 141.85 36.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -66.56 -68.91 0.34 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.066 -176.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.91 -53.28 2.94 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.831 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 18' ' ' ARG . 5.9 m -114.47 136.05 53.44 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.2 m -61.4 -22.79 65.3 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -174.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.0 t -77.31 -170.58 1.78 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -76.41 32.37 0.13 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -175.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 25.0 ttm180 -96.27 134.37 39.46 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.631 ' HB3' HG13 ' A' ' 10' ' ' VAL . 95.8 m-70 -139.6 119.03 12.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.009 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -125.19 -179.31 4.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.027 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.949 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 56.2 mt-30 64.61 96.87 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.394 0 O-C-N 123.518 0.511 . . . . 0.0 110.395 -171.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.912 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.5 t-160 -138.99 121.71 16.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.53 0.681 . . . . 0.0 111.854 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -139.77 -178.33 5.37 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.749 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.733 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 15.0 tt0 -136.67 132.29 34.75 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.705 1.24 . . . . 0.0 109.679 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.571 HG22 HG22 ' A' ' 28' ' ' VAL . 59.8 mt -90.22 114.77 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 112.39 -2.186 . . . . 0.0 111.267 -167.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.706 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -106.79 -16.23 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.571 170.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.67 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 32.2 mt-10 -139.11 153.08 47.96 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.03 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.571 HG22 HG22 ' A' ' 25' ' ' ILE . 18.5 t -137.76 99.93 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -170.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -98.46 33.1 2.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -164.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 p -122.79 -90.86 0.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.702 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 176.0 -66.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.491 0.495 . . . . 0.0 109.919 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -92.75 -58.81 2.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.925 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.467 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 173.88 80.58 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.769 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.489 ' HB3' ' HD2' ' A' ' 35' ' ' PRO . 59.2 m -155.28 165.38 18.43 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 34' ' ' SER . 36.2 Cg_endo -66.85 155.7 69.46 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 121.937 1.758 . . . . 0.0 111.678 173.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.654 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 95.6 Cg_endo -87.91 -177.24 12.65 Favored 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.244 -1.565 . . . . 0.0 113.008 0.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -138.74 174.6 10.36 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.396 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 81.5 t -137.86 115.12 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.91 170.38 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.087 0 CA-C-N 112.556 -2.111 . . . . 0.0 109.091 -152.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 46' ' ' HIS . 25.9 ttm180 -138.73 132.03 30.12 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.669 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 9.8 m95 -78.47 83.76 4.66 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 169.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.641 HD23 ' HB3' ' A' ' 24' ' ' GLU . 5.7 mt -60.37 -66.2 0.56 Allowed 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 123.584 0.553 . . . . 0.0 111.261 -167.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.61 HG11 ' NE2' ' A' ' 64' ' ' HIS . 0.5 OUTLIER -60.19 -35.68 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.821 -176.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -60.4 -66.37 0.54 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.929 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 130.6 29.76 0.62 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.687 -0.768 . . . . 0.0 114.613 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.669 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 4.9 t-80 -139.29 168.85 18.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.386 1.093 . . . . 0.0 110.787 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.51 126.16 22.12 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.142 0.496 . . . . 0.0 110.05 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.506 HG23 ' CZ2' ' A' ' 41' ' ' TRP . 13.2 t -139.46 -178.97 5.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.107 0.956 . . . . 0.0 113.285 -162.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.508 ' HG1' HG23 ' A' ' 38' ' ' VAL . 87.3 m -137.93 115.52 11.29 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 m -138.77 175.77 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -161.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.654 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 26.6 m-85 -132.58 108.46 13.23 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.336 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.63 5.56 5.49 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.863 2.375 . . . . 0.0 112.564 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.62 -92.45 1.32 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.869 -177.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.2 t -170.19 178.26 3.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.7 t70 59.57 44.22 14.91 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.091 0.948 . . . . 0.0 109.716 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.9 128.19 35.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.964 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.2 m -105.11 143.3 16.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.647 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.74 118.2 46.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.052 0.453 . . . . 0.0 110.998 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.781 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -105.22 -179.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.735 -178.104 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.4 p -122.72 -164.52 1.2 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.87 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.58 -43.3 99.17 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -172.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -51.64 64.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.728 -0.607 . . . . 0.0 111.884 -174.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 32.0 mm-40 -62.91 -17.17 61.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.114 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.634 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -69.81 -34.22 73.41 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.454 -176.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.46 -76.43 0.06 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 122.109 0.956 . . . . 0.0 110.858 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.18 -55.8 22.08 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.214 -176.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 63' ' ' GLU . . . -64.91 -34.5 78.55 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.909 -173.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.912 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 32.9 tt0 -72.72 -34.56 67.18 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 119.554 -0.859 . . . . 0.0 110.717 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -52.93 -65.58 0.53 Allowed 'General case' 0 C--O 1.25 1.087 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.606 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.46 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 14.8 ptm180 -61.69 -47.77 83.82 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.943 0.878 . . . . 0.0 111.506 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.686 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -77.02 -17.14 59.02 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.2 -170.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.67 -41.02 55.07 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.317 172.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.59 -31.45 64.27 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.334 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 74' ' ' ARG . 2.4 mmt85 -80.33 -51.81 8.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.264 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.949 ' HB3' ' HA ' ' A' ' 21' ' ' GLN . . . -57.98 -65.97 0.55 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.161 0.505 . . . . 0.0 112.058 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.03 57.71 2.12 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.872 -1.156 . . . . 0.0 111.94 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -86.23 0.46 53.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.482 0.658 . . . . 0.0 109.661 175.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.65 -64.9 1.25 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.195 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -101.38 101.42 12.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.763 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.8 m . . . . . 0 C--O 1.254 1.314 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.865 -175.457 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.462 ' HE3' ' CB ' ' A' ' 56' ' ' ALA . 22.5 ttt . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.748 0.309 . . . . 0.0 110.729 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -139.18 147.69 42.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.495 ' HA ' HG21 ' A' ' 58' ' ' VAL . . . -138.94 152.17 47.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.733 0.302 . . . . 0.0 111.478 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -139.1 172.78 12.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.221 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' A' ' 26' ' ' ILE . 4.1 p -93.08 144.89 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.401 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.27 17.38 59.09 Favored Glycine 0 CA--C 1.51 -0.257 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -138.74 -179.1 5.62 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.746 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 91.7 m-85 -137.11 172.75 12.53 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.093 -168.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.777 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 8.0 tt -138.56 142.78 39.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.844 -169.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 19' ' ' HIS . 4.9 t -138.85 155.19 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 124.878 1.361 . . . . 0.0 109.356 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.668 HG21 ' H ' ' A' ' 53' ' ' GLY . 92.9 t -138.72 134.82 43.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -90.5 143.64 26.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.976 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.16 123.89 7.34 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 p -61.88 -20.01 63.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -174.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 p -112.64 -2.03 14.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.812 0.339 . . . . 0.0 111.674 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 p -132.75 112.41 11.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.591 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -75.23 74.67 2.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.002 0.906 . . . . 0.0 110.994 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.5 151.89 38.1 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.788 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.802 ' HB2' HG11 ' A' ' 10' ' ' VAL . 31.2 p-80 -101.42 93.09 5.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.984 0.897 . . . . 0.0 109.396 173.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.68 -172.96 2.88 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.26 -175.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.78 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 51.8 mt-30 53.48 90.6 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.165 0 O-C-N 124.159 0.912 . . . . 0.0 111.466 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.881 ' NE2' ' HA ' ' A' ' 64' ' ' HIS . 10.9 t60 -138.85 125.78 21.1 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 122.461 1.124 . . . . 0.0 113.227 -171.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.616 ' HB3' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.34 -178.56 5.43 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.701 -1.591 . . . . 0.0 109.017 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.746 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 14.4 tt0 -137.26 123.6 20.66 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.459 ' CG2' HG22 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -88.16 113.9 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.935 -168.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.747 ' HA ' HG21 ' A' ' 5' ' ' VAL . 1.3 pp -110.18 -7.75 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.951 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 1.117 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -138.91 127.74 23.54 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.459 HG22 ' CG2' ' A' ' 25' ' ' ILE . 32.3 t -138.28 110.98 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.6 -167.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.414 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 21.6 mmt85 -66.58 -46.0 77.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.072 0.463 . . . . 0.0 111.875 -173.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.0 m -154.34 144.41 21.92 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.494 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.49 0.37 29.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.555 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -71.29 -26.17 62.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.91 -10.75 29.64 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.399 173.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.4 m -69.11 130.54 91.22 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 117.542 0.671 . . . . 0.0 111.139 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -62.94 173.14 4.08 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.005 2.47 . . . . 0.0 111.451 174.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.596 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 95.0 Cg_endo -76.98 -170.75 9.01 Favored 'Cis proline' 0 CA--C 1.52 -0.218 0 C-N-CA 123.877 -1.301 . . . . 0.0 113.371 2.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -138.38 168.92 18.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.466 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 1.117 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 68.0 t -137.78 107.2 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.92 177.53 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 112.833 -1.985 . . . . 0.0 109.972 -151.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.705 ' HB2' HD21 ' A' ' 42' ' ' LEU . 86.1 mtm180 -138.74 133.8 32.68 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.498 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.616 ' CZ3' ' HB3' ' A' ' 23' ' ' ALA . 16.1 m95 -87.01 60.13 6.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 163.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.737 HD23 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -60.3 -52.66 64.32 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -158.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.524 HG21 ' OE2' ' A' ' 68' ' ' GLU . 0.5 OUTLIER -60.39 -33.76 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 118.555 0.616 . . . . 0.0 111.639 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -60.44 -42.94 97.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.384 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 130.68 6.6 3.66 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.549 -0.834 . . . . 0.0 114.58 172.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.474 ' ND1' ' H ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -138.92 176.55 8.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.798 1.299 . . . . 0.0 112.592 -176.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 1.9 mp0 -138.53 139.45 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.537 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.602 HG21 ' HE1' ' A' ' 41' ' ' TRP . 16.5 p -139.25 -179.37 5.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.691 0.758 . . . . 0.0 112.422 -169.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.442 HG23 HG23 ' A' ' 38' ' ' VAL . 31.6 m -138.33 107.96 6.23 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.1 m -138.9 179.94 2.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -157.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 14.1 m-85 -138.84 130.92 15.58 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 113.455 -1.702 . . . . 0.0 107.908 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.35 -170.77 0.8 Allowed 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.61 2.207 . . . . 0.0 112.882 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.668 ' H ' HG21 ' A' ' 11' ' ' VAL . . . -98.56 -132.48 7.64 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.855 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 11' ' ' VAL . 23.5 m -96.1 156.97 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 t70 70.88 -60.56 0.5 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.349 1.031 . . . . 0.0 110.122 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' CB ' ' HE3' ' A' ' 1' ' ' MET . . . 51.95 132.14 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.937 -175.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.88 HG21 ' H ' ' A' ' 58' ' ' VAL . 7.5 p -138.97 -179.79 2.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.017 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.88 ' H ' HG21 ' A' ' 57' ' ' VAL . 53.3 t -138.19 134.82 44.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.951 -172.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.675 HG21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.71 -179.84 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.968 -166.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.7 p -118.86 -164.33 1.03 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.135 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.04 -46.61 82.28 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -175.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -61.08 2.73 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 121.597 -0.689 . . . . 0.0 111.774 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.42 ' HG3' HG13 ' A' ' 59' ' ' VAL . 8.3 mm-40 -57.41 -24.87 58.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.937 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.881 ' HA ' ' NE2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.33 -45.17 84.56 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.126 -178.226 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.35 -73.21 0.09 Allowed 'General case' 0 C--O 1.254 1.326 0 CA-C-O 122.136 0.97 . . . . 0.0 112.587 -170.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.584 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -63.87 -42.9 97.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.76 -172.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.413 ' HB2' ' CD2' ' A' ' 19' ' ' HIS . . . -67.36 -27.81 67.43 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.778 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 3.2 tt0 -70.57 -31.03 67.9 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.677 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 50.4 mttp -56.03 -51.96 65.96 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.94 165.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 66' ' ' GLU . 2.3 mpt_? -56.93 -20.52 23.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.277 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.769 ' HB3' ' H ' ' A' ' 22' ' ' HIS . . . -75.99 -60.26 2.4 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.44 -22.03 64.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.046 0.451 . . . . 0.0 109.935 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.71 -73.43 0.26 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.281 169.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -82.56 -54.91 4.8 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -170.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.78 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -58.17 -60.49 3.67 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -172.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.76 76.13 0.41 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.977 -1.106 . . . . 0.0 113.084 -171.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -103.96 -14.1 16.09 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -136.97 25.82 3.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.628 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.76 36.54 4.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.889 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.6 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.382 179.668 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.492 ' HE2' ' OH ' ' A' ' 37' ' ' TYR . 1.5 tmt? . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -162.08 100.1 1.09 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.807 0.337 . . . . 0.0 110.116 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.29 119.41 38.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.837 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.609 ' HA ' HG21 ' A' ' 28' ' ' VAL . 14.5 tptm -126.35 164.62 20.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.863 0.363 . . . . 0.0 110.966 -175.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.897 HG21 ' HA ' ' A' ' 26' ' ' ILE . 3.0 p -66.27 150.03 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.319 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.11 1.71 48.32 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -143.06 175.92 9.49 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.881 ' HB2' HG21 ' A' ' 59' ' ' VAL . 93.5 m-85 -104.51 154.35 20.01 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.284 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.8 tt -98.96 132.2 44.46 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.395 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.836 HG12 ' HB2' ' A' ' 19' ' ' HIS . 10.5 t -137.79 143.65 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 124.951 1.407 . . . . 0.0 109.485 174.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 54' ' ' SER . 54.7 t -99.05 134.65 37.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 120.731 0.3 . . . . 0.0 111.561 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.6 tptm 78.55 -51.75 0.47 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 124.608 1.193 . . . . 0.0 112.306 170.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.43 -90.58 1.6 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.543 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.21 121.62 5.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.417 0.627 . . . . 0.0 111.602 175.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.6 m -152.11 -79.31 0.11 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.4 m -111.91 -33.5 6.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 171.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -94.12 167.02 11.84 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.82 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -83.98 176.12 9.08 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 173.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.836 ' HB2' HG12 ' A' ' 10' ' ' VAL . 12.8 p80 -75.16 98.31 3.69 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.722 0.772 . . . . 0.0 109.404 175.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.457 ' OD2' ' HD3' ' A' ' 74' ' ' ARG . 18.7 t70 -121.37 165.01 16.16 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.48 -164.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.711 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 7.0 mt-30 63.07 101.29 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.794 0.437 . . . . 0.0 110.352 -174.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.709 ' CE1' ' HA ' ' A' ' 64' ' ' HIS . 58.6 t60 -148.26 151.22 35.07 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -167.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -179.01 -179.82 0.61 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.944 1.298 . . . . 0.0 107.51 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.591 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 41.1 tt0 -98.34 129.91 45.01 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.064 -0.655 . . . . 0.0 112.106 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.475 ' CG1' ' HB2' ' A' ' 9' ' ' LEU . 53.0 mt -85.8 111.21 20.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.383 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.897 ' HA ' HG21 ' A' ' 5' ' ' VAL . 1.5 pp -120.44 -16.63 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.642 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.737 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 48.2 mt-10 -130.26 107.96 9.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.136 0.493 . . . . 0.0 110.718 175.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' A' ' 4' ' ' LYS . 58.6 t -98.74 114.25 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.477 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 29.0 mmt180 -95.5 38.78 1.14 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.244 0.545 . . . . 0.0 111.251 -176.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.8 m -151.37 150.3 30.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.761 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.77 69.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.438 . . . . 0.0 110.8 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -115.1 -65.5 1.18 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.752 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.46 104.12 0.17 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.592 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.8 t -154.28 145.68 16.62 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -67.26 155.07 72.13 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.44 2.094 . . . . 0.0 111.468 173.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.454 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 95.4 Cg_endo -87.89 178.87 19.07 Favored 'Cis proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.498 -1.459 . . . . 0.0 113.037 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.492 ' OH ' ' HE2' ' A' ' 1' ' ' MET . 96.2 m-85 -126.67 146.91 50.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.004 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.737 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 59.4 t -98.74 110.4 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.41 145.39 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.668 -159.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.704 ' HG2' ' HG3' ' A' ' 47' ' ' GLU . 73.4 mtp180 -106.36 129.42 54.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.493 0.664 . . . . 0.0 110.855 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.618 ' CE3' ' HB2' ' A' ' 72' ' ' ALA . 4.5 m0 -93.68 87.76 5.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.486 HD12 ' CD ' ' A' ' 24' ' ' GLU . 18.6 mt -70.05 -68.89 0.39 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.464 -162.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.526 HG22 ' OE2' ' A' ' 68' ' ' GLU . 4.2 m -74.96 -6.86 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.712 -173.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.06 -54.38 4.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.278 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.5 54.07 0.31 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.047 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -153.7 168.22 26.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.736 0.303 . . . . 0.0 111.131 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.704 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 32.7 tt0 -149.54 124.0 9.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 t -167.1 175.9 7.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.452 0.644 . . . . 0.0 112.029 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 m -101.5 110.25 22.21 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.292 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -106.88 149.77 10.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.39 0.614 . . . . 0.0 111.815 -171.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.454 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 81.9 m-85 -106.28 103.01 43.52 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.784 172.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.56 154.32 55.02 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.245 1.963 . . . . 0.0 110.861 175.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.84 -76.05 0.24 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.173 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.57 ' O ' HG12 ' A' ' 11' ' ' VAL . 28.4 t -169.68 162.63 9.83 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 55.51 60.28 3.43 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.285 0.564 . . . . 0.0 110.686 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.34 127.21 33.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.06 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.6 t -120.43 157.56 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.423 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -100.42 115.76 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.341 0.591 . . . . 0.0 111.94 -178.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.881 HG21 ' HB2' ' A' ' 8' ' ' TYR . 6.6 m -102.0 178.29 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.987 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 p -119.41 -165.1 1.11 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.807 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -50.1 -47.14 53.98 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.19 -38.1 78.46 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.49 -0.756 . . . . 0.0 112.248 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.668 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 30.5 mm-40 -74.97 -16.78 60.62 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.528 0.68 . . . . 0.0 109.352 176.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.709 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -71.84 -43.4 65.6 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.401 -177.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.04 -70.23 0.18 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-O 121.258 0.551 . . . . 0.0 112.362 -171.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -31.51 72.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.381 -173.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -80.97 -22.18 39.75 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.524 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.689 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 2.0 tt0 -73.81 -46.68 43.75 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.416 -0.913 . . . . 0.0 108.993 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -56.67 -71.46 0.09 Allowed 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.563 0.697 . . . . 0.0 110.285 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -66.35 -52.6 45.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.452 -171.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.676 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -82.07 -23.11 35.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.971 -167.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.618 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -76.41 -39.93 52.22 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.361 173.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.27 -29.32 67.49 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.518 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HD3' ' OD2' ' A' ' 20' ' ' ASP . 14.7 ttt180 -82.19 -40.66 21.41 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.726 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.711 ' HB3' ' HA ' ' A' ' 21' ' ' GLN . . . -54.07 -62.07 1.9 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.149 0.5 . . . . 0.0 110.774 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.4 50.63 1.62 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.368 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -74.67 -6.1 46.84 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.68 0.276 . . . . 0.0 111.34 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -168.59 22.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.367 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.5 94.22 3.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.062 0.458 . . . . 0.0 111.652 -172.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.1 m . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.09 173.134 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.636 0.255 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 35.3 t-80 -138.76 150.19 45.84 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.77 171.74 13.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.787 0.327 . . . . 0.0 111.373 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 8.3 ttpm? -139.03 151.97 47.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.803 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -82.96 139.33 17.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.17 26.71 27.73 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -168.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 14.5 m-20 -138.35 -178.92 5.5 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.665 ' CE2' ' HB2' ' A' ' 64' ' ' HIS . 88.9 m-85 -137.22 169.67 17.38 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -169.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' A' ' 52' ' ' PRO . 5.7 tt -138.66 145.36 40.34 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.205 -167.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 40.1 t -139.11 164.53 25.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.788 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.9 p -138.83 139.09 41.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 120.877 0.37 . . . . 0.0 110.125 173.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.538 ' HD2' ' HA ' ' A' ' 17' ' ' GLU . 2.5 ttpm? -85.71 -35.33 20.9 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.583 ' H ' ' HB3' ' A' ' 55' ' ' ASP . . . 57.88 -124.12 35.15 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.899 171.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 p -102.79 4.68 38.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -174.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.531 ' CG2' ' HB3' ' A' ' 18' ' ' ARG . 13.3 t -107.04 154.65 20.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.756 0.312 . . . . 0.0 110.324 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.3 m -86.45 100.97 12.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.118 0.485 . . . . 0.0 111.743 -173.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.538 ' HA ' ' HD2' ' A' ' 12' ' ' LYS . 47.0 mt-10 63.29 19.37 11.64 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.778 172.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.531 ' HB3' ' CG2' ' A' ' 15' ' ' THR . 32.4 ttm180 -92.14 132.38 36.66 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.619 ' HB3' HG13 ' A' ' 10' ' ' VAL . 68.2 m80 -93.68 104.41 16.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.092 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -131.44 174.38 10.14 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.509 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.788 ' HB2' HG12 ' A' ' 11' ' ' VAL . 17.2 mt-30 53.73 104.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.466 0.706 . . . . 0.0 111.326 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.888 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 36.0 t-80 -138.7 123.78 19.04 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.199 0.523 . . . . 0.0 111.947 -171.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.725 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.45 -178.5 5.41 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.02 -176.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.652 ' HB3' HD21 ' A' ' 42' ' ' LEU . 3.3 tm-20 -137.4 122.78 19.48 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.274 1.035 . . . . 0.0 108.244 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.414 ' HA ' HG23 ' A' ' 39' ' ' VAL . 1.2 mt -87.05 105.03 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.158 -167.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.701 HD11 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -98.61 -13.37 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 124.091 0.869 . . . . 0.0 109.386 174.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.693 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.04 140.92 38.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.498 -0.774 . . . . 0.0 108.988 174.115 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.08 99.86 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -167.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -94.41 78.97 3.88 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.617 0.246 . . . . 0.0 110.787 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.511 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 23.4 p 172.23 -35.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.151 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 74.63 -16.44 0.55 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.761 0.824 . . . . 0.0 111.761 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.511 ' OD1' ' HB2' ' A' ' 30' ' ' SER . 4.2 p-10 -103.3 -37.91 7.46 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.71 8.31 3.52 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.441 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 48.9 m -76.19 143.99 74.34 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 122.633 -0.333 . . . . 0.0 110.369 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 17.9 Cg_exo -67.26 160.69 46.4 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.818 2.345 . . . . 0.0 111.938 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.58 ' HB3' ' HD1' ' A' ' 51' ' ' TYR . 90.0 Cg_endo -81.08 -171.28 9.43 Favored 'Cis proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.838 -1.317 . . . . 0.0 112.816 -1.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.52 175.91 9.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.532 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 98.1 t -137.89 112.75 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 25' ' ' ILE . 0.4 OUTLIER -138.95 169.44 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.761 -2.018 . . . . 0.0 109.339 -151.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 33.2 ttm180 -138.77 128.05 24.26 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.725 ' CZ3' ' HB1' ' A' ' 23' ' ' ALA . 5.7 m95 -80.07 86.03 5.58 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 170.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.652 HD21 ' HB3' ' A' ' 24' ' ' GLU . 7.1 mt -59.93 -67.17 0.41 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.606 -166.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.51 HG11 ' NE2' ' A' ' 64' ' ' HIS . 1.2 m -60.05 -34.24 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.496 -176.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.5 ' ND2' ' HB2' ' A' ' 72' ' ' ALA . 37.1 m-80 -60.45 -60.18 4.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.407 171.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.37 40.22 0.69 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.956 -0.565 . . . . 0.0 113.36 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.605 ' CB ' ' HD1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -139.11 160.89 38.72 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 117.25 0.525 . . . . 0.0 110.851 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -139.0 120.54 15.08 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.879 0.371 . . . . 0.0 110.446 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.578 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 8.8 t -139.29 -178.86 5.55 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.384 1.088 . . . . 0.0 113.807 -163.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.56 HG23 HG22 ' A' ' 38' ' ' VAL . 85.4 m -138.14 108.1 6.35 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.651 HG22 ' H ' ' A' ' 51' ' ' TYR . 4.6 p -138.9 176.31 6.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.046 -158.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.651 ' H ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -138.81 114.08 8.54 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.741 ' HB3' HD23 ' A' ' 9' ' ' LEU . 31.3 Cg_endo -64.01 -69.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.475 0.425 0 C-N-CA 123.13 2.553 . . . . 0.0 112.978 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.37 -164.67 37.38 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -91.2 20.78 4.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.125 0.488 . . . . 0.0 111.842 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.583 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 4.7 t0 -143.86 50.95 1.33 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.73 133.25 42.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.714 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.824 HG22 ' H ' ' A' ' 58' ' ' VAL . 5.3 p -138.96 -179.76 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.408 0.623 . . . . 0.0 109.882 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.824 ' H ' HG22 ' A' ' 57' ' ' VAL . 87.5 t -138.23 139.77 41.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.351 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.642 HG22 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.71 176.73 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 123.97 0.908 . . . . 0.0 110.82 -174.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 t -116.39 -169.18 1.57 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.23 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.03 -49.69 75.04 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.322 -175.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.51 -56.69 18.58 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.69 -0.631 . . . . 0.0 111.022 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -57.44 -26.26 60.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.47 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.759 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.3 -49.37 76.32 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 177.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . -56.98 -76.02 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.729 0.776 . . . . 0.0 111.883 -163.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -57.39 -59.13 5.61 Favored 'General case' 0 C--O 1.26 1.637 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.306 -178.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.599 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . . . -57.11 -37.18 71.58 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.944 -174.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.888 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 21.7 tt0 -71.68 -40.02 69.87 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.091 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 28.9 mtpp -52.61 -58.87 5.4 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.942 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.599 ' HE ' ' HA ' ' A' ' 67' ' ' ALA . 27.6 ptt180 -69.61 -53.16 20.12 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 122.137 0.97 . . . . 0.0 112.071 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.767 ' HB3' ' N ' ' A' ' 21' ' ' GLN . . . -70.43 -31.14 68.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.334 -170.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 22' ' ' HIS . . . -76.39 -34.56 58.86 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.187 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.15 54.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.576 0.548 . . . . 0.0 110.273 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -82.09 -47.82 12.12 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -46.36 -51.1 15.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.396 0.678 . . . . 0.0 112.714 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' HA3' ' CZ2' ' A' ' 41' ' ' TRP . . . -138.41 52.78 0.73 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.968 -174.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -59.17 -48.98 79.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.363 . . . . 0.0 110.942 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.7 -50.13 1.15 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.681 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 67.17 131.55 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.983 0.802 . . . . 0.0 111.627 -178.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 C--O 1.247 0.96 0 C-N-CA 123.626 0.77 . . . . 0.0 112.057 -179.733 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.851 0.357 . . . . 0.0 110.649 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -138.97 141.06 38.4 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.85 140.33 40.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.935 0.874 . . . . 0.0 111.057 -167.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 6.8 mmmm -138.96 141.08 38.43 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.44 -158.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.88 HG21 ' HA ' ' A' ' 26' ' ' ILE . 3.0 p -61.41 138.6 21.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 121.655 -0.653 . . . . 0.0 110.777 171.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.69 14.99 71.8 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 1.4 t70 -139.04 143.52 38.43 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.942 -1.629 . . . . 0.0 107.324 -167.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.768 ' HB2' HG22 ' A' ' 59' ' ' VAL 0.266 65.4 m-85 -134.37 141.9 47.02 Favored 'General case' 0 C--O 1.206 -1.227 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -142.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.809 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 4.6 tt -136.52 140.27 42.87 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.539 1.161 . . . . 0.0 110.401 -149.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.998 ' HB ' HG22 ' A' ' 57' ' ' VAL . 14.3 t -138.72 141.55 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 111.397 -2.638 . . . . 0.0 109.038 -153.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.7 t -137.46 139.78 42.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 122.257 1.027 . . . . 0.0 109.869 -173.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.538 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 87.2 tttt -82.85 92.67 7.32 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.122 -171.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.81 -46.13 95.12 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.7 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.538 ' OG1' ' HG2' ' A' ' 12' ' ' LYS . 17.1 m 72.95 -68.02 0.24 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.968 0.507 . . . . 0.0 111.057 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.53 -28.25 65.86 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 120.942 0.401 . . . . 0.0 110.637 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.7 p -106.96 80.62 1.45 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.624 174.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 63.75 -150.19 0.31 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.207 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -75.69 -155.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.897 0.856 . . . . 0.0 112.342 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -83.93 101.79 11.95 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 171.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 21' ' ' GLN . 23.4 t70 -120.85 -158.55 0.76 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -169.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 1.034 ' HG2' ' HB3' ' A' ' 74' ' ' ARG . 38.7 mt-30 64.87 105.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.353 0.408 . . . . 0.0 111.012 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.809 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 1.6 m170 -138.21 136.61 36.76 Favored 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 117.219 -1.792 . . . . 0.0 110.319 167.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.481 ' HB2' ' CG1' ' A' ' 39' ' ' VAL . . . -142.41 144.37 33.08 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 129.068 2.947 . . . . 0.0 107.055 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.739 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -134.56 139.85 45.69 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 122.269 2.304 . . . . 0.0 110.66 -166.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.729 HD12 HG23 ' A' ' 28' ' ' VAL . 5.4 pt -92.08 128.53 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 109.86 -3.336 . . . . 0.0 111.457 -159.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.88 ' HA ' HG21 ' A' ' 5' ' ' VAL . 1.8 pp -102.62 -6.29 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 112.022 -2.354 . . . . 0.0 108.981 169.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.631 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 33.3 mt-10 -139.02 139.69 37.9 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.901 172.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.729 HG23 HD12 ' A' ' 25' ' ' ILE . 8.5 t -138.28 139.81 41.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -175.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -125.8 25.31 6.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.388 0.613 . . . . 0.0 110.256 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 t -173.44 124.4 0.39 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.923 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.85 -16.45 41.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.323 0.582 . . . . 0.0 109.445 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.82 -46.0 55.41 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.291 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.29 40.12 0.49 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.651 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.4 m -117.58 151.53 48.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 122.197 0.199 . . . . 0.0 110.586 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.8 169.13 22.79 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.826 2.351 . . . . 0.0 112.334 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.58 179.9 29.5 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.603 -1.415 . . . . 0.0 112.63 0.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -138.71 142.07 38.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.723 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.849 HG21 HG22 ' A' ' 49' ' ' THR . 99.8 t -135.88 138.91 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 CA-C-O 125.147 2.403 . . . . 0.0 108.955 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 23' ' ' ALA . 47.2 t -139.7 142.17 33.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 108.558 -3.928 . . . . 0.0 112.533 -129.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.639 ' HG3' ' O ' ' A' ' 46' ' ' HIS . 51.7 ttp180 -137.19 139.5 41.13 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 166.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.516 ' HH2' ' HA3' ' A' ' 76' ' ' GLY . 10.1 m0 -99.38 70.2 1.71 Allowed 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.517 HD21 ' HE ' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -60.56 -41.34 94.39 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 113.357 -1.747 . . . . 0.0 113.15 -150.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.755 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -61.56 -41.48 90.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.075 174.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -61.48 -40.49 94.74 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.57 50.27 2.98 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.295 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.639 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 8.1 t-160 -139.3 159.32 42.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.593 0.696 . . . . 0.0 110.554 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.45 ' HG2' ' HD3' ' A' ' 40' ' ' ARG . 48.8 mt-10 -138.3 112.24 8.44 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.159 0.98 . . . . 0.0 110.46 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 t -139.68 -178.21 5.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.752 -1.567 . . . . 0.0 112.164 -165.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.849 HG22 HG21 ' A' ' 38' ' ' VAL . 94.6 m -137.65 122.19 18.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.454 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.752 HG12 ' H ' ' A' ' 51' ' ' TYR . 2.3 t -138.52 179.32 3.33 Favored 'Isoleucine or valine' 0 C--O 1.255 1.351 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.761 -164.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.752 ' H ' HG12 ' A' ' 50' ' ' VAL . 8.0 m-85 -138.78 114.69 8.67 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.203 176.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.634 ' HB3' HD21 ' A' ' 9' ' ' LEU . 27.6 Cg_exo -63.32 -66.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.312 2.674 . . . . 0.0 112.522 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.63 -136.18 8.71 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.734 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.7 p -101.27 162.19 13.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 58.9 45.76 14.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.913 0.863 . . . . 0.0 110.466 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 1' ' ' MET . . . -77.5 130.04 36.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.627 -177.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.998 HG22 ' HB ' ' A' ' 10' ' ' VAL . 6.2 m -138.89 175.18 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.4 151.86 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -170.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 8' ' ' TYR . 3.0 m -138.87 178.78 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 C-N-CA 126.246 1.818 . . . . 0.0 109.69 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.1 p -117.69 -171.16 2.0 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.006 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.11 -47.77 80.28 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -174.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -54.26 48.87 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 121.67 -0.644 . . . . 0.0 111.166 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.442 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 21.1 mt-10 -57.12 -33.43 67.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.518 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.755 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.15 -37.97 72.83 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 114.563 -1.199 . . . . 0.0 114.107 -177.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.736 ' HA ' HG12 ' A' ' 43' ' ' VAL . . . -57.05 -76.29 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.053 0.93 . . . . 0.0 110.288 -171.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.44 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -57.37 -64.4 0.9 Allowed 'General case' 0 C--O 1.268 2.062 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.065 178.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 63' ' ' GLU . . . -56.88 -58.93 6.01 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.035 -175.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.696 ' HB3' ' O ' ' A' ' 64' ' ' HIS . 39.4 tt0 -57.41 -32.84 67.26 Favored 'General case' 0 C--O 1.204 -1.297 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.44 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -57.12 -71.33 0.1 Allowed 'General case' 0 C--O 1.261 1.676 0 CA-C-N 119.627 1.103 . . . . 0.0 110.808 174.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -53.82 53.83 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-O 123.262 1.506 . . . . 0.0 110.651 -175.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.778 ' O ' ' HA ' ' A' ' 21' ' ' GLN . . . -57.37 -39.39 75.93 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 112.999 -1.909 . . . . 0.0 112.923 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.464 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -57.1 -43.78 82.58 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 118.584 0.629 . . . . 0.0 109.891 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.49 -40.82 75.61 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 119.604 -0.839 . . . . 0.0 109.334 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 1.034 ' HB3' ' HG2' ' A' ' 21' ' ' GLN . 1.8 mpt_? -57.53 -57.93 10.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 172.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.593 ' HA ' HE21 ' A' ' 21' ' ' GLN . . . -47.09 -42.2 18.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.016 0.927 . . . . 0.0 113.065 -173.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.516 ' HA3' ' HH2' ' A' ' 41' ' ' TRP . . . -108.06 3.93 33.66 Favored Glycine 0 C--N 1.323 -0.179 0 C-N-CA 118.661 -1.733 . . . . 0.0 113.35 -173.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -89.62 -21.79 22.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.446 0.641 . . . . 0.0 109.393 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.45 -12.55 58.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.84 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.15 90.74 3.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.994 0.426 . . . . 0.0 110.535 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.299 -179.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptm . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.711 0.291 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -139.04 132.17 29.72 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 172.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.34 148.05 48.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.147 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.652 ' HA ' ' HE3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -130.92 169.58 15.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.843 0.354 . . . . 0.0 110.307 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.828 HG22 ' HA ' ' A' ' 26' ' ' ILE . 3.7 p -85.88 146.02 7.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.795 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.17 9.2 60.84 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -129.24 169.46 14.8 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.835 ' HB2' HG22 ' A' ' 59' ' ' VAL . 97.7 m-85 -105.95 150.77 25.37 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.317 0.579 . . . . 0.0 111.113 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.761 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 6.5 tt -98.75 146.22 26.13 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.468 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.845 HG12 ' HB2' ' A' ' 19' ' ' HIS . 47.8 t -127.65 144.74 36.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 O-C-N 125.295 1.622 . . . . 0.0 110.291 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.624 HG23 ' HB3' ' A' ' 52' ' ' PRO . 3.2 t -137.12 162.33 34.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 O-C-N 123.588 0.555 . . . . 0.0 110.367 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.48 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 47.6 tptt -142.72 -74.63 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 167.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.52 -6.4 5.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.333 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.2 m -159.64 -65.09 0.07 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.527 -0.396 . . . . 0.0 110.878 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.4 m -95.28 108.87 21.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -74.22 82.37 1.83 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.102 0.953 . . . . 0.0 109.957 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -164.7 -69.72 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.889 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.421 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 6.8 mmm180 -69.84 99.16 1.34 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.845 ' HB2' HG12 ' A' ' 10' ' ' VAL . 17.8 p-80 -90.0 98.75 11.95 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.6 -172.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -113.73 -169.0 1.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.811 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.576 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 39.1 mt-30 52.61 87.86 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.622 0.576 . . . . 0.0 111.959 173.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.761 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 55.0 m170 -117.95 158.31 25.13 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -175.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.673 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . . . -169.92 179.17 3.71 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.41 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 34.4 tt0 -98.32 126.1 43.7 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.086 -175.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.453 ' CG2' HG23 ' A' ' 28' ' ' VAL . 7.7 mt -88.15 105.82 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.016 174.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.828 ' HA ' HG22 ' A' ' 5' ' ' VAL . 1.2 pp -109.39 -27.02 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.228 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 1.047 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 47.3 mt-10 -118.81 101.81 8.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.086 0.469 . . . . 0.0 110.034 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.453 HG23 ' CG2' ' A' ' 25' ' ' ILE . 28.5 t -98.97 104.07 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.1 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -90.02 35.48 0.85 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.374 0.607 . . . . 0.0 110.725 -174.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -156.54 141.52 17.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.589 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.18 92.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.008 0.432 . . . . 0.0 110.644 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.4 -78.25 0.43 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.948 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.44 108.5 0.21 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.191 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.8 p -156.12 137.52 9.55 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.41 153.5 53.64 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.76 2.307 . . . . 0.0 112.092 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 83.2 Cg_endo -83.36 167.64 62.76 Favored 'Cis proline' 0 N--CA 1.463 -0.293 0 C-N-CA 123.276 -1.552 . . . . 0.0 113.317 2.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -120.14 144.24 47.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.186 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 1.047 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 58.5 t -98.79 111.06 27.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.11 148.77 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.833 -164.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.827 ' HD2' ' HB3' ' A' ' 42' ' ' LEU . 31.2 ttm-85 -114.29 121.57 44.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.279 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.431 ' CE3' ' HB1' ' A' ' 23' ' ' ALA . 12.0 m95 -83.14 76.72 9.84 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 168.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.827 ' HB3' ' HD2' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -76.35 -34.03 58.96 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -166.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.531 HG22 ' OE2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -77.26 -9.31 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.924 179.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.19 -32.16 11.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.546 171.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.85 35.84 3.62 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.787 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -136.39 168.38 19.56 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 122.634 -0.333 . . . . 0.0 110.435 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -153.6 141.62 20.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 t -175.4 -179.96 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.691 0.758 . . . . 0.0 111.674 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.9 m -98.77 107.83 20.36 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.69 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.5 p -98.98 148.68 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.304 0.573 . . . . 0.0 111.196 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 24.2 m-85 -118.15 99.78 51.83 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.68 174.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HB3' HG23 ' A' ' 11' ' ' VAL . 3.3 Cg_exo -75.62 -46.15 0.22 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.721 2.28 . . . . 0.0 112.268 -175.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.3 -94.75 1.44 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.801 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.7 m -126.72 167.39 15.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.569 0.185 . . . . 0.0 111.137 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 12' ' ' LYS . 67.4 m-20 67.25 22.14 9.74 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.933 0.771 . . . . 0.0 111.345 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.763 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -75.52 127.6 33.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.168 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.854 HG21 ' H ' ' A' ' 58' ' ' VAL . 7.4 p -147.27 -179.99 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.347 0.594 . . . . 0.0 110.346 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.854 ' H ' HG21 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -111.26 127.94 68.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.504 -175.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.835 HG22 ' HB2' ' A' ' 8' ' ' TYR . 1.4 m -119.57 179.24 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 123.285 0.634 . . . . 0.0 110.768 173.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 p -112.05 -171.79 1.92 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.55 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -49.14 -52.23 27.52 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -172.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.56 -40.94 84.92 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.308 -170.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -63.04 -24.93 68.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.411 0.624 . . . . 0.0 110.227 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.457 ' CE1' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -67.2 -49.37 64.87 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.687 -173.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.61 -67.66 0.23 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.828 0.823 . . . . 0.0 112.684 -164.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -52.48 64.21 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.349 -174.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.463 ' HB2' ' ND1' ' A' ' 22' ' ' HIS . . . -72.79 -16.69 61.62 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.673 ' OE1' ' HA ' ' A' ' 23' ' ' ALA . 29.9 tt0 -77.59 -40.68 41.36 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -55.56 -49.3 73.06 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.924 0.869 . . . . 0.0 109.105 170.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -68.33 -16.65 64.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.093 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -81.26 -41.19 22.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.648 0.261 . . . . 0.0 110.867 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.0 -27.29 68.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.644 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -79.25 -52.67 7.82 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.885 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -82.0 -65.61 0.99 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.51 73.91 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.041 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.3 -4.53 64.35 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.973 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.644 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 47.2 t-80 -67.83 -28.23 67.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.958 0.409 . . . . 0.0 109.946 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.73 -64.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.728 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -144.81 125.98 14.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.059 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 C--O 1.254 1.307 0 CA-C-O 118.506 -0.759 . . . . 0.0 109.314 176.362 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 tmm? . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -138.85 136.44 35.59 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.84 171.72 13.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.901 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 88.2 tttt -139.09 155.52 47.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.208 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.805 HG12 ' HA ' ' A' ' 26' ' ' ILE . 37.4 t -69.85 142.22 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.88 19.07 44.84 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -174.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 9.0 m-20 -138.7 -179.01 5.57 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 114.025 -1.087 . . . . 0.0 108.549 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.746 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 95.9 m-85 -137.17 165.13 26.82 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.971 -168.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.1 tt -138.63 138.73 38.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.662 -166.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.721 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 37.8 t -139.02 157.66 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.396 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.79 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.9 p -139.0 166.96 21.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.671 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 33.1 ttmt -85.26 76.08 10.2 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.161 0.505 . . . . 0.0 110.879 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.91 -13.2 72.6 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.615 HG21 ' HB2' ' A' ' 20' ' ' ASP . 5.0 t -160.59 134.77 7.21 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -90.45 -37.48 13.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.014 0.435 . . . . 0.0 110.875 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 p -74.39 -32.06 62.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.665 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB3' HG22 ' A' ' 14' ' ' THR . 18.0 tt0 -95.12 37.28 1.17 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.321 0.581 . . . . 0.0 110.147 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER 75.32 -72.26 0.11 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.727 175.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.697 ' HB3' HG11 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -170.9 162.46 7.39 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -177.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.638 ' OD2' ' HD3' ' A' ' 74' ' ' ARG . 15.2 t70 -139.56 165.59 26.84 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 111.249 0.092 . . . . 0.0 111.249 -170.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.79 ' HB2' HG12 ' A' ' 11' ' ' VAL . 78.8 mt-30 61.24 105.18 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.542 0.737 . . . . 0.0 111.707 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.949 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.7 t-160 -139.26 126.6 21.49 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 121.254 0.55 . . . . 0.0 111.599 -174.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.717 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.51 -178.65 5.49 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.402 1.081 . . . . 0.0 110.09 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.746 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 20.5 tt0 -136.95 122.51 19.67 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.287 1.042 . . . . 0.0 108.483 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.844 HG21 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -85.05 113.8 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.192 -174.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.805 ' HA ' HG12 ' A' ' 5' ' ' VAL . 1.5 pp -106.35 -3.51 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.237 172.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.834 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.0 124.46 19.35 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.284 172.032 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -138.19 99.67 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -105.49 -3.92 21.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.58 0.705 . . . . 0.0 109.97 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 6.9 m -65.0 -25.98 68.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.383 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 63.2 -82.17 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.791 0.682 . . . . 0.0 110.841 -176.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.75 -44.24 67.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.585 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 30' ' ' SER . . . 153.67 -164.25 31.1 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p 67.75 154.26 0.14 Allowed Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 124.476 1.111 . . . . 0.0 111.956 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.56 161.38 38.75 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.948 2.432 . . . . 0.0 112.533 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.646 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 89.4 Cg_endo -83.34 179.0 26.64 Favored 'Cis proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.071 -1.637 . . . . 0.0 113.376 0.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -138.76 173.52 11.49 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.834 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 97.4 t -137.77 115.58 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.844 HG23 HG21 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -138.84 171.16 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 CA-C-N 112.878 -1.965 . . . . 0.0 109.155 -152.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.404 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 31.6 ttt180 -138.66 123.75 19.07 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.732 ' HD1' ' HB2' ' A' ' 46' ' ' HIS . 25.6 m95 -78.99 84.42 5.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.681 HD23 ' HB3' ' A' ' 24' ' ' GLU . 6.9 mt -60.21 -68.6 0.28 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.346 0.593 . . . . 0.0 111.951 -166.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.68 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -60.25 -38.35 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.155 -174.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.495 ' ND2' ' HB1' ' A' ' 72' ' ' ALA . 44.3 m-80 -60.59 -50.86 71.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.298 171.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.98 48.94 0.86 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.506 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.732 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 46.9 m-70 -139.13 169.17 18.26 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.446 0.623 . . . . 0.0 111.283 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -138.88 119.14 13.62 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.519 HG22 ' CZ2' ' A' ' 41' ' ' TRP . 6.7 t -139.42 -179.36 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.315 1.055 . . . . 0.0 113.684 -165.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.437 HG21 HG23 ' A' ' 38' ' ' VAL . 57.8 m -138.55 112.67 8.59 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.092 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.445 HG12 ' HZ2' ' A' ' 41' ' ' TRP . 8.5 m -138.89 -179.8 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -163.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.646 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 50.1 m-85 -138.73 108.56 7.76 Favored Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.738 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HG3' HD12 ' A' ' 9' ' ' LEU . 72.6 Cg_endo -74.63 -169.2 0.58 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.089 2.526 . . . . 0.0 111.608 176.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.572 ' HA3' HG21 ' A' ' 11' ' ' VAL . . . -98.61 -166.2 30.78 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.546 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.8 m -97.07 21.58 9.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.34 0.59 . . . . 0.0 112.019 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.671 ' HB3' ' H ' ' A' ' 12' ' ' LYS . 18.2 t70 -122.91 38.09 4.26 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.97 135.6 54.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.761 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.776 HG11 ' H ' ' A' ' 58' ' ' VAL . 2.9 t -138.71 179.93 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.776 ' H ' HG11 ' A' ' 57' ' ' VAL . 58.0 t -138.0 136.02 45.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.739 -174.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.636 HG22 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.75 177.33 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.752 -170.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.6 t -122.2 -164.02 1.13 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.799 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.25 94.2 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -42.68 72.64 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 121.858 -0.526 . . . . 0.0 110.98 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.563 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 9.4 mm-40 -62.14 -17.26 57.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.838 0.827 . . . . 0.0 109.446 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.68 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -81.73 -43.99 17.68 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.78 -172.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.77 -70.79 0.09 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.838 0.828 . . . . 0.0 111.627 -168.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -70.08 -55.04 10.49 Favored 'General case' 0 C--O 1.257 1.457 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.748 -175.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -59.55 -42.29 92.06 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.577 -175.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.949 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 36.0 tt0 -70.47 -35.78 73.5 Favored 'General case' 0 C--O 1.212 -0.921 0 C-N-CA 120.204 -0.599 . . . . 0.0 110.978 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 69' ' ' LYS . 11.1 tptm -51.87 -61.76 2.06 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.734 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -67.12 -52.77 37.63 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.235 1.017 . . . . 0.0 111.709 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.74 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -68.85 -30.7 69.28 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.248 -171.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.569 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . . . -69.74 -41.07 75.74 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -52.75 -35.42 56.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.825 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.638 ' HD3' ' OD2' ' A' ' 20' ' ' ASP . 49.6 ttt180 -81.79 -49.46 10.37 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.511 ' HA ' ' HG2' ' A' ' 21' ' ' GLN . . . -45.14 -50.23 11.39 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.63 0.772 . . . . 0.0 112.036 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -105.73 24.32 27.34 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.423 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.466 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 8.7 t60 -71.6 -41.74 68.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.59 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.5 45.63 0.63 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.581 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.2 -49.89 65.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.529 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.732 -0.651 . . . . 0.0 109.743 175.649 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' HE3' ' O ' ' A' ' 56' ' ' ALA . 13.8 tpt . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.834 0.349 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -133.79 128.7 35.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.028 0.442 . . . . 0.0 110.312 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.89 145.3 19.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.019 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -144.79 171.02 15.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.174 0.511 . . . . 0.0 111.561 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.961 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.3 p -72.63 147.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.197 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.31 -0.34 43.69 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -130.73 176.38 8.25 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.685 ' HB2' HG22 ' A' ' 59' ' ' VAL . 94.8 m-85 -115.59 151.54 34.75 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.116 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.3 tt -98.6 142.23 30.44 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.562 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 44.4 t -134.78 154.86 37.52 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.139 0 O-C-N 125.229 1.581 . . . . 0.0 109.848 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.747 HG21 ' HB3' ' A' ' 21' ' ' GLN . 29.5 m -124.86 150.51 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 168.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 49.6 mtmt -130.31 -81.8 0.54 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.093 0.473 . . . . 0.0 110.634 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.83 121.79 2.22 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.7 m 68.27 -80.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 122.783 0.433 . . . . 0.0 111.17 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.0 m -160.24 -58.12 0.06 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.016 0.436 . . . . 0.0 110.953 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.4 p -108.76 11.74 26.12 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -75.17 175.81 7.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.155 0.502 . . . . 0.0 112.043 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -58.74 131.25 50.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.532 -176.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.43 ' HB2' HG12 ' A' ' 10' ' ' VAL . 24.5 p-80 -87.19 122.99 31.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 174.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -151.15 174.61 13.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.747 ' HB3' HG21 ' A' ' 11' ' ' VAL . 0.6 OUTLIER 65.45 100.63 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 O-C-N 123.485 0.49 . . . . 0.0 110.175 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.725 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 3.8 m80 -129.79 146.64 51.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.167 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -160.8 176.38 11.54 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 172.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.609 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 43.9 tt0 -98.61 132.31 44.12 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.45 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.594 HG23 HG22 ' A' ' 28' ' ' VAL . 2.6 mt -97.43 109.69 23.85 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.96 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.961 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -109.03 -31.88 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.341 175.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.998 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 10.5 mm-40 -112.21 99.87 8.38 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.39 0.614 . . . . 0.0 109.427 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.646 HG12 ' H ' ' A' ' 30' ' ' SER . 15.7 t -106.86 144.72 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.017 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.3 mtp-105 -68.79 -35.98 77.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.361 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.646 ' H ' HG12 ' A' ' 28' ' ' VAL . 66.3 m 58.38 -159.75 0.27 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.856 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 65.39 -88.09 0.03 OUTLIER 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.829 0.452 . . . . 0.0 111.227 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -92.63 -27.47 17.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.733 0.301 . . . . 0.0 110.31 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.38 86.77 0.54 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.484 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.8 p -160.2 162.03 24.71 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.05 162.9 12.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.86 2.373 . . . . 0.0 112.126 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.21 151.64 96.87 Favored 'Cis proline' 0 C--N 1.343 0.262 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.747 2.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -111.46 139.9 46.5 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.998 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 57.8 t -98.35 99.92 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.62 142.02 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.212 -168.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -121.38 129.05 52.82 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.622 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.425 ' CZ3' ' HB1' ' A' ' 23' ' ' ALA . 12.8 m95 -81.05 100.39 8.97 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.605 HD11 ' CD ' ' A' ' 24' ' ' GLU . 13.2 mt -76.43 -56.78 4.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.249 0.547 . . . . 0.0 111.263 -172.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 65' ' ' ALA . 1.4 m -79.49 -7.89 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.245 -172.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -96.9 -47.98 5.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.791 170.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.49 70.81 0.82 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.746 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -174.11 148.62 1.36 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.843 0.354 . . . . 0.0 110.536 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.417 ' C ' ' HG1' ' A' ' 48' ' ' THR . 3.8 mp0 -99.04 143.87 28.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.824 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.417 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 24.9 m -154.6 167.16 31.06 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.818 0.342 . . . . 0.0 110.249 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.4 ' N ' HG23 ' A' ' 48' ' ' THR . 26.5 m -127.79 118.67 24.17 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.14 162.92 35.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.805 0.812 . . . . 0.0 113.054 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -120.8 99.86 46.85 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.229 171.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.691 ' HG3' HD12 ' A' ' 9' ' ' LEU . 43.3 Cg_endo -66.51 149.45 84.39 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.672 2.248 . . . . 0.0 112.248 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.24 68.08 3.59 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.054 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.0 m 69.21 168.19 0.29 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.112 0.565 . . . . 0.0 112.395 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.28 42.48 31.45 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.3 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -77.63 110.69 12.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.122 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.622 HG11 ' HB ' ' A' ' 10' ' ' VAL . 1.2 p -119.34 156.46 21.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.143 0.497 . . . . 0.0 110.84 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -102.21 107.08 20.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.467 -174.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.685 HG22 ' HB2' ' A' ' 8' ' ' TYR . 14.2 m -102.1 -179.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.589 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.2 t -96.71 -170.61 2.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.252 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.581 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . . . -63.38 -50.59 69.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.033 -172.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -71.8 -40.52 69.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.833 0.349 . . . . 0.0 111.689 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -55.78 -29.1 59.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.707 0.765 . . . . 0.0 109.698 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.721 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -82.22 -46.64 13.46 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -171.483 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' A' ' 43' ' ' VAL . . . -49.66 -60.15 3.14 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -159.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.74 -53.22 57.92 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 122.377 1.084 . . . . 0.0 110.33 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.93 -16.4 63.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.554 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 26.6 tt0 -70.77 -42.17 70.77 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 176.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -57.07 -47.15 81.69 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.639 0.733 . . . . 0.0 109.075 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -61.86 -24.05 66.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.647 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.67 ' HB1' ' H ' ' A' ' 22' ' ' HIS . . . -81.95 -48.86 10.95 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.445 -175.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.91 -23.39 65.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.645 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -69.61 -64.83 0.8 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.191 173.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -82.25 -60.12 2.32 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.589 ' HB3' ' CG ' ' A' ' 21' ' ' GLN . . . -52.51 -48.72 65.82 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.908 0.483 . . . . 0.0 112.033 -173.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.64 21.65 41.65 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.944 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.645 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 7.6 t-160 -70.06 -52.95 19.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.058 0.456 . . . . 0.0 109.839 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -140.16 84.07 1.95 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.079 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.26 -43.62 8.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.454 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.676 178.191 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.573 ' HB3' ' O ' ' A' ' 32' ' ' ASP . 19.4 ttt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.437 ' N ' ' HG2' ' A' ' 1' ' ' MET . 31.7 p-80 -120.9 124.57 45.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.984 0.421 . . . . 0.0 109.998 173.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.53 150.68 40.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.6 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -137.02 146.76 45.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.951 0.405 . . . . 0.0 110.941 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.564 HG22 ' HA ' ' A' ' 26' ' ' ILE . 2.8 p -89.37 137.13 21.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.416 172.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.34 2.29 56.71 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.19 173.38 6.96 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.69 ' HE2' ' HB3' ' A' ' 42' ' ' LEU . 92.5 m-85 -110.96 161.13 16.16 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.382 -174.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.4 tt -106.92 137.38 45.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.247 -176.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.588 HG23 HG21 ' A' ' 59' ' ' VAL . 11.1 t -136.94 148.42 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.049 0.843 . . . . 0.0 108.89 172.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 21' ' ' GLN . 92.2 t -125.7 144.01 37.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.138 0.494 . . . . 0.0 110.249 175.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HD2' ' OD2' ' A' ' 55' ' ' ASP . 68.0 mttt -77.82 78.11 4.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.324 176.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.07 86.31 1.37 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.31 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.671 HG22 ' H ' ' A' ' 15' ' ' THR . 9.0 m 68.85 -178.77 0.22 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.671 ' H ' HG22 ' A' ' 14' ' ' THR . 6.6 m -74.97 76.81 2.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.273 0.559 . . . . 0.0 109.723 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -109.73 122.35 47.29 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.926 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -67.39 143.4 56.33 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 77.13 -20.81 0.36 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.283 0.989 . . . . 0.0 110.617 -174.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.454 ' H ' ' C ' ' A' ' 17' ' ' GLU . 39.5 m80 73.04 169.64 0.31 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.665 0.786 . . . . 0.0 111.453 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -131.26 -171.17 2.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.746 -173.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.687 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 78.8 mt-30 45.62 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.993 0.917 . . . . 0.0 112.374 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.712 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 59.8 t-80 -135.05 145.77 48.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -171.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.473 ' HB3' ' HZ3' ' A' ' 41' ' ' TRP . . . -169.81 179.81 3.54 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.808 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.664 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 38.4 tt0 -100.64 123.56 45.02 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.515 0.509 . . . . 0.0 110.469 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 9' ' ' LEU . 18.8 mt -91.85 106.1 17.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 120.7 0.286 . . . . 0.0 110.267 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.564 ' HA ' HG22 ' A' ' 5' ' ' VAL . 2.0 pp -114.93 -10.42 12.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.157 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.857 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 30.9 mt-10 -139.92 107.99 5.74 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.113 0.483 . . . . 0.0 110.839 173.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.65 126.85 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.298 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -74.4 -34.97 63.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.123 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.5 t -145.51 136.81 24.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.27 -18.41 65.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.917 0.389 . . . . 0.0 111.167 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.573 ' O ' ' HB3' ' A' ' 1' ' ' MET . 3.7 t70 -89.77 1.3 56.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.143 0.497 . . . . 0.0 110.021 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.03 99.47 0.52 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.714 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 53.8 m -139.89 121.22 9.56 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 2.9 Cg_exo -75.49 157.2 40.84 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.144 2.563 . . . . 0.0 111.763 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.45 ' HB3' ' CD1' ' A' ' 51' ' ' TYR . 79.8 Cg_endo -82.77 167.22 66.96 Favored 'Cis proline' 0 N--CA 1.462 -0.332 0 C-N-CA 123.111 -1.621 . . . . 0.0 112.889 -1.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -109.32 153.9 23.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.773 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.857 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 85.5 t -98.79 113.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.477 ' HB ' HG23 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -118.85 151.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.022 -166.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.516 ' HD2' ' OE1' ' A' ' 24' ' ' GLU . 37.7 ttm180 -116.81 137.18 52.39 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.065 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.473 ' HZ3' ' HB3' ' A' ' 23' ' ' ALA . 18.5 m95 -74.06 83.47 1.78 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 168.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.925 HD13 HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -22.52 -76.9 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.221 -1.808 . . . . 0.0 115.778 -170.252 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.925 HG23 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -95.34 0.33 10.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -168.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.408 ' N ' HD21 ' A' ' 44' ' ' ASN . 0.9 OUTLIER -88.91 -46.13 9.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.881 0.372 . . . . 0.0 110.074 173.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.77 73.26 1.06 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.38 -0.915 . . . . 0.0 113.564 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -170.29 137.63 1.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.95 142.45 46.77 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.758 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 t -157.51 176.49 12.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.167 -173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.4 m -105.3 108.81 20.52 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.749 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.477 HG23 ' HB ' ' A' ' 39' ' ' VAL . 35.1 m -106.49 152.18 8.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.356 0.598 . . . . 0.0 111.99 -174.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 36' ' ' PRO . 50.7 m-85 -116.19 99.8 52.97 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.181 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.97 168.31 12.24 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.803 2.335 . . . . 0.0 111.746 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 55' ' ' ASP . . . -66.26 162.8 43.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.015 175.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.3 m -76.47 29.0 0.12 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.008 0.433 . . . . 0.0 111.716 -177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.475 ' OD2' ' HD2' ' A' ' 12' ' ' LYS . 9.6 t0 -144.3 55.65 1.29 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.787 0.803 . . . . 0.0 108.909 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.82 136.35 35.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.763 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.84 158.37 42.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 1.5 m -99.22 149.89 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.235 0.54 . . . . 0.0 112.319 -177.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -135.09 173.3 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.803 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.89 -168.15 1.61 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.053 -175.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.21 -42.57 81.59 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -71.19 -44.62 65.09 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.236 -0.915 . . . . 0.0 110.934 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.0 mm-40 -64.76 -16.42 62.96 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.986 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.641 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -69.73 -33.82 73.0 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.669 -174.49 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 64' ' ' HIS . . . -77.14 -73.77 0.28 Allowed 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.834 0.826 . . . . 0.0 112.8 -165.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.401 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -61.07 -39.66 90.72 Favored 'General case' 0 C--O 1.251 1.182 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.136 -175.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -69.48 -28.8 66.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.308 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.713 ' HB2' HD11 ' A' ' 42' ' ' LEU . 18.0 tt0 -57.37 -57.3 13.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 1.006 ' HE2' ' HA ' ' A' ' 69' ' ' LYS . 9.3 mmpt? -50.64 -64.85 0.68 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.656 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -66.15 -54.81 20.84 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.839 0.828 . . . . 0.0 111.625 -174.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.579 ' HB3' ' N ' ' A' ' 21' ' ' GLN . . . -77.02 -25.15 52.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.87 -167.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.82 -32.41 52.25 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.834 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.21 72.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.23 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -80.58 -44.03 19.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.254 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' A' ' 21' ' ' GLN . . . -54.65 -53.02 60.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.6 -16.99 74.4 Favored Glycine 0 N--CA 1.454 -0.121 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.358 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -85.26 -14.12 47.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.29 0.566 . . . . 0.0 109.989 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.25 7.0 42.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.507 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.26 119.11 10.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.832 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.244 0.773 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.426 -176.474 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.621 ' HE1' ' HB3' ' A' ' 3' ' ' ALA . 8.7 tpt . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.916 0.388 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.437 ' O ' HG23 ' A' ' 58' ' ' VAL . 21.2 m80 -138.97 108.38 6.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 174.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.621 ' HB3' ' HE1' ' A' ' 1' ' ' MET . . . -138.76 166.64 23.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.029 0.442 . . . . 0.0 111.709 -172.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -139.1 176.06 9.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.827 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.792 HG21 ' HA ' ' A' ' 26' ' ' ILE . 2.5 p -91.46 135.49 26.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.9 17.46 32.57 Favored Glycine 0 C--N 1.322 -0.201 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.36 -179.24 5.68 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.785 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 92.1 m-85 -137.03 169.54 17.6 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.595 -166.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 10' ' ' VAL . 6.1 tt -138.6 141.31 39.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.829 -164.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.811 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 37.2 t -138.75 151.98 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 124.889 1.368 . . . . 0.0 109.039 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.931 HG21 ' HB2' ' A' ' 54' ' ' SER . 0.5 OUTLIER -138.88 153.09 24.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.318 177.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.1 tptt 70.41 90.96 0.09 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.241 0.543 . . . . 0.0 111.288 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -146.18 15.86 1.7 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.517 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 p -81.89 -41.13 21.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.123 0.487 . . . . 0.0 111.454 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.0 t -129.56 -16.51 3.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.398 0.618 . . . . 0.0 110.423 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.634 HG21 ' HB2' ' A' ' 18' ' ' ARG . 6.2 m -101.17 108.95 20.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.615 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -78.19 9.44 3.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.56 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.634 ' HB2' HG21 ' A' ' 16' ' ' THR . 7.4 mpt_? -72.61 -35.18 67.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 175.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 55.16 73.72 0.4 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.256 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.635 ' OD1' ' HD3' ' A' ' 74' ' ' ARG . 9.0 m-20 -76.45 -175.32 3.23 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.264 -172.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.882 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 6.2 tp-100 53.5 99.76 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.423 0 O-C-N 123.608 0.567 . . . . 0.0 110.533 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.921 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -138.69 103.04 4.74 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 121.451 -0.781 . . . . 0.0 110.376 -173.168 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.532 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.49 -178.77 5.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.207 -172.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.785 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 23.5 tt0 -137.07 127.77 27.07 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 122.473 1.13 . . . . 0.0 109.089 172.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.52 ' CG2' HG22 ' A' ' 28' ' ' VAL . 3.0 mt -87.46 111.48 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-N 112.518 -2.128 . . . . 0.0 110.084 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.792 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -106.13 -12.12 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 O-C-N 123.961 0.788 . . . . 0.0 109.401 172.239 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.578 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 33.0 mt-10 -138.98 139.58 37.96 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.933 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.52 HG22 ' CG2' ' A' ' 25' ' ' ILE . 23.2 t -137.89 102.65 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -163.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.41 35.83 0.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.27 -173.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.3 t -158.76 150.83 21.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.98 -14.5 29.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.401 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -118.54 -66.22 1.1 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.618 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 165.57 51.82 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.267 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 m -118.87 148.29 44.23 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.03 156.79 52.58 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.62 2.214 . . . . 0.0 111.925 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.583 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 75.1 Cg_endo -89.16 -172.43 6.82 Favored 'Cis proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.723 -1.365 . . . . 0.0 113.447 1.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.72 168.33 20.03 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.168 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 84.3 t -137.96 117.41 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.437 HG11 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.93 172.24 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 113.112 -1.858 . . . . 0.0 109.656 -154.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.841 ' HG2' HD23 ' A' ' 42' ' ' LEU . 11.6 ttt85 -138.71 134.48 33.62 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.598 ' CZ2' HG23 ' A' ' 48' ' ' THR . 9.9 m95 -78.68 89.32 4.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 168.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.841 HD23 ' HG2' ' A' ' 40' ' ' ARG . 8.3 mt -59.92 -72.66 0.1 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.328 0.585 . . . . 0.0 111.533 -168.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.617 HG12 ' NE2' ' A' ' 64' ' ' HIS . 2.4 m -60.08 -30.68 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.293 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.466 ' HB2' ' CB ' ' A' ' 41' ' ' TRP . 33.9 m-80 -60.68 -66.18 0.57 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.241 170.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.79 33.31 0.65 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.86 -0.686 . . . . 0.0 114.759 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.75 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 2.4 m170 -139.28 174.48 10.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.328 1.064 . . . . 0.0 112.164 175.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -138.49 127.7 24.28 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.598 HG23 ' CZ2' ' A' ' 41' ' ' TRP . 9.7 t -139.42 -179.23 5.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 122.065 0.936 . . . . 0.0 113.335 -168.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.533 HG21 HG23 ' A' ' 38' ' ' VAL . 63.4 m -138.46 110.67 7.36 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.87 -179.86 2.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -161.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.583 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 9.8 m-85 -138.71 121.93 10.95 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.264 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 24.6 Cg_exo -63.13 -53.45 1.53 Allowed 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 122.937 2.425 . . . . 0.0 112.653 -177.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.67 -46.82 1.11 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.204 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.931 ' HB2' HG21 ' A' ' 11' ' ' VAL . 26.4 m -91.66 -170.9 2.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.688 0.244 . . . . 0.0 111.33 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.61 -14.81 5.93 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.85 0.719 . . . . 0.0 110.525 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.4 ' HA ' HG23 ' A' ' 11' ' ' VAL . . . 71.44 130.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.985 172.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.547 HG21 ' HB ' ' A' ' 10' ' ' VAL . 29.0 m -135.41 169.84 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 122.046 -0.408 . . . . 0.0 110.969 176.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 2' ' ' HIS . 56.1 t -118.02 136.26 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -173.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.647 HG22 ' CB ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -123.86 174.74 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 123.111 0.565 . . . . 0.0 110.845 176.039 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -121.4 -164.97 1.18 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.503 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.15 91.17 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -171.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -81.82 -33.96 30.46 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.466 -0.771 . . . . 0.0 110.872 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 36.9 mt-10 -65.83 -16.52 63.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.919 0.866 . . . . 0.0 109.267 174.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.617 ' NE2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.37 -57.73 3.67 Favored 'General case' 0 C--O 1.198 -1.642 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.292 -176.028 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.84 -67.14 0.28 Allowed 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -160.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.26 -53.5 14.11 Favored 'General case' 0 C--O 1.259 1.593 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.132 -169.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.52 -17.69 63.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.271 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.921 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 10.9 tt0 -74.01 -44.73 53.47 Favored 'General case' 0 C--O 1.205 -1.272 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -50.14 -57.55 7.46 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.611 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.77 -60.56 2.96 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 121.838 0.828 . . . . 0.0 112.424 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.849 ' HB3' ' HB2' ' A' ' 22' ' ' HIS . . . -73.18 -16.64 61.42 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -169.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -79.93 -39.25 30.68 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 118.27 0.486 . . . . 0.0 109.948 174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -52.59 -36.66 56.56 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.762 171.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.635 ' HD3' ' OD1' ' A' ' 20' ' ' ASP . 35.7 mtt180 -79.59 -42.93 23.91 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.65 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.882 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -46.05 -52.77 11.34 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.138 0.975 . . . . 0.0 112.228 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -107.99 29.89 9.69 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.006 -1.092 . . . . 0.0 111.956 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 3.8 t-160 -80.47 -57.02 3.78 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.5 91.79 3.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.533 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.01 141.46 51.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.143 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.251 1.135 0 O-C-N 123.719 0.637 . . . . 0.0 110.521 -179.215 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.753 0.311 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 68.9 m-70 -143.53 131.9 22.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.96 154.76 17.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.534 0.207 . . . . 0.0 110.793 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -135.52 163.44 30.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 111.2 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.17 135.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.837 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.85 3.96 61.97 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.99 171.39 8.48 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.703 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 84.5 m-85 -106.25 148.58 27.79 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.321 0.581 . . . . 0.0 111.259 -175.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.4 tt -99.06 136.73 38.6 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.664 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.658 HG11 ' HB2' ' A' ' 19' ' ' HIS . 3.3 t -141.14 139.71 32.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 O-C-N 125.044 1.465 . . . . 0.0 109.895 174.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.0 t -111.49 103.58 15.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 170.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -97.1 -18.88 19.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.046 -177.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.41 -100.2 2.65 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.009 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.598 HG21 ' H ' ' A' ' 15' ' ' THR . 1.8 t -128.98 -70.95 0.65 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.598 ' H ' HG21 ' A' ' 14' ' ' THR . 1.2 p -144.65 -67.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -169.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.0 p -84.91 -0.03 52.75 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -169.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -90.8 171.64 9.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.644 0.259 . . . . 0.0 110.514 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.525 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 6.2 ptp180 -77.59 178.7 7.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.658 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.658 ' HB2' HG11 ' A' ' 10' ' ' VAL . 5.9 p80 -102.18 92.18 4.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.569 0.699 . . . . 0.0 109.888 170.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.525 ' OD2' ' HD2' ' A' ' 18' ' ' ARG . 1.9 t0 -100.03 -169.97 1.81 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.923 -174.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.694 ' N ' ' HB2' ' A' ' 71' ' ' ALA . 1.0 OUTLIER 43.23 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.807 0.843 . . . . 0.0 112.475 -177.38 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.933 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.7 t60 -134.49 137.96 44.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.565 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . . . -171.08 -179.86 2.85 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.488 173.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.703 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 38.4 tt0 -98.59 136.1 39.16 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.033 0.444 . . . . 0.0 110.341 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 9' ' ' LEU . 1.5 mt -97.17 107.18 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.697 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -107.33 -24.88 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.993 176.384 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 1.085 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 19.3 mm-40 -115.72 99.88 7.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.795 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.3 t -106.72 124.62 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.636 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -69.13 -37.81 78.52 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.5 p -146.07 144.65 30.16 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.95 74.1 0.88 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.078 0.466 . . . . 0.0 111.928 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 19.1 t70 -171.38 -57.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.092 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 146.39 89.99 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.949 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 p -132.02 97.05 18.91 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.857 0.361 . . . . 0.0 111.363 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.75 150.68 84.82 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.485 2.123 . . . . 0.0 111.213 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.406 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.3 Cg_endo -78.1 169.22 73.8 Favored 'Cis proline' 0 C--N 1.344 0.295 0 C-N-CA 123.346 -1.523 . . . . 0.0 112.826 0.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -113.58 155.47 25.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 1.085 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 66.4 t -98.76 102.07 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 172.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.408 HG21 ' HB2' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -106.14 158.01 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.077 -163.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.553 ' HB2' HD11 ' A' ' 26' ' ' ILE . 62.9 ttt180 -131.51 99.99 5.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.162 -169.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.736 ' HE1' HG21 ' A' ' 48' ' ' THR . 0.3 OUTLIER -81.75 71.66 8.78 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 174.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.526 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 3.0 pp -84.83 -23.7 28.96 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.86 -166.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.681 ' HB ' ' CE1' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -85.17 -6.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.968 0.889 . . . . 0.0 108.812 178.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.537 ' OD1' ' HA ' ' A' ' 69' ' ' LYS . 50.1 m-80 -99.84 -61.57 1.35 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.123 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.88 42.4 0.1 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.044 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -157.04 164.59 37.78 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.907 0.354 . . . . 0.0 110.927 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -149.44 133.56 17.24 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.736 HG21 ' HE1' ' A' ' 41' ' ' TRP . 12.0 t -167.49 177.8 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.541 0.686 . . . . 0.0 111.182 -176.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.4 m -98.88 123.04 42.88 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.533 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.84 155.85 41.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.216 0.531 . . . . 0.0 111.543 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 46.4 m-85 -107.24 99.94 30.23 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.04 174.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.446 ' HG3' HD12 ' A' ' 9' ' ' LEU . 43.6 Cg_endo -68.07 -30.48 31.92 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 122.68 2.253 . . . . 0.0 112.595 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.25 -128.8 9.02 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.9 m -124.59 164.31 20.09 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 59.71 53.77 4.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.466 0.65 . . . . 0.0 111.323 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.37 117.33 29.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.41 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.0 169.44 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.36 116.0 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.108 0.48 . . . . 0.0 111.106 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -109.22 178.3 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.302 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.7 p -126.96 -166.8 1.64 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.27 -176.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -51.6 -46.69 63.65 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.99 -50.78 67.17 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.481 -0.762 . . . . 0.0 111.441 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 25.2 mm-40 -63.57 -17.04 62.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.39 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.681 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -76.07 -32.68 59.4 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.462 -175.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.53 -77.22 0.06 Allowed 'General case' 0 C--O 1.25 1.114 0 CA-C-O 122.097 0.951 . . . . 0.0 111.609 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -47.58 80.09 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.741 -173.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 63' ' ' GLU . . . -66.63 -38.71 87.47 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.185 -177.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.933 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 41.2 tt0 -66.3 -39.95 89.69 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.479 -176.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.537 ' HA ' ' OD1' ' A' ' 44' ' ' ASN . 69.1 mttm -57.85 -63.3 1.29 Allowed 'General case' 0 C--O 1.25 1.096 0 C-N-CA 119.731 -0.787 . . . . 0.0 110.957 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -62.77 -43.14 99.58 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.425 0.631 . . . . 0.0 110.897 -174.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.694 ' HB2' ' N ' ' A' ' 21' ' ' GLN . . . -81.76 -16.79 49.93 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -171.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.71 -38.71 62.26 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 119.716 -0.794 . . . . 0.0 108.882 171.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.1 -38.69 80.15 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.06 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.15 -38.16 25.11 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.593 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -56.94 -53.79 53.97 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.946 0.403 . . . . 0.0 111.786 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.54 27.72 11.59 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.16 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -78.62 92.19 4.7 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.488 -0.189 . . . . 0.0 110.488 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 65.06 21.45 12.24 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.413 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.31 -20.62 51.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.378 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.542 179.803 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 121.012 0.434 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -138.83 162.97 33.47 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 169.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.89 149.84 45.29 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.56 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 52.1 tptt -139.06 148.51 43.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.469 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.723 HG21 ' HA ' ' A' ' 26' ' ' ILE . 5.2 p -80.13 146.23 7.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.5 38.81 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -172.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -138.56 -179.15 5.64 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.712 -1.244 . . . . 0.0 108.392 -176.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.636 ' CD2' HD22 ' A' ' 42' ' ' LEU . 87.9 m-85 -137.54 171.87 13.82 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.394 -172.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' ' 52' ' ' PRO . 9.2 tt -138.53 137.16 36.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.157 -169.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.779 HG12 ' HD1' ' A' ' 19' ' ' HIS . 93.3 t -139.22 161.29 28.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.992 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.9 HG23 ' HB2' ' A' ' 21' ' ' GLN . 26.7 m -138.68 163.71 27.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.445 ' HE2' ' HB2' ' A' ' 12' ' ' LYS . 1.5 mppt? -134.53 159.01 42.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.976 0.417 . . . . 0.0 110.789 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.17 161.26 27.67 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -74.42 -13.32 60.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.257 0.551 . . . . 0.0 110.676 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.7 p -80.41 8.97 6.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.843 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.3 m 74.46 84.83 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.978 0.894 . . . . 0.0 111.117 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -103.19 156.22 17.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.619 -1.173 . . . . 0.0 107.863 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -90.58 -70.65 0.66 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.723 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.779 ' HD1' HG12 ' A' ' 10' ' ' VAL . 52.9 m-70 -142.79 92.94 2.45 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.0 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.44 152.99 35.94 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.935 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 2.2 mp0 57.73 97.64 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.385 0.428 . . . . 0.0 110.261 -170.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.692 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 82.8 t60 -138.75 127.31 23.23 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.832 0.825 . . . . 0.0 112.53 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.469 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -139.42 -178.7 5.5 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.308 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.602 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 28.6 tt0 -136.99 111.69 8.75 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.515 ' CG2' HG22 ' A' ' 28' ' ' VAL . 9.7 mt -81.14 103.06 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.402 -167.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.723 ' HA ' HG21 ' A' ' 5' ' ' VAL . 1.9 pp -107.88 -7.56 10.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.114 176.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.924 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 3.0 tp10 -139.21 136.2 34.76 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.382 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.515 HG22 ' CG2' ' A' ' 25' ' ' ILE . 46.8 t -137.99 99.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -168.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -105.26 84.03 2.05 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.6 m -151.61 109.64 3.71 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.605 -175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.81 -16.81 24.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.41 -45.28 9.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.528 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.88 40.11 3.41 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 -169.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.667 ' HB3' ' HD2' ' A' ' 35' ' ' PRO . 62.4 m -152.18 167.59 12.93 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.667 ' HD2' ' HB3' ' A' ' 34' ' ' SER . 12.5 Cg_endo -56.13 159.57 12.23 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.013 2.475 . . . . 0.0 112.68 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.546 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 84.3 Cg_endo -82.4 179.59 26.36 Favored 'Cis proline' 0 C--N 1.347 0.451 0 C-N-CA 123.153 -1.603 . . . . 0.0 113.263 1.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -138.76 174.86 10.08 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.924 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 84.2 t -137.6 122.32 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.64 176.19 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 CA-C-N 113.378 -1.737 . . . . 0.0 110.498 -149.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.602 ' HD3' ' OE2' ' A' ' 24' ' ' GLU . 35.6 ttt180 -138.54 124.04 19.53 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -174.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.443 ' HZ3' ' O ' ' A' ' 22' ' ' HIS . 8.9 m95 -65.16 102.98 0.7 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 166.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.636 HD22 ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -59.85 -89.58 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.902 -1.499 . . . . 0.0 113.845 -154.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.678 HG22 ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -60.41 -26.27 36.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -176.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -60.54 -57.2 13.74 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 172.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.33 51.41 0.72 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.64 -0.79 . . . . 0.0 114.152 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -139.21 170.37 16.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.062 0.431 . . . . 0.0 109.888 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 7.9 mp0 -138.21 134.73 34.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.515 0.674 . . . . 0.0 111.002 -175.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.485 ' CG2' HG11 ' A' ' 39' ' ' VAL . 10.0 t -139.36 -178.97 5.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.087 -172.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.476 HG21 HG22 ' A' ' 38' ' ' VAL . 44.7 m -138.21 113.71 9.6 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.87 -179.82 2.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-O 121.672 0.749 . . . . 0.0 112.954 -161.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 2.0 m-85 -138.86 116.7 9.01 Favored Pre-proline 0 N--CA 1.455 -0.223 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.674 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.702 ' HB3' HD23 ' A' ' 9' ' ' LEU . 28.5 Cg_endo -64.38 -65.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.474 0.353 0 C-N-CA 122.564 2.176 . . . . 0.0 113.55 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 138.05 -146.82 18.72 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.285 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.0 m -81.14 151.42 28.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 0.0 111.248 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 t70 48.74 64.81 1.55 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.813 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.882 ' HA ' HG13 ' A' ' 11' ' ' VAL . . . -79.46 133.61 36.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.817 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.681 HG11 ' H ' ' A' ' 58' ' ' VAL . 2.3 t -138.75 -179.83 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.681 ' H ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -138.18 152.37 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.983 -177.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.563 HG22 ' CB ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.77 179.75 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.018 -172.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.2 p -120.21 -165.44 1.19 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.302 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.451 ' O ' ' ND1' ' A' ' 64' ' ' HIS . . . -56.9 -48.2 78.76 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -59.96 4.34 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.102 -0.999 . . . . 0.0 111.827 -175.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -57.27 -21.27 33.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.021 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.615 ' HE2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.35 -44.12 84.07 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.263 -176.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.574 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . -57.62 -70.33 0.14 Allowed 'General case' 0 C--O 1.251 1.145 0 CA-C-O 122.337 1.065 . . . . 0.0 113.051 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -57.01 -55.01 40.23 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.553 -176.021 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.555 ' O ' ' HB1' ' A' ' 71' ' ' ALA . . . -57.41 -29.07 63.81 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.909 176.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.678 ' HG2' HG22 ' A' ' 43' ' ' VAL . 3.2 tp10 -56.87 -58.74 6.81 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.76 -72.63 0.08 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.825 -178.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.566 ' HG3' ' H ' ' A' ' 71' ' ' ALA . 31.9 ptt180 -57.46 -67.68 0.3 Allowed 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.743 0.783 . . . . 0.0 112.281 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.608 ' HB1' ' HB3' ' A' ' 22' ' ' HIS . . . -57.38 -47.79 80.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.074 -0.966 . . . . 0.0 113.584 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.38 -46.11 83.75 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.089 0.859 . . . . 0.0 111.177 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 77' ' ' HIS . . . -56.97 -29.64 63.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.04 0.448 . . . . 0.0 111.322 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -81.59 -50.07 9.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.994 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.935 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -54.63 -66.53 0.39 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.661 0.784 . . . . 0.0 112.004 -176.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.09 59.12 0.37 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.796 -1.193 . . . . 0.0 112.196 -172.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.47 ' HB3' ' O ' ' A' ' 73' ' ' ALA . 42.6 p-80 -83.54 -27.13 29.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.047 0.451 . . . . 0.0 110.616 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.05 103.8 4.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.484 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.92 81.61 1.77 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.074 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.402 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.504 ' HE1' ' HB2' ' A' ' 56' ' ' ALA . 25.1 ptm . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -138.8 123.05 18.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.564 0.221 . . . . 0.0 110.489 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.06 120.18 14.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.729 ' HA ' HG21 ' A' ' 28' ' ' VAL . 98.6 mttt -138.88 176.31 8.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 112.144 -173.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.794 HG21 ' HA ' ' A' ' 26' ' ' ILE . 8.5 p -71.1 156.78 6.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.514 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.28 12.52 82.08 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.13 -178.79 5.5 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 113.754 -1.223 . . . . 0.0 107.836 -172.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.782 ' HB2' HG21 ' A' ' 59' ' ' VAL . 67.6 m-85 -137.39 174.03 11.04 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.535 -174.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.759 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 4.4 tt -138.14 153.11 49.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.23 -164.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 1.051 HG13 ' HB2' ' A' ' 19' ' ' HIS . 38.3 t -138.89 151.72 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 125.106 1.504 . . . . 0.0 109.614 -169.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.763 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.8 p -127.57 165.54 26.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -70.98 112.93 7.52 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.837 0.351 . . . . 0.0 110.121 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.03 -51.13 60.41 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.435 ' C ' ' HG1' ' A' ' 15' ' ' THR . 7.7 t -132.28 -26.48 1.88 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.772 0.796 . . . . 0.0 108.92 171.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.435 ' HG1' ' C ' ' A' ' 14' ' ' THR . 9.2 m -157.15 172.69 18.2 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 175.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.419 ' N ' HG23 ' A' ' 15' ' ' THR . 9.4 m -60.43 -25.66 66.13 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.475 0.655 . . . . 0.0 109.606 173.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -63.59 115.42 4.69 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.377 172.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 71.21 99.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 124.05 0.844 . . . . 0.0 110.114 -173.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 1.051 ' HB2' HG13 ' A' ' 10' ' ' VAL . 8.5 p-80 -86.44 125.57 33.79 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.737 -175.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -133.41 171.79 13.59 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -173.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 1.014 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 2.0 mp0 65.11 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.922 0.489 . . . . 0.0 110.94 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.759 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 1.2 m-70 -128.03 147.4 50.51 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 122.151 -0.343 . . . . 0.0 111.143 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.642 ' HA ' ' HE1' ' A' ' 64' ' ' HIS . . . -157.87 175.12 14.27 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.681 ' HA ' ' HD1' ' A' ' 8' ' ' TYR . 40.1 tt0 -98.63 130.85 45.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.769 0.795 . . . . 0.0 112.664 -172.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.631 HD13 ' HB2' ' A' ' 9' ' ' LEU . 49.4 mt -90.66 108.01 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.66 171.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.794 ' HA ' HG21 ' A' ' 5' ' ' VAL . 1.3 pp -108.01 -28.5 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.921 177.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.99 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 45.2 mt-10 -124.02 117.21 24.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.23 0.538 . . . . 0.0 110.123 175.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.729 HG21 ' HA ' ' A' ' 4' ' ' LYS . 79.5 t -98.87 116.18 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.854 -176.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 29' ' ' ARG . 14.8 mmm180 -88.18 -13.96 39.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.895 0.379 . . . . 0.0 111.342 -174.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 34' ' ' SER . 23.0 t -129.71 104.08 7.21 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.75 -35.13 55.75 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.738 0.649 . . . . 0.0 112.656 -174.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.45 -58.56 3.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 110.203 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.45 83.37 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.699 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 30' ' ' SER . 50.0 m -154.58 148.5 18.93 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 175.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 16.8 Cg_exo -68.36 160.3 49.65 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.768 2.312 . . . . 0.0 111.822 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -88.56 179.53 16.92 Favored 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.745 -1.356 . . . . 0.0 112.648 0.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -131.75 158.59 40.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.912 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.99 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 59.8 t -98.78 116.38 41.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.28 133.19 58.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.31 -162.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.527 ' HG2' HG12 ' A' ' 26' ' ' ILE . 6.5 ptp180 -112.0 142.84 43.92 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.533 176.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.586 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 23.6 m95 -90.56 111.02 22.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.45 HD22 ' HG3' ' A' ' 40' ' ' ARG . 7.2 mt -82.67 -58.44 2.9 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.198 0.523 . . . . 0.0 111.47 -169.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.936 HG22 ' HA ' ' A' ' 65' ' ' ALA . 1.3 m -80.58 -5.54 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.611 -170.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -100.04 -47.24 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.138 167.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.9 79.07 1.14 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.911 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.586 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -163.77 164.48 23.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.642 0.258 . . . . 0.0 110.911 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -134.79 121.01 20.09 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.0 p -143.09 -179.92 6.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.581 0.705 . . . . 0.0 111.861 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.2 m -123.75 110.09 14.5 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 168.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.13 139.16 25.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-O 121.526 0.679 . . . . 0.0 112.251 -166.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -105.5 99.61 21.98 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.884 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.449 ' HG3' HD12 ' A' ' 9' ' ' LEU . 90.9 Cg_endo -83.66 163.13 14.37 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.263 1.975 . . . . 0.0 111.63 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.61 171.42 53.99 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.684 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 17.2 m -61.26 145.91 49.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.505 0.193 . . . . 0.0 111.267 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 54' ' ' SER . 6.3 m-20 72.98 63.22 0.1 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.979 0.799 . . . . 0.0 110.643 -174.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.504 ' HB2' ' HE1' ' A' ' 1' ' ' MET . . . -86.94 124.44 33.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.926 175.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' A' ' 10' ' ' VAL . 6.6 t -99.05 157.78 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -108.34 123.83 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.664 178.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.782 HG21 ' HB2' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -121.91 172.52 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-O 121.056 0.455 . . . . 0.0 111.278 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.604 ' CG2' ' H ' ' A' ' 61' ' ' ALA . 1.3 m -111.57 -173.92 2.35 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.604 ' H ' ' CG2' ' A' ' 60' ' ' THR . . . -52.51 -45.87 66.43 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -166.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.85 -61.0 2.44 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -58.28 -26.92 63.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.901 0.858 . . . . 0.0 109.699 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.642 ' HE1' ' HA ' ' A' ' 23' ' ' ALA . 47.4 t60 -64.1 -37.19 86.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.657 -1.156 . . . . 0.0 113.182 -175.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.936 ' HA ' HG22 ' A' ' 43' ' ' VAL . . . -64.09 -69.29 0.29 Allowed 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.726 0.774 . . . . 0.0 113.046 -169.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.47 -39.89 89.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.132 -175.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.13 -16.8 61.44 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.837 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 20.0 tt0 -72.56 -46.16 55.75 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.054 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -61.99 -40.39 95.45 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.653 176.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -64.41 -22.43 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.18 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 1.014 ' HA ' ' HG3' ' A' ' 21' ' ' GLN . . . -82.26 -42.92 18.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.718 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.46 -21.33 65.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.86 -64.3 0.99 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.584 172.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.516 ' HD2' ' OE1' ' A' ' 21' ' ' GLN . 62.8 mtt180 -81.84 -64.26 1.22 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -175.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.59 -52.68 62.44 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.953 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.86 33.91 2.13 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.973 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -123.28 -21.81 5.27 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.53 0.205 . . . . 0.0 111.215 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -152.18 -171.01 3.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.577 0.227 . . . . 0.0 110.971 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -143.14 111.16 6.04 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.76 -175.667 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.617 ' CD2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 m170 -131.95 132.7 43.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.941 0.4 . . . . 0.0 110.629 175.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.16 124.07 43.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.556 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -125.01 158.26 34.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.672 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.834 HG21 ' HA ' ' A' ' 26' ' ' ILE . 4.3 p -75.39 144.62 11.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.296 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.36 11.99 74.07 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.607 ' OD2' ' HB ' ' A' ' 58' ' ' VAL . 6.5 t70 -132.73 149.29 52.3 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.559 ' CE2' ' HA ' ' A' ' 61' ' ' ALA . 95.3 m-85 -98.79 155.22 17.47 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.386 0.612 . . . . 0.0 111.314 -168.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.2 tt -98.69 136.27 38.99 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.918 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 1.1 p -132.69 167.54 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 170.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.612 HG12 ' HB2' ' A' ' 12' ' ' LYS . 2.6 p -141.91 168.03 15.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.219 171.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.612 ' HB2' HG12 ' A' ' 11' ' ' VAL . 18.4 ttmt 69.34 13.92 8.49 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.515 0.51 . . . . 0.0 112.322 165.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.55 48.15 3.98 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.656 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 m -89.74 -31.08 17.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.733 -0.233 . . . . 0.0 111.487 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.7 t -124.75 130.97 53.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.813 0.34 . . . . 0.0 111.635 -172.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.3 m 58.77 -92.28 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.67 177.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -167.69 90.14 0.32 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -129.09 94.12 3.74 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.872 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.84 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 16.4 p-80 -79.32 89.92 4.96 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.289 0.566 . . . . 0.0 110.344 175.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -85.55 -138.38 0.07 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.468 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.688 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 24.8 mt-30 -41.13 120.01 1.28 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.371 0.668 . . . . 0.0 112.581 -160.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.739 ' CD2' ' HA ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -128.35 144.34 51.12 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -165.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.492 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -179.17 -179.75 0.59 Allowed 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.279 0.987 . . . . 0.0 110.2 173.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 5.0 tp10 -98.28 128.73 44.86 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.581 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.491 ' CG2' HG23 ' A' ' 28' ' ' VAL . 14.0 mt -93.15 101.16 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.834 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -103.06 -23.33 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.297 178.183 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.802 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 38.7 mt-10 -129.59 103.35 6.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.017 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.491 HG23 ' CG2' ' A' ' 25' ' ' ILE . 46.3 t -98.98 110.66 26.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.146 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.87 -46.19 66.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.304 0.573 . . . . 0.0 110.052 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.3 m -125.29 112.73 16.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.907 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.28 66.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -173.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.617 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 18.0 t70 -78.16 -65.24 1.0 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.234 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 167.24 73.96 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.474 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.0 m -151.26 126.5 4.79 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.706 0.289 . . . . 0.0 110.242 177.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.59 166.87 20.59 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.191 2.594 . . . . 0.0 111.434 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.08 152.35 88.42 Favored 'Cis proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.783 -1.34 . . . . 0.0 112.974 3.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -106.17 137.84 43.39 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.802 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 61.0 t -98.64 107.53 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HB ' HG21 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -118.07 151.23 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.086 -165.587 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -126.74 128.21 46.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.377 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 11.4 m95 -76.03 106.59 7.71 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.89 -55.44 4.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.196 0.522 . . . . 0.0 110.517 -174.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -81.71 -4.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.719 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.579 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 39.4 m-80 -97.88 -71.52 0.68 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.232 165.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.71 73.85 0.14 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.349 -0.929 . . . . 0.0 114.569 171.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.94 169.0 1.61 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.242 0.521 . . . . 0.0 110.882 169.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -120.14 145.63 46.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.33 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.6 t -172.33 -179.86 2.38 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 121.668 0.747 . . . . 0.0 112.246 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.8 m -115.14 121.89 44.4 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.23 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.437 HG21 ' HB ' ' A' ' 39' ' ' VAL . 35.8 m -118.88 159.08 19.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 CA-C-O 121.571 0.7 . . . . 0.0 112.851 -170.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -125.07 99.9 33.9 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.892 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.653 ' HA ' ' NE2' ' A' ' 21' ' ' GLN . 73.3 Cg_endo -77.16 -24.48 9.5 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.358 2.039 . . . . 0.0 112.76 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.19 -163.59 15.83 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.935 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.1 p -86.09 166.14 16.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.464 0.132 . . . . 0.0 110.772 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 62.52 42.02 9.09 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.406 0.622 . . . . 0.0 110.689 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.25 135.04 33.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.67 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.491 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 10.4 t -124.09 158.73 30.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.607 ' HB ' ' OD2' ' A' ' 7' ' ' ASP . 1.6 m -102.87 125.3 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.139 0.495 . . . . 0.0 111.409 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.549 HG23 ' NE2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -118.77 175.24 3.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.252 -175.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -111.94 -168.85 1.37 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.025 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.559 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -60.56 -47.63 85.35 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -70.41 -36.76 74.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.834 0.35 . . . . 0.0 111.488 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.34 -16.28 62.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.585 0.707 . . . . 0.0 109.471 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.739 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 2.7 t-80 -82.89 -44.77 15.02 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.19 -68.68 0.23 Allowed 'General case' 0 C--O 1.247 0.973 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -164.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -60.81 -36.8 79.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.144 -175.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.84 ' HB3' ' HD2' ' A' ' 19' ' ' HIS . . . -74.46 -22.06 59.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.741 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.54 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 13.8 tt0 -79.67 -34.59 40.19 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.833 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -56.04 -65.44 0.6 Allowed 'General case' 0 C--O 1.244 0.807 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.412 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -59.63 -65.56 0.65 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.171 0.986 . . . . 0.0 111.824 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.22 -16.93 57.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.449 -165.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 68' ' ' GLU . . . -82.26 -35.37 28.17 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.811 173.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.62 -34.35 69.2 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.136 0.494 . . . . 0.0 110.154 171.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -81.81 -40.97 21.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.868 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.5 -57.52 12.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.13 0.572 . . . . 0.0 111.872 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.17 44.59 3.39 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.305 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -83.44 -32.28 26.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.01 95.53 3.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.886 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.9 98.62 5.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.576 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 64.2 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.089 -175.728 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.524 ' SD ' ' HA3' ' A' ' 33' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 47.3 t-80 -133.79 125.19 27.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 175.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.413 ' HB2' ' HE3' ' A' ' 1' ' ' MET . . . -98.79 166.83 11.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.79 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.02 160.07 35.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.74 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' A' ' 26' ' ' ILE . 2.1 p -83.03 146.03 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.14 0.495 . . . . 0.0 111.398 -175.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.33 6.33 58.79 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.12 168.29 18.24 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.672 ' HB2' HG22 ' A' ' 59' ' ' VAL . 97.1 m-85 -103.14 157.38 17.04 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.448 0.642 . . . . 0.0 111.537 -171.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.68 ' HB2' HD12 ' A' ' 25' ' ' ILE . 9.4 tt -98.91 138.31 36.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.544 175.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 0.5 OUTLIER -136.94 164.89 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.459 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.888 ' HB ' ' HB3' ' A' ' 20' ' ' ASP . 69.8 t -117.27 146.87 21.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 171.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.651 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 79.6 tttt -72.71 101.76 3.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.875 0.369 . . . . 0.0 110.204 174.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.42 146.61 23.76 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.642 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 m -72.83 -59.8 2.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.149 0.499 . . . . 0.0 110.264 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 p -131.64 42.9 3.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.533 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.1 p -90.43 4.53 50.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.117 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 70.12 -69.19 0.18 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.612 0.765 . . . . 0.0 111.87 178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -91.82 -83.0 0.3 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.444 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.59 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 52.9 m80 -146.5 160.71 41.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -175.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.888 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 3.2 t70 -102.47 -154.46 0.49 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.719 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 68.0 mt-30 -41.15 131.62 2.62 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.706 0.802 . . . . 0.0 112.235 -168.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.796 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 49.8 t-80 -145.68 142.48 29.05 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -165.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.502 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . . . -172.62 177.96 2.81 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.801 0.84 . . . . 0.0 109.858 173.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.685 ' HG3' HD11 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -98.6 126.6 44.24 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.6 0.238 . . . . 0.0 110.853 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.68 HD12 ' HB2' ' A' ' 9' ' ' LEU . 14.4 mt -94.95 106.5 18.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 -176.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.851 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -102.0 -27.7 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.727 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.962 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 69.1 mm-40 -119.64 101.68 8.09 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.118 0.485 . . . . 0.0 110.633 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -98.93 102.5 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.081 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -89.36 -1.37 58.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.489 0.661 . . . . 0.0 109.765 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.792 ' HB3' ' H ' ' A' ' 34' ' ' SER . 1.4 m -80.59 124.36 28.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.857 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.61 -41.32 98.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.299 0.571 . . . . 0.0 109.99 175.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 52.2 m-20 -114.66 -68.59 0.91 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.472 173.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.524 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . -174.47 54.6 0.14 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.327 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.792 ' H ' ' HB3' ' A' ' 30' ' ' SER . 5.0 p -106.52 143.72 27.57 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 122.245 0.218 . . . . 0.0 111.165 -178.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.17 157.24 60.21 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.798 2.332 . . . . 0.0 111.611 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -87.46 174.34 29.17 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.45 -1.479 . . . . 0.0 112.937 -1.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -123.21 149.92 44.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.962 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 98.9 t -98.68 108.77 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 172.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.77 165.37 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.922 -162.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.549 ' HG3' HD22 ' A' ' 42' ' ' LEU . 9.9 ptp180 -142.36 133.07 25.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.958 0.408 . . . . 0.0 111.001 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -82.28 106.32 14.07 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.685 HD11 ' HG3' ' A' ' 24' ' ' GLU . 18.6 mt -77.51 -50.8 11.86 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.075 0.464 . . . . 0.0 110.977 -171.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.457 HG22 ' OE2' ' A' ' 68' ' ' GLU . 2.4 m -79.69 -6.02 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.167 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 41' ' ' TRP . 48.2 m-80 -100.03 -51.18 3.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.754 174.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.7 70.45 0.68 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.2 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.482 ' CB ' ' HD1' ' A' ' 41' ' ' TRP . 0.4 OUTLIER -174.49 161.39 3.31 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.802 0.441 . . . . 0.0 110.264 176.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.71 139.98 46.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 t -173.67 171.06 3.9 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.671 0.748 . . . . 0.0 112.359 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.7 m -98.87 111.39 23.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.943 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -107.92 156.75 8.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.502 0.667 . . . . 0.0 112.594 -169.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -120.14 104.69 43.32 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.032 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.426 ' HA ' ' OE1' ' A' ' 21' ' ' GLN . 72.1 Cg_endo -75.05 -5.22 16.5 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.829 2.353 . . . . 0.0 112.13 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.63 -78.76 1.96 Allowed Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.997 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.8 p -160.75 166.99 27.76 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.491 -0.189 . . . . 0.0 110.491 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.651 ' HB3' ' HB3' ' A' ' 12' ' ' LYS . 71.9 m-20 66.69 38.25 4.01 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.604 0.565 . . . . 0.0 111.9 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -77.63 132.4 38.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.155 0.503 . . . . 0.0 111.312 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.584 ' HB ' HG13 ' A' ' 10' ' ' VAL . 10.8 t -126.33 159.3 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.443 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.6 t -98.96 117.67 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.888 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -111.76 173.17 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.54 -178.34 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -122.67 -164.93 1.23 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.646 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -58.24 -44.95 88.53 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.35 -33.64 37.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.351 0.596 . . . . 0.0 110.96 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -63.4 -16.38 60.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.743 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.737 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.9 OUTLIER -81.8 -50.6 9.04 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -172.169 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.68 -70.5 0.1 Allowed 'General case' 0 C--O 1.247 0.964 0 CA-C-O 121.569 0.7 . . . . 0.0 112.613 -165.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.439 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -60.94 -49.4 77.59 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.376 -174.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' A' ' 19' ' ' HIS . . . -64.88 -38.32 90.57 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.626 -175.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.796 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 25.5 tt0 -69.62 -41.6 75.45 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.057 -174.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -58.49 -57.49 12.73 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.674 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -63.62 -45.93 88.06 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.725 0.774 . . . . 0.0 111.157 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.719 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -81.45 -16.42 52.07 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.03 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.98 -39.72 61.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -63.35 -25.74 68.44 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.671 174.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -82.2 -56.54 3.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.972 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.6 -62.17 1.86 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.666 0.787 . . . . 0.0 112.413 -174.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.28 30.21 4.51 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.235 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.515 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 45.9 t-80 -112.12 -29.53 7.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.14 -13.11 19.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.684 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.14 103.09 7.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.407 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.247 0.953 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.3 178.951 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HE2' ' HB1' ' A' ' 3' ' ' ALA . 1.1 tmt? . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.766 0.317 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -139.05 135.74 34.52 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 173.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.417 ' HB1' ' HE2' ' A' ' 1' ' ' MET . . . -99.2 152.4 19.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.74 0.305 . . . . 0.0 110.921 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.408 ' HD2' ' CG ' ' A' ' 7' ' ' ASP . 12.6 tmtt? -139.9 129.44 24.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.403 ' O ' ' HD3' ' A' ' 4' ' ' LYS . 7.4 p -80.24 141.2 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.024 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.04 6.86 71.14 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.408 ' CG ' ' HD2' ' A' ' 4' ' ' LYS . 1.1 m-20 -123.09 173.43 7.86 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.682 ' HB2' HG21 ' A' ' 59' ' ' VAL . 98.3 m-85 -107.92 152.9 23.81 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.37 0.605 . . . . 0.0 111.881 -173.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.79 HD12 ' HG3' ' A' ' 52' ' ' PRO . 6.8 tt -103.02 141.79 35.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.332 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 3.4 t -145.81 144.3 21.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 O-C-N 124.71 1.256 . . . . 0.0 109.707 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.1 m -100.51 149.21 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.194 0.521 . . . . 0.0 109.952 170.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -122.11 1.11 9.73 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.456 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.08 -28.75 73.92 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.209 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -78.5 80.52 4.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.2 m -65.11 -27.95 69.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.197 -171.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.8 t -70.11 -17.93 63.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.04 0.448 . . . . 0.0 111.15 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -102.09 176.83 5.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.187 0.518 . . . . 0.0 111.88 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.406 ' HD2' ' H ' ' A' ' 18' ' ' ARG . 6.4 mpt_? -79.17 -65.24 1.02 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.204 177.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.492 ' CD2' ' HB1' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -152.46 112.94 4.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.275 175.208 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -100.16 173.39 6.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.66 -169.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.609 ' N ' ' HB2' ' A' ' 71' ' ' ALA . 68.5 mt-30 38.19 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.767 1.227 . . . . 0.0 112.954 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.727 ' CE1' ' HA ' ' A' ' 64' ' ' HIS . 41.3 t-80 -133.37 139.9 47.06 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -169.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -168.02 -179.95 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.627 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.594 ' CD ' HD12 ' A' ' 42' ' ' LEU . 45.7 tt0 -98.58 129.57 45.12 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.036 0.446 . . . . 0.0 111.12 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.679 HD11 ' HB2' ' A' ' 9' ' ' LEU . 45.7 mt -92.01 105.54 16.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.765 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -102.47 -26.32 3.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.817 177.361 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 37.0 tt0 -129.69 119.83 24.16 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.405 0.621 . . . . 0.0 110.364 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.21 121.44 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.205 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -64.36 -33.58 76.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.98 0.419 . . . . 0.0 110.599 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.9 t -149.76 128.17 12.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.52 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.92 -23.06 67.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 0.0 111.006 -176.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.38 -17.63 64.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.411 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.404 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 105.38 5.49 39.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.336 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 6.6 m -67.54 122.53 83.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.572 0.225 . . . . 0.0 110.999 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 15.9 Cg_exo -68.65 165.52 29.14 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.412 2.741 . . . . 0.0 111.924 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 83.2 Cg_endo -80.56 -175.56 16.35 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.982 -1.258 . . . . 0.0 113.085 1.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -123.83 148.41 46.76 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 96.3 t -98.66 101.71 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 173.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.92 145.58 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.659 -163.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HG3' ' HG3' ' A' ' 47' ' ' GLU . 55.4 ttt180 -121.22 130.04 53.49 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.054 -176.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 13.0 m95 -79.79 96.24 6.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.594 HD12 ' CD ' ' A' ' 24' ' ' GLU . 20.1 mt -72.85 -61.28 1.87 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.352 0.596 . . . . 0.0 110.834 -173.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.463 HG22 ' OE2' ' A' ' 68' ' ' GLU . 2.0 m -73.93 -5.83 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.333 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 54.9 m-80 -98.61 -62.73 1.2 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.903 173.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.9 63.58 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.526 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -167.38 155.22 9.11 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.14 0.495 . . . . 0.0 111.794 173.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HG3' ' HG3' ' A' ' 40' ' ' ARG . 3.7 mp0 -111.77 141.91 44.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.094 175.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.451 HG21 HG21 ' A' ' 50' ' ' VAL . 8.8 t -165.89 179.84 5.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.583 0.706 . . . . 0.0 112.159 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 m -125.22 106.03 9.58 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.832 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.451 HG21 HG21 ' A' ' 48' ' ' THR . 70.3 t -109.42 147.43 13.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.32 0.581 . . . . 0.0 111.867 -169.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 62.2 m-85 -107.69 99.77 31.27 Favored Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.325 170.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.79 ' HG3' HD12 ' A' ' 9' ' ' LEU . 84.5 Cg_endo -82.12 -22.8 4.81 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.835 2.357 . . . . 0.0 111.805 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.49 -143.4 14.32 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 m -135.48 16.63 3.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.56 0.68 . . . . 0.0 110.687 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -106.49 16.46 24.62 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.124 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.51 114.68 3.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.986 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.801 HG23 ' H ' ' A' ' 58' ' ' VAL . 10.5 p -98.94 175.96 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.801 ' H ' HG23 ' A' ' 57' ' ' VAL . 46.5 t -119.36 125.1 74.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.291 -172.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.682 HG21 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -122.42 175.75 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.534 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -117.45 -167.12 1.27 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.525 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -59.66 -41.17 90.01 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -170.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.92 -46.25 62.8 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.893 -0.504 . . . . 0.0 111.462 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -62.35 -16.46 54.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.616 0.722 . . . . 0.0 109.947 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.727 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -73.47 -43.78 59.46 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.18 -176.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.58 -72.69 0.09 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.641 0.734 . . . . 0.0 112.295 -168.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.823 ' HA ' ' HE2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -61.84 -45.87 91.93 Favored 'General case' 0 C--O 1.253 1.254 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.42 -174.064 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HB1' ' CD2' ' A' ' 19' ' ' HIS . . . -58.49 -46.22 87.11 Favored 'General case' 0 C--O 1.204 -1.311 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.245 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 15.4 tt0 -65.31 -39.68 92.79 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.906 -171.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.823 ' HE2' ' HA ' ' A' ' 66' ' ' GLU . 57.3 pttt -64.19 -56.61 13.53 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.883 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.423 HH21 ' HA ' ' A' ' 67' ' ' ALA . 59.9 mtm180 -60.91 -44.7 96.81 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.547 1.165 . . . . 0.0 110.752 -177.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.609 ' HB2' ' N ' ' A' ' 21' ' ' GLN . . . -80.47 -16.52 54.13 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.416 -172.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.2 -35.81 66.4 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.059 170.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -29.67 70.04 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.659 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 12.7 mmt180 -81.92 -58.13 3.11 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 21' ' ' GLN . . . -63.06 -63.48 1.19 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.025 0.53 . . . . 0.0 111.514 -174.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -87.18 41.35 3.09 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.206 -175.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -77.24 -32.44 55.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.355 0.598 . . . . 0.0 109.531 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -147.67 82.98 1.53 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.057 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.32 -45.02 0.41 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.334 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.233 -0.889 . . . . 0.0 109.93 175.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tmt? . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 3.6 m-70 -138.93 140.57 38.36 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.469 ' HB3' ' CD1' ' A' ' 25' ' ' ILE . . . -138.34 140.48 39.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 111.471 -163.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.836 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 28.8 mmtp -138.49 140.68 39.29 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.211 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 26' ' ' ILE . 24.7 t -70.23 136.36 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 O-C-N 122.211 -0.306 . . . . 0.0 111.23 176.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.98 17.41 51.5 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.836 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.6 m-20 -138.97 144.17 38.86 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.439 -1.881 . . . . 0.0 108.288 -166.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.823 ' CD1' ' HB2' ' A' ' 24' ' ' GLU . 74.6 m-85 -134.96 141.81 46.34 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -148.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.868 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 1.3 tt -136.71 139.56 42.02 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -152.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.664 HG22 ' CD2' ' A' ' 22' ' ' HIS . 3.9 t -139.14 140.58 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 O-C-N 126.683 2.489 . . . . 0.0 109.371 -167.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.912 HG22 ' HB2' ' A' ' 21' ' ' GLN . 14.6 m -138.67 140.49 39.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.066 0.46 . . . . 0.0 110.604 176.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.546 ' HZ3' ' HB2' ' A' ' 12' ' ' LYS . 4.2 ttmp? -57.16 105.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.177 175.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.11 61.62 4.66 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.143 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m 64.34 16.63 10.27 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.61 0.719 . . . . 0.0 111.125 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.9 t -160.4 140.55 11.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.478 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 t -100.72 45.93 0.96 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.587 0.708 . . . . 0.0 110.781 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -114.92 -70.42 0.8 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -92.76 108.85 20.3 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.948 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.536 ' HB3' HG13 ' A' ' 10' ' ' VAL . 64.7 m80 -63.08 112.86 2.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 171.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.681 ' OD1' ' HB3' ' A' ' 74' ' ' ARG . 2.1 t70 -122.32 -168.35 1.71 Allowed 'General case' 0 C--O 1.217 -0.622 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.562 -161.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.912 ' HB2' HG22 ' A' ' 11' ' ' VAL . 75.3 mt-30 45.03 91.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.674 0.79 . . . . 0.0 111.413 -173.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.868 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.1 t-80 -138.85 116.24 11.21 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 121.255 0.55 . . . . 0.0 112.075 -168.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.559 ' HB1' ' NE1' ' A' ' 41' ' ' TRP . . . -139.65 -178.8 5.57 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.141 -1.391 . . . . 0.0 108.475 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.823 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 3.3 tm-20 -137.28 122.59 19.38 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.24 1.019 . . . . 0.0 110.312 -177.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.888 HG22 HG23 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -80.08 113.96 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 113.459 -1.701 . . . . 0.0 111.004 -174.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.725 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -98.86 -8.71 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.111 169.418 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.721 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -138.97 127.15 22.62 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.498 177.198 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.403 ' CG2' ' HB ' ' A' ' 25' ' ' ILE . 54.7 t -138.03 100.0 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.795 -169.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -103.81 20.35 18.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.163 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.528 ' HB3' ' H ' ' A' ' 34' ' ' SER . 3.6 m -108.88 111.08 22.6 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.434 177.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.06 93.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.31 0.576 . . . . 0.0 110.405 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 32.9 t70 -95.33 -56.83 2.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.007 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.1 70.37 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.422 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.528 ' H ' ' HB3' ' A' ' 30' ' ' SER . 20.0 t -150.25 142.6 15.79 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.32 151.56 9.5 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.467 2.778 . . . . 0.0 113.102 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.572 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.8 Cg_endo -85.51 -177.2 15.3 Favored 'Cis proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.108 -1.622 . . . . 0.0 113.664 3.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -138.78 173.36 11.65 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.157 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.721 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 72.4 t -137.78 114.47 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.453 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.888 HG23 HG22 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -138.75 165.3 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-N 111.965 -2.38 . . . . 0.0 107.664 -149.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.603 ' HB2' HD12 ' A' ' 26' ' ' ILE . 33.4 ttt180 -138.66 127.52 23.69 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.493 -172.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.608 ' CZ3' HG21 ' A' ' 48' ' ' THR . 3.4 m0 -86.99 83.79 7.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.532 HD13 ' CE1' ' A' ' 8' ' ' TYR . 8.0 mt -60.28 -64.22 1.03 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.986 -166.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.613 HG12 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -60.11 -33.07 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.216 -176.235 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 0.9 OUTLIER -60.53 -65.39 0.69 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.167 0.508 . . . . 0.0 110.792 168.505 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.33 39.11 0.6 Allowed Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.728 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -139.16 171.31 14.48 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 117.126 0.463 . . . . 0.0 110.457 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' HG3' ' HG3' ' A' ' 40' ' ' ARG . 1.7 mp0 -138.2 127.46 24.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.82 HG22 HG13 ' A' ' 39' ' ' VAL . 10.0 t -139.42 -179.64 6.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -164.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.6 m -138.48 120.55 15.62 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.593 HG23 ' H ' ' A' ' 51' ' ' TYR . 4.9 p -138.81 172.75 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.524 -160.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.593 ' H ' HG23 ' A' ' 50' ' ' VAL . 41.7 m-85 -138.57 100.03 8.44 Favored Pre-proline 0 N--CA 1.455 -0.22 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.281 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.08 163.56 16.46 Favored 'Trans proline' 0 N--CA 1.477 0.548 0 C-N-CA 123.423 2.749 . . . . 0.0 112.668 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.526 ' H ' HG23 ' A' ' 11' ' ' VAL . . . -86.4 -133.82 3.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.097 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.636 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 47.3 t -99.45 160.94 13.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 63.3 47.92 3.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.23 0.538 . . . . 0.0 110.243 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.752 ' HA ' HG12 ' A' ' 11' ' ' VAL . . . -72.89 130.53 40.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.65 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.78 179.97 2.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.04 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.32 136.81 44.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.823 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 11.9 m -138.54 175.38 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 C-N-CA 125.461 1.505 . . . . 0.0 109.262 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.521 ' H ' ' HG1' ' A' ' 60' ' ' THR . 0.4 OUTLIER -108.62 -165.48 1.03 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.4 -177.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -56.77 -47.55 79.87 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -175.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -59.04 5.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.708 0.766 . . . . 0.0 111.433 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 18.3 mt-10 -56.98 -27.97 61.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.397 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.652 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -57.36 -48.49 78.9 Favored 'General case' 0 C--O 1.198 -1.639 0 CA-C-N 114.254 -1.339 . . . . 0.0 114.207 177.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . -56.94 -72.34 0.08 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 119.201 0.91 . . . . 0.0 112.616 -162.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.21 -54.85 42.11 Favored 'General case' 0 C--O 1.281 2.722 0 CA-C-O 122.809 1.29 . . . . 0.0 112.61 -176.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.89 -50.89 71.14 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.883 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.765 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 24.3 tt0 -57.25 -31.13 65.24 Favored 'General case' 0 C--O 1.202 -1.426 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 96.1 mttt -57.08 -70.98 0.11 Allowed 'General case' 0 C--O 1.26 1.61 0 CA-C-O 121.8 0.81 . . . . 0.0 109.708 172.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -57.04 -53.22 60.57 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 123.179 1.466 . . . . 0.0 110.818 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.66 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . . . -57.18 -43.8 82.95 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.925 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.08 -37.33 71.73 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 118.487 0.585 . . . . 0.0 110.202 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.604 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . . . -56.82 -64.12 0.98 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.489 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.681 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 9.4 ttp180 -57.73 -46.49 84.37 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.748 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -55.14 -34.87 64.13 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.05 0.54 . . . . 0.0 111.852 -175.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.78 -116.86 0.82 Allowed Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.564 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.604 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 4.2 m-70 48.9 20.27 0.34 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.606 0.762 . . . . 0.0 112.319 -176.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -159.53 17.13 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.678 0.275 . . . . 0.0 111.474 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.86 163.87 22.0 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.187 -179.339 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.545 ' CE1' HG22 ' A' ' 58' ' ' VAL . 2.7 p-80 -139.04 153.08 48.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.823 ' HB2' ' HA2' ' A' ' 33' ' ' GLY . . . -138.91 105.11 5.23 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.59 ' HA ' HG21 ' A' ' 28' ' ' VAL . 50.5 mttp -139.11 165.23 27.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.175 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.977 HG22 ' HA ' ' A' ' 26' ' ' ILE . 7.4 p -70.88 151.58 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.363 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.92 14.5 59.26 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 65.4 m-20 -138.65 -179.08 5.61 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.817 ' HB2' HG23 ' A' ' 59' ' ' VAL . 97.6 m-85 -137.45 173.21 11.91 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -174.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.802 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.8 tt -138.43 136.34 36.13 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.255 -166.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 59.9 t -139.03 143.52 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 125.917 2.011 . . . . 0.0 108.995 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 52' ' ' PRO . 70.6 t -122.93 129.79 74.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.063 0.459 . . . . 0.0 110.757 177.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -85.86 92.8 8.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.615 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.97 -63.02 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.863 -173.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.471 ' C ' ' HG1' ' A' ' 15' ' ' THR . 0.3 OUTLIER -58.36 137.19 57.4 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -172.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.471 ' HG1' ' C ' ' A' ' 14' ' ' THR . 23.2 p 48.58 -99.7 0.06 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.521 0.728 . . . . 0.0 112.898 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -152.96 125.1 8.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.715 0.293 . . . . 0.0 111.2 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 59.95 16.91 6.15 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.019 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.454 ' HD3' ' HB ' ' A' ' 14' ' ' THR . 10.0 ttt180 -84.26 126.59 33.31 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.042 0.449 . . . . 0.0 110.429 -174.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.405 ' HB3' HG11 ' A' ' 10' ' ' VAL . 78.9 m80 -90.03 87.92 7.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.478 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.601 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 32.3 m-20 -112.97 -175.23 2.62 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.091 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.913 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 2.2 mp0 52.88 84.88 0.05 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.296 0.373 . . . . 0.0 110.973 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.802 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 6.7 t-80 -134.55 133.91 40.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.875 -174.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.451 ' N ' ' HD1' ' A' ' 22' ' ' HIS . . . -178.42 178.02 0.9 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.341 175.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.719 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 42.3 tt0 -98.45 131.38 44.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.457 0.646 . . . . 0.0 111.759 -174.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 26.7 mt -86.75 108.91 18.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.338 177.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.977 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -109.51 -28.02 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.517 176.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.853 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 14.7 mt-10 -120.25 111.98 18.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.59 HG21 ' HA ' ' A' ' 4' ' ' LYS . 47.2 t -98.81 115.36 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.09 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -64.62 -52.48 57.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.199 0.523 . . . . 0.0 110.193 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 43.4 m -117.55 110.42 17.92 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.362 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.426 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -63.63 -18.64 64.15 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.376 -170.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.16 -38.85 91.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.354 0.597 . . . . 0.0 110.107 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.823 ' HA2' ' HB2' ' A' ' 3' ' ' ALA . . . 129.08 53.42 0.11 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.533 -175.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 9.8 m -134.18 142.03 41.61 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.532 0.206 . . . . 0.0 110.658 -176.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.85 164.82 34.28 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.962 2.442 . . . . 0.0 111.898 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 73.1 Cg_endo -76.0 -179.59 27.56 Favored 'Cis proline' 0 C--N 1.347 0.463 0 C-N-CA 123.794 -1.336 . . . . 0.0 112.783 -0.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -131.04 142.72 50.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.216 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.853 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 58.3 t -98.62 103.4 14.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 170.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.09 138.85 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.81 -163.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.9 ' HG3' ' HB3' ' A' ' 47' ' ' GLU . 51.9 ttt180 -103.91 128.88 51.41 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.237 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.756 ' CE3' ' HB3' ' A' ' 72' ' ' ALA . 2.4 m0 -95.59 89.38 5.35 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.568 HD11 ' CD ' ' A' ' 24' ' ' GLU . 14.2 mt -70.48 -60.94 1.97 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.168 -165.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.545 HG12 ' CE1' ' A' ' 64' ' ' HIS . 3.1 m -77.76 -4.52 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.964 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.646 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 50.7 m-80 -93.84 -62.84 1.28 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.172 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.59 -80.09 0.1 Allowed Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.073 -1.06 . . . . 0.0 113.879 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.419 ' O ' ' HB2' ' A' ' 41' ' ' TRP . 20.7 m-70 -98.9 176.46 5.59 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.888 0.375 . . . . 0.0 111.903 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.9 ' HB3' ' HG3' ' A' ' 40' ' ' ARG . 13.7 pt-20 -120.03 152.06 38.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.387 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -167.06 178.35 5.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.526 0.679 . . . . 0.0 111.168 -176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.0 m -98.84 118.58 35.92 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.016 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.61 146.08 27.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 111.29 -172.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.535 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 75.8 m-85 -109.41 101.37 45.49 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.289 171.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HB2' HG23 ' A' ' 11' ' ' VAL . 72.2 Cg_endo -75.29 -10.87 20.92 Favored 'Trans proline' 0 N--CA 1.473 0.306 0 C-N-CA 122.962 2.441 . . . . 0.0 112.605 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.63 -102.52 2.88 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.677 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.9 m -153.31 171.11 19.08 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 62.2 41.06 11.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.309 0.576 . . . . 0.0 110.986 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.4 112.96 15.96 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.719 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.2 t -98.91 152.47 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.545 HG22 ' CE1' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -100.69 113.27 36.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.467 0.651 . . . . 0.0 111.867 -176.037 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.817 HG23 ' HB2' ' A' ' 8' ' ' TYR . 4.1 m -102.23 169.25 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.393 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.7 p -115.84 -163.73 0.91 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 -175.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -52.91 -46.89 68.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.23 -48.45 28.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.324 0.583 . . . . 0.0 110.866 -174.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 25.5 mt-10 -59.47 -16.6 25.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.038 176.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.724 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -75.9 -50.27 15.5 Favored 'General case' 0 C--O 1.205 -1.288 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.595 -177.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.36 -72.0 0.08 Allowed 'General case' 0 C--O 1.247 0.968 0 CA-C-O 121.779 0.799 . . . . 0.0 112.844 -163.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -66.16 -46.89 75.85 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.856 -172.304 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.42 -26.44 66.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.494 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.694 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 27.1 tt0 -73.62 -45.0 55.54 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.678 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 20.6 pttp -60.53 -47.86 84.33 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.438 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.491 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 10.9 ptp85 -68.06 -52.09 39.21 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.702 0.763 . . . . 0.0 111.669 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.601 ' HB2' ' HA ' ' A' ' 20' ' ' ASP . . . -77.98 -17.97 56.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.342 -169.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.756 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . . . -80.48 -37.18 32.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.389 173.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.02 -32.64 61.99 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.739 -0.384 . . . . 0.0 109.979 171.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -81.88 -37.19 27.26 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.684 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.913 ' HB3' ' HA ' ' A' ' 21' ' ' GLN . . . -59.52 -48.48 81.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.555 -172.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.93 -108.25 0.26 Allowed Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.365 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 63.61 -75.26 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 110.923 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -150.6 49.34 0.88 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.13 88.41 0.8 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.326 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--O 1.247 0.971 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.755 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -98.82 114.49 27.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.896 0.379 . . . . 0.0 110.221 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.86 153.95 46.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.162 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.89 173.35 7.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.923 0.392 . . . . 0.0 110.496 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' A' ' 26' ' ' ILE . 1.7 p -73.76 136.47 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.933 175.271 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.99 8.33 60.47 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -175.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.443 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 68.4 m-20 -107.38 161.72 14.56 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.775 ' CD1' ' HA ' ' A' ' 61' ' ' ALA . 1.2 m-85 -103.52 146.79 28.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.413 0.625 . . . . 0.0 111.764 -176.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.578 HD23 ' HB3' ' A' ' 52' ' ' PRO . 9.8 tt -99.47 132.75 44.59 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.604 175.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.713 HG12 ' CE1' ' A' ' 22' ' ' HIS . 54.2 t -127.98 147.42 32.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 O-C-N 124.638 1.211 . . . . 0.0 109.29 174.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 52' ' ' PRO . 53.7 t -104.76 101.67 12.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 171.665 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 11.7 tmtt? -66.85 -37.66 84.89 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.743 ' HA3' HG21 ' A' ' 16' ' ' THR . . . 78.57 154.52 7.68 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.848 175.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 m -96.3 -31.75 12.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.912 0.387 . . . . 0.0 110.487 -179.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 m -135.61 3.25 3.01 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -177.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.743 HG21 ' HA3' ' A' ' 13' ' ' GLY . 9.5 t -81.25 -27.78 35.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -173.073 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.712 ' HG3' ' O ' ' A' ' 16' ' ' THR . 1.0 OUTLIER 64.41 -43.52 0.29 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.123 1.369 . . . . 0.0 111.818 -176.391 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.498 ' HG2' ' OE2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -71.59 104.12 3.21 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 171.099 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -77.02 86.94 3.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 21' ' ' GLN . 5.8 t70 -123.1 -162.44 1.03 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.04 -164.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.749 ' N ' ' HB1' ' A' ' 71' ' ' ALA . 22.9 mt-30 58.83 94.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.206 0.602 . . . . 0.0 111.165 -177.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.713 ' CE1' HG12 ' A' ' 10' ' ' VAL . 3.4 m-70 -132.11 145.81 51.63 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.251 -0.281 . . . . 0.0 111.415 -173.498 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.649 ' HA ' ' HG3' ' A' ' 68' ' ' GLU . . . -179.04 176.09 0.92 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.568 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 41.4 tt0 -98.35 145.91 26.23 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.446 0.641 . . . . 0.0 111.201 -174.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.15 113.0 38.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.735 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -105.78 -15.5 8.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.894 0.378 . . . . 0.0 111.039 -178.622 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.949 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 37.7 mt-10 -132.15 103.59 6.34 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.658 0.742 . . . . 0.0 109.544 174.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.04 99.97 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.81 -176.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -104.56 53.57 0.73 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.603 0.716 . . . . 0.0 109.676 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.8 t -152.48 123.11 7.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.53 177.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.52 -26.27 20.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -89.88 -25.07 21.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.764 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.42 72.76 1.04 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.422 177.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 68.9 m -146.03 150.04 40.82 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.7 0.286 . . . . 0.0 110.886 178.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 19.5 Cg_exo -66.87 167.63 19.11 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.279 2.653 . . . . 0.0 112.062 177.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.99 154.66 94.11 Favored 'Cis proline' 0 C--N 1.345 0.366 0 C-N-CA 123.803 -1.332 . . . . 0.0 112.408 1.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -110.92 146.94 35.68 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.025 178.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.949 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 61.7 t -98.69 103.9 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 24' ' ' GLU . 53.2 t -116.19 121.51 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.013 -166.202 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.699 ' HB2' HD13 ' A' ' 26' ' ' ILE . 42.9 ttt180 -101.97 133.28 47.02 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.021 176.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.573 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 5.5 m0 -97.75 113.33 25.08 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.52 -49.69 17.94 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.884 0.373 . . . . 0.0 111.617 -167.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.728 ' HB ' ' HE2' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -93.96 -15.59 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.271 -176.356 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.573 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 33.0 m-80 -84.26 -36.23 22.82 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.875 175.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.01 34.73 9.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.654 177.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -123.59 166.81 14.83 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.522 -0.399 . . . . 0.0 110.438 179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -141.21 116.33 9.93 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 p -136.23 170.46 15.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.267 0.556 . . . . 0.0 112.254 -167.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.3 m -118.32 100.04 7.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 166.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.0 m -99.58 156.6 3.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-O 121.685 0.755 . . . . 0.0 112.776 -167.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -119.68 99.91 49.32 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.973 168.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.578 ' HB3' HD23 ' A' ' 9' ' ' LEU . 26.0 Cg_endo -63.7 -51.07 2.64 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.861 2.374 . . . . 0.0 112.868 -174.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.21 -117.02 1.55 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -175.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.3 m -129.64 154.13 47.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 12' ' ' LYS . 15.0 m-20 62.65 58.05 1.69 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.931 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.66 119.44 26.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.205 0.526 . . . . 0.0 110.837 179.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 t -101.07 159.72 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.472 -178.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 4.1 p -121.14 118.77 57.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.358 0.599 . . . . 0.0 111.326 -178.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.589 HG22 ' CB ' ' A' ' 8' ' ' TYR . 2.4 m -116.64 -179.93 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 123.408 0.683 . . . . 0.0 111.411 -178.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -80.98 166.4 20.86 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.732 174.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.775 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . . . -68.86 -66.54 0.56 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.598 -169.58 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 p -80.73 -25.06 38.31 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -167.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -53.94 -58.94 5.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.612 0.72 . . . . 0.0 109.578 175.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.462 ' CE1' HG13 ' A' ' 59' ' ' VAL . 11.3 m-70 -82.44 -16.5 48.7 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.472 ' O ' HG21 ' A' ' 43' ' ' VAL . . . -45.39 -39.55 7.04 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -63.08 -44.39 95.88 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-O 123.564 1.65 . . . . 0.0 109.127 177.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.436 ' CB ' ' HD2' ' A' ' 22' ' ' HIS . . . -66.3 -16.59 64.16 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.418 173.246 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.651 ' HB2' ' HE2' ' A' ' 8' ' ' TYR . 10.3 tt0 -69.82 -40.09 76.12 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 171.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.728 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 66.7 mmtt -51.07 -61.65 2.1 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.123 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -62.26 1.89 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.744 1.259 . . . . 0.0 112.076 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.749 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -78.31 -16.96 57.21 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.197 -165.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.569 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -81.74 -34.54 30.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 118.645 0.657 . . . . 0.0 109.316 173.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.82 -36.14 64.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 170.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -74.7 -55.54 5.76 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.987 174.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -49.08 -56.94 7.53 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.743 0.817 . . . . 0.0 111.967 -176.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.499 ' HA3' ' HH2' ' A' ' 41' ' ' TRP . . . -97.98 46.52 1.59 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.822 -176.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -82.2 -22.06 36.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -167.0 163.7 15.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.641 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.97 -52.16 0.9 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.077 0.465 . . . . 0.0 110.026 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.4 m . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.493 -179.843 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.73 116.17 11.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.901 0.381 . . . . 0.0 110.142 178.194 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.86 140.81 38.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.338 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -139.12 164.24 30.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.959 0.409 . . . . 0.0 111.249 -177.37 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.798 HG22 ' HA ' ' A' ' 26' ' ' ILE . 4.0 p -65.15 145.43 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.939 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.06 17.28 41.08 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -174.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 7.6 m-20 -138.76 -179.06 5.6 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 113.902 -1.149 . . . . 0.0 108.415 -174.31 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.808 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 95.4 m-85 -137.02 164.93 27.2 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.314 -168.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 6.7 tt -138.63 142.2 39.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.769 -166.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.853 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 3.5 t -138.88 -179.99 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.276 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.755 ' H ' HG13 ' A' ' 10' ' ' VAL . 41.2 t -138.18 129.41 37.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 121.648 0.737 . . . . 0.0 109.588 176.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.688 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 52.5 mttm -77.35 -156.91 0.09 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.114 -172.517 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.46 -89.41 0.18 Allowed Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.747 -177.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 19.1 m 73.47 -37.99 0.39 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.393 0.677 . . . . 0.0 112.227 175.483 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 p -77.72 0.1 24.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.314 0.578 . . . . 0.0 111.161 178.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.1 m -151.86 -76.78 0.13 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -104.52 133.79 48.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 171.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 55.9 mtt180 -70.52 -76.41 0.1 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -165.031 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -143.2 100.39 3.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 9.4 m-20 -132.85 177.79 7.37 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.691 -174.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.853 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 4.7 mt-30 63.0 98.19 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.857 0.723 . . . . 0.0 110.197 -170.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.993 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 21.3 t-80 -139.05 121.43 16.04 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.354 0.597 . . . . 0.0 111.81 -175.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.77 -178.23 5.33 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 125.222 1.409 . . . . 0.0 110.239 -177.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.808 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 26.6 tt0 -136.75 123.58 21.28 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.478 1.133 . . . . 0.0 109.079 174.016 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.716 ' HB ' HG23 ' A' ' 28' ' ' VAL . 4.6 pt -82.69 115.42 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.96 -174.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.798 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -108.01 -8.41 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 113.808 -1.542 . . . . 0.0 108.477 170.435 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.596 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -138.9 122.22 17.09 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.447 175.437 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.716 HG23 ' HB ' ' A' ' 25' ' ' ILE . 20.8 t -138.49 119.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.877 -165.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 29' ' ' ARG . 5.0 mmp_? -68.87 -35.79 77.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -174.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.8 m -147.68 149.59 32.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.757 -176.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.45 -14.71 59.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.142 0.496 . . . . 0.0 110.694 -179.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.89 -72.75 0.37 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.256 0.55 . . . . 0.0 110.001 176.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.91 88.05 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.527 -177.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -143.47 125.1 8.33 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.36 161.0 38.37 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.729 2.286 . . . . 0.0 111.534 175.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.32 -175.07 15.75 Favored 'Cis proline' 0 C--N 1.342 0.234 0 C-N-CA 123.732 -1.362 . . . . 0.0 113.392 2.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -138.87 169.55 17.6 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.594 178.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 84.2 t -137.96 116.47 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.041 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.521 HG12 HG22 ' A' ' 48' ' ' THR . 0.4 OUTLIER -138.86 174.61 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 112.676 -2.056 . . . . 0.0 109.272 -152.558 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.836 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 62.9 mtt180 -138.67 133.56 32.51 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.725 ' HD1' ' HB2' ' A' ' 46' ' ' HIS . 16.1 m95 -79.53 84.6 5.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 166.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.586 HD12 ' CD ' ' A' ' 24' ' ' GLU . 6.5 mt -60.08 -64.21 1.03 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.2 0.524 . . . . 0.0 111.617 -167.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.713 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -60.03 -35.5 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.121 -176.623 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -60.53 -60.67 3.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.797 171.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.07 39.68 0.68 Allowed Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.113 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.725 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 37.5 m80 -139.16 167.11 22.79 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.119 0.459 . . . . 0.0 111.134 178.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.836 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 6.7 pt-20 -138.86 128.79 25.11 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.487 173.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.556 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 8.9 t -139.74 -179.26 5.82 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.758 -163.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.9 m -138.25 116.83 12.13 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.688 HG11 ' H ' ' A' ' 51' ' ' TYR . 1.6 t -138.69 175.95 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.193 0.521 . . . . 0.0 111.304 -162.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.688 ' H ' HG11 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -138.82 107.27 7.56 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.78 -178.758 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.71 141.33 90.33 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.736 2.291 . . . . 0.0 111.755 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.95 67.0 2.14 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.557 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t 67.22 173.12 0.26 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.944 0.438 . . . . 0.0 110.957 179.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.688 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 8.5 m-20 56.18 38.33 29.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.221 174.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.2 139.8 54.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.328 -176.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.861 HG23 ' H ' ' A' ' 58' ' ' VAL . 5.7 p -138.93 -179.7 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.832 177.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.861 ' H ' HG23 ' A' ' 57' ' ' VAL . 56.1 t -138.45 136.27 43.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.785 -171.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.728 HG22 ' HB2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -138.87 179.92 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 C-N-CA 123.355 0.662 . . . . 0.0 111.284 -174.17 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.9 p -120.55 -172.31 2.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.349 -176.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.02 -48.44 78.48 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -172.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -55.75 30.74 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.565 -0.71 . . . . 0.0 111.437 -178.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -56.98 -29.86 63.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.87 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.713 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.22 -45.32 83.96 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.286 -179.446 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.535 ' HA ' HG12 ' A' ' 43' ' ' VAL . . . -56.85 -73.4 0.06 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.912 0.863 . . . . 0.0 111.534 -167.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.44 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -57.08 -61.71 2.27 Favored 'General case' 0 C--O 1.268 2.059 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.671 -177.272 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.15 -50.21 73.54 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.462 -175.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.993 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 29.6 tt0 -57.14 -37.89 72.68 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 118.0 0.364 . . . . 0.0 111.575 -177.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -56.93 -68.12 0.25 Allowed 'General case' 0 C--O 1.253 1.24 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.572 176.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -57.28 -58.23 9.16 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 122.776 1.274 . . . . 0.0 111.675 -177.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.635 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -57.32 -25.23 59.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.321 -178.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.46 -40.95 73.4 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 118.894 0.77 . . . . 0.0 109.827 175.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.51 62.68 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.019 172.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.417 ' HG2' ' HB3' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -74.21 -57.16 4.13 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 176.263 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -51.12 -44.61 61.35 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.556 0.946 . . . . 0.0 113.556 -169.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -87.64 24.86 9.24 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 119.8 -1.191 . . . . 0.0 112.651 -174.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -66.68 -28.6 68.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.744 0.307 . . . . 0.0 111.165 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.0 26.21 9.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.885 0.374 . . . . 0.0 111.095 -175.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.61 75.73 8.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.155 0.502 . . . . 0.0 110.513 178.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.419 -179.689 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.463 ' HG2' ' N ' ' A' ' 2' ' ' HIS . 23.4 ttt . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.463 ' N ' ' HG2' ' A' ' 1' ' ' MET . 42.2 m-70 -138.87 140.21 38.36 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.126 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.91 139.66 38.11 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.702 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 91.6 mttt -139.35 140.77 37.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.239 -173.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.804 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -71.29 139.63 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 169.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.55 13.82 66.93 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -172.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.702 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 1.8 m-20 -139.11 143.81 38.43 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.109 -2.045 . . . . 0.0 107.655 -167.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.813 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 33.2 m-85 -135.63 142.6 45.24 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -148.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.761 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 2.3 tt -136.69 140.2 42.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 119.334 0.97 . . . . 0.0 110.244 -156.473 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.614 HG22 ' HD1' ' A' ' 22' ' ' HIS . 42.3 t -138.87 140.75 38.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.211 -168.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.721 HG12 ' H ' ' A' ' 13' ' ' GLY . 72.0 t -138.41 140.16 40.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -176.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -107.4 3.69 25.5 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.002 0.43 . . . . 0.0 110.834 -178.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.721 ' H ' HG12 ' A' ' 11' ' ' VAL . . . -84.23 45.55 3.51 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.239 -174.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 p -113.15 -81.77 0.59 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.858 0.361 . . . . 0.0 110.452 176.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.433 ' HB ' ' OE1' ' A' ' 17' ' ' GLU . 40.6 m -124.34 -78.8 0.6 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.239 177.051 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.8 t -147.23 6.25 0.86 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.537 0.684 . . . . 0.0 110.277 177.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 22.5 mp0 -67.93 105.28 1.95 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.548 176.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -69.31 -11.95 61.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.333 -175.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -135.85 65.82 1.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 14.3 t0 -106.39 179.06 4.38 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -175.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.709 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 51.8 mt-30 39.7 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.699 0.8 . . . . 0.0 112.817 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.761 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 54.7 t60 -138.57 138.98 38.46 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 122.634 1.207 . . . . 0.0 113.397 -176.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.588 ' HB1' ' CZ3' ' A' ' 41' ' ' TRP . . . -140.43 -177.87 5.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 112.19 -2.277 . . . . 0.0 110.926 -174.011 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.813 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 10.7 tt0 -136.69 122.17 19.52 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 123.007 1.384 . . . . 0.0 108.046 166.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 66.0 mt -81.52 107.69 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 111.652 -2.522 . . . . 0.0 110.242 -170.028 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.804 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -102.38 -14.12 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.629 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 48.9 mm-40 -139.02 150.36 45.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.577 174.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.46 HG22 ' CG2' ' A' ' 25' ' ' ILE . 17.7 t -137.83 100.11 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -170.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -89.23 -29.08 19.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.663 -163.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.9 p -68.94 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.495 -176.378 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -176.95 -64.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.285 0.564 . . . . 0.0 109.954 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -151.05 88.13 1.44 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.905 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.64 172.84 44.11 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.218 -173.054 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m 69.36 156.76 0.15 Allowed Pre-proline 0 N--CA 1.467 0.419 0 CA-C-O 120.953 0.406 . . . . 0.0 111.529 178.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.402 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 8.8 Cg_exo -73.03 163.92 36.94 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.815 2.344 . . . . 0.0 112.331 178.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.543 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 18.9 Cg_endo -94.61 -178.01 7.35 Favored 'Cis proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.809 -1.329 . . . . 0.0 112.681 -1.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -138.83 174.27 10.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.059 177.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 89.6 t -138.03 114.54 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 174.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' A' ' 25' ' ' ILE . 0.4 OUTLIER -139.02 175.25 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.818 -153.658 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.775 ' HB2' HD22 ' A' ' 42' ' ' LEU . 84.7 mtt180 -138.51 134.96 34.6 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.74 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 12.2 m95 -80.1 81.02 6.44 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 166.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.775 HD22 ' HB2' ' A' ' 40' ' ' ARG . 3.7 mt -59.92 -67.8 0.35 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.515 0.509 . . . . 0.0 111.932 -162.573 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.54 HG21 ' OE2' ' A' ' 68' ' ' GLU . 0.9 OUTLIER -59.96 -31.19 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.974 -175.716 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.58 HD22 ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -60.59 -62.99 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.177 0.513 . . . . 0.0 110.591 169.637 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.05 43.16 0.34 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.811 -0.632 . . . . 0.0 113.576 177.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.74 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 44.6 t-80 -139.35 164.01 30.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 117.527 0.664 . . . . 0.0 111.069 178.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 42.0 tt0 -138.44 122.09 17.45 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.223 0.535 . . . . 0.0 110.023 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.47 HG23 ' CZ2' ' A' ' 41' ' ' TRP . 14.8 t -139.68 -179.0 5.67 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -165.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.8 m -138.15 110.55 7.45 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.73 -179.74 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -160.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.543 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 2.3 m-85 -138.78 125.64 12.95 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.048 -178.389 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.502 ' HB2' HG21 ' A' ' 11' ' ' VAL . 56.5 Cg_endo -74.37 -78.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.673 2.249 . . . . 0.0 113.234 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.41 -154.44 23.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.862 -178.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.7 m -87.62 159.1 18.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.569 0.184 . . . . 0.0 110.559 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 t70 65.91 39.85 4.4 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.94 0.876 . . . . 0.0 108.859 -174.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.542 ' HA ' HG23 ' A' ' 11' ' ' VAL . . . -79.9 137.74 36.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.126 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.723 HG11 ' H ' ' A' ' 58' ' ' VAL . 3.4 t -138.71 175.65 7.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -174.143 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.723 ' H ' HG11 ' A' ' 57' ' ' VAL . 58.9 t -138.34 138.33 43.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.613 0.72 . . . . 0.0 110.648 -175.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 3.1 m -138.62 179.99 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 C-N-CA 125.74 1.616 . . . . 0.0 110.023 -174.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.423 HG21 ' N ' ' A' ' 61' ' ' ALA . 5.9 t -121.85 -159.28 0.81 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.123 -174.572 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.423 ' N ' HG21 ' A' ' 60' ' ' THR . . . -56.99 -48.23 78.91 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.408 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.423 ' H ' HG21 ' A' ' 60' ' ' THR . 0.2 OUTLIER -57.35 -58.59 7.6 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 122.013 -0.429 . . . . 0.0 112.128 -179.697 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 29.5 mm-40 -57.15 -28.12 62.46 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.677 0.751 . . . . 0.0 110.307 -178.295 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.721 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.12 -42.52 81.04 Favored 'General case' 0 C--O 1.206 -1.233 0 CA-C-N 114.627 -1.17 . . . . 0.0 113.563 -176.707 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.2 -75.92 0.04 OUTLIER 'General case' 0 C--O 1.244 0.793 0 CA-C-O 122.331 1.062 . . . . 0.0 111.669 -170.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.576 ' HB2' ' NH1' ' A' ' 70' ' ' ARG . 1.2 pt-20 -57.24 -51.59 68.75 Favored 'General case' 0 C--O 1.265 1.915 0 CA-C-N 113.798 -1.547 . . . . 0.0 112.035 -177.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.11 -49.82 74.7 Favored 'General case' 0 C--O 1.2 -1.527 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.766 -178.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.721 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 4.4 tt0 -57.0 -35.73 69.57 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 118.019 0.372 . . . . 0.0 111.2 -176.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.58 ' HA ' HD22 ' A' ' 44' ' ' ASN . 93.6 mttt -57.13 -74.46 0.05 Allowed 'General case' 0 C--O 1.254 1.316 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.631 172.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.576 ' NH1' ' HB2' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -57.27 -60.87 2.98 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.908 1.337 . . . . 0.0 111.256 -173.978 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.541 ' HB3' ' N ' ' A' ' 21' ' ' GLN . . . -57.08 -51.15 70.43 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 112.928 -1.942 . . . . 0.0 113.869 -175.268 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 68' ' ' GLU . . . -57.31 -36.15 70.74 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 118.463 0.574 . . . . 0.0 111.081 -179.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.87 -48.76 77.4 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.835 174.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -57.57 -65.97 0.54 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 175.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.709 ' HB3' ' HA ' ' A' ' 21' ' ' GLN . . . -50.29 -37.11 34.63 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.99 0.916 . . . . 0.0 113.378 -166.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -113.34 15.29 22.71 Favored Glycine 0 C--N 1.322 -0.21 0 C-N-CA 118.896 -1.621 . . . . 0.0 113.535 -172.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -99.91 -46.92 5.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.861 0.363 . . . . 0.0 110.52 177.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.87 85.2 3.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.189 -177.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.16 76.86 3.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 178.252 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.713 -0.661 . . . . 0.0 109.742 178.746 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.543 ' HG2' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -138.42 105.35 5.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.343 0.592 . . . . 0.0 110.169 175.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.83 166.36 10.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.286 -178.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -134.79 173.87 11.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.869 176.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.775 HG22 ' HA ' ' A' ' 26' ' ' ILE . 7.3 p -80.97 143.68 11.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.039 0.447 . . . . 0.0 110.642 177.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.5 8.97 67.36 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -177.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -108.06 174.43 5.88 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.713 ' CD1' ' HA ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER -104.57 138.13 41.37 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.267 0.556 . . . . 0.0 110.658 179.132 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.2 tt -99.02 136.84 38.42 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.852 179.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.738 HG22 ' CD2' ' A' ' 22' ' ' HIS . 55.4 t -133.16 160.38 42.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.801 174.29 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 44.6 t -131.92 131.44 61.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 118.052 0.387 . . . . 0.0 110.575 174.689 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -80.53 68.25 6.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.619 0.723 . . . . 0.0 109.29 176.652 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.15 90.2 0.37 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 175.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 10.2 m -55.3 99.66 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.281 0.562 . . . . 0.0 112.432 -171.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 m -126.99 -76.37 0.58 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.729 176.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 m -86.2 -26.56 25.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.988 0.899 . . . . 0.0 108.839 174.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.64 ' HG3' ' H ' ' A' ' 19' ' ' HIS . 14.1 tp10 -154.01 164.87 37.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.172 -1.376 . . . . 0.0 107.706 -178.154 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -61.58 -23.87 66.28 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.711 0.767 . . . . 0.0 109.39 175.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.64 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 72.6 m80 -124.79 99.34 6.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.394 177.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -106.39 -164.24 0.99 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.595 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.8 mp0 47.36 93.6 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.616 0.572 . . . . 0.0 112.208 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.856 ' HB2' ' HA ' ' A' ' 68' ' ' GLU . 20.8 m170 -125.49 141.52 52.0 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.894 -176.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.614 ' HA ' ' HG3' ' A' ' 68' ' ' GLU . . . -177.76 -179.85 0.83 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.833 0.708 . . . . 0.0 110.484 173.486 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.426 ' OE1' HD23 ' A' ' 42' ' ' LEU . 36.7 tt0 -98.77 131.61 44.77 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.287 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.504 ' HB ' HG22 ' A' ' 28' ' ' VAL . 3.8 pt -96.81 111.26 26.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.087 0.47 . . . . 0.0 110.839 178.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.775 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -104.2 -21.96 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.688 177.58 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 1.027 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 36.2 tt0 -123.45 99.96 6.58 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.403 0.62 . . . . 0.0 110.102 172.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.859 HG11 ' HE2' ' A' ' 37' ' ' TYR . 34.6 t -112.22 100.54 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.509 -178.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -95.14 11.83 30.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.135 0.493 . . . . 0.0 110.627 -176.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.1 t -136.62 126.03 25.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.601 -179.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.2 -20.74 25.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.586 -179.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.87 -29.0 22.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.288 179.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.581 ' HA2' ' OH ' ' A' ' 37' ' ' TYR . . . 104.4 73.19 0.91 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.764 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -142.98 128.24 10.04 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -177.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.728 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 21.3 Cg_endo -62.67 165.47 15.8 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.858 2.372 . . . . 0.0 112.231 177.223 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.19 156.61 83.19 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 124.011 -1.245 . . . . 0.0 113.248 3.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.859 ' HE2' HG11 ' A' ' 28' ' ' VAL . 34.3 m-85 -119.91 147.55 44.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.984 177.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 1.027 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 98.4 t -98.9 106.63 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -114.66 155.55 15.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.311 -163.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.709 ' HB2' HD13 ' A' ' 26' ' ' ILE . 23.9 ttt180 -128.86 115.76 18.38 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.048 -176.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.715 ' CB ' ' HB2' ' A' ' 44' ' ' ASN . 6.7 m95 -75.63 120.39 20.96 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.426 HD23 ' OE1' ' A' ' 24' ' ' GLU . 12.8 mt -88.42 -45.66 9.78 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.663 -176.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.647 HG21 ' O ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -90.75 -5.84 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.155 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.715 ' HB2' ' CB ' ' A' ' 41' ' ' TRP . 39.6 m-80 -96.06 -40.36 9.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 168.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.09 63.58 1.44 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.764 172.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.503 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 54.9 t60 -172.42 154.3 3.16 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.921 0.361 . . . . 0.0 110.42 176.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.602 ' HG2' ' HG3' ' A' ' 40' ' ' ARG . 38.6 mt-10 -113.33 145.91 40.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.104 178.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -172.11 176.83 3.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.47 0.652 . . . . 0.0 111.084 178.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.1 m -108.52 115.1 29.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.942 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.92 172.59 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.277 0.56 . . . . 0.0 111.68 -176.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.542 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 68.8 m-85 -119.89 100.09 48.75 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.515 177.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.728 ' HD2' ' HB3' ' A' ' 35' ' ' PRO . 37.4 Cg_endo -66.08 -39.83 17.54 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.678 2.252 . . . . 0.0 112.486 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.94 -159.57 13.72 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.905 -178.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.519 ' O ' HG11 ' A' ' 11' ' ' VAL . 18.3 m -94.5 169.18 10.38 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.029 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.442 ' HB3' ' HB3' ' A' ' 12' ' ' LYS . 18.9 m-20 66.17 32.55 7.96 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.418 0.449 . . . . 0.0 110.765 178.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 1' ' ' MET . . . -76.57 113.74 14.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.054 0.454 . . . . 0.0 111.008 -179.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.9 t -99.21 162.33 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.742 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.7 t -110.2 152.05 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.909 0.385 . . . . 0.0 111.235 -176.352 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.57 HG21 ' N ' ' A' ' 60' ' ' THR . 11.0 p -151.73 173.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.041 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.57 ' N ' HG21 ' A' ' 59' ' ' VAL . 47.8 p -90.2 169.39 11.18 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 175.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.713 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . . . -52.64 -64.55 0.78 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -172.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 p -75.18 -28.86 60.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -163.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -58.4 -62.6 1.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.103 0.478 . . . . 0.0 110.88 -176.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.498 ' HB2' HG12 ' A' ' 59' ' ' VAL . 3.2 m80 -81.95 -16.19 51.3 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.647 ' O ' HG21 ' A' ' 43' ' ' VAL . . . -43.36 -46.47 6.52 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -170.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -59.02 -48.69 80.69 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-O 123.37 1.557 . . . . 0.0 109.627 -179.167 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.65 -16.9 63.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.668 173.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.856 ' HA ' ' HB2' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -73.2 -40.88 64.39 Favored 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.679 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.552 ' HA ' ' ND2' ' A' ' 44' ' ' ASN . 46.4 tttp -53.62 -50.63 65.28 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -64.27 -66.12 0.59 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 122.129 0.966 . . . . 0.0 112.784 178.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.67 -16.9 62.84 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -169.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.648 ' HB3' ' CE3' ' A' ' 41' ' ' TRP . . . -81.73 -33.78 30.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 173.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.75 -33.05 60.69 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.604 168.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 -76.74 -57.02 4.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.624 172.17 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -50.26 -51.52 44.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.846 0.859 . . . . 0.0 112.526 -176.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -80.09 5.95 61.21 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.959 -175.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -93.1 -20.48 20.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.027 0.441 . . . . 0.0 110.184 178.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.26 -157.67 0.73 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.8 -176.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . . . -142.28 14.24 2.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.223 0.535 . . . . 0.0 110.119 177.192 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.251 1.179 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.943 -175.014 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.429 ' HG3' ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.684 0.278 . . . . 0.0 110.843 . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -138.91 121.63 16.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.451 ' HB2' HG23 ' A' ' 58' ' ' VAL . . . -138.85 169.46 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.097 0.475 . . . . 0.0 112.062 -173.022 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 40.7 ttmt -139.3 166.13 25.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.412 -178.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 26' ' ' ILE . 6.1 p -71.53 142.65 15.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 173.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.1 16.18 45.31 Favored Glycine 0 N--CA 1.454 -0.147 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -173.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 64.7 m-20 -138.77 -178.88 5.51 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 113.971 -1.114 . . . . 0.0 108.205 -174.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.73 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 87.3 m-85 -136.83 170.13 16.6 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.932 -169.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.721 HD13 ' HG3' ' A' ' 52' ' ' PRO . 8.0 tt -138.75 144.94 39.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.61 -166.596 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.889 ' HB ' ' HB ' ' A' ' 57' ' ' VAL . 87.2 t -138.87 172.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.699 HG12 ' HB2' ' A' ' 54' ' ' SER . 13.5 t -138.65 133.26 41.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.013 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 28.5 mtpp 69.14 166.42 0.27 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.546 0.688 . . . . 0.0 111.197 -175.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.585 ' HA2' ' HB2' ' A' ' 17' ' ' GLU . . . 115.29 12.39 9.85 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.366 177.116 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -91.55 -40.61 11.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.715 0.293 . . . . 0.0 110.419 -177.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.5 p -95.36 56.44 1.85 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.064 0.459 . . . . 0.0 110.178 177.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p 50.58 52.07 15.61 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.542 -176.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.585 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 16.7 mt-10 -106.21 175.55 5.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.604 -177.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 -76.56 134.08 39.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.298 170.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.494 ' HB3' HG13 ' A' ' 10' ' ' VAL . 91.6 m-70 -83.9 100.22 10.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.625 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -113.99 179.51 3.94 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.067 -174.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.619 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 24.5 mt-30 43.72 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.767 0.827 . . . . 0.0 112.511 -173.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.975 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.3 t-160 -138.78 129.1 25.72 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.54 0.686 . . . . 0.0 111.424 -169.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.761 ' HB1' ' HZ3' ' A' ' 41' ' ' TRP . . . -139.59 -178.29 5.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.968 -176.462 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.73 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 24.2 tt0 -136.76 125.93 24.62 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.629 1.204 . . . . 0.0 109.264 173.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.593 HG21 HG23 ' A' ' 28' ' ' VAL . 4.3 mt -82.67 107.48 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 112.557 -2.11 . . . . 0.0 109.815 -170.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.902 HG12 ' HD3' ' A' ' 40' ' ' ARG . 1.8 pp -106.82 -12.68 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.274 175.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 1.08 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -138.88 136.61 35.71 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.614 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.593 HG23 HG21 ' A' ' 25' ' ' ILE . 11.2 t -138.36 107.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 -165.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.6 ' CZ ' ' HA ' ' A' ' 29' ' ' ARG . 2.7 mmp_? -71.26 -19.14 62.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.779 0.324 . . . . 0.0 111.756 -176.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 60.5 m -152.3 115.46 4.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.05 13.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.831 -174.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -93.5 -11.84 31.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.172 0.511 . . . . 0.0 110.279 176.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.18 71.37 0.99 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.171 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.458 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 17.0 m -136.47 125.86 15.72 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 15.8 Cg_exo -68.7 153.53 73.06 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.974 2.449 . . . . 0.0 112.145 178.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.553 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 6.2 Cg_exo -80.29 -169.81 8.05 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 124.129 -1.196 . . . . 0.0 113.086 2.344 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -138.42 172.8 12.35 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.994 178.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 1.08 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 48.5 t -137.84 116.8 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.077 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.91 176.57 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.964 -149.557 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 1.01 ' HG2' ' HG2' ' A' ' 47' ' ' GLU . 12.4 mtp180 -138.82 138.18 37.3 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.761 ' HZ3' ' HB1' ' A' ' 23' ' ' ALA . 11.8 m95 -86.27 82.5 7.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 168.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 24' ' ' GLU . 5.4 mt -59.89 -69.65 0.2 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.114 0.483 . . . . 0.0 111.985 -166.363 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -60.2 -34.09 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.089 -175.704 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 72' ' ' ALA . 42.6 m-80 -60.43 -45.68 92.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.287 172.543 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.7 39.75 1.99 Allowed Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.851 179.184 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.475 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 63.7 m80 -139.23 172.92 12.12 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.324 -0.515 . . . . 0.0 111.893 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 1.01 ' HG2' ' HG2' ' A' ' 40' ' ' ARG . 45.0 mt-10 -138.58 128.26 24.93 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.35 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.34 179.93 6.25 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.129 0.966 . . . . 0.0 113.599 -160.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 75.6 m -138.78 125.3 20.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 167.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.422 HG23 ' N ' ' A' ' 51' ' ' TYR . 8.0 p -138.87 165.21 24.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.415 -162.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.553 ' CD2' ' HB3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -138.72 99.86 8.35 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.254 178.187 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.721 ' HG3' HD13 ' A' ' 9' ' ' LEU . 55.3 Cg_endo -70.67 114.16 3.76 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.758 2.305 . . . . 0.0 111.632 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.08 81.98 1.14 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.419 178.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.699 ' HB2' HG12 ' A' ' 11' ' ' VAL . 43.7 t 177.79 -179.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.034 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -71.72 -15.08 62.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . 80.92 162.07 0.16 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.564 172.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.889 ' HB ' ' HB ' ' A' ' 10' ' ' VAL . 21.6 t -138.95 170.16 16.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.094 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 38.5 t -138.47 128.02 32.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.94 176.77 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.853 -174.331 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 p -120.08 -166.68 1.33 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.345 -176.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.0 79.36 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.457 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.39 -55.86 29.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.396 0.544 . . . . 0.0 111.813 -175.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.433 ' HG3' HG12 ' A' ' 59' ' ' VAL . 1.6 mm-40 -56.81 -31.39 64.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.635 -176.392 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.694 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.38 -40.8 78.94 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.766 -176.467 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.707 ' HA ' HG12 ' A' ' 43' ' ' VAL . . . -57.53 -77.08 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.052 0.93 . . . . 0.0 111.294 -170.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -60.33 3.84 Favored 'General case' 0 C--O 1.267 1.998 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.173 -178.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -56.92 -56.44 21.64 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.853 -174.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.975 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 35.6 tt0 -57.27 -34.35 68.56 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -175.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 29.8 mtpp -57.1 -65.9 0.54 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.459 175.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -57.35 -53.79 54.13 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-O 123.544 1.64 . . . . 0.0 111.049 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.608 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -57.21 -45.47 83.78 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 112.627 -2.079 . . . . 0.0 113.105 -173.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.43 ' HB3' ' ND2' ' A' ' 44' ' ' ASN . . . -68.43 -33.31 73.99 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.806 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -53.87 -37.3 63.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 123.483 0.489 . . . . 0.0 110.22 174.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.8 mtp-105 -81.6 -47.0 13.6 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 173.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -48.25 -51.61 24.84 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.237 0.615 . . . . 0.0 111.633 -177.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.84 35.34 4.11 Favored Glycine 0 N--CA 1.454 -0.125 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.943 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 55.8 t-80 -128.59 -47.3 1.28 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.096 0.474 . . . . 0.0 109.884 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.01 -4.24 58.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.168 -179.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.52 129.75 38.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.02 -178.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--O 1.247 0.949 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.71 176.418 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.7 t60 . . . . . 0 CA--C 1.522 -0.12 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.0 161.94 13.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.074 0.464 . . . . 0.0 111.672 -173.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 4' ' ' LYS . 39.8 ttmt -148.41 147.36 29.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.335 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.447 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.7 p -86.47 142.01 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.957 0.408 . . . . 0.0 110.41 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.82 4.74 65.05 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -121.2 171.39 8.74 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.929 ' HB2' HG23 ' A' ' 59' ' ' VAL . 98.9 m-85 -109.81 146.35 35.17 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.398 0.618 . . . . 0.0 111.508 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.679 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.4 tt -99.14 140.11 33.78 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.828 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.572 HG22 ' CE1' ' A' ' 22' ' ' HIS . 55.6 t -130.81 151.54 36.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 O-C-N 124.839 1.337 . . . . 0.0 109.441 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.845 ' HB ' ' HB2' ' A' ' 21' ' ' GLN . 74.6 t . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.426 0.155 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.845 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 58.6 mt-30 40.33 85.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.641 1.213 . . . . 0.0 112.347 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.735 ' CB ' ' HA ' ' A' ' 68' ' ' GLU . 7.2 m80 -118.49 146.58 44.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.249 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -176.7 177.98 1.3 Allowed 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.103 0.877 . . . . 0.0 110.857 170.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.617 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 43.4 tt0 -98.58 127.47 44.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.273 0.558 . . . . 0.0 110.742 177.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 9' ' ' LEU . 20.4 mt -88.48 103.04 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.177 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.663 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -105.76 -19.78 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.249 178.022 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.862 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 68.8 mm-40 -134.08 111.0 10.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.764 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 30' ' ' SER . 38.6 t -98.89 116.16 41.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.922 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -88.83 32.3 0.81 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.008 0.433 . . . . 0.0 110.861 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.508 ' H ' HG12 ' A' ' 28' ' ' VAL . 34.2 t -148.94 149.21 30.82 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.52 -14.6 45.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.052 0.453 . . . . 0.0 110.219 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -130.53 -70.84 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.472 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.39 75.93 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.611 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 33.3 p -146.67 132.87 9.58 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 37.3 Cg_exo -61.85 160.31 29.77 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.889 2.393 . . . . 0.0 112.098 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.52 179.26 22.23 Favored 'Cis proline' 0 N--CA 1.462 -0.34 0 C-N-CA 123.406 -1.498 . . . . 0.0 113.132 1.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -132.77 153.46 51.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.601 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.862 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 67.3 t -98.56 117.18 43.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 172.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.52 147.63 30.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.001 -164.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.788 ' HG2' ' HG3' ' A' ' 47' ' ' GLU . 98.7 mtt180 -115.4 131.88 56.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.633 176.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.7 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 13.8 m95 -85.38 101.3 12.47 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 168.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.712 ' HB2' ' HE1' ' A' ' 64' ' ' HIS . 12.7 mt -82.29 -55.55 4.45 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.432 0.634 . . . . 0.0 110.605 -173.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.617 HG11 ' HA ' ' A' ' 65' ' ' ALA . 2.0 m -76.14 -5.7 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.581 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.7 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 45.9 m-80 -100.01 -64.22 1.06 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.756 173.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . 122.02 68.42 0.25 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.532 -0.842 . . . . 0.0 114.181 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.546 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 30.3 t60 -179.18 156.92 0.79 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.217 0.509 . . . . 0.0 110.819 172.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.788 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 25.4 mp0 -110.58 150.38 29.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 t -175.18 -179.95 1.43 Allowed 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.442 0.639 . . . . 0.0 111.806 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.4 m -119.98 124.06 45.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.177 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.6 m -127.32 160.46 36.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.329 0.585 . . . . 0.0 112.545 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -111.6 106.19 56.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.558 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.59 -178.6 3.49 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.7 2.267 . . . . 0.0 111.174 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.402 ' H ' HG21 ' A' ' 11' ' ' VAL . . . -124.37 -155.17 9.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.843 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 11' ' ' VAL . 43.3 t -70.95 157.11 38.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.649 0.261 . . . . 0.0 110.963 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 66.33 39.38 4.07 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.007 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -76.88 129.11 35.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.036 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 58' ' ' VAL . 11.2 t -126.38 163.82 27.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.555 -176.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.406 ' N ' HG12 ' A' ' 57' ' ' VAL . 53.9 t -115.27 119.62 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.526 0.203 . . . . 0.0 110.737 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.929 HG23 ' HB2' ' A' ' 8' ' ' TYR . 2.3 m -113.42 178.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.211 0.529 . . . . 0.0 111.94 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.6 p -119.31 -169.78 1.81 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.239 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -47.33 -49.6 23.81 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -171.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.24 -38.97 75.3 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 121.718 -0.614 . . . . 0.0 111.581 -172.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 2.8 mm-40 -67.7 -16.81 64.33 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.093 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.712 ' HE1' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -82.04 -41.96 19.93 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.722 -177.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.617 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -56.86 -73.77 0.06 Allowed 'General case' 0 C--O 1.243 0.74 0 CA-C-N 119.996 1.271 . . . . 0.0 111.639 -166.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -66.5 -49.67 65.81 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.547 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -67.55 -31.6 71.81 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.955 -173.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.735 ' HA ' ' CB ' ' A' ' 22' ' ' HIS . 32.2 tt0 -76.09 -33.45 59.5 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 118.299 0.499 . . . . 0.0 110.626 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 99.6 mttt -54.1 -62.09 1.88 Allowed 'General case' 0 C--O 1.247 0.958 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.044 172.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -65.8 -45.19 83.34 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.739 0.78 . . . . 0.0 111.387 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.64 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -78.75 -16.39 57.25 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.437 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -77.46 -36.38 52.96 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.9 -29.31 66.95 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.022 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -74.66 -58.85 3.03 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.641 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.719 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -59.9 -64.83 0.81 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.838 0.855 . . . . 0.0 112.371 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.847 -171.06 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 . . . . . 0 CA--C 1.521 -0.172 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.29 140.14 39.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.769 0.795 . . . . 0.0 112.012 -165.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -139.06 140.82 38.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.708 -173.273 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.928 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.6 p -65.54 149.09 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 O-C-N 122.051 -0.406 . . . . 0.0 110.931 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.13 16.76 78.07 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-O 122.57 1.094 . . . . 0.0 110.449 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 1.4 t70 -139.09 144.12 38.6 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 112.572 -1.814 . . . . 0.0 107.678 -166.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.858 ' CD1' ' HB2' ' A' ' 24' ' ' GLU . 6.7 m-85 -135.79 142.46 44.9 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 -142.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.747 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 3.2 tt -136.53 139.94 42.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.132 0.968 . . . . 0.0 109.799 -153.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.738 ' N ' HD23 ' A' ' 9' ' ' LEU . 2.3 t -138.84 141.62 36.32 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 112.707 -2.042 . . . . 0.0 109.057 -165.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 54' ' ' SER . 4.0 p . . . . . 0 C--N 1.315 -0.922 0 C-N-CA 117.645 -1.622 . . . . 0.0 109.389 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.806 ' HA ' ' HB1' ' A' ' 71' ' ' ALA . 11.3 m-20 . . . . . 0 C--O 1.223 -0.319 0 CA-C-O 120.981 0.419 . . . . 0.0 111.828 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.821 ' H ' ' HB1' ' A' ' 71' ' ' ALA . 51.3 tt0 149.61 128.16 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.292 1.437 . . . . 0.0 108.667 169.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.823 ' NE2' ' HB3' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -138.68 136.69 36.11 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 117.074 -1.85 . . . . 0.0 111.013 153.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.689 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -142.08 144.06 33.38 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 111.29 -2.686 . . . . 0.0 109.38 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.858 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -134.99 138.61 44.16 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 124.698 2.19 . . . . 0.0 110.888 -177.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.527 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 19.9 mt -98.81 117.96 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 1 CA-C-N 108.363 -4.017 . . . . 0.0 111.203 -148.198 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.928 ' HA ' HG23 ' A' ' 5' ' ' VAL . 2.2 pp -114.56 -8.33 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 125.139 1.524 . . . . 0.0 110.166 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -138.8 132.22 30.27 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.433 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.9 t -138.06 101.33 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.535 -167.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -110.36 55.03 0.65 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.317 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -133.41 113.06 12.11 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.466 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.15 -42.4 17.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.343 0.592 . . . . 0.0 110.171 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -89.33 -7.78 54.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.056 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.81 18.15 60.33 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.355 -174.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 5.0 p -90.29 151.84 45.05 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 120.597 0.237 . . . . 0.0 111.173 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 26.9 Cg_exo -63.48 164.8 19.51 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.851 2.367 . . . . 0.0 111.701 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.685 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.7 Cg_endo -79.5 -173.27 12.47 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.585 -1.423 . . . . 0.0 113.685 1.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 49' ' ' THR . 53.0 m-85 -138.75 171.86 13.72 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.431 HG22 HG23 ' A' ' 49' ' ' THR . 83.9 t -137.7 116.21 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 CA-C-O 123.495 1.617 . . . . 0.0 107.257 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.689 HG11 ' HB1' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -139.25 177.78 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 CA-C-N 111.845 -2.434 . . . . 0.0 109.106 -151.538 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.884 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 15.6 mtm180 -138.32 145.61 41.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.639 ' CE3' ' HB1' ' A' ' 72' ' ' ALA . 11.4 m0 -101.37 84.78 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.685 HD11 ' HB3' ' A' ' 24' ' ' GLU . 3.4 mt -59.95 -68.04 0.33 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 112.483 -2.144 . . . . 0.0 112.772 -154.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.437 HG13 ' CE1' ' A' ' 64' ' ' HIS . 0.5 OUTLIER -60.14 -32.5 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.163 -176.268 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -60.39 -64.08 1.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.113 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.13 51.19 0.27 Allowed Glycine 0 CA--C 1.523 0.546 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.512 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -139.18 170.95 15.02 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 117.53 0.665 . . . . 0.0 111.379 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.884 ' HG3' ' HD2' ' A' ' 40' ' ' ARG . 23.7 mp0 -138.26 106.98 5.9 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.9 t -139.74 -178.98 5.66 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -165.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.431 HG23 HG22 ' A' ' 38' ' ' VAL . 92.6 m -137.95 117.35 12.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.55 HG11 ' HZ2' ' A' ' 41' ' ' TRP . 15.3 m -138.84 177.87 4.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -161.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.685 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 5.2 m-85 -138.88 141.32 29.97 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.121 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.71 -48.42 0.11 Allowed 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.21 -63.77 0.27 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.846 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.484 ' HB2' HG22 ' A' ' 11' ' ' VAL . 27.4 m -79.3 -167.94 1.35 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.707 0.289 . . . . 0.0 111.417 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.87 -1.86 3.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.799 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 73.41 158.62 0.21 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.057 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 58' ' ' VAL . 17.2 t -138.9 163.39 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 175.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.434 ' H ' HG12 ' A' ' 57' ' ' VAL . 45.4 t -138.1 120.53 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.689 0.757 . . . . 0.0 109.294 -169.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.594 HG21 HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -139.2 -179.91 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.311 -165.611 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 p -124.46 -163.43 1.16 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.145 -175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.11 -47.7 80.44 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -58.82 6.62 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.295 -0.878 . . . . 0.0 112.012 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.585 ' HG3' HG12 ' A' ' 59' ' ' VAL . 6.8 mm-40 -57.21 -25.27 58.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.962 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.787 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.26 -46.93 82.58 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.22 -178.406 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.93 -73.3 0.07 Allowed 'General case' 0 C--O 1.245 0.838 0 CA-C-O 121.97 0.89 . . . . 0.0 112.251 -165.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -55.86 29.22 Favored 'General case' 0 C--O 1.255 1.392 0 CA-C-N 114.076 -1.42 . . . . 0.0 112.141 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.17 -41.98 80.26 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.464 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.787 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 4.1 tt0 -57.06 -52.18 66.3 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -56.95 -77.48 0.03 OUTLIER 'General case' 0 C--O 1.248 1.011 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.382 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -58.08 -68.32 0.26 Allowed 'General case' 0 C--O 1.255 1.394 0 CA-C-O 123.272 1.51 . . . . 0.0 112.377 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.821 ' HB1' ' H ' ' A' ' 21' ' ' GLN . . . -57.46 -47.4 81.95 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.199 -1.818 . . . . 0.0 113.313 -173.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -57.65 -36.89 72.46 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 119.483 1.038 . . . . 0.0 111.123 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.42 -39.31 72.85 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 119.471 -0.891 . . . . 0.0 109.113 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 71' ' ' ALA . 19.1 mtp180 -57.76 -56.91 15.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.408 167.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.503 ' HB2' ' CB ' ' A' ' 21' ' ' GLN . . . -41.98 -48.76 4.61 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.827 0.851 . . . . 0.0 112.603 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.543 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.982 -173.183 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.5 p80 . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.945 0.403 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.95 142.53 38.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.569 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 26.3 pttm -139.07 161.32 37.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.157 0.503 . . . . 0.0 111.054 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.683 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.9 p -73.03 151.7 7.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.718 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.45 17.4 62.34 Favored Glycine 0 CA--C 1.511 -0.193 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 1.2 m-20 -138.62 -179.09 5.61 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 113.627 -1.286 . . . . 0.0 107.658 -174.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.812 ' HB2' HG23 ' A' ' 59' ' ' VAL . 83.2 m-85 -137.28 168.6 19.3 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -170.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.9 tt -138.5 138.8 38.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.454 -168.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.848 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 12.4 t -138.81 169.09 18.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.513 ' H ' HG12 ' A' ' 10' ' ' VAL . 89.7 t . . . . . 0 C--N 1.316 -0.888 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 C--O 1.223 -0.294 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.955 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 56.2 mt-30 64.61 96.87 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.394 0 O-C-N 123.518 0.511 . . . . 0.0 110.395 -171.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.899 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.2 t-80 -138.99 121.71 16.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.53 0.681 . . . . 0.0 111.854 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -139.77 -178.33 5.37 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.749 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.737 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 15.0 tt0 -136.67 132.29 34.75 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.705 1.24 . . . . 0.0 109.679 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.589 HG21 HG22 ' A' ' 28' ' ' VAL . 59.8 mt -90.22 114.77 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 112.39 -2.186 . . . . 0.0 111.267 -167.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.749 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -106.79 -16.23 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.571 170.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.694 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 32.2 mt-10 -139.11 153.08 47.96 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.03 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.589 HG22 HG21 ' A' ' 25' ' ' ILE . 18.5 t -137.76 99.93 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -170.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -98.46 33.1 2.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -164.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 p -122.79 -90.86 0.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.702 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 176.0 -66.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.491 0.495 . . . . 0.0 109.919 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -92.75 -58.81 2.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.925 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.88 80.58 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.769 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.486 ' HB3' ' HD2' ' A' ' 35' ' ' PRO . 59.2 m -155.28 165.38 18.43 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 34' ' ' SER . 36.2 Cg_endo -66.85 155.7 69.46 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 121.937 1.758 . . . . 0.0 111.678 173.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.663 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 95.6 Cg_endo -87.91 -177.24 12.65 Favored 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.244 -1.565 . . . . 0.0 113.008 0.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -138.74 174.6 10.36 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.396 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 81.5 t -137.86 115.12 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.405 HG12 ' CG2' ' A' ' 48' ' ' THR . 0.4 OUTLIER -138.91 170.38 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.087 0 CA-C-N 112.556 -2.111 . . . . 0.0 109.091 -152.598 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 46' ' ' HIS . 25.9 ttm180 -138.73 132.03 30.12 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.686 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 9.8 m95 -78.47 83.76 4.66 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 169.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.647 HD21 ' HB3' ' A' ' 24' ' ' GLU . 5.7 mt -60.37 -66.2 0.56 Allowed 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 123.584 0.553 . . . . 0.0 111.261 -167.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.618 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.5 OUTLIER -60.19 -35.68 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.821 -176.402 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -60.4 -66.37 0.54 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.929 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 130.6 29.76 0.62 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.687 -0.768 . . . . 0.0 114.613 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.686 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 4.9 t-80 -139.29 168.85 18.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.386 1.093 . . . . 0.0 110.787 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.51 126.16 22.12 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.142 0.496 . . . . 0.0 110.05 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.516 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 13.2 t -139.46 -178.97 5.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.107 0.956 . . . . 0.0 113.285 -162.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.3 m -137.93 115.52 11.29 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 m -138.77 175.77 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -161.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.663 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 26.6 m-85 -132.58 108.46 13.23 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.336 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.63 5.56 5.49 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.863 2.375 . . . . 0.0 112.564 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.62 -92.45 1.32 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.869 -177.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.2 t -170.19 178.26 3.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.7 t70 59.57 44.22 14.91 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.091 0.948 . . . . 0.0 109.716 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.9 128.19 35.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.964 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.2 m -105.11 143.3 16.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.647 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.74 118.2 46.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.052 0.453 . . . . 0.0 110.998 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.812 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -105.22 -179.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.735 -178.104 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.4 p -122.72 -164.52 1.2 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.87 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.58 -43.3 99.17 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -172.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -51.64 64.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.728 -0.607 . . . . 0.0 111.884 -174.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.582 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 32.0 mm-40 -62.91 -17.17 61.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.114 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.637 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -69.81 -34.22 73.41 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.454 -176.152 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.46 -76.43 0.06 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 122.109 0.956 . . . . 0.0 110.858 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 1.0 OUTLIER -63.18 -55.8 22.08 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.214 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -64.91 -34.5 78.55 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.909 -173.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.899 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 32.9 tt0 -72.72 -34.56 67.18 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 119.554 -0.859 . . . . 0.0 110.717 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -52.93 -65.58 0.53 Allowed 'General case' 0 C--O 1.25 1.087 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.606 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 14.8 ptm180 -61.69 -47.77 83.82 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.943 0.878 . . . . 0.0 111.506 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.663 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -77.02 -17.14 59.02 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.2 -170.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.67 -41.02 55.07 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.317 172.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.59 -31.45 64.27 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.334 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 74' ' ' ARG . 2.4 mmt85 -80.33 -51.81 8.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.264 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.955 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -57.98 -65.97 0.55 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.161 0.505 . . . . 0.0 112.058 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.741 0 C-N-CA 119.872 -1.156 . . . . 0.0 111.94 -169.649 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 . . . . . 0 CA--C 1.518 -0.275 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.5 ' HA ' HG21 ' A' ' 58' ' ' VAL . . . -138.94 152.17 47.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.733 0.302 . . . . 0.0 111.478 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -139.1 172.78 12.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.221 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.746 HG23 ' HA ' ' A' ' 26' ' ' ILE . 4.1 p -93.08 144.89 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.401 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.27 17.38 59.09 Favored Glycine 0 CA--C 1.51 -0.257 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -138.74 -179.1 5.62 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.75 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 91.7 m-85 -137.11 172.75 12.53 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.093 -168.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.774 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 8.0 tt -138.56 142.78 39.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.844 -169.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.699 HG23 HG21 ' A' ' 59' ' ' VAL . 4.9 t -138.85 155.19 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 124.878 1.361 . . . . 0.0 109.356 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.713 HG21 ' H ' ' A' ' 53' ' ' GLY . 92.9 t . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.401 ' CG ' ' HE ' ' A' ' 74' ' ' ARG . 4.7 m-20 . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.791 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 51.8 mt-30 53.48 90.6 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.165 0 O-C-N 124.159 0.912 . . . . 0.0 111.466 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.921 ' H ' ' HB2' ' A' ' 71' ' ' ALA . 10.9 t60 -138.85 125.78 21.1 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 122.461 1.124 . . . . 0.0 113.227 -171.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.34 -178.56 5.43 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.701 -1.591 . . . . 0.0 109.017 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.75 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 14.4 tt0 -137.26 123.6 20.66 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.461 ' CG2' HG22 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -88.16 113.9 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.935 -168.666 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.746 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.3 pp -110.18 -7.75 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.951 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 1.145 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -138.91 127.74 23.54 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.461 HG22 ' CG2' ' A' ' 25' ' ' ILE . 32.3 t -138.28 110.98 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.6 -167.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 21.6 mmt85 -66.58 -46.0 77.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.072 0.463 . . . . 0.0 111.875 -173.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.0 m -154.34 144.41 21.92 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.494 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.49 0.37 29.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.555 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -71.29 -26.17 62.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.91 -10.75 29.64 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.399 173.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.4 m -69.11 130.54 91.22 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 117.542 0.671 . . . . 0.0 111.139 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.443 ' CB ' ' HA ' ' A' ' 36' ' ' PRO . 29.4 Cg_exo -62.94 173.14 4.08 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.005 2.47 . . . . 0.0 111.451 174.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.593 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 95.0 Cg_endo -76.98 -170.75 9.01 Favored 'Cis proline' 0 CA--C 1.52 -0.218 0 C-N-CA 123.877 -1.301 . . . . 0.0 113.371 2.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -138.38 168.92 18.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.466 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.145 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 68.0 t -137.78 107.2 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 25' ' ' ILE . 0.3 OUTLIER -138.92 177.53 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 112.833 -1.985 . . . . 0.0 109.972 -151.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.732 ' HB2' HD23 ' A' ' 42' ' ' LEU . 86.1 mtm180 -138.74 133.8 32.68 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.498 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.63 ' HE1' HG21 ' A' ' 48' ' ' THR . 16.1 m95 -87.01 60.13 6.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 163.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -60.3 -52.66 64.32 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -158.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.515 HG22 ' OE2' ' A' ' 68' ' ' GLU . 0.5 OUTLIER -60.39 -33.76 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 118.555 0.616 . . . . 0.0 111.639 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -60.44 -42.94 97.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.384 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 130.68 6.6 3.66 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.549 -0.834 . . . . 0.0 114.58 172.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.92 176.55 8.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.798 1.299 . . . . 0.0 112.592 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 1.9 mp0 -138.53 139.45 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.537 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.63 HG21 ' HE1' ' A' ' 41' ' ' TRP . 16.5 p -139.25 -179.37 5.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.691 0.758 . . . . 0.0 112.422 -169.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.465 HG23 HG22 ' A' ' 38' ' ' VAL . 31.6 m -138.33 107.96 6.23 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.1 m -138.9 179.94 2.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -157.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 14.1 m-85 -138.84 130.92 15.58 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 113.455 -1.702 . . . . 0.0 107.908 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.35 -170.77 0.8 Allowed 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.61 2.207 . . . . 0.0 112.882 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.713 ' H ' HG21 ' A' ' 11' ' ' VAL . . . -98.56 -132.48 7.64 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.855 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.451 ' O ' HG13 ' A' ' 11' ' ' VAL . 23.5 m -96.1 156.97 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 t70 70.88 -60.56 0.5 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.349 1.031 . . . . 0.0 110.122 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 51.95 132.14 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.937 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.865 HG22 ' H ' ' A' ' 58' ' ' VAL . 7.5 p -138.97 -179.79 2.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.017 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.865 ' H ' HG22 ' A' ' 57' ' ' VAL . 53.3 t -138.19 134.82 44.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.951 -172.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.699 HG21 HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.71 -179.84 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.968 -166.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.7 p -118.86 -164.33 1.03 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.135 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.04 -46.61 82.28 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -175.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -61.08 2.73 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 121.597 -0.689 . . . . 0.0 111.774 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -57.41 -24.87 58.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.937 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.876 ' HA ' ' NE2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.33 -45.17 84.56 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.126 -178.226 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.35 -73.21 0.09 Allowed 'General case' 0 C--O 1.254 1.326 0 CA-C-O 122.136 0.97 . . . . 0.0 112.587 -170.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.598 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -63.87 -42.9 97.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.76 -172.466 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.36 -27.81 67.43 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.793 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 3.2 tt0 -70.57 -31.03 67.9 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.677 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 50.4 mttp -56.03 -51.96 65.96 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.94 165.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.598 ' HD3' ' O ' ' A' ' 66' ' ' GLU . 2.3 mpt_? -56.93 -20.52 23.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.277 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.921 ' HB2' ' H ' ' A' ' 22' ' ' HIS . . . -75.99 -60.26 2.4 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.44 -22.03 64.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.046 0.451 . . . . 0.0 109.935 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.71 -73.43 0.26 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.281 169.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.401 ' HE ' ' CG ' ' A' ' 20' ' ' ASP . 6.2 mtm180 -82.56 -54.91 4.8 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -170.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.791 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -58.17 -60.49 3.67 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -172.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.712 0 C-N-CA 119.977 -1.106 . . . . 0.0 113.084 -171.82 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 24.0 t60 . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.807 0.337 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.29 119.41 38.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.837 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.633 ' HA ' HG21 ' A' ' 28' ' ' VAL . 14.5 tptm -126.35 164.62 20.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.863 0.363 . . . . 0.0 110.966 -175.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.91 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.0 p -66.27 150.03 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.319 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.11 1.71 48.32 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -143.06 175.92 9.49 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.906 ' HB2' HG23 ' A' ' 59' ' ' VAL . 93.5 m-85 -104.51 154.35 20.01 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.284 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.8 tt -98.96 132.2 44.46 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.395 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 t -137.79 143.65 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 124.951 1.407 . . . . 0.0 109.485 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 54' ' ' SER . 54.7 t . . . . . 0 C--O 1.245 0.844 0 CA-C-O 120.731 0.3 . . . . 0.0 111.561 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' HD3' ' A' ' 74' ' ' ARG . 18.7 t70 . . . . . 0 C--O 1.218 -0.6 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.734 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 7.0 mt-30 63.07 101.29 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.794 0.437 . . . . 0.0 110.352 -174.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.715 ' CE1' ' HA ' ' A' ' 64' ' ' HIS . 58.6 t60 -148.26 151.22 35.07 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -167.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -179.01 -179.82 0.61 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.944 1.298 . . . . 0.0 107.51 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.587 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 41.1 tt0 -98.34 129.91 45.01 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.064 -0.655 . . . . 0.0 112.106 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.486 ' CG1' ' HB2' ' A' ' 9' ' ' LEU . 53.0 mt -85.8 111.21 20.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.383 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.91 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.5 pp -120.44 -16.63 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.642 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.766 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 48.2 mt-10 -130.26 107.96 9.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.136 0.493 . . . . 0.0 110.718 175.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.633 HG21 ' HA ' ' A' ' 4' ' ' LYS . 58.6 t -98.74 114.25 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.477 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 29.0 mmt180 -95.5 38.78 1.14 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.244 0.545 . . . . 0.0 111.251 -176.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.8 m -151.37 150.3 30.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.761 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.77 69.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.438 . . . . 0.0 110.8 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -115.1 -65.5 1.18 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.752 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.46 104.12 0.17 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.592 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 34.8 t -154.28 145.68 16.62 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 19.0 Cg_exo -67.26 155.07 72.13 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.44 2.094 . . . . 0.0 111.468 173.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.465 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 95.4 Cg_endo -87.89 178.87 19.07 Favored 'Cis proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.498 -1.459 . . . . 0.0 113.037 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -126.67 146.91 50.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.004 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.766 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 59.4 t -98.74 110.4 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.41 145.39 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.668 -159.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.719 ' HG2' ' HG3' ' A' ' 47' ' ' GLU . 73.4 mtp180 -106.36 129.42 54.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.493 0.664 . . . . 0.0 110.855 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.653 ' CE3' ' HB1' ' A' ' 72' ' ' ALA . 4.5 m0 -93.68 87.76 5.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.495 HD11 ' CD ' ' A' ' 24' ' ' GLU . 18.6 mt -70.05 -68.89 0.39 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.464 -162.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.536 HG22 ' OE2' ' A' ' 68' ' ' GLU . 4.2 m -74.96 -6.86 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.712 -173.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -89.06 -54.38 4.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.278 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.5 54.07 0.31 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.047 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -153.7 168.22 26.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.736 0.303 . . . . 0.0 111.131 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.719 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 32.7 tt0 -149.54 124.0 9.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 t -167.1 175.9 7.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.452 0.644 . . . . 0.0 112.029 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 m -101.5 110.25 22.21 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.292 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -106.88 149.77 10.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.39 0.614 . . . . 0.0 111.815 -171.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 81.9 m-85 -106.28 103.01 43.52 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.784 172.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.56 154.32 55.02 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.245 1.963 . . . . 0.0 110.861 175.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.84 -76.05 0.24 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.173 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.582 ' O ' HG13 ' A' ' 11' ' ' VAL . 28.4 t -169.68 162.63 9.83 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 55.51 60.28 3.43 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.285 0.564 . . . . 0.0 110.686 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.34 127.21 33.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.06 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.6 t -120.43 157.56 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.423 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -100.42 115.76 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.341 0.591 . . . . 0.0 111.94 -178.268 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.906 HG23 ' HB2' ' A' ' 8' ' ' TYR . 6.6 m -102.0 178.29 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.987 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 p -119.41 -165.1 1.11 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.807 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -50.1 -47.14 53.98 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.19 -38.1 78.46 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.49 -0.756 . . . . 0.0 112.248 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.705 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 30.5 mm-40 -74.97 -16.78 60.62 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.528 0.68 . . . . 0.0 109.352 176.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.715 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -71.84 -43.4 65.6 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.401 -177.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.04 -70.23 0.18 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-O 121.258 0.551 . . . . 0.0 112.362 -171.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -31.51 72.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.381 -173.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.656 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -80.97 -22.18 39.75 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.524 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.697 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 2.0 tt0 -73.81 -46.68 43.75 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.416 -0.913 . . . . 0.0 108.993 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -56.67 -71.46 0.09 Allowed 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.563 0.697 . . . . 0.0 110.285 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -66.35 -52.6 45.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.452 -171.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.692 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -82.07 -23.11 35.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.971 -167.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.653 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -76.41 -39.93 52.22 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.361 173.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.27 -29.32 67.49 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.518 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.465 ' HD3' ' OD2' ' A' ' 20' ' ' ASP . 14.7 ttt180 -82.19 -40.66 21.41 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.726 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -54.07 -62.07 1.9 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.149 0.5 . . . . 0.0 110.774 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.643 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.368 -177.91 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 35.3 t-80 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.77 171.74 13.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.787 0.327 . . . . 0.0 111.373 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 8.3 ttpm? -139.03 151.97 47.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.803 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -82.96 139.33 17.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.17 26.71 27.73 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -168.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 14.5 m-20 -138.35 -178.92 5.5 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.673 ' HB2' HG23 ' A' ' 59' ' ' VAL . 88.9 m-85 -137.22 169.67 17.38 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -169.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.769 HD21 ' HB3' ' A' ' 52' ' ' PRO . 5.7 tt -138.66 145.36 40.34 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.205 -167.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 40.1 t -139.11 164.53 25.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.81 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.9 p . . . . . 0 C--N 1.318 -0.776 0 CA-C-O 120.877 0.37 . . . . 0.0 110.125 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.407 ' CG ' ' HE ' ' A' ' 74' ' ' ARG . 3.9 t70 . . . . . 0 C--O 1.226 -0.17 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.81 ' HB2' HG12 ' A' ' 11' ' ' VAL . 66.3 mt-30 53.73 104.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.466 0.706 . . . . 0.0 111.326 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.892 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 36.0 t-80 -138.7 123.78 19.04 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.199 0.523 . . . . 0.0 111.947 -171.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.742 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.45 -178.5 5.41 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.02 -176.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.667 ' HB3' HD21 ' A' ' 42' ' ' LEU . 3.3 tm-20 -137.4 122.78 19.48 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.274 1.035 . . . . 0.0 108.244 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.418 ' HA ' HG23 ' A' ' 39' ' ' VAL . 1.2 mt -87.05 105.03 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.158 -167.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.773 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -98.61 -13.37 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 124.091 0.869 . . . . 0.0 109.386 174.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.721 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.04 140.92 38.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.498 -0.774 . . . . 0.0 108.988 174.115 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.08 99.86 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -167.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -94.41 78.97 3.88 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.617 0.246 . . . . 0.0 110.787 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.509 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 23.4 p 172.23 -35.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.151 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 74.63 -16.44 0.55 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.761 0.824 . . . . 0.0 111.761 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 30' ' ' SER . 4.2 p-10 -103.3 -37.91 7.46 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.71 8.31 3.52 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.441 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 48.9 m -76.19 143.99 74.34 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 122.633 -0.333 . . . . 0.0 110.369 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 17.9 Cg_exo -67.26 160.69 46.4 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.818 2.345 . . . . 0.0 111.938 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.593 ' HB3' ' HD1' ' A' ' 51' ' ' TYR . 90.0 Cg_endo -81.08 -171.28 9.43 Favored 'Cis proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.838 -1.317 . . . . 0.0 112.816 -1.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.52 175.91 9.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.532 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.721 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 98.1 t -137.89 112.75 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 25' ' ' ILE . 0.4 OUTLIER -138.95 169.44 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.761 -2.018 . . . . 0.0 109.339 -151.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 33.2 ttm180 -138.77 128.05 24.26 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.742 ' CZ3' ' HB2' ' A' ' 23' ' ' ALA . 5.7 m95 -80.07 86.03 5.58 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 170.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.667 HD21 ' HB3' ' A' ' 24' ' ' GLU . 7.1 mt -59.93 -67.17 0.41 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.606 -166.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.517 HG13 ' NE2' ' A' ' 64' ' ' HIS . 1.2 m -60.05 -34.24 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.496 -176.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 41' ' ' TRP . 16.6 m120 -60.45 -60.18 4.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.407 171.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.37 40.22 0.69 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.956 -0.565 . . . . 0.0 113.36 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.61 ' CB ' ' HD1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -139.11 160.89 38.72 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 117.25 0.525 . . . . 0.0 110.851 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -139.0 120.54 15.08 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.879 0.371 . . . . 0.0 110.446 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.585 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 8.8 t -139.29 -178.86 5.55 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.384 1.088 . . . . 0.0 113.807 -163.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.571 HG23 HG22 ' A' ' 38' ' ' VAL . 85.4 m -138.14 108.1 6.35 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.655 HG22 ' H ' ' A' ' 51' ' ' TYR . 4.6 p -138.9 176.31 6.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.046 -158.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.655 ' H ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -138.81 114.08 8.54 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.769 ' HB3' HD21 ' A' ' 9' ' ' LEU . 31.3 Cg_endo -64.01 -69.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.475 0.425 0 C-N-CA 123.13 2.553 . . . . 0.0 112.978 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.37 -164.67 37.38 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -91.2 20.78 4.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.125 0.488 . . . . 0.0 111.842 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -143.86 50.95 1.33 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.73 133.25 42.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.714 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.874 HG22 ' H ' ' A' ' 58' ' ' VAL . 5.3 p -138.96 -179.76 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.408 0.623 . . . . 0.0 109.882 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.874 ' H ' HG22 ' A' ' 57' ' ' VAL . 87.5 t -138.23 139.77 41.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.351 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.673 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.71 176.73 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 123.97 0.908 . . . . 0.0 110.82 -174.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 t -116.39 -169.18 1.57 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.23 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.03 -49.69 75.04 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.322 -175.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.51 -56.69 18.58 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.69 -0.631 . . . . 0.0 111.022 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 31.7 mt-10 -57.44 -26.26 60.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.47 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.76 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.3 -49.37 76.32 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 177.524 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . -56.98 -76.02 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.729 0.776 . . . . 0.0 111.883 -163.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -59.13 5.61 Favored 'General case' 0 C--O 1.26 1.637 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.306 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.646 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . . . -57.11 -37.18 71.58 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.944 -174.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.892 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 21.7 tt0 -71.68 -40.02 69.87 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.091 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 28.9 mtpp -52.61 -58.87 5.4 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.942 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.646 ' HE ' ' HA ' ' A' ' 67' ' ' ALA . 27.6 ptt180 -69.61 -53.16 20.12 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 122.137 0.97 . . . . 0.0 112.071 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.767 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -70.43 -31.14 68.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.334 -170.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -76.39 -34.56 58.86 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.187 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.15 54.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.576 0.548 . . . . 0.0 110.273 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HE ' ' CG ' ' A' ' 20' ' ' ASP . 49.8 mtm-85 -82.09 -47.82 12.12 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.755 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -46.36 -51.1 15.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.396 0.678 . . . . 0.0 112.714 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.427 ' HA3' ' CZ2' ' A' ' 41' ' ' TRP . . . . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.968 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 . . . . . 0 CA--C 1.522 -0.128 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.85 140.33 40.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.935 0.874 . . . . 0.0 111.057 -167.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 6.8 mmmm -138.96 141.08 38.43 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.44 -158.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.876 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.0 p -61.41 138.6 21.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 121.655 -0.653 . . . . 0.0 110.777 171.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.69 14.99 71.8 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 1.4 t70 -139.04 143.52 38.43 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.942 -1.629 . . . . 0.0 107.324 -167.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.801 ' HB2' HG23 ' A' ' 59' ' ' VAL 0.266 65.4 m-85 -134.37 141.9 47.02 Favored 'General case' 0 C--O 1.206 -1.227 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -142.188 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.796 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 4.6 tt -136.52 140.27 42.87 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.539 1.161 . . . . 0.0 110.401 -149.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.015 ' HB ' HG23 ' A' ' 57' ' ' VAL . 14.3 t -138.72 141.55 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 111.397 -2.638 . . . . 0.0 109.038 -153.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.45 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 48.7 t . . . . . 0 C--N 1.32 -0.682 0 CA-C-O 122.257 1.027 . . . . 0.0 109.869 -173.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 21' ' ' GLN . 23.4 t70 . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 1.051 ' HG2' ' HB3' ' A' ' 74' ' ' ARG . 39.0 mt-30 64.87 105.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.353 0.408 . . . . 0.0 111.012 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.796 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 1.6 m170 -138.21 136.61 36.76 Favored 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 117.219 -1.792 . . . . 0.0 110.319 167.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.548 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -142.41 144.37 33.08 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 129.068 2.947 . . . . 0.0 107.055 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.751 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -134.56 139.85 45.69 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 122.269 2.304 . . . . 0.0 110.66 -166.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.74 HD12 HG22 ' A' ' 28' ' ' VAL . 5.4 pt -92.08 128.53 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 109.86 -3.336 . . . . 0.0 111.457 -159.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.876 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.8 pp -102.62 -6.29 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 112.022 -2.354 . . . . 0.0 108.981 169.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.654 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 33.3 mt-10 -139.02 139.69 37.9 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.901 172.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.74 HG22 HD12 ' A' ' 25' ' ' ILE . 8.5 t -138.28 139.81 41.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -175.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -125.8 25.31 6.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.388 0.613 . . . . 0.0 110.256 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 t -173.44 124.4 0.39 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.923 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.85 -16.45 41.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.323 0.582 . . . . 0.0 109.445 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.82 -46.0 55.41 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.291 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.29 40.12 0.49 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.651 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.4 m -117.58 151.53 48.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 122.197 0.199 . . . . 0.0 110.586 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.8 169.13 22.79 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.826 2.351 . . . . 0.0 112.334 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.58 179.9 29.5 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.603 -1.415 . . . . 0.0 112.63 0.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -138.71 142.07 38.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.723 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.873 HG22 HG23 ' A' ' 49' ' ' THR . 99.8 t -135.88 138.91 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 CA-C-O 125.147 2.403 . . . . 0.0 108.955 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.548 ' CG1' ' HB1' ' A' ' 23' ' ' ALA . 47.2 t -139.7 142.17 33.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 108.558 -3.928 . . . . 0.0 112.533 -129.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.651 ' HG3' ' O ' ' A' ' 46' ' ' HIS . 51.7 ttp180 -137.19 139.5 41.13 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 166.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.553 ' HH2' ' HA3' ' A' ' 76' ' ' GLY . 10.1 m0 -99.38 70.2 1.71 Allowed 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.573 HD22 ' HE ' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -60.56 -41.34 94.39 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 113.357 -1.747 . . . . 0.0 113.15 -150.445 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.76 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -61.56 -41.48 90.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.075 174.374 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.48 -40.49 94.74 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.57 50.27 2.98 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.295 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.651 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 8.1 t-160 -139.3 159.32 42.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.593 0.696 . . . . 0.0 110.554 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HG2' ' HD3' ' A' ' 40' ' ' ARG . 48.8 mt-10 -138.3 112.24 8.44 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.159 0.98 . . . . 0.0 110.46 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 t -139.68 -178.21 5.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.752 -1.567 . . . . 0.0 112.164 -165.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.873 HG23 HG22 ' A' ' 38' ' ' VAL . 94.6 m -137.65 122.19 18.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.454 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.754 HG12 ' H ' ' A' ' 51' ' ' TYR . 2.3 t -138.52 179.32 3.33 Favored 'Isoleucine or valine' 0 C--O 1.255 1.351 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.761 -164.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.754 ' H ' HG12 ' A' ' 50' ' ' VAL . 8.0 m-85 -138.78 114.69 8.67 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.203 176.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.665 ' HB3' HD21 ' A' ' 9' ' ' LEU . 27.6 Cg_exo -63.32 -66.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.312 2.674 . . . . 0.0 112.522 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.63 -136.18 8.71 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.734 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.7 p -101.27 162.19 13.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 58.9 45.76 14.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.913 0.863 . . . . 0.0 110.466 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.5 130.04 36.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.627 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 1.015 HG23 ' HB ' ' A' ' 10' ' ' VAL . 6.2 m -138.89 175.18 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.4 151.86 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -170.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' A' ' 8' ' ' TYR . 3.0 m -138.87 178.78 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 C-N-CA 126.246 1.818 . . . . 0.0 109.69 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.1 p -117.69 -171.16 2.0 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.006 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.11 -47.77 80.28 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -174.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -54.26 48.87 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 121.67 -0.644 . . . . 0.0 111.166 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 21.1 mt-10 -57.12 -33.43 67.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.518 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.76 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.15 -37.97 72.83 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 114.563 -1.199 . . . . 0.0 114.107 -177.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.76 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -57.05 -76.29 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.053 0.93 . . . . 0.0 110.288 -171.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -57.37 -64.4 0.9 Allowed 'General case' 0 C--O 1.268 2.062 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.065 178.209 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -56.88 -58.93 6.01 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.035 -175.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.716 ' HB3' ' O ' ' A' ' 64' ' ' HIS . 39.4 tt0 -57.41 -32.84 67.26 Favored 'General case' 0 C--O 1.204 -1.297 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.44 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -57.12 -71.33 0.1 Allowed 'General case' 0 C--O 1.261 1.676 0 CA-C-N 119.627 1.103 . . . . 0.0 110.808 174.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -53.82 53.83 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-O 123.262 1.506 . . . . 0.0 110.651 -175.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.791 ' O ' ' HA ' ' A' ' 21' ' ' GLN . . . -57.37 -39.39 75.93 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 112.999 -1.909 . . . . 0.0 112.923 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.51 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -57.1 -43.78 82.58 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 118.584 0.629 . . . . 0.0 109.891 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.49 -40.82 75.61 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 119.604 -0.839 . . . . 0.0 109.334 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 1.051 ' HB3' ' HG2' ' A' ' 21' ' ' GLN . 1.8 mpt_? -57.53 -57.93 10.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 172.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 21' ' ' GLN . . . -47.09 -42.2 18.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.016 0.927 . . . . 0.0 113.065 -173.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.553 ' HA3' ' HH2' ' A' ' 41' ' ' TRP . . . . . . . . 0 C--N 1.323 -0.179 0 C-N-CA 118.661 -1.733 . . . . 0.0 113.35 -173.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.34 148.05 48.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.147 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.658 ' HA ' ' HE3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -130.92 169.58 15.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.843 0.354 . . . . 0.0 110.307 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.834 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.7 p -85.88 146.02 7.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.795 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.17 9.2 60.84 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -129.24 169.46 14.8 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.872 ' HB2' HG23 ' A' ' 59' ' ' VAL . 97.7 m-85 -105.95 150.77 25.37 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.317 0.579 . . . . 0.0 111.113 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.769 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 6.5 tt -98.75 146.22 26.13 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.468 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.775 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 47.8 t -127.65 144.74 36.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 O-C-N 125.295 1.622 . . . . 0.0 110.291 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.653 HG22 ' HB3' ' A' ' 52' ' ' PRO . 3.2 t . . . . . 0 C--O 1.236 0.368 0 O-C-N 123.588 0.555 . . . . 0.0 110.367 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 . . . . . 0 CA--C 1.519 -0.247 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.636 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 39.1 mt-30 52.61 87.86 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.622 0.576 . . . . 0.0 111.959 173.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.769 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 55.0 m170 -117.95 158.31 25.13 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -175.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . . . -169.92 179.17 3.71 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 34.4 tt0 -98.32 126.1 43.7 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.086 -175.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.468 ' CG2' HG22 ' A' ' 28' ' ' VAL . 7.7 mt -88.15 105.82 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.016 174.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.834 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.2 pp -109.39 -27.02 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.228 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 1.068 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 47.3 mt-10 -118.81 101.81 8.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.086 0.469 . . . . 0.0 110.034 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.468 HG22 ' CG2' ' A' ' 25' ' ' ILE . 28.5 t -98.97 104.07 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.1 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -90.02 35.48 0.85 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.374 0.607 . . . . 0.0 110.725 -174.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -156.54 141.52 17.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.589 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.18 92.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.008 0.432 . . . . 0.0 110.644 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.4 -78.25 0.43 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.948 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.44 108.5 0.21 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.191 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.8 p -156.12 137.52 9.55 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.41 153.5 53.64 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.76 2.307 . . . . 0.0 112.092 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 83.2 Cg_endo -83.36 167.64 62.76 Favored 'Cis proline' 0 N--CA 1.463 -0.293 0 C-N-CA 123.276 -1.552 . . . . 0.0 113.317 2.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -120.14 144.24 47.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.186 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.068 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 58.5 t -98.79 111.06 27.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -126.11 148.77 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.833 -164.601 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.851 ' HD2' ' HB3' ' A' ' 42' ' ' LEU . 31.2 ttm-85 -114.29 121.57 44.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.279 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.446 ' CE3' ' HB2' ' A' ' 23' ' ' ALA . 12.0 m95 -83.14 76.72 9.84 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 168.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.851 ' HB3' ' HD2' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -76.35 -34.03 58.96 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -166.455 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.543 HG22 ' OE2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -77.26 -9.31 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.924 179.116 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -100.19 -32.16 11.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.546 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.85 35.84 3.62 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.787 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -136.39 168.38 19.56 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 122.634 -0.333 . . . . 0.0 110.435 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -153.6 141.62 20.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 t -175.4 -179.96 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.691 0.758 . . . . 0.0 111.674 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.9 m -98.77 107.83 20.36 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.69 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.417 HG12 ' HB ' ' A' ' 39' ' ' VAL . 9.5 p -98.98 148.68 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.304 0.573 . . . . 0.0 111.196 -173.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 24.2 m-85 -118.15 99.78 51.83 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.68 174.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.653 ' HB3' HG22 ' A' ' 11' ' ' VAL . 3.3 Cg_exo -75.62 -46.15 0.22 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.721 2.28 . . . . 0.0 112.268 -175.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.3 -94.75 1.44 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.801 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.7 m -126.72 167.39 15.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.569 0.185 . . . . 0.0 111.137 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 67.25 22.14 9.74 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.933 0.771 . . . . 0.0 111.345 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.775 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -75.52 127.6 33.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.168 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.857 HG22 ' H ' ' A' ' 58' ' ' VAL . 7.4 p -147.27 -179.99 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.347 0.594 . . . . 0.0 110.346 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.857 ' H ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -111.26 127.94 68.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.504 -175.513 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.872 HG23 ' HB2' ' A' ' 8' ' ' TYR . 1.4 m -119.57 179.24 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 123.285 0.634 . . . . 0.0 110.768 173.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 p -112.05 -171.79 1.92 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.55 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.595 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -49.14 -52.23 27.52 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -172.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.56 -40.94 84.92 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.308 -170.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -63.04 -24.93 68.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.411 0.624 . . . . 0.0 110.227 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.482 ' CE1' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -67.2 -49.37 64.87 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.687 -173.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.61 -67.66 0.23 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.828 0.823 . . . . 0.0 112.684 -164.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -61.6 -52.48 64.21 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.349 -174.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HB3' ' ND1' ' A' ' 22' ' ' HIS . . . -72.79 -16.69 61.62 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.671 ' OE1' ' HA ' ' A' ' 23' ' ' ALA . 29.9 tt0 -77.59 -40.68 41.36 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -55.56 -49.3 73.06 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.924 0.869 . . . . 0.0 109.105 170.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -68.33 -16.65 64.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.093 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -81.26 -41.19 22.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.648 0.261 . . . . 0.0 110.867 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.0 -27.29 68.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.25 -52.67 7.82 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.885 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -82.0 -65.61 0.99 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.51 73.91 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.041 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.973 -177.163 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.7 t60 . . . . . 0 CA--C 1.521 -0.159 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.84 171.72 13.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.901 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 88.2 tttt -139.09 155.52 47.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.208 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 26' ' ' ILE . 37.4 t -69.85 142.22 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.88 19.07 44.84 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -174.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 9.0 m-20 -138.7 -179.01 5.57 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 114.025 -1.087 . . . . 0.0 108.549 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.755 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 95.9 m-85 -137.17 165.13 26.82 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.971 -168.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.1 tt -138.63 138.73 38.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.662 -166.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 37.8 t -139.02 157.66 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.396 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.803 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.9 p . . . . . 0 C--N 1.323 -0.565 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.643 ' OD2' ' HD3' ' A' ' 74' ' ' ARG . 15.2 t70 . . . . . 0 C--O 1.222 -0.377 0 N-CA-C 111.249 0.092 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.803 ' HB2' HG12 ' A' ' 11' ' ' VAL . 78.8 mt-30 61.24 105.18 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.542 0.737 . . . . 0.0 111.707 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.972 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.7 t-160 -139.26 126.6 21.49 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 121.254 0.55 . . . . 0.0 111.599 -174.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.742 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.51 -178.65 5.49 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.402 1.081 . . . . 0.0 110.09 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.755 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 20.5 tt0 -136.95 122.51 19.67 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.287 1.042 . . . . 0.0 108.483 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.843 HG23 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -85.05 113.8 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.192 -174.087 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.81 ' HA ' HG13 ' A' ' 5' ' ' VAL . 1.5 pp -106.35 -3.51 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.237 172.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.856 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.0 124.46 19.35 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.284 172.032 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -138.19 99.67 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -105.49 -3.92 21.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.58 0.705 . . . . 0.0 109.97 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 6.9 m -65.0 -25.98 68.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.383 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 63.2 -82.17 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.791 0.682 . . . . 0.0 110.841 -176.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.75 -44.24 67.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.585 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 30' ' ' SER . . . 153.67 -164.25 31.1 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p 67.75 154.26 0.14 Allowed Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 124.476 1.111 . . . . 0.0 111.956 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.56 161.38 38.75 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.948 2.432 . . . . 0.0 112.533 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.637 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 89.4 Cg_endo -83.34 179.0 26.64 Favored 'Cis proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.071 -1.637 . . . . 0.0 113.376 0.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -138.76 173.52 11.49 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.856 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 97.4 t -137.77 115.58 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.843 HG23 HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -138.84 171.16 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 CA-C-N 112.878 -1.965 . . . . 0.0 109.155 -152.3 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.409 ' N ' HG13 ' A' ' 39' ' ' VAL . 31.6 ttt180 -138.66 123.75 19.07 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.75 ' HD1' ' HB2' ' A' ' 46' ' ' HIS . 25.6 m95 -78.99 84.42 5.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 24' ' ' GLU . 6.9 mt -60.21 -68.6 0.28 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.346 0.593 . . . . 0.0 111.951 -166.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.682 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -60.25 -38.35 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.155 -174.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -60.59 -50.86 71.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.298 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.98 48.94 0.86 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.506 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.75 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 46.9 m-70 -139.13 169.17 18.26 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.446 0.623 . . . . 0.0 111.283 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -138.88 119.14 13.62 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.525 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 6.7 t -139.42 -179.36 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.315 1.055 . . . . 0.0 113.684 -165.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.455 HG23 HG22 ' A' ' 38' ' ' VAL . 57.8 m -138.55 112.67 8.59 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.092 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.445 HG11 ' HZ2' ' A' ' 41' ' ' TRP . 8.5 m -138.89 -179.8 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -163.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.637 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 50.1 m-85 -138.73 108.56 7.76 Favored Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.738 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.551 ' HG3' HD11 ' A' ' 9' ' ' LEU . 72.6 Cg_endo -74.63 -169.2 0.58 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.089 2.526 . . . . 0.0 111.608 176.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.568 ' HA3' HG21 ' A' ' 11' ' ' VAL . . . -98.61 -166.2 30.78 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.546 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.8 m -97.07 21.58 9.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.34 0.59 . . . . 0.0 112.019 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.41 ' H ' HG23 ' A' ' 11' ' ' VAL . 18.2 t70 -122.91 38.09 4.26 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.97 135.6 54.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.761 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.808 HG12 ' H ' ' A' ' 58' ' ' VAL . 2.9 t -138.71 179.93 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.808 ' H ' HG12 ' A' ' 57' ' ' VAL . 58.0 t -138.0 136.02 45.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.739 -174.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.669 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.75 177.33 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.752 -170.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.6 t -122.2 -164.02 1.13 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.799 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.25 94.2 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -42.68 72.64 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 121.858 -0.526 . . . . 0.0 110.98 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.602 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 9.4 mm-40 -62.14 -17.26 57.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.838 0.827 . . . . 0.0 109.446 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.682 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -81.73 -43.99 17.68 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.78 -172.201 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.77 -70.79 0.09 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.838 0.828 . . . . 0.0 111.627 -168.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 1.6 pt-20 -70.08 -55.04 10.49 Favored 'General case' 0 C--O 1.257 1.457 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.748 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -59.55 -42.29 92.06 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.577 -175.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.972 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 36.0 tt0 -70.47 -35.78 73.5 Favored 'General case' 0 C--O 1.212 -0.921 0 C-N-CA 120.204 -0.599 . . . . 0.0 110.978 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 69' ' ' LYS . 11.1 tptm -51.87 -61.76 2.06 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.734 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -67.12 -52.77 37.63 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.235 1.017 . . . . 0.0 111.709 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.735 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -68.85 -30.7 69.28 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.248 -171.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -69.74 -41.07 75.74 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.75 -35.42 56.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.825 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.643 ' HD3' ' OD2' ' A' ' 20' ' ' ASP . 49.6 ttt180 -81.79 -49.46 10.37 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.49 ' HA ' ' HG2' ' A' ' 21' ' ' GLN . . . -45.14 -50.23 11.39 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.63 0.772 . . . . 0.0 112.036 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.423 -178.039 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 p80 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.028 0.442 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.89 145.3 19.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.019 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -144.79 171.02 15.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.174 0.511 . . . . 0.0 111.561 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.951 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.3 p -72.63 147.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.197 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.31 -0.34 43.69 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -130.73 176.38 8.25 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.71 ' HB2' HG23 ' A' ' 59' ' ' VAL . 94.8 m-85 -115.59 151.54 34.75 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.116 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.731 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.3 tt -98.6 142.23 30.44 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.562 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.778 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 44.4 t -134.78 154.86 37.52 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.139 0 O-C-N 125.229 1.581 . . . . 0.0 109.848 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 21' ' ' GLN . 29.5 m . . . . . 0 C--N 1.329 -0.322 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 168.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.7 t0 . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.767 ' HB3' HG22 ' A' ' 11' ' ' VAL . 0.6 OUTLIER 65.45 100.63 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 O-C-N 123.485 0.49 . . . . 0.0 110.175 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.731 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 3.8 m80 -129.79 146.64 51.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.167 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -160.8 176.38 11.54 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 172.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.622 ' CD ' HD11 ' A' ' 42' ' ' LEU . 43.9 tt0 -98.61 132.31 44.12 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.45 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.606 HG22 HG22 ' A' ' 28' ' ' VAL . 2.6 mt -97.43 109.69 23.85 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.96 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.951 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -109.03 -31.88 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.341 175.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 1.025 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 10.5 mm-40 -112.21 99.87 8.38 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.39 0.614 . . . . 0.0 109.427 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 30' ' ' SER . 15.7 t -106.86 144.72 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.017 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.3 mtp-105 -68.79 -35.98 77.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.361 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.7 ' H ' HG12 ' A' ' 28' ' ' VAL . 66.3 m 58.38 -159.75 0.27 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.856 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 65.39 -88.09 0.03 OUTLIER 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.829 0.452 . . . . 0.0 111.227 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -92.63 -27.47 17.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.733 0.301 . . . . 0.0 110.31 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.38 86.77 0.54 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.484 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.8 p -160.2 162.03 24.71 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.05 162.9 12.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.86 2.373 . . . . 0.0 112.126 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.21 151.64 96.87 Favored 'Cis proline' 0 C--N 1.343 0.262 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.747 2.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -111.46 139.9 46.5 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.025 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 57.8 t -98.35 99.92 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.62 142.02 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.212 -168.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -121.38 129.05 52.82 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.622 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.438 ' CZ3' ' HB2' ' A' ' 23' ' ' ALA . 12.8 m95 -81.05 100.39 8.97 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.622 HD11 ' CD ' ' A' ' 24' ' ' GLU . 13.2 mt -76.43 -56.78 4.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.249 0.547 . . . . 0.0 111.263 -172.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 65' ' ' ALA . 1.4 m -79.49 -7.89 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.245 -172.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -96.9 -47.98 5.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.791 170.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.49 70.81 0.82 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.746 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -174.11 148.62 1.36 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.843 0.354 . . . . 0.0 110.536 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -99.04 143.87 28.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.824 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.413 HG22 ' N ' ' A' ' 49' ' ' THR . 24.9 m -154.6 167.16 31.06 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.818 0.342 . . . . 0.0 110.249 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 48' ' ' THR . 26.5 m -127.79 118.67 24.17 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.14 162.92 35.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.805 0.812 . . . . 0.0 113.054 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -120.8 99.86 46.85 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.229 171.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.708 ' HG3' HD11 ' A' ' 9' ' ' LEU . 43.3 Cg_endo -66.51 149.45 84.39 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.672 2.248 . . . . 0.0 112.248 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.24 68.08 3.59 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.054 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.0 m 69.21 168.19 0.29 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.112 0.565 . . . . 0.0 112.395 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.28 42.48 31.45 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.3 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.778 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -77.63 110.69 12.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.122 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 10' ' ' VAL . 1.2 p -119.34 156.46 21.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.143 0.497 . . . . 0.0 110.84 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -102.21 107.08 20.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.467 -174.361 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.71 HG23 ' HB2' ' A' ' 8' ' ' TYR . 14.2 m -102.1 -179.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.589 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.2 t -96.71 -170.61 2.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.252 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.581 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . . . -63.38 -50.59 69.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.033 -172.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -71.8 -40.52 69.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.833 0.349 . . . . 0.0 111.689 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -55.78 -29.1 59.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.707 0.765 . . . . 0.0 109.698 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.716 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -82.22 -46.64 13.46 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -171.483 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.444 ' HA ' HG21 ' A' ' 43' ' ' VAL . . . -49.66 -60.15 3.14 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -159.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.74 -53.22 57.92 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 122.377 1.084 . . . . 0.0 110.33 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.93 -16.4 63.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.554 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 26.6 tt0 -70.77 -42.17 70.77 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 176.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -57.07 -47.15 81.69 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.639 0.733 . . . . 0.0 109.075 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -61.86 -24.05 66.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.647 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.606 ' HB2' ' H ' ' A' ' 22' ' ' HIS . . . -81.95 -48.86 10.95 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.445 -175.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.91 -23.39 65.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.61 -64.83 0.8 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.191 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -82.25 -60.12 2.32 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.594 ' HB2' ' CG ' ' A' ' 21' ' ' GLN . . . -52.51 -48.72 65.82 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.908 0.483 . . . . 0.0 112.033 -173.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.944 -175.456 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.984 0.421 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.53 150.68 40.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.6 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -137.02 146.76 45.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.951 0.405 . . . . 0.0 110.941 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.8 p -89.37 137.13 21.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.416 172.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.34 2.29 56.71 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.19 173.38 6.96 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.701 ' HB2' HG23 ' A' ' 59' ' ' VAL . 92.5 m-85 -110.96 161.13 16.16 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.382 -174.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.4 tt -106.92 137.38 45.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.247 -176.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.595 HG23 HG21 ' A' ' 59' ' ' VAL . 11.1 t -136.94 148.42 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.049 0.843 . . . . 0.0 108.89 172.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.7 ' HB ' ' HB2' ' A' ' 21' ' ' GLN . 92.2 t . . . . . 0 C--N 1.321 -0.633 0 CA-C-O 121.138 0.494 . . . . 0.0 110.249 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 119.699 -0.191 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.7 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 78.8 mt-30 45.62 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.993 0.917 . . . . 0.0 112.374 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.719 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 59.8 t-80 -135.05 145.77 48.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -171.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.497 ' HB2' ' HZ3' ' A' ' 41' ' ' TRP . . . -169.81 179.81 3.54 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.808 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 38.4 tt0 -100.64 123.56 45.02 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.515 0.509 . . . . 0.0 110.469 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 9' ' ' LEU . 18.8 mt -91.85 106.1 17.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 120.7 0.286 . . . . 0.0 110.267 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.572 ' HA ' HG23 ' A' ' 5' ' ' VAL . 2.0 pp -114.93 -10.42 12.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.157 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.885 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 30.9 mt-10 -139.92 107.99 5.74 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.113 0.483 . . . . 0.0 110.839 173.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.65 126.85 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.298 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -74.4 -34.97 63.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.123 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.5 t -145.51 136.81 24.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.27 -18.41 65.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.917 0.389 . . . . 0.0 111.167 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -89.77 1.3 56.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.143 0.497 . . . . 0.0 110.021 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.03 99.47 0.52 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.714 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 53.8 m -139.89 121.22 9.56 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 2.9 Cg_exo -75.49 157.2 40.84 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.144 2.563 . . . . 0.0 111.763 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HB3' ' CD1' ' A' ' 51' ' ' TYR . 79.8 Cg_endo -82.77 167.22 66.96 Favored 'Cis proline' 0 N--CA 1.462 -0.332 0 C-N-CA 123.111 -1.621 . . . . 0.0 112.889 -1.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -109.32 153.9 23.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.773 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.885 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 85.5 t -98.79 113.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.496 ' HB ' HG22 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -118.85 151.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.022 -166.322 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.519 ' HD2' ' OE1' ' A' ' 24' ' ' GLU . 37.7 ttm180 -116.81 137.18 52.39 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.065 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.497 ' HZ3' ' HB2' ' A' ' 23' ' ' ALA . 18.5 m95 -74.06 83.47 1.78 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 168.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.926 HD12 HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -22.52 -76.9 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.221 -1.808 . . . . 0.0 115.778 -170.252 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.926 HG22 HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -95.34 0.33 10.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -168.656 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.426 HD22 ' N ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -88.91 -46.13 9.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.881 0.372 . . . . 0.0 110.074 173.141 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.77 73.26 1.06 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.38 -0.915 . . . . 0.0 113.564 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -170.29 137.63 1.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.95 142.45 46.77 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.758 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 t -157.51 176.49 12.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.167 -173.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.4 m -105.3 108.81 20.52 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.749 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.496 HG22 ' HB ' ' A' ' 39' ' ' VAL . 35.1 m -106.49 152.18 8.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.356 0.598 . . . . 0.0 111.99 -174.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 36' ' ' PRO . 50.7 m-85 -116.19 99.8 52.97 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.181 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.97 168.31 12.24 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.803 2.335 . . . . 0.0 111.746 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 55' ' ' ASP . . . -66.26 162.8 43.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.015 175.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.3 m -76.47 29.0 0.12 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.008 0.433 . . . . 0.0 111.716 -177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 53' ' ' GLY . 9.6 t0 -144.3 55.65 1.29 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.787 0.803 . . . . 0.0 108.909 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.82 136.35 35.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.763 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.84 158.37 42.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 1.5 m -99.22 149.89 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.235 0.54 . . . . 0.0 112.319 -177.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -135.09 173.3 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.803 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.89 -168.15 1.61 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.053 -175.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.21 -42.57 81.59 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -71.19 -44.62 65.09 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.236 -0.915 . . . . 0.0 110.934 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.0 mm-40 -64.76 -16.42 62.96 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.986 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.677 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -69.73 -33.82 73.0 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.669 -174.49 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 64' ' ' HIS . . . -77.14 -73.77 0.28 Allowed 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.834 0.826 . . . . 0.0 112.8 -165.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -61.07 -39.66 90.72 Favored 'General case' 0 C--O 1.251 1.182 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.136 -175.804 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -69.48 -28.8 66.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.308 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.734 ' HB2' HD11 ' A' ' 42' ' ' LEU . 18.0 tt0 -57.37 -57.3 13.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 1.009 ' HE2' ' HA ' ' A' ' 69' ' ' LYS . 9.3 mmpt? -50.64 -64.85 0.68 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.656 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -66.15 -54.81 20.84 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.839 0.828 . . . . 0.0 111.625 -174.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.554 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -77.02 -25.15 52.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.87 -167.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.82 -32.41 52.25 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.834 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.21 72.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.23 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -80.58 -44.03 19.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.254 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.69 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -54.65 -53.02 60.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.121 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.358 -177.852 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.438 ' O ' HG21 ' A' ' 58' ' ' VAL . 21.2 m80 . . . . . 0 CA--C 1.515 -0.366 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.76 166.64 23.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.029 0.442 . . . . 0.0 111.709 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -139.1 176.06 9.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.827 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.5 p -91.46 135.49 26.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.9 17.46 32.57 Favored Glycine 0 C--N 1.322 -0.201 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.36 -179.24 5.68 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.791 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 92.1 m-85 -137.03 169.54 17.6 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.595 -166.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 10' ' ' VAL . 6.1 tt -138.6 141.31 39.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.829 -164.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 37.2 t -138.75 151.98 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 124.889 1.368 . . . . 0.0 109.039 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.94 HG22 ' HB2' ' A' ' 54' ' ' SER . 0.5 OUTLIER . . . . . 0 C--N 1.31 -1.124 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.318 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.654 ' OD1' ' HD3' ' A' ' 74' ' ' ARG . 9.0 m-20 . . . . . 0 C--O 1.216 -0.678 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.963 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 47.4 tp60 53.5 99.76 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.423 0 O-C-N 123.608 0.567 . . . . 0.0 110.533 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.948 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -138.69 103.04 4.74 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 121.451 -0.781 . . . . 0.0 110.376 -173.168 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.49 -178.77 5.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.207 -172.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.791 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 23.5 tt0 -137.07 127.77 27.07 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 122.473 1.13 . . . . 0.0 109.089 172.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.539 ' CG2' HG22 ' A' ' 28' ' ' VAL . 3.0 mt -87.46 111.48 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-N 112.518 -2.128 . . . . 0.0 110.084 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.771 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -106.13 -12.12 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 O-C-N 123.961 0.788 . . . . 0.0 109.401 172.239 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.6 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 33.0 mt-10 -138.98 139.58 37.96 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.933 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.539 HG22 ' CG2' ' A' ' 25' ' ' ILE . 23.2 t -137.89 102.65 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -163.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.41 35.83 0.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.27 -173.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.3 t -158.76 150.83 21.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.98 -14.5 29.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.401 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -118.54 -66.22 1.1 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.618 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 165.57 51.82 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.267 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 m -118.87 148.29 44.23 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.03 156.79 52.58 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.62 2.214 . . . . 0.0 111.925 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.591 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 75.1 Cg_endo -89.16 -172.43 6.82 Favored 'Cis proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.723 -1.365 . . . . 0.0 113.447 1.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.72 168.33 20.03 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.168 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.6 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 84.3 t -137.96 117.41 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.93 172.24 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 113.112 -1.858 . . . . 0.0 109.656 -154.476 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.844 ' HG2' HD23 ' A' ' 42' ' ' LEU . 11.6 ttt85 -138.71 134.48 33.62 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.596 ' CZ2' HG21 ' A' ' 48' ' ' THR . 9.9 m95 -78.68 89.32 4.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 168.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.844 HD23 ' HG2' ' A' ' 40' ' ' ARG . 8.3 mt -59.92 -72.66 0.1 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.328 0.585 . . . . 0.0 111.533 -168.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.604 HG13 ' NE2' ' A' ' 64' ' ' HIS . 2.4 m -60.08 -30.68 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.293 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' ' 41' ' ' TRP . 33.9 m-80 -60.68 -66.18 0.57 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.241 170.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.79 33.31 0.65 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.86 -0.686 . . . . 0.0 114.759 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.753 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 2.4 m170 -139.28 174.48 10.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.328 1.064 . . . . 0.0 112.164 175.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -138.49 127.7 24.28 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.596 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 9.7 t -139.42 -179.23 5.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 122.065 0.936 . . . . 0.0 113.335 -168.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.524 HG23 HG22 ' A' ' 38' ' ' VAL . 63.4 m -138.46 110.67 7.36 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.87 -179.86 2.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -161.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 9.8 m-85 -138.71 121.93 10.95 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.264 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 24.6 Cg_exo -63.13 -53.45 1.53 Allowed 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 122.937 2.425 . . . . 0.0 112.653 -177.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.67 -46.82 1.11 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.204 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.94 ' HB2' HG22 ' A' ' 11' ' ' VAL . 26.4 m -91.66 -170.9 2.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.688 0.244 . . . . 0.0 111.33 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.61 -14.81 5.93 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.85 0.719 . . . . 0.0 110.525 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 71.44 130.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.985 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.584 HG23 ' HB ' ' A' ' 10' ' ' VAL . 29.0 m -135.41 169.84 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 122.046 -0.408 . . . . 0.0 110.969 176.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 2' ' ' HIS . 56.1 t -118.02 136.26 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -173.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.658 HG23 ' CB ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -123.86 174.74 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 123.111 0.565 . . . . 0.0 110.845 176.039 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -121.4 -164.97 1.18 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.503 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.15 91.17 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -171.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -81.82 -33.96 30.46 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.466 -0.771 . . . . 0.0 110.872 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 36.9 mt-10 -65.83 -16.52 63.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.919 0.866 . . . . 0.0 109.267 174.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.604 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.37 -57.73 3.67 Favored 'General case' 0 C--O 1.198 -1.642 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.292 -176.028 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.84 -67.14 0.28 Allowed 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -160.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.436 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.26 -53.5 14.11 Favored 'General case' 0 C--O 1.259 1.593 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.132 -169.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.52 -17.69 63.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.271 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.948 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 10.9 tt0 -74.01 -44.73 53.47 Favored 'General case' 0 C--O 1.205 -1.272 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -50.14 -57.55 7.46 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.611 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.77 -60.56 2.96 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 121.838 0.828 . . . . 0.0 112.424 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.77 ' HB3' ' HB2' ' A' ' 22' ' ' HIS . . . -73.18 -16.64 61.42 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -169.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -79.93 -39.25 30.68 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 118.27 0.486 . . . . 0.0 109.948 174.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.66 56.56 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.762 171.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.654 ' HD3' ' OD1' ' A' ' 20' ' ' ASP . 35.7 mtt180 -79.59 -42.93 23.91 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.65 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.963 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -46.05 -52.77 11.34 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.138 0.975 . . . . 0.0 112.228 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.523 0 C-N-CA 120.006 -1.092 . . . . 0.0 111.956 -176.723 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 68.9 m-70 . . . . . 0 C--O 1.23 0.068 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.96 154.76 17.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.534 0.207 . . . . 0.0 110.793 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -135.52 163.44 30.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 111.2 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 HG23 ' A' ' 28' ' ' VAL . 40.0 t -100.17 135.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.837 176.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.85 3.96 61.97 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.99 171.39 8.48 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.704 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 84.5 m-85 -106.25 148.58 27.79 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.321 0.581 . . . . 0.0 111.259 -175.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.4 tt -99.06 136.73 38.6 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.664 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.634 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 3.3 t -141.14 139.71 32.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 O-C-N 125.044 1.465 . . . . 0.0 109.895 174.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.0 t . . . . . 0 C--N 1.317 -0.819 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 170.892 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 t0 . . . . . 0 CA--C 1.534 0.351 0 CA-C-O 119.116 -0.468 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.687 ' N ' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER 43.23 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.807 0.843 . . . . 0.0 112.475 -177.38 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.928 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.7 t60 -134.49 137.96 44.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -171.08 -179.86 2.85 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.488 173.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.704 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 38.4 tt0 -98.59 136.1 39.16 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.033 0.444 . . . . 0.0 110.341 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 9' ' ' LEU . 1.5 mt -97.17 107.18 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.788 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -107.33 -24.88 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.993 176.384 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 1.079 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 19.3 mm-40 -115.72 99.88 7.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.795 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 5' ' ' VAL . 72.3 t -106.72 124.62 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.636 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -69.13 -37.81 78.52 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.5 p -146.07 144.65 30.16 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.95 74.1 0.88 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.078 0.466 . . . . 0.0 111.928 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 19.1 t70 -171.38 -57.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.092 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 146.39 89.99 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.949 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 p -132.02 97.05 18.91 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.857 0.361 . . . . 0.0 111.363 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.75 150.68 84.82 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.485 2.123 . . . . 0.0 111.213 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.413 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.3 Cg_endo -78.1 169.22 73.8 Favored 'Cis proline' 0 C--N 1.344 0.295 0 C-N-CA 123.346 -1.523 . . . . 0.0 112.826 0.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -113.58 155.47 25.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.079 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 66.4 t -98.76 102.07 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 172.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -106.14 158.01 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.077 -163.693 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.572 ' HB2' HD12 ' A' ' 26' ' ' ILE . 62.9 ttt180 -131.51 99.99 5.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.162 -169.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.742 ' HE1' HG22 ' A' ' 48' ' ' THR . 0.3 OUTLIER -81.75 71.66 8.78 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 174.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 3.0 pp -84.83 -23.7 28.96 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.86 -166.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.68 ' HB ' ' CE1' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -85.17 -6.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.968 0.889 . . . . 0.0 108.812 178.514 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 69' ' ' LYS . 50.1 m-80 -99.84 -61.57 1.35 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.123 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.88 42.4 0.1 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.044 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -157.04 164.59 37.78 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.907 0.354 . . . . 0.0 110.927 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -149.44 133.56 17.24 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.742 HG22 ' HE1' ' A' ' 41' ' ' TRP . 12.0 t -167.49 177.8 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.541 0.686 . . . . 0.0 111.182 -176.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.4 m -98.88 123.04 42.88 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.533 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.84 155.85 41.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.216 0.531 . . . . 0.0 111.543 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 46.4 m-85 -107.24 99.94 30.23 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.04 174.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HG3' HD11 ' A' ' 9' ' ' LEU . 43.6 Cg_endo -68.07 -30.48 31.92 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 122.68 2.253 . . . . 0.0 112.595 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.25 -128.8 9.02 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.9 m -124.59 164.31 20.09 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 59.71 53.77 4.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.466 0.65 . . . . 0.0 111.323 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.37 117.33 29.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.41 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.0 169.44 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.36 116.0 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.108 0.48 . . . . 0.0 111.106 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.632 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -109.22 178.3 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.302 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.7 p -126.96 -166.8 1.64 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.27 -176.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -51.6 -46.69 63.65 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.99 -50.78 67.17 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.481 -0.762 . . . . 0.0 111.441 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 25.2 mm-40 -63.57 -17.04 62.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.39 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.68 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -76.07 -32.68 59.4 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.462 -175.16 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.53 -77.22 0.06 Allowed 'General case' 0 C--O 1.25 1.114 0 CA-C-O 122.097 0.951 . . . . 0.0 111.609 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -63.89 -47.58 80.09 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.741 -173.332 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -66.63 -38.71 87.47 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.185 -177.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.928 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 41.2 tt0 -66.3 -39.95 89.69 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.479 -176.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.55 ' HA ' ' OD1' ' A' ' 44' ' ' ASN . 69.1 mttm -57.85 -63.3 1.29 Allowed 'General case' 0 C--O 1.25 1.096 0 C-N-CA 119.731 -0.787 . . . . 0.0 110.957 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.486 ' HD3' ' O ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -62.77 -43.14 99.58 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.425 0.631 . . . . 0.0 110.897 -174.395 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.687 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -81.76 -16.79 49.93 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -171.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.71 -38.71 62.26 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 119.716 -0.794 . . . . 0.0 108.882 171.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.1 -38.69 80.15 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.06 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.15 -38.16 25.11 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -56.94 -53.79 53.97 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.946 0.403 . . . . 0.0 111.786 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.16 -178.381 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 . . . . . 0 CA--C 1.516 -0.337 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.89 149.84 45.29 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.56 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 52.1 tptt -139.06 148.51 43.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.469 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.736 HG23 ' HA ' ' A' ' 26' ' ' ILE . 5.2 p -80.13 146.23 7.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.5 38.81 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -172.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -138.56 -179.15 5.64 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.712 -1.244 . . . . 0.0 108.392 -176.83 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.652 ' CD2' HD22 ' A' ' 42' ' ' LEU . 87.9 m-85 -137.54 171.87 13.82 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.394 -172.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.737 HD21 ' HB3' ' A' ' 52' ' ' PRO . 9.2 tt -138.53 137.16 36.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.157 -169.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 93.3 t -139.22 161.29 28.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.992 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.917 HG22 ' HB2' ' A' ' 21' ' ' GLN . 26.7 m . . . . . 0 C--O 1.241 0.625 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.518 -0.276 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.957 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 2.2 mp0 57.73 97.64 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.385 0.428 . . . . 0.0 110.261 -170.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.69 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 82.8 t60 -138.75 127.31 23.23 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.832 0.825 . . . . 0.0 112.53 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -139.42 -178.7 5.5 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.308 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.608 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 28.6 tt0 -136.99 111.69 8.75 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.529 ' CG2' HG22 ' A' ' 28' ' ' VAL . 9.7 mt -81.14 103.06 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.402 -167.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.736 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.9 pp -107.88 -7.56 10.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.114 176.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.926 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 3.0 tp10 -139.21 136.2 34.76 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.382 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.529 HG22 ' CG2' ' A' ' 25' ' ' ILE . 46.8 t -137.99 99.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -168.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -105.26 84.03 2.05 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.13 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.6 m -151.61 109.64 3.71 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.605 -175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.81 -16.81 24.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.41 -45.28 9.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.528 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.88 40.11 3.41 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 -169.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.663 ' HB3' ' HD2' ' A' ' 35' ' ' PRO . 62.4 m -152.18 167.59 12.93 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 34' ' ' SER . 12.5 Cg_endo -56.13 159.57 12.23 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.013 2.475 . . . . 0.0 112.68 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.557 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 84.3 Cg_endo -82.4 179.59 26.36 Favored 'Cis proline' 0 C--N 1.347 0.451 0 C-N-CA 123.153 -1.603 . . . . 0.0 113.263 1.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -138.76 174.86 10.08 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.926 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 84.2 t -137.6 122.32 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.64 176.19 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 CA-C-N 113.378 -1.737 . . . . 0.0 110.498 -149.192 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.608 ' HD3' ' OE2' ' A' ' 24' ' ' GLU . 35.6 ttt180 -138.54 124.04 19.53 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -174.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.445 ' HZ3' ' O ' ' A' ' 22' ' ' HIS . 8.9 m95 -65.16 102.98 0.7 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 166.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.652 HD22 ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -59.85 -89.58 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.902 -1.499 . . . . 0.0 113.845 -154.02 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.682 HG23 ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -60.41 -26.27 36.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -176.172 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -60.54 -57.2 13.74 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 172.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.33 51.41 0.72 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.64 -0.79 . . . . 0.0 114.152 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -139.21 170.37 16.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.062 0.431 . . . . 0.0 109.888 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 7.9 mp0 -138.21 134.73 34.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.515 0.674 . . . . 0.0 111.002 -175.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.493 ' CG2' HG12 ' A' ' 39' ' ' VAL . 10.0 t -139.36 -178.97 5.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.087 -172.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.504 HG23 HG22 ' A' ' 38' ' ' VAL . 44.7 m -138.21 113.71 9.6 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.87 -179.82 2.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-O 121.672 0.749 . . . . 0.0 112.954 -161.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 2.0 m-85 -138.86 116.7 9.01 Favored Pre-proline 0 N--CA 1.455 -0.223 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.674 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.737 ' HB3' HD21 ' A' ' 9' ' ' LEU . 28.5 Cg_endo -64.38 -65.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.474 0.353 0 C-N-CA 122.564 2.176 . . . . 0.0 113.55 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 138.05 -146.82 18.72 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.285 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.0 m -81.14 151.42 28.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 0.0 111.248 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 t70 48.74 64.81 1.55 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.813 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.887 ' HA ' HG12 ' A' ' 11' ' ' VAL . . . -79.46 133.61 36.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.817 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 58' ' ' VAL . 2.3 t -138.75 -179.83 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.751 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -138.18 152.37 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.983 -177.593 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.582 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.77 179.75 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.018 -172.165 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.2 p -120.21 -165.44 1.19 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.302 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.451 ' O ' ' ND1' ' A' ' 64' ' ' HIS . . . -56.9 -48.2 78.76 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -59.96 4.34 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.102 -0.999 . . . . 0.0 111.827 -175.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -57.27 -21.27 33.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.021 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.586 ' HA ' ' NE2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.35 -44.12 84.07 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.263 -176.526 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.587 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . -57.62 -70.33 0.14 Allowed 'General case' 0 C--O 1.251 1.145 0 CA-C-O 122.337 1.065 . . . . 0.0 113.051 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -57.01 -55.01 40.23 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.553 -176.021 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.637 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.41 -29.07 63.81 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.909 176.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.682 ' HG2' HG23 ' A' ' 43' ' ' VAL . 3.2 tp10 -56.87 -58.74 6.81 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.76 -72.63 0.08 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.825 -178.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.594 ' HG3' ' H ' ' A' ' 71' ' ' ALA . 31.9 ptt180 -57.46 -67.68 0.3 Allowed 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.743 0.783 . . . . 0.0 112.281 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 67' ' ' ALA . . . -57.38 -47.79 80.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.074 -0.966 . . . . 0.0 113.584 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -57.38 -46.11 83.75 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.089 0.859 . . . . 0.0 111.177 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.97 -29.64 63.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.04 0.448 . . . . 0.0 111.322 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -81.59 -50.07 9.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.994 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.957 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -54.63 -66.53 0.39 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.661 0.784 . . . . 0.0 112.004 -176.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.634 0 C-N-CA 119.796 -1.193 . . . . 0.0 112.196 -172.452 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.564 0.221 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.06 120.18 14.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.726 ' HA ' HG21 ' A' ' 28' ' ' VAL . 98.6 mttt -138.88 176.31 8.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 112.144 -173.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.805 HG23 ' HA ' ' A' ' 26' ' ' ILE . 8.5 p -71.1 156.78 6.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.514 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.28 12.52 82.08 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.13 -178.79 5.5 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 113.754 -1.223 . . . . 0.0 107.836 -172.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.815 ' HB2' HG23 ' A' ' 59' ' ' VAL . 67.6 m-85 -137.39 174.03 11.04 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.535 -174.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.764 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 4.4 tt -138.14 153.11 49.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.23 -164.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 38.3 t -138.89 151.72 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 125.106 1.504 . . . . 0.0 109.614 -169.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.777 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.8 p . . . . . 0 C--N 1.322 -0.62 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.2 t0 . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 1.025 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 2.0 mp0 65.11 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.922 0.489 . . . . 0.0 110.94 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.764 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 1.2 m-70 -128.03 147.4 50.51 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 122.151 -0.343 . . . . 0.0 111.143 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.619 ' HA ' ' HE1' ' A' ' 64' ' ' HIS . . . -157.87 175.12 14.27 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.702 ' HA ' ' HD1' ' A' ' 8' ' ' TYR . 40.1 tt0 -98.63 130.85 45.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.769 0.795 . . . . 0.0 112.664 -172.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' ' 9' ' ' LEU . 49.4 mt -90.66 108.01 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.66 171.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.805 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.3 pp -108.01 -28.5 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.921 177.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.99 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 45.2 mt-10 -124.02 117.21 24.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.23 0.538 . . . . 0.0 110.123 175.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' A' ' 4' ' ' LYS . 79.5 t -98.87 116.18 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.854 -176.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 29' ' ' ARG . 14.8 mmm180 -88.18 -13.96 39.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.895 0.379 . . . . 0.0 111.342 -174.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.455 ' HB3' ' H ' ' A' ' 34' ' ' SER . 23.0 t -129.71 104.08 7.21 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.75 -35.13 55.75 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.738 0.649 . . . . 0.0 112.656 -174.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.45 -58.56 3.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 110.203 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.45 83.37 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.699 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.455 ' H ' ' HB3' ' A' ' 30' ' ' SER . 50.0 m -154.58 148.5 18.93 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 175.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 16.8 Cg_exo -68.36 160.3 49.65 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.768 2.312 . . . . 0.0 111.822 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -88.56 179.53 16.92 Favored 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.745 -1.356 . . . . 0.0 112.648 0.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -131.75 158.59 40.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.912 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.99 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 59.8 t -98.78 116.38 41.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.28 133.19 58.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.31 -162.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.545 ' HG2' HG12 ' A' ' 26' ' ' ILE . 6.5 ptp180 -112.0 142.84 43.92 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.533 176.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.608 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 23.6 m95 -90.56 111.02 22.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.46 HD21 ' HG3' ' A' ' 40' ' ' ARG . 7.2 mt -82.67 -58.44 2.9 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.198 0.523 . . . . 0.0 111.47 -169.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.931 HG21 ' HA ' ' A' ' 65' ' ' ALA . 1.3 m -80.58 -5.54 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.611 -170.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -100.04 -47.24 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.138 167.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.9 79.07 1.14 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.911 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.608 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -163.77 164.48 23.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.642 0.258 . . . . 0.0 110.911 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' OE2' ' HB3' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -134.79 121.01 20.09 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.485 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.0 p -143.09 -179.92 6.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.581 0.705 . . . . 0.0 111.861 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.2 m -123.75 110.09 14.5 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 168.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.13 139.16 25.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-O 121.526 0.679 . . . . 0.0 112.251 -166.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -105.5 99.61 21.98 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.884 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.461 ' HG3' HD11 ' A' ' 9' ' ' LEU . 90.9 Cg_endo -83.66 163.13 14.37 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.263 1.975 . . . . 0.0 111.63 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.61 171.42 53.99 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.684 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 17.2 m -61.26 145.91 49.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.505 0.193 . . . . 0.0 111.267 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 54' ' ' SER . 6.3 m-20 72.98 63.22 0.1 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.979 0.799 . . . . 0.0 110.643 -174.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -86.94 124.44 33.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.926 175.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 10' ' ' VAL . 6.6 t -99.05 157.78 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -108.34 123.83 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.664 178.704 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -121.91 172.52 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-O 121.056 0.455 . . . . 0.0 111.278 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.554 ' CG2' ' H ' ' A' ' 61' ' ' ALA . 1.3 m -111.57 -173.92 2.35 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.614 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -52.51 -45.87 66.43 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -166.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.85 -61.0 2.44 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -58.28 -26.92 63.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.901 0.858 . . . . 0.0 109.699 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.619 ' HE1' ' HA ' ' A' ' 23' ' ' ALA . 47.4 t60 -64.1 -37.19 86.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.657 -1.156 . . . . 0.0 113.182 -175.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.931 ' HA ' HG21 ' A' ' 43' ' ' VAL . . . -64.09 -69.29 0.29 Allowed 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.726 0.774 . . . . 0.0 113.046 -169.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.47 -39.89 89.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.132 -175.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.13 -16.8 61.44 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.837 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 20.0 tt0 -72.56 -46.16 55.75 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.054 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -61.99 -40.39 95.45 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.653 176.355 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -64.41 -22.43 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.18 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 1.025 ' HA ' ' HG3' ' A' ' 21' ' ' GLN . . . -82.26 -42.92 18.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.718 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.46 -21.33 65.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.86 -64.3 0.99 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.584 172.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HD2' ' OE1' ' A' ' 21' ' ' GLN . 62.8 mtt180 -81.84 -64.26 1.22 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -175.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.59 -52.68 62.44 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.953 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.223 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.973 -175.728 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.619 ' CD2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 m170 . . . . . 0 CA--C 1.519 -0.241 0 CA-C-O 120.941 0.4 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.16 124.07 43.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.556 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -125.01 158.26 34.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.672 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.828 HG23 ' HA ' ' A' ' 26' ' ' ILE . 4.3 p -75.39 144.62 11.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.296 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.36 11.99 74.07 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.629 ' OD2' ' HB ' ' A' ' 58' ' ' VAL . 6.5 t70 -132.73 149.29 52.3 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.557 ' CE2' ' HA ' ' A' ' 61' ' ' ALA . 95.3 m-85 -98.79 155.22 17.47 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.386 0.612 . . . . 0.0 111.314 -168.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.664 HD11 ' HG3' ' A' ' 52' ' ' PRO . 10.2 tt -98.69 136.27 38.99 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.918 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 1.1 p -132.69 167.54 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 170.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 21' ' ' GLN . 2.6 p . . . . . 0 C--N 1.318 -0.792 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.219 171.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD2' ' HG3' ' A' ' 21' ' ' GLN . 4.3 t70 . . . . . 0 CA--C 1.539 0.54 0 CA-C-O 119.478 -0.296 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.666 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 77.0 mt-30 -41.13 120.01 1.28 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.371 0.668 . . . . 0.0 112.581 -160.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.74 ' CD2' ' HA ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -128.35 144.34 51.12 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -165.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -179.17 -179.75 0.59 Allowed 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.279 0.987 . . . . 0.0 110.2 173.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.517 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 5.0 tp10 -98.28 128.73 44.86 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.581 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.506 ' CG2' HG22 ' A' ' 28' ' ' VAL . 14.0 mt -93.15 101.16 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.828 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -103.06 -23.33 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.297 178.183 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.828 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 38.7 mt-10 -129.59 103.35 6.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.017 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.506 HG22 ' CG2' ' A' ' 25' ' ' ILE . 46.3 t -98.98 110.66 26.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.146 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.87 -46.19 66.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.304 0.573 . . . . 0.0 110.052 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.3 m -125.29 112.73 16.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.907 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.28 66.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -173.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.619 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 18.0 t70 -78.16 -65.24 1.0 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.234 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 167.24 73.96 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.474 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.0 m -151.26 126.5 4.79 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.706 0.289 . . . . 0.0 110.242 177.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.59 166.87 20.59 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.191 2.594 . . . . 0.0 111.434 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.08 152.35 88.42 Favored 'Cis proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.783 -1.34 . . . . 0.0 112.974 3.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -106.17 137.84 43.39 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.828 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 61.0 t -98.64 107.53 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -118.07 151.23 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.086 -165.587 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -126.74 128.21 46.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.377 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.601 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 11.4 m95 -76.03 106.59 7.71 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.89 -55.44 4.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.196 0.522 . . . . 0.0 110.517 -174.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 43' ' ' VAL . 2.3 m -81.71 -4.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.719 -176.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 39.4 m-80 -97.88 -71.52 0.68 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.232 165.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.71 73.85 0.14 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.349 -0.929 . . . . 0.0 114.569 171.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.94 169.0 1.61 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.242 0.521 . . . . 0.0 110.882 169.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -120.14 145.63 46.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.33 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.6 t -172.33 -179.86 2.38 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 121.668 0.747 . . . . 0.0 112.246 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.8 m -115.14 121.89 44.4 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.23 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 39' ' ' VAL . 35.8 m -118.88 159.08 19.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 CA-C-O 121.571 0.7 . . . . 0.0 112.851 -170.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -125.07 99.9 33.9 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.892 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.664 ' HG3' HD11 ' A' ' 9' ' ' LEU . 73.3 Cg_endo -77.16 -24.48 9.5 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.358 2.039 . . . . 0.0 112.76 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.19 -163.59 15.83 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.935 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.1 p -86.09 166.14 16.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.464 0.132 . . . . 0.0 110.772 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 62.52 42.02 9.09 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.406 0.622 . . . . 0.0 110.689 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.25 135.04 33.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.67 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.506 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 10.4 t -124.09 158.73 30.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.629 ' HB ' ' OD2' ' A' ' 7' ' ' ASP . 1.6 m -102.87 125.3 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.139 0.495 . . . . 0.0 111.409 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.566 HG21 ' NE2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -118.77 175.24 3.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.252 -175.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -111.94 -168.85 1.37 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.025 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -60.56 -47.63 85.35 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -70.41 -36.76 74.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.834 0.35 . . . . 0.0 111.488 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.34 -16.28 62.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.585 0.707 . . . . 0.0 109.471 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.74 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 2.7 t-80 -82.89 -44.77 15.02 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.19 -68.68 0.23 Allowed 'General case' 0 C--O 1.247 0.973 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -164.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.467 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -60.81 -36.8 79.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.144 -175.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -74.46 -22.06 59.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.741 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.606 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 13.8 tt0 -79.67 -34.59 40.19 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.833 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -56.04 -65.44 0.6 Allowed 'General case' 0 C--O 1.244 0.807 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.412 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -59.63 -65.56 0.65 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.171 0.986 . . . . 0.0 111.824 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -78.22 -16.93 57.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.449 -165.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -82.26 -35.37 28.17 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.811 173.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.62 -34.35 69.2 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.136 0.494 . . . . 0.0 110.154 171.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -81.81 -40.97 21.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.868 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.5 -57.52 12.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.13 0.572 . . . . 0.0 111.872 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.305 -176.636 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.482 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 47.3 t-80 . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.79 166.83 11.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.79 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.02 160.07 35.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.74 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.85 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.1 p -83.03 146.03 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.14 0.495 . . . . 0.0 111.398 -175.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.33 6.33 58.79 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.12 168.29 18.24 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.712 ' HB2' HG23 ' A' ' 59' ' ' VAL . 97.1 m-85 -103.14 157.38 17.04 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.448 0.642 . . . . 0.0 111.537 -171.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.67 ' HB2' HD11 ' A' ' 25' ' ' ILE . 9.4 tt -98.91 138.31 36.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.544 175.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 0.5 OUTLIER -136.94 164.89 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.459 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.913 ' HB ' ' HB3' ' A' ' 20' ' ' ASP . 69.8 t . . . . . 0 C--N 1.317 -0.832 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 171.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.913 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 3.2 t70 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.773 ' HA ' ' HB1' ' A' ' 71' ' ' ALA . 68.0 mt-30 -41.15 131.62 2.62 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.706 0.802 . . . . 0.0 112.235 -168.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.896 ' CE1' ' HA ' ' A' ' 64' ' ' HIS . 6.4 t60 -145.68 142.48 29.05 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -165.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.521 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -172.62 177.96 2.81 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.801 0.84 . . . . 0.0 109.858 173.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.684 ' HG3' HD11 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -98.6 126.6 44.24 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.6 0.238 . . . . 0.0 110.853 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 9' ' ' LEU . 14.4 mt -94.95 106.5 18.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 -176.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.85 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -102.0 -27.7 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.727 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.984 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 69.1 mm-40 -119.64 101.68 8.09 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.118 0.485 . . . . 0.0 110.633 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -98.93 102.5 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.081 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -89.36 -1.37 58.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.489 0.661 . . . . 0.0 109.765 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.81 ' HB3' ' H ' ' A' ' 34' ' ' SER . 1.4 m -80.59 124.36 28.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.857 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.61 -41.32 98.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.299 0.571 . . . . 0.0 109.99 175.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 52.2 m-20 -114.66 -68.59 0.91 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.472 173.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.47 54.6 0.14 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.327 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.81 ' H ' ' HB3' ' A' ' 30' ' ' SER . 5.0 p -106.52 143.72 27.57 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 122.245 0.218 . . . . 0.0 111.165 -178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 12.9 Cg_exo -70.17 157.24 60.21 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.798 2.332 . . . . 0.0 111.611 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -87.46 174.34 29.17 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.45 -1.479 . . . . 0.0 112.937 -1.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -123.21 149.92 44.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.984 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 98.9 t -98.68 108.77 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 172.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.77 165.37 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.922 -162.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.549 ' HG3' HD21 ' A' ' 42' ' ' LEU . 9.9 ptp180 -142.36 133.07 25.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.958 0.408 . . . . 0.0 111.001 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.554 ' HB2' ' HB2' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -82.28 106.32 14.07 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.912 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.684 HD11 ' HG3' ' A' ' 24' ' ' GLU . 18.6 mt -77.51 -50.8 11.86 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.075 0.464 . . . . 0.0 110.977 -171.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.472 HG22 ' OE2' ' A' ' 68' ' ' GLU . 2.4 m -79.69 -6.02 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.167 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 41' ' ' TRP . 18.2 m120 -100.03 -51.18 3.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.754 174.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.7 70.45 0.68 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.2 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.489 ' CB ' ' HD1' ' A' ' 41' ' ' TRP . 0.4 OUTLIER -174.49 161.39 3.31 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.802 0.441 . . . . 0.0 110.264 176.547 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.71 139.98 46.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 t -173.67 171.06 3.9 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.671 0.748 . . . . 0.0 112.359 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.7 m -98.87 111.39 23.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.943 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -107.92 156.75 8.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.502 0.667 . . . . 0.0 112.594 -169.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -120.14 104.69 43.32 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.032 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.459 ' HA ' ' OE1' ' A' ' 21' ' ' GLN . 72.1 Cg_endo -75.05 -5.22 16.5 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.829 2.353 . . . . 0.0 112.13 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.63 -78.76 1.96 Allowed Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.997 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.8 p -160.75 166.99 27.76 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.491 -0.189 . . . . 0.0 110.491 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 66.69 38.25 4.01 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.604 0.565 . . . . 0.0 111.9 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -77.63 132.4 38.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.155 0.503 . . . . 0.0 111.312 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.621 ' HB ' HG12 ' A' ' 10' ' ' VAL . 10.8 t -126.33 159.3 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.443 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.6 t -98.96 117.67 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.888 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.712 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -111.76 173.17 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.54 -178.34 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -122.67 -164.93 1.23 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.654 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -58.24 -44.95 88.53 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.35 -33.64 37.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.351 0.596 . . . . 0.0 110.96 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 12.5 mm-40 -63.4 -16.38 60.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.743 172.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.896 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.9 OUTLIER -81.8 -50.6 9.04 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -172.169 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.68 -70.5 0.1 Allowed 'General case' 0 C--O 1.247 0.964 0 CA-C-O 121.569 0.7 . . . . 0.0 112.613 -165.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -49.4 77.59 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.376 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.88 -38.32 90.57 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.626 -175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.807 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 25.5 tt0 -69.62 -41.6 75.45 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.057 -174.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -58.49 -57.49 12.73 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.674 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -63.62 -45.93 88.06 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.725 0.774 . . . . 0.0 111.157 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.773 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -81.45 -16.42 52.07 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.03 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.98 -39.72 61.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.35 -25.74 68.44 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.671 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -82.2 -56.54 3.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.972 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.6 -62.17 1.86 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.666 0.787 . . . . 0.0 112.413 -174.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.238 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.235 -174.418 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 70.7 t60 . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.2 152.4 19.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.74 0.305 . . . . 0.0 110.921 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 7' ' ' ASP . 12.6 tmtt? -139.9 129.44 24.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.415 ' O ' ' HD3' ' A' ' 4' ' ' LYS . 7.4 p -80.24 141.2 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.024 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.04 6.86 71.14 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.421 ' CG ' ' HD2' ' A' ' 4' ' ' LYS . 1.1 m-20 -123.09 173.43 7.86 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.71 ' HB2' HG23 ' A' ' 59' ' ' VAL . 98.3 m-85 -107.92 152.9 23.81 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.37 0.605 . . . . 0.0 111.881 -173.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.806 HD11 ' HG3' ' A' ' 52' ' ' PRO . 6.8 tt -103.02 141.79 35.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.332 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 3.4 t -145.81 144.3 21.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 O-C-N 124.71 1.256 . . . . 0.0 109.707 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 21' ' ' GLN . 21.1 m . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 121.194 0.521 . . . . 0.0 109.952 170.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.4 t0 . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 119.468 -0.301 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.576 ' N ' ' HB1' ' A' ' 71' ' ' ALA . 68.5 mt-30 38.19 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.767 1.227 . . . . 0.0 112.954 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.733 ' CE1' ' HA ' ' A' ' 64' ' ' HIS . 41.3 t-80 -133.37 139.9 47.06 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -169.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -168.02 -179.95 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.627 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.602 ' CD ' HD11 ' A' ' 42' ' ' LEU . 45.7 tt0 -98.58 129.57 45.12 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.036 0.446 . . . . 0.0 111.12 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.695 HD11 ' HB2' ' A' ' 9' ' ' LEU . 45.7 mt -92.01 105.54 16.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.765 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.682 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -102.47 -26.32 3.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.817 177.361 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 37.0 tt0 -129.69 119.83 24.16 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.405 0.621 . . . . 0.0 110.364 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.21 121.44 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.205 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -64.36 -33.58 76.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.98 0.419 . . . . 0.0 110.599 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.9 t -149.76 128.17 12.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.52 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.92 -23.06 67.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 0.0 111.006 -176.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.38 -17.63 64.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.411 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.38 5.49 39.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.336 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 6.6 m -67.54 122.53 83.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.572 0.225 . . . . 0.0 110.999 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 15.9 Cg_exo -68.65 165.52 29.14 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.412 2.741 . . . . 0.0 111.924 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 83.2 Cg_endo -80.56 -175.56 16.35 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.982 -1.258 . . . . 0.0 113.085 1.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -123.83 148.41 46.76 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 96.3 t -98.66 101.71 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 173.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.92 145.58 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.659 -163.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.42 ' HG3' ' HG3' ' A' ' 47' ' ' GLU . 55.4 ttt180 -121.22 130.04 53.49 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.054 -176.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 13.0 m95 -79.79 96.24 6.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.602 HD11 ' CD ' ' A' ' 24' ' ' GLU . 20.1 mt -72.85 -61.28 1.87 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.352 0.596 . . . . 0.0 110.834 -173.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.462 HG22 ' OE2' ' A' ' 68' ' ' GLU . 2.0 m -73.93 -5.83 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.333 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 54.9 m-80 -98.61 -62.73 1.2 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.903 173.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.9 63.58 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.526 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -167.38 155.22 9.11 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.14 0.495 . . . . 0.0 111.794 173.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HG3' ' HG3' ' A' ' 40' ' ' ARG . 3.7 mp0 -111.77 141.91 44.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.094 175.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.467 HG23 HG23 ' A' ' 50' ' ' VAL . 8.8 t -165.89 179.84 5.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.583 0.706 . . . . 0.0 112.159 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 m -125.22 106.03 9.58 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.832 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 48' ' ' THR . 70.3 t -109.42 147.43 13.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.32 0.581 . . . . 0.0 111.867 -169.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 62.2 m-85 -107.69 99.77 31.27 Favored Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.325 170.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.806 ' HG3' HD11 ' A' ' 9' ' ' LEU . 84.5 Cg_endo -82.12 -22.8 4.81 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.835 2.357 . . . . 0.0 111.805 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.49 -143.4 14.32 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 m -135.48 16.63 3.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.56 0.68 . . . . 0.0 110.687 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -106.49 16.46 24.62 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.124 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.51 114.68 3.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.986 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.813 HG22 ' H ' ' A' ' 58' ' ' VAL . 10.5 p -98.94 175.96 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.813 ' H ' HG22 ' A' ' 57' ' ' VAL . 46.5 t -119.36 125.1 74.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.291 -172.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.71 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -122.42 175.75 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.534 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -117.45 -167.12 1.27 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.525 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -59.66 -41.17 90.01 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -170.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.92 -46.25 62.8 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.893 -0.504 . . . . 0.0 111.462 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 28.3 mm-40 -62.35 -16.46 54.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.616 0.722 . . . . 0.0 109.947 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.733 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -73.47 -43.78 59.46 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.18 -176.293 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.58 -72.69 0.09 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.641 0.734 . . . . 0.0 112.295 -168.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.86 ' HA ' ' HE2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -61.84 -45.87 91.93 Favored 'General case' 0 C--O 1.253 1.254 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.42 -174.064 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HA ' HH21 ' A' ' 70' ' ' ARG . . . -58.49 -46.22 87.11 Favored 'General case' 0 C--O 1.204 -1.311 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.245 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 15.4 tt0 -65.31 -39.68 92.79 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.906 -171.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.86 ' HE2' ' HA ' ' A' ' 66' ' ' GLU . 57.3 pttt -64.19 -56.61 13.53 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.883 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.447 HH21 ' HA ' ' A' ' 67' ' ' ALA . 59.9 mtm180 -60.91 -44.7 96.81 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.547 1.165 . . . . 0.0 110.752 -177.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -80.47 -16.52 54.13 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.416 -172.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.2 -35.81 66.4 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.059 170.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -29.67 70.04 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.659 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.432 ' HB2' ' HA ' ' A' ' 71' ' ' ALA . 12.7 mmt180 -81.92 -58.13 3.11 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -63.06 -63.48 1.19 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.025 0.53 . . . . 0.0 111.514 -174.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.603 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.206 -175.021 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 3.6 m-70 . . . . . 0 CA--C 1.516 -0.338 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.48 ' HB1' ' CD1' ' A' ' 25' ' ' ILE . . . -138.34 140.48 39.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 111.471 -163.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.849 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 28.8 mmtp -138.49 140.68 39.29 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.211 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 26' ' ' ILE . 24.7 t -70.23 136.36 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 O-C-N 122.211 -0.306 . . . . 0.0 111.23 176.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.98 17.41 51.5 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.849 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.6 m-20 -138.97 144.17 38.86 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.439 -1.881 . . . . 0.0 108.288 -166.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.821 ' CD1' ' HB2' ' A' ' 24' ' ' GLU . 74.6 m-85 -134.96 141.81 46.34 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -148.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.875 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 1.3 tt -136.71 139.56 42.02 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -152.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.538 ' N ' HD23 ' A' ' 9' ' ' LEU . 3.9 t -139.14 140.58 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 O-C-N 126.683 2.489 . . . . 0.0 109.371 -167.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.927 HG22 ' HB2' ' A' ' 21' ' ' GLN . 14.6 m . . . . . 0 C--N 1.32 -0.705 0 CA-C-O 121.066 0.46 . . . . 0.0 110.604 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.695 ' OD1' ' HB3' ' A' ' 74' ' ' ARG . 2.1 t70 . . . . . 0 C--O 1.217 -0.622 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.927 ' HB2' HG22 ' A' ' 11' ' ' VAL . 75.3 mt-30 45.03 91.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.674 0.79 . . . . 0.0 111.413 -173.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.875 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 6.2 t60 -138.85 116.24 11.21 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 121.255 0.55 . . . . 0.0 112.075 -168.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.571 ' HB2' ' NE1' ' A' ' 41' ' ' TRP . . . -139.65 -178.8 5.57 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.141 -1.391 . . . . 0.0 108.475 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.821 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 3.3 tm-20 -137.28 122.59 19.38 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.24 1.019 . . . . 0.0 110.312 -177.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.867 HG23 HG23 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -80.08 113.96 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 113.459 -1.701 . . . . 0.0 111.004 -174.37 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.737 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -98.86 -8.71 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.111 169.418 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.738 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -138.97 127.15 22.62 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.498 177.198 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.415 ' CG2' ' HB ' ' A' ' 25' ' ' ILE . 54.7 t -138.03 100.0 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.795 -169.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -103.81 20.35 18.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.163 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.573 ' HB3' ' H ' ' A' ' 34' ' ' SER . 3.6 m -108.88 111.08 22.6 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.434 177.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.06 93.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.31 0.576 . . . . 0.0 110.405 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 32.9 t70 -95.33 -56.83 2.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.007 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.1 70.37 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.422 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.573 ' H ' ' HB3' ' A' ' 30' ' ' SER . 20.0 t -150.25 142.6 15.79 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.32 151.56 9.5 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.467 2.778 . . . . 0.0 113.102 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.572 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.8 Cg_endo -85.51 -177.2 15.3 Favored 'Cis proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.108 -1.622 . . . . 0.0 113.664 3.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -138.78 173.36 11.65 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.157 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.738 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 72.4 t -137.78 114.47 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.453 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.867 HG23 HG23 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -138.75 165.3 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-N 111.965 -2.38 . . . . 0.0 107.664 -149.455 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.631 ' HB2' HD12 ' A' ' 26' ' ' ILE . 33.4 ttt180 -138.66 127.52 23.69 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.493 -172.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.61 ' CZ3' HG21 ' A' ' 48' ' ' THR . 3.4 m0 -86.99 83.79 7.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.502 HD12 ' CE1' ' A' ' 8' ' ' TYR . 8.0 mt -60.28 -64.22 1.03 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.986 -166.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.605 HG13 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -60.11 -33.07 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.216 -176.235 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 4.7 m-20 -60.53 -65.39 0.69 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.167 0.508 . . . . 0.0 110.792 168.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.33 39.11 0.6 Allowed Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.728 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -139.16 171.31 14.48 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 117.126 0.463 . . . . 0.0 110.457 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' HG3' ' HG3' ' A' ' 40' ' ' ARG . 1.7 mp0 -138.2 127.46 24.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.833 HG23 HG12 ' A' ' 39' ' ' VAL . 10.0 t -139.42 -179.64 6.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -164.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.6 m -138.48 120.55 15.62 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.598 HG22 ' H ' ' A' ' 51' ' ' TYR . 4.9 p -138.81 172.75 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.524 -160.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.598 ' H ' HG22 ' A' ' 50' ' ' VAL . 41.7 m-85 -138.57 100.03 8.44 Favored Pre-proline 0 N--CA 1.455 -0.22 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.281 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.08 163.56 16.46 Favored 'Trans proline' 0 N--CA 1.477 0.548 0 C-N-CA 123.423 2.749 . . . . 0.0 112.668 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 11' ' ' VAL . . . -86.4 -133.82 3.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.097 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.647 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 47.3 t -99.45 160.94 13.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 63.3 47.92 3.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.23 0.538 . . . . 0.0 110.243 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.771 ' HA ' HG12 ' A' ' 11' ' ' VAL . . . -72.89 130.53 40.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.65 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.78 179.97 2.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.04 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.32 136.81 44.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.823 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 11.9 m -138.54 175.38 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 C-N-CA 125.461 1.505 . . . . 0.0 109.262 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.62 -165.48 1.03 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.4 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -56.77 -47.55 79.87 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -175.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -59.04 5.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.708 0.766 . . . . 0.0 111.433 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 18.3 mt-10 -56.98 -27.97 61.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.397 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.756 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -57.36 -48.49 78.9 Favored 'General case' 0 C--O 1.198 -1.639 0 CA-C-N 114.254 -1.339 . . . . 0.0 114.207 177.532 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . -56.94 -72.34 0.08 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 119.201 0.91 . . . . 0.0 112.616 -162.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -57.21 -54.85 42.11 Favored 'General case' 0 C--O 1.281 2.722 0 CA-C-O 122.809 1.29 . . . . 0.0 112.61 -176.464 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.89 -50.89 71.14 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.883 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.78 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 24.3 tt0 -57.25 -31.13 65.24 Favored 'General case' 0 C--O 1.202 -1.426 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 96.1 mttt -57.08 -70.98 0.11 Allowed 'General case' 0 C--O 1.26 1.61 0 CA-C-O 121.8 0.81 . . . . 0.0 109.708 172.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 6.8 tpm_? -57.04 -53.22 60.57 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 123.179 1.466 . . . . 0.0 110.818 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.657 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . . . -57.18 -43.8 82.95 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.925 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.08 -37.33 71.73 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 118.487 0.585 . . . . 0.0 110.202 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 70' ' ' ARG . . . -56.82 -64.12 0.98 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.489 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.695 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 9.4 ttp180 -57.73 -46.49 84.37 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.754 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -55.14 -34.87 64.13 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.05 0.54 . . . . 0.0 111.852 -175.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.43 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.564 178.554 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.559 ' CE1' HG21 ' A' ' 58' ' ' VAL . 2.7 p-80 . . . . . 0 CA--C 1.516 -0.348 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.878 ' HB3' ' HA2' ' A' ' 33' ' ' GLY . . . -138.91 105.11 5.23 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.628 ' HA ' HG21 ' A' ' 28' ' ' VAL . 50.5 mttp -139.11 165.23 27.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.175 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.958 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.4 p -70.88 151.58 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.363 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.92 14.5 59.26 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 65.4 m-20 -138.65 -179.08 5.61 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.845 ' HB2' HG23 ' A' ' 59' ' ' VAL . 97.6 m-85 -137.45 173.21 11.91 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -174.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.805 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.8 tt -138.43 136.34 36.13 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.255 -166.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.499 HG22 ' CD2' ' A' ' 22' ' ' HIS . 59.9 t -139.03 143.52 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 125.917 2.011 . . . . 0.0 108.995 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 52' ' ' PRO . 70.6 t . . . . . 0 C--N 1.321 -0.638 0 CA-C-O 121.063 0.459 . . . . 0.0 110.757 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.568 ' HA ' ' CB ' ' A' ' 71' ' ' ALA . 32.3 m-20 . . . . . 0 C--O 1.22 -0.495 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.961 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 2.2 mp0 52.88 84.88 0.05 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.296 0.373 . . . . 0.0 110.973 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.805 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 6.7 t-80 -134.55 133.91 40.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.875 -174.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -178.42 178.02 0.9 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.341 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.719 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 42.3 tt0 -98.45 131.38 44.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.457 0.646 . . . . 0.0 111.759 -174.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 26.7 mt -86.75 108.91 18.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.338 177.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.958 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -109.51 -28.02 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.517 176.38 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.874 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 14.7 mt-10 -120.25 111.98 18.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' A' ' 4' ' ' LYS . 47.2 t -98.81 115.36 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.09 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -64.62 -52.48 57.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.199 0.523 . . . . 0.0 110.193 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 43.4 m -117.55 110.42 17.92 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.362 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.433 ' HA ' HG11 ' A' ' 28' ' ' VAL . . . -63.63 -18.64 64.15 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.376 -170.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.16 -38.85 91.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.354 0.597 . . . . 0.0 110.107 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.878 ' HA2' ' HB3' ' A' ' 3' ' ' ALA . . . 129.08 53.42 0.11 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.533 -175.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 9.8 m -134.18 142.03 41.61 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.532 0.206 . . . . 0.0 110.658 -176.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 12.8 Cg_exo -70.85 164.82 34.28 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.962 2.442 . . . . 0.0 111.898 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.549 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 73.1 Cg_endo -76.0 -179.59 27.56 Favored 'Cis proline' 0 C--N 1.347 0.463 0 C-N-CA 123.794 -1.336 . . . . 0.0 112.783 -0.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -131.04 142.72 50.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.216 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.874 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 58.3 t -98.62 103.4 14.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 170.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.09 138.85 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.81 -163.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.915 ' HG3' ' HB3' ' A' ' 47' ' ' GLU . 51.9 ttt180 -103.91 128.88 51.41 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.237 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.771 ' CE3' ' HB1' ' A' ' 72' ' ' ALA . 2.4 m0 -95.59 89.38 5.35 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.576 HD11 ' CD ' ' A' ' 24' ' ' GLU . 14.2 mt -70.48 -60.94 1.97 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.168 -165.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.554 HG13 ' CE1' ' A' ' 64' ' ' HIS . 3.1 m -77.76 -4.52 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.964 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.679 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 50.7 m-80 -93.84 -62.84 1.28 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.172 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.59 -80.09 0.1 Allowed Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.073 -1.06 . . . . 0.0 113.879 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 41' ' ' TRP . 20.7 m-70 -98.9 176.46 5.59 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.888 0.375 . . . . 0.0 111.903 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.915 ' HB3' ' HG3' ' A' ' 40' ' ' ARG . 13.7 pt-20 -120.03 152.06 38.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.387 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -167.06 178.35 5.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.526 0.679 . . . . 0.0 111.168 -176.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.0 m -98.84 118.58 35.92 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.016 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.61 146.08 27.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 111.29 -172.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 75.8 m-85 -109.41 101.37 45.49 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.289 171.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.482 ' HB2' HG21 ' A' ' 11' ' ' VAL . 72.2 Cg_endo -75.29 -10.87 20.92 Favored 'Trans proline' 0 N--CA 1.473 0.306 0 C-N-CA 122.962 2.441 . . . . 0.0 112.605 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.63 -102.52 2.88 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.677 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.9 m -153.31 171.11 19.08 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 62.2 41.06 11.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.309 0.576 . . . . 0.0 110.986 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.4 112.96 15.96 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.719 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.2 t -98.91 152.47 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.559 HG21 ' CE1' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -100.69 113.27 36.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.467 0.651 . . . . 0.0 111.867 -176.037 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.845 HG23 ' HB2' ' A' ' 8' ' ' TYR . 4.1 m -102.23 169.25 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.393 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.7 p -115.84 -163.73 0.91 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 -175.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -52.91 -46.89 68.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.23 -48.45 28.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.324 0.583 . . . . 0.0 110.866 -174.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.731 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 25.5 mt-10 -59.47 -16.6 25.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.038 176.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.742 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -75.9 -50.27 15.5 Favored 'General case' 0 C--O 1.205 -1.288 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.595 -177.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.36 -72.0 0.08 Allowed 'General case' 0 C--O 1.247 0.968 0 CA-C-O 121.779 0.799 . . . . 0.0 112.844 -163.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -66.16 -46.89 75.85 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.856 -172.304 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.42 -26.44 66.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.494 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.687 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 27.1 tt0 -73.62 -45.0 55.54 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.678 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 20.6 pttp -60.53 -47.86 84.33 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.438 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.497 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 10.9 ptp85 -68.06 -52.09 39.21 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.702 0.763 . . . . 0.0 111.669 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.568 ' CB ' ' HA ' ' A' ' 20' ' ' ASP . . . -77.98 -17.97 56.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.342 -169.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.771 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -80.48 -37.18 32.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.389 173.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.02 -32.64 61.99 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.739 -0.384 . . . . 0.0 109.979 171.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -81.88 -37.19 27.26 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.684 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.961 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -59.52 -48.48 81.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.555 -172.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.912 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.365 -177.149 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 . . . . . 0 CA--C 1.519 -0.244 0 CA-C-O 120.896 0.379 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.86 153.95 46.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.162 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.89 173.35 7.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.923 0.392 . . . . 0.0 110.496 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.733 HG23 ' HA ' ' A' ' 26' ' ' ILE . 1.7 p -73.76 136.47 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.933 175.271 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.99 8.33 60.47 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -175.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.452 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 68.4 m-20 -107.38 161.72 14.56 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 61' ' ' ALA . 1.2 m-85 -103.52 146.79 28.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.413 0.625 . . . . 0.0 111.764 -176.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' A' ' 52' ' ' PRO . 9.8 tt -99.47 132.75 44.59 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.604 175.866 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.71 HG13 ' CE1' ' A' ' 22' ' ' HIS . 54.2 t -127.98 147.42 32.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 O-C-N 124.638 1.211 . . . . 0.0 109.29 174.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 52' ' ' PRO . 53.7 t . . . . . 0 C--N 1.318 -0.773 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 171.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.745 ' N ' ' HB1' ' A' ' 71' ' ' ALA . 72.1 mt-30 58.83 94.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.206 0.602 . . . . 0.0 111.165 -177.726 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.71 ' CE1' HG13 ' A' ' 10' ' ' VAL . 3.4 m-70 -132.11 145.81 51.63 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.251 -0.281 . . . . 0.0 111.415 -173.498 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.695 ' HA ' ' HG3' ' A' ' 68' ' ' GLU . . . -179.04 176.09 0.92 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.118 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 41.4 tt0 -98.35 145.91 26.23 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.446 0.641 . . . . 0.0 111.201 -174.497 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.15 113.0 38.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 40' ' ' ARG . 0.2 OUTLIER -105.78 -15.5 8.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.894 0.378 . . . . 0.0 111.039 -178.622 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.966 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 37.7 mt-10 -132.15 103.59 6.34 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.658 0.742 . . . . 0.0 109.544 174.524 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.04 99.97 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.81 -176.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -104.56 53.57 0.73 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.603 0.716 . . . . 0.0 109.676 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.8 t -152.48 123.11 7.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.53 177.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.52 -26.27 20.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -89.88 -25.07 21.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.764 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.42 72.76 1.04 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.422 177.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 68.9 m -146.03 150.04 40.82 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.7 0.286 . . . . 0.0 110.886 178.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 19.5 Cg_exo -66.87 167.63 19.11 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.279 2.653 . . . . 0.0 112.062 177.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.99 154.66 94.11 Favored 'Cis proline' 0 C--N 1.345 0.366 0 C-N-CA 123.803 -1.332 . . . . 0.0 112.408 1.183 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -110.92 146.94 35.68 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.025 178.248 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.966 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 61.7 t -98.69 103.9 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.646 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 23' ' ' ALA . 53.2 t -116.19 121.51 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.013 -166.202 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.735 ' HB2' HD12 ' A' ' 26' ' ' ILE . 42.9 ttt180 -101.97 133.28 47.02 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.021 176.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.596 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 5.5 m0 -97.75 113.33 25.08 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.214 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' A' ' 24' ' ' GLU . 11.6 mt -75.52 -49.69 17.94 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.884 0.373 . . . . 0.0 111.617 -167.185 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.74 ' HB ' ' HE2' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -93.96 -15.59 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.271 -176.356 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.596 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 33.0 m-80 -84.26 -36.23 22.82 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.875 175.057 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.01 34.73 9.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.654 177.492 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.487 ' H ' ' HB2' ' A' ' 41' ' ' TRP . 6.9 m170 -123.59 166.81 14.83 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.522 -0.399 . . . . 0.0 110.438 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -141.21 116.33 9.93 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 p -136.23 170.46 15.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.267 0.556 . . . . 0.0 112.254 -167.267 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.3 m -118.32 100.04 7.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 166.04 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.0 m -99.58 156.6 3.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-O 121.685 0.755 . . . . 0.0 112.776 -167.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -119.68 99.91 49.32 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.973 168.388 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HB3' HD21 ' A' ' 9' ' ' LEU . 26.0 Cg_endo -63.7 -51.07 2.64 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.861 2.374 . . . . 0.0 112.868 -174.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.21 -117.02 1.55 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -175.212 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.3 m -129.64 154.13 47.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 62.65 58.05 1.69 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.931 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -86.66 119.44 26.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.205 0.526 . . . . 0.0 110.837 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 t -101.07 159.72 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.472 -178.578 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 4.1 p -121.14 118.77 57.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.358 0.599 . . . . 0.0 111.326 -178.538 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.598 HG23 ' CB ' ' A' ' 8' ' ' TYR . 2.4 m -116.64 -179.93 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 123.408 0.683 . . . . 0.0 111.411 -178.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -80.98 166.4 20.86 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.732 174.345 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.788 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . . . -68.86 -66.54 0.56 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.598 -169.58 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 p -80.73 -25.06 38.31 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -167.316 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -53.94 -58.94 5.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.612 0.72 . . . . 0.0 109.578 175.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.47 ' CE1' HG11 ' A' ' 59' ' ' VAL . 11.3 m-70 -82.44 -16.5 48.7 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.68 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 43' ' ' VAL . . . -45.39 -39.55 7.04 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.489 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -63.08 -44.39 95.88 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-O 123.564 1.65 . . . . 0.0 109.127 177.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.434 ' CB ' ' HD2' ' A' ' 22' ' ' HIS . . . -66.3 -16.59 64.16 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.418 173.246 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.695 ' HG3' ' HA ' ' A' ' 23' ' ' ALA . 10.3 tt0 -69.82 -40.09 76.12 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 171.214 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.74 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 66.7 mmtt -51.07 -61.65 2.1 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.123 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -62.26 1.89 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.744 1.259 . . . . 0.0 112.076 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.745 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -78.31 -16.96 57.21 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.197 -165.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.59 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -81.74 -34.54 30.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 118.645 0.657 . . . . 0.0 109.316 173.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.82 -36.14 64.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 170.301 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -74.7 -55.54 5.76 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.987 174.056 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -49.08 -56.94 7.53 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.743 0.817 . . . . 0.0 111.967 -176.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.511 ' HA3' ' HH2' ' A' ' 41' ' ' TRP . . . . . . . . 0 N--CA 1.444 -0.799 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.822 -176.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.901 0.381 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.86 140.81 38.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.338 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -139.12 164.24 30.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.959 0.409 . . . . 0.0 111.249 -177.37 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.819 HG23 ' HA ' ' A' ' 26' ' ' ILE . 4.0 p -65.15 145.43 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.939 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.06 17.28 41.08 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -174.429 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 7.6 m-20 -138.76 -179.06 5.6 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 113.902 -1.149 . . . . 0.0 108.415 -174.31 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.812 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 95.4 m-85 -137.02 164.93 27.2 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.314 -168.035 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 6.7 tt -138.63 142.2 39.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.769 -166.714 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.848 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 3.5 t -138.88 -179.99 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.276 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.785 ' H ' HG12 ' A' ' 10' ' ' VAL . 41.2 t . . . . . 0 C--N 1.312 -1.054 0 CA-C-O 121.648 0.737 . . . . 0.0 109.588 176.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 9.4 m-20 . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.848 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 13.6 mt-30 63.0 98.19 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.857 0.723 . . . . 0.0 110.197 -170.371 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.984 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 21.3 t-80 -139.05 121.43 16.04 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.354 0.597 . . . . 0.0 111.81 -175.816 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.654 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.77 -178.23 5.33 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 125.222 1.409 . . . . 0.0 110.239 -177.645 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.812 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 26.6 tt0 -136.75 123.58 21.28 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.478 1.133 . . . . 0.0 109.079 174.016 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.741 ' HB ' HG22 ' A' ' 28' ' ' VAL . 4.6 pt -82.69 115.42 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.96 -174.466 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.819 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -108.01 -8.41 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 113.808 -1.542 . . . . 0.0 108.477 170.435 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -138.9 122.22 17.09 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.447 175.437 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.741 HG22 ' HB ' ' A' ' 25' ' ' ILE . 20.8 t -138.49 119.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.877 -165.172 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 29' ' ' ARG . 5.0 mmp_? -68.87 -35.79 77.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -174.572 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.8 m -147.68 149.59 32.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.757 -176.617 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.45 -14.71 59.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.142 0.496 . . . . 0.0 110.694 -179.324 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.89 -72.75 0.37 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.256 0.55 . . . . 0.0 110.001 176.042 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.91 88.05 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.527 -177.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -143.47 125.1 8.33 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.36 161.0 38.37 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.729 2.286 . . . . 0.0 111.534 175.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.32 -175.07 15.75 Favored 'Cis proline' 0 C--N 1.342 0.234 0 C-N-CA 123.732 -1.362 . . . . 0.0 113.392 2.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -138.87 169.55 17.6 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.594 178.12 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 84.2 t -137.96 116.47 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.041 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.505 HG12 HG23 ' A' ' 48' ' ' THR . 0.4 OUTLIER -138.86 174.61 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 112.676 -2.056 . . . . 0.0 109.272 -152.558 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.842 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 62.9 mtt180 -138.67 133.56 32.51 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.034 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.733 ' HD1' ' HB2' ' A' ' 46' ' ' HIS . 16.1 m95 -79.53 84.6 5.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 166.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.593 HD11 ' CD ' ' A' ' 24' ' ' GLU . 6.5 mt -60.08 -64.21 1.03 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.2 0.524 . . . . 0.0 111.617 -167.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.706 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -60.03 -35.5 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.121 -176.623 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 41' ' ' TRP . 17.2 m120 -60.53 -60.67 3.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.797 171.211 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.07 39.68 0.68 Allowed Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.113 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.733 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 37.5 m80 -139.16 167.11 22.79 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.119 0.459 . . . . 0.0 111.134 178.475 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.842 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 6.7 pt-20 -138.86 128.79 25.11 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.487 173.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.569 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 8.9 t -139.74 -179.26 5.82 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.758 -163.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.9 m -138.25 116.83 12.13 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.545 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 51' ' ' TYR . 1.6 t -138.69 175.95 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.193 0.521 . . . . 0.0 111.304 -162.839 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.701 ' H ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -138.82 107.27 7.56 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.78 -178.758 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.71 141.33 90.33 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.736 2.291 . . . . 0.0 111.755 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.95 67.0 2.14 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.557 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t 67.22 173.12 0.26 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.944 0.438 . . . . 0.0 110.957 179.099 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 56.18 38.33 29.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.221 174.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.2 139.8 54.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.328 -176.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.881 HG22 ' H ' ' A' ' 58' ' ' VAL . 5.7 p -138.93 -179.7 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.832 177.507 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.881 ' H ' HG22 ' A' ' 57' ' ' VAL . 56.1 t -138.45 136.27 43.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.785 -171.504 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.764 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -138.87 179.92 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 C-N-CA 123.355 0.662 . . . . 0.0 111.284 -174.17 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.9 p -120.55 -172.31 2.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.349 -176.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.02 -48.44 78.48 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -172.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -55.75 30.74 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.565 -0.71 . . . . 0.0 111.437 -178.115 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -56.98 -29.86 63.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.87 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.706 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.22 -45.32 83.96 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.286 -179.446 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.554 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -56.85 -73.4 0.06 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.912 0.863 . . . . 0.0 111.534 -167.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.523 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -57.08 -61.71 2.27 Favored 'General case' 0 C--O 1.268 2.059 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.671 -177.272 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.15 -50.21 73.54 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.462 -175.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.984 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 29.6 tt0 -57.14 -37.89 72.68 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 118.0 0.364 . . . . 0.0 111.575 -177.311 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -56.93 -68.12 0.25 Allowed 'General case' 0 C--O 1.253 1.24 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.572 176.432 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -57.28 -58.23 9.16 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 122.776 1.274 . . . . 0.0 111.675 -177.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.604 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -57.32 -25.23 59.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.321 -178.616 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.46 -40.95 73.4 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 118.894 0.77 . . . . 0.0 109.827 175.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.51 62.68 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.019 172.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.41 ' HG2' ' HB3' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -74.21 -57.16 4.13 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 176.263 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -51.12 -44.61 61.35 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.556 0.946 . . . . 0.0 113.556 -169.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.218 0 C-N-CA 119.8 -1.191 . . . . 0.0 112.651 -174.044 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 . . . . . 0 CA--C 1.517 -0.293 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.91 139.66 38.11 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.387 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.719 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 91.6 mttt -139.35 140.77 37.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.239 -173.193 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.787 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -71.29 139.63 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 169.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.55 13.82 66.93 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -172.288 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.719 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 1.8 m-20 -139.11 143.81 38.43 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.109 -2.045 . . . . 0.0 107.655 -167.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.811 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 33.2 m-85 -135.63 142.6 45.24 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -148.481 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.757 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 2.3 tt -136.69 140.2 42.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 119.334 0.97 . . . . 0.0 110.244 -156.473 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.405 HG23 HG21 ' A' ' 59' ' ' VAL . 42.3 t -138.87 140.75 38.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.211 -168.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.568 HG22 ' HA ' ' A' ' 56' ' ' ALA . 72.0 t . . . . . 0 C--N 1.32 -0.712 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -176.585 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t0 . . . . . 0 C--O 1.222 -0.354 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.677 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 51.8 mt-30 39.7 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.699 0.8 . . . . 0.0 112.817 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.757 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 54.7 t60 -138.57 138.98 38.46 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 122.634 1.207 . . . . 0.0 113.397 -176.732 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.617 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -140.43 -177.87 5.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 112.19 -2.277 . . . . 0.0 110.926 -174.011 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.811 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 10.7 tt0 -136.69 122.17 19.52 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 123.007 1.384 . . . . 0.0 108.046 166.444 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 66.0 mt -81.52 107.69 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 111.652 -2.522 . . . . 0.0 110.242 -170.028 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.787 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -102.38 -14.12 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.629 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 48.9 mm-40 -139.02 150.36 45.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.577 174.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.473 HG22 ' CG2' ' A' ' 25' ' ' ILE . 17.7 t -137.83 100.11 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -170.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -89.23 -29.08 19.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.663 -163.617 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.9 p -68.94 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.495 -176.378 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -176.95 -64.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.285 0.564 . . . . 0.0 109.954 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -151.05 88.13 1.44 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.905 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.64 172.84 44.11 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.218 -173.054 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m 69.36 156.76 0.15 Allowed Pre-proline 0 N--CA 1.467 0.419 0 CA-C-O 120.953 0.406 . . . . 0.0 111.529 178.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -73.03 163.92 36.94 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.815 2.344 . . . . 0.0 112.331 178.083 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 18.9 Cg_endo -94.61 -178.01 7.35 Favored 'Cis proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.809 -1.329 . . . . 0.0 112.681 -1.412 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -138.83 174.27 10.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.059 177.399 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 89.6 t -138.03 114.54 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 174.282 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 25' ' ' ILE . 0.4 OUTLIER -139.02 175.25 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.818 -153.658 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.803 ' HB2' HD23 ' A' ' 42' ' ' LEU . 84.7 mtt180 -138.51 134.96 34.6 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.745 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 12.2 m95 -80.1 81.02 6.44 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 166.482 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.803 HD23 ' HB2' ' A' ' 40' ' ' ARG . 3.7 mt -59.92 -67.8 0.35 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.515 0.509 . . . . 0.0 111.932 -162.573 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.547 HG22 ' OE2' ' A' ' 68' ' ' GLU . 0.9 OUTLIER -59.96 -31.19 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.974 -175.716 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -60.59 -62.99 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.177 0.513 . . . . 0.0 110.591 169.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.05 43.16 0.34 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.811 -0.632 . . . . 0.0 113.576 177.569 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.745 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 44.6 t-80 -139.35 164.01 30.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 117.527 0.664 . . . . 0.0 111.069 178.262 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 42.0 tt0 -138.44 122.09 17.45 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.223 0.535 . . . . 0.0 110.023 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.479 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 14.8 t -139.68 -179.0 5.67 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -165.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.418 HG23 HG22 ' A' ' 38' ' ' VAL . 89.8 m -138.15 110.55 7.45 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.413 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.73 -179.74 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -160.401 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.558 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 2.3 m-85 -138.78 125.64 12.95 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.048 -178.389 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HB2' HG21 ' A' ' 11' ' ' VAL . 56.5 Cg_endo -74.37 -78.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.673 2.249 . . . . 0.0 113.234 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.41 -154.44 23.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.862 -178.124 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.7 m -87.62 159.1 18.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.569 0.184 . . . . 0.0 110.559 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 t70 65.91 39.85 4.4 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.94 0.876 . . . . 0.0 108.859 -174.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.568 ' HA ' HG22 ' A' ' 11' ' ' VAL . . . -79.9 137.74 36.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.126 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.711 HG12 ' H ' ' A' ' 58' ' ' VAL . 3.4 t -138.71 175.65 7.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -174.143 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.711 ' H ' HG12 ' A' ' 57' ' ' VAL . 58.9 t -138.34 138.33 43.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.613 0.72 . . . . 0.0 110.648 -175.283 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 3.1 m -138.62 179.99 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 C-N-CA 125.74 1.616 . . . . 0.0 110.023 -174.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 61' ' ' ALA . 5.9 t -121.85 -159.28 0.81 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.123 -174.572 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.427 ' N ' HG23 ' A' ' 60' ' ' THR . . . -56.99 -48.23 78.91 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.408 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.414 ' H ' HG23 ' A' ' 60' ' ' THR . 0.2 OUTLIER -57.35 -58.59 7.6 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 122.013 -0.429 . . . . 0.0 112.128 -179.697 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.667 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 29.5 mm-40 -57.15 -28.12 62.46 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.677 0.751 . . . . 0.0 110.307 -178.295 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.74 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.12 -42.52 81.04 Favored 'General case' 0 C--O 1.206 -1.233 0 CA-C-N 114.627 -1.17 . . . . 0.0 113.563 -176.707 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.2 -75.92 0.04 OUTLIER 'General case' 0 C--O 1.244 0.793 0 CA-C-O 122.331 1.062 . . . . 0.0 111.669 -170.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.584 ' HB2' ' NH1' ' A' ' 70' ' ' ARG . 1.2 pt-20 -57.24 -51.59 68.75 Favored 'General case' 0 C--O 1.265 1.915 0 CA-C-N 113.798 -1.547 . . . . 0.0 112.035 -177.347 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.11 -49.82 74.7 Favored 'General case' 0 C--O 1.2 -1.527 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.766 -178.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.74 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 4.4 tt0 -57.0 -35.73 69.57 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 118.019 0.372 . . . . 0.0 111.2 -176.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -57.13 -74.46 0.05 Allowed 'General case' 0 C--O 1.254 1.316 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.631 172.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.584 ' NH1' ' HB2' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -57.27 -60.87 2.98 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.908 1.337 . . . . 0.0 111.256 -173.978 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 22' ' ' HIS . . . -57.08 -51.15 70.43 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 112.928 -1.942 . . . . 0.0 113.869 -175.268 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -57.31 -36.15 70.74 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 118.463 0.574 . . . . 0.0 111.081 -179.013 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.87 -48.76 77.4 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.835 174.398 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -57.57 -65.97 0.54 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 175.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -50.29 -37.11 34.63 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.99 0.916 . . . . 0.0 113.378 -166.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.21 0 C-N-CA 118.896 -1.621 . . . . 0.0 113.535 -172.405 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.343 0.592 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.83 166.36 10.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.286 -178.559 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -134.79 173.87 11.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.869 176.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.762 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.3 p -80.97 143.68 11.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.039 0.447 . . . . 0.0 110.642 177.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.5 8.97 67.36 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -177.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -108.06 174.43 5.88 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.099 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.726 ' CD1' ' HA ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER -104.57 138.13 41.37 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.267 0.556 . . . . 0.0 110.658 179.132 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.2 tt -99.02 136.84 38.42 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.852 179.305 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.746 HG22 ' CD2' ' A' ' 22' ' ' HIS . 55.4 t -133.16 160.38 42.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.801 174.29 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 44.6 t . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 118.052 0.387 . . . . 0.0 110.575 174.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 t70 . . . . . 0 C--O 1.224 -0.279 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.8 mp0 47.36 93.6 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.616 0.572 . . . . 0.0 112.208 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.889 ' HB2' ' HA ' ' A' ' 68' ' ' GLU . 20.8 m170 -125.49 141.52 52.0 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.894 -176.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HA ' ' HG3' ' A' ' 68' ' ' GLU . . . -177.76 -179.85 0.83 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.833 0.708 . . . . 0.0 110.484 173.486 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.435 ' OE1' HD21 ' A' ' 42' ' ' LEU . 36.7 tt0 -98.77 131.61 44.77 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.287 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.529 ' HB ' HG22 ' A' ' 28' ' ' VAL . 3.8 pt -96.81 111.26 26.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.087 0.47 . . . . 0.0 110.839 178.848 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.762 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -104.2 -21.96 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.688 177.58 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 1.053 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 36.2 tt0 -123.45 99.96 6.58 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.403 0.62 . . . . 0.0 110.102 172.499 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.867 HG13 ' HE2' ' A' ' 37' ' ' TYR . 34.6 t -112.22 100.54 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.509 -178.082 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -95.14 11.83 30.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.135 0.493 . . . . 0.0 110.627 -176.556 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.1 t -136.62 126.03 25.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.601 -179.177 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.2 -20.74 25.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.586 -179.12 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.87 -29.0 22.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.288 179.274 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.585 ' HA2' ' OH ' ' A' ' 37' ' ' TYR . . . 104.4 73.19 0.91 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.764 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -142.98 128.24 10.04 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -177.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.742 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 21.3 Cg_endo -62.67 165.47 15.8 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.858 2.372 . . . . 0.0 112.231 177.223 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.19 156.61 83.19 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 124.011 -1.245 . . . . 0.0 113.248 3.546 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.867 ' HE2' HG13 ' A' ' 28' ' ' VAL . 34.3 m-85 -119.91 147.55 44.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.984 177.857 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.053 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 98.4 t -98.9 106.63 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.41 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -114.66 155.55 15.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.311 -163.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.739 ' HB2' HD12 ' A' ' 26' ' ' ILE . 23.9 ttt180 -128.86 115.76 18.38 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.048 -176.932 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.729 ' CB ' ' HB2' ' A' ' 44' ' ' ASN . 6.7 m95 -75.63 120.39 20.96 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.66 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.435 HD21 ' OE1' ' A' ' 24' ' ' GLU . 12.8 mt -88.42 -45.66 9.78 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.663 -176.191 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.654 HG21 ' O ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -90.75 -5.84 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.155 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.729 ' HB2' ' CB ' ' A' ' 41' ' ' TRP . 15.7 m120 -96.06 -40.36 9.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 168.662 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.09 63.58 1.44 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.764 172.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.526 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 54.9 t60 -172.42 154.3 3.16 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.921 0.361 . . . . 0.0 110.42 176.92 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.609 ' HG2' ' HG3' ' A' ' 40' ' ' ARG . 38.6 mt-10 -113.33 145.91 40.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.104 178.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -172.11 176.83 3.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.47 0.652 . . . . 0.0 111.084 178.099 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.1 m -108.52 115.1 29.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.942 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.92 172.59 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.277 0.56 . . . . 0.0 111.68 -176.01 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 68.8 m-85 -119.89 100.09 48.75 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.515 177.79 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.742 ' HD2' ' HB3' ' A' ' 35' ' ' PRO . 37.4 Cg_endo -66.08 -39.83 17.54 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.678 2.252 . . . . 0.0 112.486 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.94 -159.57 13.72 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.905 -178.488 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.526 ' O ' HG13 ' A' ' 11' ' ' VAL . 18.3 m -94.5 169.18 10.38 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.029 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 66.17 32.55 7.96 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.418 0.449 . . . . 0.0 110.765 178.74 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 11' ' ' VAL . . . -76.57 113.74 14.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.054 0.454 . . . . 0.0 111.008 -179.082 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 58' ' ' VAL . 13.9 t -99.21 162.33 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.742 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.402 ' N ' HG12 ' A' ' 57' ' ' VAL . 5.7 t -110.2 152.05 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.909 0.385 . . . . 0.0 111.235 -176.352 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.57 HG22 ' N ' ' A' ' 60' ' ' THR . 11.0 p -151.73 173.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.041 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.57 ' N ' HG22 ' A' ' 59' ' ' VAL . 47.8 p -90.2 169.39 11.18 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 175.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.726 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . . . -52.64 -64.55 0.78 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -172.179 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 p -75.18 -28.86 60.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -163.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -58.4 -62.6 1.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.103 0.478 . . . . 0.0 110.88 -176.58 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.505 ' HB2' HG11 ' A' ' 59' ' ' VAL . 3.2 m80 -81.95 -16.19 51.3 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.654 ' O ' HG21 ' A' ' 43' ' ' VAL . . . -43.36 -46.47 6.52 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -170.557 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -59.02 -48.69 80.69 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-O 123.37 1.557 . . . . 0.0 109.627 -179.167 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.426 ' C ' ' HD1' ' A' ' 22' ' ' HIS . . . -64.65 -16.9 63.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.668 173.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.889 ' HA ' ' HB2' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -73.2 -40.88 64.39 Favored 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.679 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -53.62 -50.63 65.28 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -64.27 -66.12 0.59 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 122.129 0.966 . . . . 0.0 112.784 178.245 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.423 ' HB3' ' ND1' ' A' ' 22' ' ' HIS . . . -70.67 -16.9 62.84 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -169.433 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.636 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -81.73 -33.78 30.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 173.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.75 -33.05 60.69 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.604 168.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 -76.74 -57.02 4.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.624 172.17 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -50.26 -51.52 44.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.846 0.859 . . . . 0.0 112.526 -176.658 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.201 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.959 -175.287 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' A' ' 58' ' ' VAL . . . -138.85 169.46 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.097 0.475 . . . . 0.0 112.062 -173.022 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 40.7 ttmt -139.3 166.13 25.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.412 -178.545 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.532 HG23 ' HA ' ' A' ' 26' ' ' ILE . 6.1 p -71.53 142.65 15.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 173.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.1 16.18 45.31 Favored Glycine 0 N--CA 1.454 -0.147 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -173.387 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 64.7 m-20 -138.77 -178.88 5.51 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 113.971 -1.114 . . . . 0.0 108.205 -174.125 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.737 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 87.3 m-85 -136.83 170.13 16.6 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.932 -169.472 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.736 HD11 ' HG3' ' A' ' 52' ' ' PRO . 8.0 tt -138.75 144.94 39.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.61 -166.596 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.907 ' HB ' ' HB ' ' A' ' 57' ' ' VAL . 87.2 t -138.87 172.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.718 HG13 ' HB2' ' A' ' 54' ' ' SER . 13.5 t . . . . . 0 C--N 1.314 -0.948 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.013 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 119.32 -0.371 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.618 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 86.8 mt-30 43.72 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.767 0.827 . . . . 0.0 112.511 -173.538 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.986 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 2.1 t-80 -138.78 129.1 25.72 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.54 0.686 . . . . 0.0 111.424 -169.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.772 ' HB2' ' HZ3' ' A' ' 41' ' ' TRP . . . -139.59 -178.29 5.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.968 -176.462 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.737 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 24.2 tt0 -136.76 125.93 24.62 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.629 1.204 . . . . 0.0 109.264 173.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.61 HG22 HG22 ' A' ' 28' ' ' VAL . 4.3 mt -82.67 107.48 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 112.557 -2.11 . . . . 0.0 109.815 -170.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.91 HG12 ' HD3' ' A' ' 40' ' ' ARG . 1.8 pp -106.82 -12.68 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.274 175.295 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 1.079 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -138.88 136.61 35.71 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.614 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 25' ' ' ILE . 11.2 t -138.36 107.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 -165.732 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.608 ' CZ ' ' HA ' ' A' ' 29' ' ' ARG . 2.7 mmp_? -71.26 -19.14 62.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.779 0.324 . . . . 0.0 111.756 -176.773 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 60.5 m -152.3 115.46 4.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.622 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.05 13.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.831 -174.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -93.5 -11.84 31.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.172 0.511 . . . . 0.0 110.279 176.534 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.18 71.37 0.99 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.171 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.474 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 17.0 m -136.47 125.86 15.72 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 15.8 Cg_exo -68.7 153.53 73.06 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.974 2.449 . . . . 0.0 112.145 178.799 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.564 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 6.2 Cg_exo -80.29 -169.81 8.05 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 124.129 -1.196 . . . . 0.0 113.086 2.344 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -138.42 172.8 12.35 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.994 178.302 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.079 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 48.5 t -137.84 116.8 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.077 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.91 176.57 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.964 -149.557 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 1.041 ' HG2' ' HG2' ' A' ' 47' ' ' GLU . 12.4 mtp180 -138.82 138.18 37.3 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.214 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.772 ' HZ3' ' HB2' ' A' ' 23' ' ' ALA . 11.8 m95 -86.27 82.5 7.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 168.843 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 24' ' ' GLU . 5.4 mt -59.89 -69.65 0.2 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.114 0.483 . . . . 0.0 111.985 -166.363 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.727 HG11 ' HA ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -60.2 -34.09 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.089 -175.704 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -60.43 -45.68 92.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.287 172.543 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.7 39.75 1.99 Allowed Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.851 179.184 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.485 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 63.7 m80 -139.23 172.92 12.12 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.324 -0.515 . . . . 0.0 111.893 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 1.041 ' HG2' ' HG2' ' A' ' 40' ' ' ARG . 45.0 mt-10 -138.58 128.26 24.93 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.35 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.34 179.93 6.25 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.129 0.966 . . . . 0.0 113.599 -160.724 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 75.6 m -138.78 125.3 20.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 167.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 51' ' ' TYR . 8.0 p -138.87 165.21 24.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.415 -162.563 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.564 ' CD2' ' HB3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -138.72 99.86 8.35 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.254 178.187 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.736 ' HG3' HD11 ' A' ' 9' ' ' LEU . 55.3 Cg_endo -70.67 114.16 3.76 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.758 2.305 . . . . 0.0 111.632 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.08 81.98 1.14 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.419 178.794 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.718 ' HB2' HG13 ' A' ' 11' ' ' VAL . 43.7 t 177.79 -179.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.034 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -71.72 -15.08 62.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.218 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 80.92 162.07 0.16 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.564 172.615 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.907 ' HB ' ' HB ' ' A' ' 10' ' ' VAL . 21.6 t -138.95 170.16 16.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.094 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 38.5 t -138.47 128.02 32.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.264 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.94 176.77 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.853 -174.331 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 p -120.08 -166.68 1.33 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.345 -176.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.0 79.36 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.457 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.39 -55.86 29.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.396 0.544 . . . . 0.0 111.813 -175.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.473 ' HG3' HG12 ' A' ' 59' ' ' VAL . 1.6 mm-40 -56.81 -31.39 64.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.635 -176.392 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.707 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.38 -40.8 78.94 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.766 -176.467 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.727 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -57.53 -77.08 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.052 0.93 . . . . 0.0 111.294 -170.645 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -57.66 -60.33 3.84 Favored 'General case' 0 C--O 1.267 1.998 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.173 -178.749 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -56.92 -56.44 21.64 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.853 -174.425 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.986 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 35.6 tt0 -57.27 -34.35 68.56 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -175.525 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 29.8 mtpp -57.1 -65.9 0.54 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.459 175.756 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -57.35 -53.79 54.13 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-O 123.544 1.64 . . . . 0.0 111.049 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.587 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -57.21 -45.47 83.78 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 112.627 -2.079 . . . . 0.0 113.105 -173.589 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -68.43 -33.31 73.99 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.806 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.87 -37.3 63.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 123.483 0.489 . . . . 0.0 110.22 174.027 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.8 mtp-105 -81.6 -47.0 13.6 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 173.406 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -48.25 -51.61 24.84 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.237 0.615 . . . . 0.0 111.633 -177.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.125 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.943 179.74 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -127.9 128.79 45.77 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.0 161.94 13.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.074 0.464 . . . . 0.0 111.672 -173.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 4' ' ' LYS . 39.8 ttmt -148.41 147.36 29.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.335 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.447 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.7 p -86.47 142.01 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.957 0.408 . . . . 0.0 110.41 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.82 4.74 65.05 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -121.2 171.39 8.74 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.929 ' HB2' HG23 ' A' ' 59' ' ' VAL . 98.9 m-85 -109.81 146.35 35.17 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.398 0.618 . . . . 0.0 111.508 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.679 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.4 tt -99.14 140.11 33.78 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.828 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.572 HG22 ' CE1' ' A' ' 22' ' ' HIS . 55.6 t -130.81 151.54 36.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 O-C-N 124.839 1.337 . . . . 0.0 109.441 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.875 HG12 ' HG3' ' A' ' 12' ' ' LYS . 74.6 t -134.23 151.32 32.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.875 ' HG3' HG12 ' A' ' 11' ' ' VAL . 8.9 mtpm? 78.53 138.38 0.07 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.599 0.714 . . . . 0.0 112.73 174.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.91 57.37 4.89 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 114.864 -1.062 . . . . 0.0 114.606 168.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.631 HG23 ' HB3' ' A' ' 55' ' ' ASP . 19.2 p -69.57 -17.22 63.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.498 0.649 . . . . 0.0 111.025 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -67.14 -15.07 63.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.112 0.482 . . . . 0.0 110.235 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.3 m 75.61 84.57 0.09 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.117 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.53 -60.13 0.15 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -123.41 105.89 10.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.141 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -103.11 112.99 26.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.025 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.546 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 16.3 m-20 -109.44 -166.06 1.07 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.231 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.845 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 58.6 mt-30 40.33 85.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.641 1.213 . . . . 0.0 112.347 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.735 ' CB ' ' HA ' ' A' ' 68' ' ' GLU . 7.2 m80 -118.49 146.58 44.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.249 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -176.7 177.98 1.3 Allowed 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.103 0.877 . . . . 0.0 110.857 170.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.617 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 43.4 tt0 -98.58 127.47 44.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.273 0.558 . . . . 0.0 110.742 177.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 9' ' ' LEU . 20.4 mt -88.48 103.04 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.177 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.663 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -105.76 -19.78 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.249 178.022 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.862 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 68.8 mm-40 -134.08 111.0 10.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.764 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 30' ' ' SER . 38.6 t -98.89 116.16 41.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.922 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -88.83 32.3 0.81 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.008 0.433 . . . . 0.0 110.861 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.508 ' H ' HG12 ' A' ' 28' ' ' VAL . 34.2 t -148.94 149.21 30.82 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.52 -14.6 45.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.052 0.453 . . . . 0.0 110.219 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -130.53 -70.84 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.472 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.39 75.93 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.611 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 33.3 p -146.67 132.87 9.58 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 37.3 Cg_exo -61.85 160.31 29.77 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.889 2.393 . . . . 0.0 112.098 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.52 179.26 22.23 Favored 'Cis proline' 0 N--CA 1.462 -0.34 0 C-N-CA 123.406 -1.498 . . . . 0.0 113.132 1.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -132.77 153.46 51.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.601 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.862 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 67.3 t -98.56 117.18 43.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 172.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.52 147.63 30.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.001 -164.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.788 ' HG2' ' HG3' ' A' ' 47' ' ' GLU . 98.7 mtt180 -115.4 131.88 56.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.633 176.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.7 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 13.8 m95 -85.38 101.3 12.47 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 168.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.712 ' HB2' ' HE1' ' A' ' 64' ' ' HIS . 12.7 mt -82.29 -55.55 4.45 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.432 0.634 . . . . 0.0 110.605 -173.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.617 HG11 ' HA ' ' A' ' 65' ' ' ALA . 2.0 m -76.14 -5.7 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.581 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.7 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 45.9 m-80 -100.01 -64.22 1.06 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.756 173.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . 122.02 68.42 0.25 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.532 -0.842 . . . . 0.0 114.181 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.546 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 30.3 t60 -179.18 156.92 0.79 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.217 0.509 . . . . 0.0 110.819 172.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.788 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 25.4 mp0 -110.58 150.38 29.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 t -175.18 -179.95 1.43 Allowed 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.442 0.639 . . . . 0.0 111.806 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.4 m -119.98 124.06 45.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.177 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.435 HG12 HG22 ' A' ' 80' ' ' THR . 29.6 m -127.32 160.46 36.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.329 0.585 . . . . 0.0 112.545 -172.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -111.6 106.19 56.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.558 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.59 -178.6 3.49 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.7 2.267 . . . . 0.0 111.174 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.402 ' H ' HG21 ' A' ' 11' ' ' VAL . . . -124.37 -155.17 9.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.843 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 11' ' ' VAL . 43.3 t -70.95 157.11 38.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.649 0.261 . . . . 0.0 110.963 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.631 ' HB3' HG23 ' A' ' 14' ' ' THR . 3.7 m-20 66.33 39.38 4.07 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.007 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -76.88 129.11 35.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.036 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 58' ' ' VAL . 11.2 t -126.38 163.82 27.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.555 -176.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.406 ' N ' HG12 ' A' ' 57' ' ' VAL . 53.9 t -115.27 119.62 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.526 0.203 . . . . 0.0 110.737 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.929 HG23 ' HB2' ' A' ' 8' ' ' TYR . 2.3 m -113.42 178.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.211 0.529 . . . . 0.0 111.94 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.6 p -119.31 -169.78 1.81 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.239 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -47.33 -49.6 23.81 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -171.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.24 -38.97 75.3 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 121.718 -0.614 . . . . 0.0 111.581 -172.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 2.8 mm-40 -67.7 -16.81 64.33 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.093 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.712 ' HE1' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -82.04 -41.96 19.93 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.722 -177.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.617 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -56.86 -73.77 0.06 Allowed 'General case' 0 C--O 1.243 0.74 0 CA-C-N 119.996 1.271 . . . . 0.0 111.639 -166.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -66.5 -49.67 65.81 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.547 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -67.55 -31.6 71.81 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.955 -173.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.735 ' HA ' ' CB ' ' A' ' 22' ' ' HIS . 32.2 tt0 -76.09 -33.45 59.5 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 118.299 0.499 . . . . 0.0 110.626 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 99.6 mttt -54.1 -62.09 1.88 Allowed 'General case' 0 C--O 1.247 0.958 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.044 172.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -65.8 -45.19 83.34 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.739 0.78 . . . . 0.0 111.387 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.64 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -78.75 -16.39 57.25 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.437 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -77.46 -36.38 52.96 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.9 -29.31 66.95 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.022 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -74.66 -58.85 3.03 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.641 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.719 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -59.9 -64.83 0.81 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.838 0.855 . . . . 0.0 112.371 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.41 29.27 4.03 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.847 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.86 -24.28 30.95 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.08 -175.58 5.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.357 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 65.75 11.46 7.59 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.387 0.429 . . . . 0.0 111.877 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.435 HG22 HG12 ' A' ' 50' ' ' VAL . 24.5 p . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.902 -0.571 . . . . 0.0 110.071 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.514 ' HG2' ' N ' ' A' ' 2' ' ' HIS . 23.8 ttt . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.955 0.407 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.514 ' N ' ' HG2' ' A' ' 1' ' ' MET . 11.5 m-70 -138.81 140.54 38.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.29 140.14 39.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.769 0.795 . . . . 0.0 112.012 -165.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -139.06 140.82 38.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.708 -173.273 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.928 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.6 p -65.54 149.09 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 O-C-N 122.051 -0.406 . . . . 0.0 110.931 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.13 16.76 78.07 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-O 122.57 1.094 . . . . 0.0 110.449 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 1.4 t70 -139.09 144.12 38.6 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 112.572 -1.814 . . . . 0.0 107.678 -166.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.858 ' CD1' ' HB2' ' A' ' 24' ' ' GLU . 6.7 m-85 -135.79 142.46 44.9 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 -142.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.747 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 3.2 tt -136.53 139.94 42.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.132 0.968 . . . . 0.0 109.799 -153.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.738 ' N ' HD23 ' A' ' 9' ' ' LEU . 2.3 t -138.84 141.62 36.32 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 112.707 -2.042 . . . . 0.0 109.057 -165.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 54' ' ' SER . 4.0 p -137.57 139.78 42.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 C-N-CA 117.645 -1.622 . . . . 0.0 109.389 174.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 12' ' ' LYS . 43.4 mtpt -97.27 115.54 27.82 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.045 -168.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.02 101.73 1.26 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 167.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -68.85 4.88 1.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.902 0.382 . . . . 0.0 111.541 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -61.66 2.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.224 0.535 . . . . 0.0 109.67 173.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.742 ' HB ' ' HG2' ' A' ' 18' ' ' ARG . 3.7 m -101.27 -2.15 31.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.199 177.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 69.27 25.39 5.64 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.529 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.742 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 4.2 ptm180 -104.07 178.63 4.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.189 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -99.62 115.34 29.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.31 0.576 . . . . 0.0 110.756 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.806 ' HA ' ' HB1' ' A' ' 71' ' ' ALA . 11.3 m-20 -122.31 93.82 4.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.828 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.821 ' H ' ' HB1' ' A' ' 71' ' ' ALA . 51.3 tt0 149.61 128.16 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.292 1.437 . . . . 0.0 108.667 169.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.823 ' NE2' ' HB3' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -138.68 136.69 36.11 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 117.074 -1.85 . . . . 0.0 111.013 153.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.689 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -142.08 144.06 33.38 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 111.29 -2.686 . . . . 0.0 109.38 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.858 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -134.99 138.61 44.16 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 124.698 2.19 . . . . 0.0 110.888 -177.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.527 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 19.9 mt -98.81 117.96 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 1 CA-C-N 108.363 -4.017 . . . . 0.0 111.203 -148.198 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.928 ' HA ' HG23 ' A' ' 5' ' ' VAL . 2.2 pp -114.56 -8.33 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 125.139 1.524 . . . . 0.0 110.166 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -138.8 132.22 30.27 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.433 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.9 t -138.06 101.33 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.535 -167.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -110.36 55.03 0.65 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.317 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -133.41 113.06 12.11 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.466 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.15 -42.4 17.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.343 0.592 . . . . 0.0 110.171 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -89.33 -7.78 54.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.056 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 1' ' ' MET . . . 85.81 18.15 60.33 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.355 -174.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 5.0 p -90.29 151.84 45.05 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 120.597 0.237 . . . . 0.0 111.173 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 26.9 Cg_exo -63.48 164.8 19.51 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.851 2.367 . . . . 0.0 111.701 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.685 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.7 Cg_endo -79.5 -173.27 12.47 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.585 -1.423 . . . . 0.0 113.685 1.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 49' ' ' THR . 53.0 m-85 -138.75 171.86 13.72 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.431 HG22 HG23 ' A' ' 49' ' ' THR . 83.9 t -137.7 116.21 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 CA-C-O 123.495 1.617 . . . . 0.0 107.257 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.689 HG11 ' HB1' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -139.25 177.78 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 CA-C-N 111.845 -2.434 . . . . 0.0 109.106 -151.538 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.884 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 15.6 mtm180 -138.32 145.61 41.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.639 ' CE3' ' HB1' ' A' ' 72' ' ' ALA . 11.4 m0 -101.37 84.78 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.685 HD11 ' HB3' ' A' ' 24' ' ' GLU . 3.4 mt -59.95 -68.04 0.33 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 112.483 -2.144 . . . . 0.0 112.772 -154.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.437 HG13 ' CE1' ' A' ' 64' ' ' HIS . 0.5 OUTLIER -60.14 -32.5 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.163 -176.268 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -60.39 -64.08 1.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.113 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.13 51.19 0.27 Allowed Glycine 0 CA--C 1.523 0.546 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.512 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -139.18 170.95 15.02 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 117.53 0.665 . . . . 0.0 111.379 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.884 ' HG3' ' HD2' ' A' ' 40' ' ' ARG . 23.7 mp0 -138.26 106.98 5.9 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.9 t -139.74 -178.98 5.66 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -165.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.431 HG23 HG22 ' A' ' 38' ' ' VAL . 92.6 m -137.95 117.35 12.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.55 HG11 ' HZ2' ' A' ' 41' ' ' TRP . 15.3 m -138.84 177.87 4.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -161.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.685 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 5.2 m-85 -138.88 141.32 29.97 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.121 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.71 -48.42 0.11 Allowed 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.21 -63.77 0.27 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.846 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.484 ' HB2' HG22 ' A' ' 11' ' ' VAL . 27.4 m -79.3 -167.94 1.35 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.707 0.289 . . . . 0.0 111.417 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.87 -1.86 3.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.799 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 73.41 158.62 0.21 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.057 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 58' ' ' VAL . 17.2 t -138.9 163.39 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 175.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.434 ' H ' HG12 ' A' ' 57' ' ' VAL . 45.4 t -138.1 120.53 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.689 0.757 . . . . 0.0 109.294 -169.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.594 HG21 HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -139.2 -179.91 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.311 -165.611 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 p -124.46 -163.43 1.16 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.145 -175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.11 -47.7 80.44 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -58.82 6.62 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.295 -0.878 . . . . 0.0 112.012 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.585 ' HG3' HG12 ' A' ' 59' ' ' VAL . 6.8 mm-40 -57.21 -25.27 58.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.962 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.787 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.26 -46.93 82.58 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.22 -178.406 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.93 -73.3 0.07 Allowed 'General case' 0 C--O 1.245 0.838 0 CA-C-O 121.97 0.89 . . . . 0.0 112.251 -165.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -55.86 29.22 Favored 'General case' 0 C--O 1.255 1.392 0 CA-C-N 114.076 -1.42 . . . . 0.0 112.141 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.17 -41.98 80.26 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.464 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.787 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 4.1 tt0 -57.06 -52.18 66.3 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -56.95 -77.48 0.03 OUTLIER 'General case' 0 C--O 1.248 1.011 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.382 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -58.08 -68.32 0.26 Allowed 'General case' 0 C--O 1.255 1.394 0 CA-C-O 123.272 1.51 . . . . 0.0 112.377 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.821 ' HB1' ' H ' ' A' ' 21' ' ' GLN . . . -57.46 -47.4 81.95 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.199 -1.818 . . . . 0.0 113.313 -173.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -57.65 -36.89 72.46 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 119.483 1.038 . . . . 0.0 111.123 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.42 -39.31 72.85 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 119.471 -0.891 . . . . 0.0 109.113 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 71' ' ' ALA . 19.1 mtp180 -57.76 -56.91 15.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.408 167.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.503 ' HB2' ' CB ' ' A' ' 21' ' ' GLN . . . -41.98 -48.76 4.61 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.827 0.851 . . . . 0.0 112.603 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.33 35.03 4.86 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.982 -173.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -66.46 -24.76 66.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.99 0.424 . . . . 0.0 110.617 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.23 14.96 17.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.616 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -125.1 98.88 5.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.018 0.437 . . . . 0.0 110.829 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.196 178.555 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.481 ' SD ' ' HA3' ' A' ' 33' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -138.92 122.67 17.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.945 0.403 . . . . 0.0 110.531 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.95 142.53 38.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.569 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 26.3 pttm -139.07 161.32 37.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.157 0.503 . . . . 0.0 111.054 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.683 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.9 p -73.03 151.7 7.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.718 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.45 17.4 62.34 Favored Glycine 0 CA--C 1.511 -0.193 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 1.2 m-20 -138.62 -179.09 5.61 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 113.627 -1.286 . . . . 0.0 107.658 -174.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.812 ' HB2' HG23 ' A' ' 59' ' ' VAL . 83.2 m-85 -137.28 168.6 19.3 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -170.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.9 tt -138.5 138.8 38.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.454 -168.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.848 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 12.4 t -138.81 169.09 18.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.513 ' H ' HG12 ' A' ' 10' ' ' VAL . 89.7 t -138.38 141.85 36.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -66.56 -68.91 0.34 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.066 -176.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.91 -53.28 2.94 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.831 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 18' ' ' ARG . 5.9 m -114.47 136.05 53.44 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.2 m -61.4 -22.79 65.3 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -174.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.0 t -77.31 -170.58 1.78 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -76.41 32.37 0.13 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -175.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.426 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 25.0 ttm180 -96.27 134.37 39.46 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.66 ' HB3' HG11 ' A' ' 10' ' ' VAL . 95.8 m-70 -139.6 119.03 12.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.009 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -125.19 -179.31 4.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.027 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.955 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 56.2 mt-30 64.61 96.87 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.394 0 O-C-N 123.518 0.511 . . . . 0.0 110.395 -171.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.899 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.2 t-80 -138.99 121.71 16.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.53 0.681 . . . . 0.0 111.854 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -139.77 -178.33 5.37 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.749 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.737 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 15.0 tt0 -136.67 132.29 34.75 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.705 1.24 . . . . 0.0 109.679 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.589 HG21 HG22 ' A' ' 28' ' ' VAL . 59.8 mt -90.22 114.77 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 112.39 -2.186 . . . . 0.0 111.267 -167.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.749 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -106.79 -16.23 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.571 170.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.694 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 32.2 mt-10 -139.11 153.08 47.96 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.03 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.589 HG22 HG21 ' A' ' 25' ' ' ILE . 18.5 t -137.76 99.93 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -170.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -98.46 33.1 2.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -164.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 p -122.79 -90.86 0.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.702 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 176.0 -66.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.491 0.495 . . . . 0.0 109.919 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -92.75 -58.81 2.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.925 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.481 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 173.88 80.58 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.769 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.486 ' HB3' ' HD2' ' A' ' 35' ' ' PRO . 59.2 m -155.28 165.38 18.43 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 34' ' ' SER . 36.2 Cg_endo -66.85 155.7 69.46 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 121.937 1.758 . . . . 0.0 111.678 173.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.663 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 95.6 Cg_endo -87.91 -177.24 12.65 Favored 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.244 -1.565 . . . . 0.0 113.008 0.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -138.74 174.6 10.36 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.396 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 81.5 t -137.86 115.12 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.405 HG12 ' CG2' ' A' ' 48' ' ' THR . 0.4 OUTLIER -138.91 170.38 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.087 0 CA-C-N 112.556 -2.111 . . . . 0.0 109.091 -152.598 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 46' ' ' HIS . 25.9 ttm180 -138.73 132.03 30.12 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.686 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 9.8 m95 -78.47 83.76 4.66 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 169.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.647 HD21 ' HB3' ' A' ' 24' ' ' GLU . 5.7 mt -60.37 -66.2 0.56 Allowed 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 123.584 0.553 . . . . 0.0 111.261 -167.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.618 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.5 OUTLIER -60.19 -35.68 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.821 -176.402 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -60.4 -66.37 0.54 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.929 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 130.6 29.76 0.62 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.687 -0.768 . . . . 0.0 114.613 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.686 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 4.9 t-80 -139.29 168.85 18.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.386 1.093 . . . . 0.0 110.787 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.51 126.16 22.12 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.142 0.496 . . . . 0.0 110.05 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.516 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 13.2 t -139.46 -178.97 5.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.107 0.956 . . . . 0.0 113.285 -162.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.3 m -137.93 115.52 11.29 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 m -138.77 175.77 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -161.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.663 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 26.6 m-85 -132.58 108.46 13.23 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.336 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.63 5.56 5.49 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.863 2.375 . . . . 0.0 112.564 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.62 -92.45 1.32 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.869 -177.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.2 t -170.19 178.26 3.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.7 t70 59.57 44.22 14.91 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.091 0.948 . . . . 0.0 109.716 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.9 128.19 35.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.964 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.2 m -105.11 143.3 16.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.647 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.74 118.2 46.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.052 0.453 . . . . 0.0 110.998 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.812 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -105.22 -179.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.735 -178.104 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.4 p -122.72 -164.52 1.2 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.87 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.58 -43.3 99.17 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -172.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -51.64 64.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.728 -0.607 . . . . 0.0 111.884 -174.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.582 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 32.0 mm-40 -62.91 -17.17 61.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.114 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.637 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -69.81 -34.22 73.41 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.454 -176.152 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.46 -76.43 0.06 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 122.109 0.956 . . . . 0.0 110.858 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 1.0 OUTLIER -63.18 -55.8 22.08 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.214 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -64.91 -34.5 78.55 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.909 -173.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.899 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 32.9 tt0 -72.72 -34.56 67.18 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 119.554 -0.859 . . . . 0.0 110.717 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -52.93 -65.58 0.53 Allowed 'General case' 0 C--O 1.25 1.087 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.606 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 14.8 ptm180 -61.69 -47.77 83.82 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.943 0.878 . . . . 0.0 111.506 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.663 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -77.02 -17.14 59.02 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.2 -170.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.67 -41.02 55.07 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.317 172.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.59 -31.45 64.27 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.334 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 74' ' ' ARG . 2.4 mmt85 -80.33 -51.81 8.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.264 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.955 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -57.98 -65.97 0.55 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.161 0.505 . . . . 0.0 112.058 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.03 57.71 2.12 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.872 -1.156 . . . . 0.0 111.94 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -86.23 0.46 53.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.482 0.658 . . . . 0.0 109.661 175.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.65 -64.9 1.25 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.195 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -101.38 101.42 12.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.763 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.8 m . . . . . 0 C--O 1.254 1.314 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.865 -175.457 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ttt . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.748 0.309 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -139.18 147.69 42.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.5 ' HA ' HG21 ' A' ' 58' ' ' VAL . . . -138.94 152.17 47.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.733 0.302 . . . . 0.0 111.478 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -139.1 172.78 12.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.221 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.746 HG23 ' HA ' ' A' ' 26' ' ' ILE . 4.1 p -93.08 144.89 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.401 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.27 17.38 59.09 Favored Glycine 0 CA--C 1.51 -0.257 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -138.74 -179.1 5.62 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.75 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 91.7 m-85 -137.11 172.75 12.53 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.093 -168.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.774 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 8.0 tt -138.56 142.78 39.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.844 -169.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.817 HG11 ' HB2' ' A' ' 19' ' ' HIS . 4.9 t -138.85 155.19 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 124.878 1.361 . . . . 0.0 109.356 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.713 HG21 ' H ' ' A' ' 53' ' ' GLY . 92.9 t -138.72 134.82 43.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -90.5 143.64 26.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.976 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.16 123.89 7.34 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 p -61.88 -20.01 63.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -174.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 p -112.64 -2.03 14.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.812 0.339 . . . . 0.0 111.674 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 p -132.75 112.41 11.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.591 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -75.23 74.67 2.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.002 0.906 . . . . 0.0 110.994 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.409 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -146.5 151.89 38.1 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.788 178.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.817 ' HB2' HG11 ' A' ' 10' ' ' VAL . 31.2 p-80 -101.42 93.09 5.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.984 0.897 . . . . 0.0 109.396 173.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 18' ' ' ARG . 4.7 m-20 -94.68 -172.96 2.88 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.26 -175.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.791 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 51.8 mt-30 53.48 90.6 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.165 0 O-C-N 124.159 0.912 . . . . 0.0 111.466 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.921 ' H ' ' HB2' ' A' ' 71' ' ' ALA . 10.9 t60 -138.85 125.78 21.1 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 122.461 1.124 . . . . 0.0 113.227 -171.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.34 -178.56 5.43 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.701 -1.591 . . . . 0.0 109.017 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.75 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 14.4 tt0 -137.26 123.6 20.66 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.461 ' CG2' HG22 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -88.16 113.9 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.935 -168.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.746 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.3 pp -110.18 -7.75 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.951 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 1.145 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -138.91 127.74 23.54 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.461 HG22 ' CG2' ' A' ' 25' ' ' ILE . 32.3 t -138.28 110.98 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.6 -167.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 21.6 mmt85 -66.58 -46.0 77.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.072 0.463 . . . . 0.0 111.875 -173.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.0 m -154.34 144.41 21.92 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.494 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.49 0.37 29.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.555 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -71.29 -26.17 62.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.91 -10.75 29.64 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.399 173.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.4 m -69.11 130.54 91.22 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 117.542 0.671 . . . . 0.0 111.139 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.443 ' CB ' ' HA ' ' A' ' 36' ' ' PRO . 29.4 Cg_exo -62.94 173.14 4.08 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.005 2.47 . . . . 0.0 111.451 174.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.593 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 95.0 Cg_endo -76.98 -170.75 9.01 Favored 'Cis proline' 0 CA--C 1.52 -0.218 0 C-N-CA 123.877 -1.301 . . . . 0.0 113.371 2.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -138.38 168.92 18.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.466 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.145 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 68.0 t -137.78 107.2 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 25' ' ' ILE . 0.3 OUTLIER -138.92 177.53 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 112.833 -1.985 . . . . 0.0 109.972 -151.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.732 ' HB2' HD23 ' A' ' 42' ' ' LEU . 86.1 mtm180 -138.74 133.8 32.68 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.498 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.63 ' HE1' HG21 ' A' ' 48' ' ' THR . 16.1 m95 -87.01 60.13 6.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 163.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -60.3 -52.66 64.32 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -158.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.515 HG22 ' OE2' ' A' ' 68' ' ' GLU . 0.5 OUTLIER -60.39 -33.76 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 118.555 0.616 . . . . 0.0 111.639 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -60.44 -42.94 97.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.384 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 130.68 6.6 3.66 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.549 -0.834 . . . . 0.0 114.58 172.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.92 176.55 8.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.798 1.299 . . . . 0.0 112.592 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 1.9 mp0 -138.53 139.45 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.537 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.63 HG21 ' HE1' ' A' ' 41' ' ' TRP . 16.5 p -139.25 -179.37 5.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.691 0.758 . . . . 0.0 112.422 -169.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.465 HG23 HG22 ' A' ' 38' ' ' VAL . 31.6 m -138.33 107.96 6.23 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.1 m -138.9 179.94 2.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -157.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 14.1 m-85 -138.84 130.92 15.58 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 113.455 -1.702 . . . . 0.0 107.908 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.35 -170.77 0.8 Allowed 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.61 2.207 . . . . 0.0 112.882 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.713 ' H ' HG21 ' A' ' 11' ' ' VAL . . . -98.56 -132.48 7.64 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.855 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.451 ' O ' HG13 ' A' ' 11' ' ' VAL . 23.5 m -96.1 156.97 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 t70 70.88 -60.56 0.5 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.349 1.031 . . . . 0.0 110.122 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 51.95 132.14 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.937 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.865 HG22 ' H ' ' A' ' 58' ' ' VAL . 7.5 p -138.97 -179.79 2.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.017 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.865 ' H ' HG22 ' A' ' 57' ' ' VAL . 53.3 t -138.19 134.82 44.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.951 -172.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.699 HG21 HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.71 -179.84 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.968 -166.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.7 p -118.86 -164.33 1.03 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.135 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.04 -46.61 82.28 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -175.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -61.08 2.73 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 121.597 -0.689 . . . . 0.0 111.774 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -57.41 -24.87 58.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.937 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.876 ' HA ' ' NE2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.33 -45.17 84.56 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.126 -178.226 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.35 -73.21 0.09 Allowed 'General case' 0 C--O 1.254 1.326 0 CA-C-O 122.136 0.97 . . . . 0.0 112.587 -170.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.598 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -63.87 -42.9 97.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.76 -172.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' HB2' ' CD2' ' A' ' 19' ' ' HIS . . . -67.36 -27.81 67.43 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.793 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 3.2 tt0 -70.57 -31.03 67.9 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.677 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 50.4 mttp -56.03 -51.96 65.96 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.94 165.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.598 ' HD3' ' O ' ' A' ' 66' ' ' GLU . 2.3 mpt_? -56.93 -20.52 23.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.277 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.921 ' HB2' ' H ' ' A' ' 22' ' ' HIS . . . -75.99 -60.26 2.4 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.44 -22.03 64.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.046 0.451 . . . . 0.0 109.935 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.71 -73.43 0.26 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.281 169.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.401 ' HE ' ' CG ' ' A' ' 20' ' ' ASP . 6.2 mtm180 -82.56 -54.91 4.8 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -170.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.791 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -58.17 -60.49 3.67 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -172.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.76 76.13 0.41 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.977 -1.106 . . . . 0.0 113.084 -171.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -103.96 -14.1 16.09 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -136.97 25.82 3.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.628 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.76 36.54 4.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.889 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.6 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.382 179.668 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HE2' ' HB3' ' A' ' 56' ' ' ALA . 1.5 tmt? . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -162.08 100.1 1.09 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.807 0.337 . . . . 0.0 110.116 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.29 119.41 38.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.837 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.633 ' HA ' HG21 ' A' ' 28' ' ' VAL . 14.5 tptm -126.35 164.62 20.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.863 0.363 . . . . 0.0 110.966 -175.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.91 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.0 p -66.27 150.03 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.319 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.11 1.71 48.32 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -143.06 175.92 9.49 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.906 ' HB2' HG23 ' A' ' 59' ' ' VAL . 93.5 m-85 -104.51 154.35 20.01 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.284 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.8 tt -98.96 132.2 44.46 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.395 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.86 HG11 ' HB2' ' A' ' 19' ' ' HIS . 10.5 t -137.79 143.65 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 124.951 1.407 . . . . 0.0 109.485 174.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 54' ' ' SER . 54.7 t -99.05 134.65 37.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 120.731 0.3 . . . . 0.0 111.561 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.6 tptm 78.55 -51.75 0.47 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 124.608 1.193 . . . . 0.0 112.306 170.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.43 -90.58 1.6 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.543 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.21 121.62 5.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.417 0.627 . . . . 0.0 111.602 175.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.6 m -152.11 -79.31 0.11 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.4 m -111.91 -33.5 6.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 171.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -94.12 167.02 11.84 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.82 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -83.98 176.12 9.08 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 173.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.86 ' HB2' HG11 ' A' ' 10' ' ' VAL . 7.1 p-80 -75.16 98.31 3.69 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.722 0.772 . . . . 0.0 109.404 175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' HD3' ' A' ' 74' ' ' ARG . 18.7 t70 -121.37 165.01 16.16 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.48 -164.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.734 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 7.0 mt-30 63.07 101.29 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.794 0.437 . . . . 0.0 110.352 -174.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.715 ' CE1' ' HA ' ' A' ' 64' ' ' HIS . 58.6 t60 -148.26 151.22 35.07 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -167.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -179.01 -179.82 0.61 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.944 1.298 . . . . 0.0 107.51 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.587 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 41.1 tt0 -98.34 129.91 45.01 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.064 -0.655 . . . . 0.0 112.106 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.486 ' CG1' ' HB2' ' A' ' 9' ' ' LEU . 53.0 mt -85.8 111.21 20.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.383 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.91 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.5 pp -120.44 -16.63 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.642 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.766 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 48.2 mt-10 -130.26 107.96 9.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.136 0.493 . . . . 0.0 110.718 175.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.633 HG21 ' HA ' ' A' ' 4' ' ' LYS . 58.6 t -98.74 114.25 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.477 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 29.0 mmt180 -95.5 38.78 1.14 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.244 0.545 . . . . 0.0 111.251 -176.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.8 m -151.37 150.3 30.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.761 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.77 69.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.438 . . . . 0.0 110.8 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -115.1 -65.5 1.18 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.752 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.46 104.12 0.17 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.592 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 34.8 t -154.28 145.68 16.62 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 19.0 Cg_exo -67.26 155.07 72.13 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.44 2.094 . . . . 0.0 111.468 173.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.465 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 95.4 Cg_endo -87.89 178.87 19.07 Favored 'Cis proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.498 -1.459 . . . . 0.0 113.037 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -126.67 146.91 50.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.004 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.766 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 59.4 t -98.74 110.4 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.41 145.39 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.668 -159.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.719 ' HG2' ' HG3' ' A' ' 47' ' ' GLU . 73.4 mtp180 -106.36 129.42 54.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.493 0.664 . . . . 0.0 110.855 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.653 ' CE3' ' HB1' ' A' ' 72' ' ' ALA . 4.5 m0 -93.68 87.76 5.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.495 HD11 ' CD ' ' A' ' 24' ' ' GLU . 18.6 mt -70.05 -68.89 0.39 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.464 -162.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.536 HG22 ' OE2' ' A' ' 68' ' ' GLU . 4.2 m -74.96 -6.86 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.712 -173.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -89.06 -54.38 4.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.278 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.5 54.07 0.31 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.047 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -153.7 168.22 26.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.736 0.303 . . . . 0.0 111.131 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.719 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 32.7 tt0 -149.54 124.0 9.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 t -167.1 175.9 7.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.452 0.644 . . . . 0.0 112.029 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 m -101.5 110.25 22.21 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.292 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -106.88 149.77 10.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.39 0.614 . . . . 0.0 111.815 -171.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 81.9 m-85 -106.28 103.01 43.52 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.784 172.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.56 154.32 55.02 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.245 1.963 . . . . 0.0 110.861 175.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.84 -76.05 0.24 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.173 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.582 ' O ' HG13 ' A' ' 11' ' ' VAL . 28.4 t -169.68 162.63 9.83 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 55.51 60.28 3.43 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.285 0.564 . . . . 0.0 110.686 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.413 ' HB3' ' HE2' ' A' ' 1' ' ' MET . . . -82.34 127.21 33.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.06 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.6 t -120.43 157.56 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.423 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -100.42 115.76 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.341 0.591 . . . . 0.0 111.94 -178.268 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.906 HG23 ' HB2' ' A' ' 8' ' ' TYR . 6.6 m -102.0 178.29 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.987 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 p -119.41 -165.1 1.11 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.807 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -50.1 -47.14 53.98 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.19 -38.1 78.46 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.49 -0.756 . . . . 0.0 112.248 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.705 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 30.5 mm-40 -74.97 -16.78 60.62 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.528 0.68 . . . . 0.0 109.352 176.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.715 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -71.84 -43.4 65.6 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.401 -177.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.04 -70.23 0.18 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-O 121.258 0.551 . . . . 0.0 112.362 -171.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -31.51 72.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.381 -173.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.656 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -80.97 -22.18 39.75 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.524 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.697 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 2.0 tt0 -73.81 -46.68 43.75 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.416 -0.913 . . . . 0.0 108.993 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -56.67 -71.46 0.09 Allowed 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.563 0.697 . . . . 0.0 110.285 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -66.35 -52.6 45.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.452 -171.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.692 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -82.07 -23.11 35.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.971 -167.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.653 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -76.41 -39.93 52.22 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.361 173.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.27 -29.32 67.49 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.518 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.465 ' HD3' ' OD2' ' A' ' 20' ' ' ASP . 14.7 ttt180 -82.19 -40.66 21.41 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.726 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -54.07 -62.07 1.9 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.149 0.5 . . . . 0.0 110.774 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.4 50.63 1.62 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.368 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -74.67 -6.1 46.84 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.68 0.276 . . . . 0.0 111.34 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -168.59 22.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.367 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.5 94.22 3.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.062 0.458 . . . . 0.0 111.652 -172.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.1 m . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.09 173.134 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.636 0.255 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 35.3 t-80 -138.76 150.19 45.84 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.77 171.74 13.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.787 0.327 . . . . 0.0 111.373 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 8.3 ttpm? -139.03 151.97 47.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.803 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -82.96 139.33 17.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.17 26.71 27.73 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -168.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 14.5 m-20 -138.35 -178.92 5.5 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.673 ' HB2' HG23 ' A' ' 59' ' ' VAL . 88.9 m-85 -137.22 169.67 17.38 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -169.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.769 HD21 ' HB3' ' A' ' 52' ' ' PRO . 5.7 tt -138.66 145.36 40.34 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.205 -167.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 40.1 t -139.11 164.53 25.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.81 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.9 p -138.83 139.09 41.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 120.877 0.37 . . . . 0.0 110.125 173.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.549 ' HD2' ' HA ' ' A' ' 17' ' ' GLU . 2.5 ttpm? -85.71 -35.33 20.9 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.633 ' H ' ' HB3' ' A' ' 55' ' ' ASP . . . 57.88 -124.12 35.15 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.899 171.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 p -102.79 4.68 38.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -174.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.538 ' CG2' ' HB3' ' A' ' 18' ' ' ARG . 13.3 t -107.04 154.65 20.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.756 0.312 . . . . 0.0 110.324 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.3 m -86.45 100.97 12.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.118 0.485 . . . . 0.0 111.743 -173.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.549 ' HA ' ' HD2' ' A' ' 12' ' ' LYS . 47.0 mt-10 63.29 19.37 11.64 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.778 172.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' HB3' ' CG2' ' A' ' 15' ' ' THR . 32.4 ttm180 -92.14 132.38 36.66 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.617 ' HB3' HG11 ' A' ' 10' ' ' VAL . 68.2 m80 -93.68 104.41 16.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.092 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.407 ' CG ' ' HE ' ' A' ' 74' ' ' ARG . 3.9 t70 -131.44 174.38 10.14 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.509 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.81 ' HB2' HG12 ' A' ' 11' ' ' VAL . 66.3 mt-30 53.73 104.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.466 0.706 . . . . 0.0 111.326 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.892 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 36.0 t-80 -138.7 123.78 19.04 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.199 0.523 . . . . 0.0 111.947 -171.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.742 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.45 -178.5 5.41 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.02 -176.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.667 ' HB3' HD21 ' A' ' 42' ' ' LEU . 3.3 tm-20 -137.4 122.78 19.48 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.274 1.035 . . . . 0.0 108.244 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.418 ' HA ' HG23 ' A' ' 39' ' ' VAL . 1.2 mt -87.05 105.03 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.158 -167.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.773 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -98.61 -13.37 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 124.091 0.869 . . . . 0.0 109.386 174.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.721 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.04 140.92 38.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.498 -0.774 . . . . 0.0 108.988 174.115 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.08 99.86 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -167.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -94.41 78.97 3.88 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.617 0.246 . . . . 0.0 110.787 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.509 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 23.4 p 172.23 -35.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.151 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 74.63 -16.44 0.55 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.761 0.824 . . . . 0.0 111.761 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 30' ' ' SER . 4.2 p-10 -103.3 -37.91 7.46 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.71 8.31 3.52 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.441 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 48.9 m -76.19 143.99 74.34 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 122.633 -0.333 . . . . 0.0 110.369 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 17.9 Cg_exo -67.26 160.69 46.4 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.818 2.345 . . . . 0.0 111.938 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.593 ' HB3' ' HD1' ' A' ' 51' ' ' TYR . 90.0 Cg_endo -81.08 -171.28 9.43 Favored 'Cis proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.838 -1.317 . . . . 0.0 112.816 -1.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.52 175.91 9.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.532 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.721 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 98.1 t -137.89 112.75 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 25' ' ' ILE . 0.4 OUTLIER -138.95 169.44 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.761 -2.018 . . . . 0.0 109.339 -151.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 33.2 ttm180 -138.77 128.05 24.26 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.742 ' CZ3' ' HB2' ' A' ' 23' ' ' ALA . 5.7 m95 -80.07 86.03 5.58 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 170.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.667 HD21 ' HB3' ' A' ' 24' ' ' GLU . 7.1 mt -59.93 -67.17 0.41 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.606 -166.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.517 HG13 ' NE2' ' A' ' 64' ' ' HIS . 1.2 m -60.05 -34.24 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.496 -176.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 41' ' ' TRP . 16.6 m120 -60.45 -60.18 4.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.407 171.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.37 40.22 0.69 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.956 -0.565 . . . . 0.0 113.36 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.61 ' CB ' ' HD1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -139.11 160.89 38.72 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 117.25 0.525 . . . . 0.0 110.851 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -139.0 120.54 15.08 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.879 0.371 . . . . 0.0 110.446 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.585 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 8.8 t -139.29 -178.86 5.55 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.384 1.088 . . . . 0.0 113.807 -163.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.571 HG23 HG22 ' A' ' 38' ' ' VAL . 85.4 m -138.14 108.1 6.35 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.655 HG22 ' H ' ' A' ' 51' ' ' TYR . 4.6 p -138.9 176.31 6.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.046 -158.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.655 ' H ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -138.81 114.08 8.54 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.769 ' HB3' HD21 ' A' ' 9' ' ' LEU . 31.3 Cg_endo -64.01 -69.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.475 0.425 0 C-N-CA 123.13 2.553 . . . . 0.0 112.978 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.37 -164.67 37.38 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -91.2 20.78 4.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.125 0.488 . . . . 0.0 111.842 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.633 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 4.7 t0 -143.86 50.95 1.33 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.73 133.25 42.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.714 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.874 HG22 ' H ' ' A' ' 58' ' ' VAL . 5.3 p -138.96 -179.76 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.408 0.623 . . . . 0.0 109.882 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.874 ' H ' HG22 ' A' ' 57' ' ' VAL . 87.5 t -138.23 139.77 41.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.351 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.673 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.71 176.73 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 123.97 0.908 . . . . 0.0 110.82 -174.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 t -116.39 -169.18 1.57 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.23 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.03 -49.69 75.04 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.322 -175.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.51 -56.69 18.58 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.69 -0.631 . . . . 0.0 111.022 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 31.7 mt-10 -57.44 -26.26 60.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.47 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.76 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.3 -49.37 76.32 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 177.524 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . -56.98 -76.02 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.729 0.776 . . . . 0.0 111.883 -163.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -59.13 5.61 Favored 'General case' 0 C--O 1.26 1.637 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.306 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.646 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . . . -57.11 -37.18 71.58 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.944 -174.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.892 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 21.7 tt0 -71.68 -40.02 69.87 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.091 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 28.9 mtpp -52.61 -58.87 5.4 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.942 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.646 ' HE ' ' HA ' ' A' ' 67' ' ' ALA . 27.6 ptt180 -69.61 -53.16 20.12 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 122.137 0.97 . . . . 0.0 112.071 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.767 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -70.43 -31.14 68.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.334 -170.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -76.39 -34.56 58.86 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.187 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.15 54.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.576 0.548 . . . . 0.0 110.273 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HE ' ' CG ' ' A' ' 20' ' ' ASP . 49.8 mtm-85 -82.09 -47.82 12.12 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.755 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -46.36 -51.1 15.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.396 0.678 . . . . 0.0 112.714 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.427 ' HA3' ' CZ2' ' A' ' 41' ' ' TRP . . . -138.41 52.78 0.73 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.968 -174.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -59.17 -48.98 79.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.363 . . . . 0.0 110.942 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.7 -50.13 1.15 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.681 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 67.17 131.55 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.983 0.802 . . . . 0.0 111.627 -178.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 C--O 1.247 0.96 0 C-N-CA 123.626 0.77 . . . . 0.0 112.057 -179.733 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.851 0.357 . . . . 0.0 110.649 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -138.97 141.06 38.4 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.85 140.33 40.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.935 0.874 . . . . 0.0 111.057 -167.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 6.8 mmmm -138.96 141.08 38.43 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.44 -158.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.876 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.0 p -61.41 138.6 21.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 121.655 -0.653 . . . . 0.0 110.777 171.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.69 14.99 71.8 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 1.4 t70 -139.04 143.52 38.43 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.942 -1.629 . . . . 0.0 107.324 -167.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.801 ' HB2' HG23 ' A' ' 59' ' ' VAL 0.266 65.4 m-85 -134.37 141.9 47.02 Favored 'General case' 0 C--O 1.206 -1.227 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -142.188 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.796 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 4.6 tt -136.52 140.27 42.87 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.539 1.161 . . . . 0.0 110.401 -149.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.015 ' HB ' HG23 ' A' ' 57' ' ' VAL . 14.3 t -138.72 141.55 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 111.397 -2.638 . . . . 0.0 109.038 -153.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.45 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 48.7 t -137.46 139.78 42.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 122.257 1.027 . . . . 0.0 109.869 -173.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.545 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 87.2 tttt -82.85 92.67 7.32 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.122 -171.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.81 -46.13 95.12 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.7 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.545 ' OG1' ' HG2' ' A' ' 12' ' ' LYS . 17.1 m 72.95 -68.02 0.24 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.968 0.507 . . . . 0.0 111.057 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.53 -28.25 65.86 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 120.942 0.401 . . . . 0.0 110.637 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.7 p -106.96 80.62 1.45 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.624 174.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 63.75 -150.19 0.31 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.207 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -75.69 -155.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.897 0.856 . . . . 0.0 112.342 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.93 101.79 11.95 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 171.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 21' ' ' GLN . 23.4 t70 -120.85 -158.55 0.76 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -169.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 1.051 ' HG2' ' HB3' ' A' ' 74' ' ' ARG . 39.0 mt-30 64.87 105.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.353 0.408 . . . . 0.0 111.012 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.796 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 1.6 m170 -138.21 136.61 36.76 Favored 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 117.219 -1.792 . . . . 0.0 110.319 167.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.548 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -142.41 144.37 33.08 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 129.068 2.947 . . . . 0.0 107.055 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.751 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -134.56 139.85 45.69 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 122.269 2.304 . . . . 0.0 110.66 -166.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.74 HD12 HG22 ' A' ' 28' ' ' VAL . 5.4 pt -92.08 128.53 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 109.86 -3.336 . . . . 0.0 111.457 -159.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.876 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.8 pp -102.62 -6.29 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 112.022 -2.354 . . . . 0.0 108.981 169.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.654 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 33.3 mt-10 -139.02 139.69 37.9 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.901 172.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.74 HG22 HD12 ' A' ' 25' ' ' ILE . 8.5 t -138.28 139.81 41.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -175.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -125.8 25.31 6.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.388 0.613 . . . . 0.0 110.256 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 t -173.44 124.4 0.39 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.923 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.85 -16.45 41.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.323 0.582 . . . . 0.0 109.445 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.82 -46.0 55.41 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.291 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.29 40.12 0.49 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.651 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.4 m -117.58 151.53 48.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 122.197 0.199 . . . . 0.0 110.586 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.8 169.13 22.79 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.826 2.351 . . . . 0.0 112.334 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.58 179.9 29.5 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.603 -1.415 . . . . 0.0 112.63 0.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -138.71 142.07 38.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.723 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.873 HG22 HG23 ' A' ' 49' ' ' THR . 99.8 t -135.88 138.91 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 CA-C-O 125.147 2.403 . . . . 0.0 108.955 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.548 ' CG1' ' HB1' ' A' ' 23' ' ' ALA . 47.2 t -139.7 142.17 33.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 108.558 -3.928 . . . . 0.0 112.533 -129.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.651 ' HG3' ' O ' ' A' ' 46' ' ' HIS . 51.7 ttp180 -137.19 139.5 41.13 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 166.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.553 ' HH2' ' HA3' ' A' ' 76' ' ' GLY . 10.1 m0 -99.38 70.2 1.71 Allowed 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.573 HD22 ' HE ' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -60.56 -41.34 94.39 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 113.357 -1.747 . . . . 0.0 113.15 -150.445 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.76 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -61.56 -41.48 90.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.075 174.374 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.48 -40.49 94.74 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.57 50.27 2.98 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.295 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.651 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 8.1 t-160 -139.3 159.32 42.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.593 0.696 . . . . 0.0 110.554 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HG2' ' HD3' ' A' ' 40' ' ' ARG . 48.8 mt-10 -138.3 112.24 8.44 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.159 0.98 . . . . 0.0 110.46 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 t -139.68 -178.21 5.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.752 -1.567 . . . . 0.0 112.164 -165.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.873 HG23 HG22 ' A' ' 38' ' ' VAL . 94.6 m -137.65 122.19 18.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.454 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.754 HG12 ' H ' ' A' ' 51' ' ' TYR . 2.3 t -138.52 179.32 3.33 Favored 'Isoleucine or valine' 0 C--O 1.255 1.351 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.761 -164.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.754 ' H ' HG12 ' A' ' 50' ' ' VAL . 8.0 m-85 -138.78 114.69 8.67 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.203 176.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.665 ' HB3' HD21 ' A' ' 9' ' ' LEU . 27.6 Cg_exo -63.32 -66.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.312 2.674 . . . . 0.0 112.522 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.63 -136.18 8.71 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.734 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.7 p -101.27 162.19 13.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 58.9 45.76 14.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.913 0.863 . . . . 0.0 110.466 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' A' ' 1' ' ' MET . . . -77.5 130.04 36.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.627 -177.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 1.015 HG23 ' HB ' ' A' ' 10' ' ' VAL . 6.2 m -138.89 175.18 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.4 151.86 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -170.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' A' ' 8' ' ' TYR . 3.0 m -138.87 178.78 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 C-N-CA 126.246 1.818 . . . . 0.0 109.69 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.1 p -117.69 -171.16 2.0 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.006 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.11 -47.77 80.28 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -174.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -54.26 48.87 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 121.67 -0.644 . . . . 0.0 111.166 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 21.1 mt-10 -57.12 -33.43 67.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.518 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.76 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.15 -37.97 72.83 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 114.563 -1.199 . . . . 0.0 114.107 -177.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.76 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -57.05 -76.29 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.053 0.93 . . . . 0.0 110.288 -171.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -57.37 -64.4 0.9 Allowed 'General case' 0 C--O 1.268 2.062 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.065 178.209 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -56.88 -58.93 6.01 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.035 -175.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.716 ' HB3' ' O ' ' A' ' 64' ' ' HIS . 39.4 tt0 -57.41 -32.84 67.26 Favored 'General case' 0 C--O 1.204 -1.297 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.44 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -57.12 -71.33 0.1 Allowed 'General case' 0 C--O 1.261 1.676 0 CA-C-N 119.627 1.103 . . . . 0.0 110.808 174.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -53.82 53.83 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-O 123.262 1.506 . . . . 0.0 110.651 -175.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.791 ' O ' ' HA ' ' A' ' 21' ' ' GLN . . . -57.37 -39.39 75.93 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 112.999 -1.909 . . . . 0.0 112.923 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.51 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -57.1 -43.78 82.58 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 118.584 0.629 . . . . 0.0 109.891 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.49 -40.82 75.61 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 119.604 -0.839 . . . . 0.0 109.334 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 1.051 ' HB3' ' HG2' ' A' ' 21' ' ' GLN . 1.8 mpt_? -57.53 -57.93 10.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 172.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 21' ' ' GLN . . . -47.09 -42.2 18.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.016 0.927 . . . . 0.0 113.065 -173.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.553 ' HA3' ' HH2' ' A' ' 41' ' ' TRP . . . -108.06 3.93 33.66 Favored Glycine 0 C--N 1.323 -0.179 0 C-N-CA 118.661 -1.733 . . . . 0.0 113.35 -173.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -89.62 -21.79 22.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.446 0.641 . . . . 0.0 109.393 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.45 -12.55 58.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.84 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.15 90.74 3.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.994 0.426 . . . . 0.0 110.535 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.299 -179.963 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptm . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.711 0.291 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -139.04 132.17 29.72 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 172.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.34 148.05 48.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.147 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.658 ' HA ' ' HE3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -130.92 169.58 15.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.843 0.354 . . . . 0.0 110.307 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.834 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.7 p -85.88 146.02 7.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.795 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.17 9.2 60.84 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -129.24 169.46 14.8 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.872 ' HB2' HG23 ' A' ' 59' ' ' VAL . 97.7 m-85 -105.95 150.77 25.37 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.317 0.579 . . . . 0.0 111.113 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.769 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 6.5 tt -98.75 146.22 26.13 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.468 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.871 HG11 ' HB2' ' A' ' 19' ' ' HIS . 47.8 t -127.65 144.74 36.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 O-C-N 125.295 1.622 . . . . 0.0 110.291 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.653 HG22 ' HB3' ' A' ' 52' ' ' PRO . 3.2 t -137.12 162.33 34.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 O-C-N 123.588 0.555 . . . . 0.0 110.367 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.487 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 47.6 tptt -142.72 -74.63 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 167.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.52 -6.4 5.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.333 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.2 m -159.64 -65.09 0.07 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.527 -0.396 . . . . 0.0 110.878 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.4 m -95.28 108.87 21.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -74.22 82.37 1.83 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.102 0.953 . . . . 0.0 109.957 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -164.7 -69.72 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.889 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 6.8 mmm180 -69.84 99.16 1.34 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.871 ' HB2' HG11 ' A' ' 10' ' ' VAL . 17.8 p-80 -90.0 98.75 11.95 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.6 -172.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -113.73 -169.0 1.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.811 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.636 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 39.1 mt-30 52.61 87.86 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.622 0.576 . . . . 0.0 111.959 173.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.769 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 55.0 m170 -117.95 158.31 25.13 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -175.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . . . -169.92 179.17 3.71 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 34.4 tt0 -98.32 126.1 43.7 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.086 -175.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.468 ' CG2' HG22 ' A' ' 28' ' ' VAL . 7.7 mt -88.15 105.82 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.016 174.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.834 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.2 pp -109.39 -27.02 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.228 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 1.068 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 47.3 mt-10 -118.81 101.81 8.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.086 0.469 . . . . 0.0 110.034 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.468 HG22 ' CG2' ' A' ' 25' ' ' ILE . 28.5 t -98.97 104.07 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.1 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -90.02 35.48 0.85 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.374 0.607 . . . . 0.0 110.725 -174.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -156.54 141.52 17.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.589 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.18 92.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.008 0.432 . . . . 0.0 110.644 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.4 -78.25 0.43 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.948 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.44 108.5 0.21 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.191 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.8 p -156.12 137.52 9.55 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.41 153.5 53.64 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.76 2.307 . . . . 0.0 112.092 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 83.2 Cg_endo -83.36 167.64 62.76 Favored 'Cis proline' 0 N--CA 1.463 -0.293 0 C-N-CA 123.276 -1.552 . . . . 0.0 113.317 2.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -120.14 144.24 47.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.186 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.068 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 58.5 t -98.79 111.06 27.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -126.11 148.77 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.833 -164.601 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.851 ' HD2' ' HB3' ' A' ' 42' ' ' LEU . 31.2 ttm-85 -114.29 121.57 44.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.279 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.446 ' CE3' ' HB2' ' A' ' 23' ' ' ALA . 12.0 m95 -83.14 76.72 9.84 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 168.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.851 ' HB3' ' HD2' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -76.35 -34.03 58.96 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -166.455 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG22 ' OE2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -77.26 -9.31 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.924 179.116 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -100.19 -32.16 11.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.546 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.85 35.84 3.62 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.787 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -136.39 168.38 19.56 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 122.634 -0.333 . . . . 0.0 110.435 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -153.6 141.62 20.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 t -175.4 -179.96 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.691 0.758 . . . . 0.0 111.674 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.9 m -98.77 107.83 20.36 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.69 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.417 HG12 ' HB ' ' A' ' 39' ' ' VAL . 9.5 p -98.98 148.68 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.304 0.573 . . . . 0.0 111.196 -173.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 24.2 m-85 -118.15 99.78 51.83 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.68 174.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.653 ' HB3' HG22 ' A' ' 11' ' ' VAL . 3.3 Cg_exo -75.62 -46.15 0.22 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.721 2.28 . . . . 0.0 112.268 -175.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.3 -94.75 1.44 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.801 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.7 m -126.72 167.39 15.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.569 0.185 . . . . 0.0 111.137 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 12' ' ' LYS . 67.4 m-20 67.25 22.14 9.74 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.933 0.771 . . . . 0.0 111.345 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.775 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -75.52 127.6 33.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.168 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.857 HG22 ' H ' ' A' ' 58' ' ' VAL . 7.4 p -147.27 -179.99 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.347 0.594 . . . . 0.0 110.346 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.857 ' H ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -111.26 127.94 68.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.504 -175.513 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.872 HG23 ' HB2' ' A' ' 8' ' ' TYR . 1.4 m -119.57 179.24 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 123.285 0.634 . . . . 0.0 110.768 173.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 p -112.05 -171.79 1.92 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.55 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.595 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -49.14 -52.23 27.52 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -172.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.56 -40.94 84.92 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.308 -170.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -63.04 -24.93 68.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.411 0.624 . . . . 0.0 110.227 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.482 ' CE1' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -67.2 -49.37 64.87 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.687 -173.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.61 -67.66 0.23 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.828 0.823 . . . . 0.0 112.684 -164.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -61.6 -52.48 64.21 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.349 -174.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HB3' ' ND1' ' A' ' 22' ' ' HIS . . . -72.79 -16.69 61.62 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.671 ' OE1' ' HA ' ' A' ' 23' ' ' ALA . 29.9 tt0 -77.59 -40.68 41.36 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -55.56 -49.3 73.06 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.924 0.869 . . . . 0.0 109.105 170.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -68.33 -16.65 64.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.093 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -81.26 -41.19 22.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.648 0.261 . . . . 0.0 110.867 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.0 -27.29 68.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.655 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -79.25 -52.67 7.82 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.885 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -82.0 -65.61 0.99 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.51 73.91 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.041 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.3 -4.53 64.35 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.973 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.655 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 47.2 t-80 -67.83 -28.23 67.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.958 0.409 . . . . 0.0 109.946 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.73 -64.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.728 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -144.81 125.98 14.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.059 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 C--O 1.254 1.307 0 CA-C-O 118.506 -0.759 . . . . 0.0 109.314 176.362 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 tmm? . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -138.85 136.44 35.59 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.84 171.72 13.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.901 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 88.2 tttt -139.09 155.52 47.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.208 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 26' ' ' ILE . 37.4 t -69.85 142.22 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.88 19.07 44.84 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -174.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 9.0 m-20 -138.7 -179.01 5.57 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 114.025 -1.087 . . . . 0.0 108.549 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.755 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 95.9 m-85 -137.17 165.13 26.82 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.971 -168.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.1 tt -138.63 138.73 38.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.662 -166.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 37.8 t -139.02 157.66 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.396 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.803 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.9 p -139.0 166.96 21.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.718 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 33.1 ttmt -85.26 76.08 10.2 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.161 0.505 . . . . 0.0 110.879 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.91 -13.2 72.6 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.644 HG22 ' HB2' ' A' ' 20' ' ' ASP . 5.0 t -160.59 134.77 7.21 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -90.45 -37.48 13.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.014 0.435 . . . . 0.0 110.875 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 p -74.39 -32.06 62.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.665 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB3' HG21 ' A' ' 14' ' ' THR . 18.0 tt0 -95.12 37.28 1.17 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.321 0.581 . . . . 0.0 110.147 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.439 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER 75.32 -72.26 0.11 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.727 175.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.714 ' HB3' HG11 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -170.9 162.46 7.39 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -177.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.644 ' HB2' HG22 ' A' ' 14' ' ' THR . 15.2 t70 -139.56 165.59 26.84 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 111.249 0.092 . . . . 0.0 111.249 -170.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.803 ' HB2' HG12 ' A' ' 11' ' ' VAL . 78.8 mt-30 61.24 105.18 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.542 0.737 . . . . 0.0 111.707 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.972 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.7 t-160 -139.26 126.6 21.49 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 121.254 0.55 . . . . 0.0 111.599 -174.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.742 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.51 -178.65 5.49 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.402 1.081 . . . . 0.0 110.09 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.755 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 20.5 tt0 -136.95 122.51 19.67 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.287 1.042 . . . . 0.0 108.483 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.843 HG23 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -85.05 113.8 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.192 -174.087 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.81 ' HA ' HG13 ' A' ' 5' ' ' VAL . 1.5 pp -106.35 -3.51 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.237 172.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.856 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.0 124.46 19.35 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.284 172.032 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -138.19 99.67 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -105.49 -3.92 21.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.58 0.705 . . . . 0.0 109.97 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 6.9 m -65.0 -25.98 68.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.383 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 63.2 -82.17 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.791 0.682 . . . . 0.0 110.841 -176.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.75 -44.24 67.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.585 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 30' ' ' SER . . . 153.67 -164.25 31.1 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p 67.75 154.26 0.14 Allowed Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 124.476 1.111 . . . . 0.0 111.956 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.56 161.38 38.75 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.948 2.432 . . . . 0.0 112.533 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.637 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 89.4 Cg_endo -83.34 179.0 26.64 Favored 'Cis proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.071 -1.637 . . . . 0.0 113.376 0.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -138.76 173.52 11.49 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.856 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 97.4 t -137.77 115.58 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.843 HG23 HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -138.84 171.16 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 CA-C-N 112.878 -1.965 . . . . 0.0 109.155 -152.3 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.409 ' N ' HG13 ' A' ' 39' ' ' VAL . 31.6 ttt180 -138.66 123.75 19.07 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.75 ' HD1' ' HB2' ' A' ' 46' ' ' HIS . 25.6 m95 -78.99 84.42 5.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 24' ' ' GLU . 6.9 mt -60.21 -68.6 0.28 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.346 0.593 . . . . 0.0 111.951 -166.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.682 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -60.25 -38.35 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.155 -174.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -60.59 -50.86 71.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.298 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.98 48.94 0.86 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.506 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.75 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 46.9 m-70 -139.13 169.17 18.26 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.446 0.623 . . . . 0.0 111.283 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -138.88 119.14 13.62 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.525 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 6.7 t -139.42 -179.36 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.315 1.055 . . . . 0.0 113.684 -165.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.455 HG23 HG22 ' A' ' 38' ' ' VAL . 57.8 m -138.55 112.67 8.59 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.092 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.445 HG11 ' HZ2' ' A' ' 41' ' ' TRP . 8.5 m -138.89 -179.8 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -163.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.637 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 50.1 m-85 -138.73 108.56 7.76 Favored Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.738 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.551 ' HG3' HD11 ' A' ' 9' ' ' LEU . 72.6 Cg_endo -74.63 -169.2 0.58 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.089 2.526 . . . . 0.0 111.608 176.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.568 ' HA3' HG21 ' A' ' 11' ' ' VAL . . . -98.61 -166.2 30.78 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.546 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.8 m -97.07 21.58 9.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.34 0.59 . . . . 0.0 112.019 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.718 ' HB3' ' H ' ' A' ' 12' ' ' LYS . 18.2 t70 -122.91 38.09 4.26 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.97 135.6 54.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.761 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.808 HG12 ' H ' ' A' ' 58' ' ' VAL . 2.9 t -138.71 179.93 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.808 ' H ' HG12 ' A' ' 57' ' ' VAL . 58.0 t -138.0 136.02 45.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.739 -174.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.669 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.75 177.33 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.752 -170.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.6 t -122.2 -164.02 1.13 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.799 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.25 94.2 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -42.68 72.64 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 121.858 -0.526 . . . . 0.0 110.98 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.602 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 9.4 mm-40 -62.14 -17.26 57.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.838 0.827 . . . . 0.0 109.446 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.682 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -81.73 -43.99 17.68 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.78 -172.201 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.77 -70.79 0.09 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.838 0.828 . . . . 0.0 111.627 -168.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 1.6 pt-20 -70.08 -55.04 10.49 Favored 'General case' 0 C--O 1.257 1.457 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.748 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -59.55 -42.29 92.06 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.577 -175.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.972 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 36.0 tt0 -70.47 -35.78 73.5 Favored 'General case' 0 C--O 1.212 -0.921 0 C-N-CA 120.204 -0.599 . . . . 0.0 110.978 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 69' ' ' LYS . 11.1 tptm -51.87 -61.76 2.06 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.734 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -67.12 -52.77 37.63 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.235 1.017 . . . . 0.0 111.709 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.735 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -68.85 -30.7 69.28 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.248 -171.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -69.74 -41.07 75.74 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -52.75 -35.42 56.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.825 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.643 ' HD3' ' OD2' ' A' ' 20' ' ' ASP . 49.6 ttt180 -81.79 -49.46 10.37 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.49 ' HA ' ' HG2' ' A' ' 21' ' ' GLN . . . -45.14 -50.23 11.39 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.63 0.772 . . . . 0.0 112.036 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -105.73 24.32 27.34 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.423 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 8.7 t60 -71.6 -41.74 68.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.59 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.5 45.63 0.63 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.581 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.2 -49.89 65.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.529 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.732 -0.651 . . . . 0.0 109.743 175.649 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.834 0.349 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -133.79 128.7 35.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.028 0.442 . . . . 0.0 110.312 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.89 145.3 19.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.019 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -144.79 171.02 15.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.174 0.511 . . . . 0.0 111.561 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.951 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.3 p -72.63 147.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.197 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.31 -0.34 43.69 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -130.73 176.38 8.25 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.71 ' HB2' HG23 ' A' ' 59' ' ' VAL . 94.8 m-85 -115.59 151.54 34.75 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.116 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.731 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.3 tt -98.6 142.23 30.44 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.562 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.778 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 44.4 t -134.78 154.86 37.52 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.139 0 O-C-N 125.229 1.581 . . . . 0.0 109.848 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 21' ' ' GLN . 29.5 m -124.86 150.51 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 168.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.468 ' HG2' ' HA ' ' A' ' 19' ' ' HIS . 49.6 mtmt -130.31 -81.8 0.54 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.093 0.473 . . . . 0.0 110.634 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.83 121.79 2.22 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.7 m 68.27 -80.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 122.783 0.433 . . . . 0.0 111.17 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.0 m -160.24 -58.12 0.06 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.016 0.436 . . . . 0.0 110.953 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.4 p -108.76 11.74 26.12 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -75.17 175.81 7.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.155 0.502 . . . . 0.0 112.043 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -58.74 131.25 50.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.532 -176.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.468 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 24.5 p-80 -87.19 122.99 31.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 174.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -151.15 174.61 13.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.767 ' HB3' HG22 ' A' ' 11' ' ' VAL . 0.6 OUTLIER 65.45 100.63 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 O-C-N 123.485 0.49 . . . . 0.0 110.175 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.731 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 3.8 m80 -129.79 146.64 51.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.167 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -160.8 176.38 11.54 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 172.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.622 ' CD ' HD11 ' A' ' 42' ' ' LEU . 43.9 tt0 -98.61 132.31 44.12 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.45 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.606 HG22 HG22 ' A' ' 28' ' ' VAL . 2.6 mt -97.43 109.69 23.85 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.96 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.951 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -109.03 -31.88 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.341 175.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 1.025 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 10.5 mm-40 -112.21 99.87 8.38 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.39 0.614 . . . . 0.0 109.427 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 30' ' ' SER . 15.7 t -106.86 144.72 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.017 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.3 mtp-105 -68.79 -35.98 77.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.361 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.7 ' H ' HG12 ' A' ' 28' ' ' VAL . 66.3 m 58.38 -159.75 0.27 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.856 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 65.39 -88.09 0.03 OUTLIER 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.829 0.452 . . . . 0.0 111.227 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -92.63 -27.47 17.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.733 0.301 . . . . 0.0 110.31 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.38 86.77 0.54 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.484 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.8 p -160.2 162.03 24.71 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.05 162.9 12.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.86 2.373 . . . . 0.0 112.126 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.21 151.64 96.87 Favored 'Cis proline' 0 C--N 1.343 0.262 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.747 2.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -111.46 139.9 46.5 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.025 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 57.8 t -98.35 99.92 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.62 142.02 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.212 -168.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -121.38 129.05 52.82 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.622 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.438 ' CZ3' ' HB2' ' A' ' 23' ' ' ALA . 12.8 m95 -81.05 100.39 8.97 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.622 HD11 ' CD ' ' A' ' 24' ' ' GLU . 13.2 mt -76.43 -56.78 4.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.249 0.547 . . . . 0.0 111.263 -172.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 65' ' ' ALA . 1.4 m -79.49 -7.89 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.245 -172.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -96.9 -47.98 5.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.791 170.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.49 70.81 0.82 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.746 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -174.11 148.62 1.36 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.843 0.354 . . . . 0.0 110.536 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -99.04 143.87 28.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.824 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.413 HG22 ' N ' ' A' ' 49' ' ' THR . 24.9 m -154.6 167.16 31.06 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.818 0.342 . . . . 0.0 110.249 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 48' ' ' THR . 26.5 m -127.79 118.67 24.17 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.14 162.92 35.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.805 0.812 . . . . 0.0 113.054 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -120.8 99.86 46.85 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.229 171.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.708 ' HG3' HD11 ' A' ' 9' ' ' LEU . 43.3 Cg_endo -66.51 149.45 84.39 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.672 2.248 . . . . 0.0 112.248 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.24 68.08 3.59 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.054 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.0 m 69.21 168.19 0.29 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.112 0.565 . . . . 0.0 112.395 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.28 42.48 31.45 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.3 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.778 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -77.63 110.69 12.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.122 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 10' ' ' VAL . 1.2 p -119.34 156.46 21.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.143 0.497 . . . . 0.0 110.84 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -102.21 107.08 20.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.467 -174.361 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.71 HG23 ' HB2' ' A' ' 8' ' ' TYR . 14.2 m -102.1 -179.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.589 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.2 t -96.71 -170.61 2.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.252 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.581 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . . . -63.38 -50.59 69.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.033 -172.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -71.8 -40.52 69.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.833 0.349 . . . . 0.0 111.689 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -55.78 -29.1 59.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.707 0.765 . . . . 0.0 109.698 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.716 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -82.22 -46.64 13.46 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -171.483 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.444 ' HA ' HG21 ' A' ' 43' ' ' VAL . . . -49.66 -60.15 3.14 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -159.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.74 -53.22 57.92 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 122.377 1.084 . . . . 0.0 110.33 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.93 -16.4 63.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.554 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 26.6 tt0 -70.77 -42.17 70.77 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 176.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -57.07 -47.15 81.69 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.639 0.733 . . . . 0.0 109.075 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -61.86 -24.05 66.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.647 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.606 ' HB2' ' H ' ' A' ' 22' ' ' HIS . . . -81.95 -48.86 10.95 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.445 -175.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.91 -23.39 65.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.646 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -69.61 -64.83 0.8 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.191 173.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -82.25 -60.12 2.32 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.594 ' HB2' ' CG ' ' A' ' 21' ' ' GLN . . . -52.51 -48.72 65.82 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.908 0.483 . . . . 0.0 112.033 -173.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.64 21.65 41.65 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.944 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.646 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 7.6 t-160 -70.06 -52.95 19.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.058 0.456 . . . . 0.0 109.839 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -140.16 84.07 1.95 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.079 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.26 -43.62 8.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.454 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.676 178.191 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.574 ' HB3' ' O ' ' A' ' 32' ' ' ASP . 19.4 ttt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.45 ' N ' ' HG2' ' A' ' 1' ' ' MET . 31.7 p-80 -120.9 124.57 45.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.984 0.421 . . . . 0.0 109.998 173.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.53 150.68 40.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.6 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -137.02 146.76 45.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.951 0.405 . . . . 0.0 110.941 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.8 p -89.37 137.13 21.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.416 172.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.34 2.29 56.71 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.19 173.38 6.96 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.701 ' HB2' HG23 ' A' ' 59' ' ' VAL . 92.5 m-85 -110.96 161.13 16.16 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.382 -174.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.4 tt -106.92 137.38 45.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.247 -176.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.595 HG23 HG21 ' A' ' 59' ' ' VAL . 11.1 t -136.94 148.42 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.049 0.843 . . . . 0.0 108.89 172.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.7 ' HB ' ' HB2' ' A' ' 21' ' ' GLN . 92.2 t -125.7 144.01 37.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.138 0.494 . . . . 0.0 110.249 175.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.484 ' HD2' ' OD2' ' A' ' 55' ' ' ASP . 68.0 mttt -77.82 78.11 4.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.324 176.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.07 86.31 1.37 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.31 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 15' ' ' THR . 9.0 m 68.85 -178.77 0.22 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.67 ' H ' HG22 ' A' ' 14' ' ' THR . 6.6 m -74.97 76.81 2.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.273 0.559 . . . . 0.0 109.723 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -109.73 122.35 47.29 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.926 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.424 ' C ' ' H ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -67.39 143.4 56.33 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.093 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 77.13 -20.81 0.36 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.283 0.989 . . . . 0.0 110.617 -174.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 17' ' ' GLU . 39.5 m80 73.04 169.64 0.31 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.665 0.786 . . . . 0.0 111.453 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -131.26 -171.17 2.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.746 -173.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.7 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 78.8 mt-30 45.62 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.993 0.917 . . . . 0.0 112.374 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.719 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 59.8 t-80 -135.05 145.77 48.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -171.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.497 ' HB2' ' HZ3' ' A' ' 41' ' ' TRP . . . -169.81 179.81 3.54 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.808 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 38.4 tt0 -100.64 123.56 45.02 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.515 0.509 . . . . 0.0 110.469 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 9' ' ' LEU . 18.8 mt -91.85 106.1 17.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 120.7 0.286 . . . . 0.0 110.267 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.572 ' HA ' HG23 ' A' ' 5' ' ' VAL . 2.0 pp -114.93 -10.42 12.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.157 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.885 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 30.9 mt-10 -139.92 107.99 5.74 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.113 0.483 . . . . 0.0 110.839 173.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.65 126.85 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.298 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -74.4 -34.97 63.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.123 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.5 t -145.51 136.81 24.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.27 -18.41 65.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.917 0.389 . . . . 0.0 111.167 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 1' ' ' MET . 3.7 t70 -89.77 1.3 56.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.143 0.497 . . . . 0.0 110.021 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.03 99.47 0.52 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.714 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 53.8 m -139.89 121.22 9.56 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 2.9 Cg_exo -75.49 157.2 40.84 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.144 2.563 . . . . 0.0 111.763 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HB3' ' CD1' ' A' ' 51' ' ' TYR . 79.8 Cg_endo -82.77 167.22 66.96 Favored 'Cis proline' 0 N--CA 1.462 -0.332 0 C-N-CA 123.111 -1.621 . . . . 0.0 112.889 -1.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -109.32 153.9 23.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.773 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.885 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 85.5 t -98.79 113.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.496 ' HB ' HG22 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -118.85 151.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.022 -166.322 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.519 ' HD2' ' OE1' ' A' ' 24' ' ' GLU . 37.7 ttm180 -116.81 137.18 52.39 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.065 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.497 ' HZ3' ' HB2' ' A' ' 23' ' ' ALA . 18.5 m95 -74.06 83.47 1.78 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 168.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.926 HD12 HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -22.52 -76.9 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.221 -1.808 . . . . 0.0 115.778 -170.252 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.926 HG22 HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -95.34 0.33 10.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -168.656 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.426 HD22 ' N ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -88.91 -46.13 9.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.881 0.372 . . . . 0.0 110.074 173.141 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.77 73.26 1.06 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.38 -0.915 . . . . 0.0 113.564 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -170.29 137.63 1.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.95 142.45 46.77 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.758 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 t -157.51 176.49 12.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.167 -173.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.4 m -105.3 108.81 20.52 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.749 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.496 HG22 ' HB ' ' A' ' 39' ' ' VAL . 35.1 m -106.49 152.18 8.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.356 0.598 . . . . 0.0 111.99 -174.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 36' ' ' PRO . 50.7 m-85 -116.19 99.8 52.97 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.181 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.97 168.31 12.24 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.803 2.335 . . . . 0.0 111.746 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 55' ' ' ASP . . . -66.26 162.8 43.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.015 175.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.3 m -76.47 29.0 0.12 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.008 0.433 . . . . 0.0 111.716 -177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.484 ' OD2' ' HD2' ' A' ' 12' ' ' LYS . 9.6 t0 -144.3 55.65 1.29 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.787 0.803 . . . . 0.0 108.909 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.82 136.35 35.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.763 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.84 158.37 42.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 1.5 m -99.22 149.89 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.235 0.54 . . . . 0.0 112.319 -177.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -135.09 173.3 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.803 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.89 -168.15 1.61 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.053 -175.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.21 -42.57 81.59 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -71.19 -44.62 65.09 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.236 -0.915 . . . . 0.0 110.934 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.0 mm-40 -64.76 -16.42 62.96 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.986 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.677 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -69.73 -33.82 73.0 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.669 -174.49 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 64' ' ' HIS . . . -77.14 -73.77 0.28 Allowed 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.834 0.826 . . . . 0.0 112.8 -165.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -61.07 -39.66 90.72 Favored 'General case' 0 C--O 1.251 1.182 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.136 -175.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -69.48 -28.8 66.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.308 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.734 ' HB2' HD11 ' A' ' 42' ' ' LEU . 18.0 tt0 -57.37 -57.3 13.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 1.009 ' HE2' ' HA ' ' A' ' 69' ' ' LYS . 9.3 mmpt? -50.64 -64.85 0.68 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.656 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -66.15 -54.81 20.84 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.839 0.828 . . . . 0.0 111.625 -174.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.554 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -77.02 -25.15 52.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.87 -167.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.82 -32.41 52.25 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.834 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.21 72.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.23 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -80.58 -44.03 19.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.254 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.69 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -54.65 -53.02 60.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.6 -16.99 74.4 Favored Glycine 0 N--CA 1.454 -0.121 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.358 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -85.26 -14.12 47.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.29 0.566 . . . . 0.0 109.989 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.25 7.0 42.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.507 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.26 119.11 10.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.832 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.244 0.773 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.426 -176.474 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HE3' ' HB2' ' A' ' 3' ' ' ALA . 8.7 tpt . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.916 0.388 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.438 ' O ' HG21 ' A' ' 58' ' ' VAL . 21.2 m80 -138.97 108.38 6.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 174.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.414 ' HB2' ' HE3' ' A' ' 1' ' ' MET . . . -138.76 166.64 23.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.029 0.442 . . . . 0.0 111.709 -172.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -139.1 176.06 9.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.827 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.5 p -91.46 135.49 26.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.9 17.46 32.57 Favored Glycine 0 C--N 1.322 -0.201 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.36 -179.24 5.68 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.791 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 92.1 m-85 -137.03 169.54 17.6 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.595 -166.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 10' ' ' VAL . 6.1 tt -138.6 141.31 39.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.829 -164.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 37.2 t -138.75 151.98 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 124.889 1.368 . . . . 0.0 109.039 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.94 HG22 ' HB2' ' A' ' 54' ' ' SER . 0.5 OUTLIER -138.88 153.09 24.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.318 177.473 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.1 tptt 70.41 90.96 0.09 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.241 0.543 . . . . 0.0 111.288 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -146.18 15.86 1.7 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.517 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 p -81.89 -41.13 21.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.123 0.487 . . . . 0.0 111.454 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.0 t -129.56 -16.51 3.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.398 0.618 . . . . 0.0 110.423 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.651 HG22 ' HB2' ' A' ' 18' ' ' ARG . 6.2 m -101.17 108.95 20.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.615 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -78.19 9.44 3.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.56 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.651 ' HB2' HG22 ' A' ' 16' ' ' THR . 7.4 mpt_? -72.61 -35.18 67.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 175.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 55.16 73.72 0.4 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.256 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.654 ' OD1' ' HD3' ' A' ' 74' ' ' ARG . 9.0 m-20 -76.45 -175.32 3.23 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.264 -172.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.963 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 47.4 tp60 53.5 99.76 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.423 0 O-C-N 123.608 0.567 . . . . 0.0 110.533 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.948 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -138.69 103.04 4.74 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 121.451 -0.781 . . . . 0.0 110.376 -173.168 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.49 -178.77 5.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.207 -172.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.791 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 23.5 tt0 -137.07 127.77 27.07 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 122.473 1.13 . . . . 0.0 109.089 172.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.539 ' CG2' HG22 ' A' ' 28' ' ' VAL . 3.0 mt -87.46 111.48 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-N 112.518 -2.128 . . . . 0.0 110.084 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.771 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -106.13 -12.12 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 O-C-N 123.961 0.788 . . . . 0.0 109.401 172.239 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.6 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 33.0 mt-10 -138.98 139.58 37.96 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.933 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.539 HG22 ' CG2' ' A' ' 25' ' ' ILE . 23.2 t -137.89 102.65 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -163.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.41 35.83 0.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.27 -173.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.3 t -158.76 150.83 21.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.98 -14.5 29.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.401 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -118.54 -66.22 1.1 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.618 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 165.57 51.82 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.267 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 m -118.87 148.29 44.23 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.03 156.79 52.58 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.62 2.214 . . . . 0.0 111.925 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.591 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 75.1 Cg_endo -89.16 -172.43 6.82 Favored 'Cis proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.723 -1.365 . . . . 0.0 113.447 1.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.72 168.33 20.03 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.168 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.6 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 84.3 t -137.96 117.41 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.93 172.24 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 113.112 -1.858 . . . . 0.0 109.656 -154.476 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.844 ' HG2' HD23 ' A' ' 42' ' ' LEU . 11.6 ttt85 -138.71 134.48 33.62 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.596 ' CZ2' HG21 ' A' ' 48' ' ' THR . 9.9 m95 -78.68 89.32 4.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 168.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.844 HD23 ' HG2' ' A' ' 40' ' ' ARG . 8.3 mt -59.92 -72.66 0.1 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.328 0.585 . . . . 0.0 111.533 -168.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.604 HG13 ' NE2' ' A' ' 64' ' ' HIS . 2.4 m -60.08 -30.68 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.293 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' ' 41' ' ' TRP . 33.9 m-80 -60.68 -66.18 0.57 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.241 170.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.79 33.31 0.65 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.86 -0.686 . . . . 0.0 114.759 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.753 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 2.4 m170 -139.28 174.48 10.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.328 1.064 . . . . 0.0 112.164 175.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -138.49 127.7 24.28 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.596 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 9.7 t -139.42 -179.23 5.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 122.065 0.936 . . . . 0.0 113.335 -168.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.524 HG23 HG22 ' A' ' 38' ' ' VAL . 63.4 m -138.46 110.67 7.36 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.87 -179.86 2.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -161.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 9.8 m-85 -138.71 121.93 10.95 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.264 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 24.6 Cg_exo -63.13 -53.45 1.53 Allowed 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 122.937 2.425 . . . . 0.0 112.653 -177.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.67 -46.82 1.11 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.204 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.94 ' HB2' HG22 ' A' ' 11' ' ' VAL . 26.4 m -91.66 -170.9 2.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.688 0.244 . . . . 0.0 111.33 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.61 -14.81 5.93 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.85 0.719 . . . . 0.0 110.525 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 71.44 130.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.985 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.584 HG23 ' HB ' ' A' ' 10' ' ' VAL . 29.0 m -135.41 169.84 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 122.046 -0.408 . . . . 0.0 110.969 176.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 2' ' ' HIS . 56.1 t -118.02 136.26 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -173.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.658 HG23 ' CB ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -123.86 174.74 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 123.111 0.565 . . . . 0.0 110.845 176.039 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -121.4 -164.97 1.18 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.503 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.15 91.17 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -171.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -81.82 -33.96 30.46 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.466 -0.771 . . . . 0.0 110.872 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 36.9 mt-10 -65.83 -16.52 63.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.919 0.866 . . . . 0.0 109.267 174.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.604 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.37 -57.73 3.67 Favored 'General case' 0 C--O 1.198 -1.642 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.292 -176.028 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.84 -67.14 0.28 Allowed 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -160.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.436 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.26 -53.5 14.11 Favored 'General case' 0 C--O 1.259 1.593 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.132 -169.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.52 -17.69 63.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.271 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.948 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 10.9 tt0 -74.01 -44.73 53.47 Favored 'General case' 0 C--O 1.205 -1.272 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -50.14 -57.55 7.46 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.611 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.77 -60.56 2.96 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 121.838 0.828 . . . . 0.0 112.424 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.77 ' HB3' ' HB2' ' A' ' 22' ' ' HIS . . . -73.18 -16.64 61.42 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -169.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -79.93 -39.25 30.68 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 118.27 0.486 . . . . 0.0 109.948 174.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -52.59 -36.66 56.56 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.762 171.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.654 ' HD3' ' OD1' ' A' ' 20' ' ' ASP . 35.7 mtt180 -79.59 -42.93 23.91 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.65 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.963 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -46.05 -52.77 11.34 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.138 0.975 . . . . 0.0 112.228 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -107.99 29.89 9.69 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.006 -1.092 . . . . 0.0 111.956 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 3.8 t-160 -80.47 -57.02 3.78 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.5 91.79 3.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.533 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.01 141.46 51.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.143 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.251 1.135 0 O-C-N 123.719 0.637 . . . . 0.0 110.521 -179.215 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.753 0.311 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 68.9 m-70 -143.53 131.9 22.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.96 154.76 17.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.534 0.207 . . . . 0.0 110.793 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -135.52 163.44 30.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 111.2 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 HG23 ' A' ' 28' ' ' VAL . 40.0 t -100.17 135.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.837 176.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.85 3.96 61.97 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.99 171.39 8.48 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.704 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 84.5 m-85 -106.25 148.58 27.79 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.321 0.581 . . . . 0.0 111.259 -175.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.4 tt -99.06 136.73 38.6 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.664 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.679 HG11 ' HB2' ' A' ' 19' ' ' HIS . 3.3 t -141.14 139.71 32.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 O-C-N 125.044 1.465 . . . . 0.0 109.895 174.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.0 t -111.49 103.58 15.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 170.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 21.3 ptmt -97.1 -18.88 19.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.046 -177.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.41 -100.2 2.65 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.009 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.605 HG23 ' H ' ' A' ' 15' ' ' THR . 1.8 t -128.98 -70.95 0.65 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.605 ' H ' HG23 ' A' ' 14' ' ' THR . 1.2 p -144.65 -67.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -169.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.0 p -84.91 -0.03 52.75 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -169.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -90.8 171.64 9.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.644 0.259 . . . . 0.0 110.514 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.535 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 6.2 ptp180 -77.59 178.7 7.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.658 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.679 ' HB2' HG11 ' A' ' 10' ' ' VAL . 5.9 p80 -102.18 92.18 4.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.569 0.699 . . . . 0.0 109.888 170.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.535 ' OD2' ' HD2' ' A' ' 18' ' ' ARG . 1.9 t0 -100.03 -169.97 1.81 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.923 -174.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.687 ' N ' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER 43.23 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.807 0.843 . . . . 0.0 112.475 -177.38 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.928 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.7 t60 -134.49 137.96 44.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -171.08 -179.86 2.85 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.488 173.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.704 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 38.4 tt0 -98.59 136.1 39.16 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.033 0.444 . . . . 0.0 110.341 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 9' ' ' LEU . 1.5 mt -97.17 107.18 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.788 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -107.33 -24.88 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.993 176.384 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 1.079 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 19.3 mm-40 -115.72 99.88 7.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.795 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 5' ' ' VAL . 72.3 t -106.72 124.62 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.636 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -69.13 -37.81 78.52 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.5 p -146.07 144.65 30.16 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.95 74.1 0.88 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.078 0.466 . . . . 0.0 111.928 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 19.1 t70 -171.38 -57.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.092 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 146.39 89.99 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.949 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 p -132.02 97.05 18.91 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.857 0.361 . . . . 0.0 111.363 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.75 150.68 84.82 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.485 2.123 . . . . 0.0 111.213 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.413 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.3 Cg_endo -78.1 169.22 73.8 Favored 'Cis proline' 0 C--N 1.344 0.295 0 C-N-CA 123.346 -1.523 . . . . 0.0 112.826 0.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -113.58 155.47 25.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.079 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 66.4 t -98.76 102.07 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 172.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -106.14 158.01 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.077 -163.693 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.572 ' HB2' HD12 ' A' ' 26' ' ' ILE . 62.9 ttt180 -131.51 99.99 5.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.162 -169.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.742 ' HE1' HG22 ' A' ' 48' ' ' THR . 0.3 OUTLIER -81.75 71.66 8.78 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 174.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 3.0 pp -84.83 -23.7 28.96 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.86 -166.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.68 ' HB ' ' CE1' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -85.17 -6.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.968 0.889 . . . . 0.0 108.812 178.514 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 69' ' ' LYS . 50.1 m-80 -99.84 -61.57 1.35 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.123 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.88 42.4 0.1 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.044 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -157.04 164.59 37.78 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.907 0.354 . . . . 0.0 110.927 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -149.44 133.56 17.24 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.742 HG22 ' HE1' ' A' ' 41' ' ' TRP . 12.0 t -167.49 177.8 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.541 0.686 . . . . 0.0 111.182 -176.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.4 m -98.88 123.04 42.88 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.533 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.84 155.85 41.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.216 0.531 . . . . 0.0 111.543 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 46.4 m-85 -107.24 99.94 30.23 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.04 174.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HG3' HD11 ' A' ' 9' ' ' LEU . 43.6 Cg_endo -68.07 -30.48 31.92 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 122.68 2.253 . . . . 0.0 112.595 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.25 -128.8 9.02 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.9 m -124.59 164.31 20.09 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 59.71 53.77 4.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.466 0.65 . . . . 0.0 111.323 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.37 117.33 29.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.41 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.0 169.44 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.36 116.0 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.108 0.48 . . . . 0.0 111.106 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.632 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -109.22 178.3 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.302 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.7 p -126.96 -166.8 1.64 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.27 -176.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -51.6 -46.69 63.65 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.99 -50.78 67.17 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.481 -0.762 . . . . 0.0 111.441 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 25.2 mm-40 -63.57 -17.04 62.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.39 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.68 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -76.07 -32.68 59.4 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.462 -175.16 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.53 -77.22 0.06 Allowed 'General case' 0 C--O 1.25 1.114 0 CA-C-O 122.097 0.951 . . . . 0.0 111.609 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -63.89 -47.58 80.09 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.741 -173.332 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -66.63 -38.71 87.47 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.185 -177.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.928 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 41.2 tt0 -66.3 -39.95 89.69 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.479 -176.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.55 ' HA ' ' OD1' ' A' ' 44' ' ' ASN . 69.1 mttm -57.85 -63.3 1.29 Allowed 'General case' 0 C--O 1.25 1.096 0 C-N-CA 119.731 -0.787 . . . . 0.0 110.957 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.486 ' HD3' ' O ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -62.77 -43.14 99.58 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.425 0.631 . . . . 0.0 110.897 -174.395 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.687 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -81.76 -16.79 49.93 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -171.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.71 -38.71 62.26 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 119.716 -0.794 . . . . 0.0 108.882 171.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.1 -38.69 80.15 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.06 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.15 -38.16 25.11 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -56.94 -53.79 53.97 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.946 0.403 . . . . 0.0 111.786 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.54 27.72 11.59 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.16 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -78.62 92.19 4.7 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.488 -0.189 . . . . 0.0 110.488 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 65.06 21.45 12.24 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.413 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.31 -20.62 51.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.378 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.542 179.803 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 121.012 0.434 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -138.83 162.97 33.47 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 169.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.89 149.84 45.29 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.56 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 52.1 tptt -139.06 148.51 43.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.469 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.736 HG23 ' HA ' ' A' ' 26' ' ' ILE . 5.2 p -80.13 146.23 7.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.5 38.81 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -172.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -138.56 -179.15 5.64 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.712 -1.244 . . . . 0.0 108.392 -176.83 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.652 ' CD2' HD22 ' A' ' 42' ' ' LEU . 87.9 m-85 -137.54 171.87 13.82 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.394 -172.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.737 HD21 ' HB3' ' A' ' 52' ' ' PRO . 9.2 tt -138.53 137.16 36.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.157 -169.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 93.3 t -139.22 161.29 28.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.992 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.917 HG22 ' HB2' ' A' ' 21' ' ' GLN . 26.7 m -138.68 163.71 27.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 1.5 mppt? -134.53 159.01 42.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.976 0.417 . . . . 0.0 110.789 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.429 ' H ' ' CB ' ' A' ' 17' ' ' GLU . . . -91.17 161.26 27.67 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 172.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -74.42 -13.32 60.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.257 0.551 . . . . 0.0 110.676 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.7 p -80.41 8.97 6.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.843 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.3 m 74.46 84.83 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.978 0.894 . . . . 0.0 111.117 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' CB ' ' H ' ' A' ' 13' ' ' GLY . 4.8 tp10 -103.19 156.22 17.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.619 -1.173 . . . . 0.0 107.863 173.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -90.58 -70.65 0.66 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.723 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 52.9 m-70 -142.79 92.94 2.45 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.0 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.44 152.99 35.94 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.957 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 2.2 mp0 57.73 97.64 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.385 0.428 . . . . 0.0 110.261 -170.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.69 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 82.8 t60 -138.75 127.31 23.23 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.832 0.825 . . . . 0.0 112.53 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -139.42 -178.7 5.5 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.308 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.608 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 28.6 tt0 -136.99 111.69 8.75 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.529 ' CG2' HG22 ' A' ' 28' ' ' VAL . 9.7 mt -81.14 103.06 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.402 -167.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.736 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.9 pp -107.88 -7.56 10.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.114 176.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.926 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 3.0 tp10 -139.21 136.2 34.76 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.382 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.529 HG22 ' CG2' ' A' ' 25' ' ' ILE . 46.8 t -137.99 99.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -168.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -105.26 84.03 2.05 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.13 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.6 m -151.61 109.64 3.71 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.605 -175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.81 -16.81 24.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.41 -45.28 9.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.528 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.88 40.11 3.41 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 -169.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.663 ' HB3' ' HD2' ' A' ' 35' ' ' PRO . 62.4 m -152.18 167.59 12.93 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 34' ' ' SER . 12.5 Cg_endo -56.13 159.57 12.23 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.013 2.475 . . . . 0.0 112.68 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.557 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 84.3 Cg_endo -82.4 179.59 26.36 Favored 'Cis proline' 0 C--N 1.347 0.451 0 C-N-CA 123.153 -1.603 . . . . 0.0 113.263 1.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -138.76 174.86 10.08 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.926 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 84.2 t -137.6 122.32 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.64 176.19 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 CA-C-N 113.378 -1.737 . . . . 0.0 110.498 -149.192 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.608 ' HD3' ' OE2' ' A' ' 24' ' ' GLU . 35.6 ttt180 -138.54 124.04 19.53 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -174.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.445 ' HZ3' ' O ' ' A' ' 22' ' ' HIS . 8.9 m95 -65.16 102.98 0.7 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 166.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.652 HD22 ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -59.85 -89.58 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.902 -1.499 . . . . 0.0 113.845 -154.02 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.682 HG23 ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -60.41 -26.27 36.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -176.172 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -60.54 -57.2 13.74 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 172.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.33 51.41 0.72 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.64 -0.79 . . . . 0.0 114.152 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -139.21 170.37 16.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.062 0.431 . . . . 0.0 109.888 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 7.9 mp0 -138.21 134.73 34.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.515 0.674 . . . . 0.0 111.002 -175.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.493 ' CG2' HG12 ' A' ' 39' ' ' VAL . 10.0 t -139.36 -178.97 5.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.087 -172.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.504 HG23 HG22 ' A' ' 38' ' ' VAL . 44.7 m -138.21 113.71 9.6 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.87 -179.82 2.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-O 121.672 0.749 . . . . 0.0 112.954 -161.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 2.0 m-85 -138.86 116.7 9.01 Favored Pre-proline 0 N--CA 1.455 -0.223 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.674 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.737 ' HB3' HD21 ' A' ' 9' ' ' LEU . 28.5 Cg_endo -64.38 -65.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.474 0.353 0 C-N-CA 122.564 2.176 . . . . 0.0 113.55 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 138.05 -146.82 18.72 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.285 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.0 m -81.14 151.42 28.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 0.0 111.248 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 t70 48.74 64.81 1.55 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.813 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.887 ' HA ' HG12 ' A' ' 11' ' ' VAL . . . -79.46 133.61 36.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.817 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 58' ' ' VAL . 2.3 t -138.75 -179.83 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.751 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -138.18 152.37 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.983 -177.593 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.582 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.77 179.75 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.018 -172.165 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.2 p -120.21 -165.44 1.19 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.302 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.451 ' O ' ' ND1' ' A' ' 64' ' ' HIS . . . -56.9 -48.2 78.76 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -59.96 4.34 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.102 -0.999 . . . . 0.0 111.827 -175.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -57.27 -21.27 33.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.021 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.586 ' HA ' ' NE2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.35 -44.12 84.07 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.263 -176.526 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.587 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . -57.62 -70.33 0.14 Allowed 'General case' 0 C--O 1.251 1.145 0 CA-C-O 122.337 1.065 . . . . 0.0 113.051 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -57.01 -55.01 40.23 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.553 -176.021 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.637 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.41 -29.07 63.81 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.909 176.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.682 ' HG2' HG23 ' A' ' 43' ' ' VAL . 3.2 tp10 -56.87 -58.74 6.81 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.76 -72.63 0.08 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.825 -178.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.594 ' HG3' ' H ' ' A' ' 71' ' ' ALA . 31.9 ptt180 -57.46 -67.68 0.3 Allowed 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.743 0.783 . . . . 0.0 112.281 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 67' ' ' ALA . . . -57.38 -47.79 80.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.074 -0.966 . . . . 0.0 113.584 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -57.38 -46.11 83.75 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.089 0.859 . . . . 0.0 111.177 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 77' ' ' HIS . . . -56.97 -29.64 63.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.04 0.448 . . . . 0.0 111.322 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -81.59 -50.07 9.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.994 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.957 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -54.63 -66.53 0.39 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.661 0.784 . . . . 0.0 112.004 -176.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.09 59.12 0.37 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.796 -1.193 . . . . 0.0 112.196 -172.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.482 ' HB3' ' O ' ' A' ' 73' ' ' ALA . 42.6 p-80 -83.54 -27.13 29.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.047 0.451 . . . . 0.0 110.616 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.05 103.8 4.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.484 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.92 81.61 1.77 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.074 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.402 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -138.8 123.05 18.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.564 0.221 . . . . 0.0 110.489 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.06 120.18 14.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.726 ' HA ' HG21 ' A' ' 28' ' ' VAL . 98.6 mttt -138.88 176.31 8.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 112.144 -173.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.805 HG23 ' HA ' ' A' ' 26' ' ' ILE . 8.5 p -71.1 156.78 6.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.514 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.28 12.52 82.08 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.13 -178.79 5.5 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 113.754 -1.223 . . . . 0.0 107.836 -172.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.815 ' HB2' HG23 ' A' ' 59' ' ' VAL . 67.6 m-85 -137.39 174.03 11.04 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.535 -174.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.764 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 4.4 tt -138.14 153.11 49.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.23 -164.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.071 HG11 ' HB2' ' A' ' 19' ' ' HIS . 38.3 t -138.89 151.72 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 125.106 1.504 . . . . 0.0 109.614 -169.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.777 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.8 p -127.57 165.54 26.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -70.98 112.93 7.52 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.837 0.351 . . . . 0.0 110.121 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.03 -51.13 60.41 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.7 t -132.28 -26.48 1.88 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.772 0.796 . . . . 0.0 108.92 171.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 16' ' ' THR . 9.2 m -157.15 172.69 18.2 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 175.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 15' ' ' THR . 9.4 m -60.43 -25.66 66.13 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.475 0.655 . . . . 0.0 109.606 173.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -63.59 115.42 4.69 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.377 172.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 71.21 99.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 124.05 0.844 . . . . 0.0 110.114 -173.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 1.071 ' HB2' HG11 ' A' ' 10' ' ' VAL . 8.5 p-80 -86.44 125.57 33.79 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.737 -175.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -133.41 171.79 13.59 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -173.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 1.025 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 2.0 mp0 65.11 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.922 0.489 . . . . 0.0 110.94 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.764 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 1.2 m-70 -128.03 147.4 50.51 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 122.151 -0.343 . . . . 0.0 111.143 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.619 ' HA ' ' HE1' ' A' ' 64' ' ' HIS . . . -157.87 175.12 14.27 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.702 ' HA ' ' HD1' ' A' ' 8' ' ' TYR . 40.1 tt0 -98.63 130.85 45.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.769 0.795 . . . . 0.0 112.664 -172.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' ' 9' ' ' LEU . 49.4 mt -90.66 108.01 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.66 171.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.805 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.3 pp -108.01 -28.5 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.921 177.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.99 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 45.2 mt-10 -124.02 117.21 24.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.23 0.538 . . . . 0.0 110.123 175.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' A' ' 4' ' ' LYS . 79.5 t -98.87 116.18 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.854 -176.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 29' ' ' ARG . 14.8 mmm180 -88.18 -13.96 39.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.895 0.379 . . . . 0.0 111.342 -174.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.455 ' HB3' ' H ' ' A' ' 34' ' ' SER . 23.0 t -129.71 104.08 7.21 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.75 -35.13 55.75 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.738 0.649 . . . . 0.0 112.656 -174.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.45 -58.56 3.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 110.203 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.45 83.37 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.699 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.455 ' H ' ' HB3' ' A' ' 30' ' ' SER . 50.0 m -154.58 148.5 18.93 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 175.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 16.8 Cg_exo -68.36 160.3 49.65 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.768 2.312 . . . . 0.0 111.822 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -88.56 179.53 16.92 Favored 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.745 -1.356 . . . . 0.0 112.648 0.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -131.75 158.59 40.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.912 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.99 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 59.8 t -98.78 116.38 41.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.28 133.19 58.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.31 -162.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.545 ' HG2' HG12 ' A' ' 26' ' ' ILE . 6.5 ptp180 -112.0 142.84 43.92 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.533 176.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.608 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 23.6 m95 -90.56 111.02 22.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.46 HD21 ' HG3' ' A' ' 40' ' ' ARG . 7.2 mt -82.67 -58.44 2.9 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.198 0.523 . . . . 0.0 111.47 -169.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.931 HG21 ' HA ' ' A' ' 65' ' ' ALA . 1.3 m -80.58 -5.54 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.611 -170.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -100.04 -47.24 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.138 167.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.9 79.07 1.14 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.911 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.608 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -163.77 164.48 23.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.642 0.258 . . . . 0.0 110.911 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.478 ' OE2' ' HB3' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -134.79 121.01 20.09 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.485 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.0 p -143.09 -179.92 6.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.581 0.705 . . . . 0.0 111.861 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.2 m -123.75 110.09 14.5 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 168.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.13 139.16 25.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-O 121.526 0.679 . . . . 0.0 112.251 -166.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -105.5 99.61 21.98 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.884 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.461 ' HG3' HD11 ' A' ' 9' ' ' LEU . 90.9 Cg_endo -83.66 163.13 14.37 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.263 1.975 . . . . 0.0 111.63 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.61 171.42 53.99 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.684 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 17.2 m -61.26 145.91 49.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.505 0.193 . . . . 0.0 111.267 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 54' ' ' SER . 6.3 m-20 72.98 63.22 0.1 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.979 0.799 . . . . 0.0 110.643 -174.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -86.94 124.44 33.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.926 175.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 10' ' ' VAL . 6.6 t -99.05 157.78 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -108.34 123.83 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.664 178.704 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -121.91 172.52 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-O 121.056 0.455 . . . . 0.0 111.278 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.554 ' CG2' ' H ' ' A' ' 61' ' ' ALA . 1.3 m -111.57 -173.92 2.35 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.614 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -52.51 -45.87 66.43 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -166.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.85 -61.0 2.44 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -58.28 -26.92 63.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.901 0.858 . . . . 0.0 109.699 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.619 ' HE1' ' HA ' ' A' ' 23' ' ' ALA . 47.4 t60 -64.1 -37.19 86.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.657 -1.156 . . . . 0.0 113.182 -175.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.931 ' HA ' HG21 ' A' ' 43' ' ' VAL . . . -64.09 -69.29 0.29 Allowed 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.726 0.774 . . . . 0.0 113.046 -169.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.47 -39.89 89.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.132 -175.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.13 -16.8 61.44 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.837 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 20.0 tt0 -72.56 -46.16 55.75 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.054 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -61.99 -40.39 95.45 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.653 176.355 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -64.41 -22.43 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.18 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 1.025 ' HA ' ' HG3' ' A' ' 21' ' ' GLN . . . -82.26 -42.92 18.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.718 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.46 -21.33 65.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.86 -64.3 0.99 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.584 172.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HD2' ' OE1' ' A' ' 21' ' ' GLN . 62.8 mtt180 -81.84 -64.26 1.22 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -175.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.59 -52.68 62.44 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.953 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.86 33.91 2.13 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.973 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -123.28 -21.81 5.27 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.53 0.205 . . . . 0.0 111.215 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -152.18 -171.01 3.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.577 0.227 . . . . 0.0 110.971 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -143.14 111.16 6.04 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.76 -175.667 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.619 ' CD2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 m170 -131.95 132.7 43.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.941 0.4 . . . . 0.0 110.629 175.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.16 124.07 43.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.556 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -125.01 158.26 34.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.672 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.828 HG23 ' HA ' ' A' ' 26' ' ' ILE . 4.3 p -75.39 144.62 11.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.296 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.36 11.99 74.07 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.629 ' OD2' ' HB ' ' A' ' 58' ' ' VAL . 6.5 t70 -132.73 149.29 52.3 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.557 ' CE2' ' HA ' ' A' ' 61' ' ' ALA . 95.3 m-85 -98.79 155.22 17.47 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.386 0.612 . . . . 0.0 111.314 -168.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.664 HD11 ' HG3' ' A' ' 52' ' ' PRO . 10.2 tt -98.69 136.27 38.99 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.918 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 1.1 p -132.69 167.54 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 170.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.636 HG13 ' HB2' ' A' ' 12' ' ' LYS . 2.6 p -141.91 168.03 15.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.219 171.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.636 ' HB2' HG13 ' A' ' 11' ' ' VAL . 18.4 ttmt 69.34 13.92 8.49 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.515 0.51 . . . . 0.0 112.322 165.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.55 48.15 3.98 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.656 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 m -89.74 -31.08 17.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.733 -0.233 . . . . 0.0 111.487 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.7 t -124.75 130.97 53.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.813 0.34 . . . . 0.0 111.635 -172.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 17' ' ' GLU . 7.3 m 58.77 -92.28 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.67 177.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.417 ' H ' ' HB ' ' A' ' 16' ' ' THR . 0.6 OUTLIER -167.69 90.14 0.32 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.264 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -129.09 94.12 3.74 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.872 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.904 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 16.4 p-80 -79.32 89.92 4.96 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.289 0.566 . . . . 0.0 110.344 175.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD2' ' HG3' ' A' ' 21' ' ' GLN . 4.3 t70 -85.55 -138.38 0.07 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.468 -176.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.666 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 77.0 mt-30 -41.13 120.01 1.28 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.371 0.668 . . . . 0.0 112.581 -160.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.74 ' CD2' ' HA ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -128.35 144.34 51.12 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -165.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -179.17 -179.75 0.59 Allowed 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.279 0.987 . . . . 0.0 110.2 173.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.517 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 5.0 tp10 -98.28 128.73 44.86 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.581 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.506 ' CG2' HG22 ' A' ' 28' ' ' VAL . 14.0 mt -93.15 101.16 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.828 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -103.06 -23.33 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.297 178.183 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.828 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 38.7 mt-10 -129.59 103.35 6.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.017 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.506 HG22 ' CG2' ' A' ' 25' ' ' ILE . 46.3 t -98.98 110.66 26.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.146 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.87 -46.19 66.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.304 0.573 . . . . 0.0 110.052 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.3 m -125.29 112.73 16.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.907 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.28 66.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -173.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.619 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 18.0 t70 -78.16 -65.24 1.0 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.234 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 167.24 73.96 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.474 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.0 m -151.26 126.5 4.79 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.706 0.289 . . . . 0.0 110.242 177.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.59 166.87 20.59 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.191 2.594 . . . . 0.0 111.434 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.08 152.35 88.42 Favored 'Cis proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.783 -1.34 . . . . 0.0 112.974 3.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -106.17 137.84 43.39 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.828 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 61.0 t -98.64 107.53 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -118.07 151.23 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.086 -165.587 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -126.74 128.21 46.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.377 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.601 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 11.4 m95 -76.03 106.59 7.71 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.89 -55.44 4.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.196 0.522 . . . . 0.0 110.517 -174.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 43' ' ' VAL . 2.3 m -81.71 -4.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.719 -176.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 39.4 m-80 -97.88 -71.52 0.68 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.232 165.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.71 73.85 0.14 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.349 -0.929 . . . . 0.0 114.569 171.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.94 169.0 1.61 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.242 0.521 . . . . 0.0 110.882 169.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -120.14 145.63 46.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.33 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.6 t -172.33 -179.86 2.38 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 121.668 0.747 . . . . 0.0 112.246 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.8 m -115.14 121.89 44.4 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.23 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 39' ' ' VAL . 35.8 m -118.88 159.08 19.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 CA-C-O 121.571 0.7 . . . . 0.0 112.851 -170.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -125.07 99.9 33.9 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.892 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.664 ' HG3' HD11 ' A' ' 9' ' ' LEU . 73.3 Cg_endo -77.16 -24.48 9.5 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.358 2.039 . . . . 0.0 112.76 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.19 -163.59 15.83 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.935 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.1 p -86.09 166.14 16.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.464 0.132 . . . . 0.0 110.772 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 62.52 42.02 9.09 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.406 0.622 . . . . 0.0 110.689 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.25 135.04 33.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.67 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.506 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 10.4 t -124.09 158.73 30.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.629 ' HB ' ' OD2' ' A' ' 7' ' ' ASP . 1.6 m -102.87 125.3 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.139 0.495 . . . . 0.0 111.409 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.566 HG21 ' NE2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -118.77 175.24 3.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.252 -175.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -111.94 -168.85 1.37 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.025 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -60.56 -47.63 85.35 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -70.41 -36.76 74.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.834 0.35 . . . . 0.0 111.488 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.34 -16.28 62.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.585 0.707 . . . . 0.0 109.471 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.74 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 2.7 t-80 -82.89 -44.77 15.02 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.19 -68.68 0.23 Allowed 'General case' 0 C--O 1.247 0.973 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -164.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.467 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -60.81 -36.8 79.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.144 -175.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.904 ' HB2' ' HD2' ' A' ' 19' ' ' HIS . . . -74.46 -22.06 59.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.741 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.606 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 13.8 tt0 -79.67 -34.59 40.19 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.833 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -56.04 -65.44 0.6 Allowed 'General case' 0 C--O 1.244 0.807 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.412 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -59.63 -65.56 0.65 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.171 0.986 . . . . 0.0 111.824 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -78.22 -16.93 57.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.449 -165.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -82.26 -35.37 28.17 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.811 173.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.62 -34.35 69.2 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.136 0.494 . . . . 0.0 110.154 171.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -81.81 -40.97 21.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.868 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.5 -57.52 12.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.13 0.572 . . . . 0.0 111.872 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.17 44.59 3.39 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.305 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -83.44 -32.28 26.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.01 95.53 3.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.886 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.9 98.62 5.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.576 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 64.2 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.089 -175.728 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.539 ' SD ' ' HA3' ' A' ' 33' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.482 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 47.3 t-80 -133.79 125.19 27.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 175.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.79 166.83 11.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.79 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.02 160.07 35.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.74 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.85 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.1 p -83.03 146.03 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.14 0.495 . . . . 0.0 111.398 -175.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.33 6.33 58.79 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.12 168.29 18.24 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.712 ' HB2' HG23 ' A' ' 59' ' ' VAL . 97.1 m-85 -103.14 157.38 17.04 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.448 0.642 . . . . 0.0 111.537 -171.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.67 ' HB2' HD11 ' A' ' 25' ' ' ILE . 9.4 tt -98.91 138.31 36.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.544 175.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 0.5 OUTLIER -136.94 164.89 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.459 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.913 ' HB ' ' HB3' ' A' ' 20' ' ' ASP . 69.8 t -117.27 146.87 21.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 171.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 79.6 tttt -72.71 101.76 3.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.875 0.369 . . . . 0.0 110.204 174.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.42 146.61 23.76 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.642 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 m -72.83 -59.8 2.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.149 0.499 . . . . 0.0 110.264 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 p -131.64 42.9 3.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.533 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.1 p -90.43 4.53 50.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.117 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 70.12 -69.19 0.18 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.612 0.765 . . . . 0.0 111.87 178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -91.82 -83.0 0.3 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.444 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.559 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . 52.9 m80 -146.5 160.71 41.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -175.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.913 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 3.2 t70 -102.47 -154.46 0.49 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.773 ' HA ' ' HB1' ' A' ' 71' ' ' ALA . 68.0 mt-30 -41.15 131.62 2.62 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.706 0.802 . . . . 0.0 112.235 -168.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.896 ' CE1' ' HA ' ' A' ' 64' ' ' HIS . 6.4 t60 -145.68 142.48 29.05 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -165.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.521 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -172.62 177.96 2.81 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.801 0.84 . . . . 0.0 109.858 173.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.684 ' HG3' HD11 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -98.6 126.6 44.24 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.6 0.238 . . . . 0.0 110.853 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 9' ' ' LEU . 14.4 mt -94.95 106.5 18.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 -176.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.85 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -102.0 -27.7 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.727 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.984 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 69.1 mm-40 -119.64 101.68 8.09 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.118 0.485 . . . . 0.0 110.633 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -98.93 102.5 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.081 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -89.36 -1.37 58.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.489 0.661 . . . . 0.0 109.765 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.81 ' HB3' ' H ' ' A' ' 34' ' ' SER . 1.4 m -80.59 124.36 28.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.857 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.61 -41.32 98.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.299 0.571 . . . . 0.0 109.99 175.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 52.2 m-20 -114.66 -68.59 0.91 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.472 173.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.539 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . -174.47 54.6 0.14 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.327 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.81 ' H ' ' HB3' ' A' ' 30' ' ' SER . 5.0 p -106.52 143.72 27.57 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 122.245 0.218 . . . . 0.0 111.165 -178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 12.9 Cg_exo -70.17 157.24 60.21 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.798 2.332 . . . . 0.0 111.611 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -87.46 174.34 29.17 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.45 -1.479 . . . . 0.0 112.937 -1.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -123.21 149.92 44.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.984 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 98.9 t -98.68 108.77 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 172.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.77 165.37 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.922 -162.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.549 ' HG3' HD21 ' A' ' 42' ' ' LEU . 9.9 ptp180 -142.36 133.07 25.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.958 0.408 . . . . 0.0 111.001 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.554 ' HB2' ' HB2' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -82.28 106.32 14.07 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.912 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.684 HD11 ' HG3' ' A' ' 24' ' ' GLU . 18.6 mt -77.51 -50.8 11.86 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.075 0.464 . . . . 0.0 110.977 -171.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.472 HG22 ' OE2' ' A' ' 68' ' ' GLU . 2.4 m -79.69 -6.02 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.167 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 41' ' ' TRP . 18.2 m120 -100.03 -51.18 3.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.754 174.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.7 70.45 0.68 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.2 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.489 ' CB ' ' HD1' ' A' ' 41' ' ' TRP . 0.4 OUTLIER -174.49 161.39 3.31 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.802 0.441 . . . . 0.0 110.264 176.547 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.71 139.98 46.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 t -173.67 171.06 3.9 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.671 0.748 . . . . 0.0 112.359 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.7 m -98.87 111.39 23.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.943 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -107.92 156.75 8.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.502 0.667 . . . . 0.0 112.594 -169.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -120.14 104.69 43.32 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.032 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.459 ' HA ' ' OE1' ' A' ' 21' ' ' GLN . 72.1 Cg_endo -75.05 -5.22 16.5 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.829 2.353 . . . . 0.0 112.13 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.63 -78.76 1.96 Allowed Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.997 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.8 p -160.75 166.99 27.76 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.491 -0.189 . . . . 0.0 110.491 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.678 ' HB3' ' HB3' ' A' ' 12' ' ' LYS . 71.9 m-20 66.69 38.25 4.01 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.604 0.565 . . . . 0.0 111.9 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -77.63 132.4 38.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.155 0.503 . . . . 0.0 111.312 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.621 ' HB ' HG12 ' A' ' 10' ' ' VAL . 10.8 t -126.33 159.3 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.443 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.6 t -98.96 117.67 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.888 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.712 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -111.76 173.17 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.54 -178.34 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -122.67 -164.93 1.23 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.654 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -58.24 -44.95 88.53 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.35 -33.64 37.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.351 0.596 . . . . 0.0 110.96 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 12.5 mm-40 -63.4 -16.38 60.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.743 172.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.896 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.9 OUTLIER -81.8 -50.6 9.04 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -172.169 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.68 -70.5 0.1 Allowed 'General case' 0 C--O 1.247 0.964 0 CA-C-O 121.569 0.7 . . . . 0.0 112.613 -165.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -49.4 77.59 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.376 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' A' ' 19' ' ' HIS . . . -64.88 -38.32 90.57 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.626 -175.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.807 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 25.5 tt0 -69.62 -41.6 75.45 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.057 -174.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -58.49 -57.49 12.73 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.674 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -63.62 -45.93 88.06 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.725 0.774 . . . . 0.0 111.157 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.773 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -81.45 -16.42 52.07 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.03 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.98 -39.72 61.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -63.35 -25.74 68.44 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.671 174.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -82.2 -56.54 3.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.972 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.6 -62.17 1.86 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.666 0.787 . . . . 0.0 112.413 -174.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.28 30.21 4.51 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.235 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.53 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 45.9 t-80 -112.12 -29.53 7.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.14 -13.11 19.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.684 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.14 103.09 7.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.407 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.247 0.953 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.3 178.951 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.421 ' SD ' ' HA3' ' A' ' 33' ' ' GLY . 1.1 tmt? . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.766 0.317 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -139.05 135.74 34.52 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 173.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.2 152.4 19.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.74 0.305 . . . . 0.0 110.921 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 7' ' ' ASP . 12.6 tmtt? -139.9 129.44 24.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.415 ' O ' ' HD3' ' A' ' 4' ' ' LYS . 7.4 p -80.24 141.2 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.024 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.04 6.86 71.14 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.421 ' CG ' ' HD2' ' A' ' 4' ' ' LYS . 1.1 m-20 -123.09 173.43 7.86 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.71 ' HB2' HG23 ' A' ' 59' ' ' VAL . 98.3 m-85 -107.92 152.9 23.81 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.37 0.605 . . . . 0.0 111.881 -173.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.806 HD11 ' HG3' ' A' ' 52' ' ' PRO . 6.8 tt -103.02 141.79 35.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.332 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 3.4 t -145.81 144.3 21.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 O-C-N 124.71 1.256 . . . . 0.0 109.707 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 21' ' ' GLN . 21.1 m -100.51 149.21 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.194 0.521 . . . . 0.0 109.952 170.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -122.11 1.11 9.73 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.456 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.08 -28.75 73.92 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.209 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -78.5 80.52 4.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.2 m -65.11 -27.95 69.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.197 -171.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.8 t -70.11 -17.93 63.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.04 0.448 . . . . 0.0 111.15 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -102.09 176.83 5.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.187 0.518 . . . . 0.0 111.88 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.453 ' HD2' ' H ' ' A' ' 18' ' ' ARG . 6.4 mpt_? -79.17 -65.24 1.02 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.204 177.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.553 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -152.46 112.94 4.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.275 175.208 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -100.16 173.39 6.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.66 -169.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.576 ' N ' ' HB1' ' A' ' 71' ' ' ALA . 68.5 mt-30 38.19 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.767 1.227 . . . . 0.0 112.954 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.733 ' CE1' ' HA ' ' A' ' 64' ' ' HIS . 41.3 t-80 -133.37 139.9 47.06 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -169.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -168.02 -179.95 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.627 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.602 ' CD ' HD11 ' A' ' 42' ' ' LEU . 45.7 tt0 -98.58 129.57 45.12 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.036 0.446 . . . . 0.0 111.12 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.695 HD11 ' HB2' ' A' ' 9' ' ' LEU . 45.7 mt -92.01 105.54 16.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.765 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.682 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -102.47 -26.32 3.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.817 177.361 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 37.0 tt0 -129.69 119.83 24.16 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.405 0.621 . . . . 0.0 110.364 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.21 121.44 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.205 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -64.36 -33.58 76.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.98 0.419 . . . . 0.0 110.599 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.9 t -149.76 128.17 12.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.52 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.92 -23.06 67.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 0.0 111.006 -176.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.38 -17.63 64.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.411 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 105.38 5.49 39.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.336 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 6.6 m -67.54 122.53 83.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.572 0.225 . . . . 0.0 110.999 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 15.9 Cg_exo -68.65 165.52 29.14 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.412 2.741 . . . . 0.0 111.924 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 83.2 Cg_endo -80.56 -175.56 16.35 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.982 -1.258 . . . . 0.0 113.085 1.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -123.83 148.41 46.76 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 96.3 t -98.66 101.71 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 173.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.92 145.58 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.659 -163.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.42 ' HG3' ' HG3' ' A' ' 47' ' ' GLU . 55.4 ttt180 -121.22 130.04 53.49 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.054 -176.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 13.0 m95 -79.79 96.24 6.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.602 HD11 ' CD ' ' A' ' 24' ' ' GLU . 20.1 mt -72.85 -61.28 1.87 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.352 0.596 . . . . 0.0 110.834 -173.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.462 HG22 ' OE2' ' A' ' 68' ' ' GLU . 2.0 m -73.93 -5.83 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.333 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 54.9 m-80 -98.61 -62.73 1.2 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.903 173.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.9 63.58 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.526 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -167.38 155.22 9.11 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.14 0.495 . . . . 0.0 111.794 173.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HG3' ' HG3' ' A' ' 40' ' ' ARG . 3.7 mp0 -111.77 141.91 44.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.094 175.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.467 HG23 HG23 ' A' ' 50' ' ' VAL . 8.8 t -165.89 179.84 5.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.583 0.706 . . . . 0.0 112.159 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 m -125.22 106.03 9.58 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.832 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 48' ' ' THR . 70.3 t -109.42 147.43 13.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.32 0.581 . . . . 0.0 111.867 -169.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 62.2 m-85 -107.69 99.77 31.27 Favored Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.325 170.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.806 ' HG3' HD11 ' A' ' 9' ' ' LEU . 84.5 Cg_endo -82.12 -22.8 4.81 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.835 2.357 . . . . 0.0 111.805 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.49 -143.4 14.32 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 m -135.48 16.63 3.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.56 0.68 . . . . 0.0 110.687 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -106.49 16.46 24.62 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.124 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.51 114.68 3.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.986 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.813 HG22 ' H ' ' A' ' 58' ' ' VAL . 10.5 p -98.94 175.96 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.813 ' H ' HG22 ' A' ' 57' ' ' VAL . 46.5 t -119.36 125.1 74.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.291 -172.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.71 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -122.42 175.75 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.534 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -117.45 -167.12 1.27 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.525 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -59.66 -41.17 90.01 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -170.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.92 -46.25 62.8 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.893 -0.504 . . . . 0.0 111.462 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 28.3 mm-40 -62.35 -16.46 54.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.616 0.722 . . . . 0.0 109.947 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.733 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -73.47 -43.78 59.46 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.18 -176.293 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.58 -72.69 0.09 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.641 0.734 . . . . 0.0 112.295 -168.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.86 ' HA ' ' HE2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -61.84 -45.87 91.93 Favored 'General case' 0 C--O 1.253 1.254 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.42 -174.064 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.553 ' HB2' ' CD2' ' A' ' 19' ' ' HIS . . . -58.49 -46.22 87.11 Favored 'General case' 0 C--O 1.204 -1.311 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.245 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 15.4 tt0 -65.31 -39.68 92.79 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.906 -171.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.86 ' HE2' ' HA ' ' A' ' 66' ' ' GLU . 57.3 pttt -64.19 -56.61 13.53 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.883 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.447 HH21 ' HA ' ' A' ' 67' ' ' ALA . 59.9 mtm180 -60.91 -44.7 96.81 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.547 1.165 . . . . 0.0 110.752 -177.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -80.47 -16.52 54.13 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.416 -172.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.2 -35.81 66.4 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.059 170.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -29.67 70.04 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.659 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.432 ' HB2' ' HA ' ' A' ' 71' ' ' ALA . 12.7 mmt180 -81.92 -58.13 3.11 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -63.06 -63.48 1.19 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.025 0.53 . . . . 0.0 111.514 -174.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -87.18 41.35 3.09 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.206 -175.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -77.24 -32.44 55.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.355 0.598 . . . . 0.0 109.531 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -147.67 82.98 1.53 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.057 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.32 -45.02 0.41 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.334 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.233 -0.889 . . . . 0.0 109.93 175.996 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tmt? . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 3.6 m-70 -138.93 140.57 38.36 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.48 ' HB1' ' CD1' ' A' ' 25' ' ' ILE . . . -138.34 140.48 39.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 111.471 -163.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.849 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 28.8 mmtp -138.49 140.68 39.29 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.211 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 26' ' ' ILE . 24.7 t -70.23 136.36 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 O-C-N 122.211 -0.306 . . . . 0.0 111.23 176.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.98 17.41 51.5 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.849 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.6 m-20 -138.97 144.17 38.86 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.439 -1.881 . . . . 0.0 108.288 -166.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.821 ' CD1' ' HB2' ' A' ' 24' ' ' GLU . 74.6 m-85 -134.96 141.81 46.34 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -148.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.875 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 1.3 tt -136.71 139.56 42.02 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -152.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.583 HG11 ' HB3' ' A' ' 19' ' ' HIS . 3.9 t -139.14 140.58 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 O-C-N 126.683 2.489 . . . . 0.0 109.371 -167.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.927 HG22 ' HB2' ' A' ' 21' ' ' GLN . 14.6 m -138.67 140.49 39.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.066 0.46 . . . . 0.0 110.604 176.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.4 ' HE3' ' HB ' ' A' ' 16' ' ' THR . 4.2 ttmp? -57.16 105.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.177 175.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.11 61.62 4.66 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.143 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m 64.34 16.63 10.27 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.61 0.719 . . . . 0.0 111.125 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.9 t -160.4 140.55 11.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.478 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.4 ' HB ' ' HE3' ' A' ' 12' ' ' LYS . 8.3 t -100.72 45.93 0.96 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.587 0.708 . . . . 0.0 110.781 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -114.92 -70.42 0.8 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 18' ' ' ARG . 3.2 tpt180 -92.76 108.85 20.3 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.948 178.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.583 ' HB3' HG11 ' A' ' 10' ' ' VAL . 64.7 m80 -63.08 112.86 2.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 171.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.695 ' OD1' ' HB3' ' A' ' 74' ' ' ARG . 2.1 t70 -122.32 -168.35 1.71 Allowed 'General case' 0 C--O 1.217 -0.622 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.562 -161.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.927 ' HB2' HG22 ' A' ' 11' ' ' VAL . 75.3 mt-30 45.03 91.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.674 0.79 . . . . 0.0 111.413 -173.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.875 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 6.2 t60 -138.85 116.24 11.21 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 121.255 0.55 . . . . 0.0 112.075 -168.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.571 ' HB2' ' NE1' ' A' ' 41' ' ' TRP . . . -139.65 -178.8 5.57 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.141 -1.391 . . . . 0.0 108.475 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.821 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 3.3 tm-20 -137.28 122.59 19.38 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.24 1.019 . . . . 0.0 110.312 -177.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.867 HG23 HG23 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -80.08 113.96 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 113.459 -1.701 . . . . 0.0 111.004 -174.37 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.737 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -98.86 -8.71 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.111 169.418 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.738 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -138.97 127.15 22.62 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.498 177.198 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.415 ' CG2' ' HB ' ' A' ' 25' ' ' ILE . 54.7 t -138.03 100.0 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.795 -169.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -103.81 20.35 18.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.163 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.573 ' HB3' ' H ' ' A' ' 34' ' ' SER . 3.6 m -108.88 111.08 22.6 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.434 177.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.06 93.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.31 0.576 . . . . 0.0 110.405 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 32.9 t70 -95.33 -56.83 2.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.007 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.1 70.37 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.422 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.573 ' H ' ' HB3' ' A' ' 30' ' ' SER . 20.0 t -150.25 142.6 15.79 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.32 151.56 9.5 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.467 2.778 . . . . 0.0 113.102 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.572 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.8 Cg_endo -85.51 -177.2 15.3 Favored 'Cis proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.108 -1.622 . . . . 0.0 113.664 3.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -138.78 173.36 11.65 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.157 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.738 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 72.4 t -137.78 114.47 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.453 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.867 HG23 HG23 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -138.75 165.3 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-N 111.965 -2.38 . . . . 0.0 107.664 -149.455 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.631 ' HB2' HD12 ' A' ' 26' ' ' ILE . 33.4 ttt180 -138.66 127.52 23.69 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.493 -172.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.61 ' CZ3' HG21 ' A' ' 48' ' ' THR . 3.4 m0 -86.99 83.79 7.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.502 HD12 ' CE1' ' A' ' 8' ' ' TYR . 8.0 mt -60.28 -64.22 1.03 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.986 -166.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.605 HG13 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -60.11 -33.07 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.216 -176.235 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 0.9 OUTLIER -60.53 -65.39 0.69 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.167 0.508 . . . . 0.0 110.792 168.505 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.33 39.11 0.6 Allowed Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.728 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -139.16 171.31 14.48 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 117.126 0.463 . . . . 0.0 110.457 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' HG3' ' HG3' ' A' ' 40' ' ' ARG . 1.7 mp0 -138.2 127.46 24.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.833 HG23 HG12 ' A' ' 39' ' ' VAL . 10.0 t -139.42 -179.64 6.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -164.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.6 m -138.48 120.55 15.62 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.598 HG22 ' H ' ' A' ' 51' ' ' TYR . 4.9 p -138.81 172.75 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.524 -160.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.598 ' H ' HG22 ' A' ' 50' ' ' VAL . 41.7 m-85 -138.57 100.03 8.44 Favored Pre-proline 0 N--CA 1.455 -0.22 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.281 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.08 163.56 16.46 Favored 'Trans proline' 0 N--CA 1.477 0.548 0 C-N-CA 123.423 2.749 . . . . 0.0 112.668 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 11' ' ' VAL . . . -86.4 -133.82 3.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.097 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.647 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 47.3 t -99.45 160.94 13.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 63.3 47.92 3.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.23 0.538 . . . . 0.0 110.243 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.771 ' HA ' HG12 ' A' ' 11' ' ' VAL . . . -72.89 130.53 40.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.65 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.78 179.97 2.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.04 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.32 136.81 44.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.823 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 11.9 m -138.54 175.38 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 C-N-CA 125.461 1.505 . . . . 0.0 109.262 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.62 -165.48 1.03 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.4 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -56.77 -47.55 79.87 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -175.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -59.04 5.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.708 0.766 . . . . 0.0 111.433 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 18.3 mt-10 -56.98 -27.97 61.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.397 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.756 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -57.36 -48.49 78.9 Favored 'General case' 0 C--O 1.198 -1.639 0 CA-C-N 114.254 -1.339 . . . . 0.0 114.207 177.532 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . -56.94 -72.34 0.08 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 119.201 0.91 . . . . 0.0 112.616 -162.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -57.21 -54.85 42.11 Favored 'General case' 0 C--O 1.281 2.722 0 CA-C-O 122.809 1.29 . . . . 0.0 112.61 -176.464 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.89 -50.89 71.14 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.883 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.78 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 24.3 tt0 -57.25 -31.13 65.24 Favored 'General case' 0 C--O 1.202 -1.426 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 96.1 mttt -57.08 -70.98 0.11 Allowed 'General case' 0 C--O 1.26 1.61 0 CA-C-O 121.8 0.81 . . . . 0.0 109.708 172.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 6.8 tpm_? -57.04 -53.22 60.57 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 123.179 1.466 . . . . 0.0 110.818 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.657 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . . . -57.18 -43.8 82.95 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.925 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.08 -37.33 71.73 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 118.487 0.585 . . . . 0.0 110.202 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.606 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . . . -56.82 -64.12 0.98 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.489 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.695 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 9.4 ttp180 -57.73 -46.49 84.37 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.754 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -55.14 -34.87 64.13 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.05 0.54 . . . . 0.0 111.852 -175.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.78 -116.86 0.82 Allowed Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.564 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.606 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 4.2 m-70 48.9 20.27 0.34 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.606 0.762 . . . . 0.0 112.319 -176.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -159.53 17.13 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.678 0.275 . . . . 0.0 111.474 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.86 163.87 22.0 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.187 -179.339 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.559 ' CE1' HG21 ' A' ' 58' ' ' VAL . 2.7 p-80 -139.04 153.08 48.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.878 ' HB3' ' HA2' ' A' ' 33' ' ' GLY . . . -138.91 105.11 5.23 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.628 ' HA ' HG21 ' A' ' 28' ' ' VAL . 50.5 mttp -139.11 165.23 27.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.175 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.958 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.4 p -70.88 151.58 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.363 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.92 14.5 59.26 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 65.4 m-20 -138.65 -179.08 5.61 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.845 ' HB2' HG23 ' A' ' 59' ' ' VAL . 97.6 m-85 -137.45 173.21 11.91 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -174.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.805 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.8 tt -138.43 136.34 36.13 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.255 -166.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.499 HG22 ' CD2' ' A' ' 22' ' ' HIS . 59.9 t -139.03 143.52 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 125.917 2.011 . . . . 0.0 108.995 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 52' ' ' PRO . 70.6 t -122.93 129.79 74.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.063 0.459 . . . . 0.0 110.757 177.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -85.86 92.8 8.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.615 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.97 -63.02 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.863 -173.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.474 ' HB ' ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -58.36 137.19 57.4 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -172.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.404 ' OG1' ' HD2' ' A' ' 18' ' ' ARG . 23.2 p 48.58 -99.7 0.06 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.521 0.728 . . . . 0.0 112.898 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -152.96 125.1 8.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.715 0.293 . . . . 0.0 111.2 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 59.95 16.91 6.15 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.019 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.474 ' HD3' ' HB ' ' A' ' 14' ' ' THR . 10.0 ttt180 -84.26 126.59 33.31 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.042 0.449 . . . . 0.0 110.429 -174.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -90.03 87.92 7.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.478 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.568 ' HA ' ' CB ' ' A' ' 71' ' ' ALA . 32.3 m-20 -112.97 -175.23 2.62 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.091 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.961 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 2.2 mp0 52.88 84.88 0.05 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.296 0.373 . . . . 0.0 110.973 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.805 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 6.7 t-80 -134.55 133.91 40.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.875 -174.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -178.42 178.02 0.9 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.341 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.719 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 42.3 tt0 -98.45 131.38 44.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.457 0.646 . . . . 0.0 111.759 -174.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 26.7 mt -86.75 108.91 18.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.338 177.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.958 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -109.51 -28.02 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.517 176.38 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.874 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 14.7 mt-10 -120.25 111.98 18.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' A' ' 4' ' ' LYS . 47.2 t -98.81 115.36 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.09 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -64.62 -52.48 57.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.199 0.523 . . . . 0.0 110.193 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 43.4 m -117.55 110.42 17.92 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.362 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.433 ' HA ' HG11 ' A' ' 28' ' ' VAL . . . -63.63 -18.64 64.15 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.376 -170.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.16 -38.85 91.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.354 0.597 . . . . 0.0 110.107 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.878 ' HA2' ' HB3' ' A' ' 3' ' ' ALA . . . 129.08 53.42 0.11 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.533 -175.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 9.8 m -134.18 142.03 41.61 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.532 0.206 . . . . 0.0 110.658 -176.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 12.8 Cg_exo -70.85 164.82 34.28 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.962 2.442 . . . . 0.0 111.898 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.549 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 73.1 Cg_endo -76.0 -179.59 27.56 Favored 'Cis proline' 0 C--N 1.347 0.463 0 C-N-CA 123.794 -1.336 . . . . 0.0 112.783 -0.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -131.04 142.72 50.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.216 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.874 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 58.3 t -98.62 103.4 14.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 170.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.09 138.85 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.81 -163.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.915 ' HG3' ' HB3' ' A' ' 47' ' ' GLU . 51.9 ttt180 -103.91 128.88 51.41 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.237 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.771 ' CE3' ' HB1' ' A' ' 72' ' ' ALA . 2.4 m0 -95.59 89.38 5.35 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.576 HD11 ' CD ' ' A' ' 24' ' ' GLU . 14.2 mt -70.48 -60.94 1.97 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.168 -165.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.554 HG13 ' CE1' ' A' ' 64' ' ' HIS . 3.1 m -77.76 -4.52 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.964 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.679 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 50.7 m-80 -93.84 -62.84 1.28 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.172 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.59 -80.09 0.1 Allowed Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.073 -1.06 . . . . 0.0 113.879 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 41' ' ' TRP . 20.7 m-70 -98.9 176.46 5.59 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.888 0.375 . . . . 0.0 111.903 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.915 ' HB3' ' HG3' ' A' ' 40' ' ' ARG . 13.7 pt-20 -120.03 152.06 38.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.387 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -167.06 178.35 5.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.526 0.679 . . . . 0.0 111.168 -176.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.0 m -98.84 118.58 35.92 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.016 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.61 146.08 27.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 111.29 -172.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 75.8 m-85 -109.41 101.37 45.49 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.289 171.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.482 ' HB2' HG21 ' A' ' 11' ' ' VAL . 72.2 Cg_endo -75.29 -10.87 20.92 Favored 'Trans proline' 0 N--CA 1.473 0.306 0 C-N-CA 122.962 2.441 . . . . 0.0 112.605 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.63 -102.52 2.88 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.677 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.9 m -153.31 171.11 19.08 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 62.2 41.06 11.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.309 0.576 . . . . 0.0 110.986 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.4 112.96 15.96 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.719 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.2 t -98.91 152.47 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.559 HG21 ' CE1' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -100.69 113.27 36.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.467 0.651 . . . . 0.0 111.867 -176.037 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.845 HG23 ' HB2' ' A' ' 8' ' ' TYR . 4.1 m -102.23 169.25 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.393 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.7 p -115.84 -163.73 0.91 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 -175.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -52.91 -46.89 68.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.23 -48.45 28.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.324 0.583 . . . . 0.0 110.866 -174.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.731 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 25.5 mt-10 -59.47 -16.6 25.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.038 176.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.742 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -75.9 -50.27 15.5 Favored 'General case' 0 C--O 1.205 -1.288 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.595 -177.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.36 -72.0 0.08 Allowed 'General case' 0 C--O 1.247 0.968 0 CA-C-O 121.779 0.799 . . . . 0.0 112.844 -163.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -66.16 -46.89 75.85 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.856 -172.304 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.42 -26.44 66.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.494 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.687 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 27.1 tt0 -73.62 -45.0 55.54 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.678 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 20.6 pttp -60.53 -47.86 84.33 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.438 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.497 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 10.9 ptp85 -68.06 -52.09 39.21 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.702 0.763 . . . . 0.0 111.669 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.568 ' CB ' ' HA ' ' A' ' 20' ' ' ASP . . . -77.98 -17.97 56.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.342 -169.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.771 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -80.48 -37.18 32.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.389 173.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.02 -32.64 61.99 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.739 -0.384 . . . . 0.0 109.979 171.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -81.88 -37.19 27.26 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.684 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.961 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -59.52 -48.48 81.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.555 -172.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.93 -108.25 0.26 Allowed Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.365 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 63.61 -75.26 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 110.923 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -150.6 49.34 0.88 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.13 88.41 0.8 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.326 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--O 1.247 0.971 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.755 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -98.82 114.49 27.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.896 0.379 . . . . 0.0 110.221 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.86 153.95 46.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.162 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.89 173.35 7.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.923 0.392 . . . . 0.0 110.496 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.733 HG23 ' HA ' ' A' ' 26' ' ' ILE . 1.7 p -73.76 136.47 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.933 175.271 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.99 8.33 60.47 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -175.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 68.4 m-20 -107.38 161.72 14.56 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 61' ' ' ALA . 1.2 m-85 -103.52 146.79 28.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.413 0.625 . . . . 0.0 111.764 -176.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' A' ' 52' ' ' PRO . 9.8 tt -99.47 132.75 44.59 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.604 175.866 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.71 HG13 ' CE1' ' A' ' 22' ' ' HIS . 54.2 t -127.98 147.42 32.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 O-C-N 124.638 1.211 . . . . 0.0 109.29 174.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 52' ' ' PRO . 53.7 t -104.76 101.67 12.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 171.665 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 11.7 tmtt? -66.85 -37.66 84.89 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.762 ' HA3' HG22 ' A' ' 16' ' ' THR . . . 78.57 154.52 7.68 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.848 175.319 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 m -96.3 -31.75 12.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.912 0.387 . . . . 0.0 110.487 -179.328 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 m -135.61 3.25 3.01 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -177.203 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.762 HG22 ' HA3' ' A' ' 13' ' ' GLY . 9.5 t -81.25 -27.78 35.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -173.073 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.717 ' HG3' ' O ' ' A' ' 16' ' ' THR . 1.0 OUTLIER 64.41 -43.52 0.29 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.123 1.369 . . . . 0.0 111.818 -176.391 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.511 ' HG2' ' OE2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -71.59 104.12 3.21 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 171.099 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -77.02 86.94 3.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -123.1 -162.44 1.03 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.04 -164.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.745 ' N ' ' HB1' ' A' ' 71' ' ' ALA . 72.1 mt-30 58.83 94.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.206 0.602 . . . . 0.0 111.165 -177.726 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.71 ' CE1' HG13 ' A' ' 10' ' ' VAL . 3.4 m-70 -132.11 145.81 51.63 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.251 -0.281 . . . . 0.0 111.415 -173.498 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.695 ' HA ' ' HG3' ' A' ' 68' ' ' GLU . . . -179.04 176.09 0.92 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.118 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 41.4 tt0 -98.35 145.91 26.23 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.446 0.641 . . . . 0.0 111.201 -174.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.15 113.0 38.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 40' ' ' ARG . 0.2 OUTLIER -105.78 -15.5 8.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.894 0.378 . . . . 0.0 111.039 -178.622 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.966 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 37.7 mt-10 -132.15 103.59 6.34 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.658 0.742 . . . . 0.0 109.544 174.524 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.04 99.97 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.81 -176.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -104.56 53.57 0.73 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.603 0.716 . . . . 0.0 109.676 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.8 t -152.48 123.11 7.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.53 177.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.52 -26.27 20.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -89.88 -25.07 21.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.764 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.42 72.76 1.04 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.422 177.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 68.9 m -146.03 150.04 40.82 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.7 0.286 . . . . 0.0 110.886 178.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 19.5 Cg_exo -66.87 167.63 19.11 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.279 2.653 . . . . 0.0 112.062 177.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.99 154.66 94.11 Favored 'Cis proline' 0 C--N 1.345 0.366 0 C-N-CA 123.803 -1.332 . . . . 0.0 112.408 1.183 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -110.92 146.94 35.68 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.025 178.248 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.966 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 61.7 t -98.69 103.9 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.646 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 23' ' ' ALA . 53.2 t -116.19 121.51 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.013 -166.202 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.735 ' HB2' HD12 ' A' ' 26' ' ' ILE . 42.9 ttt180 -101.97 133.28 47.02 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.021 176.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.596 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 5.5 m0 -97.75 113.33 25.08 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.214 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' A' ' 24' ' ' GLU . 11.6 mt -75.52 -49.69 17.94 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.884 0.373 . . . . 0.0 111.617 -167.185 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.74 ' HB ' ' HE2' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -93.96 -15.59 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.271 -176.356 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.596 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 33.0 m-80 -84.26 -36.23 22.82 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.875 175.057 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.01 34.73 9.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.654 177.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.487 ' H ' ' HB2' ' A' ' 41' ' ' TRP . 6.9 m170 -123.59 166.81 14.83 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.522 -0.399 . . . . 0.0 110.438 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -141.21 116.33 9.93 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 p -136.23 170.46 15.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.267 0.556 . . . . 0.0 112.254 -167.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.3 m -118.32 100.04 7.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 166.04 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.0 m -99.58 156.6 3.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-O 121.685 0.755 . . . . 0.0 112.776 -167.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -119.68 99.91 49.32 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.973 168.388 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HB3' HD21 ' A' ' 9' ' ' LEU . 26.0 Cg_endo -63.7 -51.07 2.64 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.861 2.374 . . . . 0.0 112.868 -174.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.21 -117.02 1.55 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -175.212 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.3 m -129.64 154.13 47.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 12' ' ' LYS . 15.0 m-20 62.65 58.05 1.69 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.931 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -86.66 119.44 26.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.205 0.526 . . . . 0.0 110.837 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 t -101.07 159.72 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.472 -178.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 4.1 p -121.14 118.77 57.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.358 0.599 . . . . 0.0 111.326 -178.538 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.598 HG23 ' CB ' ' A' ' 8' ' ' TYR . 2.4 m -116.64 -179.93 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 123.408 0.683 . . . . 0.0 111.411 -178.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -80.98 166.4 20.86 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.732 174.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.788 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . . . -68.86 -66.54 0.56 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.598 -169.58 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 p -80.73 -25.06 38.31 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -167.316 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -53.94 -58.94 5.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.612 0.72 . . . . 0.0 109.578 175.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.47 ' CE1' HG11 ' A' ' 59' ' ' VAL . 11.3 m-70 -82.44 -16.5 48.7 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.68 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 43' ' ' VAL . . . -45.39 -39.55 7.04 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.489 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -63.08 -44.39 95.88 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-O 123.564 1.65 . . . . 0.0 109.127 177.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.434 ' CB ' ' HD2' ' A' ' 22' ' ' HIS . . . -66.3 -16.59 64.16 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.418 173.246 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.695 ' HG3' ' HA ' ' A' ' 23' ' ' ALA . 10.3 tt0 -69.82 -40.09 76.12 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 171.214 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.74 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 66.7 mmtt -51.07 -61.65 2.1 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.123 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -62.26 1.89 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.744 1.259 . . . . 0.0 112.076 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.745 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -78.31 -16.96 57.21 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.197 -165.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.59 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -81.74 -34.54 30.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 118.645 0.657 . . . . 0.0 109.316 173.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.82 -36.14 64.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 170.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -74.7 -55.54 5.76 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.987 174.056 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -49.08 -56.94 7.53 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.743 0.817 . . . . 0.0 111.967 -176.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.511 ' HA3' ' HH2' ' A' ' 41' ' ' TRP . . . -97.98 46.52 1.59 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.822 -176.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -82.2 -22.06 36.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.514 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -167.0 163.7 15.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.641 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.97 -52.16 0.9 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.077 0.465 . . . . 0.0 110.026 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.4 m . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.493 -179.843 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.73 116.17 11.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.901 0.381 . . . . 0.0 110.142 178.194 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.86 140.81 38.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.338 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -139.12 164.24 30.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.959 0.409 . . . . 0.0 111.249 -177.37 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.819 HG23 ' HA ' ' A' ' 26' ' ' ILE . 4.0 p -65.15 145.43 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.939 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.06 17.28 41.08 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -174.429 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 7.6 m-20 -138.76 -179.06 5.6 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 113.902 -1.149 . . . . 0.0 108.415 -174.31 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.812 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 95.4 m-85 -137.02 164.93 27.2 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.314 -168.035 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 6.7 tt -138.63 142.2 39.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.769 -166.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.848 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 3.5 t -138.88 -179.99 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.276 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.785 ' H ' HG12 ' A' ' 10' ' ' VAL . 41.2 t -138.18 129.41 37.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 121.648 0.737 . . . . 0.0 109.588 176.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.706 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 52.5 mttm -77.35 -156.91 0.09 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.114 -172.517 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.46 -89.41 0.18 Allowed Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.747 -177.055 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 19.1 m 73.47 -37.99 0.39 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.393 0.677 . . . . 0.0 112.227 175.483 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 p -77.72 0.1 24.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.314 0.578 . . . . 0.0 111.161 178.132 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.1 m -151.86 -76.78 0.13 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.236 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -104.52 133.79 48.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 171.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.595 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 55.9 mtt180 -70.52 -76.41 0.1 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -165.031 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -143.2 100.39 3.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 9.4 m-20 -132.85 177.79 7.37 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.691 -174.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.848 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 13.6 mt-30 63.0 98.19 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.857 0.723 . . . . 0.0 110.197 -170.371 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.984 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 21.3 t-80 -139.05 121.43 16.04 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.354 0.597 . . . . 0.0 111.81 -175.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.654 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.77 -178.23 5.33 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 125.222 1.409 . . . . 0.0 110.239 -177.645 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.812 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 26.6 tt0 -136.75 123.58 21.28 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.478 1.133 . . . . 0.0 109.079 174.016 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.741 ' HB ' HG22 ' A' ' 28' ' ' VAL . 4.6 pt -82.69 115.42 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.96 -174.466 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.819 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -108.01 -8.41 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 113.808 -1.542 . . . . 0.0 108.477 170.435 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -138.9 122.22 17.09 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.447 175.437 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.741 HG22 ' HB ' ' A' ' 25' ' ' ILE . 20.8 t -138.49 119.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.877 -165.172 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 29' ' ' ARG . 5.0 mmp_? -68.87 -35.79 77.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -174.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.8 m -147.68 149.59 32.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.757 -176.617 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.45 -14.71 59.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.142 0.496 . . . . 0.0 110.694 -179.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.89 -72.75 0.37 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.256 0.55 . . . . 0.0 110.001 176.042 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.91 88.05 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.527 -177.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -143.47 125.1 8.33 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.36 161.0 38.37 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.729 2.286 . . . . 0.0 111.534 175.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.32 -175.07 15.75 Favored 'Cis proline' 0 C--N 1.342 0.234 0 C-N-CA 123.732 -1.362 . . . . 0.0 113.392 2.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -138.87 169.55 17.6 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.594 178.12 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 84.2 t -137.96 116.47 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.041 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.505 HG12 HG23 ' A' ' 48' ' ' THR . 0.4 OUTLIER -138.86 174.61 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 112.676 -2.056 . . . . 0.0 109.272 -152.558 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.842 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 62.9 mtt180 -138.67 133.56 32.51 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.034 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.733 ' HD1' ' HB2' ' A' ' 46' ' ' HIS . 16.1 m95 -79.53 84.6 5.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 166.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.593 HD11 ' CD ' ' A' ' 24' ' ' GLU . 6.5 mt -60.08 -64.21 1.03 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.2 0.524 . . . . 0.0 111.617 -167.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.706 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -60.03 -35.5 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.121 -176.623 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 41' ' ' TRP . 17.2 m120 -60.53 -60.67 3.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.797 171.211 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.07 39.68 0.68 Allowed Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.113 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.733 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 37.5 m80 -139.16 167.11 22.79 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.119 0.459 . . . . 0.0 111.134 178.475 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.842 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 6.7 pt-20 -138.86 128.79 25.11 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.487 173.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.569 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 8.9 t -139.74 -179.26 5.82 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.758 -163.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.9 m -138.25 116.83 12.13 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.545 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 51' ' ' TYR . 1.6 t -138.69 175.95 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.193 0.521 . . . . 0.0 111.304 -162.839 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.701 ' H ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -138.82 107.27 7.56 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.78 -178.758 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.71 141.33 90.33 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.736 2.291 . . . . 0.0 111.755 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.95 67.0 2.14 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.557 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t 67.22 173.12 0.26 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.944 0.438 . . . . 0.0 110.957 179.099 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.706 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 8.5 m-20 56.18 38.33 29.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.221 174.508 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.2 139.8 54.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.328 -176.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.881 HG22 ' H ' ' A' ' 58' ' ' VAL . 5.7 p -138.93 -179.7 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.832 177.507 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.881 ' H ' HG22 ' A' ' 57' ' ' VAL . 56.1 t -138.45 136.27 43.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.785 -171.504 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.764 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -138.87 179.92 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 C-N-CA 123.355 0.662 . . . . 0.0 111.284 -174.17 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.9 p -120.55 -172.31 2.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.349 -176.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.02 -48.44 78.48 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -172.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -55.75 30.74 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.565 -0.71 . . . . 0.0 111.437 -178.115 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -56.98 -29.86 63.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.87 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.706 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.22 -45.32 83.96 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.286 -179.446 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.554 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -56.85 -73.4 0.06 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.912 0.863 . . . . 0.0 111.534 -167.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.523 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -57.08 -61.71 2.27 Favored 'General case' 0 C--O 1.268 2.059 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.671 -177.272 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.15 -50.21 73.54 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.462 -175.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.984 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 29.6 tt0 -57.14 -37.89 72.68 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 118.0 0.364 . . . . 0.0 111.575 -177.311 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -56.93 -68.12 0.25 Allowed 'General case' 0 C--O 1.253 1.24 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.572 176.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -57.28 -58.23 9.16 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 122.776 1.274 . . . . 0.0 111.675 -177.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.604 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -57.32 -25.23 59.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.321 -178.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.46 -40.95 73.4 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 118.894 0.77 . . . . 0.0 109.827 175.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.51 62.68 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.019 172.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.41 ' HG2' ' HB3' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -74.21 -57.16 4.13 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 176.263 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -51.12 -44.61 61.35 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.556 0.946 . . . . 0.0 113.556 -169.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -87.64 24.86 9.24 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 119.8 -1.191 . . . . 0.0 112.651 -174.044 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -66.68 -28.6 68.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.744 0.307 . . . . 0.0 111.165 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.0 26.21 9.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.885 0.374 . . . . 0.0 111.095 -175.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.61 75.73 8.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.155 0.502 . . . . 0.0 110.513 178.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.419 -179.689 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.471 ' HG2' ' N ' ' A' ' 2' ' ' HIS . 23.4 ttt . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.471 ' N ' ' HG2' ' A' ' 1' ' ' MET . 42.2 m-70 -138.87 140.21 38.36 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.126 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.91 139.66 38.11 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.387 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.719 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 91.6 mttt -139.35 140.77 37.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.239 -173.193 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.787 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -71.29 139.63 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 169.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.55 13.82 66.93 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -172.288 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.719 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 1.8 m-20 -139.11 143.81 38.43 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.109 -2.045 . . . . 0.0 107.655 -167.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.811 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 33.2 m-85 -135.63 142.6 45.24 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -148.481 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.757 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 2.3 tt -136.69 140.2 42.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 119.334 0.97 . . . . 0.0 110.244 -156.473 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.405 HG23 HG21 ' A' ' 59' ' ' VAL . 42.3 t -138.87 140.75 38.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.211 -168.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.767 HG12 ' H ' ' A' ' 13' ' ' GLY . 72.0 t -138.41 140.16 40.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -176.585 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -107.4 3.69 25.5 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.002 0.43 . . . . 0.0 110.834 -178.411 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.767 ' H ' HG12 ' A' ' 11' ' ' VAL . . . -84.23 45.55 3.51 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.239 -174.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 p -113.15 -81.77 0.59 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.858 0.361 . . . . 0.0 110.452 176.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.441 ' HB ' ' OE1' ' A' ' 17' ' ' GLU . 40.6 m -124.34 -78.8 0.6 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.239 177.051 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.8 t -147.23 6.25 0.86 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.537 0.684 . . . . 0.0 110.277 177.247 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 22.5 mp0 -67.93 105.28 1.95 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.548 176.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -69.31 -11.95 61.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.333 -175.373 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -135.85 65.82 1.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 14.3 t0 -106.39 179.06 4.38 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -175.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.677 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 51.8 mt-30 39.7 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.699 0.8 . . . . 0.0 112.817 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.757 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 54.7 t60 -138.57 138.98 38.46 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 122.634 1.207 . . . . 0.0 113.397 -176.732 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.617 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -140.43 -177.87 5.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 112.19 -2.277 . . . . 0.0 110.926 -174.011 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.811 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 10.7 tt0 -136.69 122.17 19.52 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 123.007 1.384 . . . . 0.0 108.046 166.444 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 66.0 mt -81.52 107.69 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 111.652 -2.522 . . . . 0.0 110.242 -170.028 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.787 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -102.38 -14.12 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.629 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 48.9 mm-40 -139.02 150.36 45.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.577 174.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.473 HG22 ' CG2' ' A' ' 25' ' ' ILE . 17.7 t -137.83 100.11 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -170.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -89.23 -29.08 19.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.663 -163.617 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.9 p -68.94 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.495 -176.378 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -176.95 -64.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.285 0.564 . . . . 0.0 109.954 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -151.05 88.13 1.44 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.905 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.64 172.84 44.11 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.218 -173.054 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m 69.36 156.76 0.15 Allowed Pre-proline 0 N--CA 1.467 0.419 0 CA-C-O 120.953 0.406 . . . . 0.0 111.529 178.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -73.03 163.92 36.94 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.815 2.344 . . . . 0.0 112.331 178.083 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 18.9 Cg_endo -94.61 -178.01 7.35 Favored 'Cis proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.809 -1.329 . . . . 0.0 112.681 -1.412 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -138.83 174.27 10.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.059 177.399 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 89.6 t -138.03 114.54 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 174.282 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 25' ' ' ILE . 0.4 OUTLIER -139.02 175.25 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.818 -153.658 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.803 ' HB2' HD23 ' A' ' 42' ' ' LEU . 84.7 mtt180 -138.51 134.96 34.6 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.745 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 12.2 m95 -80.1 81.02 6.44 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 166.482 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.803 HD23 ' HB2' ' A' ' 40' ' ' ARG . 3.7 mt -59.92 -67.8 0.35 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.515 0.509 . . . . 0.0 111.932 -162.573 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.547 HG22 ' OE2' ' A' ' 68' ' ' GLU . 0.9 OUTLIER -59.96 -31.19 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.974 -175.716 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -60.59 -62.99 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.177 0.513 . . . . 0.0 110.591 169.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.05 43.16 0.34 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.811 -0.632 . . . . 0.0 113.576 177.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.745 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 44.6 t-80 -139.35 164.01 30.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 117.527 0.664 . . . . 0.0 111.069 178.262 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 42.0 tt0 -138.44 122.09 17.45 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.223 0.535 . . . . 0.0 110.023 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.479 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 14.8 t -139.68 -179.0 5.67 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -165.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.418 HG23 HG22 ' A' ' 38' ' ' VAL . 89.8 m -138.15 110.55 7.45 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.413 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.73 -179.74 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -160.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.558 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 2.3 m-85 -138.78 125.64 12.95 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.048 -178.389 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HB2' HG21 ' A' ' 11' ' ' VAL . 56.5 Cg_endo -74.37 -78.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.673 2.249 . . . . 0.0 113.234 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.41 -154.44 23.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.862 -178.124 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.7 m -87.62 159.1 18.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.569 0.184 . . . . 0.0 110.559 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 t70 65.91 39.85 4.4 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.94 0.876 . . . . 0.0 108.859 -174.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.568 ' HA ' HG22 ' A' ' 11' ' ' VAL . . . -79.9 137.74 36.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.126 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.711 HG12 ' H ' ' A' ' 58' ' ' VAL . 3.4 t -138.71 175.65 7.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -174.143 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.711 ' H ' HG12 ' A' ' 57' ' ' VAL . 58.9 t -138.34 138.33 43.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.613 0.72 . . . . 0.0 110.648 -175.283 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 3.1 m -138.62 179.99 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 C-N-CA 125.74 1.616 . . . . 0.0 110.023 -174.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 61' ' ' ALA . 5.9 t -121.85 -159.28 0.81 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.123 -174.572 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.427 ' N ' HG23 ' A' ' 60' ' ' THR . . . -56.99 -48.23 78.91 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.408 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.414 ' H ' HG23 ' A' ' 60' ' ' THR . 0.2 OUTLIER -57.35 -58.59 7.6 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 122.013 -0.429 . . . . 0.0 112.128 -179.697 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.667 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 29.5 mm-40 -57.15 -28.12 62.46 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.677 0.751 . . . . 0.0 110.307 -178.295 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.74 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.12 -42.52 81.04 Favored 'General case' 0 C--O 1.206 -1.233 0 CA-C-N 114.627 -1.17 . . . . 0.0 113.563 -176.707 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.2 -75.92 0.04 OUTLIER 'General case' 0 C--O 1.244 0.793 0 CA-C-O 122.331 1.062 . . . . 0.0 111.669 -170.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.584 ' HB2' ' NH1' ' A' ' 70' ' ' ARG . 1.2 pt-20 -57.24 -51.59 68.75 Favored 'General case' 0 C--O 1.265 1.915 0 CA-C-N 113.798 -1.547 . . . . 0.0 112.035 -177.347 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.11 -49.82 74.7 Favored 'General case' 0 C--O 1.2 -1.527 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.766 -178.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.74 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 4.4 tt0 -57.0 -35.73 69.57 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 118.019 0.372 . . . . 0.0 111.2 -176.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -57.13 -74.46 0.05 Allowed 'General case' 0 C--O 1.254 1.316 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.631 172.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.584 ' NH1' ' HB2' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -57.27 -60.87 2.98 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.908 1.337 . . . . 0.0 111.256 -173.978 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 22' ' ' HIS . . . -57.08 -51.15 70.43 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 112.928 -1.942 . . . . 0.0 113.869 -175.268 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -57.31 -36.15 70.74 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 118.463 0.574 . . . . 0.0 111.081 -179.013 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.87 -48.76 77.4 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.835 174.398 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -57.57 -65.97 0.54 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 175.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -50.29 -37.11 34.63 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.99 0.916 . . . . 0.0 113.378 -166.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -113.34 15.29 22.71 Favored Glycine 0 C--N 1.322 -0.21 0 C-N-CA 118.896 -1.621 . . . . 0.0 113.535 -172.405 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -99.91 -46.92 5.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.861 0.363 . . . . 0.0 110.52 177.365 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.87 85.2 3.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.189 -177.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.16 76.86 3.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 178.252 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.713 -0.661 . . . . 0.0 109.742 178.746 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -138.42 105.35 5.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.343 0.592 . . . . 0.0 110.169 175.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.83 166.36 10.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.286 -178.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -134.79 173.87 11.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.869 176.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.762 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.3 p -80.97 143.68 11.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.039 0.447 . . . . 0.0 110.642 177.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.5 8.97 67.36 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -177.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -108.06 174.43 5.88 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.099 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.726 ' CD1' ' HA ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER -104.57 138.13 41.37 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.267 0.556 . . . . 0.0 110.658 179.132 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.2 tt -99.02 136.84 38.42 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.852 179.305 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.746 HG22 ' CD2' ' A' ' 22' ' ' HIS . 55.4 t -133.16 160.38 42.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.801 174.29 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 44.6 t -131.92 131.44 61.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 118.052 0.387 . . . . 0.0 110.575 174.689 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -80.53 68.25 6.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.619 0.723 . . . . 0.0 109.29 176.652 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.15 90.2 0.37 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 175.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 10.2 m -55.3 99.66 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.281 0.562 . . . . 0.0 112.432 -171.44 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 m -126.99 -76.37 0.58 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.729 176.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 m -86.2 -26.56 25.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.988 0.899 . . . . 0.0 108.839 174.142 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.692 ' HG3' ' H ' ' A' ' 19' ' ' HIS . 14.1 tp10 -154.01 164.87 37.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.172 -1.376 . . . . 0.0 107.706 -178.154 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -61.58 -23.87 66.28 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.711 0.767 . . . . 0.0 109.39 175.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.692 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 72.6 m80 -124.79 99.34 6.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.394 177.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -106.39 -164.24 0.99 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.466 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.8 mp0 47.36 93.6 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.616 0.572 . . . . 0.0 112.208 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.889 ' HB2' ' HA ' ' A' ' 68' ' ' GLU . 20.8 m170 -125.49 141.52 52.0 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.894 -176.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HA ' ' HG3' ' A' ' 68' ' ' GLU . . . -177.76 -179.85 0.83 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.833 0.708 . . . . 0.0 110.484 173.486 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.435 ' OE1' HD21 ' A' ' 42' ' ' LEU . 36.7 tt0 -98.77 131.61 44.77 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.287 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.529 ' HB ' HG22 ' A' ' 28' ' ' VAL . 3.8 pt -96.81 111.26 26.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.087 0.47 . . . . 0.0 110.839 178.848 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.762 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -104.2 -21.96 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.688 177.58 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 1.053 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 36.2 tt0 -123.45 99.96 6.58 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.403 0.62 . . . . 0.0 110.102 172.499 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.867 HG13 ' HE2' ' A' ' 37' ' ' TYR . 34.6 t -112.22 100.54 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.509 -178.082 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -95.14 11.83 30.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.135 0.493 . . . . 0.0 110.627 -176.556 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.1 t -136.62 126.03 25.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.601 -179.177 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.2 -20.74 25.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.586 -179.12 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.87 -29.0 22.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.288 179.274 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.585 ' HA2' ' OH ' ' A' ' 37' ' ' TYR . . . 104.4 73.19 0.91 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.764 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -142.98 128.24 10.04 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -177.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.742 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 21.3 Cg_endo -62.67 165.47 15.8 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.858 2.372 . . . . 0.0 112.231 177.223 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.19 156.61 83.19 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 124.011 -1.245 . . . . 0.0 113.248 3.546 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.867 ' HE2' HG13 ' A' ' 28' ' ' VAL . 34.3 m-85 -119.91 147.55 44.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.984 177.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.053 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 98.4 t -98.9 106.63 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.41 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -114.66 155.55 15.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.311 -163.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.739 ' HB2' HD12 ' A' ' 26' ' ' ILE . 23.9 ttt180 -128.86 115.76 18.38 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.048 -176.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.729 ' CB ' ' HB2' ' A' ' 44' ' ' ASN . 6.7 m95 -75.63 120.39 20.96 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.66 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.435 HD21 ' OE1' ' A' ' 24' ' ' GLU . 12.8 mt -88.42 -45.66 9.78 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.663 -176.191 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.654 HG21 ' O ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -90.75 -5.84 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.155 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.729 ' HB2' ' CB ' ' A' ' 41' ' ' TRP . 15.7 m120 -96.06 -40.36 9.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 168.662 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.09 63.58 1.44 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.764 172.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.526 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 54.9 t60 -172.42 154.3 3.16 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.921 0.361 . . . . 0.0 110.42 176.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.609 ' HG2' ' HG3' ' A' ' 40' ' ' ARG . 38.6 mt-10 -113.33 145.91 40.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.104 178.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -172.11 176.83 3.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.47 0.652 . . . . 0.0 111.084 178.099 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.1 m -108.52 115.1 29.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.942 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.92 172.59 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.277 0.56 . . . . 0.0 111.68 -176.01 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.533 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 68.8 m-85 -119.89 100.09 48.75 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.515 177.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.742 ' HD2' ' HB3' ' A' ' 35' ' ' PRO . 37.4 Cg_endo -66.08 -39.83 17.54 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.678 2.252 . . . . 0.0 112.486 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.94 -159.57 13.72 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.905 -178.488 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.526 ' O ' HG13 ' A' ' 11' ' ' VAL . 18.3 m -94.5 169.18 10.38 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.029 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 12' ' ' LYS . 18.9 m-20 66.17 32.55 7.96 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.418 0.449 . . . . 0.0 110.765 178.74 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' A' ' 1' ' ' MET . . . -76.57 113.74 14.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.054 0.454 . . . . 0.0 111.008 -179.082 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 58' ' ' VAL . 13.9 t -99.21 162.33 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.742 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.402 ' N ' HG12 ' A' ' 57' ' ' VAL . 5.7 t -110.2 152.05 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.909 0.385 . . . . 0.0 111.235 -176.352 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.57 HG22 ' N ' ' A' ' 60' ' ' THR . 11.0 p -151.73 173.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.041 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.57 ' N ' HG22 ' A' ' 59' ' ' VAL . 47.8 p -90.2 169.39 11.18 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 175.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.726 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . . . -52.64 -64.55 0.78 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -172.179 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 p -75.18 -28.86 60.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -163.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -58.4 -62.6 1.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.103 0.478 . . . . 0.0 110.88 -176.58 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.505 ' HB2' HG11 ' A' ' 59' ' ' VAL . 3.2 m80 -81.95 -16.19 51.3 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.654 ' O ' HG21 ' A' ' 43' ' ' VAL . . . -43.36 -46.47 6.52 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -170.557 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -59.02 -48.69 80.69 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-O 123.37 1.557 . . . . 0.0 109.627 -179.167 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.426 ' C ' ' HD1' ' A' ' 22' ' ' HIS . . . -64.65 -16.9 63.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.668 173.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.889 ' HA ' ' HB2' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -73.2 -40.88 64.39 Favored 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.679 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -53.62 -50.63 65.28 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -64.27 -66.12 0.59 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 122.129 0.966 . . . . 0.0 112.784 178.245 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.423 ' HB3' ' ND1' ' A' ' 22' ' ' HIS . . . -70.67 -16.9 62.84 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -169.433 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.636 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -81.73 -33.78 30.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 173.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.75 -33.05 60.69 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.604 168.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 -76.74 -57.02 4.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.624 172.17 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -50.26 -51.52 44.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.846 0.859 . . . . 0.0 112.526 -176.658 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -80.09 5.95 61.21 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.959 -175.287 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -93.1 -20.48 20.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.027 0.441 . . . . 0.0 110.184 178.548 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.26 -157.67 0.73 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.8 -176.448 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 51' ' ' TYR . . . -142.28 14.24 2.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.223 0.535 . . . . 0.0 110.119 177.192 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.251 1.179 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.943 -175.014 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.684 0.278 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -138.91 121.63 16.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' A' ' 58' ' ' VAL . . . -138.85 169.46 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.097 0.475 . . . . 0.0 112.062 -173.022 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 40.7 ttmt -139.3 166.13 25.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.412 -178.545 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG23 ' HA ' ' A' ' 26' ' ' ILE . 6.1 p -71.53 142.65 15.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 173.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.1 16.18 45.31 Favored Glycine 0 N--CA 1.454 -0.147 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -173.387 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 64.7 m-20 -138.77 -178.88 5.51 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 113.971 -1.114 . . . . 0.0 108.205 -174.125 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.737 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 87.3 m-85 -136.83 170.13 16.6 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.932 -169.472 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.736 HD11 ' HG3' ' A' ' 52' ' ' PRO . 8.0 tt -138.75 144.94 39.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.61 -166.596 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.907 ' HB ' ' HB ' ' A' ' 57' ' ' VAL . 87.2 t -138.87 172.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.718 HG13 ' HB2' ' A' ' 54' ' ' SER . 13.5 t -138.65 133.26 41.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.013 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 28.5 mtpp 69.14 166.42 0.27 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.546 0.688 . . . . 0.0 111.197 -175.744 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 17' ' ' GLU . . . 115.29 12.39 9.85 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.366 177.116 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -91.55 -40.61 11.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.715 0.293 . . . . 0.0 110.419 -177.325 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.5 p -95.36 56.44 1.85 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.064 0.459 . . . . 0.0 110.178 177.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p 50.58 52.07 15.61 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.542 -176.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.575 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 16.7 mt-10 -106.21 175.55 5.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.604 -177.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 -76.56 134.08 39.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.298 170.334 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.505 ' HB3' HG11 ' A' ' 10' ' ' VAL . 91.6 m-70 -83.9 100.22 10.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.625 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -113.99 179.51 3.94 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.067 -174.627 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.618 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 86.8 mt-30 43.72 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.767 0.827 . . . . 0.0 112.511 -173.538 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.986 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 2.1 t-80 -138.78 129.1 25.72 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.54 0.686 . . . . 0.0 111.424 -169.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.772 ' HB2' ' HZ3' ' A' ' 41' ' ' TRP . . . -139.59 -178.29 5.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.968 -176.462 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.737 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 24.2 tt0 -136.76 125.93 24.62 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.629 1.204 . . . . 0.0 109.264 173.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.61 HG22 HG22 ' A' ' 28' ' ' VAL . 4.3 mt -82.67 107.48 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 112.557 -2.11 . . . . 0.0 109.815 -170.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.91 HG12 ' HD3' ' A' ' 40' ' ' ARG . 1.8 pp -106.82 -12.68 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.274 175.295 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 1.079 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -138.88 136.61 35.71 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.614 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 25' ' ' ILE . 11.2 t -138.36 107.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 -165.732 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.608 ' CZ ' ' HA ' ' A' ' 29' ' ' ARG . 2.7 mmp_? -71.26 -19.14 62.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.779 0.324 . . . . 0.0 111.756 -176.773 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 60.5 m -152.3 115.46 4.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.622 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.05 13.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.831 -174.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -93.5 -11.84 31.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.172 0.511 . . . . 0.0 110.279 176.534 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.18 71.37 0.99 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.171 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.474 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 17.0 m -136.47 125.86 15.72 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 15.8 Cg_exo -68.7 153.53 73.06 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.974 2.449 . . . . 0.0 112.145 178.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.564 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 6.2 Cg_exo -80.29 -169.81 8.05 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 124.129 -1.196 . . . . 0.0 113.086 2.344 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -138.42 172.8 12.35 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.994 178.302 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.079 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 48.5 t -137.84 116.8 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.077 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.91 176.57 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.964 -149.557 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 1.041 ' HG2' ' HG2' ' A' ' 47' ' ' GLU . 12.4 mtp180 -138.82 138.18 37.3 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.214 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.772 ' HZ3' ' HB2' ' A' ' 23' ' ' ALA . 11.8 m95 -86.27 82.5 7.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 168.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 24' ' ' GLU . 5.4 mt -59.89 -69.65 0.2 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.114 0.483 . . . . 0.0 111.985 -166.363 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.727 HG11 ' HA ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -60.2 -34.09 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.089 -175.704 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -60.43 -45.68 92.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.287 172.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.7 39.75 1.99 Allowed Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.851 179.184 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.485 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 63.7 m80 -139.23 172.92 12.12 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.324 -0.515 . . . . 0.0 111.893 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 1.041 ' HG2' ' HG2' ' A' ' 40' ' ' ARG . 45.0 mt-10 -138.58 128.26 24.93 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.35 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.34 179.93 6.25 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.129 0.966 . . . . 0.0 113.599 -160.724 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 75.6 m -138.78 125.3 20.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 167.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 51' ' ' TYR . 8.0 p -138.87 165.21 24.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.415 -162.563 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.564 ' CD2' ' HB3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -138.72 99.86 8.35 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.254 178.187 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.736 ' HG3' HD11 ' A' ' 9' ' ' LEU . 55.3 Cg_endo -70.67 114.16 3.76 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.758 2.305 . . . . 0.0 111.632 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.08 81.98 1.14 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.419 178.794 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.718 ' HB2' HG13 ' A' ' 11' ' ' VAL . 43.7 t 177.79 -179.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.034 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -71.72 -15.08 62.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.218 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 80.92 162.07 0.16 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.564 172.615 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.907 ' HB ' ' HB ' ' A' ' 10' ' ' VAL . 21.6 t -138.95 170.16 16.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.094 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 38.5 t -138.47 128.02 32.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.264 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.94 176.77 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.853 -174.331 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 p -120.08 -166.68 1.33 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.345 -176.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.0 79.36 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.457 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.39 -55.86 29.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.396 0.544 . . . . 0.0 111.813 -175.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.473 ' HG3' HG12 ' A' ' 59' ' ' VAL . 1.6 mm-40 -56.81 -31.39 64.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.635 -176.392 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.707 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.38 -40.8 78.94 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.766 -176.467 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.727 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -57.53 -77.08 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.052 0.93 . . . . 0.0 111.294 -170.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -57.66 -60.33 3.84 Favored 'General case' 0 C--O 1.267 1.998 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.173 -178.749 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -56.92 -56.44 21.64 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.853 -174.425 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.986 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 35.6 tt0 -57.27 -34.35 68.56 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -175.525 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 29.8 mtpp -57.1 -65.9 0.54 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.459 175.756 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -57.35 -53.79 54.13 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-O 123.544 1.64 . . . . 0.0 111.049 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.587 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -57.21 -45.47 83.78 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 112.627 -2.079 . . . . 0.0 113.105 -173.589 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -68.43 -33.31 73.99 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.806 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -53.87 -37.3 63.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 123.483 0.489 . . . . 0.0 110.22 174.027 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.8 mtp-105 -81.6 -47.0 13.6 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 173.406 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -48.25 -51.61 24.84 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.237 0.615 . . . . 0.0 111.633 -177.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.84 35.34 4.11 Favored Glycine 0 N--CA 1.454 -0.125 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.943 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 55.8 t-80 -128.59 -47.3 1.28 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.096 0.474 . . . . 0.0 109.884 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.01 -4.24 58.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.168 -179.644 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.52 129.75 38.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.02 -178.268 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--O 1.247 0.949 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.71 176.418 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.7 t60 . . . . . 0 CA--C 1.522 -0.12 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.0 161.94 13.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.074 0.464 . . . . 0.0 111.672 -173.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 4' ' ' LYS . 39.8 ttmt -148.41 147.36 29.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.335 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.447 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.7 p -86.47 142.01 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.957 0.408 . . . . 0.0 110.41 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.82 4.74 65.05 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -121.2 171.39 8.74 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.929 ' HB2' HG23 ' A' ' 59' ' ' VAL . 98.9 m-85 -109.81 146.35 35.17 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.398 0.618 . . . . 0.0 111.508 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.679 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.4 tt -99.14 140.11 33.78 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.828 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.572 HG22 ' CE1' ' A' ' 22' ' ' HIS . 55.6 t -130.81 151.54 36.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 O-C-N 124.839 1.337 . . . . 0.0 109.441 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.845 ' HB ' ' HB2' ' A' ' 21' ' ' GLN . 74.6 t . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.426 0.155 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.845 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 14.0 mt-30 40.33 85.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.641 1.213 . . . . 0.0 112.347 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.735 ' CB ' ' HA ' ' A' ' 68' ' ' GLU . 7.2 m80 -118.49 146.58 44.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.249 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -176.7 177.98 1.3 Allowed 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.103 0.877 . . . . 0.0 110.857 170.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.617 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 43.4 tt0 -98.58 127.47 44.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.273 0.558 . . . . 0.0 110.742 177.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 9' ' ' LEU . 20.4 mt -88.48 103.04 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.177 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.663 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -105.76 -19.78 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.249 178.022 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.862 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 68.8 mm-40 -134.08 111.0 10.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.764 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 30' ' ' SER . 38.6 t -98.89 116.16 41.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.922 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -88.83 32.3 0.81 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.008 0.433 . . . . 0.0 110.861 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.508 ' H ' HG12 ' A' ' 28' ' ' VAL . 34.2 t -148.94 149.21 30.82 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.52 -14.6 45.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.052 0.453 . . . . 0.0 110.219 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -130.53 -70.84 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.472 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.39 75.93 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.611 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 33.3 p -146.67 132.87 9.58 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 37.3 Cg_exo -61.85 160.31 29.77 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.889 2.393 . . . . 0.0 112.098 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.52 179.26 22.23 Favored 'Cis proline' 0 N--CA 1.462 -0.34 0 C-N-CA 123.406 -1.498 . . . . 0.0 113.132 1.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -132.77 153.46 51.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.601 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.862 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 67.3 t -98.56 117.18 43.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 172.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.52 147.63 30.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.001 -164.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.788 ' HG2' ' HG3' ' A' ' 47' ' ' GLU . 98.7 mtt180 -115.4 131.88 56.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.633 176.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.7 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 13.8 m95 -85.38 101.3 12.47 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 168.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.712 ' HB2' ' HE1' ' A' ' 64' ' ' HIS . 12.7 mt -82.29 -55.55 4.45 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.432 0.634 . . . . 0.0 110.605 -173.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.617 HG11 ' HA ' ' A' ' 65' ' ' ALA . 2.0 m -76.14 -5.7 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.581 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.7 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 45.9 m-80 -100.01 -64.22 1.06 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.756 173.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . 122.02 68.42 0.25 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.532 -0.842 . . . . 0.0 114.181 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.546 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 30.3 t60 -179.18 156.92 0.79 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.217 0.509 . . . . 0.0 110.819 172.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.788 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 25.4 mp0 -110.58 150.38 29.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 t -175.18 -179.95 1.43 Allowed 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.442 0.639 . . . . 0.0 111.806 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.4 m -119.98 124.06 45.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.177 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.6 m -127.32 160.46 36.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.329 0.585 . . . . 0.0 112.545 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -111.6 106.19 56.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.558 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.59 -178.6 3.49 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.7 2.267 . . . . 0.0 111.174 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.402 ' H ' HG21 ' A' ' 11' ' ' VAL . . . -124.37 -155.17 9.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.843 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 11' ' ' VAL . 43.3 t -70.95 157.11 38.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.649 0.261 . . . . 0.0 110.963 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 66.33 39.38 4.07 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.007 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -76.88 129.11 35.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.036 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 58' ' ' VAL . 11.2 t -126.38 163.82 27.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.555 -176.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.406 ' N ' HG12 ' A' ' 57' ' ' VAL . 53.9 t -115.27 119.62 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.526 0.203 . . . . 0.0 110.737 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.929 HG23 ' HB2' ' A' ' 8' ' ' TYR . 2.3 m -113.42 178.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.211 0.529 . . . . 0.0 111.94 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.6 p -119.31 -169.78 1.81 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.239 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -47.33 -49.6 23.81 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -171.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.24 -38.97 75.3 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 121.718 -0.614 . . . . 0.0 111.581 -172.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 2.8 mm-40 -67.7 -16.81 64.33 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.093 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.712 ' HE1' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -82.04 -41.96 19.93 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.722 -177.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.617 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -56.86 -73.77 0.06 Allowed 'General case' 0 C--O 1.243 0.74 0 CA-C-N 119.996 1.271 . . . . 0.0 111.639 -166.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -66.5 -49.67 65.81 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.547 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -67.55 -31.6 71.81 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.955 -173.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.735 ' HA ' ' CB ' ' A' ' 22' ' ' HIS . 32.2 tt0 -76.09 -33.45 59.5 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 118.299 0.499 . . . . 0.0 110.626 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 99.6 mttt -54.1 -62.09 1.88 Allowed 'General case' 0 C--O 1.247 0.958 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.044 172.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -65.8 -45.19 83.34 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.739 0.78 . . . . 0.0 111.387 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.64 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -78.75 -16.39 57.25 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.437 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -77.46 -36.38 52.96 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.9 -29.31 66.95 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.022 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -74.66 -58.85 3.03 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.641 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.719 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -59.9 -64.83 0.81 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.838 0.855 . . . . 0.0 112.371 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.847 -171.06 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 . . . . . 0 CA--C 1.521 -0.172 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.29 140.14 39.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.769 0.795 . . . . 0.0 112.012 -165.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -139.06 140.82 38.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.708 -173.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.928 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.6 p -65.54 149.09 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 O-C-N 122.051 -0.406 . . . . 0.0 110.931 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.13 16.76 78.07 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-O 122.57 1.094 . . . . 0.0 110.449 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 1.4 t70 -139.09 144.12 38.6 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 112.572 -1.814 . . . . 0.0 107.678 -166.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.858 ' CD1' ' HB2' ' A' ' 24' ' ' GLU . 6.7 m-85 -135.79 142.46 44.9 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 -142.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.747 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 3.2 tt -136.53 139.94 42.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.132 0.968 . . . . 0.0 109.799 -153.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.738 ' N ' HD23 ' A' ' 9' ' ' LEU . 2.3 t -138.84 141.62 36.32 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 112.707 -2.042 . . . . 0.0 109.057 -165.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 54' ' ' SER . 4.0 p . . . . . 0 C--N 1.315 -0.922 0 C-N-CA 117.645 -1.622 . . . . 0.0 109.389 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.806 ' HA ' ' HB1' ' A' ' 71' ' ' ALA . 11.3 m-20 . . . . . 0 C--O 1.223 -0.319 0 CA-C-O 120.981 0.419 . . . . 0.0 111.828 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.821 ' H ' ' HB1' ' A' ' 71' ' ' ALA . 51.3 tt0 149.61 128.16 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.292 1.437 . . . . 0.0 108.667 169.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.823 ' NE2' ' HB3' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -138.68 136.69 36.11 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 117.074 -1.85 . . . . 0.0 111.013 153.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.689 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -142.08 144.06 33.38 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 111.29 -2.686 . . . . 0.0 109.38 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.858 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -134.99 138.61 44.16 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 124.698 2.19 . . . . 0.0 110.888 -177.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.527 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 19.9 mt -98.81 117.96 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 1 CA-C-N 108.363 -4.017 . . . . 0.0 111.203 -148.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.928 ' HA ' HG23 ' A' ' 5' ' ' VAL . 2.2 pp -114.56 -8.33 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 125.139 1.524 . . . . 0.0 110.166 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -138.8 132.22 30.27 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.433 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.9 t -138.06 101.33 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.535 -167.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -110.36 55.03 0.65 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.317 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -133.41 113.06 12.11 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.466 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.15 -42.4 17.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.343 0.592 . . . . 0.0 110.171 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -89.33 -7.78 54.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.056 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.81 18.15 60.33 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.355 -174.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 5.0 p -90.29 151.84 45.05 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 120.597 0.237 . . . . 0.0 111.173 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 26.9 Cg_exo -63.48 164.8 19.51 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.851 2.367 . . . . 0.0 111.701 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.685 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.7 Cg_endo -79.5 -173.27 12.47 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.585 -1.423 . . . . 0.0 113.685 1.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 49' ' ' THR . 53.0 m-85 -138.75 171.86 13.72 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.431 HG22 HG23 ' A' ' 49' ' ' THR . 83.9 t -137.7 116.21 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 CA-C-O 123.495 1.617 . . . . 0.0 107.257 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.689 HG11 ' HB1' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -139.25 177.78 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 CA-C-N 111.845 -2.434 . . . . 0.0 109.106 -151.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.884 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 15.6 mtm180 -138.32 145.61 41.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.639 ' CE3' ' HB1' ' A' ' 72' ' ' ALA . 11.4 m0 -101.37 84.78 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.685 HD11 ' HB3' ' A' ' 24' ' ' GLU . 3.4 mt -59.95 -68.04 0.33 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 112.483 -2.144 . . . . 0.0 112.772 -154.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.437 HG13 ' CE1' ' A' ' 64' ' ' HIS . 0.5 OUTLIER -60.14 -32.5 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.163 -176.268 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.421 ' ND2' ' HG2' ' A' ' 68' ' ' GLU . 39.9 m-80 -60.39 -64.08 1.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.113 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.13 51.19 0.27 Allowed Glycine 0 CA--C 1.523 0.546 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.512 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -139.18 170.95 15.02 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 117.53 0.665 . . . . 0.0 111.379 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.884 ' HG3' ' HD2' ' A' ' 40' ' ' ARG . 23.7 mp0 -138.26 106.98 5.9 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.9 t -139.74 -178.98 5.66 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -165.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.431 HG23 HG22 ' A' ' 38' ' ' VAL . 92.6 m -137.95 117.35 12.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.55 HG11 ' HZ2' ' A' ' 41' ' ' TRP . 15.3 m -138.84 177.87 4.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -161.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.685 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 5.2 m-85 -138.88 141.32 29.97 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.121 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.71 -48.42 0.11 Allowed 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.21 -63.77 0.27 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.846 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.484 ' HB2' HG22 ' A' ' 11' ' ' VAL . 27.4 m -79.3 -167.94 1.35 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.707 0.289 . . . . 0.0 111.417 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.87 -1.86 3.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.799 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 73.41 158.62 0.21 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.057 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 58' ' ' VAL . 17.2 t -138.9 163.39 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 175.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.434 ' H ' HG12 ' A' ' 57' ' ' VAL . 45.4 t -138.1 120.53 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.689 0.757 . . . . 0.0 109.294 -169.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.594 HG21 HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -139.2 -179.91 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.311 -165.611 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 p -124.46 -163.43 1.16 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.145 -175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.11 -47.7 80.44 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -58.82 6.62 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.295 -0.878 . . . . 0.0 112.012 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.585 ' HG3' HG12 ' A' ' 59' ' ' VAL . 6.8 mm-40 -57.21 -25.27 58.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.962 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.787 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.26 -46.93 82.58 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.22 -178.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.93 -73.3 0.07 Allowed 'General case' 0 C--O 1.245 0.838 0 CA-C-O 121.97 0.89 . . . . 0.0 112.251 -165.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -55.86 29.22 Favored 'General case' 0 C--O 1.255 1.392 0 CA-C-N 114.076 -1.42 . . . . 0.0 112.141 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.17 -41.98 80.26 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.464 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.787 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 4.1 tt0 -57.06 -52.18 66.3 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -56.95 -77.48 0.03 OUTLIER 'General case' 0 C--O 1.248 1.011 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.382 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -58.08 -68.32 0.26 Allowed 'General case' 0 C--O 1.255 1.394 0 CA-C-O 123.272 1.51 . . . . 0.0 112.377 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.821 ' HB1' ' H ' ' A' ' 21' ' ' GLN . . . -57.46 -47.4 81.95 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.199 -1.818 . . . . 0.0 113.313 -173.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -57.65 -36.89 72.46 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 119.483 1.038 . . . . 0.0 111.123 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.42 -39.31 72.85 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 119.471 -0.891 . . . . 0.0 109.113 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 71' ' ' ALA . 19.1 mtp180 -57.76 -56.91 15.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.408 167.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.503 ' HB2' ' CB ' ' A' ' 21' ' ' GLN . . . -41.98 -48.76 4.61 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.827 0.851 . . . . 0.0 112.603 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.543 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.982 -173.183 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.5 p80 . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.945 0.403 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.95 142.53 38.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.569 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 26.3 pttm -139.07 161.32 37.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.157 0.503 . . . . 0.0 111.054 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.683 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.9 p -73.03 151.7 7.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.718 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.45 17.4 62.34 Favored Glycine 0 CA--C 1.511 -0.193 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 1.2 m-20 -138.62 -179.09 5.61 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 113.627 -1.286 . . . . 0.0 107.658 -174.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.812 ' HB2' HG23 ' A' ' 59' ' ' VAL . 83.2 m-85 -137.28 168.6 19.3 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -170.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.9 tt -138.5 138.8 38.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.454 -168.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.848 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 12.4 t -138.81 169.09 18.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.513 ' H ' HG12 ' A' ' 10' ' ' VAL . 89.7 t . . . . . 0 C--N 1.316 -0.888 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 C--O 1.223 -0.294 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.955 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 56.2 mt-30 64.61 96.87 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.394 0 O-C-N 123.518 0.511 . . . . 0.0 110.395 -171.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.899 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.5 t-160 -138.99 121.71 16.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.53 0.681 . . . . 0.0 111.854 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -139.77 -178.33 5.37 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.749 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.737 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 15.0 tt0 -136.67 132.29 34.75 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.705 1.24 . . . . 0.0 109.679 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.589 HG21 HG22 ' A' ' 28' ' ' VAL . 59.8 mt -90.22 114.77 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 112.39 -2.186 . . . . 0.0 111.267 -167.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.749 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -106.79 -16.23 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.571 170.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.694 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 32.2 mt-10 -139.11 153.08 47.96 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.03 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.589 HG22 HG21 ' A' ' 25' ' ' ILE . 18.5 t -137.76 99.93 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -170.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -98.46 33.1 2.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -164.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 p -122.79 -90.86 0.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.702 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 176.0 -66.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.491 0.495 . . . . 0.0 109.919 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -92.75 -58.81 2.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.925 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.88 80.58 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.769 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.486 ' HB3' ' HD2' ' A' ' 35' ' ' PRO . 59.2 m -155.28 165.38 18.43 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 34' ' ' SER . 36.2 Cg_endo -66.85 155.7 69.46 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 121.937 1.758 . . . . 0.0 111.678 173.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.663 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 95.6 Cg_endo -87.91 -177.24 12.65 Favored 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.244 -1.565 . . . . 0.0 113.008 0.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -138.74 174.6 10.36 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.396 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 81.5 t -137.86 115.12 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.405 HG12 ' CG2' ' A' ' 48' ' ' THR . 0.4 OUTLIER -138.91 170.38 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.087 0 CA-C-N 112.556 -2.111 . . . . 0.0 109.091 -152.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 46' ' ' HIS . 25.9 ttm180 -138.73 132.03 30.12 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.686 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 9.8 m95 -78.47 83.76 4.66 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 169.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.647 HD21 ' HB3' ' A' ' 24' ' ' GLU . 5.7 mt -60.37 -66.2 0.56 Allowed 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 123.584 0.553 . . . . 0.0 111.261 -167.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.618 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.5 OUTLIER -60.19 -35.68 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.821 -176.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -60.4 -66.37 0.54 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.929 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 130.6 29.76 0.62 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.687 -0.768 . . . . 0.0 114.613 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.686 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 4.9 t-80 -139.29 168.85 18.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.386 1.093 . . . . 0.0 110.787 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.51 126.16 22.12 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.142 0.496 . . . . 0.0 110.05 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.516 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 13.2 t -139.46 -178.97 5.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.107 0.956 . . . . 0.0 113.285 -162.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.3 m -137.93 115.52 11.29 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 m -138.77 175.77 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -161.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.663 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 26.6 m-85 -132.58 108.46 13.23 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.336 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.63 5.56 5.49 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.863 2.375 . . . . 0.0 112.564 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.62 -92.45 1.32 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.869 -177.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.2 t -170.19 178.26 3.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.7 t70 59.57 44.22 14.91 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.091 0.948 . . . . 0.0 109.716 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.9 128.19 35.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.964 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.2 m -105.11 143.3 16.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.647 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.74 118.2 46.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.052 0.453 . . . . 0.0 110.998 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.812 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -105.22 -179.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.735 -178.104 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.4 p -122.72 -164.52 1.2 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.87 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.58 -43.3 99.17 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -172.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -51.64 64.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.728 -0.607 . . . . 0.0 111.884 -174.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.582 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 32.0 mm-40 -62.91 -17.17 61.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.114 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.637 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -69.81 -34.22 73.41 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.454 -176.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.46 -76.43 0.06 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 122.109 0.956 . . . . 0.0 110.858 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 1.0 OUTLIER -63.18 -55.8 22.08 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.214 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -64.91 -34.5 78.55 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.909 -173.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.899 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 32.9 tt0 -72.72 -34.56 67.18 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 119.554 -0.859 . . . . 0.0 110.717 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -52.93 -65.58 0.53 Allowed 'General case' 0 C--O 1.25 1.087 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.606 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 14.8 ptm180 -61.69 -47.77 83.82 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.943 0.878 . . . . 0.0 111.506 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.663 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -77.02 -17.14 59.02 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.2 -170.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.67 -41.02 55.07 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.317 172.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.59 -31.45 64.27 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.334 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 74' ' ' ARG . 2.4 mmt85 -80.33 -51.81 8.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.264 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.955 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -57.98 -65.97 0.55 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.161 0.505 . . . . 0.0 112.058 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.741 0 C-N-CA 119.872 -1.156 . . . . 0.0 111.94 -169.649 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 . . . . . 0 CA--C 1.518 -0.275 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.5 ' HA ' HG21 ' A' ' 58' ' ' VAL . . . -138.94 152.17 47.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.733 0.302 . . . . 0.0 111.478 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -139.1 172.78 12.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.221 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.746 HG23 ' HA ' ' A' ' 26' ' ' ILE . 4.1 p -93.08 144.89 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.401 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.27 17.38 59.09 Favored Glycine 0 CA--C 1.51 -0.257 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -138.74 -179.1 5.62 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.75 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 91.7 m-85 -137.11 172.75 12.53 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.093 -168.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.774 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 8.0 tt -138.56 142.78 39.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.844 -169.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.699 HG23 HG21 ' A' ' 59' ' ' VAL . 4.9 t -138.85 155.19 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 124.878 1.361 . . . . 0.0 109.356 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.713 HG21 ' H ' ' A' ' 53' ' ' GLY . 92.9 t . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.401 ' CG ' ' HE ' ' A' ' 74' ' ' ARG . 4.7 m-20 . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.791 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 51.8 mt-30 53.48 90.6 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.165 0 O-C-N 124.159 0.912 . . . . 0.0 111.466 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.921 ' H ' ' HB2' ' A' ' 71' ' ' ALA . 10.9 t60 -138.85 125.78 21.1 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 122.461 1.124 . . . . 0.0 113.227 -171.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.34 -178.56 5.43 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.701 -1.591 . . . . 0.0 109.017 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.75 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 14.4 tt0 -137.26 123.6 20.66 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.461 ' CG2' HG22 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -88.16 113.9 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.935 -168.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.746 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.3 pp -110.18 -7.75 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.951 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 1.145 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -138.91 127.74 23.54 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.461 HG22 ' CG2' ' A' ' 25' ' ' ILE . 32.3 t -138.28 110.98 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.6 -167.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 21.6 mmt85 -66.58 -46.0 77.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.072 0.463 . . . . 0.0 111.875 -173.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.0 m -154.34 144.41 21.92 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.494 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.49 0.37 29.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.555 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -71.29 -26.17 62.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.91 -10.75 29.64 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.399 173.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.4 m -69.11 130.54 91.22 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 117.542 0.671 . . . . 0.0 111.139 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.443 ' CB ' ' HA ' ' A' ' 36' ' ' PRO . 29.4 Cg_exo -62.94 173.14 4.08 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.005 2.47 . . . . 0.0 111.451 174.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.593 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 95.0 Cg_endo -76.98 -170.75 9.01 Favored 'Cis proline' 0 CA--C 1.52 -0.218 0 C-N-CA 123.877 -1.301 . . . . 0.0 113.371 2.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -138.38 168.92 18.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.466 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.145 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 68.0 t -137.78 107.2 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 25' ' ' ILE . 0.3 OUTLIER -138.92 177.53 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 112.833 -1.985 . . . . 0.0 109.972 -151.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.732 ' HB2' HD23 ' A' ' 42' ' ' LEU . 86.1 mtm180 -138.74 133.8 32.68 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.498 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.63 ' HE1' HG21 ' A' ' 48' ' ' THR . 16.1 m95 -87.01 60.13 6.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 163.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -60.3 -52.66 64.32 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -158.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.515 HG22 ' OE2' ' A' ' 68' ' ' GLU . 0.5 OUTLIER -60.39 -33.76 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 118.555 0.616 . . . . 0.0 111.639 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -60.44 -42.94 97.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.384 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 130.68 6.6 3.66 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.549 -0.834 . . . . 0.0 114.58 172.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.92 176.55 8.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.798 1.299 . . . . 0.0 112.592 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 1.9 mp0 -138.53 139.45 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.537 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.63 HG21 ' HE1' ' A' ' 41' ' ' TRP . 16.5 p -139.25 -179.37 5.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.691 0.758 . . . . 0.0 112.422 -169.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.465 HG23 HG22 ' A' ' 38' ' ' VAL . 31.6 m -138.33 107.96 6.23 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.1 m -138.9 179.94 2.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -157.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 14.1 m-85 -138.84 130.92 15.58 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 113.455 -1.702 . . . . 0.0 107.908 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.35 -170.77 0.8 Allowed 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.61 2.207 . . . . 0.0 112.882 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.713 ' H ' HG21 ' A' ' 11' ' ' VAL . . . -98.56 -132.48 7.64 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.855 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.451 ' O ' HG13 ' A' ' 11' ' ' VAL . 23.5 m -96.1 156.97 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 t70 70.88 -60.56 0.5 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.349 1.031 . . . . 0.0 110.122 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 51.95 132.14 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.937 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.865 HG22 ' H ' ' A' ' 58' ' ' VAL . 7.5 p -138.97 -179.79 2.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.017 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.865 ' H ' HG22 ' A' ' 57' ' ' VAL . 53.3 t -138.19 134.82 44.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.951 -172.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.699 HG21 HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.71 -179.84 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.968 -166.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.7 p -118.86 -164.33 1.03 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.135 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.04 -46.61 82.28 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -175.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -61.08 2.73 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 121.597 -0.689 . . . . 0.0 111.774 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -57.41 -24.87 58.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.937 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.876 ' HA ' ' NE2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.33 -45.17 84.56 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.126 -178.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.35 -73.21 0.09 Allowed 'General case' 0 C--O 1.254 1.326 0 CA-C-O 122.136 0.97 . . . . 0.0 112.587 -170.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.598 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -63.87 -42.9 97.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.76 -172.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.36 -27.81 67.43 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.793 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 3.2 tt0 -70.57 -31.03 67.9 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.677 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 50.4 mttp -56.03 -51.96 65.96 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.94 165.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.598 ' HD3' ' O ' ' A' ' 66' ' ' GLU . 2.3 mpt_? -56.93 -20.52 23.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.277 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.921 ' HB2' ' H ' ' A' ' 22' ' ' HIS . . . -75.99 -60.26 2.4 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.44 -22.03 64.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.046 0.451 . . . . 0.0 109.935 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.71 -73.43 0.26 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.281 169.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.401 ' HE ' ' CG ' ' A' ' 20' ' ' ASP . 6.2 mtm180 -82.56 -54.91 4.8 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -170.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.791 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -58.17 -60.49 3.67 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -172.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.712 0 C-N-CA 119.977 -1.106 . . . . 0.0 113.084 -171.82 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 24.0 t60 . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.807 0.337 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.29 119.41 38.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.837 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.633 ' HA ' HG21 ' A' ' 28' ' ' VAL . 14.5 tptm -126.35 164.62 20.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.863 0.363 . . . . 0.0 110.966 -175.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.91 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.0 p -66.27 150.03 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.319 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.11 1.71 48.32 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -143.06 175.92 9.49 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.906 ' HB2' HG23 ' A' ' 59' ' ' VAL . 93.5 m-85 -104.51 154.35 20.01 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.284 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.8 tt -98.96 132.2 44.46 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.395 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 t -137.79 143.65 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 124.951 1.407 . . . . 0.0 109.485 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 54' ' ' SER . 54.7 t . . . . . 0 C--O 1.245 0.844 0 CA-C-O 120.731 0.3 . . . . 0.0 111.561 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' HD3' ' A' ' 74' ' ' ARG . 18.7 t70 . . . . . 0 C--O 1.218 -0.6 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.734 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 7.0 mt-30 63.07 101.29 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.794 0.437 . . . . 0.0 110.352 -174.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.715 ' CE1' ' HA ' ' A' ' 64' ' ' HIS . 58.6 t60 -148.26 151.22 35.07 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -167.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -179.01 -179.82 0.61 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.944 1.298 . . . . 0.0 107.51 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.587 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 41.1 tt0 -98.34 129.91 45.01 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.064 -0.655 . . . . 0.0 112.106 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.486 ' CG1' ' HB2' ' A' ' 9' ' ' LEU . 53.0 mt -85.8 111.21 20.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.383 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.91 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.5 pp -120.44 -16.63 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.642 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.766 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 48.2 mt-10 -130.26 107.96 9.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.136 0.493 . . . . 0.0 110.718 175.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.633 HG21 ' HA ' ' A' ' 4' ' ' LYS . 58.6 t -98.74 114.25 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.477 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 29.0 mmt180 -95.5 38.78 1.14 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.244 0.545 . . . . 0.0 111.251 -176.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.8 m -151.37 150.3 30.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.761 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.77 69.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.438 . . . . 0.0 110.8 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -115.1 -65.5 1.18 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.752 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.46 104.12 0.17 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.592 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 34.8 t -154.28 145.68 16.62 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 19.0 Cg_exo -67.26 155.07 72.13 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.44 2.094 . . . . 0.0 111.468 173.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.465 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 95.4 Cg_endo -87.89 178.87 19.07 Favored 'Cis proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.498 -1.459 . . . . 0.0 113.037 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -126.67 146.91 50.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.004 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.766 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 59.4 t -98.74 110.4 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.41 145.39 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.668 -159.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.719 ' HG2' ' HG3' ' A' ' 47' ' ' GLU . 73.4 mtp180 -106.36 129.42 54.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.493 0.664 . . . . 0.0 110.855 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.653 ' CE3' ' HB1' ' A' ' 72' ' ' ALA . 4.5 m0 -93.68 87.76 5.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.495 HD11 ' CD ' ' A' ' 24' ' ' GLU . 18.6 mt -70.05 -68.89 0.39 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.464 -162.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.536 HG22 ' OE2' ' A' ' 68' ' ' GLU . 4.2 m -74.96 -6.86 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.712 -173.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.06 -54.38 4.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.278 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.5 54.07 0.31 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.047 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -153.7 168.22 26.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.736 0.303 . . . . 0.0 111.131 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.719 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 32.7 tt0 -149.54 124.0 9.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 t -167.1 175.9 7.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.452 0.644 . . . . 0.0 112.029 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 m -101.5 110.25 22.21 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.292 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -106.88 149.77 10.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.39 0.614 . . . . 0.0 111.815 -171.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 81.9 m-85 -106.28 103.01 43.52 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.784 172.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.56 154.32 55.02 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.245 1.963 . . . . 0.0 110.861 175.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.84 -76.05 0.24 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.173 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.582 ' O ' HG13 ' A' ' 11' ' ' VAL . 28.4 t -169.68 162.63 9.83 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 55.51 60.28 3.43 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.285 0.564 . . . . 0.0 110.686 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.34 127.21 33.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.06 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.6 t -120.43 157.56 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.423 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -100.42 115.76 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.341 0.591 . . . . 0.0 111.94 -178.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.906 HG23 ' HB2' ' A' ' 8' ' ' TYR . 6.6 m -102.0 178.29 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.987 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 p -119.41 -165.1 1.11 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.807 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -50.1 -47.14 53.98 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.19 -38.1 78.46 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.49 -0.756 . . . . 0.0 112.248 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.705 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 30.5 mm-40 -74.97 -16.78 60.62 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.528 0.68 . . . . 0.0 109.352 176.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.715 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -71.84 -43.4 65.6 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.401 -177.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.04 -70.23 0.18 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-O 121.258 0.551 . . . . 0.0 112.362 -171.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -31.51 72.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.381 -173.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.656 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -80.97 -22.18 39.75 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.524 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.697 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 2.0 tt0 -73.81 -46.68 43.75 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.416 -0.913 . . . . 0.0 108.993 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -56.67 -71.46 0.09 Allowed 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.563 0.697 . . . . 0.0 110.285 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -66.35 -52.6 45.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.452 -171.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.692 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -82.07 -23.11 35.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.971 -167.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.653 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -76.41 -39.93 52.22 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.361 173.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.27 -29.32 67.49 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.518 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.465 ' HD3' ' OD2' ' A' ' 20' ' ' ASP . 14.7 ttt180 -82.19 -40.66 21.41 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.726 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -54.07 -62.07 1.9 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.149 0.5 . . . . 0.0 110.774 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.643 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.368 -177.91 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 35.3 t-80 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.77 171.74 13.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.787 0.327 . . . . 0.0 111.373 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 8.3 ttpm? -139.03 151.97 47.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.803 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -82.96 139.33 17.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.17 26.71 27.73 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -168.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 14.5 m-20 -138.35 -178.92 5.5 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.673 ' HB2' HG23 ' A' ' 59' ' ' VAL . 88.9 m-85 -137.22 169.67 17.38 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -169.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.769 HD21 ' HB3' ' A' ' 52' ' ' PRO . 5.7 tt -138.66 145.36 40.34 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.205 -167.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 40.1 t -139.11 164.53 25.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.81 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.9 p . . . . . 0 C--N 1.318 -0.776 0 CA-C-O 120.877 0.37 . . . . 0.0 110.125 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.407 ' CG ' ' HE ' ' A' ' 74' ' ' ARG . 3.9 t70 . . . . . 0 C--O 1.226 -0.17 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.81 ' HB2' HG12 ' A' ' 11' ' ' VAL . 17.2 mt-30 53.73 104.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.466 0.706 . . . . 0.0 111.326 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.892 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 36.0 t-80 -138.7 123.78 19.04 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.199 0.523 . . . . 0.0 111.947 -171.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.742 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.45 -178.5 5.41 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.02 -176.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.667 ' HB3' HD21 ' A' ' 42' ' ' LEU . 3.3 tm-20 -137.4 122.78 19.48 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.274 1.035 . . . . 0.0 108.244 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.418 ' HA ' HG23 ' A' ' 39' ' ' VAL . 1.2 mt -87.05 105.03 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.158 -167.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.773 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -98.61 -13.37 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 124.091 0.869 . . . . 0.0 109.386 174.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.721 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.04 140.92 38.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.498 -0.774 . . . . 0.0 108.988 174.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.08 99.86 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -167.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -94.41 78.97 3.88 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.617 0.246 . . . . 0.0 110.787 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.509 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 23.4 p 172.23 -35.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.151 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 74.63 -16.44 0.55 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.761 0.824 . . . . 0.0 111.761 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 30' ' ' SER . 4.2 p-10 -103.3 -37.91 7.46 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.71 8.31 3.52 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.441 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 48.9 m -76.19 143.99 74.34 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 122.633 -0.333 . . . . 0.0 110.369 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 17.9 Cg_exo -67.26 160.69 46.4 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.818 2.345 . . . . 0.0 111.938 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.593 ' HB3' ' HD1' ' A' ' 51' ' ' TYR . 90.0 Cg_endo -81.08 -171.28 9.43 Favored 'Cis proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.838 -1.317 . . . . 0.0 112.816 -1.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.52 175.91 9.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.532 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.721 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 98.1 t -137.89 112.75 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 25' ' ' ILE . 0.4 OUTLIER -138.95 169.44 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.761 -2.018 . . . . 0.0 109.339 -151.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 33.2 ttm180 -138.77 128.05 24.26 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.742 ' CZ3' ' HB2' ' A' ' 23' ' ' ALA . 5.7 m95 -80.07 86.03 5.58 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 170.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.667 HD21 ' HB3' ' A' ' 24' ' ' GLU . 7.1 mt -59.93 -67.17 0.41 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.606 -166.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.517 HG13 ' NE2' ' A' ' 64' ' ' HIS . 1.2 m -60.05 -34.24 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.496 -176.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.51 ' ND2' ' HB3' ' A' ' 72' ' ' ALA . 37.1 m-80 -60.45 -60.18 4.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.407 171.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.37 40.22 0.69 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.956 -0.565 . . . . 0.0 113.36 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.61 ' CB ' ' HD1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -139.11 160.89 38.72 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 117.25 0.525 . . . . 0.0 110.851 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -139.0 120.54 15.08 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.879 0.371 . . . . 0.0 110.446 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.585 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 8.8 t -139.29 -178.86 5.55 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.384 1.088 . . . . 0.0 113.807 -163.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.571 HG23 HG22 ' A' ' 38' ' ' VAL . 85.4 m -138.14 108.1 6.35 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.655 HG22 ' H ' ' A' ' 51' ' ' TYR . 4.6 p -138.9 176.31 6.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.046 -158.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.655 ' H ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -138.81 114.08 8.54 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.769 ' HB3' HD21 ' A' ' 9' ' ' LEU . 31.3 Cg_endo -64.01 -69.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.475 0.425 0 C-N-CA 123.13 2.553 . . . . 0.0 112.978 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.37 -164.67 37.38 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -91.2 20.78 4.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.125 0.488 . . . . 0.0 111.842 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -143.86 50.95 1.33 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.73 133.25 42.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.714 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.874 HG22 ' H ' ' A' ' 58' ' ' VAL . 5.3 p -138.96 -179.76 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.408 0.623 . . . . 0.0 109.882 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.874 ' H ' HG22 ' A' ' 57' ' ' VAL . 87.5 t -138.23 139.77 41.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.351 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.673 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.71 176.73 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 123.97 0.908 . . . . 0.0 110.82 -174.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 t -116.39 -169.18 1.57 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.23 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.03 -49.69 75.04 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.322 -175.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.51 -56.69 18.58 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.69 -0.631 . . . . 0.0 111.022 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 31.7 mt-10 -57.44 -26.26 60.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.47 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.76 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.3 -49.37 76.32 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 177.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . -56.98 -76.02 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.729 0.776 . . . . 0.0 111.883 -163.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -59.13 5.61 Favored 'General case' 0 C--O 1.26 1.637 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.306 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.646 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . . . -57.11 -37.18 71.58 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.944 -174.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.892 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 21.7 tt0 -71.68 -40.02 69.87 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.091 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 28.9 mtpp -52.61 -58.87 5.4 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.942 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.646 ' HE ' ' HA ' ' A' ' 67' ' ' ALA . 27.6 ptt180 -69.61 -53.16 20.12 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 122.137 0.97 . . . . 0.0 112.071 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.767 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -70.43 -31.14 68.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.334 -170.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -76.39 -34.56 58.86 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.187 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.15 54.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.576 0.548 . . . . 0.0 110.273 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HE ' ' CG ' ' A' ' 20' ' ' ASP . 49.8 mtm-85 -82.09 -47.82 12.12 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.755 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -46.36 -51.1 15.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.396 0.678 . . . . 0.0 112.714 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.427 ' HA3' ' CZ2' ' A' ' 41' ' ' TRP . . . . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.968 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 . . . . . 0 CA--C 1.522 -0.128 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.85 140.33 40.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.935 0.874 . . . . 0.0 111.057 -167.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 6.8 mmmm -138.96 141.08 38.43 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.44 -158.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.876 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.0 p -61.41 138.6 21.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 121.655 -0.653 . . . . 0.0 110.777 171.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.69 14.99 71.8 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 1.4 t70 -139.04 143.52 38.43 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.942 -1.629 . . . . 0.0 107.324 -167.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.801 ' HB2' HG23 ' A' ' 59' ' ' VAL 0.266 65.4 m-85 -134.37 141.9 47.02 Favored 'General case' 0 C--O 1.206 -1.227 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -142.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.796 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 4.6 tt -136.52 140.27 42.87 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.539 1.161 . . . . 0.0 110.401 -149.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.015 ' HB ' HG23 ' A' ' 57' ' ' VAL . 14.3 t -138.72 141.55 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 111.397 -2.638 . . . . 0.0 109.038 -153.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.32 -0.682 0 CA-C-O 122.257 1.027 . . . . 0.0 109.869 -173.201 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 21' ' ' GLN . 23.4 t70 . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 1.051 ' HG2' ' HB3' ' A' ' 74' ' ' ARG . 38.7 mt-30 64.87 105.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.353 0.408 . . . . 0.0 111.012 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.796 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 1.6 m170 -138.21 136.61 36.76 Favored 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 117.219 -1.792 . . . . 0.0 110.319 167.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.548 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -142.41 144.37 33.08 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 129.068 2.947 . . . . 0.0 107.055 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.751 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -134.56 139.85 45.69 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 122.269 2.304 . . . . 0.0 110.66 -166.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.74 HD12 HG22 ' A' ' 28' ' ' VAL . 5.4 pt -92.08 128.53 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 109.86 -3.336 . . . . 0.0 111.457 -159.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.876 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.8 pp -102.62 -6.29 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 112.022 -2.354 . . . . 0.0 108.981 169.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.654 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 33.3 mt-10 -139.02 139.69 37.9 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.901 172.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.74 HG22 HD12 ' A' ' 25' ' ' ILE . 8.5 t -138.28 139.81 41.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -175.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -125.8 25.31 6.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.388 0.613 . . . . 0.0 110.256 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 t -173.44 124.4 0.39 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.923 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.85 -16.45 41.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.323 0.582 . . . . 0.0 109.445 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.82 -46.0 55.41 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.291 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.29 40.12 0.49 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.651 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.4 m -117.58 151.53 48.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 122.197 0.199 . . . . 0.0 110.586 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.8 169.13 22.79 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.826 2.351 . . . . 0.0 112.334 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.58 179.9 29.5 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.603 -1.415 . . . . 0.0 112.63 0.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -138.71 142.07 38.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.723 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.873 HG22 HG23 ' A' ' 49' ' ' THR . 99.8 t -135.88 138.91 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 CA-C-O 125.147 2.403 . . . . 0.0 108.955 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.548 ' CG1' ' HB1' ' A' ' 23' ' ' ALA . 47.2 t -139.7 142.17 33.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 108.558 -3.928 . . . . 0.0 112.533 -129.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.651 ' HG3' ' O ' ' A' ' 46' ' ' HIS . 51.7 ttp180 -137.19 139.5 41.13 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 166.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.553 ' HH2' ' HA3' ' A' ' 76' ' ' GLY . 10.1 m0 -99.38 70.2 1.71 Allowed 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.573 HD22 ' HE ' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -60.56 -41.34 94.39 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 113.357 -1.747 . . . . 0.0 113.15 -150.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.76 HG11 ' HA ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -61.56 -41.48 90.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.075 174.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -61.48 -40.49 94.74 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.57 50.27 2.98 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.295 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.651 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 8.1 t-160 -139.3 159.32 42.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.593 0.696 . . . . 0.0 110.554 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HG2' ' HD3' ' A' ' 40' ' ' ARG . 48.8 mt-10 -138.3 112.24 8.44 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.159 0.98 . . . . 0.0 110.46 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 t -139.68 -178.21 5.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.752 -1.567 . . . . 0.0 112.164 -165.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.873 HG23 HG22 ' A' ' 38' ' ' VAL . 94.6 m -137.65 122.19 18.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.454 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.754 HG12 ' H ' ' A' ' 51' ' ' TYR . 2.3 t -138.52 179.32 3.33 Favored 'Isoleucine or valine' 0 C--O 1.255 1.351 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.761 -164.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.754 ' H ' HG12 ' A' ' 50' ' ' VAL . 8.0 m-85 -138.78 114.69 8.67 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.203 176.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.665 ' HB3' HD21 ' A' ' 9' ' ' LEU . 27.6 Cg_exo -63.32 -66.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.312 2.674 . . . . 0.0 112.522 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.63 -136.18 8.71 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.734 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.7 p -101.27 162.19 13.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 58.9 45.76 14.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.913 0.863 . . . . 0.0 110.466 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.5 130.04 36.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.627 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 1.015 HG23 ' HB ' ' A' ' 10' ' ' VAL . 6.2 m -138.89 175.18 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.4 151.86 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -170.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' A' ' 8' ' ' TYR . 3.0 m -138.87 178.78 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 C-N-CA 126.246 1.818 . . . . 0.0 109.69 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.1 p -117.69 -171.16 2.0 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.006 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.11 -47.77 80.28 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -174.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -54.26 48.87 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 121.67 -0.644 . . . . 0.0 111.166 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 21.1 mt-10 -57.12 -33.43 67.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.518 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.76 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.15 -37.97 72.83 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 114.563 -1.199 . . . . 0.0 114.107 -177.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.76 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -57.05 -76.29 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.053 0.93 . . . . 0.0 110.288 -171.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -57.37 -64.4 0.9 Allowed 'General case' 0 C--O 1.268 2.062 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.065 178.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -56.88 -58.93 6.01 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.035 -175.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.716 ' HB3' ' O ' ' A' ' 64' ' ' HIS . 39.4 tt0 -57.41 -32.84 67.26 Favored 'General case' 0 C--O 1.204 -1.297 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.44 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -57.12 -71.33 0.1 Allowed 'General case' 0 C--O 1.261 1.676 0 CA-C-N 119.627 1.103 . . . . 0.0 110.808 174.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -53.82 53.83 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-O 123.262 1.506 . . . . 0.0 110.651 -175.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.791 ' O ' ' HA ' ' A' ' 21' ' ' GLN . . . -57.37 -39.39 75.93 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 112.999 -1.909 . . . . 0.0 112.923 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.51 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -57.1 -43.78 82.58 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 118.584 0.629 . . . . 0.0 109.891 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.49 -40.82 75.61 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 119.604 -0.839 . . . . 0.0 109.334 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 1.051 ' HB3' ' HG2' ' A' ' 21' ' ' GLN . 1.8 mpt_? -57.53 -57.93 10.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 172.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.671 ' HA ' HE21 ' A' ' 21' ' ' GLN . . . -47.09 -42.2 18.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.016 0.927 . . . . 0.0 113.065 -173.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.553 ' HA3' ' HH2' ' A' ' 41' ' ' TRP . . . . . . . . 0 C--N 1.323 -0.179 0 C-N-CA 118.661 -1.733 . . . . 0.0 113.35 -173.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.34 148.05 48.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.147 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.658 ' HE3' ' HA ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -130.92 169.58 15.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.843 0.354 . . . . 0.0 110.307 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.834 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.7 p -85.88 146.02 7.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.795 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.17 9.2 60.84 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -129.24 169.46 14.8 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.872 ' HB2' HG23 ' A' ' 59' ' ' VAL . 97.7 m-85 -105.95 150.77 25.37 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.317 0.579 . . . . 0.0 111.113 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.769 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 6.5 tt -98.75 146.22 26.13 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.468 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.775 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 47.8 t -127.65 144.74 36.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 O-C-N 125.295 1.622 . . . . 0.0 110.291 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.653 HG22 ' HB3' ' A' ' 52' ' ' PRO . 3.2 t . . . . . 0 C--O 1.236 0.368 0 O-C-N 123.588 0.555 . . . . 0.0 110.367 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 . . . . . 0 CA--C 1.519 -0.247 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.636 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 39.1 mt-30 52.61 87.86 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.622 0.576 . . . . 0.0 111.959 173.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.769 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 55.0 m170 -117.95 158.31 25.13 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -175.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . . . -169.92 179.17 3.71 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 34.4 tt0 -98.32 126.1 43.7 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.086 -175.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.468 ' CG2' HG22 ' A' ' 28' ' ' VAL . 7.7 mt -88.15 105.82 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.016 174.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.834 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.2 pp -109.39 -27.02 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.228 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 1.068 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 47.3 mt-10 -118.81 101.81 8.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.086 0.469 . . . . 0.0 110.034 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.468 HG22 ' CG2' ' A' ' 25' ' ' ILE . 28.5 t -98.97 104.07 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.1 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -90.02 35.48 0.85 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.374 0.607 . . . . 0.0 110.725 -174.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -156.54 141.52 17.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.589 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.18 92.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.008 0.432 . . . . 0.0 110.644 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.4 -78.25 0.43 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.948 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.44 108.5 0.21 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.191 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.8 p -156.12 137.52 9.55 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.41 153.5 53.64 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.76 2.307 . . . . 0.0 112.092 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 83.2 Cg_endo -83.36 167.64 62.76 Favored 'Cis proline' 0 N--CA 1.463 -0.293 0 C-N-CA 123.276 -1.552 . . . . 0.0 113.317 2.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -120.14 144.24 47.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.186 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.068 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 58.5 t -98.79 111.06 27.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -126.11 148.77 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.833 -164.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.851 ' HD2' ' HB3' ' A' ' 42' ' ' LEU . 31.2 ttm-85 -114.29 121.57 44.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.279 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.446 ' CE3' ' HB2' ' A' ' 23' ' ' ALA . 12.0 m95 -83.14 76.72 9.84 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 168.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.851 ' HB3' ' HD2' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -76.35 -34.03 58.96 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -166.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.543 HG22 ' OE2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -77.26 -9.31 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.924 179.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.19 -32.16 11.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.546 171.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.85 35.84 3.62 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.787 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -136.39 168.38 19.56 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 122.634 -0.333 . . . . 0.0 110.435 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -153.6 141.62 20.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 t -175.4 -179.96 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.691 0.758 . . . . 0.0 111.674 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.9 m -98.77 107.83 20.36 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.69 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.417 HG12 ' HB ' ' A' ' 39' ' ' VAL . 9.5 p -98.98 148.68 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.304 0.573 . . . . 0.0 111.196 -173.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 24.2 m-85 -118.15 99.78 51.83 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.68 174.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.653 ' HB3' HG22 ' A' ' 11' ' ' VAL . 3.3 Cg_exo -75.62 -46.15 0.22 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.721 2.28 . . . . 0.0 112.268 -175.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.3 -94.75 1.44 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.801 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.7 m -126.72 167.39 15.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.569 0.185 . . . . 0.0 111.137 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 67.25 22.14 9.74 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.933 0.771 . . . . 0.0 111.345 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.775 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -75.52 127.6 33.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.168 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.857 HG22 ' H ' ' A' ' 58' ' ' VAL . 7.4 p -147.27 -179.99 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.347 0.594 . . . . 0.0 110.346 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.857 ' H ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -111.26 127.94 68.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.504 -175.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.872 HG23 ' HB2' ' A' ' 8' ' ' TYR . 1.4 m -119.57 179.24 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 123.285 0.634 . . . . 0.0 110.768 173.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 p -112.05 -171.79 1.92 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.55 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.595 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -49.14 -52.23 27.52 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -172.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.56 -40.94 84.92 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.308 -170.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -63.04 -24.93 68.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.411 0.624 . . . . 0.0 110.227 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.482 ' CE1' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -67.2 -49.37 64.87 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.687 -173.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.61 -67.66 0.23 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.828 0.823 . . . . 0.0 112.684 -164.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -61.6 -52.48 64.21 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.349 -174.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HB3' ' ND1' ' A' ' 22' ' ' HIS . . . -72.79 -16.69 61.62 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.671 ' OE1' ' HA ' ' A' ' 23' ' ' ALA . 29.9 tt0 -77.59 -40.68 41.36 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -55.56 -49.3 73.06 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.924 0.869 . . . . 0.0 109.105 170.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -68.33 -16.65 64.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.093 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -81.26 -41.19 22.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.648 0.261 . . . . 0.0 110.867 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.0 -27.29 68.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.25 -52.67 7.82 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.885 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -82.0 -65.61 0.99 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.51 73.91 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.041 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.973 -177.163 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 . . . . . 0 CA--C 1.521 -0.159 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.84 171.72 13.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.901 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 88.2 tttt -139.09 155.52 47.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.208 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 26' ' ' ILE . 37.4 t -69.85 142.22 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.88 19.07 44.84 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -174.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 9.0 m-20 -138.7 -179.01 5.57 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 114.025 -1.087 . . . . 0.0 108.549 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.755 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 95.9 m-85 -137.17 165.13 26.82 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.971 -168.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.1 tt -138.63 138.73 38.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.662 -166.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 37.8 t -139.02 157.66 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.396 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.803 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.9 p . . . . . 0 C--N 1.323 -0.565 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.643 ' OD2' ' HD3' ' A' ' 74' ' ' ARG . 15.2 t70 . . . . . 0 C--O 1.222 -0.377 0 N-CA-C 111.249 0.092 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.803 ' HB2' HG12 ' A' ' 11' ' ' VAL . 78.8 mt-30 61.24 105.18 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.542 0.737 . . . . 0.0 111.707 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.972 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.7 t-160 -139.26 126.6 21.49 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 121.254 0.55 . . . . 0.0 111.599 -174.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.742 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.51 -178.65 5.49 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.402 1.081 . . . . 0.0 110.09 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.755 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 20.5 tt0 -136.95 122.51 19.67 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.287 1.042 . . . . 0.0 108.483 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.843 HG23 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -85.05 113.8 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.192 -174.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.81 ' HA ' HG13 ' A' ' 5' ' ' VAL . 1.5 pp -106.35 -3.51 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.237 172.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.856 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.0 124.46 19.35 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.284 172.032 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -138.19 99.67 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -105.49 -3.92 21.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.58 0.705 . . . . 0.0 109.97 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 6.9 m -65.0 -25.98 68.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.383 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 63.2 -82.17 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.791 0.682 . . . . 0.0 110.841 -176.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.75 -44.24 67.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.585 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 30' ' ' SER . . . 153.67 -164.25 31.1 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p 67.75 154.26 0.14 Allowed Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 124.476 1.111 . . . . 0.0 111.956 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.56 161.38 38.75 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.948 2.432 . . . . 0.0 112.533 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.637 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 89.4 Cg_endo -83.34 179.0 26.64 Favored 'Cis proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.071 -1.637 . . . . 0.0 113.376 0.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -138.76 173.52 11.49 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.856 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 97.4 t -137.77 115.58 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.843 HG23 HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -138.84 171.16 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 CA-C-N 112.878 -1.965 . . . . 0.0 109.155 -152.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.409 ' N ' HG13 ' A' ' 39' ' ' VAL . 31.6 ttt180 -138.66 123.75 19.07 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.75 ' HD1' ' HB2' ' A' ' 46' ' ' HIS . 25.6 m95 -78.99 84.42 5.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 24' ' ' GLU . 6.9 mt -60.21 -68.6 0.28 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.346 0.593 . . . . 0.0 111.951 -166.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.682 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -60.25 -38.35 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.155 -174.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' ' 72' ' ' ALA . 44.3 m-80 -60.59 -50.86 71.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.298 171.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.98 48.94 0.86 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.506 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.75 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 46.9 m-70 -139.13 169.17 18.26 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.446 0.623 . . . . 0.0 111.283 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -138.88 119.14 13.62 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.525 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 6.7 t -139.42 -179.36 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.315 1.055 . . . . 0.0 113.684 -165.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.455 HG23 HG22 ' A' ' 38' ' ' VAL . 57.8 m -138.55 112.67 8.59 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.092 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.445 HG11 ' HZ2' ' A' ' 41' ' ' TRP . 8.5 m -138.89 -179.8 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -163.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.637 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 50.1 m-85 -138.73 108.56 7.76 Favored Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.738 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.551 ' HG3' HD11 ' A' ' 9' ' ' LEU . 72.6 Cg_endo -74.63 -169.2 0.58 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.089 2.526 . . . . 0.0 111.608 176.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.568 ' HA3' HG21 ' A' ' 11' ' ' VAL . . . -98.61 -166.2 30.78 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.546 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.8 m -97.07 21.58 9.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.34 0.59 . . . . 0.0 112.019 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.41 ' H ' HG23 ' A' ' 11' ' ' VAL . 18.2 t70 -122.91 38.09 4.26 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.97 135.6 54.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.761 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.808 HG12 ' H ' ' A' ' 58' ' ' VAL . 2.9 t -138.71 179.93 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.808 ' H ' HG12 ' A' ' 57' ' ' VAL . 58.0 t -138.0 136.02 45.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.739 -174.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.669 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.75 177.33 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.752 -170.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.6 t -122.2 -164.02 1.13 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.799 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.25 94.2 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -42.68 72.64 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 121.858 -0.526 . . . . 0.0 110.98 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.602 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 9.4 mm-40 -62.14 -17.26 57.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.838 0.827 . . . . 0.0 109.446 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.682 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -81.73 -43.99 17.68 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.78 -172.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.77 -70.79 0.09 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.838 0.828 . . . . 0.0 111.627 -168.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 1.6 pt-20 -70.08 -55.04 10.49 Favored 'General case' 0 C--O 1.257 1.457 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.748 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -59.55 -42.29 92.06 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.577 -175.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.972 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 36.0 tt0 -70.47 -35.78 73.5 Favored 'General case' 0 C--O 1.212 -0.921 0 C-N-CA 120.204 -0.599 . . . . 0.0 110.978 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 69' ' ' LYS . 11.1 tptm -51.87 -61.76 2.06 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.734 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -67.12 -52.77 37.63 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.235 1.017 . . . . 0.0 111.709 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.735 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -68.85 -30.7 69.28 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.248 -171.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -69.74 -41.07 75.74 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.75 -35.42 56.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.825 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.643 ' HD3' ' OD2' ' A' ' 20' ' ' ASP . 49.6 ttt180 -81.79 -49.46 10.37 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.49 ' HA ' ' HG2' ' A' ' 21' ' ' GLN . . . -45.14 -50.23 11.39 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.63 0.772 . . . . 0.0 112.036 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.423 -178.039 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 p80 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.028 0.442 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.89 145.3 19.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.019 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -144.79 171.02 15.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.174 0.511 . . . . 0.0 111.561 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.951 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.3 p -72.63 147.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.197 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.31 -0.34 43.69 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -130.73 176.38 8.25 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.71 ' HB2' HG23 ' A' ' 59' ' ' VAL . 94.8 m-85 -115.59 151.54 34.75 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.116 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.731 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.3 tt -98.6 142.23 30.44 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.562 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.778 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 44.4 t -134.78 154.86 37.52 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.139 0 O-C-N 125.229 1.581 . . . . 0.0 109.848 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 21' ' ' GLN . 29.5 m . . . . . 0 C--N 1.329 -0.322 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 168.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.7 t0 . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.767 ' HB3' HG22 ' A' ' 11' ' ' VAL . 0.6 OUTLIER 65.45 100.63 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 O-C-N 123.485 0.49 . . . . 0.0 110.175 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.731 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 3.8 m80 -129.79 146.64 51.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.167 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -160.8 176.38 11.54 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 172.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.622 ' CD ' HD11 ' A' ' 42' ' ' LEU . 43.9 tt0 -98.61 132.31 44.12 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.45 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.606 HG22 HG22 ' A' ' 28' ' ' VAL . 2.6 mt -97.43 109.69 23.85 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.96 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.951 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -109.03 -31.88 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.341 175.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 1.025 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 10.5 mm-40 -112.21 99.87 8.38 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.39 0.614 . . . . 0.0 109.427 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 30' ' ' SER . 15.7 t -106.86 144.72 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.017 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.3 mtp-105 -68.79 -35.98 77.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.361 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.7 ' H ' HG12 ' A' ' 28' ' ' VAL . 66.3 m 58.38 -159.75 0.27 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.856 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 65.39 -88.09 0.03 OUTLIER 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.829 0.452 . . . . 0.0 111.227 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -92.63 -27.47 17.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.733 0.301 . . . . 0.0 110.31 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.38 86.77 0.54 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.484 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.8 p -160.2 162.03 24.71 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.05 162.9 12.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.86 2.373 . . . . 0.0 112.126 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.21 151.64 96.87 Favored 'Cis proline' 0 C--N 1.343 0.262 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.747 2.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -111.46 139.9 46.5 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.025 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 57.8 t -98.35 99.92 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.62 142.02 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.212 -168.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -121.38 129.05 52.82 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.622 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.438 ' CZ3' ' HB2' ' A' ' 23' ' ' ALA . 12.8 m95 -81.05 100.39 8.97 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.622 HD11 ' CD ' ' A' ' 24' ' ' GLU . 13.2 mt -76.43 -56.78 4.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.249 0.547 . . . . 0.0 111.263 -172.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 65' ' ' ALA . 1.4 m -79.49 -7.89 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.245 -172.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -96.9 -47.98 5.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.791 170.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.49 70.81 0.82 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.746 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -174.11 148.62 1.36 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.843 0.354 . . . . 0.0 110.536 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -99.04 143.87 28.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.824 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.413 HG22 ' N ' ' A' ' 49' ' ' THR . 24.9 m -154.6 167.16 31.06 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.818 0.342 . . . . 0.0 110.249 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 48' ' ' THR . 26.5 m -127.79 118.67 24.17 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.14 162.92 35.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.805 0.812 . . . . 0.0 113.054 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -120.8 99.86 46.85 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.229 171.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.708 ' HG3' HD11 ' A' ' 9' ' ' LEU . 43.3 Cg_endo -66.51 149.45 84.39 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.672 2.248 . . . . 0.0 112.248 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.24 68.08 3.59 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.054 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.0 m 69.21 168.19 0.29 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.112 0.565 . . . . 0.0 112.395 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.28 42.48 31.45 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.3 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.778 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -77.63 110.69 12.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.122 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 10' ' ' VAL . 1.2 p -119.34 156.46 21.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.143 0.497 . . . . 0.0 110.84 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -102.21 107.08 20.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.467 -174.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.71 HG23 ' HB2' ' A' ' 8' ' ' TYR . 14.2 m -102.1 -179.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.589 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.2 t -96.71 -170.61 2.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.252 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.581 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . . . -63.38 -50.59 69.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.033 -172.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -71.8 -40.52 69.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.833 0.349 . . . . 0.0 111.689 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -55.78 -29.1 59.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.707 0.765 . . . . 0.0 109.698 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.716 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -82.22 -46.64 13.46 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -171.483 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.444 ' HA ' HG21 ' A' ' 43' ' ' VAL . . . -49.66 -60.15 3.14 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -159.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.74 -53.22 57.92 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 122.377 1.084 . . . . 0.0 110.33 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.93 -16.4 63.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.554 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 26.6 tt0 -70.77 -42.17 70.77 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 176.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -57.07 -47.15 81.69 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.639 0.733 . . . . 0.0 109.075 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -61.86 -24.05 66.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.647 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.606 ' HB2' ' H ' ' A' ' 22' ' ' HIS . . . -81.95 -48.86 10.95 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.445 -175.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.91 -23.39 65.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.61 -64.83 0.8 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.191 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -82.25 -60.12 2.32 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.594 ' HB2' ' CG ' ' A' ' 21' ' ' GLN . . . -52.51 -48.72 65.82 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.908 0.483 . . . . 0.0 112.033 -173.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.944 -175.456 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.984 0.421 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.53 150.68 40.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.6 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -137.02 146.76 45.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.951 0.405 . . . . 0.0 110.941 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.8 p -89.37 137.13 21.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.416 172.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.34 2.29 56.71 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.19 173.38 6.96 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.701 ' HB2' HG23 ' A' ' 59' ' ' VAL . 92.5 m-85 -110.96 161.13 16.16 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.382 -174.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.4 tt -106.92 137.38 45.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.247 -176.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.595 HG23 HG21 ' A' ' 59' ' ' VAL . 11.1 t -136.94 148.42 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.049 0.843 . . . . 0.0 108.89 172.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.7 ' HB ' ' HB2' ' A' ' 21' ' ' GLN . 92.2 t . . . . . 0 C--N 1.321 -0.633 0 CA-C-O 121.138 0.494 . . . . 0.0 110.249 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 119.699 -0.191 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.7 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 78.8 mt-30 45.62 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.993 0.917 . . . . 0.0 112.374 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.719 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 59.8 t-80 -135.05 145.77 48.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -171.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.497 ' HB2' ' HZ3' ' A' ' 41' ' ' TRP . . . -169.81 179.81 3.54 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.808 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 38.4 tt0 -100.64 123.56 45.02 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.515 0.509 . . . . 0.0 110.469 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 9' ' ' LEU . 18.8 mt -91.85 106.1 17.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 120.7 0.286 . . . . 0.0 110.267 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.572 ' HA ' HG23 ' A' ' 5' ' ' VAL . 2.0 pp -114.93 -10.42 12.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.157 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.885 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 30.9 mt-10 -139.92 107.99 5.74 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.113 0.483 . . . . 0.0 110.839 173.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.65 126.85 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.298 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -74.4 -34.97 63.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.123 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.5 t -145.51 136.81 24.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.27 -18.41 65.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.917 0.389 . . . . 0.0 111.167 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -89.77 1.3 56.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.143 0.497 . . . . 0.0 110.021 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.03 99.47 0.52 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.714 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 53.8 m -139.89 121.22 9.56 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 2.9 Cg_exo -75.49 157.2 40.84 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.144 2.563 . . . . 0.0 111.763 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HB3' ' CD1' ' A' ' 51' ' ' TYR . 79.8 Cg_endo -82.77 167.22 66.96 Favored 'Cis proline' 0 N--CA 1.462 -0.332 0 C-N-CA 123.111 -1.621 . . . . 0.0 112.889 -1.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -109.32 153.9 23.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.773 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.885 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 85.5 t -98.79 113.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.496 ' HB ' HG22 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -118.85 151.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.022 -166.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.519 ' HD2' ' OE1' ' A' ' 24' ' ' GLU . 37.7 ttm180 -116.81 137.18 52.39 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.065 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.497 ' HZ3' ' HB2' ' A' ' 23' ' ' ALA . 18.5 m95 -74.06 83.47 1.78 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 168.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.926 HD12 HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -22.52 -76.9 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.221 -1.808 . . . . 0.0 115.778 -170.252 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.926 HG22 HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -95.34 0.33 10.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -168.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.426 HD22 ' N ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -88.91 -46.13 9.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.881 0.372 . . . . 0.0 110.074 173.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.77 73.26 1.06 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.38 -0.915 . . . . 0.0 113.564 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -170.29 137.63 1.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.95 142.45 46.77 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.758 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 t -157.51 176.49 12.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.167 -173.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.4 m -105.3 108.81 20.52 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.749 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.496 HG22 ' HB ' ' A' ' 39' ' ' VAL . 35.1 m -106.49 152.18 8.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.356 0.598 . . . . 0.0 111.99 -174.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 36' ' ' PRO . 50.7 m-85 -116.19 99.8 52.97 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.181 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.97 168.31 12.24 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.803 2.335 . . . . 0.0 111.746 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 55' ' ' ASP . . . -66.26 162.8 43.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.015 175.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.3 m -76.47 29.0 0.12 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.008 0.433 . . . . 0.0 111.716 -177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 53' ' ' GLY . 9.6 t0 -144.3 55.65 1.29 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.787 0.803 . . . . 0.0 108.909 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.82 136.35 35.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.763 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.84 158.37 42.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 1.5 m -99.22 149.89 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.235 0.54 . . . . 0.0 112.319 -177.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -135.09 173.3 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.803 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.89 -168.15 1.61 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.053 -175.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.21 -42.57 81.59 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -71.19 -44.62 65.09 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.236 -0.915 . . . . 0.0 110.934 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.0 mm-40 -64.76 -16.42 62.96 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.986 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.677 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -69.73 -33.82 73.0 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.669 -174.49 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 64' ' ' HIS . . . -77.14 -73.77 0.28 Allowed 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.834 0.826 . . . . 0.0 112.8 -165.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -61.07 -39.66 90.72 Favored 'General case' 0 C--O 1.251 1.182 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.136 -175.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -69.48 -28.8 66.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.308 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.734 ' HB2' HD11 ' A' ' 42' ' ' LEU . 18.0 tt0 -57.37 -57.3 13.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 1.009 ' HA ' ' HE2' ' A' ' 69' ' ' LYS . 9.3 mmpt? -50.64 -64.85 0.68 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.656 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -66.15 -54.81 20.84 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.839 0.828 . . . . 0.0 111.625 -174.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.554 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -77.02 -25.15 52.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.87 -167.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.82 -32.41 52.25 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.834 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.21 72.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.23 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -80.58 -44.03 19.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.254 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.69 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -54.65 -53.02 60.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.121 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.358 -177.852 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.438 ' O ' HG21 ' A' ' 58' ' ' VAL . 21.2 m80 . . . . . 0 CA--C 1.515 -0.366 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.76 166.64 23.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.029 0.442 . . . . 0.0 111.709 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -139.1 176.06 9.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.827 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.5 p -91.46 135.49 26.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.9 17.46 32.57 Favored Glycine 0 C--N 1.322 -0.201 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.36 -179.24 5.68 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.791 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 92.1 m-85 -137.03 169.54 17.6 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.595 -166.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 10' ' ' VAL . 6.1 tt -138.6 141.31 39.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.829 -164.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 37.2 t -138.75 151.98 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 124.889 1.368 . . . . 0.0 109.039 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.94 HG22 ' HB2' ' A' ' 54' ' ' SER . 0.5 OUTLIER . . . . . 0 C--N 1.31 -1.124 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.318 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.654 ' OD1' ' HD3' ' A' ' 74' ' ' ARG . 9.0 m-20 . . . . . 0 C--O 1.216 -0.678 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.963 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 6.2 tp-100 53.5 99.76 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.423 0 O-C-N 123.608 0.567 . . . . 0.0 110.533 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.948 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -138.69 103.04 4.74 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 121.451 -0.781 . . . . 0.0 110.376 -173.168 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.49 -178.77 5.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.207 -172.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.791 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 23.5 tt0 -137.07 127.77 27.07 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 122.473 1.13 . . . . 0.0 109.089 172.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.539 ' CG2' HG22 ' A' ' 28' ' ' VAL . 3.0 mt -87.46 111.48 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-N 112.518 -2.128 . . . . 0.0 110.084 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.771 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -106.13 -12.12 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 O-C-N 123.961 0.788 . . . . 0.0 109.401 172.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.6 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 33.0 mt-10 -138.98 139.58 37.96 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.933 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.539 HG22 ' CG2' ' A' ' 25' ' ' ILE . 23.2 t -137.89 102.65 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -163.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.41 35.83 0.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.27 -173.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.3 t -158.76 150.83 21.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.98 -14.5 29.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.401 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -118.54 -66.22 1.1 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.618 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 165.57 51.82 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.267 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 m -118.87 148.29 44.23 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.03 156.79 52.58 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.62 2.214 . . . . 0.0 111.925 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.591 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 75.1 Cg_endo -89.16 -172.43 6.82 Favored 'Cis proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.723 -1.365 . . . . 0.0 113.447 1.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.72 168.33 20.03 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.168 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.6 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 84.3 t -137.96 117.41 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.93 172.24 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 113.112 -1.858 . . . . 0.0 109.656 -154.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.844 ' HG2' HD23 ' A' ' 42' ' ' LEU . 11.6 ttt85 -138.71 134.48 33.62 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.596 ' CZ2' HG21 ' A' ' 48' ' ' THR . 9.9 m95 -78.68 89.32 4.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 168.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.844 HD23 ' HG2' ' A' ' 40' ' ' ARG . 8.3 mt -59.92 -72.66 0.1 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.328 0.585 . . . . 0.0 111.533 -168.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.604 HG13 ' NE2' ' A' ' 64' ' ' HIS . 2.4 m -60.08 -30.68 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.293 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' ' 41' ' ' TRP . 33.9 m-80 -60.68 -66.18 0.57 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.241 170.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.79 33.31 0.65 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.86 -0.686 . . . . 0.0 114.759 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.753 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 2.4 m170 -139.28 174.48 10.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.328 1.064 . . . . 0.0 112.164 175.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -138.49 127.7 24.28 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.596 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 9.7 t -139.42 -179.23 5.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 122.065 0.936 . . . . 0.0 113.335 -168.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.524 HG23 HG22 ' A' ' 38' ' ' VAL . 63.4 m -138.46 110.67 7.36 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.87 -179.86 2.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -161.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 9.8 m-85 -138.71 121.93 10.95 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.264 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 24.6 Cg_exo -63.13 -53.45 1.53 Allowed 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 122.937 2.425 . . . . 0.0 112.653 -177.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.67 -46.82 1.11 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.204 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.94 ' HB2' HG22 ' A' ' 11' ' ' VAL . 26.4 m -91.66 -170.9 2.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.688 0.244 . . . . 0.0 111.33 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.61 -14.81 5.93 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.85 0.719 . . . . 0.0 110.525 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 71.44 130.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.985 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.584 HG23 ' HB ' ' A' ' 10' ' ' VAL . 29.0 m -135.41 169.84 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 122.046 -0.408 . . . . 0.0 110.969 176.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 2' ' ' HIS . 56.1 t -118.02 136.26 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -173.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.658 HG23 ' CB ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -123.86 174.74 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 123.111 0.565 . . . . 0.0 110.845 176.039 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -121.4 -164.97 1.18 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.503 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.15 91.17 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -171.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -81.82 -33.96 30.46 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.466 -0.771 . . . . 0.0 110.872 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 36.9 mt-10 -65.83 -16.52 63.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.919 0.866 . . . . 0.0 109.267 174.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.604 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.37 -57.73 3.67 Favored 'General case' 0 C--O 1.198 -1.642 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.292 -176.028 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.84 -67.14 0.28 Allowed 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -160.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.436 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.26 -53.5 14.11 Favored 'General case' 0 C--O 1.259 1.593 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.132 -169.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.52 -17.69 63.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.271 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.948 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 10.9 tt0 -74.01 -44.73 53.47 Favored 'General case' 0 C--O 1.205 -1.272 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -50.14 -57.55 7.46 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.611 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.77 -60.56 2.96 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 121.838 0.828 . . . . 0.0 112.424 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.77 ' HB3' ' HB2' ' A' ' 22' ' ' HIS . . . -73.18 -16.64 61.42 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -169.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -79.93 -39.25 30.68 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 118.27 0.486 . . . . 0.0 109.948 174.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.66 56.56 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.762 171.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.654 ' HD3' ' OD1' ' A' ' 20' ' ' ASP . 35.7 mtt180 -79.59 -42.93 23.91 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.65 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.963 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -46.05 -52.77 11.34 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.138 0.975 . . . . 0.0 112.228 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.523 0 C-N-CA 120.006 -1.092 . . . . 0.0 111.956 -176.723 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 68.9 m-70 . . . . . 0 C--O 1.23 0.068 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.96 154.76 17.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.534 0.207 . . . . 0.0 110.793 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -135.52 163.44 30.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 111.2 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 HG23 ' A' ' 28' ' ' VAL . 40.0 t -100.17 135.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.837 176.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.85 3.96 61.97 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.99 171.39 8.48 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.704 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 84.5 m-85 -106.25 148.58 27.79 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.321 0.581 . . . . 0.0 111.259 -175.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.4 tt -99.06 136.73 38.6 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.664 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.634 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 3.3 t -141.14 139.71 32.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 O-C-N 125.044 1.465 . . . . 0.0 109.895 174.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.0 t . . . . . 0 C--N 1.317 -0.819 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 170.892 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 t0 . . . . . 0 CA--C 1.534 0.351 0 CA-C-O 119.116 -0.468 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.687 ' N ' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER 43.23 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.807 0.843 . . . . 0.0 112.475 -177.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.928 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.7 t60 -134.49 137.96 44.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -171.08 -179.86 2.85 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.488 173.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.704 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 38.4 tt0 -98.59 136.1 39.16 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.033 0.444 . . . . 0.0 110.341 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 9' ' ' LEU . 1.5 mt -97.17 107.18 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.788 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -107.33 -24.88 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.993 176.384 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 1.079 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 19.3 mm-40 -115.72 99.88 7.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.795 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 5' ' ' VAL . 72.3 t -106.72 124.62 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.636 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -69.13 -37.81 78.52 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.5 p -146.07 144.65 30.16 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.95 74.1 0.88 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.078 0.466 . . . . 0.0 111.928 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 19.1 t70 -171.38 -57.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.092 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 146.39 89.99 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.949 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 p -132.02 97.05 18.91 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.857 0.361 . . . . 0.0 111.363 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.75 150.68 84.82 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.485 2.123 . . . . 0.0 111.213 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.413 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.3 Cg_endo -78.1 169.22 73.8 Favored 'Cis proline' 0 C--N 1.344 0.295 0 C-N-CA 123.346 -1.523 . . . . 0.0 112.826 0.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -113.58 155.47 25.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.079 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 66.4 t -98.76 102.07 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 172.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -106.14 158.01 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.077 -163.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.572 ' HB2' HD12 ' A' ' 26' ' ' ILE . 62.9 ttt180 -131.51 99.99 5.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.162 -169.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.742 ' HE1' HG22 ' A' ' 48' ' ' THR . 0.3 OUTLIER -81.75 71.66 8.78 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 174.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 3.0 pp -84.83 -23.7 28.96 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.86 -166.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.68 ' HB ' ' CE1' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -85.17 -6.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.968 0.889 . . . . 0.0 108.812 178.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 69' ' ' LYS . 50.1 m-80 -99.84 -61.57 1.35 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.123 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.88 42.4 0.1 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.044 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -157.04 164.59 37.78 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.907 0.354 . . . . 0.0 110.927 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -149.44 133.56 17.24 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.742 HG22 ' HE1' ' A' ' 41' ' ' TRP . 12.0 t -167.49 177.8 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.541 0.686 . . . . 0.0 111.182 -176.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.4 m -98.88 123.04 42.88 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.533 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.84 155.85 41.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.216 0.531 . . . . 0.0 111.543 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 46.4 m-85 -107.24 99.94 30.23 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.04 174.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HG3' HD11 ' A' ' 9' ' ' LEU . 43.6 Cg_endo -68.07 -30.48 31.92 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 122.68 2.253 . . . . 0.0 112.595 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.25 -128.8 9.02 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.9 m -124.59 164.31 20.09 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 59.71 53.77 4.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.466 0.65 . . . . 0.0 111.323 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.37 117.33 29.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.41 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.0 169.44 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.36 116.0 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.108 0.48 . . . . 0.0 111.106 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.632 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -109.22 178.3 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.302 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.7 p -126.96 -166.8 1.64 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.27 -176.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -51.6 -46.69 63.65 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.99 -50.78 67.17 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.481 -0.762 . . . . 0.0 111.441 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 25.2 mm-40 -63.57 -17.04 62.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.39 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.68 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -76.07 -32.68 59.4 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.462 -175.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.53 -77.22 0.06 Allowed 'General case' 0 C--O 1.25 1.114 0 CA-C-O 122.097 0.951 . . . . 0.0 111.609 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.459 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -63.89 -47.58 80.09 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.741 -173.332 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -66.63 -38.71 87.47 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.185 -177.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.928 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 41.2 tt0 -66.3 -39.95 89.69 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.479 -176.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.55 ' HA ' ' OD1' ' A' ' 44' ' ' ASN . 69.1 mttm -57.85 -63.3 1.29 Allowed 'General case' 0 C--O 1.25 1.096 0 C-N-CA 119.731 -0.787 . . . . 0.0 110.957 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.486 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -62.77 -43.14 99.58 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.425 0.631 . . . . 0.0 110.897 -174.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.687 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -81.76 -16.79 49.93 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -171.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.71 -38.71 62.26 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 119.716 -0.794 . . . . 0.0 108.882 171.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.1 -38.69 80.15 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.06 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.15 -38.16 25.11 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -56.94 -53.79 53.97 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.946 0.403 . . . . 0.0 111.786 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.16 -178.381 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 . . . . . 0 CA--C 1.516 -0.337 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.89 149.84 45.29 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.56 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 52.1 tptt -139.06 148.51 43.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.469 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.736 HG23 ' HA ' ' A' ' 26' ' ' ILE . 5.2 p -80.13 146.23 7.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.5 38.81 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -172.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -138.56 -179.15 5.64 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.712 -1.244 . . . . 0.0 108.392 -176.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.652 ' CD2' HD22 ' A' ' 42' ' ' LEU . 87.9 m-85 -137.54 171.87 13.82 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.394 -172.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.737 HD21 ' HB3' ' A' ' 52' ' ' PRO . 9.2 tt -138.53 137.16 36.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.157 -169.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 93.3 t -139.22 161.29 28.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.992 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.917 HG22 ' HB2' ' A' ' 21' ' ' GLN . 26.7 m . . . . . 0 C--O 1.241 0.625 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.518 -0.276 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.957 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 2.2 mp0 57.73 97.64 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.385 0.428 . . . . 0.0 110.261 -170.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.69 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 82.8 t60 -138.75 127.31 23.23 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.832 0.825 . . . . 0.0 112.53 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -139.42 -178.7 5.5 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.308 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.608 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 28.6 tt0 -136.99 111.69 8.75 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.529 ' CG2' HG22 ' A' ' 28' ' ' VAL . 9.7 mt -81.14 103.06 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.402 -167.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.736 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.9 pp -107.88 -7.56 10.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.114 176.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.926 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 3.0 tp10 -139.21 136.2 34.76 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.382 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.529 HG22 ' CG2' ' A' ' 25' ' ' ILE . 46.8 t -137.99 99.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -168.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -105.26 84.03 2.05 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.6 m -151.61 109.64 3.71 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.605 -175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.81 -16.81 24.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.41 -45.28 9.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.528 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.88 40.11 3.41 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 -169.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.663 ' HB3' ' HD2' ' A' ' 35' ' ' PRO . 62.4 m -152.18 167.59 12.93 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 34' ' ' SER . 12.5 Cg_endo -56.13 159.57 12.23 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.013 2.475 . . . . 0.0 112.68 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.557 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 84.3 Cg_endo -82.4 179.59 26.36 Favored 'Cis proline' 0 C--N 1.347 0.451 0 C-N-CA 123.153 -1.603 . . . . 0.0 113.263 1.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -138.76 174.86 10.08 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.926 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 84.2 t -137.6 122.32 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.64 176.19 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 CA-C-N 113.378 -1.737 . . . . 0.0 110.498 -149.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.608 ' HD3' ' OE2' ' A' ' 24' ' ' GLU . 35.6 ttt180 -138.54 124.04 19.53 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -174.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.445 ' HZ3' ' O ' ' A' ' 22' ' ' HIS . 8.9 m95 -65.16 102.98 0.7 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 166.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.652 HD22 ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -59.85 -89.58 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.902 -1.499 . . . . 0.0 113.845 -154.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.682 HG23 ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -60.41 -26.27 36.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -176.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -60.54 -57.2 13.74 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 172.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.33 51.41 0.72 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.64 -0.79 . . . . 0.0 114.152 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -139.21 170.37 16.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.062 0.431 . . . . 0.0 109.888 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 7.9 mp0 -138.21 134.73 34.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.515 0.674 . . . . 0.0 111.002 -175.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.493 ' CG2' HG12 ' A' ' 39' ' ' VAL . 10.0 t -139.36 -178.97 5.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.087 -172.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.504 HG23 HG22 ' A' ' 38' ' ' VAL . 44.7 m -138.21 113.71 9.6 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.87 -179.82 2.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-O 121.672 0.749 . . . . 0.0 112.954 -161.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 2.0 m-85 -138.86 116.7 9.01 Favored Pre-proline 0 N--CA 1.455 -0.223 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.674 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.737 ' HB3' HD21 ' A' ' 9' ' ' LEU . 28.5 Cg_endo -64.38 -65.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.474 0.353 0 C-N-CA 122.564 2.176 . . . . 0.0 113.55 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 138.05 -146.82 18.72 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.285 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.0 m -81.14 151.42 28.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 0.0 111.248 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 t70 48.74 64.81 1.55 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.813 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.887 ' HA ' HG12 ' A' ' 11' ' ' VAL . . . -79.46 133.61 36.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.817 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 58' ' ' VAL . 2.3 t -138.75 -179.83 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.751 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -138.18 152.37 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.983 -177.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.582 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.77 179.75 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.018 -172.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.2 p -120.21 -165.44 1.19 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.302 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.451 ' O ' ' ND1' ' A' ' 64' ' ' HIS . . . -56.9 -48.2 78.76 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -59.96 4.34 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.102 -0.999 . . . . 0.0 111.827 -175.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -57.27 -21.27 33.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.021 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.586 ' HA ' ' NE2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.35 -44.12 84.07 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.263 -176.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.587 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . -57.62 -70.33 0.14 Allowed 'General case' 0 C--O 1.251 1.145 0 CA-C-O 122.337 1.065 . . . . 0.0 113.051 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -57.01 -55.01 40.23 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.553 -176.021 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.637 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.41 -29.07 63.81 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.909 176.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.682 ' HG2' HG23 ' A' ' 43' ' ' VAL . 3.2 tp10 -56.87 -58.74 6.81 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.76 -72.63 0.08 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.825 -178.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.594 ' HG3' ' H ' ' A' ' 71' ' ' ALA . 31.9 ptt180 -57.46 -67.68 0.3 Allowed 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.743 0.783 . . . . 0.0 112.281 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 67' ' ' ALA . . . -57.38 -47.79 80.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.074 -0.966 . . . . 0.0 113.584 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -57.38 -46.11 83.75 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.089 0.859 . . . . 0.0 111.177 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.97 -29.64 63.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.04 0.448 . . . . 0.0 111.322 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -81.59 -50.07 9.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.994 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.957 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -54.63 -66.53 0.39 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.661 0.784 . . . . 0.0 112.004 -176.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.634 0 C-N-CA 119.796 -1.193 . . . . 0.0 112.196 -172.452 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.5 m80 . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.564 0.221 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.06 120.18 14.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.726 ' HA ' HG21 ' A' ' 28' ' ' VAL . 98.6 mttt -138.88 176.31 8.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 112.144 -173.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.805 HG23 ' HA ' ' A' ' 26' ' ' ILE . 8.5 p -71.1 156.78 6.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.514 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.28 12.52 82.08 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.13 -178.79 5.5 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 113.754 -1.223 . . . . 0.0 107.836 -172.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.815 ' HB2' HG23 ' A' ' 59' ' ' VAL . 67.6 m-85 -137.39 174.03 11.04 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.535 -174.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.764 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 4.4 tt -138.14 153.11 49.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.23 -164.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 38.3 t -138.89 151.72 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 125.106 1.504 . . . . 0.0 109.614 -169.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.777 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.8 p . . . . . 0 C--N 1.322 -0.62 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.2 t0 . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 1.025 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 2.0 mp0 65.11 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.922 0.489 . . . . 0.0 110.94 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.764 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 1.2 m-70 -128.03 147.4 50.51 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 122.151 -0.343 . . . . 0.0 111.143 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.619 ' HA ' ' HE1' ' A' ' 64' ' ' HIS . . . -157.87 175.12 14.27 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.702 ' HA ' ' HD1' ' A' ' 8' ' ' TYR . 40.1 tt0 -98.63 130.85 45.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.769 0.795 . . . . 0.0 112.664 -172.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' ' 9' ' ' LEU . 49.4 mt -90.66 108.01 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.66 171.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.805 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.3 pp -108.01 -28.5 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.921 177.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.99 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 45.2 mt-10 -124.02 117.21 24.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.23 0.538 . . . . 0.0 110.123 175.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' A' ' 4' ' ' LYS . 79.5 t -98.87 116.18 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.854 -176.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 29' ' ' ARG . 14.8 mmm180 -88.18 -13.96 39.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.895 0.379 . . . . 0.0 111.342 -174.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.455 ' HB3' ' H ' ' A' ' 34' ' ' SER . 23.0 t -129.71 104.08 7.21 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.75 -35.13 55.75 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.738 0.649 . . . . 0.0 112.656 -174.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.45 -58.56 3.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 110.203 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.45 83.37 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.699 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.455 ' H ' ' HB3' ' A' ' 30' ' ' SER . 50.0 m -154.58 148.5 18.93 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 175.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 16.8 Cg_exo -68.36 160.3 49.65 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.768 2.312 . . . . 0.0 111.822 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -88.56 179.53 16.92 Favored 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.745 -1.356 . . . . 0.0 112.648 0.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -131.75 158.59 40.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.912 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.99 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 59.8 t -98.78 116.38 41.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.28 133.19 58.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.31 -162.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.545 ' HG2' HG12 ' A' ' 26' ' ' ILE . 6.5 ptp180 -112.0 142.84 43.92 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.533 176.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.608 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 23.6 m95 -90.56 111.02 22.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.46 HD21 ' HG3' ' A' ' 40' ' ' ARG . 7.2 mt -82.67 -58.44 2.9 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.198 0.523 . . . . 0.0 111.47 -169.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.931 HG21 ' HA ' ' A' ' 65' ' ' ALA . 1.3 m -80.58 -5.54 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.611 -170.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -100.04 -47.24 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.138 167.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.9 79.07 1.14 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.911 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.608 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -163.77 164.48 23.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.642 0.258 . . . . 0.0 110.911 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' OE2' ' HB3' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -134.79 121.01 20.09 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.0 p -143.09 -179.92 6.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.581 0.705 . . . . 0.0 111.861 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.2 m -123.75 110.09 14.5 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 168.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.13 139.16 25.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-O 121.526 0.679 . . . . 0.0 112.251 -166.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -105.5 99.61 21.98 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.884 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.461 ' HG3' HD11 ' A' ' 9' ' ' LEU . 90.9 Cg_endo -83.66 163.13 14.37 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.263 1.975 . . . . 0.0 111.63 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.61 171.42 53.99 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.684 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 17.2 m -61.26 145.91 49.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.505 0.193 . . . . 0.0 111.267 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 54' ' ' SER . 6.3 m-20 72.98 63.22 0.1 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.979 0.799 . . . . 0.0 110.643 -174.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -86.94 124.44 33.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.926 175.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 10' ' ' VAL . 6.6 t -99.05 157.78 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -108.34 123.83 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.664 178.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -121.91 172.52 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-O 121.056 0.455 . . . . 0.0 111.278 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.554 ' CG2' ' H ' ' A' ' 61' ' ' ALA . 1.3 m -111.57 -173.92 2.35 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.614 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -52.51 -45.87 66.43 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -166.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.85 -61.0 2.44 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -58.28 -26.92 63.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.901 0.858 . . . . 0.0 109.699 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.619 ' HE1' ' HA ' ' A' ' 23' ' ' ALA . 47.4 t60 -64.1 -37.19 86.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.657 -1.156 . . . . 0.0 113.182 -175.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.931 ' HA ' HG21 ' A' ' 43' ' ' VAL . . . -64.09 -69.29 0.29 Allowed 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.726 0.774 . . . . 0.0 113.046 -169.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.47 -39.89 89.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.132 -175.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.13 -16.8 61.44 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.837 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 20.0 tt0 -72.56 -46.16 55.75 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.054 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -61.99 -40.39 95.45 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.653 176.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -64.41 -22.43 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.18 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 1.025 ' HA ' ' HG3' ' A' ' 21' ' ' GLN . . . -82.26 -42.92 18.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.718 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.46 -21.33 65.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.86 -64.3 0.99 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.584 172.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HD2' ' OE1' ' A' ' 21' ' ' GLN . 62.8 mtt180 -81.84 -64.26 1.22 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -175.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.59 -52.68 62.44 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.953 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.223 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.973 -175.728 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.619 ' CD2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 m170 . . . . . 0 CA--C 1.519 -0.241 0 CA-C-O 120.941 0.4 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.16 124.07 43.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.556 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -125.01 158.26 34.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.672 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.828 HG23 ' HA ' ' A' ' 26' ' ' ILE . 4.3 p -75.39 144.62 11.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.296 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.36 11.99 74.07 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.629 ' OD2' ' HB ' ' A' ' 58' ' ' VAL . 6.5 t70 -132.73 149.29 52.3 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.557 ' CE2' ' HA ' ' A' ' 61' ' ' ALA . 95.3 m-85 -98.79 155.22 17.47 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.386 0.612 . . . . 0.0 111.314 -168.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.664 HD11 ' HG3' ' A' ' 52' ' ' PRO . 10.2 tt -98.69 136.27 38.99 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.918 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 1.1 p -132.69 167.54 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 170.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 21' ' ' GLN . 2.6 p . . . . . 0 C--N 1.318 -0.792 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.219 171.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD2' ' HG3' ' A' ' 21' ' ' GLN . 4.3 t70 . . . . . 0 CA--C 1.539 0.54 0 CA-C-O 119.478 -0.296 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.666 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 24.8 mt-30 -41.13 120.01 1.28 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.371 0.668 . . . . 0.0 112.581 -160.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.74 ' CD2' ' HA ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -128.35 144.34 51.12 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -165.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -179.17 -179.75 0.59 Allowed 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.279 0.987 . . . . 0.0 110.2 173.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.517 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 5.0 tp10 -98.28 128.73 44.86 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.581 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.506 ' CG2' HG22 ' A' ' 28' ' ' VAL . 14.0 mt -93.15 101.16 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.828 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -103.06 -23.33 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.297 178.183 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.828 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 38.7 mt-10 -129.59 103.35 6.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.017 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.506 HG22 ' CG2' ' A' ' 25' ' ' ILE . 46.3 t -98.98 110.66 26.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.146 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.87 -46.19 66.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.304 0.573 . . . . 0.0 110.052 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.3 m -125.29 112.73 16.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.907 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.28 66.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -173.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.619 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 18.0 t70 -78.16 -65.24 1.0 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.234 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 167.24 73.96 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.474 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.0 m -151.26 126.5 4.79 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.706 0.289 . . . . 0.0 110.242 177.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.59 166.87 20.59 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.191 2.594 . . . . 0.0 111.434 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.08 152.35 88.42 Favored 'Cis proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.783 -1.34 . . . . 0.0 112.974 3.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -106.17 137.84 43.39 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.828 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 61.0 t -98.64 107.53 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -118.07 151.23 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.086 -165.587 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -126.74 128.21 46.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.377 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.601 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 11.4 m95 -76.03 106.59 7.71 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.89 -55.44 4.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.196 0.522 . . . . 0.0 110.517 -174.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 43' ' ' VAL . 2.3 m -81.71 -4.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.719 -176.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 39.4 m-80 -97.88 -71.52 0.68 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.232 165.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.71 73.85 0.14 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.349 -0.929 . . . . 0.0 114.569 171.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.94 169.0 1.61 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.242 0.521 . . . . 0.0 110.882 169.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -120.14 145.63 46.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.33 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.6 t -172.33 -179.86 2.38 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 121.668 0.747 . . . . 0.0 112.246 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.8 m -115.14 121.89 44.4 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.23 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 39' ' ' VAL . 35.8 m -118.88 159.08 19.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 CA-C-O 121.571 0.7 . . . . 0.0 112.851 -170.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -125.07 99.9 33.9 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.892 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.664 ' HG3' HD11 ' A' ' 9' ' ' LEU . 73.3 Cg_endo -77.16 -24.48 9.5 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.358 2.039 . . . . 0.0 112.76 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.19 -163.59 15.83 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.935 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.1 p -86.09 166.14 16.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.464 0.132 . . . . 0.0 110.772 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 62.52 42.02 9.09 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.406 0.622 . . . . 0.0 110.689 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.25 135.04 33.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.67 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.506 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 10.4 t -124.09 158.73 30.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.629 ' HB ' ' OD2' ' A' ' 7' ' ' ASP . 1.6 m -102.87 125.3 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.139 0.495 . . . . 0.0 111.409 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.566 HG21 ' NE2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -118.77 175.24 3.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.252 -175.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -111.94 -168.85 1.37 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.025 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -60.56 -47.63 85.35 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -70.41 -36.76 74.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.834 0.35 . . . . 0.0 111.488 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.34 -16.28 62.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.585 0.707 . . . . 0.0 109.471 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.74 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 2.7 t-80 -82.89 -44.77 15.02 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.19 -68.68 0.23 Allowed 'General case' 0 C--O 1.247 0.973 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -164.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.467 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -60.81 -36.8 79.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.144 -175.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -74.46 -22.06 59.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.741 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.606 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 13.8 tt0 -79.67 -34.59 40.19 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.833 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -56.04 -65.44 0.6 Allowed 'General case' 0 C--O 1.244 0.807 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.412 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -59.63 -65.56 0.65 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.171 0.986 . . . . 0.0 111.824 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -78.22 -16.93 57.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.449 -165.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -82.26 -35.37 28.17 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.811 173.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.62 -34.35 69.2 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.136 0.494 . . . . 0.0 110.154 171.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -81.81 -40.97 21.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.868 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.5 -57.52 12.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.13 0.572 . . . . 0.0 111.872 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.305 -176.636 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.482 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 47.3 t-80 . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.79 166.83 11.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.79 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.02 160.07 35.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.74 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.85 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.1 p -83.03 146.03 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.14 0.495 . . . . 0.0 111.398 -175.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.33 6.33 58.79 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.12 168.29 18.24 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.712 ' HB2' HG23 ' A' ' 59' ' ' VAL . 97.1 m-85 -103.14 157.38 17.04 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.448 0.642 . . . . 0.0 111.537 -171.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.4 tt -98.91 138.31 36.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.544 175.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 0.5 OUTLIER -136.94 164.89 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.459 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.913 ' HB ' ' HB3' ' A' ' 20' ' ' ASP . 69.8 t . . . . . 0 C--N 1.317 -0.832 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 171.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.913 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 3.2 t70 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.773 ' HA ' ' HB1' ' A' ' 71' ' ' ALA . 68.0 mt-30 -41.15 131.62 2.62 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.706 0.802 . . . . 0.0 112.235 -168.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.807 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 49.8 t-80 -145.68 142.48 29.05 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -165.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.521 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -172.62 177.96 2.81 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.801 0.84 . . . . 0.0 109.858 173.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.684 ' HG3' HD11 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -98.6 126.6 44.24 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.6 0.238 . . . . 0.0 110.853 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 9' ' ' LEU . 14.4 mt -94.95 106.5 18.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 -176.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.85 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -102.0 -27.7 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.727 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.984 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 69.1 mm-40 -119.64 101.68 8.09 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.118 0.485 . . . . 0.0 110.633 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -98.93 102.5 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.081 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -89.36 -1.37 58.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.489 0.661 . . . . 0.0 109.765 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.81 ' HB3' ' H ' ' A' ' 34' ' ' SER . 1.4 m -80.59 124.36 28.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.857 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.61 -41.32 98.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.299 0.571 . . . . 0.0 109.99 175.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 52.2 m-20 -114.66 -68.59 0.91 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.472 173.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.47 54.6 0.14 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.327 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.81 ' H ' ' HB3' ' A' ' 30' ' ' SER . 5.0 p -106.52 143.72 27.57 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 122.245 0.218 . . . . 0.0 111.165 -178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 12.9 Cg_exo -70.17 157.24 60.21 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.798 2.332 . . . . 0.0 111.611 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -87.46 174.34 29.17 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.45 -1.479 . . . . 0.0 112.937 -1.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -123.21 149.92 44.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.984 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 98.9 t -98.68 108.77 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 172.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.77 165.37 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.922 -162.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.549 ' HG3' HD21 ' A' ' 42' ' ' LEU . 9.9 ptp180 -142.36 133.07 25.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.958 0.408 . . . . 0.0 111.001 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.554 ' HB2' ' HB2' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -82.28 106.32 14.07 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.684 HD11 ' HG3' ' A' ' 24' ' ' GLU . 18.6 mt -77.51 -50.8 11.86 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.075 0.464 . . . . 0.0 110.977 -171.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.472 HG22 ' OE2' ' A' ' 68' ' ' GLU . 2.4 m -79.69 -6.02 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.167 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 41' ' ' TRP . 48.2 m-80 -100.03 -51.18 3.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.754 174.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.7 70.45 0.68 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.2 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.489 ' CB ' ' HD1' ' A' ' 41' ' ' TRP . 0.4 OUTLIER -174.49 161.39 3.31 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.802 0.441 . . . . 0.0 110.264 176.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.71 139.98 46.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 t -173.67 171.06 3.9 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.671 0.748 . . . . 0.0 112.359 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.7 m -98.87 111.39 23.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.943 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -107.92 156.75 8.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.502 0.667 . . . . 0.0 112.594 -169.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -120.14 104.69 43.32 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.032 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.459 ' HA ' ' OE1' ' A' ' 21' ' ' GLN . 72.1 Cg_endo -75.05 -5.22 16.5 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.829 2.353 . . . . 0.0 112.13 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.63 -78.76 1.96 Allowed Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.997 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.8 p -160.75 166.99 27.76 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.491 -0.189 . . . . 0.0 110.491 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 66.69 38.25 4.01 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.604 0.565 . . . . 0.0 111.9 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -77.63 132.4 38.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.155 0.503 . . . . 0.0 111.312 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.621 ' HB ' HG12 ' A' ' 10' ' ' VAL . 10.8 t -126.33 159.3 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.443 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.6 t -98.96 117.67 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.888 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.712 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -111.76 173.17 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.54 -178.34 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -122.67 -164.93 1.23 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.654 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -58.24 -44.95 88.53 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.35 -33.64 37.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.351 0.596 . . . . 0.0 110.96 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 12.5 mm-40 -63.4 -16.38 60.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.743 172.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.734 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.9 OUTLIER -81.8 -50.6 9.04 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -172.169 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.68 -70.5 0.1 Allowed 'General case' 0 C--O 1.247 0.964 0 CA-C-O 121.569 0.7 . . . . 0.0 112.613 -165.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -49.4 77.59 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.376 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.88 -38.32 90.57 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.626 -175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.807 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 25.5 tt0 -69.62 -41.6 75.45 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.057 -174.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HA ' HD21 ' A' ' 44' ' ' ASN . 33.9 mtpt -58.49 -57.49 12.73 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.674 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -63.62 -45.93 88.06 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.725 0.774 . . . . 0.0 111.157 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.773 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -81.45 -16.42 52.07 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.03 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.98 -39.72 61.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.35 -25.74 68.44 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.671 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -82.2 -56.54 3.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.972 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.6 -62.17 1.86 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.666 0.787 . . . . 0.0 112.413 -174.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.238 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.235 -174.418 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 70.7 t60 . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.2 152.4 19.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.74 0.305 . . . . 0.0 110.921 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 7' ' ' ASP . 12.6 tmtt? -139.9 129.44 24.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.415 ' O ' ' HD3' ' A' ' 4' ' ' LYS . 7.4 p -80.24 141.2 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.024 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.04 6.86 71.14 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.421 ' CG ' ' HD2' ' A' ' 4' ' ' LYS . 1.1 m-20 -123.09 173.43 7.86 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.71 ' HB2' HG23 ' A' ' 59' ' ' VAL . 98.3 m-85 -107.92 152.9 23.81 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.37 0.605 . . . . 0.0 111.881 -173.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.806 HD11 ' HG3' ' A' ' 52' ' ' PRO . 6.8 tt -103.02 141.79 35.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.332 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 3.4 t -145.81 144.3 21.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 O-C-N 124.71 1.256 . . . . 0.0 109.707 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 21' ' ' GLN . 21.1 m . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 121.194 0.521 . . . . 0.0 109.952 170.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.4 t0 . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 119.468 -0.301 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.576 ' N ' ' HB1' ' A' ' 71' ' ' ALA . 68.5 mt-30 38.19 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.767 1.227 . . . . 0.0 112.954 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.733 ' CE1' ' HA ' ' A' ' 64' ' ' HIS . 41.3 t-80 -133.37 139.9 47.06 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -169.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -168.02 -179.95 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.627 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.602 ' CD ' HD11 ' A' ' 42' ' ' LEU . 45.7 tt0 -98.58 129.57 45.12 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.036 0.446 . . . . 0.0 111.12 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.695 HD11 ' HB2' ' A' ' 9' ' ' LEU . 45.7 mt -92.01 105.54 16.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.765 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.682 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -102.47 -26.32 3.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.817 177.361 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 37.0 tt0 -129.69 119.83 24.16 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.405 0.621 . . . . 0.0 110.364 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.21 121.44 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.205 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -64.36 -33.58 76.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.98 0.419 . . . . 0.0 110.599 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.9 t -149.76 128.17 12.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.52 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.92 -23.06 67.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 0.0 111.006 -176.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.38 -17.63 64.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.411 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.38 5.49 39.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.336 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 6.6 m -67.54 122.53 83.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.572 0.225 . . . . 0.0 110.999 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 15.9 Cg_exo -68.65 165.52 29.14 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.412 2.741 . . . . 0.0 111.924 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 83.2 Cg_endo -80.56 -175.56 16.35 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.982 -1.258 . . . . 0.0 113.085 1.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -123.83 148.41 46.76 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 96.3 t -98.66 101.71 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 173.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.92 145.58 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.659 -163.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.42 ' HG3' ' HG3' ' A' ' 47' ' ' GLU . 55.4 ttt180 -121.22 130.04 53.49 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.054 -176.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 13.0 m95 -79.79 96.24 6.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.602 HD11 ' CD ' ' A' ' 24' ' ' GLU . 20.1 mt -72.85 -61.28 1.87 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.352 0.596 . . . . 0.0 110.834 -173.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.462 HG22 ' OE2' ' A' ' 68' ' ' GLU . 2.0 m -73.93 -5.83 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.333 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 54.9 m-80 -98.61 -62.73 1.2 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.903 173.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.9 63.58 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.526 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -167.38 155.22 9.11 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.14 0.495 . . . . 0.0 111.794 173.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HG3' ' HG3' ' A' ' 40' ' ' ARG . 3.7 mp0 -111.77 141.91 44.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.094 175.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.467 HG23 HG23 ' A' ' 50' ' ' VAL . 8.8 t -165.89 179.84 5.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.583 0.706 . . . . 0.0 112.159 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 m -125.22 106.03 9.58 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.832 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 48' ' ' THR . 70.3 t -109.42 147.43 13.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.32 0.581 . . . . 0.0 111.867 -169.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 62.2 m-85 -107.69 99.77 31.27 Favored Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.325 170.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.806 ' HG3' HD11 ' A' ' 9' ' ' LEU . 84.5 Cg_endo -82.12 -22.8 4.81 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.835 2.357 . . . . 0.0 111.805 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.49 -143.4 14.32 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 m -135.48 16.63 3.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.56 0.68 . . . . 0.0 110.687 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -106.49 16.46 24.62 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.124 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.51 114.68 3.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.986 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.813 HG22 ' H ' ' A' ' 58' ' ' VAL . 10.5 p -98.94 175.96 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.813 ' H ' HG22 ' A' ' 57' ' ' VAL . 46.5 t -119.36 125.1 74.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.291 -172.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.71 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -122.42 175.75 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.534 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -117.45 -167.12 1.27 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.525 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -59.66 -41.17 90.01 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -170.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.92 -46.25 62.8 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.893 -0.504 . . . . 0.0 111.462 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 28.3 mm-40 -62.35 -16.46 54.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.616 0.722 . . . . 0.0 109.947 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.733 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -73.47 -43.78 59.46 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.18 -176.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.58 -72.69 0.09 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.641 0.734 . . . . 0.0 112.295 -168.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.86 ' HA ' ' HE2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -61.84 -45.87 91.93 Favored 'General case' 0 C--O 1.253 1.254 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.42 -174.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HA ' HH21 ' A' ' 70' ' ' ARG . . . -58.49 -46.22 87.11 Favored 'General case' 0 C--O 1.204 -1.311 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.245 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 15.4 tt0 -65.31 -39.68 92.79 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.906 -171.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.86 ' HE2' ' HA ' ' A' ' 66' ' ' GLU . 57.3 pttt -64.19 -56.61 13.53 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.883 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.447 HH21 ' HA ' ' A' ' 67' ' ' ALA . 59.9 mtm180 -60.91 -44.7 96.81 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.547 1.165 . . . . 0.0 110.752 -177.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -80.47 -16.52 54.13 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.416 -172.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.2 -35.81 66.4 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.059 170.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -29.67 70.04 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.659 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.432 ' HB2' ' HA ' ' A' ' 71' ' ' ALA . 12.7 mmt180 -81.92 -58.13 3.11 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -63.06 -63.48 1.19 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.025 0.53 . . . . 0.0 111.514 -174.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.603 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.206 -175.021 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 3.6 m-70 . . . . . 0 CA--C 1.516 -0.338 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.48 ' HB1' ' CD1' ' A' ' 25' ' ' ILE . . . -138.34 140.48 39.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 111.471 -163.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.849 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 28.8 mmtp -138.49 140.68 39.29 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.211 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 26' ' ' ILE . 24.7 t -70.23 136.36 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 O-C-N 122.211 -0.306 . . . . 0.0 111.23 176.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.98 17.41 51.5 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.849 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.6 m-20 -138.97 144.17 38.86 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.439 -1.881 . . . . 0.0 108.288 -166.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.821 ' CD1' ' HB2' ' A' ' 24' ' ' GLU . 74.6 m-85 -134.96 141.81 46.34 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -148.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.875 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 1.3 tt -136.71 139.56 42.02 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -152.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.671 HG22 ' CD2' ' A' ' 22' ' ' HIS . 3.9 t -139.14 140.58 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 O-C-N 126.683 2.489 . . . . 0.0 109.371 -167.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.927 HG22 ' HB2' ' A' ' 21' ' ' GLN . 14.6 m . . . . . 0 C--N 1.32 -0.705 0 CA-C-O 121.066 0.46 . . . . 0.0 110.604 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.695 ' OD1' ' HB3' ' A' ' 74' ' ' ARG . 2.1 t70 . . . . . 0 C--O 1.217 -0.622 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.927 ' HB2' HG22 ' A' ' 11' ' ' VAL . 75.3 mt-30 45.03 91.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.674 0.79 . . . . 0.0 111.413 -173.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.875 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.1 t-80 -138.85 116.24 11.21 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 121.255 0.55 . . . . 0.0 112.075 -168.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.571 ' HB2' ' NE1' ' A' ' 41' ' ' TRP . . . -139.65 -178.8 5.57 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.141 -1.391 . . . . 0.0 108.475 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.821 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 3.3 tm-20 -137.28 122.59 19.38 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.24 1.019 . . . . 0.0 110.312 -177.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.867 HG23 HG23 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -80.08 113.96 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 113.459 -1.701 . . . . 0.0 111.004 -174.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.737 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -98.86 -8.71 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.111 169.418 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.738 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -138.97 127.15 22.62 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.498 177.198 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.415 ' CG2' ' HB ' ' A' ' 25' ' ' ILE . 54.7 t -138.03 100.0 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.795 -169.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -103.81 20.35 18.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.163 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.573 ' HB3' ' H ' ' A' ' 34' ' ' SER . 3.6 m -108.88 111.08 22.6 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.434 177.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.06 93.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.31 0.576 . . . . 0.0 110.405 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 32.9 t70 -95.33 -56.83 2.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.007 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.1 70.37 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.422 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.573 ' H ' ' HB3' ' A' ' 30' ' ' SER . 20.0 t -150.25 142.6 15.79 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.32 151.56 9.5 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.467 2.778 . . . . 0.0 113.102 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.572 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.8 Cg_endo -85.51 -177.2 15.3 Favored 'Cis proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.108 -1.622 . . . . 0.0 113.664 3.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -138.78 173.36 11.65 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.157 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.738 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 72.4 t -137.78 114.47 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.453 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.867 HG23 HG23 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -138.75 165.3 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-N 111.965 -2.38 . . . . 0.0 107.664 -149.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.631 ' HB2' HD12 ' A' ' 26' ' ' ILE . 33.4 ttt180 -138.66 127.52 23.69 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.493 -172.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.61 ' CZ3' HG21 ' A' ' 48' ' ' THR . 3.4 m0 -86.99 83.79 7.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.502 HD12 ' CE1' ' A' ' 8' ' ' TYR . 8.0 mt -60.28 -64.22 1.03 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.986 -166.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.605 HG13 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -60.11 -33.07 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.216 -176.235 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 0.9 OUTLIER -60.53 -65.39 0.69 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.167 0.508 . . . . 0.0 110.792 168.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.33 39.11 0.6 Allowed Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.728 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -139.16 171.31 14.48 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 117.126 0.463 . . . . 0.0 110.457 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' HG3' ' HG3' ' A' ' 40' ' ' ARG . 1.7 mp0 -138.2 127.46 24.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.833 HG23 HG12 ' A' ' 39' ' ' VAL . 10.0 t -139.42 -179.64 6.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -164.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.6 m -138.48 120.55 15.62 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.598 HG22 ' H ' ' A' ' 51' ' ' TYR . 4.9 p -138.81 172.75 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.524 -160.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.598 ' H ' HG22 ' A' ' 50' ' ' VAL . 41.7 m-85 -138.57 100.03 8.44 Favored Pre-proline 0 N--CA 1.455 -0.22 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.281 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.08 163.56 16.46 Favored 'Trans proline' 0 N--CA 1.477 0.548 0 C-N-CA 123.423 2.749 . . . . 0.0 112.668 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 11' ' ' VAL . . . -86.4 -133.82 3.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.097 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.647 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 47.3 t -99.45 160.94 13.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 63.3 47.92 3.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.23 0.538 . . . . 0.0 110.243 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.771 ' HA ' HG12 ' A' ' 11' ' ' VAL . . . -72.89 130.53 40.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.65 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.78 179.97 2.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.04 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.32 136.81 44.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.823 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 11.9 m -138.54 175.38 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 C-N-CA 125.461 1.505 . . . . 0.0 109.262 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.62 -165.48 1.03 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.4 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -56.77 -47.55 79.87 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -175.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -59.04 5.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.708 0.766 . . . . 0.0 111.433 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 18.3 mt-10 -56.98 -27.97 61.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.397 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.646 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -57.36 -48.49 78.9 Favored 'General case' 0 C--O 1.198 -1.639 0 CA-C-N 114.254 -1.339 . . . . 0.0 114.207 177.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . -56.94 -72.34 0.08 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 119.201 0.91 . . . . 0.0 112.616 -162.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -57.21 -54.85 42.11 Favored 'General case' 0 C--O 1.281 2.722 0 CA-C-O 122.809 1.29 . . . . 0.0 112.61 -176.464 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.89 -50.89 71.14 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.883 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.78 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 24.3 tt0 -57.25 -31.13 65.24 Favored 'General case' 0 C--O 1.202 -1.426 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 96.1 mttt -57.08 -70.98 0.11 Allowed 'General case' 0 C--O 1.26 1.61 0 CA-C-O 121.8 0.81 . . . . 0.0 109.708 172.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 6.8 tpm_? -57.04 -53.22 60.57 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 123.179 1.466 . . . . 0.0 110.818 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.657 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . . . -57.18 -43.8 82.95 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.925 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.08 -37.33 71.73 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 118.487 0.585 . . . . 0.0 110.202 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 70' ' ' ARG . . . -56.82 -64.12 0.98 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.489 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.695 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 9.4 ttp180 -57.73 -46.49 84.37 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.754 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -55.14 -34.87 64.13 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.05 0.54 . . . . 0.0 111.852 -175.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.43 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.564 178.554 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.559 ' CE1' HG21 ' A' ' 58' ' ' VAL . 2.7 p-80 . . . . . 0 CA--C 1.516 -0.348 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.878 ' HB3' ' HA2' ' A' ' 33' ' ' GLY . . . -138.91 105.11 5.23 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.628 ' HA ' HG21 ' A' ' 28' ' ' VAL . 50.5 mttp -139.11 165.23 27.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.175 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.958 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.4 p -70.88 151.58 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.363 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.92 14.5 59.26 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 65.4 m-20 -138.65 -179.08 5.61 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.845 ' HB2' HG23 ' A' ' 59' ' ' VAL . 97.6 m-85 -137.45 173.21 11.91 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -174.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.805 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.8 tt -138.43 136.34 36.13 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.255 -166.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.499 HG22 ' CD2' ' A' ' 22' ' ' HIS . 59.9 t -139.03 143.52 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 125.917 2.011 . . . . 0.0 108.995 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 52' ' ' PRO . 70.6 t . . . . . 0 C--N 1.321 -0.638 0 CA-C-O 121.063 0.459 . . . . 0.0 110.757 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.568 ' HA ' ' CB ' ' A' ' 71' ' ' ALA . 32.3 m-20 . . . . . 0 C--O 1.22 -0.495 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.961 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 2.2 mp0 52.88 84.88 0.05 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.296 0.373 . . . . 0.0 110.973 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.805 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 6.7 t-80 -134.55 133.91 40.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.875 -174.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -178.42 178.02 0.9 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.341 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.719 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 42.3 tt0 -98.45 131.38 44.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.457 0.646 . . . . 0.0 111.759 -174.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 26.7 mt -86.75 108.91 18.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.338 177.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.958 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -109.51 -28.02 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.517 176.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.874 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 14.7 mt-10 -120.25 111.98 18.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' A' ' 4' ' ' LYS . 47.2 t -98.81 115.36 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.09 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -64.62 -52.48 57.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.199 0.523 . . . . 0.0 110.193 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 43.4 m -117.55 110.42 17.92 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.362 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.433 ' HA ' HG11 ' A' ' 28' ' ' VAL . . . -63.63 -18.64 64.15 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.376 -170.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.16 -38.85 91.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.354 0.597 . . . . 0.0 110.107 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.878 ' HA2' ' HB3' ' A' ' 3' ' ' ALA . . . 129.08 53.42 0.11 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.533 -175.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 9.8 m -134.18 142.03 41.61 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.532 0.206 . . . . 0.0 110.658 -176.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 12.8 Cg_exo -70.85 164.82 34.28 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.962 2.442 . . . . 0.0 111.898 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.549 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 73.1 Cg_endo -76.0 -179.59 27.56 Favored 'Cis proline' 0 C--N 1.347 0.463 0 C-N-CA 123.794 -1.336 . . . . 0.0 112.783 -0.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -131.04 142.72 50.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.216 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.874 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 58.3 t -98.62 103.4 14.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 170.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.09 138.85 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.81 -163.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.915 ' HG3' ' HB3' ' A' ' 47' ' ' GLU . 51.9 ttt180 -103.91 128.88 51.41 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.237 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.771 ' CE3' ' HB1' ' A' ' 72' ' ' ALA . 2.4 m0 -95.59 89.38 5.35 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.576 HD11 ' CD ' ' A' ' 24' ' ' GLU . 14.2 mt -70.48 -60.94 1.97 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.168 -165.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.554 HG13 ' CE1' ' A' ' 64' ' ' HIS . 3.1 m -77.76 -4.52 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.964 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.679 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 50.7 m-80 -93.84 -62.84 1.28 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.172 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.59 -80.09 0.1 Allowed Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.073 -1.06 . . . . 0.0 113.879 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 41' ' ' TRP . 20.7 m-70 -98.9 176.46 5.59 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.888 0.375 . . . . 0.0 111.903 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.915 ' HB3' ' HG3' ' A' ' 40' ' ' ARG . 13.7 pt-20 -120.03 152.06 38.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.387 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -167.06 178.35 5.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.526 0.679 . . . . 0.0 111.168 -176.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.0 m -98.84 118.58 35.92 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.016 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.61 146.08 27.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 111.29 -172.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 75.8 m-85 -109.41 101.37 45.49 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.289 171.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.482 ' HB2' HG21 ' A' ' 11' ' ' VAL . 72.2 Cg_endo -75.29 -10.87 20.92 Favored 'Trans proline' 0 N--CA 1.473 0.306 0 C-N-CA 122.962 2.441 . . . . 0.0 112.605 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.63 -102.52 2.88 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.677 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.9 m -153.31 171.11 19.08 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 62.2 41.06 11.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.309 0.576 . . . . 0.0 110.986 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.4 112.96 15.96 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.719 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.2 t -98.91 152.47 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.559 HG21 ' CE1' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -100.69 113.27 36.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.467 0.651 . . . . 0.0 111.867 -176.037 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.845 HG23 ' HB2' ' A' ' 8' ' ' TYR . 4.1 m -102.23 169.25 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.393 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.7 p -115.84 -163.73 0.91 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 -175.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -52.91 -46.89 68.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.23 -48.45 28.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.324 0.583 . . . . 0.0 110.866 -174.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.731 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 25.5 mt-10 -59.47 -16.6 25.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.038 176.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.742 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -75.9 -50.27 15.5 Favored 'General case' 0 C--O 1.205 -1.288 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.595 -177.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.36 -72.0 0.08 Allowed 'General case' 0 C--O 1.247 0.968 0 CA-C-O 121.779 0.799 . . . . 0.0 112.844 -163.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -66.16 -46.89 75.85 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.856 -172.304 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.42 -26.44 66.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.494 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.687 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 27.1 tt0 -73.62 -45.0 55.54 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.678 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 20.6 pttp -60.53 -47.86 84.33 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.438 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.497 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 10.9 ptp85 -68.06 -52.09 39.21 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.702 0.763 . . . . 0.0 111.669 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.568 ' CB ' ' HA ' ' A' ' 20' ' ' ASP . . . -77.98 -17.97 56.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.342 -169.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.771 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -80.48 -37.18 32.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.389 173.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.02 -32.64 61.99 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.739 -0.384 . . . . 0.0 109.979 171.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -81.88 -37.19 27.26 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.684 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.961 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -59.52 -48.48 81.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.555 -172.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.912 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.365 -177.149 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.3 m170 . . . . . 0 CA--C 1.519 -0.244 0 CA-C-O 120.896 0.379 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.86 153.95 46.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.162 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.89 173.35 7.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.923 0.392 . . . . 0.0 110.496 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.733 HG23 ' HA ' ' A' ' 26' ' ' ILE . 1.7 p -73.76 136.47 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.933 175.271 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.99 8.33 60.47 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -175.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.452 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 68.4 m-20 -107.38 161.72 14.56 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 61' ' ' ALA . 1.2 m-85 -103.52 146.79 28.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.413 0.625 . . . . 0.0 111.764 -176.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' A' ' 52' ' ' PRO . 9.8 tt -99.47 132.75 44.59 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.604 175.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.71 HG13 ' CE1' ' A' ' 22' ' ' HIS . 54.2 t -127.98 147.42 32.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 O-C-N 124.638 1.211 . . . . 0.0 109.29 174.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 52' ' ' PRO . 53.7 t . . . . . 0 C--N 1.318 -0.773 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 171.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.745 ' N ' ' HB1' ' A' ' 71' ' ' ALA . 22.9 mt-30 58.83 94.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.206 0.602 . . . . 0.0 111.165 -177.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.71 ' CE1' HG13 ' A' ' 10' ' ' VAL . 3.4 m-70 -132.11 145.81 51.63 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.251 -0.281 . . . . 0.0 111.415 -173.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.695 ' HA ' ' HG3' ' A' ' 68' ' ' GLU . . . -179.04 176.09 0.92 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 41.4 tt0 -98.35 145.91 26.23 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.446 0.641 . . . . 0.0 111.201 -174.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.15 113.0 38.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 40' ' ' ARG . 0.2 OUTLIER -105.78 -15.5 8.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.894 0.378 . . . . 0.0 111.039 -178.622 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.966 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 37.7 mt-10 -132.15 103.59 6.34 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.658 0.742 . . . . 0.0 109.544 174.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.04 99.97 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.81 -176.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -104.56 53.57 0.73 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.603 0.716 . . . . 0.0 109.676 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.8 t -152.48 123.11 7.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.53 177.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.52 -26.27 20.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -89.88 -25.07 21.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.764 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.42 72.76 1.04 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.422 177.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 68.9 m -146.03 150.04 40.82 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.7 0.286 . . . . 0.0 110.886 178.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 19.5 Cg_exo -66.87 167.63 19.11 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.279 2.653 . . . . 0.0 112.062 177.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.99 154.66 94.11 Favored 'Cis proline' 0 C--N 1.345 0.366 0 C-N-CA 123.803 -1.332 . . . . 0.0 112.408 1.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -110.92 146.94 35.68 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.025 178.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.966 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 61.7 t -98.69 103.9 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 23' ' ' ALA . 53.2 t -116.19 121.51 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.013 -166.202 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.735 ' HB2' HD12 ' A' ' 26' ' ' ILE . 42.9 ttt180 -101.97 133.28 47.02 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.021 176.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.596 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 5.5 m0 -97.75 113.33 25.08 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' A' ' 24' ' ' GLU . 11.6 mt -75.52 -49.69 17.94 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.884 0.373 . . . . 0.0 111.617 -167.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.74 ' HB ' ' HE2' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -93.96 -15.59 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.271 -176.356 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.596 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 33.0 m-80 -84.26 -36.23 22.82 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.875 175.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.01 34.73 9.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.654 177.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.487 ' H ' ' HB2' ' A' ' 41' ' ' TRP . 6.9 m170 -123.59 166.81 14.83 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.522 -0.399 . . . . 0.0 110.438 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -141.21 116.33 9.93 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 p -136.23 170.46 15.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.267 0.556 . . . . 0.0 112.254 -167.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.3 m -118.32 100.04 7.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 166.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.0 m -99.58 156.6 3.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-O 121.685 0.755 . . . . 0.0 112.776 -167.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -119.68 99.91 49.32 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.973 168.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HB3' HD21 ' A' ' 9' ' ' LEU . 26.0 Cg_endo -63.7 -51.07 2.64 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.861 2.374 . . . . 0.0 112.868 -174.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.21 -117.02 1.55 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -175.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.3 m -129.64 154.13 47.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 62.65 58.05 1.69 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.931 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -86.66 119.44 26.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.205 0.526 . . . . 0.0 110.837 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 t -101.07 159.72 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.472 -178.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 4.1 p -121.14 118.77 57.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.358 0.599 . . . . 0.0 111.326 -178.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.598 HG23 ' CB ' ' A' ' 8' ' ' TYR . 2.4 m -116.64 -179.93 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 123.408 0.683 . . . . 0.0 111.411 -178.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -80.98 166.4 20.86 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.732 174.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.788 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . . . -68.86 -66.54 0.56 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.598 -169.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 p -80.73 -25.06 38.31 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -167.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -53.94 -58.94 5.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.612 0.72 . . . . 0.0 109.578 175.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.47 ' CE1' HG11 ' A' ' 59' ' ' VAL . 11.3 m-70 -82.44 -16.5 48.7 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 43' ' ' VAL . . . -45.39 -39.55 7.04 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -63.08 -44.39 95.88 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-O 123.564 1.65 . . . . 0.0 109.127 177.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.434 ' CB ' ' HD2' ' A' ' 22' ' ' HIS . . . -66.3 -16.59 64.16 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.418 173.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.695 ' HG3' ' HA ' ' A' ' 23' ' ' ALA . 10.3 tt0 -69.82 -40.09 76.12 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 171.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.74 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 66.7 mmtt -51.07 -61.65 2.1 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.123 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -62.26 1.89 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.744 1.259 . . . . 0.0 112.076 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.745 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -78.31 -16.96 57.21 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.197 -165.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.59 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -81.74 -34.54 30.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 118.645 0.657 . . . . 0.0 109.316 173.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.82 -36.14 64.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 170.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -74.7 -55.54 5.76 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.987 174.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -49.08 -56.94 7.53 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.743 0.817 . . . . 0.0 111.967 -176.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.511 ' HA3' ' HH2' ' A' ' 41' ' ' TRP . . . . . . . . 0 N--CA 1.444 -0.799 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.822 -176.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.901 0.381 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.86 140.81 38.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.338 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -139.12 164.24 30.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.959 0.409 . . . . 0.0 111.249 -177.37 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.819 HG23 ' HA ' ' A' ' 26' ' ' ILE . 4.0 p -65.15 145.43 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.939 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.06 17.28 41.08 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -174.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 7.6 m-20 -138.76 -179.06 5.6 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 113.902 -1.149 . . . . 0.0 108.415 -174.31 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.812 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 95.4 m-85 -137.02 164.93 27.2 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.314 -168.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 6.7 tt -138.63 142.2 39.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.769 -166.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.848 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 3.5 t -138.88 -179.99 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.276 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.785 ' H ' HG12 ' A' ' 10' ' ' VAL . 41.2 t . . . . . 0 C--N 1.312 -1.054 0 CA-C-O 121.648 0.737 . . . . 0.0 109.588 176.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 9.4 m-20 . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.848 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 4.7 mt-30 63.0 98.19 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.857 0.723 . . . . 0.0 110.197 -170.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.984 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 21.3 t-80 -139.05 121.43 16.04 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.354 0.597 . . . . 0.0 111.81 -175.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.654 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.77 -178.23 5.33 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 125.222 1.409 . . . . 0.0 110.239 -177.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.812 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 26.6 tt0 -136.75 123.58 21.28 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.478 1.133 . . . . 0.0 109.079 174.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.741 ' HB ' HG22 ' A' ' 28' ' ' VAL . 4.6 pt -82.69 115.42 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.96 -174.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.819 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -108.01 -8.41 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 113.808 -1.542 . . . . 0.0 108.477 170.435 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -138.9 122.22 17.09 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.447 175.437 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.741 HG22 ' HB ' ' A' ' 25' ' ' ILE . 20.8 t -138.49 119.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.877 -165.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 29' ' ' ARG . 5.0 mmp_? -68.87 -35.79 77.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -174.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.8 m -147.68 149.59 32.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.757 -176.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.45 -14.71 59.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.142 0.496 . . . . 0.0 110.694 -179.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.89 -72.75 0.37 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.256 0.55 . . . . 0.0 110.001 176.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.91 88.05 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.527 -177.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -143.47 125.1 8.33 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.36 161.0 38.37 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.729 2.286 . . . . 0.0 111.534 175.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.32 -175.07 15.75 Favored 'Cis proline' 0 C--N 1.342 0.234 0 C-N-CA 123.732 -1.362 . . . . 0.0 113.392 2.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -138.87 169.55 17.6 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.594 178.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 84.2 t -137.96 116.47 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.041 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.505 HG12 HG23 ' A' ' 48' ' ' THR . 0.4 OUTLIER -138.86 174.61 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 112.676 -2.056 . . . . 0.0 109.272 -152.558 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.842 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 62.9 mtt180 -138.67 133.56 32.51 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.733 ' HD1' ' HB2' ' A' ' 46' ' ' HIS . 16.1 m95 -79.53 84.6 5.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 166.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.593 HD11 ' CD ' ' A' ' 24' ' ' GLU . 6.5 mt -60.08 -64.21 1.03 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.2 0.524 . . . . 0.0 111.617 -167.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.706 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -60.03 -35.5 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.121 -176.623 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 41' ' ' TRP . 35.4 m-80 -60.53 -60.67 3.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.797 171.211 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.07 39.68 0.68 Allowed Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.113 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.733 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 37.5 m80 -139.16 167.11 22.79 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.119 0.459 . . . . 0.0 111.134 178.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.842 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 6.7 pt-20 -138.86 128.79 25.11 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.487 173.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.569 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 8.9 t -139.74 -179.26 5.82 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.758 -163.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.9 m -138.25 116.83 12.13 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 51' ' ' TYR . 1.6 t -138.69 175.95 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.193 0.521 . . . . 0.0 111.304 -162.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.701 ' H ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -138.82 107.27 7.56 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.78 -178.758 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.71 141.33 90.33 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.736 2.291 . . . . 0.0 111.755 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.95 67.0 2.14 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.557 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t 67.22 173.12 0.26 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.944 0.438 . . . . 0.0 110.957 179.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 56.18 38.33 29.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.221 174.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.2 139.8 54.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.328 -176.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.881 HG22 ' H ' ' A' ' 58' ' ' VAL . 5.7 p -138.93 -179.7 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.832 177.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.881 ' H ' HG22 ' A' ' 57' ' ' VAL . 56.1 t -138.45 136.27 43.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.785 -171.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.764 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -138.87 179.92 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 C-N-CA 123.355 0.662 . . . . 0.0 111.284 -174.17 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.9 p -120.55 -172.31 2.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.349 -176.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.02 -48.44 78.48 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -172.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -55.75 30.74 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.565 -0.71 . . . . 0.0 111.437 -178.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -56.98 -29.86 63.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.87 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.706 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.22 -45.32 83.96 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.286 -179.446 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.554 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -56.85 -73.4 0.06 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.912 0.863 . . . . 0.0 111.534 -167.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.523 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -57.08 -61.71 2.27 Favored 'General case' 0 C--O 1.268 2.059 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.671 -177.272 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.15 -50.21 73.54 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.462 -175.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.984 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 29.6 tt0 -57.14 -37.89 72.68 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 118.0 0.364 . . . . 0.0 111.575 -177.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -56.93 -68.12 0.25 Allowed 'General case' 0 C--O 1.253 1.24 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.572 176.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -57.28 -58.23 9.16 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 122.776 1.274 . . . . 0.0 111.675 -177.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.604 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -57.32 -25.23 59.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.321 -178.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.46 -40.95 73.4 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 118.894 0.77 . . . . 0.0 109.827 175.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.51 62.68 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.019 172.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.41 ' HG2' ' HB3' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -74.21 -57.16 4.13 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 176.263 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -51.12 -44.61 61.35 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.556 0.946 . . . . 0.0 113.556 -169.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.218 0 C-N-CA 119.8 -1.191 . . . . 0.0 112.651 -174.044 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 . . . . . 0 CA--C 1.517 -0.293 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.91 139.66 38.11 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.719 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 91.6 mttt -139.35 140.77 37.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.239 -173.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.787 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -71.29 139.63 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 169.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.55 13.82 66.93 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -172.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.719 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 1.8 m-20 -139.11 143.81 38.43 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.109 -2.045 . . . . 0.0 107.655 -167.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.811 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 33.2 m-85 -135.63 142.6 45.24 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -148.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.757 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 2.3 tt -136.69 140.2 42.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 119.334 0.97 . . . . 0.0 110.244 -156.473 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.405 HG23 HG21 ' A' ' 59' ' ' VAL . 42.3 t -138.87 140.75 38.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.211 -168.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.568 HG22 ' HA ' ' A' ' 56' ' ' ALA . 72.0 t . . . . . 0 C--N 1.32 -0.712 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -176.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t0 . . . . . 0 C--O 1.222 -0.354 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.677 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 51.8 mt-30 39.7 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.699 0.8 . . . . 0.0 112.817 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.757 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 54.7 t60 -138.57 138.98 38.46 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 122.634 1.207 . . . . 0.0 113.397 -176.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.617 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -140.43 -177.87 5.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 112.19 -2.277 . . . . 0.0 110.926 -174.011 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.811 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 10.7 tt0 -136.69 122.17 19.52 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 123.007 1.384 . . . . 0.0 108.046 166.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 66.0 mt -81.52 107.69 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 111.652 -2.522 . . . . 0.0 110.242 -170.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.787 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -102.38 -14.12 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.629 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 48.9 mm-40 -139.02 150.36 45.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.577 174.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.473 HG22 ' CG2' ' A' ' 25' ' ' ILE . 17.7 t -137.83 100.11 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -170.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -89.23 -29.08 19.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.663 -163.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.9 p -68.94 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.495 -176.378 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -176.95 -64.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.285 0.564 . . . . 0.0 109.954 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -151.05 88.13 1.44 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.905 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.64 172.84 44.11 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.218 -173.054 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m 69.36 156.76 0.15 Allowed Pre-proline 0 N--CA 1.467 0.419 0 CA-C-O 120.953 0.406 . . . . 0.0 111.529 178.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -73.03 163.92 36.94 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.815 2.344 . . . . 0.0 112.331 178.083 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 18.9 Cg_endo -94.61 -178.01 7.35 Favored 'Cis proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.809 -1.329 . . . . 0.0 112.681 -1.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -138.83 174.27 10.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.059 177.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 89.6 t -138.03 114.54 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 174.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 25' ' ' ILE . 0.4 OUTLIER -139.02 175.25 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.818 -153.658 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.803 ' HB2' HD23 ' A' ' 42' ' ' LEU . 84.7 mtt180 -138.51 134.96 34.6 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.745 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 12.2 m95 -80.1 81.02 6.44 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 166.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.803 HD23 ' HB2' ' A' ' 40' ' ' ARG . 3.7 mt -59.92 -67.8 0.35 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.515 0.509 . . . . 0.0 111.932 -162.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.547 HG22 ' OE2' ' A' ' 68' ' ' GLU . 0.9 OUTLIER -59.96 -31.19 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.974 -175.716 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.627 HD21 ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -60.59 -62.99 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.177 0.513 . . . . 0.0 110.591 169.637 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.05 43.16 0.34 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.811 -0.632 . . . . 0.0 113.576 177.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.745 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 44.6 t-80 -139.35 164.01 30.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 117.527 0.664 . . . . 0.0 111.069 178.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 42.0 tt0 -138.44 122.09 17.45 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.223 0.535 . . . . 0.0 110.023 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.479 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 14.8 t -139.68 -179.0 5.67 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -165.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.418 HG23 HG22 ' A' ' 38' ' ' VAL . 89.8 m -138.15 110.55 7.45 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.73 -179.74 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -160.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.558 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 2.3 m-85 -138.78 125.64 12.95 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.048 -178.389 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HB2' HG21 ' A' ' 11' ' ' VAL . 56.5 Cg_endo -74.37 -78.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.673 2.249 . . . . 0.0 113.234 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.41 -154.44 23.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.862 -178.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.7 m -87.62 159.1 18.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.569 0.184 . . . . 0.0 110.559 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 t70 65.91 39.85 4.4 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.94 0.876 . . . . 0.0 108.859 -174.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.568 ' HA ' HG22 ' A' ' 11' ' ' VAL . . . -79.9 137.74 36.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.126 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.711 HG12 ' H ' ' A' ' 58' ' ' VAL . 3.4 t -138.71 175.65 7.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -174.143 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.711 ' H ' HG12 ' A' ' 57' ' ' VAL . 58.9 t -138.34 138.33 43.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.613 0.72 . . . . 0.0 110.648 -175.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 3.1 m -138.62 179.99 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 C-N-CA 125.74 1.616 . . . . 0.0 110.023 -174.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 61' ' ' ALA . 5.9 t -121.85 -159.28 0.81 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.123 -174.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.427 ' N ' HG23 ' A' ' 60' ' ' THR . . . -56.99 -48.23 78.91 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.414 ' H ' HG23 ' A' ' 60' ' ' THR . 0.2 OUTLIER -57.35 -58.59 7.6 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 122.013 -0.429 . . . . 0.0 112.128 -179.697 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.667 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 29.5 mm-40 -57.15 -28.12 62.46 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.677 0.751 . . . . 0.0 110.307 -178.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.74 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.12 -42.52 81.04 Favored 'General case' 0 C--O 1.206 -1.233 0 CA-C-N 114.627 -1.17 . . . . 0.0 113.563 -176.707 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.2 -75.92 0.04 OUTLIER 'General case' 0 C--O 1.244 0.793 0 CA-C-O 122.331 1.062 . . . . 0.0 111.669 -170.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.584 ' HB2' ' NH1' ' A' ' 70' ' ' ARG . 1.2 pt-20 -57.24 -51.59 68.75 Favored 'General case' 0 C--O 1.265 1.915 0 CA-C-N 113.798 -1.547 . . . . 0.0 112.035 -177.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.11 -49.82 74.7 Favored 'General case' 0 C--O 1.2 -1.527 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.766 -178.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.74 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 4.4 tt0 -57.0 -35.73 69.57 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 118.019 0.372 . . . . 0.0 111.2 -176.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.627 ' HA ' HD21 ' A' ' 44' ' ' ASN . 93.6 mttt -57.13 -74.46 0.05 Allowed 'General case' 0 C--O 1.254 1.316 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.631 172.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.584 ' NH1' ' HB2' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -57.27 -60.87 2.98 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.908 1.337 . . . . 0.0 111.256 -173.978 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 22' ' ' HIS . . . -57.08 -51.15 70.43 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 112.928 -1.942 . . . . 0.0 113.869 -175.268 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -57.31 -36.15 70.74 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 118.463 0.574 . . . . 0.0 111.081 -179.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.87 -48.76 77.4 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.835 174.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -57.57 -65.97 0.54 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 175.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -50.29 -37.11 34.63 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.99 0.916 . . . . 0.0 113.378 -166.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.21 0 C-N-CA 118.896 -1.621 . . . . 0.0 113.535 -172.405 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.343 0.592 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.83 166.36 10.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.286 -178.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -134.79 173.87 11.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.869 176.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.762 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.3 p -80.97 143.68 11.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.039 0.447 . . . . 0.0 110.642 177.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.5 8.97 67.36 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -177.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -108.06 174.43 5.88 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.726 ' CD1' ' HA ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER -104.57 138.13 41.37 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.267 0.556 . . . . 0.0 110.658 179.132 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.2 tt -99.02 136.84 38.42 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.852 179.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.746 HG22 ' CD2' ' A' ' 22' ' ' HIS . 55.4 t -133.16 160.38 42.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.801 174.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 44.6 t . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 118.052 0.387 . . . . 0.0 110.575 174.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 t70 . . . . . 0 C--O 1.224 -0.279 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.8 mp0 47.36 93.6 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.616 0.572 . . . . 0.0 112.208 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.889 ' HB2' ' HA ' ' A' ' 68' ' ' GLU . 20.8 m170 -125.49 141.52 52.0 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.894 -176.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HA ' ' HG3' ' A' ' 68' ' ' GLU . . . -177.76 -179.85 0.83 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.833 0.708 . . . . 0.0 110.484 173.486 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.435 ' OE1' HD21 ' A' ' 42' ' ' LEU . 36.7 tt0 -98.77 131.61 44.77 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.287 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.529 ' HB ' HG22 ' A' ' 28' ' ' VAL . 3.8 pt -96.81 111.26 26.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.087 0.47 . . . . 0.0 110.839 178.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.762 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -104.2 -21.96 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.688 177.58 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 1.053 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 36.2 tt0 -123.45 99.96 6.58 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.403 0.62 . . . . 0.0 110.102 172.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.867 HG13 ' HE2' ' A' ' 37' ' ' TYR . 34.6 t -112.22 100.54 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.509 -178.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -95.14 11.83 30.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.135 0.493 . . . . 0.0 110.627 -176.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.1 t -136.62 126.03 25.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.601 -179.177 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.2 -20.74 25.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.586 -179.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.87 -29.0 22.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.288 179.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.585 ' HA2' ' OH ' ' A' ' 37' ' ' TYR . . . 104.4 73.19 0.91 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.764 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -142.98 128.24 10.04 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -177.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.742 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 21.3 Cg_endo -62.67 165.47 15.8 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.858 2.372 . . . . 0.0 112.231 177.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.19 156.61 83.19 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 124.011 -1.245 . . . . 0.0 113.248 3.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.867 ' HE2' HG13 ' A' ' 28' ' ' VAL . 34.3 m-85 -119.91 147.55 44.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.984 177.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.053 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 98.4 t -98.9 106.63 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -114.66 155.55 15.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.311 -163.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.739 ' HB2' HD12 ' A' ' 26' ' ' ILE . 23.9 ttt180 -128.86 115.76 18.38 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.048 -176.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.729 ' CB ' ' HB2' ' A' ' 44' ' ' ASN . 6.7 m95 -75.63 120.39 20.96 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.435 HD21 ' OE1' ' A' ' 24' ' ' GLU . 12.8 mt -88.42 -45.66 9.78 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.663 -176.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.654 HG21 ' O ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -90.75 -5.84 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.155 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.729 ' HB2' ' CB ' ' A' ' 41' ' ' TRP . 39.6 m-80 -96.06 -40.36 9.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 168.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.09 63.58 1.44 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.764 172.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.526 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 54.9 t60 -172.42 154.3 3.16 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.921 0.361 . . . . 0.0 110.42 176.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.609 ' HG2' ' HG3' ' A' ' 40' ' ' ARG . 38.6 mt-10 -113.33 145.91 40.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.104 178.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -172.11 176.83 3.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.47 0.652 . . . . 0.0 111.084 178.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.1 m -108.52 115.1 29.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.942 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.92 172.59 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.277 0.56 . . . . 0.0 111.68 -176.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 68.8 m-85 -119.89 100.09 48.75 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.515 177.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.742 ' HD2' ' HB3' ' A' ' 35' ' ' PRO . 37.4 Cg_endo -66.08 -39.83 17.54 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.678 2.252 . . . . 0.0 112.486 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.94 -159.57 13.72 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.905 -178.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.526 ' O ' HG13 ' A' ' 11' ' ' VAL . 18.3 m -94.5 169.18 10.38 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.029 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 66.17 32.55 7.96 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.418 0.449 . . . . 0.0 110.765 178.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 11' ' ' VAL . . . -76.57 113.74 14.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.054 0.454 . . . . 0.0 111.008 -179.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 58' ' ' VAL . 13.9 t -99.21 162.33 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.742 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.402 ' N ' HG12 ' A' ' 57' ' ' VAL . 5.7 t -110.2 152.05 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.909 0.385 . . . . 0.0 111.235 -176.352 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.57 HG22 ' N ' ' A' ' 60' ' ' THR . 11.0 p -151.73 173.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.57 ' N ' HG22 ' A' ' 59' ' ' VAL . 47.8 p -90.2 169.39 11.18 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 175.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.726 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . . . -52.64 -64.55 0.78 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -172.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 p -75.18 -28.86 60.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -163.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -58.4 -62.6 1.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.103 0.478 . . . . 0.0 110.88 -176.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.505 ' HB2' HG11 ' A' ' 59' ' ' VAL . 3.2 m80 -81.95 -16.19 51.3 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.654 ' O ' HG21 ' A' ' 43' ' ' VAL . . . -43.36 -46.47 6.52 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -170.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -59.02 -48.69 80.69 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-O 123.37 1.557 . . . . 0.0 109.627 -179.167 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.426 ' C ' ' HD1' ' A' ' 22' ' ' HIS . . . -64.65 -16.9 63.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.668 173.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.889 ' HA ' ' HB2' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -73.2 -40.88 64.39 Favored 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.679 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.55 ' HA ' ' ND2' ' A' ' 44' ' ' ASN . 46.4 tttp -53.62 -50.63 65.28 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -64.27 -66.12 0.59 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 122.129 0.966 . . . . 0.0 112.784 178.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.423 ' HB3' ' ND1' ' A' ' 22' ' ' HIS . . . -70.67 -16.9 62.84 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -169.433 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.636 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -81.73 -33.78 30.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 173.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.75 -33.05 60.69 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.604 168.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 -76.74 -57.02 4.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.624 172.17 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -50.26 -51.52 44.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.846 0.859 . . . . 0.0 112.526 -176.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.201 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.959 -175.287 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' A' ' 58' ' ' VAL . . . -138.85 169.46 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.097 0.475 . . . . 0.0 112.062 -173.022 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 40.7 ttmt -139.3 166.13 25.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.412 -178.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.532 HG23 ' HA ' ' A' ' 26' ' ' ILE . 6.1 p -71.53 142.65 15.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 173.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.1 16.18 45.31 Favored Glycine 0 N--CA 1.454 -0.147 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -173.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 64.7 m-20 -138.77 -178.88 5.51 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 113.971 -1.114 . . . . 0.0 108.205 -174.125 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.737 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 87.3 m-85 -136.83 170.13 16.6 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.932 -169.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.736 HD11 ' HG3' ' A' ' 52' ' ' PRO . 8.0 tt -138.75 144.94 39.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.61 -166.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.907 ' HB ' ' HB ' ' A' ' 57' ' ' VAL . 87.2 t -138.87 172.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.718 HG13 ' HB2' ' A' ' 54' ' ' SER . 13.5 t . . . . . 0 C--N 1.314 -0.948 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 119.32 -0.371 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.618 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 24.5 mt-30 43.72 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.767 0.827 . . . . 0.0 112.511 -173.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.986 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.3 t-160 -138.78 129.1 25.72 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.54 0.686 . . . . 0.0 111.424 -169.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.772 ' HB2' ' HZ3' ' A' ' 41' ' ' TRP . . . -139.59 -178.29 5.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.968 -176.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.737 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 24.2 tt0 -136.76 125.93 24.62 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.629 1.204 . . . . 0.0 109.264 173.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.61 HG22 HG22 ' A' ' 28' ' ' VAL . 4.3 mt -82.67 107.48 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 112.557 -2.11 . . . . 0.0 109.815 -170.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.91 HG12 ' HD3' ' A' ' 40' ' ' ARG . 1.8 pp -106.82 -12.68 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.274 175.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 1.079 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -138.88 136.61 35.71 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.614 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 25' ' ' ILE . 11.2 t -138.36 107.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 -165.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.608 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 2.7 mmp_? -71.26 -19.14 62.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.779 0.324 . . . . 0.0 111.756 -176.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 60.5 m -152.3 115.46 4.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.05 13.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.831 -174.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -93.5 -11.84 31.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.172 0.511 . . . . 0.0 110.279 176.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.18 71.37 0.99 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.171 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.474 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 17.0 m -136.47 125.86 15.72 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 15.8 Cg_exo -68.7 153.53 73.06 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.974 2.449 . . . . 0.0 112.145 178.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.564 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 6.2 Cg_exo -80.29 -169.81 8.05 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 124.129 -1.196 . . . . 0.0 113.086 2.344 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -138.42 172.8 12.35 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.994 178.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.079 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 48.5 t -137.84 116.8 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.077 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.91 176.57 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.964 -149.557 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 1.041 ' HG2' ' HG2' ' A' ' 47' ' ' GLU . 12.4 mtp180 -138.82 138.18 37.3 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.772 ' HZ3' ' HB2' ' A' ' 23' ' ' ALA . 11.8 m95 -86.27 82.5 7.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 168.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 24' ' ' GLU . 5.4 mt -59.89 -69.65 0.2 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.114 0.483 . . . . 0.0 111.985 -166.363 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.727 HG11 ' HA ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -60.2 -34.09 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.089 -175.704 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.456 ' ND2' ' HB3' ' A' ' 72' ' ' ALA . 42.6 m-80 -60.43 -45.68 92.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.287 172.543 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.7 39.75 1.99 Allowed Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.851 179.184 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.485 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 63.7 m80 -139.23 172.92 12.12 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.324 -0.515 . . . . 0.0 111.893 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 1.041 ' HG2' ' HG2' ' A' ' 40' ' ' ARG . 45.0 mt-10 -138.58 128.26 24.93 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.35 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.34 179.93 6.25 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.129 0.966 . . . . 0.0 113.599 -160.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 75.6 m -138.78 125.3 20.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 167.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 51' ' ' TYR . 8.0 p -138.87 165.21 24.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.415 -162.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.564 ' CD2' ' HB3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -138.72 99.86 8.35 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.254 178.187 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.736 ' HG3' HD11 ' A' ' 9' ' ' LEU . 55.3 Cg_endo -70.67 114.16 3.76 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.758 2.305 . . . . 0.0 111.632 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.08 81.98 1.14 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.419 178.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.718 ' HB2' HG13 ' A' ' 11' ' ' VAL . 43.7 t 177.79 -179.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -71.72 -15.08 62.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 80.92 162.07 0.16 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.564 172.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.907 ' HB ' ' HB ' ' A' ' 10' ' ' VAL . 21.6 t -138.95 170.16 16.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.094 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 38.5 t -138.47 128.02 32.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.94 176.77 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.853 -174.331 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 p -120.08 -166.68 1.33 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.345 -176.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.0 79.36 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.457 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.39 -55.86 29.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.396 0.544 . . . . 0.0 111.813 -175.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.473 ' HG3' HG12 ' A' ' 59' ' ' VAL . 1.6 mm-40 -56.81 -31.39 64.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.635 -176.392 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.707 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.38 -40.8 78.94 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.766 -176.467 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.727 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -57.53 -77.08 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.052 0.93 . . . . 0.0 111.294 -170.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -57.66 -60.33 3.84 Favored 'General case' 0 C--O 1.267 1.998 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.173 -178.749 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -56.92 -56.44 21.64 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.853 -174.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.986 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 35.6 tt0 -57.27 -34.35 68.56 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -175.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 29.8 mtpp -57.1 -65.9 0.54 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.459 175.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -57.35 -53.79 54.13 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-O 123.544 1.64 . . . . 0.0 111.049 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.587 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -57.21 -45.47 83.78 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 112.627 -2.079 . . . . 0.0 113.105 -173.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.456 ' HB3' ' ND2' ' A' ' 44' ' ' ASN . . . -68.43 -33.31 73.99 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.806 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.87 -37.3 63.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 123.483 0.489 . . . . 0.0 110.22 174.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.8 mtp-105 -81.6 -47.0 13.6 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 173.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -48.25 -51.61 24.84 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.237 0.615 . . . . 0.0 111.633 -177.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.125 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.943 179.74 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -127.9 128.79 45.77 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.0 161.94 13.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.074 0.464 . . . . 0.0 111.672 -173.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 4' ' ' LYS . 39.8 ttmt -148.41 147.36 29.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.335 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.447 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.7 p -86.47 142.01 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.957 0.408 . . . . 0.0 110.41 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.82 4.74 65.05 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -121.2 171.39 8.74 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.929 ' HB2' HG23 ' A' ' 59' ' ' VAL . 98.9 m-85 -109.81 146.35 35.17 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.398 0.618 . . . . 0.0 111.508 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.679 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.4 tt -99.14 140.11 33.78 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.828 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.572 HG22 ' CE1' ' A' ' 22' ' ' HIS . 55.6 t -130.81 151.54 36.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 O-C-N 124.839 1.337 . . . . 0.0 109.441 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.875 HG12 ' HG3' ' A' ' 12' ' ' LYS . 74.6 t -134.23 151.32 32.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.875 ' HG3' HG12 ' A' ' 11' ' ' VAL . 8.9 mtpm? 78.53 138.38 0.07 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.599 0.714 . . . . 0.0 112.73 174.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.91 57.37 4.89 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 114.864 -1.062 . . . . 0.0 114.606 168.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.631 HG23 ' HB3' ' A' ' 55' ' ' ASP . 19.2 p -69.57 -17.22 63.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.498 0.649 . . . . 0.0 111.025 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -67.14 -15.07 63.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.112 0.482 . . . . 0.0 110.235 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.3 m 75.61 84.57 0.09 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.117 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.53 -60.13 0.15 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -123.41 105.89 10.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.141 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -103.11 112.99 26.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.025 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.546 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 16.3 m-20 -109.44 -166.06 1.07 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.231 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.845 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 14.0 mt-30 40.33 85.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.641 1.213 . . . . 0.0 112.347 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.735 ' CB ' ' HA ' ' A' ' 68' ' ' GLU . 7.2 m80 -118.49 146.58 44.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.249 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -176.7 177.98 1.3 Allowed 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.103 0.877 . . . . 0.0 110.857 170.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.617 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 43.4 tt0 -98.58 127.47 44.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.273 0.558 . . . . 0.0 110.742 177.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 9' ' ' LEU . 20.4 mt -88.48 103.04 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.177 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.663 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -105.76 -19.78 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.249 178.022 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.862 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 68.8 mm-40 -134.08 111.0 10.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.764 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 30' ' ' SER . 38.6 t -98.89 116.16 41.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.922 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -88.83 32.3 0.81 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.008 0.433 . . . . 0.0 110.861 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.508 ' H ' HG12 ' A' ' 28' ' ' VAL . 34.2 t -148.94 149.21 30.82 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.52 -14.6 45.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.052 0.453 . . . . 0.0 110.219 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -130.53 -70.84 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.472 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.39 75.93 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.611 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 33.3 p -146.67 132.87 9.58 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 37.3 Cg_exo -61.85 160.31 29.77 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.889 2.393 . . . . 0.0 112.098 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.52 179.26 22.23 Favored 'Cis proline' 0 N--CA 1.462 -0.34 0 C-N-CA 123.406 -1.498 . . . . 0.0 113.132 1.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -132.77 153.46 51.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.601 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.862 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 67.3 t -98.56 117.18 43.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 172.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.52 147.63 30.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.001 -164.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.788 ' HG2' ' HG3' ' A' ' 47' ' ' GLU . 98.7 mtt180 -115.4 131.88 56.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.633 176.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.7 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 13.8 m95 -85.38 101.3 12.47 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 168.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.712 ' HB2' ' HE1' ' A' ' 64' ' ' HIS . 12.7 mt -82.29 -55.55 4.45 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.432 0.634 . . . . 0.0 110.605 -173.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.617 HG11 ' HA ' ' A' ' 65' ' ' ALA . 2.0 m -76.14 -5.7 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.581 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.7 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 45.9 m-80 -100.01 -64.22 1.06 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.756 173.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . 122.02 68.42 0.25 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.532 -0.842 . . . . 0.0 114.181 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.546 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 30.3 t60 -179.18 156.92 0.79 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.217 0.509 . . . . 0.0 110.819 172.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.788 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 25.4 mp0 -110.58 150.38 29.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 t -175.18 -179.95 1.43 Allowed 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.442 0.639 . . . . 0.0 111.806 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.4 m -119.98 124.06 45.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.177 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.435 HG12 HG22 ' A' ' 80' ' ' THR . 29.6 m -127.32 160.46 36.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.329 0.585 . . . . 0.0 112.545 -172.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -111.6 106.19 56.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.558 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.59 -178.6 3.49 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.7 2.267 . . . . 0.0 111.174 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.402 ' H ' HG21 ' A' ' 11' ' ' VAL . . . -124.37 -155.17 9.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.843 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 11' ' ' VAL . 43.3 t -70.95 157.11 38.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.649 0.261 . . . . 0.0 110.963 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.631 ' HB3' HG23 ' A' ' 14' ' ' THR . 3.7 m-20 66.33 39.38 4.07 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.007 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -76.88 129.11 35.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.036 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 58' ' ' VAL . 11.2 t -126.38 163.82 27.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.555 -176.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.406 ' N ' HG12 ' A' ' 57' ' ' VAL . 53.9 t -115.27 119.62 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.526 0.203 . . . . 0.0 110.737 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.929 HG23 ' HB2' ' A' ' 8' ' ' TYR . 2.3 m -113.42 178.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.211 0.529 . . . . 0.0 111.94 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.6 p -119.31 -169.78 1.81 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.239 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -47.33 -49.6 23.81 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -171.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.24 -38.97 75.3 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 121.718 -0.614 . . . . 0.0 111.581 -172.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 2.8 mm-40 -67.7 -16.81 64.33 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.093 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.712 ' HE1' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -82.04 -41.96 19.93 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.722 -177.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.617 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -56.86 -73.77 0.06 Allowed 'General case' 0 C--O 1.243 0.74 0 CA-C-N 119.996 1.271 . . . . 0.0 111.639 -166.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -66.5 -49.67 65.81 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.547 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -67.55 -31.6 71.81 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.955 -173.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.735 ' HA ' ' CB ' ' A' ' 22' ' ' HIS . 32.2 tt0 -76.09 -33.45 59.5 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 118.299 0.499 . . . . 0.0 110.626 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 99.6 mttt -54.1 -62.09 1.88 Allowed 'General case' 0 C--O 1.247 0.958 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.044 172.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -65.8 -45.19 83.34 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.739 0.78 . . . . 0.0 111.387 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.64 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -78.75 -16.39 57.25 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.437 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -77.46 -36.38 52.96 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.9 -29.31 66.95 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.022 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -74.66 -58.85 3.03 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.641 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.719 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -59.9 -64.83 0.81 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.838 0.855 . . . . 0.0 112.371 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.41 29.27 4.03 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.847 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.86 -24.28 30.95 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.08 -175.58 5.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.357 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 65.75 11.46 7.59 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.387 0.429 . . . . 0.0 111.877 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.435 HG22 HG12 ' A' ' 50' ' ' VAL . 24.5 p . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.902 -0.571 . . . . 0.0 110.071 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.514 ' HG2' ' N ' ' A' ' 2' ' ' HIS . 23.8 ttt . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.955 0.407 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.514 ' N ' ' HG2' ' A' ' 1' ' ' MET . 11.5 m-70 -138.81 140.54 38.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.29 140.14 39.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.769 0.795 . . . . 0.0 112.012 -165.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -139.06 140.82 38.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.708 -173.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.928 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.6 p -65.54 149.09 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 O-C-N 122.051 -0.406 . . . . 0.0 110.931 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.13 16.76 78.07 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-O 122.57 1.094 . . . . 0.0 110.449 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 1.4 t70 -139.09 144.12 38.6 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 112.572 -1.814 . . . . 0.0 107.678 -166.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.858 ' CD1' ' HB2' ' A' ' 24' ' ' GLU . 6.7 m-85 -135.79 142.46 44.9 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 -142.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.747 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 3.2 tt -136.53 139.94 42.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.132 0.968 . . . . 0.0 109.799 -153.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.738 ' N ' HD23 ' A' ' 9' ' ' LEU . 2.3 t -138.84 141.62 36.32 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 112.707 -2.042 . . . . 0.0 109.057 -165.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 54' ' ' SER . 4.0 p -137.57 139.78 42.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 C-N-CA 117.645 -1.622 . . . . 0.0 109.389 174.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 12' ' ' LYS . 43.4 mtpt -97.27 115.54 27.82 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.045 -168.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.02 101.73 1.26 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 167.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -68.85 4.88 1.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.902 0.382 . . . . 0.0 111.541 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -61.66 2.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.224 0.535 . . . . 0.0 109.67 173.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.742 ' HB ' ' HG2' ' A' ' 18' ' ' ARG . 3.7 m -101.27 -2.15 31.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.199 177.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 69.27 25.39 5.64 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.529 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.742 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 4.2 ptm180 -104.07 178.63 4.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.189 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -99.62 115.34 29.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.31 0.576 . . . . 0.0 110.756 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.806 ' HA ' ' HB1' ' A' ' 71' ' ' ALA . 11.3 m-20 -122.31 93.82 4.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.828 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.821 ' H ' ' HB1' ' A' ' 71' ' ' ALA . 51.3 tt0 149.61 128.16 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.292 1.437 . . . . 0.0 108.667 169.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.823 ' NE2' ' HB3' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -138.68 136.69 36.11 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 117.074 -1.85 . . . . 0.0 111.013 153.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.689 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -142.08 144.06 33.38 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 111.29 -2.686 . . . . 0.0 109.38 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.858 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -134.99 138.61 44.16 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 124.698 2.19 . . . . 0.0 110.888 -177.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.527 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 19.9 mt -98.81 117.96 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 1 CA-C-N 108.363 -4.017 . . . . 0.0 111.203 -148.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.928 ' HA ' HG23 ' A' ' 5' ' ' VAL . 2.2 pp -114.56 -8.33 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 125.139 1.524 . . . . 0.0 110.166 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -138.8 132.22 30.27 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.433 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.9 t -138.06 101.33 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.535 -167.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -110.36 55.03 0.65 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.317 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -133.41 113.06 12.11 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.466 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.15 -42.4 17.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.343 0.592 . . . . 0.0 110.171 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -89.33 -7.78 54.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.056 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 1' ' ' MET . . . 85.81 18.15 60.33 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.355 -174.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 5.0 p -90.29 151.84 45.05 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 120.597 0.237 . . . . 0.0 111.173 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 26.9 Cg_exo -63.48 164.8 19.51 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.851 2.367 . . . . 0.0 111.701 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.685 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.7 Cg_endo -79.5 -173.27 12.47 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.585 -1.423 . . . . 0.0 113.685 1.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 49' ' ' THR . 53.0 m-85 -138.75 171.86 13.72 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.431 HG22 HG23 ' A' ' 49' ' ' THR . 83.9 t -137.7 116.21 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 CA-C-O 123.495 1.617 . . . . 0.0 107.257 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.689 HG11 ' HB1' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -139.25 177.78 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 CA-C-N 111.845 -2.434 . . . . 0.0 109.106 -151.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.884 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 15.6 mtm180 -138.32 145.61 41.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.639 ' CE3' ' HB1' ' A' ' 72' ' ' ALA . 11.4 m0 -101.37 84.78 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.685 HD11 ' HB3' ' A' ' 24' ' ' GLU . 3.4 mt -59.95 -68.04 0.33 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 112.483 -2.144 . . . . 0.0 112.772 -154.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.437 HG13 ' CE1' ' A' ' 64' ' ' HIS . 0.5 OUTLIER -60.14 -32.5 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.163 -176.268 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.421 ' ND2' ' HG2' ' A' ' 68' ' ' GLU . 39.9 m-80 -60.39 -64.08 1.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.113 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.13 51.19 0.27 Allowed Glycine 0 CA--C 1.523 0.546 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.512 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -139.18 170.95 15.02 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 117.53 0.665 . . . . 0.0 111.379 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.884 ' HG3' ' HD2' ' A' ' 40' ' ' ARG . 23.7 mp0 -138.26 106.98 5.9 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.9 t -139.74 -178.98 5.66 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -165.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.431 HG23 HG22 ' A' ' 38' ' ' VAL . 92.6 m -137.95 117.35 12.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.55 HG11 ' HZ2' ' A' ' 41' ' ' TRP . 15.3 m -138.84 177.87 4.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -161.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.685 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 5.2 m-85 -138.88 141.32 29.97 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.121 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.71 -48.42 0.11 Allowed 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.21 -63.77 0.27 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.846 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.484 ' HB2' HG22 ' A' ' 11' ' ' VAL . 27.4 m -79.3 -167.94 1.35 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.707 0.289 . . . . 0.0 111.417 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.87 -1.86 3.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.799 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 73.41 158.62 0.21 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.057 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 58' ' ' VAL . 17.2 t -138.9 163.39 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 175.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.434 ' H ' HG12 ' A' ' 57' ' ' VAL . 45.4 t -138.1 120.53 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.689 0.757 . . . . 0.0 109.294 -169.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.594 HG21 HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -139.2 -179.91 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.311 -165.611 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 p -124.46 -163.43 1.16 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.145 -175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.11 -47.7 80.44 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.55 -58.82 6.62 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.295 -0.878 . . . . 0.0 112.012 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.585 ' HG3' HG12 ' A' ' 59' ' ' VAL . 6.8 mm-40 -57.21 -25.27 58.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.962 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.787 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.26 -46.93 82.58 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.22 -178.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.93 -73.3 0.07 Allowed 'General case' 0 C--O 1.245 0.838 0 CA-C-O 121.97 0.89 . . . . 0.0 112.251 -165.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -55.86 29.22 Favored 'General case' 0 C--O 1.255 1.392 0 CA-C-N 114.076 -1.42 . . . . 0.0 112.141 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.17 -41.98 80.26 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.464 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.787 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 4.1 tt0 -57.06 -52.18 66.3 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -56.95 -77.48 0.03 OUTLIER 'General case' 0 C--O 1.248 1.011 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.382 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -58.08 -68.32 0.26 Allowed 'General case' 0 C--O 1.255 1.394 0 CA-C-O 123.272 1.51 . . . . 0.0 112.377 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.821 ' HB1' ' H ' ' A' ' 21' ' ' GLN . . . -57.46 -47.4 81.95 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.199 -1.818 . . . . 0.0 113.313 -173.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -57.65 -36.89 72.46 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 119.483 1.038 . . . . 0.0 111.123 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.42 -39.31 72.85 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 119.471 -0.891 . . . . 0.0 109.113 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 71' ' ' ALA . 19.1 mtp180 -57.76 -56.91 15.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.408 167.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.503 ' HB2' ' CB ' ' A' ' 21' ' ' GLN . . . -41.98 -48.76 4.61 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.827 0.851 . . . . 0.0 112.603 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.33 35.03 4.86 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.982 -173.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -66.46 -24.76 66.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.99 0.424 . . . . 0.0 110.617 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.23 14.96 17.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.616 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -125.1 98.88 5.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.018 0.437 . . . . 0.0 110.829 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.196 178.555 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.481 ' SD ' ' HA3' ' A' ' 33' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -138.92 122.67 17.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.945 0.403 . . . . 0.0 110.531 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.95 142.53 38.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.569 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 26.3 pttm -139.07 161.32 37.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.157 0.503 . . . . 0.0 111.054 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.683 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.9 p -73.03 151.7 7.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.718 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.45 17.4 62.34 Favored Glycine 0 CA--C 1.511 -0.193 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 1.2 m-20 -138.62 -179.09 5.61 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 113.627 -1.286 . . . . 0.0 107.658 -174.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.812 ' HB2' HG23 ' A' ' 59' ' ' VAL . 83.2 m-85 -137.28 168.6 19.3 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -170.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.9 tt -138.5 138.8 38.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.454 -168.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.848 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 12.4 t -138.81 169.09 18.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.513 ' H ' HG12 ' A' ' 10' ' ' VAL . 89.7 t -138.38 141.85 36.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -66.56 -68.91 0.34 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.066 -176.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.91 -53.28 2.94 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.831 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 18' ' ' ARG . 5.9 m -114.47 136.05 53.44 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.2 m -61.4 -22.79 65.3 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -174.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.0 t -77.31 -170.58 1.78 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -76.41 32.37 0.13 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -175.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.426 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 25.0 ttm180 -96.27 134.37 39.46 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.66 ' HB3' HG11 ' A' ' 10' ' ' VAL . 95.8 m-70 -139.6 119.03 12.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.009 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -125.19 -179.31 4.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.027 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.955 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 56.2 mt-30 64.61 96.87 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.394 0 O-C-N 123.518 0.511 . . . . 0.0 110.395 -171.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.899 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.5 t-160 -138.99 121.71 16.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.53 0.681 . . . . 0.0 111.854 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -139.77 -178.33 5.37 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.749 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.737 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 15.0 tt0 -136.67 132.29 34.75 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.705 1.24 . . . . 0.0 109.679 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.589 HG21 HG22 ' A' ' 28' ' ' VAL . 59.8 mt -90.22 114.77 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 112.39 -2.186 . . . . 0.0 111.267 -167.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.749 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -106.79 -16.23 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.571 170.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.694 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 32.2 mt-10 -139.11 153.08 47.96 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.03 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.589 HG22 HG21 ' A' ' 25' ' ' ILE . 18.5 t -137.76 99.93 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -170.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -98.46 33.1 2.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -164.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 p -122.79 -90.86 0.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.702 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 176.0 -66.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.491 0.495 . . . . 0.0 109.919 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -92.75 -58.81 2.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.925 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.481 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 173.88 80.58 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.769 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.486 ' HB3' ' HD2' ' A' ' 35' ' ' PRO . 59.2 m -155.28 165.38 18.43 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 34' ' ' SER . 36.2 Cg_endo -66.85 155.7 69.46 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 121.937 1.758 . . . . 0.0 111.678 173.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.663 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 95.6 Cg_endo -87.91 -177.24 12.65 Favored 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.244 -1.565 . . . . 0.0 113.008 0.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -138.74 174.6 10.36 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.396 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 81.5 t -137.86 115.12 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.405 HG12 ' CG2' ' A' ' 48' ' ' THR . 0.4 OUTLIER -138.91 170.38 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.087 0 CA-C-N 112.556 -2.111 . . . . 0.0 109.091 -152.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 46' ' ' HIS . 25.9 ttm180 -138.73 132.03 30.12 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.686 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 9.8 m95 -78.47 83.76 4.66 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 169.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.647 HD21 ' HB3' ' A' ' 24' ' ' GLU . 5.7 mt -60.37 -66.2 0.56 Allowed 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 123.584 0.553 . . . . 0.0 111.261 -167.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.618 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.5 OUTLIER -60.19 -35.68 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.821 -176.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -60.4 -66.37 0.54 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.929 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 130.6 29.76 0.62 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.687 -0.768 . . . . 0.0 114.613 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.686 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 4.9 t-80 -139.29 168.85 18.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.386 1.093 . . . . 0.0 110.787 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.51 126.16 22.12 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.142 0.496 . . . . 0.0 110.05 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.516 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 13.2 t -139.46 -178.97 5.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.107 0.956 . . . . 0.0 113.285 -162.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.3 m -137.93 115.52 11.29 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 m -138.77 175.77 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -161.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.663 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 26.6 m-85 -132.58 108.46 13.23 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.336 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.63 5.56 5.49 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.863 2.375 . . . . 0.0 112.564 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.62 -92.45 1.32 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.869 -177.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.2 t -170.19 178.26 3.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.7 t70 59.57 44.22 14.91 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.091 0.948 . . . . 0.0 109.716 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.9 128.19 35.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.964 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.2 m -105.11 143.3 16.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.647 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.74 118.2 46.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.052 0.453 . . . . 0.0 110.998 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.812 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -105.22 -179.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.735 -178.104 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.4 p -122.72 -164.52 1.2 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.87 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.58 -43.3 99.17 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -172.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -51.64 64.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.728 -0.607 . . . . 0.0 111.884 -174.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.582 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 32.0 mm-40 -62.91 -17.17 61.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.114 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.637 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -69.81 -34.22 73.41 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.454 -176.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.46 -76.43 0.06 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 122.109 0.956 . . . . 0.0 110.858 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 1.0 OUTLIER -63.18 -55.8 22.08 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.214 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -64.91 -34.5 78.55 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.909 -173.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.899 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 32.9 tt0 -72.72 -34.56 67.18 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 119.554 -0.859 . . . . 0.0 110.717 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -52.93 -65.58 0.53 Allowed 'General case' 0 C--O 1.25 1.087 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.606 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 14.8 ptm180 -61.69 -47.77 83.82 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.943 0.878 . . . . 0.0 111.506 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.663 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -77.02 -17.14 59.02 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.2 -170.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.67 -41.02 55.07 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.317 172.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.59 -31.45 64.27 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.334 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 74' ' ' ARG . 2.4 mmt85 -80.33 -51.81 8.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.264 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.955 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -57.98 -65.97 0.55 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.161 0.505 . . . . 0.0 112.058 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.03 57.71 2.12 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.872 -1.156 . . . . 0.0 111.94 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -86.23 0.46 53.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.482 0.658 . . . . 0.0 109.661 175.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.65 -64.9 1.25 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.195 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -101.38 101.42 12.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.763 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.8 m . . . . . 0 C--O 1.254 1.314 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.865 -175.457 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ttt . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.748 0.309 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -139.18 147.69 42.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.5 ' HA ' HG21 ' A' ' 58' ' ' VAL . . . -138.94 152.17 47.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.733 0.302 . . . . 0.0 111.478 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -139.1 172.78 12.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.221 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.746 HG23 ' HA ' ' A' ' 26' ' ' ILE . 4.1 p -93.08 144.89 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.401 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.27 17.38 59.09 Favored Glycine 0 CA--C 1.51 -0.257 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -138.74 -179.1 5.62 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.75 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 91.7 m-85 -137.11 172.75 12.53 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.093 -168.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.774 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 8.0 tt -138.56 142.78 39.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.844 -169.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.817 HG11 ' HB2' ' A' ' 19' ' ' HIS . 4.9 t -138.85 155.19 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 124.878 1.361 . . . . 0.0 109.356 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.713 HG21 ' H ' ' A' ' 53' ' ' GLY . 92.9 t -138.72 134.82 43.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -90.5 143.64 26.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.976 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.16 123.89 7.34 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 p -61.88 -20.01 63.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -174.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 p -112.64 -2.03 14.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.812 0.339 . . . . 0.0 111.674 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 p -132.75 112.41 11.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.591 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -75.23 74.67 2.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.002 0.906 . . . . 0.0 110.994 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.409 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -146.5 151.89 38.1 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.788 178.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.817 ' HB2' HG11 ' A' ' 10' ' ' VAL . 31.2 p-80 -101.42 93.09 5.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.984 0.897 . . . . 0.0 109.396 173.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 18' ' ' ARG . 4.7 m-20 -94.68 -172.96 2.88 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.26 -175.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.791 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 51.8 mt-30 53.48 90.6 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.165 0 O-C-N 124.159 0.912 . . . . 0.0 111.466 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.921 ' H ' ' HB2' ' A' ' 71' ' ' ALA . 10.9 t60 -138.85 125.78 21.1 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 122.461 1.124 . . . . 0.0 113.227 -171.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.34 -178.56 5.43 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.701 -1.591 . . . . 0.0 109.017 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.75 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 14.4 tt0 -137.26 123.6 20.66 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.461 ' CG2' HG22 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -88.16 113.9 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.935 -168.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.746 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.3 pp -110.18 -7.75 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.951 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 1.145 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -138.91 127.74 23.54 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.461 HG22 ' CG2' ' A' ' 25' ' ' ILE . 32.3 t -138.28 110.98 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.6 -167.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 21.6 mmt85 -66.58 -46.0 77.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.072 0.463 . . . . 0.0 111.875 -173.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.0 m -154.34 144.41 21.92 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.494 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.49 0.37 29.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.555 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -71.29 -26.17 62.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.91 -10.75 29.64 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.399 173.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.4 m -69.11 130.54 91.22 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 117.542 0.671 . . . . 0.0 111.139 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.443 ' CB ' ' HA ' ' A' ' 36' ' ' PRO . 29.4 Cg_exo -62.94 173.14 4.08 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.005 2.47 . . . . 0.0 111.451 174.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.593 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 95.0 Cg_endo -76.98 -170.75 9.01 Favored 'Cis proline' 0 CA--C 1.52 -0.218 0 C-N-CA 123.877 -1.301 . . . . 0.0 113.371 2.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -138.38 168.92 18.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.466 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.145 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 68.0 t -137.78 107.2 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 25' ' ' ILE . 0.3 OUTLIER -138.92 177.53 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 112.833 -1.985 . . . . 0.0 109.972 -151.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.732 ' HB2' HD23 ' A' ' 42' ' ' LEU . 86.1 mtm180 -138.74 133.8 32.68 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.498 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.63 ' HE1' HG21 ' A' ' 48' ' ' THR . 16.1 m95 -87.01 60.13 6.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 163.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -60.3 -52.66 64.32 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -158.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.515 HG22 ' OE2' ' A' ' 68' ' ' GLU . 0.5 OUTLIER -60.39 -33.76 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 118.555 0.616 . . . . 0.0 111.639 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -60.44 -42.94 97.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.384 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 130.68 6.6 3.66 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.549 -0.834 . . . . 0.0 114.58 172.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.92 176.55 8.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.798 1.299 . . . . 0.0 112.592 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 1.9 mp0 -138.53 139.45 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.537 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.63 HG21 ' HE1' ' A' ' 41' ' ' TRP . 16.5 p -139.25 -179.37 5.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.691 0.758 . . . . 0.0 112.422 -169.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.465 HG23 HG22 ' A' ' 38' ' ' VAL . 31.6 m -138.33 107.96 6.23 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.1 m -138.9 179.94 2.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -157.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 14.1 m-85 -138.84 130.92 15.58 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 113.455 -1.702 . . . . 0.0 107.908 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.35 -170.77 0.8 Allowed 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.61 2.207 . . . . 0.0 112.882 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.713 ' H ' HG21 ' A' ' 11' ' ' VAL . . . -98.56 -132.48 7.64 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.855 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.451 ' O ' HG13 ' A' ' 11' ' ' VAL . 23.5 m -96.1 156.97 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 t70 70.88 -60.56 0.5 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.349 1.031 . . . . 0.0 110.122 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 51.95 132.14 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.937 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.865 HG22 ' H ' ' A' ' 58' ' ' VAL . 7.5 p -138.97 -179.79 2.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.017 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.865 ' H ' HG22 ' A' ' 57' ' ' VAL . 53.3 t -138.19 134.82 44.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.951 -172.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.699 HG21 HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.71 -179.84 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.968 -166.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.7 p -118.86 -164.33 1.03 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.135 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.04 -46.61 82.28 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -175.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -61.08 2.73 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 121.597 -0.689 . . . . 0.0 111.774 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -57.41 -24.87 58.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.937 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.876 ' HA ' ' NE2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.33 -45.17 84.56 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.126 -178.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.35 -73.21 0.09 Allowed 'General case' 0 C--O 1.254 1.326 0 CA-C-O 122.136 0.97 . . . . 0.0 112.587 -170.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.598 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -63.87 -42.9 97.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.76 -172.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' HB2' ' CD2' ' A' ' 19' ' ' HIS . . . -67.36 -27.81 67.43 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.793 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 3.2 tt0 -70.57 -31.03 67.9 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.677 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 50.4 mttp -56.03 -51.96 65.96 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.94 165.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.598 ' HD3' ' O ' ' A' ' 66' ' ' GLU . 2.3 mpt_? -56.93 -20.52 23.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.277 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.921 ' HB2' ' H ' ' A' ' 22' ' ' HIS . . . -75.99 -60.26 2.4 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.44 -22.03 64.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.046 0.451 . . . . 0.0 109.935 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.71 -73.43 0.26 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.281 169.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.401 ' HE ' ' CG ' ' A' ' 20' ' ' ASP . 6.2 mtm180 -82.56 -54.91 4.8 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -170.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.791 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -58.17 -60.49 3.67 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -172.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.76 76.13 0.41 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.977 -1.106 . . . . 0.0 113.084 -171.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -103.96 -14.1 16.09 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -136.97 25.82 3.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.628 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.76 36.54 4.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.889 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.6 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.382 179.668 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HE2' ' HB3' ' A' ' 56' ' ' ALA . 1.5 tmt? . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -162.08 100.1 1.09 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.807 0.337 . . . . 0.0 110.116 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.29 119.41 38.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.837 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.633 ' HA ' HG21 ' A' ' 28' ' ' VAL . 14.5 tptm -126.35 164.62 20.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.863 0.363 . . . . 0.0 110.966 -175.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.91 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.0 p -66.27 150.03 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.319 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.11 1.71 48.32 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -143.06 175.92 9.49 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.906 ' HB2' HG23 ' A' ' 59' ' ' VAL . 93.5 m-85 -104.51 154.35 20.01 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.284 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.8 tt -98.96 132.2 44.46 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.395 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.86 HG11 ' HB2' ' A' ' 19' ' ' HIS . 10.5 t -137.79 143.65 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 124.951 1.407 . . . . 0.0 109.485 174.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 54' ' ' SER . 54.7 t -99.05 134.65 37.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 120.731 0.3 . . . . 0.0 111.561 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.6 tptm 78.55 -51.75 0.47 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 124.608 1.193 . . . . 0.0 112.306 170.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.43 -90.58 1.6 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.543 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.21 121.62 5.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.417 0.627 . . . . 0.0 111.602 175.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.6 m -152.11 -79.31 0.11 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.4 m -111.91 -33.5 6.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 171.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -94.12 167.02 11.84 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.82 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -83.98 176.12 9.08 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 173.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.86 ' HB2' HG11 ' A' ' 10' ' ' VAL . 12.8 p80 -75.16 98.31 3.69 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.722 0.772 . . . . 0.0 109.404 175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' HD3' ' A' ' 74' ' ' ARG . 18.7 t70 -121.37 165.01 16.16 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.48 -164.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.734 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 7.0 mt-30 63.07 101.29 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.794 0.437 . . . . 0.0 110.352 -174.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.715 ' CE1' ' HA ' ' A' ' 64' ' ' HIS . 58.6 t60 -148.26 151.22 35.07 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -167.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -179.01 -179.82 0.61 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.944 1.298 . . . . 0.0 107.51 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.587 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 41.1 tt0 -98.34 129.91 45.01 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.064 -0.655 . . . . 0.0 112.106 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.486 ' CG1' ' HB2' ' A' ' 9' ' ' LEU . 53.0 mt -85.8 111.21 20.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.383 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.91 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.5 pp -120.44 -16.63 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.642 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.766 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 48.2 mt-10 -130.26 107.96 9.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.136 0.493 . . . . 0.0 110.718 175.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.633 HG21 ' HA ' ' A' ' 4' ' ' LYS . 58.6 t -98.74 114.25 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.477 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 29.0 mmt180 -95.5 38.78 1.14 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.244 0.545 . . . . 0.0 111.251 -176.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.8 m -151.37 150.3 30.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.761 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.77 69.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.438 . . . . 0.0 110.8 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -115.1 -65.5 1.18 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.752 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.46 104.12 0.17 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.592 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 34.8 t -154.28 145.68 16.62 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 19.0 Cg_exo -67.26 155.07 72.13 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.44 2.094 . . . . 0.0 111.468 173.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.465 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 95.4 Cg_endo -87.89 178.87 19.07 Favored 'Cis proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.498 -1.459 . . . . 0.0 113.037 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -126.67 146.91 50.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.004 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.766 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 59.4 t -98.74 110.4 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.41 145.39 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.668 -159.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.719 ' HG2' ' HG3' ' A' ' 47' ' ' GLU . 73.4 mtp180 -106.36 129.42 54.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.493 0.664 . . . . 0.0 110.855 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.653 ' CE3' ' HB1' ' A' ' 72' ' ' ALA . 4.5 m0 -93.68 87.76 5.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.495 HD11 ' CD ' ' A' ' 24' ' ' GLU . 18.6 mt -70.05 -68.89 0.39 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.464 -162.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.536 HG22 ' OE2' ' A' ' 68' ' ' GLU . 4.2 m -74.96 -6.86 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.712 -173.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.06 -54.38 4.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.278 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.5 54.07 0.31 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.047 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -153.7 168.22 26.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.736 0.303 . . . . 0.0 111.131 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.719 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 32.7 tt0 -149.54 124.0 9.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 t -167.1 175.9 7.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.452 0.644 . . . . 0.0 112.029 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 m -101.5 110.25 22.21 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.292 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -106.88 149.77 10.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.39 0.614 . . . . 0.0 111.815 -171.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 81.9 m-85 -106.28 103.01 43.52 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.784 172.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.56 154.32 55.02 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.245 1.963 . . . . 0.0 110.861 175.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.84 -76.05 0.24 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.173 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.582 ' O ' HG13 ' A' ' 11' ' ' VAL . 28.4 t -169.68 162.63 9.83 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 55.51 60.28 3.43 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.285 0.564 . . . . 0.0 110.686 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.413 ' HB3' ' HE2' ' A' ' 1' ' ' MET . . . -82.34 127.21 33.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.06 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.6 t -120.43 157.56 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.423 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -100.42 115.76 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.341 0.591 . . . . 0.0 111.94 -178.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.906 HG23 ' HB2' ' A' ' 8' ' ' TYR . 6.6 m -102.0 178.29 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.987 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 p -119.41 -165.1 1.11 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.807 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -50.1 -47.14 53.98 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.19 -38.1 78.46 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.49 -0.756 . . . . 0.0 112.248 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.705 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 30.5 mm-40 -74.97 -16.78 60.62 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.528 0.68 . . . . 0.0 109.352 176.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.715 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -71.84 -43.4 65.6 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.401 -177.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.04 -70.23 0.18 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-O 121.258 0.551 . . . . 0.0 112.362 -171.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -31.51 72.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.381 -173.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.656 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -80.97 -22.18 39.75 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.524 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.697 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 2.0 tt0 -73.81 -46.68 43.75 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.416 -0.913 . . . . 0.0 108.993 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -56.67 -71.46 0.09 Allowed 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.563 0.697 . . . . 0.0 110.285 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -66.35 -52.6 45.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.452 -171.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.692 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -82.07 -23.11 35.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.971 -167.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.653 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -76.41 -39.93 52.22 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.361 173.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.27 -29.32 67.49 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.518 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.465 ' HD3' ' OD2' ' A' ' 20' ' ' ASP . 14.7 ttt180 -82.19 -40.66 21.41 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.726 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -54.07 -62.07 1.9 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.149 0.5 . . . . 0.0 110.774 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.4 50.63 1.62 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.368 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -74.67 -6.1 46.84 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.68 0.276 . . . . 0.0 111.34 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -168.59 22.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.367 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.5 94.22 3.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.062 0.458 . . . . 0.0 111.652 -172.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.1 m . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.09 173.134 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.636 0.255 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 35.3 t-80 -138.76 150.19 45.84 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.77 171.74 13.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.787 0.327 . . . . 0.0 111.373 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 8.3 ttpm? -139.03 151.97 47.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.803 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -82.96 139.33 17.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.17 26.71 27.73 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -168.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 14.5 m-20 -138.35 -178.92 5.5 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.673 ' HB2' HG23 ' A' ' 59' ' ' VAL . 88.9 m-85 -137.22 169.67 17.38 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -169.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.769 HD21 ' HB3' ' A' ' 52' ' ' PRO . 5.7 tt -138.66 145.36 40.34 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.205 -167.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 40.1 t -139.11 164.53 25.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.81 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.9 p -138.83 139.09 41.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 120.877 0.37 . . . . 0.0 110.125 173.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.549 ' HD2' ' HA ' ' A' ' 17' ' ' GLU . 2.5 ttpm? -85.71 -35.33 20.9 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.633 ' H ' ' HB3' ' A' ' 55' ' ' ASP . . . 57.88 -124.12 35.15 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.899 171.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 p -102.79 4.68 38.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -174.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.538 ' CG2' ' HB3' ' A' ' 18' ' ' ARG . 13.3 t -107.04 154.65 20.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.756 0.312 . . . . 0.0 110.324 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.3 m -86.45 100.97 12.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.118 0.485 . . . . 0.0 111.743 -173.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.549 ' HA ' ' HD2' ' A' ' 12' ' ' LYS . 47.0 mt-10 63.29 19.37 11.64 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.778 172.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' HB3' ' CG2' ' A' ' 15' ' ' THR . 32.4 ttm180 -92.14 132.38 36.66 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.617 ' HB3' HG11 ' A' ' 10' ' ' VAL . 68.2 m80 -93.68 104.41 16.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.092 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.407 ' CG ' ' HE ' ' A' ' 74' ' ' ARG . 3.9 t70 -131.44 174.38 10.14 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.509 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.81 ' HB2' HG12 ' A' ' 11' ' ' VAL . 17.2 mt-30 53.73 104.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.466 0.706 . . . . 0.0 111.326 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.892 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 36.0 t-80 -138.7 123.78 19.04 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.199 0.523 . . . . 0.0 111.947 -171.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.742 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.45 -178.5 5.41 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.02 -176.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.667 ' HB3' HD21 ' A' ' 42' ' ' LEU . 3.3 tm-20 -137.4 122.78 19.48 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.274 1.035 . . . . 0.0 108.244 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.418 ' HA ' HG23 ' A' ' 39' ' ' VAL . 1.2 mt -87.05 105.03 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.158 -167.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.773 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -98.61 -13.37 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 124.091 0.869 . . . . 0.0 109.386 174.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.721 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.04 140.92 38.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.498 -0.774 . . . . 0.0 108.988 174.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.08 99.86 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -167.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -94.41 78.97 3.88 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.617 0.246 . . . . 0.0 110.787 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.509 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 23.4 p 172.23 -35.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.151 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 74.63 -16.44 0.55 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.761 0.824 . . . . 0.0 111.761 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 30' ' ' SER . 4.2 p-10 -103.3 -37.91 7.46 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.71 8.31 3.52 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.441 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 48.9 m -76.19 143.99 74.34 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 122.633 -0.333 . . . . 0.0 110.369 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 17.9 Cg_exo -67.26 160.69 46.4 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.818 2.345 . . . . 0.0 111.938 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.593 ' HB3' ' HD1' ' A' ' 51' ' ' TYR . 90.0 Cg_endo -81.08 -171.28 9.43 Favored 'Cis proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.838 -1.317 . . . . 0.0 112.816 -1.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.52 175.91 9.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.532 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.721 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 98.1 t -137.89 112.75 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 25' ' ' ILE . 0.4 OUTLIER -138.95 169.44 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.761 -2.018 . . . . 0.0 109.339 -151.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 33.2 ttm180 -138.77 128.05 24.26 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.742 ' CZ3' ' HB2' ' A' ' 23' ' ' ALA . 5.7 m95 -80.07 86.03 5.58 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 170.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.667 HD21 ' HB3' ' A' ' 24' ' ' GLU . 7.1 mt -59.93 -67.17 0.41 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.606 -166.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.517 HG13 ' NE2' ' A' ' 64' ' ' HIS . 1.2 m -60.05 -34.24 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.496 -176.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.51 ' ND2' ' HB3' ' A' ' 72' ' ' ALA . 37.1 m-80 -60.45 -60.18 4.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.407 171.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.37 40.22 0.69 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.956 -0.565 . . . . 0.0 113.36 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.61 ' CB ' ' HD1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -139.11 160.89 38.72 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 117.25 0.525 . . . . 0.0 110.851 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -139.0 120.54 15.08 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.879 0.371 . . . . 0.0 110.446 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.585 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 8.8 t -139.29 -178.86 5.55 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.384 1.088 . . . . 0.0 113.807 -163.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.571 HG23 HG22 ' A' ' 38' ' ' VAL . 85.4 m -138.14 108.1 6.35 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.655 HG22 ' H ' ' A' ' 51' ' ' TYR . 4.6 p -138.9 176.31 6.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.046 -158.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.655 ' H ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -138.81 114.08 8.54 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.769 ' HB3' HD21 ' A' ' 9' ' ' LEU . 31.3 Cg_endo -64.01 -69.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.475 0.425 0 C-N-CA 123.13 2.553 . . . . 0.0 112.978 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.37 -164.67 37.38 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -91.2 20.78 4.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.125 0.488 . . . . 0.0 111.842 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.633 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 4.7 t0 -143.86 50.95 1.33 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.73 133.25 42.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.714 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.874 HG22 ' H ' ' A' ' 58' ' ' VAL . 5.3 p -138.96 -179.76 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.408 0.623 . . . . 0.0 109.882 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.874 ' H ' HG22 ' A' ' 57' ' ' VAL . 87.5 t -138.23 139.77 41.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.351 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.673 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.71 176.73 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 123.97 0.908 . . . . 0.0 110.82 -174.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 t -116.39 -169.18 1.57 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.23 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -57.03 -49.69 75.04 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.322 -175.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.51 -56.69 18.58 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.69 -0.631 . . . . 0.0 111.022 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 31.7 mt-10 -57.44 -26.26 60.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.47 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.76 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.3 -49.37 76.32 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 177.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . -56.98 -76.02 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.729 0.776 . . . . 0.0 111.883 -163.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -59.13 5.61 Favored 'General case' 0 C--O 1.26 1.637 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.306 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.646 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . . . -57.11 -37.18 71.58 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.944 -174.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.892 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 21.7 tt0 -71.68 -40.02 69.87 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.091 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 28.9 mtpp -52.61 -58.87 5.4 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.942 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.646 ' HE ' ' HA ' ' A' ' 67' ' ' ALA . 27.6 ptt180 -69.61 -53.16 20.12 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 122.137 0.97 . . . . 0.0 112.071 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.767 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -70.43 -31.14 68.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.334 -170.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -76.39 -34.56 58.86 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.187 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.15 54.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.576 0.548 . . . . 0.0 110.273 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HE ' ' CG ' ' A' ' 20' ' ' ASP . 49.8 mtm-85 -82.09 -47.82 12.12 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.755 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -46.36 -51.1 15.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.396 0.678 . . . . 0.0 112.714 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.427 ' HA3' ' CZ2' ' A' ' 41' ' ' TRP . . . -138.41 52.78 0.73 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.968 -174.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -59.17 -48.98 79.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.363 . . . . 0.0 110.942 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.7 -50.13 1.15 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.681 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 67.17 131.55 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.983 0.802 . . . . 0.0 111.627 -178.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 C--O 1.247 0.96 0 C-N-CA 123.626 0.77 . . . . 0.0 112.057 -179.733 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.851 0.357 . . . . 0.0 110.649 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -138.97 141.06 38.4 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.85 140.33 40.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.935 0.874 . . . . 0.0 111.057 -167.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 6.8 mmmm -138.96 141.08 38.43 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.44 -158.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.876 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.0 p -61.41 138.6 21.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 121.655 -0.653 . . . . 0.0 110.777 171.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.69 14.99 71.8 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 1.4 t70 -139.04 143.52 38.43 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.942 -1.629 . . . . 0.0 107.324 -167.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.801 ' HB2' HG23 ' A' ' 59' ' ' VAL 0.266 65.4 m-85 -134.37 141.9 47.02 Favored 'General case' 0 C--O 1.206 -1.227 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -142.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.796 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 4.6 tt -136.52 140.27 42.87 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.539 1.161 . . . . 0.0 110.401 -149.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.015 ' HB ' HG23 ' A' ' 57' ' ' VAL . 14.3 t -138.72 141.55 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 111.397 -2.638 . . . . 0.0 109.038 -153.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.7 t -137.46 139.78 42.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 122.257 1.027 . . . . 0.0 109.869 -173.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.545 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 87.2 tttt -82.85 92.67 7.32 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.122 -171.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.81 -46.13 95.12 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.7 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.545 ' OG1' ' HG2' ' A' ' 12' ' ' LYS . 17.1 m 72.95 -68.02 0.24 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.968 0.507 . . . . 0.0 111.057 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.53 -28.25 65.86 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 120.942 0.401 . . . . 0.0 110.637 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.7 p -106.96 80.62 1.45 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.624 174.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 63.75 -150.19 0.31 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.207 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -75.69 -155.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.897 0.856 . . . . 0.0 112.342 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -83.93 101.79 11.95 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 171.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 21' ' ' GLN . 23.4 t70 -120.85 -158.55 0.76 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -169.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 1.051 ' HG2' ' HB3' ' A' ' 74' ' ' ARG . 38.7 mt-30 64.87 105.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.353 0.408 . . . . 0.0 111.012 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.796 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 1.6 m170 -138.21 136.61 36.76 Favored 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 117.219 -1.792 . . . . 0.0 110.319 167.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.548 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -142.41 144.37 33.08 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 129.068 2.947 . . . . 0.0 107.055 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.751 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -134.56 139.85 45.69 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 122.269 2.304 . . . . 0.0 110.66 -166.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.74 HD12 HG22 ' A' ' 28' ' ' VAL . 5.4 pt -92.08 128.53 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 109.86 -3.336 . . . . 0.0 111.457 -159.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.876 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.8 pp -102.62 -6.29 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 112.022 -2.354 . . . . 0.0 108.981 169.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.654 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 33.3 mt-10 -139.02 139.69 37.9 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.901 172.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.74 HG22 HD12 ' A' ' 25' ' ' ILE . 8.5 t -138.28 139.81 41.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -175.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -125.8 25.31 6.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.388 0.613 . . . . 0.0 110.256 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 t -173.44 124.4 0.39 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.923 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.85 -16.45 41.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.323 0.582 . . . . 0.0 109.445 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.82 -46.0 55.41 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.291 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.29 40.12 0.49 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.651 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.4 m -117.58 151.53 48.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 122.197 0.199 . . . . 0.0 110.586 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.8 169.13 22.79 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.826 2.351 . . . . 0.0 112.334 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.58 179.9 29.5 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.603 -1.415 . . . . 0.0 112.63 0.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -138.71 142.07 38.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.723 -175.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.873 HG22 HG23 ' A' ' 49' ' ' THR . 99.8 t -135.88 138.91 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 CA-C-O 125.147 2.403 . . . . 0.0 108.955 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.548 ' CG1' ' HB1' ' A' ' 23' ' ' ALA . 47.2 t -139.7 142.17 33.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 108.558 -3.928 . . . . 0.0 112.533 -129.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.651 ' HG3' ' O ' ' A' ' 46' ' ' HIS . 51.7 ttp180 -137.19 139.5 41.13 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 166.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.553 ' HH2' ' HA3' ' A' ' 76' ' ' GLY . 10.1 m0 -99.38 70.2 1.71 Allowed 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.573 HD22 ' HE ' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -60.56 -41.34 94.39 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 113.357 -1.747 . . . . 0.0 113.15 -150.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.76 HG11 ' HA ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -61.56 -41.48 90.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.075 174.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -61.48 -40.49 94.74 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.57 50.27 2.98 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.295 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.651 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 8.1 t-160 -139.3 159.32 42.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.593 0.696 . . . . 0.0 110.554 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HG2' ' HD3' ' A' ' 40' ' ' ARG . 48.8 mt-10 -138.3 112.24 8.44 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.159 0.98 . . . . 0.0 110.46 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 t -139.68 -178.21 5.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.752 -1.567 . . . . 0.0 112.164 -165.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.873 HG23 HG22 ' A' ' 38' ' ' VAL . 94.6 m -137.65 122.19 18.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.454 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.754 HG12 ' H ' ' A' ' 51' ' ' TYR . 2.3 t -138.52 179.32 3.33 Favored 'Isoleucine or valine' 0 C--O 1.255 1.351 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.761 -164.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.754 ' H ' HG12 ' A' ' 50' ' ' VAL . 8.0 m-85 -138.78 114.69 8.67 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.203 176.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.665 ' HB3' HD21 ' A' ' 9' ' ' LEU . 27.6 Cg_exo -63.32 -66.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.312 2.674 . . . . 0.0 112.522 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.63 -136.18 8.71 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.734 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.7 p -101.27 162.19 13.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 58.9 45.76 14.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.913 0.863 . . . . 0.0 110.466 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' A' ' 1' ' ' MET . . . -77.5 130.04 36.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.627 -177.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 1.015 HG23 ' HB ' ' A' ' 10' ' ' VAL . 6.2 m -138.89 175.18 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.4 151.86 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -170.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' A' ' 8' ' ' TYR . 3.0 m -138.87 178.78 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 C-N-CA 126.246 1.818 . . . . 0.0 109.69 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.1 p -117.69 -171.16 2.0 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.006 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.11 -47.77 80.28 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -174.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -54.26 48.87 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 121.67 -0.644 . . . . 0.0 111.166 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 21.1 mt-10 -57.12 -33.43 67.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.518 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.76 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.15 -37.97 72.83 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 114.563 -1.199 . . . . 0.0 114.107 -177.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.76 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -57.05 -76.29 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.053 0.93 . . . . 0.0 110.288 -171.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -57.37 -64.4 0.9 Allowed 'General case' 0 C--O 1.268 2.062 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.065 178.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -56.88 -58.93 6.01 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.035 -175.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.716 ' HB3' ' O ' ' A' ' 64' ' ' HIS . 39.4 tt0 -57.41 -32.84 67.26 Favored 'General case' 0 C--O 1.204 -1.297 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.44 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -57.12 -71.33 0.1 Allowed 'General case' 0 C--O 1.261 1.676 0 CA-C-N 119.627 1.103 . . . . 0.0 110.808 174.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -53.82 53.83 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-O 123.262 1.506 . . . . 0.0 110.651 -175.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.791 ' O ' ' HA ' ' A' ' 21' ' ' GLN . . . -57.37 -39.39 75.93 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 112.999 -1.909 . . . . 0.0 112.923 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.51 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -57.1 -43.78 82.58 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 118.584 0.629 . . . . 0.0 109.891 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.49 -40.82 75.61 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 119.604 -0.839 . . . . 0.0 109.334 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 1.051 ' HB3' ' HG2' ' A' ' 21' ' ' GLN . 1.8 mpt_? -57.53 -57.93 10.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 172.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.671 ' HA ' HE21 ' A' ' 21' ' ' GLN . . . -47.09 -42.2 18.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.016 0.927 . . . . 0.0 113.065 -173.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.553 ' HA3' ' HH2' ' A' ' 41' ' ' TRP . . . -108.06 3.93 33.66 Favored Glycine 0 C--N 1.323 -0.179 0 C-N-CA 118.661 -1.733 . . . . 0.0 113.35 -173.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -89.62 -21.79 22.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.446 0.641 . . . . 0.0 109.393 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.45 -12.55 58.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.84 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.15 90.74 3.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.994 0.426 . . . . 0.0 110.535 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.299 -179.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptm . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.711 0.291 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -139.04 132.17 29.72 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 172.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.34 148.05 48.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.147 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.658 ' HE3' ' HA ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -130.92 169.58 15.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.843 0.354 . . . . 0.0 110.307 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.834 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.7 p -85.88 146.02 7.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.795 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.17 9.2 60.84 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -129.24 169.46 14.8 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.872 ' HB2' HG23 ' A' ' 59' ' ' VAL . 97.7 m-85 -105.95 150.77 25.37 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.317 0.579 . . . . 0.0 111.113 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.769 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 6.5 tt -98.75 146.22 26.13 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.468 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.871 HG11 ' HB2' ' A' ' 19' ' ' HIS . 47.8 t -127.65 144.74 36.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 O-C-N 125.295 1.622 . . . . 0.0 110.291 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.653 HG22 ' HB3' ' A' ' 52' ' ' PRO . 3.2 t -137.12 162.33 34.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 O-C-N 123.588 0.555 . . . . 0.0 110.367 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.487 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 47.6 tptt -142.72 -74.63 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 167.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.52 -6.4 5.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.333 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.2 m -159.64 -65.09 0.07 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.527 -0.396 . . . . 0.0 110.878 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.4 m -95.28 108.87 21.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -74.22 82.37 1.83 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.102 0.953 . . . . 0.0 109.957 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -164.7 -69.72 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.889 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 6.8 mmm180 -69.84 99.16 1.34 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.871 ' HB2' HG11 ' A' ' 10' ' ' VAL . 17.8 p-80 -90.0 98.75 11.95 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.6 -172.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -113.73 -169.0 1.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.811 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.636 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 39.1 mt-30 52.61 87.86 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.622 0.576 . . . . 0.0 111.959 173.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.769 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 55.0 m170 -117.95 158.31 25.13 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -175.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . . . -169.92 179.17 3.71 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 34.4 tt0 -98.32 126.1 43.7 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.086 -175.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.468 ' CG2' HG22 ' A' ' 28' ' ' VAL . 7.7 mt -88.15 105.82 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.016 174.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.834 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.2 pp -109.39 -27.02 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.228 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 1.068 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 47.3 mt-10 -118.81 101.81 8.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.086 0.469 . . . . 0.0 110.034 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.468 HG22 ' CG2' ' A' ' 25' ' ' ILE . 28.5 t -98.97 104.07 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.1 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -90.02 35.48 0.85 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.374 0.607 . . . . 0.0 110.725 -174.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -156.54 141.52 17.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.589 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.18 92.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.008 0.432 . . . . 0.0 110.644 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.4 -78.25 0.43 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.948 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.44 108.5 0.21 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.191 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.8 p -156.12 137.52 9.55 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.41 153.5 53.64 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.76 2.307 . . . . 0.0 112.092 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 83.2 Cg_endo -83.36 167.64 62.76 Favored 'Cis proline' 0 N--CA 1.463 -0.293 0 C-N-CA 123.276 -1.552 . . . . 0.0 113.317 2.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -120.14 144.24 47.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.186 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.068 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 58.5 t -98.79 111.06 27.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -126.11 148.77 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.833 -164.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.851 ' HD2' ' HB3' ' A' ' 42' ' ' LEU . 31.2 ttm-85 -114.29 121.57 44.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.279 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.446 ' CE3' ' HB2' ' A' ' 23' ' ' ALA . 12.0 m95 -83.14 76.72 9.84 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 168.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.851 ' HB3' ' HD2' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -76.35 -34.03 58.96 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -166.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG22 ' OE2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -77.26 -9.31 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.924 179.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.19 -32.16 11.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.546 171.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.85 35.84 3.62 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.787 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -136.39 168.38 19.56 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 122.634 -0.333 . . . . 0.0 110.435 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -153.6 141.62 20.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 t -175.4 -179.96 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.691 0.758 . . . . 0.0 111.674 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.9 m -98.77 107.83 20.36 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.69 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.417 HG12 ' HB ' ' A' ' 39' ' ' VAL . 9.5 p -98.98 148.68 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.304 0.573 . . . . 0.0 111.196 -173.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 24.2 m-85 -118.15 99.78 51.83 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.68 174.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.653 ' HB3' HG22 ' A' ' 11' ' ' VAL . 3.3 Cg_exo -75.62 -46.15 0.22 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.721 2.28 . . . . 0.0 112.268 -175.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.3 -94.75 1.44 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.801 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.7 m -126.72 167.39 15.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.569 0.185 . . . . 0.0 111.137 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 12' ' ' LYS . 67.4 m-20 67.25 22.14 9.74 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.933 0.771 . . . . 0.0 111.345 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.775 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -75.52 127.6 33.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.168 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.857 HG22 ' H ' ' A' ' 58' ' ' VAL . 7.4 p -147.27 -179.99 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.347 0.594 . . . . 0.0 110.346 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.857 ' H ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -111.26 127.94 68.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.504 -175.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.872 HG23 ' HB2' ' A' ' 8' ' ' TYR . 1.4 m -119.57 179.24 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 123.285 0.634 . . . . 0.0 110.768 173.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 p -112.05 -171.79 1.92 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.55 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.595 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -49.14 -52.23 27.52 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -172.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.56 -40.94 84.92 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.308 -170.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -63.04 -24.93 68.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.411 0.624 . . . . 0.0 110.227 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.482 ' CE1' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -67.2 -49.37 64.87 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.687 -173.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.61 -67.66 0.23 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.828 0.823 . . . . 0.0 112.684 -164.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -61.6 -52.48 64.21 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.349 -174.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HB3' ' ND1' ' A' ' 22' ' ' HIS . . . -72.79 -16.69 61.62 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.671 ' OE1' ' HA ' ' A' ' 23' ' ' ALA . 29.9 tt0 -77.59 -40.68 41.36 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -55.56 -49.3 73.06 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.924 0.869 . . . . 0.0 109.105 170.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -68.33 -16.65 64.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.093 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -81.26 -41.19 22.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.648 0.261 . . . . 0.0 110.867 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.0 -27.29 68.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.655 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -79.25 -52.67 7.82 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.885 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -82.0 -65.61 0.99 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.51 73.91 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.041 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.3 -4.53 64.35 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.973 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.655 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 47.2 t-80 -67.83 -28.23 67.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.958 0.409 . . . . 0.0 109.946 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.73 -64.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.728 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -144.81 125.98 14.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.059 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 C--O 1.254 1.307 0 CA-C-O 118.506 -0.759 . . . . 0.0 109.314 176.362 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 tmm? . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -138.85 136.44 35.59 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.84 171.72 13.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.901 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 88.2 tttt -139.09 155.52 47.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.208 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 26' ' ' ILE . 37.4 t -69.85 142.22 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.88 19.07 44.84 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -174.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 9.0 m-20 -138.7 -179.01 5.57 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 114.025 -1.087 . . . . 0.0 108.549 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.755 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 95.9 m-85 -137.17 165.13 26.82 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.971 -168.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.1 tt -138.63 138.73 38.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.662 -166.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 37.8 t -139.02 157.66 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.396 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.803 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.9 p -139.0 166.96 21.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.718 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 33.1 ttmt -85.26 76.08 10.2 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.161 0.505 . . . . 0.0 110.879 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.91 -13.2 72.6 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.644 HG22 ' HB2' ' A' ' 20' ' ' ASP . 5.0 t -160.59 134.77 7.21 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -90.45 -37.48 13.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.014 0.435 . . . . 0.0 110.875 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 p -74.39 -32.06 62.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.665 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB3' HG21 ' A' ' 14' ' ' THR . 18.0 tt0 -95.12 37.28 1.17 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.321 0.581 . . . . 0.0 110.147 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.439 ' NE ' ' HA ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER 75.32 -72.26 0.11 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.727 175.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.714 ' HB3' HG11 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -170.9 162.46 7.39 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -177.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.644 ' HB2' HG22 ' A' ' 14' ' ' THR . 15.2 t70 -139.56 165.59 26.84 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 111.249 0.092 . . . . 0.0 111.249 -170.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.803 ' HB2' HG12 ' A' ' 11' ' ' VAL . 78.8 mt-30 61.24 105.18 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.542 0.737 . . . . 0.0 111.707 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.972 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.7 t-160 -139.26 126.6 21.49 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 121.254 0.55 . . . . 0.0 111.599 -174.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.742 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.51 -178.65 5.49 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.402 1.081 . . . . 0.0 110.09 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.755 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 20.5 tt0 -136.95 122.51 19.67 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.287 1.042 . . . . 0.0 108.483 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.843 HG23 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -85.05 113.8 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.192 -174.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.81 ' HA ' HG13 ' A' ' 5' ' ' VAL . 1.5 pp -106.35 -3.51 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.237 172.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.856 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.0 124.46 19.35 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.284 172.032 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -138.19 99.67 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -105.49 -3.92 21.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.58 0.705 . . . . 0.0 109.97 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 6.9 m -65.0 -25.98 68.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.383 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 63.2 -82.17 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.791 0.682 . . . . 0.0 110.841 -176.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.75 -44.24 67.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.585 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 30' ' ' SER . . . 153.67 -164.25 31.1 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p 67.75 154.26 0.14 Allowed Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 124.476 1.111 . . . . 0.0 111.956 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.56 161.38 38.75 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.948 2.432 . . . . 0.0 112.533 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.637 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 89.4 Cg_endo -83.34 179.0 26.64 Favored 'Cis proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.071 -1.637 . . . . 0.0 113.376 0.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -138.76 173.52 11.49 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.856 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 97.4 t -137.77 115.58 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.843 HG23 HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -138.84 171.16 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 CA-C-N 112.878 -1.965 . . . . 0.0 109.155 -152.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.409 ' N ' HG13 ' A' ' 39' ' ' VAL . 31.6 ttt180 -138.66 123.75 19.07 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.75 ' HD1' ' HB2' ' A' ' 46' ' ' HIS . 25.6 m95 -78.99 84.42 5.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 24' ' ' GLU . 6.9 mt -60.21 -68.6 0.28 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.346 0.593 . . . . 0.0 111.951 -166.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.682 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -60.25 -38.35 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.155 -174.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' ' 72' ' ' ALA . 44.3 m-80 -60.59 -50.86 71.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.298 171.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.98 48.94 0.86 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.506 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.75 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 46.9 m-70 -139.13 169.17 18.26 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.446 0.623 . . . . 0.0 111.283 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -138.88 119.14 13.62 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.525 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 6.7 t -139.42 -179.36 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.315 1.055 . . . . 0.0 113.684 -165.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.455 HG23 HG22 ' A' ' 38' ' ' VAL . 57.8 m -138.55 112.67 8.59 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.092 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.445 HG11 ' HZ2' ' A' ' 41' ' ' TRP . 8.5 m -138.89 -179.8 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -163.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.637 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 50.1 m-85 -138.73 108.56 7.76 Favored Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.738 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.551 ' HG3' HD11 ' A' ' 9' ' ' LEU . 72.6 Cg_endo -74.63 -169.2 0.58 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.089 2.526 . . . . 0.0 111.608 176.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.568 ' HA3' HG21 ' A' ' 11' ' ' VAL . . . -98.61 -166.2 30.78 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.546 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.8 m -97.07 21.58 9.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.34 0.59 . . . . 0.0 112.019 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.718 ' HB3' ' H ' ' A' ' 12' ' ' LYS . 18.2 t70 -122.91 38.09 4.26 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.97 135.6 54.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.761 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.808 HG12 ' H ' ' A' ' 58' ' ' VAL . 2.9 t -138.71 179.93 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.808 ' H ' HG12 ' A' ' 57' ' ' VAL . 58.0 t -138.0 136.02 45.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.739 -174.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.669 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.75 177.33 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.752 -170.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.6 t -122.2 -164.02 1.13 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.799 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.25 94.2 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -42.68 72.64 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 121.858 -0.526 . . . . 0.0 110.98 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.602 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 9.4 mm-40 -62.14 -17.26 57.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.838 0.827 . . . . 0.0 109.446 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.682 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -81.73 -43.99 17.68 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.78 -172.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.77 -70.79 0.09 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.838 0.828 . . . . 0.0 111.627 -168.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 1.6 pt-20 -70.08 -55.04 10.49 Favored 'General case' 0 C--O 1.257 1.457 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.748 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -59.55 -42.29 92.06 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.577 -175.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.972 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 36.0 tt0 -70.47 -35.78 73.5 Favored 'General case' 0 C--O 1.212 -0.921 0 C-N-CA 120.204 -0.599 . . . . 0.0 110.978 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 69' ' ' LYS . 11.1 tptm -51.87 -61.76 2.06 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.734 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -67.12 -52.77 37.63 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.235 1.017 . . . . 0.0 111.709 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.735 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -68.85 -30.7 69.28 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.248 -171.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -69.74 -41.07 75.74 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -52.75 -35.42 56.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.825 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.643 ' HD3' ' OD2' ' A' ' 20' ' ' ASP . 49.6 ttt180 -81.79 -49.46 10.37 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.49 ' HA ' ' HG2' ' A' ' 21' ' ' GLN . . . -45.14 -50.23 11.39 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.63 0.772 . . . . 0.0 112.036 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -105.73 24.32 27.34 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.423 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 8.7 t60 -71.6 -41.74 68.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.59 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.5 45.63 0.63 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.581 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.2 -49.89 65.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.529 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.732 -0.651 . . . . 0.0 109.743 175.649 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.834 0.349 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -133.79 128.7 35.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.028 0.442 . . . . 0.0 110.312 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.89 145.3 19.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.019 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -144.79 171.02 15.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.174 0.511 . . . . 0.0 111.561 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.951 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.3 p -72.63 147.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.197 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.31 -0.34 43.69 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -130.73 176.38 8.25 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.71 ' HB2' HG23 ' A' ' 59' ' ' VAL . 94.8 m-85 -115.59 151.54 34.75 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.116 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.731 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.3 tt -98.6 142.23 30.44 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.562 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.778 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 44.4 t -134.78 154.86 37.52 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.139 0 O-C-N 125.229 1.581 . . . . 0.0 109.848 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 21' ' ' GLN . 29.5 m -124.86 150.51 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 168.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.468 ' HG2' ' HA ' ' A' ' 19' ' ' HIS . 49.6 mtmt -130.31 -81.8 0.54 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.093 0.473 . . . . 0.0 110.634 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.83 121.79 2.22 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.7 m 68.27 -80.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 122.783 0.433 . . . . 0.0 111.17 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.0 m -160.24 -58.12 0.06 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.016 0.436 . . . . 0.0 110.953 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.4 p -108.76 11.74 26.12 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -75.17 175.81 7.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.155 0.502 . . . . 0.0 112.043 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -58.74 131.25 50.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.532 -176.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.468 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 24.5 p-80 -87.19 122.99 31.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 174.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -151.15 174.61 13.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.767 ' HB3' HG22 ' A' ' 11' ' ' VAL . 0.6 OUTLIER 65.45 100.63 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 O-C-N 123.485 0.49 . . . . 0.0 110.175 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.731 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 3.8 m80 -129.79 146.64 51.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.167 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -160.8 176.38 11.54 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 172.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.622 ' CD ' HD11 ' A' ' 42' ' ' LEU . 43.9 tt0 -98.61 132.31 44.12 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.45 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.606 HG22 HG22 ' A' ' 28' ' ' VAL . 2.6 mt -97.43 109.69 23.85 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.96 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.951 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -109.03 -31.88 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.341 175.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 1.025 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 10.5 mm-40 -112.21 99.87 8.38 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.39 0.614 . . . . 0.0 109.427 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 30' ' ' SER . 15.7 t -106.86 144.72 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.017 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.3 mtp-105 -68.79 -35.98 77.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.361 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.7 ' H ' HG12 ' A' ' 28' ' ' VAL . 66.3 m 58.38 -159.75 0.27 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.856 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 65.39 -88.09 0.03 OUTLIER 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.829 0.452 . . . . 0.0 111.227 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -92.63 -27.47 17.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.733 0.301 . . . . 0.0 110.31 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.38 86.77 0.54 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.484 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.8 p -160.2 162.03 24.71 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.05 162.9 12.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.86 2.373 . . . . 0.0 112.126 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.21 151.64 96.87 Favored 'Cis proline' 0 C--N 1.343 0.262 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.747 2.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -111.46 139.9 46.5 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.025 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 57.8 t -98.35 99.92 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.62 142.02 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.212 -168.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -121.38 129.05 52.82 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.622 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.438 ' CZ3' ' HB2' ' A' ' 23' ' ' ALA . 12.8 m95 -81.05 100.39 8.97 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.622 HD11 ' CD ' ' A' ' 24' ' ' GLU . 13.2 mt -76.43 -56.78 4.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.249 0.547 . . . . 0.0 111.263 -172.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 65' ' ' ALA . 1.4 m -79.49 -7.89 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.245 -172.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -96.9 -47.98 5.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.791 170.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.49 70.81 0.82 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.746 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -174.11 148.62 1.36 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.843 0.354 . . . . 0.0 110.536 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -99.04 143.87 28.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.824 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.413 HG22 ' N ' ' A' ' 49' ' ' THR . 24.9 m -154.6 167.16 31.06 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.818 0.342 . . . . 0.0 110.249 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 48' ' ' THR . 26.5 m -127.79 118.67 24.17 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.14 162.92 35.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.805 0.812 . . . . 0.0 113.054 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -120.8 99.86 46.85 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.229 171.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.708 ' HG3' HD11 ' A' ' 9' ' ' LEU . 43.3 Cg_endo -66.51 149.45 84.39 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.672 2.248 . . . . 0.0 112.248 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.24 68.08 3.59 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.054 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.0 m 69.21 168.19 0.29 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.112 0.565 . . . . 0.0 112.395 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.28 42.48 31.45 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.3 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.778 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -77.63 110.69 12.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.122 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 10' ' ' VAL . 1.2 p -119.34 156.46 21.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.143 0.497 . . . . 0.0 110.84 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -102.21 107.08 20.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.467 -174.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.71 HG23 ' HB2' ' A' ' 8' ' ' TYR . 14.2 m -102.1 -179.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.589 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.2 t -96.71 -170.61 2.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.252 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.581 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . . . -63.38 -50.59 69.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.033 -172.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -71.8 -40.52 69.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.833 0.349 . . . . 0.0 111.689 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -55.78 -29.1 59.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.707 0.765 . . . . 0.0 109.698 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.716 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -82.22 -46.64 13.46 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -171.483 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.444 ' HA ' HG21 ' A' ' 43' ' ' VAL . . . -49.66 -60.15 3.14 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -159.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.74 -53.22 57.92 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 122.377 1.084 . . . . 0.0 110.33 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.93 -16.4 63.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.554 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 26.6 tt0 -70.77 -42.17 70.77 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 176.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -57.07 -47.15 81.69 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.639 0.733 . . . . 0.0 109.075 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -61.86 -24.05 66.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.647 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.606 ' HB2' ' H ' ' A' ' 22' ' ' HIS . . . -81.95 -48.86 10.95 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.445 -175.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.91 -23.39 65.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.646 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -69.61 -64.83 0.8 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.191 173.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -82.25 -60.12 2.32 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.594 ' HB2' ' CG ' ' A' ' 21' ' ' GLN . . . -52.51 -48.72 65.82 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.908 0.483 . . . . 0.0 112.033 -173.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.64 21.65 41.65 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.944 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.646 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 7.6 t-160 -70.06 -52.95 19.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.058 0.456 . . . . 0.0 109.839 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -140.16 84.07 1.95 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.079 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.26 -43.62 8.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.454 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.676 178.191 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.574 ' HB3' ' O ' ' A' ' 32' ' ' ASP . 19.4 ttt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.45 ' N ' ' HG2' ' A' ' 1' ' ' MET . 31.7 p-80 -120.9 124.57 45.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.984 0.421 . . . . 0.0 109.998 173.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.53 150.68 40.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.6 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -137.02 146.76 45.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.951 0.405 . . . . 0.0 110.941 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.8 p -89.37 137.13 21.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.416 172.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.34 2.29 56.71 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.19 173.38 6.96 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.701 ' HB2' HG23 ' A' ' 59' ' ' VAL . 92.5 m-85 -110.96 161.13 16.16 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.382 -174.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 10.4 tt -106.92 137.38 45.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.247 -176.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.595 HG23 HG21 ' A' ' 59' ' ' VAL . 11.1 t -136.94 148.42 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.049 0.843 . . . . 0.0 108.89 172.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.7 ' HB ' ' HB2' ' A' ' 21' ' ' GLN . 92.2 t -125.7 144.01 37.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.138 0.494 . . . . 0.0 110.249 175.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.484 ' HD2' ' OD2' ' A' ' 55' ' ' ASP . 68.0 mttt -77.82 78.11 4.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.324 176.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.07 86.31 1.37 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.31 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 15' ' ' THR . 9.0 m 68.85 -178.77 0.22 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.67 ' H ' HG22 ' A' ' 14' ' ' THR . 6.6 m -74.97 76.81 2.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.273 0.559 . . . . 0.0 109.723 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -109.73 122.35 47.29 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.926 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.424 ' C ' ' H ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -67.39 143.4 56.33 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 77.13 -20.81 0.36 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.283 0.989 . . . . 0.0 110.617 -174.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 17' ' ' GLU . 39.5 m80 73.04 169.64 0.31 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.665 0.786 . . . . 0.0 111.453 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -131.26 -171.17 2.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.746 -173.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.7 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 78.8 mt-30 45.62 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.993 0.917 . . . . 0.0 112.374 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.719 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 59.8 t-80 -135.05 145.77 48.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -171.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.497 ' HB2' ' HZ3' ' A' ' 41' ' ' TRP . . . -169.81 179.81 3.54 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.808 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 38.4 tt0 -100.64 123.56 45.02 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.515 0.509 . . . . 0.0 110.469 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 9' ' ' LEU . 18.8 mt -91.85 106.1 17.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 120.7 0.286 . . . . 0.0 110.267 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.572 ' HA ' HG23 ' A' ' 5' ' ' VAL . 2.0 pp -114.93 -10.42 12.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.157 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.885 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 30.9 mt-10 -139.92 107.99 5.74 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.113 0.483 . . . . 0.0 110.839 173.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.65 126.85 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.298 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -74.4 -34.97 63.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.123 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.5 t -145.51 136.81 24.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.27 -18.41 65.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.917 0.389 . . . . 0.0 111.167 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 1' ' ' MET . 3.7 t70 -89.77 1.3 56.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.143 0.497 . . . . 0.0 110.021 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.03 99.47 0.52 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.714 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 53.8 m -139.89 121.22 9.56 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 2.9 Cg_exo -75.49 157.2 40.84 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.144 2.563 . . . . 0.0 111.763 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HB3' ' CD1' ' A' ' 51' ' ' TYR . 79.8 Cg_endo -82.77 167.22 66.96 Favored 'Cis proline' 0 N--CA 1.462 -0.332 0 C-N-CA 123.111 -1.621 . . . . 0.0 112.889 -1.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -109.32 153.9 23.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.773 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.885 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 85.5 t -98.79 113.07 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.496 ' HB ' HG22 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -118.85 151.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.022 -166.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.519 ' HD2' ' OE1' ' A' ' 24' ' ' GLU . 37.7 ttm180 -116.81 137.18 52.39 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.065 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.497 ' HZ3' ' HB2' ' A' ' 23' ' ' ALA . 18.5 m95 -74.06 83.47 1.78 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 168.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.926 HD12 HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -22.52 -76.9 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.221 -1.808 . . . . 0.0 115.778 -170.252 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.926 HG22 HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -95.34 0.33 10.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -168.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.426 HD22 ' N ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -88.91 -46.13 9.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.881 0.372 . . . . 0.0 110.074 173.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.77 73.26 1.06 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.38 -0.915 . . . . 0.0 113.564 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -170.29 137.63 1.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.95 142.45 46.77 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.758 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 t -157.51 176.49 12.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.167 -173.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.4 m -105.3 108.81 20.52 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.749 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.496 HG22 ' HB ' ' A' ' 39' ' ' VAL . 35.1 m -106.49 152.18 8.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.356 0.598 . . . . 0.0 111.99 -174.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 36' ' ' PRO . 50.7 m-85 -116.19 99.8 52.97 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.181 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.97 168.31 12.24 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.803 2.335 . . . . 0.0 111.746 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 55' ' ' ASP . . . -66.26 162.8 43.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.015 175.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.3 m -76.47 29.0 0.12 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.008 0.433 . . . . 0.0 111.716 -177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.484 ' OD2' ' HD2' ' A' ' 12' ' ' LYS . 9.6 t0 -144.3 55.65 1.29 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.787 0.803 . . . . 0.0 108.909 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.82 136.35 35.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.763 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.84 158.37 42.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 1.5 m -99.22 149.89 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.235 0.54 . . . . 0.0 112.319 -177.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -135.09 173.3 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.803 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.89 -168.15 1.61 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.053 -175.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.21 -42.57 81.59 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -71.19 -44.62 65.09 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.236 -0.915 . . . . 0.0 110.934 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.0 mm-40 -64.76 -16.42 62.96 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.986 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.677 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -69.73 -33.82 73.0 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.669 -174.49 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 64' ' ' HIS . . . -77.14 -73.77 0.28 Allowed 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.834 0.826 . . . . 0.0 112.8 -165.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -61.07 -39.66 90.72 Favored 'General case' 0 C--O 1.251 1.182 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.136 -175.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -69.48 -28.8 66.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.308 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.734 ' HB2' HD11 ' A' ' 42' ' ' LEU . 18.0 tt0 -57.37 -57.3 13.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 1.009 ' HA ' ' HE2' ' A' ' 69' ' ' LYS . 9.3 mmpt? -50.64 -64.85 0.68 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.656 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -66.15 -54.81 20.84 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.839 0.828 . . . . 0.0 111.625 -174.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.554 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -77.02 -25.15 52.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.87 -167.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.82 -32.41 52.25 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.834 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.21 72.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.23 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -80.58 -44.03 19.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.254 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.69 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -54.65 -53.02 60.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.6 -16.99 74.4 Favored Glycine 0 N--CA 1.454 -0.121 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.358 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -85.26 -14.12 47.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.29 0.566 . . . . 0.0 109.989 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.25 7.0 42.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.507 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.26 119.11 10.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.832 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.244 0.773 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.426 -176.474 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HE3' ' HB2' ' A' ' 3' ' ' ALA . 8.7 tpt . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.916 0.388 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.438 ' O ' HG21 ' A' ' 58' ' ' VAL . 21.2 m80 -138.97 108.38 6.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 174.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.414 ' HB2' ' HE3' ' A' ' 1' ' ' MET . . . -138.76 166.64 23.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.029 0.442 . . . . 0.0 111.709 -172.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -139.1 176.06 9.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.827 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.5 p -91.46 135.49 26.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.9 17.46 32.57 Favored Glycine 0 C--N 1.322 -0.201 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.36 -179.24 5.68 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.791 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 92.1 m-85 -137.03 169.54 17.6 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.595 -166.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 10' ' ' VAL . 6.1 tt -138.6 141.31 39.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.829 -164.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 37.2 t -138.75 151.98 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 124.889 1.368 . . . . 0.0 109.039 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.94 HG22 ' HB2' ' A' ' 54' ' ' SER . 0.5 OUTLIER -138.88 153.09 24.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.318 177.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.1 tptt 70.41 90.96 0.09 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.241 0.543 . . . . 0.0 111.288 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -146.18 15.86 1.7 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.517 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 p -81.89 -41.13 21.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.123 0.487 . . . . 0.0 111.454 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.0 t -129.56 -16.51 3.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.398 0.618 . . . . 0.0 110.423 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.651 HG22 ' HB2' ' A' ' 18' ' ' ARG . 6.2 m -101.17 108.95 20.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.615 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -78.19 9.44 3.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.56 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.651 ' HB2' HG22 ' A' ' 16' ' ' THR . 7.4 mpt_? -72.61 -35.18 67.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 175.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 55.16 73.72 0.4 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.256 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.654 ' OD1' ' HD3' ' A' ' 74' ' ' ARG . 9.0 m-20 -76.45 -175.32 3.23 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.264 -172.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.963 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 6.2 tp-100 53.5 99.76 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.423 0 O-C-N 123.608 0.567 . . . . 0.0 110.533 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.948 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -138.69 103.04 4.74 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 121.451 -0.781 . . . . 0.0 110.376 -173.168 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.49 -178.77 5.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.207 -172.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.791 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 23.5 tt0 -137.07 127.77 27.07 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 122.473 1.13 . . . . 0.0 109.089 172.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.539 ' CG2' HG22 ' A' ' 28' ' ' VAL . 3.0 mt -87.46 111.48 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-N 112.518 -2.128 . . . . 0.0 110.084 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.771 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -106.13 -12.12 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 O-C-N 123.961 0.788 . . . . 0.0 109.401 172.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.6 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 33.0 mt-10 -138.98 139.58 37.96 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.933 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.539 HG22 ' CG2' ' A' ' 25' ' ' ILE . 23.2 t -137.89 102.65 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -163.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.41 35.83 0.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.27 -173.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.3 t -158.76 150.83 21.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.98 -14.5 29.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.401 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -118.54 -66.22 1.1 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.618 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 165.57 51.82 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.267 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 m -118.87 148.29 44.23 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.03 156.79 52.58 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.62 2.214 . . . . 0.0 111.925 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.591 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 75.1 Cg_endo -89.16 -172.43 6.82 Favored 'Cis proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.723 -1.365 . . . . 0.0 113.447 1.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.72 168.33 20.03 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.168 174.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.6 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 84.3 t -137.96 117.41 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.93 172.24 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 113.112 -1.858 . . . . 0.0 109.656 -154.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.844 ' HG2' HD23 ' A' ' 42' ' ' LEU . 11.6 ttt85 -138.71 134.48 33.62 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.596 ' CZ2' HG21 ' A' ' 48' ' ' THR . 9.9 m95 -78.68 89.32 4.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 168.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.844 HD23 ' HG2' ' A' ' 40' ' ' ARG . 8.3 mt -59.92 -72.66 0.1 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.328 0.585 . . . . 0.0 111.533 -168.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.604 HG13 ' NE2' ' A' ' 64' ' ' HIS . 2.4 m -60.08 -30.68 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.293 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' ' 41' ' ' TRP . 33.9 m-80 -60.68 -66.18 0.57 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.241 170.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.79 33.31 0.65 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.86 -0.686 . . . . 0.0 114.759 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.753 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 2.4 m170 -139.28 174.48 10.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.328 1.064 . . . . 0.0 112.164 175.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -138.49 127.7 24.28 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.596 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 9.7 t -139.42 -179.23 5.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 122.065 0.936 . . . . 0.0 113.335 -168.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.524 HG23 HG22 ' A' ' 38' ' ' VAL . 63.4 m -138.46 110.67 7.36 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.87 -179.86 2.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -161.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 9.8 m-85 -138.71 121.93 10.95 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.264 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 24.6 Cg_exo -63.13 -53.45 1.53 Allowed 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 122.937 2.425 . . . . 0.0 112.653 -177.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.67 -46.82 1.11 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.204 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.94 ' HB2' HG22 ' A' ' 11' ' ' VAL . 26.4 m -91.66 -170.9 2.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.688 0.244 . . . . 0.0 111.33 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.61 -14.81 5.93 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.85 0.719 . . . . 0.0 110.525 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 71.44 130.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.985 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.584 HG23 ' HB ' ' A' ' 10' ' ' VAL . 29.0 m -135.41 169.84 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 122.046 -0.408 . . . . 0.0 110.969 176.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 2' ' ' HIS . 56.1 t -118.02 136.26 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -173.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.658 HG23 ' CB ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -123.86 174.74 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 123.111 0.565 . . . . 0.0 110.845 176.039 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -121.4 -164.97 1.18 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.503 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.15 91.17 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -171.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -81.82 -33.96 30.46 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.466 -0.771 . . . . 0.0 110.872 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 36.9 mt-10 -65.83 -16.52 63.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.919 0.866 . . . . 0.0 109.267 174.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.604 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.37 -57.73 3.67 Favored 'General case' 0 C--O 1.198 -1.642 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.292 -176.028 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.84 -67.14 0.28 Allowed 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -160.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.436 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.26 -53.5 14.11 Favored 'General case' 0 C--O 1.259 1.593 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.132 -169.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.52 -17.69 63.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.271 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.948 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 10.9 tt0 -74.01 -44.73 53.47 Favored 'General case' 0 C--O 1.205 -1.272 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -50.14 -57.55 7.46 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.611 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.77 -60.56 2.96 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 121.838 0.828 . . . . 0.0 112.424 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.77 ' HB3' ' HB2' ' A' ' 22' ' ' HIS . . . -73.18 -16.64 61.42 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -169.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 22' ' ' HIS . . . -79.93 -39.25 30.68 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 118.27 0.486 . . . . 0.0 109.948 174.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -52.59 -36.66 56.56 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.762 171.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.654 ' HD3' ' OD1' ' A' ' 20' ' ' ASP . 35.7 mtt180 -79.59 -42.93 23.91 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.65 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.963 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -46.05 -52.77 11.34 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.138 0.975 . . . . 0.0 112.228 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -107.99 29.89 9.69 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.006 -1.092 . . . . 0.0 111.956 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 3.8 t-160 -80.47 -57.02 3.78 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.5 91.79 3.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.533 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.01 141.46 51.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.143 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.251 1.135 0 O-C-N 123.719 0.637 . . . . 0.0 110.521 -179.215 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.753 0.311 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 68.9 m-70 -143.53 131.9 22.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.96 154.76 17.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.534 0.207 . . . . 0.0 110.793 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -135.52 163.44 30.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 111.2 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 HG23 ' A' ' 28' ' ' VAL . 40.0 t -100.17 135.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.837 176.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.85 3.96 61.97 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.99 171.39 8.48 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.704 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 84.5 m-85 -106.25 148.58 27.79 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.321 0.581 . . . . 0.0 111.259 -175.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.4 tt -99.06 136.73 38.6 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.664 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.679 HG11 ' HB2' ' A' ' 19' ' ' HIS . 3.3 t -141.14 139.71 32.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 O-C-N 125.044 1.465 . . . . 0.0 109.895 174.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.0 t -111.49 103.58 15.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 170.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 21.3 ptmt -97.1 -18.88 19.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.046 -177.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.41 -100.2 2.65 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.009 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.605 HG23 ' H ' ' A' ' 15' ' ' THR . 1.8 t -128.98 -70.95 0.65 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.605 ' H ' HG23 ' A' ' 14' ' ' THR . 1.2 p -144.65 -67.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -169.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.0 p -84.91 -0.03 52.75 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -169.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -90.8 171.64 9.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.644 0.259 . . . . 0.0 110.514 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.535 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 6.2 ptp180 -77.59 178.7 7.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.658 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.679 ' HB2' HG11 ' A' ' 10' ' ' VAL . 5.9 p80 -102.18 92.18 4.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.569 0.699 . . . . 0.0 109.888 170.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.535 ' OD2' ' HD2' ' A' ' 18' ' ' ARG . 1.9 t0 -100.03 -169.97 1.81 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.923 -174.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.687 ' N ' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER 43.23 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.807 0.843 . . . . 0.0 112.475 -177.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.928 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.7 t60 -134.49 137.96 44.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -171.08 -179.86 2.85 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.488 173.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.704 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 38.4 tt0 -98.59 136.1 39.16 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.033 0.444 . . . . 0.0 110.341 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 9' ' ' LEU . 1.5 mt -97.17 107.18 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.788 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -107.33 -24.88 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.993 176.384 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 1.079 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 19.3 mm-40 -115.72 99.88 7.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.795 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 5' ' ' VAL . 72.3 t -106.72 124.62 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.636 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -69.13 -37.81 78.52 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.5 p -146.07 144.65 30.16 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.95 74.1 0.88 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.078 0.466 . . . . 0.0 111.928 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 19.1 t70 -171.38 -57.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.092 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 146.39 89.99 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.949 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 p -132.02 97.05 18.91 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.857 0.361 . . . . 0.0 111.363 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.75 150.68 84.82 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.485 2.123 . . . . 0.0 111.213 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.413 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.3 Cg_endo -78.1 169.22 73.8 Favored 'Cis proline' 0 C--N 1.344 0.295 0 C-N-CA 123.346 -1.523 . . . . 0.0 112.826 0.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -113.58 155.47 25.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.079 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 66.4 t -98.76 102.07 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 172.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -106.14 158.01 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.077 -163.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.572 ' HB2' HD12 ' A' ' 26' ' ' ILE . 62.9 ttt180 -131.51 99.99 5.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.162 -169.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.742 ' HE1' HG22 ' A' ' 48' ' ' THR . 0.3 OUTLIER -81.75 71.66 8.78 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 174.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 3.0 pp -84.83 -23.7 28.96 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.86 -166.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.68 ' HB ' ' CE1' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -85.17 -6.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.968 0.889 . . . . 0.0 108.812 178.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 69' ' ' LYS . 50.1 m-80 -99.84 -61.57 1.35 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.123 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.88 42.4 0.1 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.044 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -157.04 164.59 37.78 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.907 0.354 . . . . 0.0 110.927 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -149.44 133.56 17.24 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.742 HG22 ' HE1' ' A' ' 41' ' ' TRP . 12.0 t -167.49 177.8 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.541 0.686 . . . . 0.0 111.182 -176.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.4 m -98.88 123.04 42.88 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.533 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.84 155.85 41.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.216 0.531 . . . . 0.0 111.543 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 46.4 m-85 -107.24 99.94 30.23 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.04 174.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HG3' HD11 ' A' ' 9' ' ' LEU . 43.6 Cg_endo -68.07 -30.48 31.92 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 122.68 2.253 . . . . 0.0 112.595 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.25 -128.8 9.02 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.9 m -124.59 164.31 20.09 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 59.71 53.77 4.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.466 0.65 . . . . 0.0 111.323 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.37 117.33 29.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.41 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.0 169.44 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.36 116.0 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.108 0.48 . . . . 0.0 111.106 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.632 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -109.22 178.3 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.302 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.7 p -126.96 -166.8 1.64 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.27 -176.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -51.6 -46.69 63.65 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.99 -50.78 67.17 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.481 -0.762 . . . . 0.0 111.441 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 25.2 mm-40 -63.57 -17.04 62.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.39 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.68 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -76.07 -32.68 59.4 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.462 -175.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.53 -77.22 0.06 Allowed 'General case' 0 C--O 1.25 1.114 0 CA-C-O 122.097 0.951 . . . . 0.0 111.609 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.459 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -63.89 -47.58 80.09 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.741 -173.332 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -66.63 -38.71 87.47 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.185 -177.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.928 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 41.2 tt0 -66.3 -39.95 89.69 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.479 -176.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.55 ' HA ' ' OD1' ' A' ' 44' ' ' ASN . 69.1 mttm -57.85 -63.3 1.29 Allowed 'General case' 0 C--O 1.25 1.096 0 C-N-CA 119.731 -0.787 . . . . 0.0 110.957 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.486 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -62.77 -43.14 99.58 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.425 0.631 . . . . 0.0 110.897 -174.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.687 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -81.76 -16.79 49.93 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -171.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.71 -38.71 62.26 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 119.716 -0.794 . . . . 0.0 108.882 171.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.1 -38.69 80.15 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.06 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.15 -38.16 25.11 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -56.94 -53.79 53.97 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.946 0.403 . . . . 0.0 111.786 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.54 27.72 11.59 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.16 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -78.62 92.19 4.7 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.488 -0.189 . . . . 0.0 110.488 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 65.06 21.45 12.24 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.413 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.31 -20.62 51.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.378 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.542 179.803 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 121.012 0.434 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -138.83 162.97 33.47 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 169.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.89 149.84 45.29 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.56 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 52.1 tptt -139.06 148.51 43.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.469 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.736 HG23 ' HA ' ' A' ' 26' ' ' ILE . 5.2 p -80.13 146.23 7.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.5 38.81 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -172.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -138.56 -179.15 5.64 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.712 -1.244 . . . . 0.0 108.392 -176.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.652 ' CD2' HD22 ' A' ' 42' ' ' LEU . 87.9 m-85 -137.54 171.87 13.82 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.394 -172.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.737 HD21 ' HB3' ' A' ' 52' ' ' PRO . 9.2 tt -138.53 137.16 36.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.157 -169.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 93.3 t -139.22 161.29 28.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.992 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.917 HG22 ' HB2' ' A' ' 21' ' ' GLN . 26.7 m -138.68 163.71 27.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 12' ' ' LYS . 1.5 mppt? -134.53 159.01 42.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.976 0.417 . . . . 0.0 110.789 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.429 ' H ' ' CB ' ' A' ' 17' ' ' GLU . . . -91.17 161.26 27.67 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 172.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -74.42 -13.32 60.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.257 0.551 . . . . 0.0 110.676 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.7 p -80.41 8.97 6.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.843 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.3 m 74.46 84.83 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.978 0.894 . . . . 0.0 111.117 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' CB ' ' H ' ' A' ' 13' ' ' GLY . 4.8 tp10 -103.19 156.22 17.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.619 -1.173 . . . . 0.0 107.863 173.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -90.58 -70.65 0.66 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.723 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 52.9 m-70 -142.79 92.94 2.45 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.0 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.44 152.99 35.94 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.957 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 2.2 mp0 57.73 97.64 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.385 0.428 . . . . 0.0 110.261 -170.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.69 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 82.8 t60 -138.75 127.31 23.23 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.832 0.825 . . . . 0.0 112.53 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -139.42 -178.7 5.5 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.308 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.608 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 28.6 tt0 -136.99 111.69 8.75 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.529 ' CG2' HG22 ' A' ' 28' ' ' VAL . 9.7 mt -81.14 103.06 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.402 -167.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.736 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.9 pp -107.88 -7.56 10.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.114 176.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.926 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 3.0 tp10 -139.21 136.2 34.76 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.382 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.529 HG22 ' CG2' ' A' ' 25' ' ' ILE . 46.8 t -137.99 99.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -168.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -105.26 84.03 2.05 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.6 m -151.61 109.64 3.71 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.605 -175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.81 -16.81 24.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.41 -45.28 9.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.528 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.88 40.11 3.41 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 -169.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.663 ' HB3' ' HD2' ' A' ' 35' ' ' PRO . 62.4 m -152.18 167.59 12.93 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 34' ' ' SER . 12.5 Cg_endo -56.13 159.57 12.23 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.013 2.475 . . . . 0.0 112.68 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.557 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 84.3 Cg_endo -82.4 179.59 26.36 Favored 'Cis proline' 0 C--N 1.347 0.451 0 C-N-CA 123.153 -1.603 . . . . 0.0 113.263 1.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -138.76 174.86 10.08 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.926 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 84.2 t -137.6 122.32 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.64 176.19 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 CA-C-N 113.378 -1.737 . . . . 0.0 110.498 -149.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.608 ' HD3' ' OE2' ' A' ' 24' ' ' GLU . 35.6 ttt180 -138.54 124.04 19.53 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -174.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.445 ' HZ3' ' O ' ' A' ' 22' ' ' HIS . 8.9 m95 -65.16 102.98 0.7 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 166.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.652 HD22 ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -59.85 -89.58 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.902 -1.499 . . . . 0.0 113.845 -154.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.682 HG23 ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -60.41 -26.27 36.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -176.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -60.54 -57.2 13.74 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 172.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.33 51.41 0.72 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.64 -0.79 . . . . 0.0 114.152 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -139.21 170.37 16.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.062 0.431 . . . . 0.0 109.888 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 7.9 mp0 -138.21 134.73 34.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.515 0.674 . . . . 0.0 111.002 -175.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.493 ' CG2' HG12 ' A' ' 39' ' ' VAL . 10.0 t -139.36 -178.97 5.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.087 -172.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.504 HG23 HG22 ' A' ' 38' ' ' VAL . 44.7 m -138.21 113.71 9.6 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.87 -179.82 2.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-O 121.672 0.749 . . . . 0.0 112.954 -161.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 2.0 m-85 -138.86 116.7 9.01 Favored Pre-proline 0 N--CA 1.455 -0.223 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.674 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.737 ' HB3' HD21 ' A' ' 9' ' ' LEU . 28.5 Cg_endo -64.38 -65.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.474 0.353 0 C-N-CA 122.564 2.176 . . . . 0.0 113.55 -176.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 138.05 -146.82 18.72 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.285 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.0 m -81.14 151.42 28.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 0.0 111.248 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 t70 48.74 64.81 1.55 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.813 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.887 ' HA ' HG12 ' A' ' 11' ' ' VAL . . . -79.46 133.61 36.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.817 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 58' ' ' VAL . 2.3 t -138.75 -179.83 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.751 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -138.18 152.37 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.983 -177.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.582 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.77 179.75 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.018 -172.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.2 p -120.21 -165.44 1.19 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.302 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.451 ' O ' ' ND1' ' A' ' 64' ' ' HIS . . . -56.9 -48.2 78.76 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -59.96 4.34 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.102 -0.999 . . . . 0.0 111.827 -175.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -57.27 -21.27 33.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.021 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.586 ' HA ' ' NE2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -57.35 -44.12 84.07 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.263 -176.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.587 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . -57.62 -70.33 0.14 Allowed 'General case' 0 C--O 1.251 1.145 0 CA-C-O 122.337 1.065 . . . . 0.0 113.051 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -57.01 -55.01 40.23 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.553 -176.021 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.637 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.41 -29.07 63.81 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.909 176.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.682 ' HG2' HG23 ' A' ' 43' ' ' VAL . 3.2 tp10 -56.87 -58.74 6.81 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.76 -72.63 0.08 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.825 -178.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.594 ' HG3' ' H ' ' A' ' 71' ' ' ALA . 31.9 ptt180 -57.46 -67.68 0.3 Allowed 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.743 0.783 . . . . 0.0 112.281 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 67' ' ' ALA . . . -57.38 -47.79 80.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.074 -0.966 . . . . 0.0 113.584 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -57.38 -46.11 83.75 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.089 0.859 . . . . 0.0 111.177 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 77' ' ' HIS . . . -56.97 -29.64 63.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.04 0.448 . . . . 0.0 111.322 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -81.59 -50.07 9.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.994 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.957 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -54.63 -66.53 0.39 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.661 0.784 . . . . 0.0 112.004 -176.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.09 59.12 0.37 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.796 -1.193 . . . . 0.0 112.196 -172.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.482 ' HB3' ' O ' ' A' ' 73' ' ' ALA . 42.6 p-80 -83.54 -27.13 29.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.047 0.451 . . . . 0.0 110.616 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.05 103.8 4.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.484 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.92 81.61 1.77 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.074 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.402 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -138.8 123.05 18.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.564 0.221 . . . . 0.0 110.489 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.06 120.18 14.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.726 ' HA ' HG21 ' A' ' 28' ' ' VAL . 98.6 mttt -138.88 176.31 8.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 112.144 -173.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.805 HG23 ' HA ' ' A' ' 26' ' ' ILE . 8.5 p -71.1 156.78 6.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.514 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.28 12.52 82.08 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.13 -178.79 5.5 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 113.754 -1.223 . . . . 0.0 107.836 -172.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.815 ' HB2' HG23 ' A' ' 59' ' ' VAL . 67.6 m-85 -137.39 174.03 11.04 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.535 -174.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.764 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 4.4 tt -138.14 153.11 49.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.23 -164.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.071 HG11 ' HB2' ' A' ' 19' ' ' HIS . 38.3 t -138.89 151.72 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 125.106 1.504 . . . . 0.0 109.614 -169.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.777 HG12 ' HB2' ' A' ' 21' ' ' GLN . 9.8 p -127.57 165.54 26.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -70.98 112.93 7.52 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.837 0.351 . . . . 0.0 110.121 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.03 -51.13 60.41 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.7 t -132.28 -26.48 1.88 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.772 0.796 . . . . 0.0 108.92 171.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 16' ' ' THR . 9.2 m -157.15 172.69 18.2 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 175.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 15' ' ' THR . 9.4 m -60.43 -25.66 66.13 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.475 0.655 . . . . 0.0 109.606 173.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -63.59 115.42 4.69 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.377 172.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 71.21 99.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 124.05 0.844 . . . . 0.0 110.114 -173.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 1.071 ' HB2' HG11 ' A' ' 10' ' ' VAL . 8.5 p-80 -86.44 125.57 33.79 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.737 -175.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -133.41 171.79 13.59 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -173.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 1.025 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 2.0 mp0 65.11 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.922 0.489 . . . . 0.0 110.94 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.764 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 1.2 m-70 -128.03 147.4 50.51 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 122.151 -0.343 . . . . 0.0 111.143 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.619 ' HA ' ' HE1' ' A' ' 64' ' ' HIS . . . -157.87 175.12 14.27 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.702 ' HA ' ' HD1' ' A' ' 8' ' ' TYR . 40.1 tt0 -98.63 130.85 45.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.769 0.795 . . . . 0.0 112.664 -172.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' ' 9' ' ' LEU . 49.4 mt -90.66 108.01 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.66 171.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.805 ' HA ' HG23 ' A' ' 5' ' ' VAL . 1.3 pp -108.01 -28.5 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.921 177.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.99 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 45.2 mt-10 -124.02 117.21 24.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.23 0.538 . . . . 0.0 110.123 175.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' A' ' 4' ' ' LYS . 79.5 t -98.87 116.18 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.854 -176.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 29' ' ' ARG . 14.8 mmm180 -88.18 -13.96 39.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.895 0.379 . . . . 0.0 111.342 -174.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.455 ' HB3' ' H ' ' A' ' 34' ' ' SER . 23.0 t -129.71 104.08 7.21 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.75 -35.13 55.75 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.738 0.649 . . . . 0.0 112.656 -174.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.45 -58.56 3.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 110.203 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.45 83.37 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.699 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.455 ' H ' ' HB3' ' A' ' 30' ' ' SER . 50.0 m -154.58 148.5 18.93 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 175.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 16.8 Cg_exo -68.36 160.3 49.65 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.768 2.312 . . . . 0.0 111.822 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -88.56 179.53 16.92 Favored 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.745 -1.356 . . . . 0.0 112.648 0.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -131.75 158.59 40.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.912 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.99 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 59.8 t -98.78 116.38 41.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.28 133.19 58.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.31 -162.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.545 ' HG2' HG12 ' A' ' 26' ' ' ILE . 6.5 ptp180 -112.0 142.84 43.92 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.533 176.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.608 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 23.6 m95 -90.56 111.02 22.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.46 HD21 ' HG3' ' A' ' 40' ' ' ARG . 7.2 mt -82.67 -58.44 2.9 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.198 0.523 . . . . 0.0 111.47 -169.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.931 HG21 ' HA ' ' A' ' 65' ' ' ALA . 1.3 m -80.58 -5.54 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.611 -170.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -100.04 -47.24 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.138 167.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.9 79.07 1.14 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.911 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.608 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -163.77 164.48 23.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.642 0.258 . . . . 0.0 110.911 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.478 ' OE2' ' HB3' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -134.79 121.01 20.09 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.0 p -143.09 -179.92 6.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.581 0.705 . . . . 0.0 111.861 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.2 m -123.75 110.09 14.5 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 168.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.13 139.16 25.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-O 121.526 0.679 . . . . 0.0 112.251 -166.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -105.5 99.61 21.98 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.884 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.461 ' HG3' HD11 ' A' ' 9' ' ' LEU . 90.9 Cg_endo -83.66 163.13 14.37 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.263 1.975 . . . . 0.0 111.63 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.61 171.42 53.99 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.684 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 17.2 m -61.26 145.91 49.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.505 0.193 . . . . 0.0 111.267 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 54' ' ' SER . 6.3 m-20 72.98 63.22 0.1 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.979 0.799 . . . . 0.0 110.643 -174.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -86.94 124.44 33.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.926 175.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 10' ' ' VAL . 6.6 t -99.05 157.78 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -108.34 123.83 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.664 178.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -121.91 172.52 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-O 121.056 0.455 . . . . 0.0 111.278 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.554 ' CG2' ' H ' ' A' ' 61' ' ' ALA . 1.3 m -111.57 -173.92 2.35 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.614 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -52.51 -45.87 66.43 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -166.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.85 -61.0 2.44 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -58.28 -26.92 63.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.901 0.858 . . . . 0.0 109.699 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.619 ' HE1' ' HA ' ' A' ' 23' ' ' ALA . 47.4 t60 -64.1 -37.19 86.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.657 -1.156 . . . . 0.0 113.182 -175.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.931 ' HA ' HG21 ' A' ' 43' ' ' VAL . . . -64.09 -69.29 0.29 Allowed 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.726 0.774 . . . . 0.0 113.046 -169.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.47 -39.89 89.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.132 -175.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.13 -16.8 61.44 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.837 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 22' ' ' HIS . 20.0 tt0 -72.56 -46.16 55.75 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.054 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -61.99 -40.39 95.45 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.653 176.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -64.41 -22.43 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.18 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 1.025 ' HA ' ' HG3' ' A' ' 21' ' ' GLN . . . -82.26 -42.92 18.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.718 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.46 -21.33 65.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.86 -64.3 0.99 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.584 172.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HD2' ' OE1' ' A' ' 21' ' ' GLN . 62.8 mtt180 -81.84 -64.26 1.22 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -175.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.59 -52.68 62.44 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.953 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.86 33.91 2.13 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.973 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -123.28 -21.81 5.27 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.53 0.205 . . . . 0.0 111.215 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -152.18 -171.01 3.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.577 0.227 . . . . 0.0 110.971 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -143.14 111.16 6.04 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.76 -175.667 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.619 ' CD2' ' HA ' ' A' ' 32' ' ' ASP . 15.9 m170 -131.95 132.7 43.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.941 0.4 . . . . 0.0 110.629 175.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.16 124.07 43.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.556 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -125.01 158.26 34.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.672 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.828 HG23 ' HA ' ' A' ' 26' ' ' ILE . 4.3 p -75.39 144.62 11.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.296 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.36 11.99 74.07 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.629 ' OD2' ' HB ' ' A' ' 58' ' ' VAL . 6.5 t70 -132.73 149.29 52.3 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.557 ' CE2' ' HA ' ' A' ' 61' ' ' ALA . 95.3 m-85 -98.79 155.22 17.47 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.386 0.612 . . . . 0.0 111.314 -168.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.664 HD11 ' HG3' ' A' ' 52' ' ' PRO . 10.2 tt -98.69 136.27 38.99 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.918 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 1.1 p -132.69 167.54 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 170.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.636 HG13 ' HB2' ' A' ' 12' ' ' LYS . 2.6 p -141.91 168.03 15.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.219 171.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.636 ' HB2' HG13 ' A' ' 11' ' ' VAL . 18.4 ttmt 69.34 13.92 8.49 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.515 0.51 . . . . 0.0 112.322 165.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.55 48.15 3.98 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.656 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 m -89.74 -31.08 17.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.733 -0.233 . . . . 0.0 111.487 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.7 t -124.75 130.97 53.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.813 0.34 . . . . 0.0 111.635 -172.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 17' ' ' GLU . 7.3 m 58.77 -92.28 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.67 177.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.417 ' H ' ' HB ' ' A' ' 16' ' ' THR . 0.6 OUTLIER -167.69 90.14 0.32 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -129.09 94.12 3.74 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.872 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.904 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 16.4 p-80 -79.32 89.92 4.96 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.289 0.566 . . . . 0.0 110.344 175.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD2' ' HG3' ' A' ' 21' ' ' GLN . 4.3 t70 -85.55 -138.38 0.07 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.468 -176.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.666 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 24.8 mt-30 -41.13 120.01 1.28 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.371 0.668 . . . . 0.0 112.581 -160.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.74 ' CD2' ' HA ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -128.35 144.34 51.12 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -165.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -179.17 -179.75 0.59 Allowed 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.279 0.987 . . . . 0.0 110.2 173.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.517 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 5.0 tp10 -98.28 128.73 44.86 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.581 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.506 ' CG2' HG22 ' A' ' 28' ' ' VAL . 14.0 mt -93.15 101.16 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.828 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -103.06 -23.33 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.297 178.183 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.828 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 38.7 mt-10 -129.59 103.35 6.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.017 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.506 HG22 ' CG2' ' A' ' 25' ' ' ILE . 46.3 t -98.98 110.66 26.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.146 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.87 -46.19 66.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.304 0.573 . . . . 0.0 110.052 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.3 m -125.29 112.73 16.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.907 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.28 66.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -173.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.619 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 18.0 t70 -78.16 -65.24 1.0 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.234 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 167.24 73.96 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.474 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.0 m -151.26 126.5 4.79 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.706 0.289 . . . . 0.0 110.242 177.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.59 166.87 20.59 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.191 2.594 . . . . 0.0 111.434 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.08 152.35 88.42 Favored 'Cis proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.783 -1.34 . . . . 0.0 112.974 3.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -106.17 137.84 43.39 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.828 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 61.0 t -98.64 107.53 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -118.07 151.23 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.086 -165.587 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -126.74 128.21 46.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.377 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.601 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 11.4 m95 -76.03 106.59 7.71 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.89 -55.44 4.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.196 0.522 . . . . 0.0 110.517 -174.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 43' ' ' VAL . 2.3 m -81.71 -4.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.719 -176.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 39.4 m-80 -97.88 -71.52 0.68 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.232 165.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.71 73.85 0.14 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.349 -0.929 . . . . 0.0 114.569 171.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.94 169.0 1.61 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.242 0.521 . . . . 0.0 110.882 169.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -120.14 145.63 46.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.33 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.6 t -172.33 -179.86 2.38 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 121.668 0.747 . . . . 0.0 112.246 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.8 m -115.14 121.89 44.4 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.23 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 39' ' ' VAL . 35.8 m -118.88 159.08 19.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 CA-C-O 121.571 0.7 . . . . 0.0 112.851 -170.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -125.07 99.9 33.9 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.892 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.664 ' HG3' HD11 ' A' ' 9' ' ' LEU . 73.3 Cg_endo -77.16 -24.48 9.5 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.358 2.039 . . . . 0.0 112.76 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.19 -163.59 15.83 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.935 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.1 p -86.09 166.14 16.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.464 0.132 . . . . 0.0 110.772 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 62.52 42.02 9.09 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.406 0.622 . . . . 0.0 110.689 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.25 135.04 33.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.67 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.506 ' HB ' ' CG1' ' A' ' 10' ' ' VAL . 10.4 t -124.09 158.73 30.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.629 ' HB ' ' OD2' ' A' ' 7' ' ' ASP . 1.6 m -102.87 125.3 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.139 0.495 . . . . 0.0 111.409 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.566 HG21 ' NE2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -118.77 175.24 3.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.252 -175.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -111.94 -168.85 1.37 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.025 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 8' ' ' TYR . . . -60.56 -47.63 85.35 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -70.41 -36.76 74.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.834 0.35 . . . . 0.0 111.488 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.34 -16.28 62.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.585 0.707 . . . . 0.0 109.471 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.74 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 2.7 t-80 -82.89 -44.77 15.02 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.19 -68.68 0.23 Allowed 'General case' 0 C--O 1.247 0.973 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -164.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.467 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -60.81 -36.8 79.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.144 -175.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.904 ' HB2' ' HD2' ' A' ' 19' ' ' HIS . . . -74.46 -22.06 59.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.741 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.606 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 13.8 tt0 -79.67 -34.59 40.19 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.833 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -56.04 -65.44 0.6 Allowed 'General case' 0 C--O 1.244 0.807 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.412 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -59.63 -65.56 0.65 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.171 0.986 . . . . 0.0 111.824 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -78.22 -16.93 57.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.449 -165.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -82.26 -35.37 28.17 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.811 173.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.62 -34.35 69.2 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.136 0.494 . . . . 0.0 110.154 171.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -81.81 -40.97 21.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.868 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.5 -57.52 12.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.13 0.572 . . . . 0.0 111.872 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.17 44.59 3.39 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.305 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -83.44 -32.28 26.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.01 95.53 3.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.886 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.9 98.62 5.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.576 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 64.2 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.089 -175.728 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.539 ' SD ' ' HA3' ' A' ' 33' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.482 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 47.3 t-80 -133.79 125.19 27.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 175.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.79 166.83 11.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.79 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.02 160.07 35.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.74 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.85 HG23 ' HA ' ' A' ' 26' ' ' ILE . 2.1 p -83.03 146.03 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.14 0.495 . . . . 0.0 111.398 -175.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.33 6.33 58.79 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.12 168.29 18.24 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.712 ' HB2' HG23 ' A' ' 59' ' ' VAL . 97.1 m-85 -103.14 157.38 17.04 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.448 0.642 . . . . 0.0 111.537 -171.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.4 tt -98.91 138.31 36.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.544 175.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 0.5 OUTLIER -136.94 164.89 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.459 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.913 ' HB ' ' HB3' ' A' ' 20' ' ' ASP . 69.8 t -117.27 146.87 21.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 171.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 79.6 tttt -72.71 101.76 3.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.875 0.369 . . . . 0.0 110.204 174.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.42 146.61 23.76 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.642 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 m -72.83 -59.8 2.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.149 0.499 . . . . 0.0 110.264 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 p -131.64 42.9 3.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.533 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.1 p -90.43 4.53 50.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.117 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 70.12 -69.19 0.18 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.612 0.765 . . . . 0.0 111.87 178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -91.82 -83.0 0.3 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.444 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.559 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . 52.9 m80 -146.5 160.71 41.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -175.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.913 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 3.2 t70 -102.47 -154.46 0.49 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.773 ' HA ' ' HB1' ' A' ' 71' ' ' ALA . 68.0 mt-30 -41.15 131.62 2.62 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.706 0.802 . . . . 0.0 112.235 -168.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.807 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 49.8 t-80 -145.68 142.48 29.05 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -165.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.521 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -172.62 177.96 2.81 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.801 0.84 . . . . 0.0 109.858 173.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.684 ' HG3' HD11 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -98.6 126.6 44.24 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.6 0.238 . . . . 0.0 110.853 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 9' ' ' LEU . 14.4 mt -94.95 106.5 18.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 -176.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.85 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -102.0 -27.7 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.727 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.984 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 69.1 mm-40 -119.64 101.68 8.09 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.118 0.485 . . . . 0.0 110.633 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -98.93 102.5 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.081 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -89.36 -1.37 58.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.489 0.661 . . . . 0.0 109.765 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.81 ' HB3' ' H ' ' A' ' 34' ' ' SER . 1.4 m -80.59 124.36 28.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.857 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.61 -41.32 98.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.299 0.571 . . . . 0.0 109.99 175.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 52.2 m-20 -114.66 -68.59 0.91 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.472 173.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.539 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . -174.47 54.6 0.14 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.327 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.81 ' H ' ' HB3' ' A' ' 30' ' ' SER . 5.0 p -106.52 143.72 27.57 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 122.245 0.218 . . . . 0.0 111.165 -178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 12.9 Cg_exo -70.17 157.24 60.21 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.798 2.332 . . . . 0.0 111.611 175.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -87.46 174.34 29.17 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.45 -1.479 . . . . 0.0 112.937 -1.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -123.21 149.92 44.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.984 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 98.9 t -98.68 108.77 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 172.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.77 165.37 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.922 -162.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.549 ' HG3' HD21 ' A' ' 42' ' ' LEU . 9.9 ptp180 -142.36 133.07 25.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.958 0.408 . . . . 0.0 111.001 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.554 ' HB2' ' HB2' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -82.28 106.32 14.07 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.684 HD11 ' HG3' ' A' ' 24' ' ' GLU . 18.6 mt -77.51 -50.8 11.86 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.075 0.464 . . . . 0.0 110.977 -171.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.472 HG22 ' OE2' ' A' ' 68' ' ' GLU . 2.4 m -79.69 -6.02 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.167 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 41' ' ' TRP . 48.2 m-80 -100.03 -51.18 3.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.754 174.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.7 70.45 0.68 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.2 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.489 ' CB ' ' HD1' ' A' ' 41' ' ' TRP . 0.4 OUTLIER -174.49 161.39 3.31 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.802 0.441 . . . . 0.0 110.264 176.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.71 139.98 46.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 t -173.67 171.06 3.9 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.671 0.748 . . . . 0.0 112.359 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.7 m -98.87 111.39 23.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.943 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -107.92 156.75 8.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.502 0.667 . . . . 0.0 112.594 -169.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -120.14 104.69 43.32 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.032 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.459 ' HA ' ' OE1' ' A' ' 21' ' ' GLN . 72.1 Cg_endo -75.05 -5.22 16.5 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.829 2.353 . . . . 0.0 112.13 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.63 -78.76 1.96 Allowed Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.997 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.8 p -160.75 166.99 27.76 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.491 -0.189 . . . . 0.0 110.491 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.678 ' HB3' ' HB3' ' A' ' 12' ' ' LYS . 71.9 m-20 66.69 38.25 4.01 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.604 0.565 . . . . 0.0 111.9 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -77.63 132.4 38.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.155 0.503 . . . . 0.0 111.312 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.621 ' HB ' HG12 ' A' ' 10' ' ' VAL . 10.8 t -126.33 159.3 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.443 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.6 t -98.96 117.67 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.888 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.712 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -111.76 173.17 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.54 -178.34 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -122.67 -164.93 1.23 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.654 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -58.24 -44.95 88.53 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.35 -33.64 37.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.351 0.596 . . . . 0.0 110.96 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 12.5 mm-40 -63.4 -16.38 60.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.743 172.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.734 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.9 OUTLIER -81.8 -50.6 9.04 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -172.169 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.68 -70.5 0.1 Allowed 'General case' 0 C--O 1.247 0.964 0 CA-C-O 121.569 0.7 . . . . 0.0 112.613 -165.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -49.4 77.59 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.376 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' A' ' 19' ' ' HIS . . . -64.88 -38.32 90.57 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.626 -175.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.807 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 25.5 tt0 -69.62 -41.6 75.45 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.057 -174.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HA ' HD21 ' A' ' 44' ' ' ASN . 33.9 mtpt -58.49 -57.49 12.73 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.674 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -63.62 -45.93 88.06 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.725 0.774 . . . . 0.0 111.157 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.773 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -81.45 -16.42 52.07 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.03 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.98 -39.72 61.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -63.35 -25.74 68.44 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.671 174.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -82.2 -56.54 3.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.972 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.6 -62.17 1.86 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.666 0.787 . . . . 0.0 112.413 -174.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.28 30.21 4.51 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.235 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.53 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 45.9 t-80 -112.12 -29.53 7.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.14 -13.11 19.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.684 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.14 103.09 7.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.407 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.247 0.953 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.3 178.951 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.421 ' SD ' ' HA3' ' A' ' 33' ' ' GLY . 1.1 tmt? . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.766 0.317 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -139.05 135.74 34.52 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 173.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.2 152.4 19.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.74 0.305 . . . . 0.0 110.921 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 7' ' ' ASP . 12.6 tmtt? -139.9 129.44 24.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.415 ' O ' ' HD3' ' A' ' 4' ' ' LYS . 7.4 p -80.24 141.2 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.024 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.04 6.86 71.14 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.421 ' CG ' ' HD2' ' A' ' 4' ' ' LYS . 1.1 m-20 -123.09 173.43 7.86 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.71 ' HB2' HG23 ' A' ' 59' ' ' VAL . 98.3 m-85 -107.92 152.9 23.81 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.37 0.605 . . . . 0.0 111.881 -173.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.806 HD11 ' HG3' ' A' ' 52' ' ' PRO . 6.8 tt -103.02 141.79 35.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.332 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 3.4 t -145.81 144.3 21.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 O-C-N 124.71 1.256 . . . . 0.0 109.707 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 21' ' ' GLN . 21.1 m -100.51 149.21 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.194 0.521 . . . . 0.0 109.952 170.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -122.11 1.11 9.73 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.456 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.08 -28.75 73.92 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.209 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -78.5 80.52 4.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.2 m -65.11 -27.95 69.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.197 -171.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.8 t -70.11 -17.93 63.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.04 0.448 . . . . 0.0 111.15 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -102.09 176.83 5.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.187 0.518 . . . . 0.0 111.88 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.453 ' H ' ' HD2' ' A' ' 18' ' ' ARG . 6.4 mpt_? -79.17 -65.24 1.02 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.204 177.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.553 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -152.46 112.94 4.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.275 175.208 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -100.16 173.39 6.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.66 -169.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.576 ' N ' ' HB1' ' A' ' 71' ' ' ALA . 68.5 mt-30 38.19 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.767 1.227 . . . . 0.0 112.954 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.733 ' CE1' ' HA ' ' A' ' 64' ' ' HIS . 41.3 t-80 -133.37 139.9 47.06 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -169.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . . . -168.02 -179.95 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.627 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.602 ' CD ' HD11 ' A' ' 42' ' ' LEU . 45.7 tt0 -98.58 129.57 45.12 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.036 0.446 . . . . 0.0 111.12 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.695 HD11 ' HB2' ' A' ' 9' ' ' LEU . 45.7 mt -92.01 105.54 16.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.765 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.682 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -102.47 -26.32 3.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.817 177.361 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 37.0 tt0 -129.69 119.83 24.16 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.405 0.621 . . . . 0.0 110.364 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.21 121.44 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.205 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -64.36 -33.58 76.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.98 0.419 . . . . 0.0 110.599 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.9 t -149.76 128.17 12.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.52 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.92 -23.06 67.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 0.0 111.006 -176.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.38 -17.63 64.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.411 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 105.38 5.49 39.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.336 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 6.6 m -67.54 122.53 83.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.572 0.225 . . . . 0.0 110.999 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 15.9 Cg_exo -68.65 165.52 29.14 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.412 2.741 . . . . 0.0 111.924 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 83.2 Cg_endo -80.56 -175.56 16.35 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.982 -1.258 . . . . 0.0 113.085 1.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -123.83 148.41 46.76 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 96.3 t -98.66 101.71 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 173.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.92 145.58 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.659 -163.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.42 ' HG3' ' HG3' ' A' ' 47' ' ' GLU . 55.4 ttt180 -121.22 130.04 53.49 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.054 -176.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 13.0 m95 -79.79 96.24 6.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.602 HD11 ' CD ' ' A' ' 24' ' ' GLU . 20.1 mt -72.85 -61.28 1.87 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.352 0.596 . . . . 0.0 110.834 -173.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.462 HG22 ' OE2' ' A' ' 68' ' ' GLU . 2.0 m -73.93 -5.83 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.333 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 54.9 m-80 -98.61 -62.73 1.2 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.903 173.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.9 63.58 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.526 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -167.38 155.22 9.11 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.14 0.495 . . . . 0.0 111.794 173.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HG3' ' HG3' ' A' ' 40' ' ' ARG . 3.7 mp0 -111.77 141.91 44.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.094 175.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.467 HG23 HG23 ' A' ' 50' ' ' VAL . 8.8 t -165.89 179.84 5.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.583 0.706 . . . . 0.0 112.159 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 m -125.22 106.03 9.58 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.832 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 48' ' ' THR . 70.3 t -109.42 147.43 13.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.32 0.581 . . . . 0.0 111.867 -169.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 62.2 m-85 -107.69 99.77 31.27 Favored Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.325 170.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.806 ' HG3' HD11 ' A' ' 9' ' ' LEU . 84.5 Cg_endo -82.12 -22.8 4.81 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.835 2.357 . . . . 0.0 111.805 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.49 -143.4 14.32 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 m -135.48 16.63 3.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.56 0.68 . . . . 0.0 110.687 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -106.49 16.46 24.62 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.124 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.51 114.68 3.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.986 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.813 HG22 ' H ' ' A' ' 58' ' ' VAL . 10.5 p -98.94 175.96 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.813 ' H ' HG22 ' A' ' 57' ' ' VAL . 46.5 t -119.36 125.1 74.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.291 -172.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.71 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -122.42 175.75 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.534 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -117.45 -167.12 1.27 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.525 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -59.66 -41.17 90.01 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -170.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.92 -46.25 62.8 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.893 -0.504 . . . . 0.0 111.462 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 28.3 mm-40 -62.35 -16.46 54.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.616 0.722 . . . . 0.0 109.947 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.733 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -73.47 -43.78 59.46 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.18 -176.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.58 -72.69 0.09 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.641 0.734 . . . . 0.0 112.295 -168.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.86 ' HA ' ' HE2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -61.84 -45.87 91.93 Favored 'General case' 0 C--O 1.253 1.254 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.42 -174.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.553 ' HB2' ' CD2' ' A' ' 19' ' ' HIS . . . -58.49 -46.22 87.11 Favored 'General case' 0 C--O 1.204 -1.311 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.245 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 15.4 tt0 -65.31 -39.68 92.79 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.906 -171.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.86 ' HE2' ' HA ' ' A' ' 66' ' ' GLU . 57.3 pttt -64.19 -56.61 13.53 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.883 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.447 HH21 ' HA ' ' A' ' 67' ' ' ALA . 59.9 mtm180 -60.91 -44.7 96.81 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.547 1.165 . . . . 0.0 110.752 -177.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -80.47 -16.52 54.13 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.416 -172.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.2 -35.81 66.4 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.059 170.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -29.67 70.04 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.659 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.432 ' HB2' ' HA ' ' A' ' 71' ' ' ALA . 12.7 mmt180 -81.92 -58.13 3.11 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -63.06 -63.48 1.19 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.025 0.53 . . . . 0.0 111.514 -174.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -87.18 41.35 3.09 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.206 -175.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -77.24 -32.44 55.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.355 0.598 . . . . 0.0 109.531 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -147.67 82.98 1.53 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.057 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.32 -45.02 0.41 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.334 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.233 -0.889 . . . . 0.0 109.93 175.996 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tmt? . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 3.6 m-70 -138.93 140.57 38.36 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.48 ' HB1' ' CD1' ' A' ' 25' ' ' ILE . . . -138.34 140.48 39.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 111.471 -163.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.849 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 28.8 mmtp -138.49 140.68 39.29 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.211 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 26' ' ' ILE . 24.7 t -70.23 136.36 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 O-C-N 122.211 -0.306 . . . . 0.0 111.23 176.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.98 17.41 51.5 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.849 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.6 m-20 -138.97 144.17 38.86 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.439 -1.881 . . . . 0.0 108.288 -166.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.821 ' CD1' ' HB2' ' A' ' 24' ' ' GLU . 74.6 m-85 -134.96 141.81 46.34 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -148.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.875 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 1.3 tt -136.71 139.56 42.02 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -152.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.671 HG22 ' CD2' ' A' ' 22' ' ' HIS . 3.9 t -139.14 140.58 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 O-C-N 126.683 2.489 . . . . 0.0 109.371 -167.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.927 HG22 ' HB2' ' A' ' 21' ' ' GLN . 14.6 m -138.67 140.49 39.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.066 0.46 . . . . 0.0 110.604 176.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.4 ' HE3' ' HB ' ' A' ' 16' ' ' THR . 4.2 ttmp? -57.16 105.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.177 175.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.11 61.62 4.66 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.143 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m 64.34 16.63 10.27 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.61 0.719 . . . . 0.0 111.125 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.9 t -160.4 140.55 11.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.478 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.4 ' HB ' ' HE3' ' A' ' 12' ' ' LYS . 8.3 t -100.72 45.93 0.96 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.587 0.708 . . . . 0.0 110.781 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -114.92 -70.42 0.8 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 18' ' ' ARG . 3.2 tpt180 -92.76 108.85 20.3 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.948 178.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.583 ' HB3' HG11 ' A' ' 10' ' ' VAL . 64.7 m80 -63.08 112.86 2.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 171.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.695 ' OD1' ' HB3' ' A' ' 74' ' ' ARG . 2.1 t70 -122.32 -168.35 1.71 Allowed 'General case' 0 C--O 1.217 -0.622 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.562 -161.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.927 ' HB2' HG22 ' A' ' 11' ' ' VAL . 75.3 mt-30 45.03 91.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.674 0.79 . . . . 0.0 111.413 -173.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.875 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.1 t-80 -138.85 116.24 11.21 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 121.255 0.55 . . . . 0.0 112.075 -168.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.571 ' HB2' ' NE1' ' A' ' 41' ' ' TRP . . . -139.65 -178.8 5.57 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.141 -1.391 . . . . 0.0 108.475 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.821 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 3.3 tm-20 -137.28 122.59 19.38 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.24 1.019 . . . . 0.0 110.312 -177.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.867 HG23 HG23 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -80.08 113.96 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 113.459 -1.701 . . . . 0.0 111.004 -174.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.737 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -98.86 -8.71 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.111 169.418 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.738 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -138.97 127.15 22.62 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.498 177.198 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.415 ' CG2' ' HB ' ' A' ' 25' ' ' ILE . 54.7 t -138.03 100.0 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.795 -169.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -103.81 20.35 18.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.163 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.573 ' HB3' ' H ' ' A' ' 34' ' ' SER . 3.6 m -108.88 111.08 22.6 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.434 177.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.06 93.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.31 0.576 . . . . 0.0 110.405 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 2' ' ' HIS . 32.9 t70 -95.33 -56.83 2.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.007 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.1 70.37 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.422 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.573 ' H ' ' HB3' ' A' ' 30' ' ' SER . 20.0 t -150.25 142.6 15.79 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.32 151.56 9.5 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.467 2.778 . . . . 0.0 113.102 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.572 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 79.8 Cg_endo -85.51 -177.2 15.3 Favored 'Cis proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.108 -1.622 . . . . 0.0 113.664 3.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -138.78 173.36 11.65 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.157 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.738 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 72.4 t -137.78 114.47 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.453 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.867 HG23 HG23 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -138.75 165.3 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-N 111.965 -2.38 . . . . 0.0 107.664 -149.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.631 ' HB2' HD12 ' A' ' 26' ' ' ILE . 33.4 ttt180 -138.66 127.52 23.69 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.493 -172.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.61 ' CZ3' HG21 ' A' ' 48' ' ' THR . 3.4 m0 -86.99 83.79 7.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.502 HD12 ' CE1' ' A' ' 8' ' ' TYR . 8.0 mt -60.28 -64.22 1.03 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.986 -166.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.605 HG13 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -60.11 -33.07 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.216 -176.235 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 0.9 OUTLIER -60.53 -65.39 0.69 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.167 0.508 . . . . 0.0 110.792 168.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.33 39.11 0.6 Allowed Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.728 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -139.16 171.31 14.48 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 117.126 0.463 . . . . 0.0 110.457 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' HG3' ' HG3' ' A' ' 40' ' ' ARG . 1.7 mp0 -138.2 127.46 24.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.833 HG23 HG12 ' A' ' 39' ' ' VAL . 10.0 t -139.42 -179.64 6.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -164.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.6 m -138.48 120.55 15.62 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.598 HG22 ' H ' ' A' ' 51' ' ' TYR . 4.9 p -138.81 172.75 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.524 -160.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.598 ' H ' HG22 ' A' ' 50' ' ' VAL . 41.7 m-85 -138.57 100.03 8.44 Favored Pre-proline 0 N--CA 1.455 -0.22 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.281 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.08 163.56 16.46 Favored 'Trans proline' 0 N--CA 1.477 0.548 0 C-N-CA 123.423 2.749 . . . . 0.0 112.668 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 11' ' ' VAL . . . -86.4 -133.82 3.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.097 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.647 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 47.3 t -99.45 160.94 13.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 63.3 47.92 3.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.23 0.538 . . . . 0.0 110.243 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.771 ' HA ' HG12 ' A' ' 11' ' ' VAL . . . -72.89 130.53 40.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.65 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.78 179.97 2.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.04 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.32 136.81 44.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.823 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 11.9 m -138.54 175.38 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 C-N-CA 125.461 1.505 . . . . 0.0 109.262 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.62 -165.48 1.03 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.4 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . -56.77 -47.55 79.87 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -175.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -59.04 5.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.708 0.766 . . . . 0.0 111.433 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 18.3 mt-10 -56.98 -27.97 61.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.397 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.646 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -57.36 -48.49 78.9 Favored 'General case' 0 C--O 1.198 -1.639 0 CA-C-N 114.254 -1.339 . . . . 0.0 114.207 177.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . -56.94 -72.34 0.08 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 119.201 0.91 . . . . 0.0 112.616 -162.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -57.21 -54.85 42.11 Favored 'General case' 0 C--O 1.281 2.722 0 CA-C-O 122.809 1.29 . . . . 0.0 112.61 -176.464 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.89 -50.89 71.14 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.883 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.78 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 24.3 tt0 -57.25 -31.13 65.24 Favored 'General case' 0 C--O 1.202 -1.426 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 96.1 mttt -57.08 -70.98 0.11 Allowed 'General case' 0 C--O 1.26 1.61 0 CA-C-O 121.8 0.81 . . . . 0.0 109.708 172.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 6.8 tpm_? -57.04 -53.22 60.57 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 123.179 1.466 . . . . 0.0 110.818 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.657 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . . . -57.18 -43.8 82.95 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.925 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.08 -37.33 71.73 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 118.487 0.585 . . . . 0.0 110.202 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.606 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . . . -56.82 -64.12 0.98 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.489 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.695 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 9.4 ttp180 -57.73 -46.49 84.37 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.754 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -55.14 -34.87 64.13 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.05 0.54 . . . . 0.0 111.852 -175.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.78 -116.86 0.82 Allowed Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.564 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.606 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 4.2 m-70 48.9 20.27 0.34 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.606 0.762 . . . . 0.0 112.319 -176.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -159.53 17.13 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.678 0.275 . . . . 0.0 111.474 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.86 163.87 22.0 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.187 -179.339 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.559 ' CE1' HG21 ' A' ' 58' ' ' VAL . 2.7 p-80 -139.04 153.08 48.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.878 ' HB3' ' HA2' ' A' ' 33' ' ' GLY . . . -138.91 105.11 5.23 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.628 ' HA ' HG21 ' A' ' 28' ' ' VAL . 50.5 mttp -139.11 165.23 27.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.175 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.958 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.4 p -70.88 151.58 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.363 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.92 14.5 59.26 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 65.4 m-20 -138.65 -179.08 5.61 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.845 ' HB2' HG23 ' A' ' 59' ' ' VAL . 97.6 m-85 -137.45 173.21 11.91 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -174.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.805 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 7.8 tt -138.43 136.34 36.13 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.255 -166.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.499 HG22 ' CD2' ' A' ' 22' ' ' HIS . 59.9 t -139.03 143.52 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 125.917 2.011 . . . . 0.0 108.995 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 52' ' ' PRO . 70.6 t -122.93 129.79 74.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.063 0.459 . . . . 0.0 110.757 177.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -85.86 92.8 8.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.615 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.97 -63.02 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.863 -173.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.474 ' HB ' ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -58.36 137.19 57.4 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -172.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.404 ' OG1' ' HD2' ' A' ' 18' ' ' ARG . 23.2 p 48.58 -99.7 0.06 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.521 0.728 . . . . 0.0 112.898 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -152.96 125.1 8.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.715 0.293 . . . . 0.0 111.2 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 59.95 16.91 6.15 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.019 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.474 ' HD3' ' HB ' ' A' ' 14' ' ' THR . 10.0 ttt180 -84.26 126.59 33.31 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.042 0.449 . . . . 0.0 110.429 -174.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -90.03 87.92 7.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.478 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.568 ' HA ' ' CB ' ' A' ' 71' ' ' ALA . 32.3 m-20 -112.97 -175.23 2.62 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.091 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.961 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 2.2 mp0 52.88 84.88 0.05 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.296 0.373 . . . . 0.0 110.973 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.805 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 6.7 t-80 -134.55 133.91 40.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.875 -174.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -178.42 178.02 0.9 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.341 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.719 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 42.3 tt0 -98.45 131.38 44.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.457 0.646 . . . . 0.0 111.759 -174.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 26.7 mt -86.75 108.91 18.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.338 177.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.958 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -109.51 -28.02 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.517 176.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.874 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 14.7 mt-10 -120.25 111.98 18.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' A' ' 4' ' ' LYS . 47.2 t -98.81 115.36 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.09 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -64.62 -52.48 57.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.199 0.523 . . . . 0.0 110.193 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 43.4 m -117.55 110.42 17.92 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.362 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.433 ' HA ' HG11 ' A' ' 28' ' ' VAL . . . -63.63 -18.64 64.15 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.376 -170.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.16 -38.85 91.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.354 0.597 . . . . 0.0 110.107 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.878 ' HA2' ' HB3' ' A' ' 3' ' ' ALA . . . 129.08 53.42 0.11 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.533 -175.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 9.8 m -134.18 142.03 41.61 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.532 0.206 . . . . 0.0 110.658 -176.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 12.8 Cg_exo -70.85 164.82 34.28 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.962 2.442 . . . . 0.0 111.898 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.549 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 73.1 Cg_endo -76.0 -179.59 27.56 Favored 'Cis proline' 0 C--N 1.347 0.463 0 C-N-CA 123.794 -1.336 . . . . 0.0 112.783 -0.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -131.04 142.72 50.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.216 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.874 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 58.3 t -98.62 103.4 14.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 170.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.09 138.85 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.81 -163.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.915 ' HG3' ' HB3' ' A' ' 47' ' ' GLU . 51.9 ttt180 -103.91 128.88 51.41 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.237 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.771 ' CE3' ' HB1' ' A' ' 72' ' ' ALA . 2.4 m0 -95.59 89.38 5.35 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.576 HD11 ' CD ' ' A' ' 24' ' ' GLU . 14.2 mt -70.48 -60.94 1.97 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.168 -165.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.554 HG13 ' CE1' ' A' ' 64' ' ' HIS . 3.1 m -77.76 -4.52 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.964 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.679 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 50.7 m-80 -93.84 -62.84 1.28 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.172 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.59 -80.09 0.1 Allowed Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.073 -1.06 . . . . 0.0 113.879 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 41' ' ' TRP . 20.7 m-70 -98.9 176.46 5.59 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.888 0.375 . . . . 0.0 111.903 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.915 ' HB3' ' HG3' ' A' ' 40' ' ' ARG . 13.7 pt-20 -120.03 152.06 38.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.387 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -167.06 178.35 5.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.526 0.679 . . . . 0.0 111.168 -176.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.0 m -98.84 118.58 35.92 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.016 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.61 146.08 27.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 111.29 -172.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 75.8 m-85 -109.41 101.37 45.49 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.289 171.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.482 ' HB2' HG21 ' A' ' 11' ' ' VAL . 72.2 Cg_endo -75.29 -10.87 20.92 Favored 'Trans proline' 0 N--CA 1.473 0.306 0 C-N-CA 122.962 2.441 . . . . 0.0 112.605 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.63 -102.52 2.88 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.677 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.9 m -153.31 171.11 19.08 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 62.2 41.06 11.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.309 0.576 . . . . 0.0 110.986 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.4 112.96 15.96 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.719 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.2 t -98.91 152.47 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.559 HG21 ' CE1' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -100.69 113.27 36.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.467 0.651 . . . . 0.0 111.867 -176.037 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.845 HG23 ' HB2' ' A' ' 8' ' ' TYR . 4.1 m -102.23 169.25 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.393 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.7 p -115.84 -163.73 0.91 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.735 -175.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -52.91 -46.89 68.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.23 -48.45 28.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.324 0.583 . . . . 0.0 110.866 -174.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.731 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 25.5 mt-10 -59.47 -16.6 25.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.038 176.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.742 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -75.9 -50.27 15.5 Favored 'General case' 0 C--O 1.205 -1.288 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.595 -177.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.36 -72.0 0.08 Allowed 'General case' 0 C--O 1.247 0.968 0 CA-C-O 121.779 0.799 . . . . 0.0 112.844 -163.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -66.16 -46.89 75.85 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.856 -172.304 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.42 -26.44 66.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.494 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.687 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 27.1 tt0 -73.62 -45.0 55.54 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.678 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 20.6 pttp -60.53 -47.86 84.33 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.438 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.497 ' HG3' ' N ' ' A' ' 71' ' ' ALA . 10.9 ptp85 -68.06 -52.09 39.21 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.702 0.763 . . . . 0.0 111.669 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.568 ' CB ' ' HA ' ' A' ' 20' ' ' ASP . . . -77.98 -17.97 56.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.342 -169.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.771 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -80.48 -37.18 32.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.389 173.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.02 -32.64 61.99 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.739 -0.384 . . . . 0.0 109.979 171.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -81.88 -37.19 27.26 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.684 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.961 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -59.52 -48.48 81.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.555 -172.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.93 -108.25 0.26 Allowed Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.365 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 63.61 -75.26 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 110.923 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -150.6 49.34 0.88 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.13 88.41 0.8 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.326 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--O 1.247 0.971 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.755 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -98.82 114.49 27.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.896 0.379 . . . . 0.0 110.221 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.86 153.95 46.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.162 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.89 173.35 7.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.923 0.392 . . . . 0.0 110.496 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.733 HG23 ' HA ' ' A' ' 26' ' ' ILE . 1.7 p -73.76 136.47 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.933 175.271 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.99 8.33 60.47 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -175.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 68.4 m-20 -107.38 161.72 14.56 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 61' ' ' ALA . 1.2 m-85 -103.52 146.79 28.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.413 0.625 . . . . 0.0 111.764 -176.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' A' ' 52' ' ' PRO . 9.8 tt -99.47 132.75 44.59 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.604 175.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.71 HG13 ' CE1' ' A' ' 22' ' ' HIS . 54.2 t -127.98 147.42 32.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 O-C-N 124.638 1.211 . . . . 0.0 109.29 174.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 52' ' ' PRO . 53.7 t -104.76 101.67 12.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 171.665 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 11.7 tmtt? -66.85 -37.66 84.89 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.762 ' HA3' HG22 ' A' ' 16' ' ' THR . . . 78.57 154.52 7.68 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.848 175.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 m -96.3 -31.75 12.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.912 0.387 . . . . 0.0 110.487 -179.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 m -135.61 3.25 3.01 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -177.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.762 HG22 ' HA3' ' A' ' 13' ' ' GLY . 9.5 t -81.25 -27.78 35.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -173.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.717 ' HG3' ' O ' ' A' ' 16' ' ' THR . 1.0 OUTLIER 64.41 -43.52 0.29 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.123 1.369 . . . . 0.0 111.818 -176.391 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.511 ' HG2' ' OE2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -71.59 104.12 3.21 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 171.099 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -77.02 86.94 3.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -123.1 -162.44 1.03 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.04 -164.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.745 ' N ' ' HB1' ' A' ' 71' ' ' ALA . 22.9 mt-30 58.83 94.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.206 0.602 . . . . 0.0 111.165 -177.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.71 ' CE1' HG13 ' A' ' 10' ' ' VAL . 3.4 m-70 -132.11 145.81 51.63 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.251 -0.281 . . . . 0.0 111.415 -173.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.695 ' HA ' ' HG3' ' A' ' 68' ' ' GLU . . . -179.04 176.09 0.92 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 41.4 tt0 -98.35 145.91 26.23 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.446 0.641 . . . . 0.0 111.201 -174.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.15 113.0 38.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 40' ' ' ARG . 0.2 OUTLIER -105.78 -15.5 8.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.894 0.378 . . . . 0.0 111.039 -178.622 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.966 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 37.7 mt-10 -132.15 103.59 6.34 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.658 0.742 . . . . 0.0 109.544 174.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.04 99.97 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.81 -176.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -104.56 53.57 0.73 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.603 0.716 . . . . 0.0 109.676 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.8 t -152.48 123.11 7.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.53 177.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.52 -26.27 20.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -89.88 -25.07 21.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.764 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.42 72.76 1.04 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.422 177.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 68.9 m -146.03 150.04 40.82 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.7 0.286 . . . . 0.0 110.886 178.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 19.5 Cg_exo -66.87 167.63 19.11 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.279 2.653 . . . . 0.0 112.062 177.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.99 154.66 94.11 Favored 'Cis proline' 0 C--N 1.345 0.366 0 C-N-CA 123.803 -1.332 . . . . 0.0 112.408 1.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -110.92 146.94 35.68 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.025 178.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.966 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 61.7 t -98.69 103.9 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 23' ' ' ALA . 53.2 t -116.19 121.51 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.013 -166.202 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.735 ' HB2' HD12 ' A' ' 26' ' ' ILE . 42.9 ttt180 -101.97 133.28 47.02 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.021 176.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.596 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 5.5 m0 -97.75 113.33 25.08 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' A' ' 24' ' ' GLU . 11.6 mt -75.52 -49.69 17.94 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.884 0.373 . . . . 0.0 111.617 -167.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.74 ' HB ' ' HE2' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -93.96 -15.59 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.271 -176.356 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.596 ' HB2' ' HB3' ' A' ' 41' ' ' TRP . 33.0 m-80 -84.26 -36.23 22.82 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.875 175.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.01 34.73 9.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.654 177.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.487 ' H ' ' HB2' ' A' ' 41' ' ' TRP . 6.9 m170 -123.59 166.81 14.83 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.522 -0.399 . . . . 0.0 110.438 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -141.21 116.33 9.93 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 p -136.23 170.46 15.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.267 0.556 . . . . 0.0 112.254 -167.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.3 m -118.32 100.04 7.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 166.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.0 m -99.58 156.6 3.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-O 121.685 0.755 . . . . 0.0 112.776 -167.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -119.68 99.91 49.32 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.973 168.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HB3' HD21 ' A' ' 9' ' ' LEU . 26.0 Cg_endo -63.7 -51.07 2.64 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.861 2.374 . . . . 0.0 112.868 -174.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.21 -117.02 1.55 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -175.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.3 m -129.64 154.13 47.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 12' ' ' LYS . 15.0 m-20 62.65 58.05 1.69 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.931 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 10' ' ' VAL . . . -86.66 119.44 26.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.205 0.526 . . . . 0.0 110.837 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 t -101.07 159.72 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.472 -178.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 4.1 p -121.14 118.77 57.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.358 0.599 . . . . 0.0 111.326 -178.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.598 HG23 ' CB ' ' A' ' 8' ' ' TYR . 2.4 m -116.64 -179.93 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 123.408 0.683 . . . . 0.0 111.411 -178.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -80.98 166.4 20.86 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.732 174.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.788 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . . . -68.86 -66.54 0.56 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.598 -169.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 p -80.73 -25.06 38.31 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -167.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -53.94 -58.94 5.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.612 0.72 . . . . 0.0 109.578 175.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.47 ' CE1' HG11 ' A' ' 59' ' ' VAL . 11.3 m-70 -82.44 -16.5 48.7 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 43' ' ' VAL . . . -45.39 -39.55 7.04 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -63.08 -44.39 95.88 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-O 123.564 1.65 . . . . 0.0 109.127 177.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.434 ' CB ' ' HD2' ' A' ' 22' ' ' HIS . . . -66.3 -16.59 64.16 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.418 173.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.695 ' HG3' ' HA ' ' A' ' 23' ' ' ALA . 10.3 tt0 -69.82 -40.09 76.12 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 171.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.74 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 66.7 mmtt -51.07 -61.65 2.1 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.123 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -62.26 1.89 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.744 1.259 . . . . 0.0 112.076 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.745 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -78.31 -16.96 57.21 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.197 -165.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.59 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -81.74 -34.54 30.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 118.645 0.657 . . . . 0.0 109.316 173.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.82 -36.14 64.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 170.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -74.7 -55.54 5.76 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.987 174.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -49.08 -56.94 7.53 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.743 0.817 . . . . 0.0 111.967 -176.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.511 ' HA3' ' HH2' ' A' ' 41' ' ' TRP . . . -97.98 46.52 1.59 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.822 -176.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -82.2 -22.06 36.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -167.0 163.7 15.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.641 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.97 -52.16 0.9 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.077 0.465 . . . . 0.0 110.026 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.4 m . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.493 -179.843 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.73 116.17 11.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.901 0.381 . . . . 0.0 110.142 178.194 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.86 140.81 38.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.338 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -139.12 164.24 30.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.959 0.409 . . . . 0.0 111.249 -177.37 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.819 HG23 ' HA ' ' A' ' 26' ' ' ILE . 4.0 p -65.15 145.43 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.939 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.06 17.28 41.08 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -174.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 7.6 m-20 -138.76 -179.06 5.6 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 113.902 -1.149 . . . . 0.0 108.415 -174.31 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.812 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 95.4 m-85 -137.02 164.93 27.2 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.314 -168.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 6.7 tt -138.63 142.2 39.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.769 -166.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.848 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 3.5 t -138.88 -179.99 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.276 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.785 ' H ' HG12 ' A' ' 10' ' ' VAL . 41.2 t -138.18 129.41 37.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 121.648 0.737 . . . . 0.0 109.588 176.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.706 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 52.5 mttm -77.35 -156.91 0.09 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.114 -172.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.46 -89.41 0.18 Allowed Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.747 -177.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 19.1 m 73.47 -37.99 0.39 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.393 0.677 . . . . 0.0 112.227 175.483 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 p -77.72 0.1 24.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.314 0.578 . . . . 0.0 111.161 178.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.1 m -151.86 -76.78 0.13 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -104.52 133.79 48.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 171.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.595 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 55.9 mtt180 -70.52 -76.41 0.1 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -165.031 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -143.2 100.39 3.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 9.4 m-20 -132.85 177.79 7.37 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.691 -174.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.848 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 4.7 mt-30 63.0 98.19 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.857 0.723 . . . . 0.0 110.197 -170.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.984 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 21.3 t-80 -139.05 121.43 16.04 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.354 0.597 . . . . 0.0 111.81 -175.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.654 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -139.77 -178.23 5.33 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 125.222 1.409 . . . . 0.0 110.239 -177.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.812 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 26.6 tt0 -136.75 123.58 21.28 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.478 1.133 . . . . 0.0 109.079 174.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.741 ' HB ' HG22 ' A' ' 28' ' ' VAL . 4.6 pt -82.69 115.42 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.96 -174.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.819 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -108.01 -8.41 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 113.808 -1.542 . . . . 0.0 108.477 170.435 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -138.9 122.22 17.09 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.447 175.437 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.741 HG22 ' HB ' ' A' ' 25' ' ' ILE . 20.8 t -138.49 119.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.877 -165.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 29' ' ' ARG . 5.0 mmp_? -68.87 -35.79 77.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -174.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.8 m -147.68 149.59 32.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.757 -176.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.45 -14.71 59.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.142 0.496 . . . . 0.0 110.694 -179.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.89 -72.75 0.37 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.256 0.55 . . . . 0.0 110.001 176.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.91 88.05 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.527 -177.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -143.47 125.1 8.33 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.36 161.0 38.37 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.729 2.286 . . . . 0.0 111.534 175.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.32 -175.07 15.75 Favored 'Cis proline' 0 C--N 1.342 0.234 0 C-N-CA 123.732 -1.362 . . . . 0.0 113.392 2.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -138.87 169.55 17.6 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.594 178.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 84.2 t -137.96 116.47 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.041 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.505 HG12 HG23 ' A' ' 48' ' ' THR . 0.4 OUTLIER -138.86 174.61 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 112.676 -2.056 . . . . 0.0 109.272 -152.558 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.842 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 62.9 mtt180 -138.67 133.56 32.51 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.733 ' HD1' ' HB2' ' A' ' 46' ' ' HIS . 16.1 m95 -79.53 84.6 5.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 166.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.593 HD11 ' CD ' ' A' ' 24' ' ' GLU . 6.5 mt -60.08 -64.21 1.03 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.2 0.524 . . . . 0.0 111.617 -167.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.706 HG13 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -60.03 -35.5 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.121 -176.623 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 41' ' ' TRP . 35.4 m-80 -60.53 -60.67 3.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.797 171.211 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.07 39.68 0.68 Allowed Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.113 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.733 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 37.5 m80 -139.16 167.11 22.79 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.119 0.459 . . . . 0.0 111.134 178.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.842 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 6.7 pt-20 -138.86 128.79 25.11 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.487 173.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.569 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 8.9 t -139.74 -179.26 5.82 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.758 -163.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.9 m -138.25 116.83 12.13 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 51' ' ' TYR . 1.6 t -138.69 175.95 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.193 0.521 . . . . 0.0 111.304 -162.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.701 ' H ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -138.82 107.27 7.56 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.78 -178.758 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.71 141.33 90.33 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.736 2.291 . . . . 0.0 111.755 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.95 67.0 2.14 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.557 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t 67.22 173.12 0.26 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.944 0.438 . . . . 0.0 110.957 179.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.706 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 8.5 m-20 56.18 38.33 29.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.221 174.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.2 139.8 54.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.328 -176.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.881 HG22 ' H ' ' A' ' 58' ' ' VAL . 5.7 p -138.93 -179.7 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.832 177.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.881 ' H ' HG22 ' A' ' 57' ' ' VAL . 56.1 t -138.45 136.27 43.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.785 -171.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.764 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -138.87 179.92 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 C-N-CA 123.355 0.662 . . . . 0.0 111.284 -174.17 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.9 p -120.55 -172.31 2.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.349 -176.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.02 -48.44 78.48 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -172.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -55.75 30.74 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.565 -0.71 . . . . 0.0 111.437 -178.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -56.98 -29.86 63.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.87 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.706 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.22 -45.32 83.96 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.286 -179.446 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.554 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -56.85 -73.4 0.06 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.912 0.863 . . . . 0.0 111.534 -167.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.523 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -57.08 -61.71 2.27 Favored 'General case' 0 C--O 1.268 2.059 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.671 -177.272 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.15 -50.21 73.54 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.462 -175.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.984 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 29.6 tt0 -57.14 -37.89 72.68 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 118.0 0.364 . . . . 0.0 111.575 -177.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -56.93 -68.12 0.25 Allowed 'General case' 0 C--O 1.253 1.24 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.572 176.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -57.28 -58.23 9.16 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 122.776 1.274 . . . . 0.0 111.675 -177.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.604 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -57.32 -25.23 59.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.321 -178.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.46 -40.95 73.4 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 118.894 0.77 . . . . 0.0 109.827 175.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.51 62.68 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.019 172.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.41 ' HG2' ' HB3' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -74.21 -57.16 4.13 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 176.263 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -51.12 -44.61 61.35 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.556 0.946 . . . . 0.0 113.556 -169.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -87.64 24.86 9.24 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 119.8 -1.191 . . . . 0.0 112.651 -174.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -66.68 -28.6 68.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.744 0.307 . . . . 0.0 111.165 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.0 26.21 9.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.885 0.374 . . . . 0.0 111.095 -175.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.61 75.73 8.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.155 0.502 . . . . 0.0 110.513 178.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.419 -179.689 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.471 ' HG2' ' N ' ' A' ' 2' ' ' HIS . 23.4 ttt . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.471 ' N ' ' HG2' ' A' ' 1' ' ' MET . 42.2 m-70 -138.87 140.21 38.36 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.91 139.66 38.11 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.719 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 91.6 mttt -139.35 140.77 37.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.239 -173.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.787 HG23 ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -71.29 139.63 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 169.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.55 13.82 66.93 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -172.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.719 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 1.8 m-20 -139.11 143.81 38.43 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.109 -2.045 . . . . 0.0 107.655 -167.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.811 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 33.2 m-85 -135.63 142.6 45.24 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -148.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.757 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 2.3 tt -136.69 140.2 42.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 119.334 0.97 . . . . 0.0 110.244 -156.473 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.405 HG23 HG21 ' A' ' 59' ' ' VAL . 42.3 t -138.87 140.75 38.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.211 -168.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.767 HG12 ' H ' ' A' ' 13' ' ' GLY . 72.0 t -138.41 140.16 40.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -176.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -107.4 3.69 25.5 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.002 0.43 . . . . 0.0 110.834 -178.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.767 ' H ' HG12 ' A' ' 11' ' ' VAL . . . -84.23 45.55 3.51 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.239 -174.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 p -113.15 -81.77 0.59 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.858 0.361 . . . . 0.0 110.452 176.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.441 ' HB ' ' OE1' ' A' ' 17' ' ' GLU . 40.6 m -124.34 -78.8 0.6 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.239 177.051 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.8 t -147.23 6.25 0.86 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.537 0.684 . . . . 0.0 110.277 177.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 22.5 mp0 -67.93 105.28 1.95 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.548 176.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -69.31 -11.95 61.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.333 -175.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -135.85 65.82 1.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 14.3 t0 -106.39 179.06 4.38 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -175.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.677 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 51.8 mt-30 39.7 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.699 0.8 . . . . 0.0 112.817 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.757 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 54.7 t60 -138.57 138.98 38.46 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 122.634 1.207 . . . . 0.0 113.397 -176.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.617 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . . . -140.43 -177.87 5.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 112.19 -2.277 . . . . 0.0 110.926 -174.011 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.811 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . 10.7 tt0 -136.69 122.17 19.52 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 123.007 1.384 . . . . 0.0 108.046 166.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 66.0 mt -81.52 107.69 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 111.652 -2.522 . . . . 0.0 110.242 -170.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.787 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -102.38 -14.12 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.629 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 48.9 mm-40 -139.02 150.36 45.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.577 174.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.473 HG22 ' CG2' ' A' ' 25' ' ' ILE . 17.7 t -137.83 100.11 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -170.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -89.23 -29.08 19.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.663 -163.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.9 p -68.94 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.495 -176.378 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -176.95 -64.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.285 0.564 . . . . 0.0 109.954 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -151.05 88.13 1.44 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.905 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.64 172.84 44.11 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.218 -173.054 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m 69.36 156.76 0.15 Allowed Pre-proline 0 N--CA 1.467 0.419 0 CA-C-O 120.953 0.406 . . . . 0.0 111.529 178.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -73.03 163.92 36.94 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.815 2.344 . . . . 0.0 112.331 178.083 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 18.9 Cg_endo -94.61 -178.01 7.35 Favored 'Cis proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.809 -1.329 . . . . 0.0 112.681 -1.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -138.83 174.27 10.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.059 177.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 89.6 t -138.03 114.54 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 174.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 25' ' ' ILE . 0.4 OUTLIER -139.02 175.25 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.818 -153.658 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.803 ' HB2' HD23 ' A' ' 42' ' ' LEU . 84.7 mtt180 -138.51 134.96 34.6 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.745 ' HD1' ' HB3' ' A' ' 46' ' ' HIS . 12.2 m95 -80.1 81.02 6.44 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 166.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.803 HD23 ' HB2' ' A' ' 40' ' ' ARG . 3.7 mt -59.92 -67.8 0.35 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.515 0.509 . . . . 0.0 111.932 -162.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.547 HG22 ' OE2' ' A' ' 68' ' ' GLU . 0.9 OUTLIER -59.96 -31.19 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.974 -175.716 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.627 HD21 ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -60.59 -62.99 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.177 0.513 . . . . 0.0 110.591 169.637 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.05 43.16 0.34 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.811 -0.632 . . . . 0.0 113.576 177.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.745 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 44.6 t-80 -139.35 164.01 30.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 117.527 0.664 . . . . 0.0 111.069 178.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 42.0 tt0 -138.44 122.09 17.45 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.223 0.535 . . . . 0.0 110.023 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.479 HG21 ' CZ2' ' A' ' 41' ' ' TRP . 14.8 t -139.68 -179.0 5.67 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -165.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.418 HG23 HG22 ' A' ' 38' ' ' VAL . 89.8 m -138.15 110.55 7.45 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.73 -179.74 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -160.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.558 ' CE1' ' HB3' ' A' ' 36' ' ' PRO . 2.3 m-85 -138.78 125.64 12.95 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.048 -178.389 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HB2' HG21 ' A' ' 11' ' ' VAL . 56.5 Cg_endo -74.37 -78.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.673 2.249 . . . . 0.0 113.234 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.41 -154.44 23.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.862 -178.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.7 m -87.62 159.1 18.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.569 0.184 . . . . 0.0 110.559 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 t70 65.91 39.85 4.4 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.94 0.876 . . . . 0.0 108.859 -174.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.568 ' HA ' HG22 ' A' ' 11' ' ' VAL . . . -79.9 137.74 36.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.126 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.711 HG12 ' H ' ' A' ' 58' ' ' VAL . 3.4 t -138.71 175.65 7.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -174.143 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.711 ' H ' HG12 ' A' ' 57' ' ' VAL . 58.9 t -138.34 138.33 43.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.613 0.72 . . . . 0.0 110.648 -175.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' A' ' 63' ' ' GLU . 3.1 m -138.62 179.99 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 C-N-CA 125.74 1.616 . . . . 0.0 110.023 -174.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 61' ' ' ALA . 5.9 t -121.85 -159.28 0.81 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.123 -174.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.427 ' N ' HG23 ' A' ' 60' ' ' THR . . . -56.99 -48.23 78.91 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.414 ' H ' HG23 ' A' ' 60' ' ' THR . 0.2 OUTLIER -57.35 -58.59 7.6 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 122.013 -0.429 . . . . 0.0 112.128 -179.697 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.667 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 29.5 mm-40 -57.15 -28.12 62.46 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.677 0.751 . . . . 0.0 110.307 -178.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.74 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.12 -42.52 81.04 Favored 'General case' 0 C--O 1.206 -1.233 0 CA-C-N 114.627 -1.17 . . . . 0.0 113.563 -176.707 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.2 -75.92 0.04 OUTLIER 'General case' 0 C--O 1.244 0.793 0 CA-C-O 122.331 1.062 . . . . 0.0 111.669 -170.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.584 ' HB2' ' NH1' ' A' ' 70' ' ' ARG . 1.2 pt-20 -57.24 -51.59 68.75 Favored 'General case' 0 C--O 1.265 1.915 0 CA-C-N 113.798 -1.547 . . . . 0.0 112.035 -177.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -57.11 -49.82 74.7 Favored 'General case' 0 C--O 1.2 -1.527 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.766 -178.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.74 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 4.4 tt0 -57.0 -35.73 69.57 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 118.019 0.372 . . . . 0.0 111.2 -176.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.627 ' HA ' HD21 ' A' ' 44' ' ' ASN . 93.6 mttt -57.13 -74.46 0.05 Allowed 'General case' 0 C--O 1.254 1.316 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.631 172.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.584 ' NH1' ' HB2' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -57.27 -60.87 2.98 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.908 1.337 . . . . 0.0 111.256 -173.978 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 22' ' ' HIS . . . -57.08 -51.15 70.43 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 112.928 -1.942 . . . . 0.0 113.869 -175.268 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 68' ' ' GLU . . . -57.31 -36.15 70.74 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 118.463 0.574 . . . . 0.0 111.081 -179.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.87 -48.76 77.4 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.835 174.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -57.57 -65.97 0.54 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 175.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -50.29 -37.11 34.63 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.99 0.916 . . . . 0.0 113.378 -166.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -113.34 15.29 22.71 Favored Glycine 0 C--N 1.322 -0.21 0 C-N-CA 118.896 -1.621 . . . . 0.0 113.535 -172.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -99.91 -46.92 5.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.861 0.363 . . . . 0.0 110.52 177.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.87 85.2 3.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.189 -177.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.16 76.86 3.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 178.252 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.713 -0.661 . . . . 0.0 109.742 178.746 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -138.42 105.35 5.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.343 0.592 . . . . 0.0 110.169 175.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.83 166.36 10.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.286 -178.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -134.79 173.87 11.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.869 176.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.762 HG23 ' HA ' ' A' ' 26' ' ' ILE . 7.3 p -80.97 143.68 11.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.039 0.447 . . . . 0.0 110.642 177.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.5 8.97 67.36 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -177.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -108.06 174.43 5.88 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.726 ' CD1' ' HA ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER -104.57 138.13 41.37 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.267 0.556 . . . . 0.0 110.658 179.132 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' HIS . 9.2 tt -99.02 136.84 38.42 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.852 179.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.746 HG22 ' CD2' ' A' ' 22' ' ' HIS . 55.4 t -133.16 160.38 42.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.801 174.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 44.6 t -131.92 131.44 61.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 118.052 0.387 . . . . 0.0 110.575 174.689 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -80.53 68.25 6.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.619 0.723 . . . . 0.0 109.29 176.652 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.15 90.2 0.37 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 175.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 10.2 m -55.3 99.66 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.281 0.562 . . . . 0.0 112.432 -171.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 m -126.99 -76.37 0.58 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.729 176.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 m -86.2 -26.56 25.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.988 0.899 . . . . 0.0 108.839 174.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.692 ' HG3' ' H ' ' A' ' 19' ' ' HIS . 14.1 tp10 -154.01 164.87 37.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.172 -1.376 . . . . 0.0 107.706 -178.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -61.58 -23.87 66.28 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.711 0.767 . . . . 0.0 109.39 175.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.692 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 72.6 m80 -124.79 99.34 6.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.394 177.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -106.39 -164.24 0.99 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.8 mp0 47.36 93.6 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.616 0.572 . . . . 0.0 112.208 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.889 ' HB2' ' HA ' ' A' ' 68' ' ' GLU . 20.8 m170 -125.49 141.52 52.0 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.894 -176.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HA ' ' HG3' ' A' ' 68' ' ' GLU . . . -177.76 -179.85 0.83 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.833 0.708 . . . . 0.0 110.484 173.486 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.435 ' OE1' HD21 ' A' ' 42' ' ' LEU . 36.7 tt0 -98.77 131.61 44.77 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.287 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.529 ' HB ' HG22 ' A' ' 28' ' ' VAL . 3.8 pt -96.81 111.26 26.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.087 0.47 . . . . 0.0 110.839 178.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.762 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -104.2 -21.96 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.688 177.58 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 1.053 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 36.2 tt0 -123.45 99.96 6.58 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.403 0.62 . . . . 0.0 110.102 172.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.867 HG13 ' HE2' ' A' ' 37' ' ' TYR . 34.6 t -112.22 100.54 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.509 -178.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -95.14 11.83 30.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.135 0.493 . . . . 0.0 110.627 -176.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.1 t -136.62 126.03 25.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.601 -179.177 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.2 -20.74 25.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.586 -179.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.87 -29.0 22.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.288 179.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.585 ' HA2' ' OH ' ' A' ' 37' ' ' TYR . . . 104.4 73.19 0.91 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.764 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -142.98 128.24 10.04 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -177.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.742 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 21.3 Cg_endo -62.67 165.47 15.8 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.858 2.372 . . . . 0.0 112.231 177.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.19 156.61 83.19 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 124.011 -1.245 . . . . 0.0 113.248 3.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.867 ' HE2' HG13 ' A' ' 28' ' ' VAL . 34.3 m-85 -119.91 147.55 44.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.984 177.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.053 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 98.4 t -98.9 106.63 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -114.66 155.55 15.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.311 -163.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.739 ' HB2' HD12 ' A' ' 26' ' ' ILE . 23.9 ttt180 -128.86 115.76 18.38 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.048 -176.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.729 ' CB ' ' HB2' ' A' ' 44' ' ' ASN . 6.7 m95 -75.63 120.39 20.96 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.435 HD21 ' OE1' ' A' ' 24' ' ' GLU . 12.8 mt -88.42 -45.66 9.78 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.663 -176.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.654 HG21 ' O ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -90.75 -5.84 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.155 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.729 ' HB2' ' CB ' ' A' ' 41' ' ' TRP . 39.6 m-80 -96.06 -40.36 9.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 168.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.09 63.58 1.44 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.764 172.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.526 ' HB3' ' HD1' ' A' ' 41' ' ' TRP . 54.9 t60 -172.42 154.3 3.16 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.921 0.361 . . . . 0.0 110.42 176.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.609 ' HG2' ' HG3' ' A' ' 40' ' ' ARG . 38.6 mt-10 -113.33 145.91 40.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.104 178.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -172.11 176.83 3.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.47 0.652 . . . . 0.0 111.084 178.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.1 m -108.52 115.1 29.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.942 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.92 172.59 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.277 0.56 . . . . 0.0 111.68 -176.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.533 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 68.8 m-85 -119.89 100.09 48.75 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.515 177.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.742 ' HD2' ' HB3' ' A' ' 35' ' ' PRO . 37.4 Cg_endo -66.08 -39.83 17.54 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.678 2.252 . . . . 0.0 112.486 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.94 -159.57 13.72 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.905 -178.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.526 ' O ' HG13 ' A' ' 11' ' ' VAL . 18.3 m -94.5 169.18 10.38 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.029 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 12' ' ' LYS . 18.9 m-20 66.17 32.55 7.96 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.418 0.449 . . . . 0.0 110.765 178.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' A' ' 1' ' ' MET . . . -76.57 113.74 14.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.054 0.454 . . . . 0.0 111.008 -179.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 58' ' ' VAL . 13.9 t -99.21 162.33 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.742 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.402 ' N ' HG12 ' A' ' 57' ' ' VAL . 5.7 t -110.2 152.05 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.909 0.385 . . . . 0.0 111.235 -176.352 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.57 HG22 ' N ' ' A' ' 60' ' ' THR . 11.0 p -151.73 173.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.57 ' N ' HG22 ' A' ' 59' ' ' VAL . 47.8 p -90.2 169.39 11.18 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 175.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.726 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . . . -52.64 -64.55 0.78 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -172.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 p -75.18 -28.86 60.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -163.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -58.4 -62.6 1.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.103 0.478 . . . . 0.0 110.88 -176.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.505 ' HB2' HG11 ' A' ' 59' ' ' VAL . 3.2 m80 -81.95 -16.19 51.3 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.654 ' O ' HG21 ' A' ' 43' ' ' VAL . . . -43.36 -46.47 6.52 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -170.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -59.02 -48.69 80.69 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-O 123.37 1.557 . . . . 0.0 109.627 -179.167 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.65 -16.9 63.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.668 173.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.889 ' HA ' ' HB2' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -73.2 -40.88 64.39 Favored 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.679 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.55 ' HA ' ' ND2' ' A' ' 44' ' ' ASN . 46.4 tttp -53.62 -50.63 65.28 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -64.27 -66.12 0.59 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 122.129 0.966 . . . . 0.0 112.784 178.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.423 ' HB3' ' ND1' ' A' ' 22' ' ' HIS . . . -70.67 -16.9 62.84 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -169.433 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.636 ' HB1' ' CE3' ' A' ' 41' ' ' TRP . . . -81.73 -33.78 30.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 173.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.75 -33.05 60.69 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.604 168.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 -76.74 -57.02 4.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.624 172.17 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -50.26 -51.52 44.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.846 0.859 . . . . 0.0 112.526 -176.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -80.09 5.95 61.21 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.959 -175.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -93.1 -20.48 20.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.027 0.441 . . . . 0.0 110.184 178.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.26 -157.67 0.73 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.8 -176.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 51' ' ' TYR . . . -142.28 14.24 2.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.223 0.535 . . . . 0.0 110.119 177.192 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.251 1.179 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.943 -175.014 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.684 0.278 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -138.91 121.63 16.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' A' ' 58' ' ' VAL . . . -138.85 169.46 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.097 0.475 . . . . 0.0 112.062 -173.022 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 40.7 ttmt -139.3 166.13 25.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.412 -178.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG23 ' HA ' ' A' ' 26' ' ' ILE . 6.1 p -71.53 142.65 15.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 173.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.1 16.18 45.31 Favored Glycine 0 N--CA 1.454 -0.147 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -173.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 64.7 m-20 -138.77 -178.88 5.51 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 113.971 -1.114 . . . . 0.0 108.205 -174.125 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.737 ' CE2' ' HB2' ' A' ' 24' ' ' GLU . 87.3 m-85 -136.83 170.13 16.6 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.932 -169.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.736 HD11 ' HG3' ' A' ' 52' ' ' PRO . 8.0 tt -138.75 144.94 39.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.61 -166.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.907 ' HB ' ' HB ' ' A' ' 57' ' ' VAL . 87.2 t -138.87 172.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.718 HG13 ' HB2' ' A' ' 54' ' ' SER . 13.5 t -138.65 133.26 41.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.013 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 28.5 mtpp 69.14 166.42 0.27 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.546 0.688 . . . . 0.0 111.197 -175.744 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 17' ' ' GLU . . . 115.29 12.39 9.85 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.366 177.116 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -91.55 -40.61 11.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.715 0.293 . . . . 0.0 110.419 -177.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.5 p -95.36 56.44 1.85 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.064 0.459 . . . . 0.0 110.178 177.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p 50.58 52.07 15.61 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.542 -176.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.575 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 16.7 mt-10 -106.21 175.55 5.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.604 -177.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 -76.56 134.08 39.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.298 170.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.505 ' HB3' HG11 ' A' ' 10' ' ' VAL . 91.6 m-70 -83.9 100.22 10.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -113.99 179.51 3.94 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.067 -174.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.618 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 24.5 mt-30 43.72 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.767 0.827 . . . . 0.0 112.511 -173.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.986 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . 3.3 t-160 -138.78 129.1 25.72 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.54 0.686 . . . . 0.0 111.424 -169.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.772 ' HB2' ' HZ3' ' A' ' 41' ' ' TRP . . . -139.59 -178.29 5.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.968 -176.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.737 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 24.2 tt0 -136.76 125.93 24.62 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.629 1.204 . . . . 0.0 109.264 173.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.61 HG22 HG22 ' A' ' 28' ' ' VAL . 4.3 mt -82.67 107.48 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 112.557 -2.11 . . . . 0.0 109.815 -170.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.91 HG12 ' HD3' ' A' ' 40' ' ' ARG . 1.8 pp -106.82 -12.68 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.274 175.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 1.079 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -138.88 136.61 35.71 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.614 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 25' ' ' ILE . 11.2 t -138.36 107.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 -165.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.608 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 2.7 mmp_? -71.26 -19.14 62.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.779 0.324 . . . . 0.0 111.756 -176.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 60.5 m -152.3 115.46 4.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.05 13.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.831 -174.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -93.5 -11.84 31.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.172 0.511 . . . . 0.0 110.279 176.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.18 71.37 0.99 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.171 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.474 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 17.0 m -136.47 125.86 15.72 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 34' ' ' SER . 15.8 Cg_exo -68.7 153.53 73.06 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.974 2.449 . . . . 0.0 112.145 178.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.564 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 6.2 Cg_exo -80.29 -169.81 8.05 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 124.129 -1.196 . . . . 0.0 113.086 2.344 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -138.42 172.8 12.35 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.994 178.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.079 ' HB ' ' HB3' ' A' ' 27' ' ' GLU . 48.5 t -137.84 116.8 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.077 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 40' ' ' ARG . 0.4 OUTLIER -138.91 176.57 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.964 -149.557 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 1.041 ' HG2' ' HG2' ' A' ' 47' ' ' GLU . 12.4 mtp180 -138.82 138.18 37.3 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.772 ' HZ3' ' HB2' ' A' ' 23' ' ' ALA . 11.8 m95 -86.27 82.5 7.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 168.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 24' ' ' GLU . 5.4 mt -59.89 -69.65 0.2 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.114 0.483 . . . . 0.0 111.985 -166.363 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.727 HG11 ' HA ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -60.2 -34.09 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.089 -175.704 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.456 ' ND2' ' HB3' ' A' ' 72' ' ' ALA . 42.6 m-80 -60.43 -45.68 92.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.287 172.543 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.7 39.75 1.99 Allowed Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.851 179.184 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.485 ' HB2' ' HD1' ' A' ' 41' ' ' TRP . 63.7 m80 -139.23 172.92 12.12 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.324 -0.515 . . . . 0.0 111.893 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 1.041 ' HG2' ' HG2' ' A' ' 40' ' ' ARG . 45.0 mt-10 -138.58 128.26 24.93 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.35 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.34 179.93 6.25 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.129 0.966 . . . . 0.0 113.599 -160.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 75.6 m -138.78 125.3 20.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 167.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 51' ' ' TYR . 8.0 p -138.87 165.21 24.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.415 -162.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.564 ' CD2' ' HB3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -138.72 99.86 8.35 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.254 178.187 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.736 ' HG3' HD11 ' A' ' 9' ' ' LEU . 55.3 Cg_endo -70.67 114.16 3.76 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.758 2.305 . . . . 0.0 111.632 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.08 81.98 1.14 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.419 178.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.718 ' HB2' HG13 ' A' ' 11' ' ' VAL . 43.7 t 177.79 -179.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -71.72 -15.08 62.19 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 80.92 162.07 0.16 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.564 172.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.907 ' HB ' ' HB ' ' A' ' 10' ' ' VAL . 21.6 t -138.95 170.16 16.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.094 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 38.5 t -138.47 128.02 32.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -138.94 176.77 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.853 -174.331 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 p -120.08 -166.68 1.33 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.345 -176.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.0 79.36 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.457 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.39 -55.86 29.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.396 0.544 . . . . 0.0 111.813 -175.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.473 ' HG3' HG12 ' A' ' 59' ' ' VAL . 1.6 mm-40 -56.81 -31.39 64.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.635 -176.392 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.707 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -57.38 -40.8 78.94 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.766 -176.467 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.727 ' HA ' HG11 ' A' ' 43' ' ' VAL . . . -57.53 -77.08 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.052 0.93 . . . . 0.0 111.294 -170.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -57.66 -60.33 3.84 Favored 'General case' 0 C--O 1.267 1.998 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.173 -178.749 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 63' ' ' GLU . . . -56.92 -56.44 21.64 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.853 -174.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.986 ' HA ' ' HB3' ' A' ' 22' ' ' HIS . 35.6 tt0 -57.27 -34.35 68.56 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -175.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 29.8 mtpp -57.1 -65.9 0.54 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.459 175.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -57.35 -53.79 54.13 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-O 123.544 1.64 . . . . 0.0 111.049 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.587 ' HB1' ' N ' ' A' ' 21' ' ' GLN . . . -57.21 -45.47 83.78 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 112.627 -2.079 . . . . 0.0 113.105 -173.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.456 ' HB3' ' ND2' ' A' ' 44' ' ' ASN . . . -68.43 -33.31 73.99 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.806 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . -53.87 -37.3 63.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 123.483 0.489 . . . . 0.0 110.22 174.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.8 mtp-105 -81.6 -47.0 13.6 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 173.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 21' ' ' GLN . . . -48.25 -51.61 24.84 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.237 0.615 . . . . 0.0 111.633 -177.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.84 35.34 4.11 Favored Glycine 0 N--CA 1.454 -0.125 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.943 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 55.8 t-80 -128.59 -47.3 1.28 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.096 0.474 . . . . 0.0 109.884 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.01 -4.24 58.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.168 -179.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.52 129.75 38.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.02 -178.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--O 1.247 0.949 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.71 176.418 . . . . . . . . 0 0 . 1 stop_ save_